concept_id	concept_synonym_name	language_concept_id
35622853	Prostaglandin analogue-containing product	4180186
35622854	Product containing precisely chloral hydrate 325 milligram/1 each conventional release rectal suppository (clinical drug)	4180186
35622857	Arteriography of left coronary artery bypass graft	4180186
35622857	Angiogram of left coronary artery bypass graft	4180186
35622857	Angiography of left coronary artery bypass graft (procedure)	4180186
35622859	Arteriography of intracranial artery	4180186
35622859	Angiography of intracranial artery (procedure)	4180186
35622859	Angiogram of intracranial artery	4180186
35622860	Product containing precisely glyceryl trinitrate 2 milligram/1 each conventional release buccal tablet (clinical drug)	4180186
35622860	Glyceryl trinitrate 2 mg buccal tablet	4180186
35622863	Product containing precisely ascorbic acid 250 milligram/1 each conventional release chewable tablet (clinical drug)	4180186
35622865	Anthralin 0.4% cutaneous cream (product)	4180186
35622867	Benzoyl peroxide 8% cutaneous cream (product)	4180186
35622870	Systemic monochloroacetic acid poisoning	4180186
35622870	Poisoning caused by monochloroacetic acid (disorder)	4180186
35622871	Spinocerebellar ataxia with axonal neuropathy type 1 (disorder)	4180186
35622875	Pantoea intestinalis (organism)	4180186
35622876	Genus Franconibacter (organism)	4180186
35622876	Franconibacter species	4180186
35622876	Genus Franconibacter	4180186
35622877	CYP2D6 extensive metaboliser	4180186
35622877	Cytochrome P450 family 2 subfamily D member 6 extensive metaboliser	4180186
35622877	Cytochrome P450 family 2 subfamily D member 6 extensive metabolizer	4180186
35622877	Cytochrome P450 family 2 subfamily D member 6 extensive metabolizer (finding)	4180186
35622878	Monitoring of elderly person	4180186
35622878	Monitoring of elderly person (regime/therapy)	4180186
35622881	Late-onset neonatal sepsis (disorder)	4180186
35622886	Sexual arousal by exposure of genitals to non-consenting prepubertal person (disorder)	4180186
35622892	Product containing tesamorelin (medicinal product)	4180186
35622893	Product containing tesamorelin in parenteral dose form (medicinal product form)	4180186
35622894	Product containing glycopeptide (product)	4180186
35622895	Product containing bile acid (product)	4180186
35622896	Product containing lithium in cutaneous dose form (medicinal product form)	4180186
35622901	Venography of left renal vein (procedure)	4180186
35622901	Venogram of left renal vein	4180186
35622902	Venography of right renal vein (procedure)	4180186
35622902	Venogram of right renal vein	4180186
35622903	Primary essential cutis verticis gyrata (disorder)	4180186
35622905	Methylmalonic acidaemia due to methylmalonyl-CoA epimerase deficiency	4180186
35622905	Methylmalonic acidaemia due to methylmalonyl-coenzyme A epimerase deficiency	4180186
35622905	Methylmalonic acidemia due to methylmalonyl-CoA racemase deficiency	4180186
35622905	Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency	4180186
35622905	Methylmalonic acidemia due to methylmalonyl-coenzyme A epimerase deficiency (disorder)	4180186
35622905	Methylmalonic acidaemia due to methylmalonyl-CoA racemase deficiency	4180186
35622906	Birth defect due to maternal hyperthermia (disorder)	4180186
35622906	Birth defect due to maternal hyperthermia	4180186
35622909	Proximal 16p11.2 microduplication syndrome (disorder)	4180186
35622909	Proximal trisomy 16p11.2	4180186
35622910	Sporadic phaeochromocytoma and secreting paraganglioma	4180186
35622910	Sporadic pheochromocytoma and secreting paraganglioma (disorder)	4180186
35622911	Dipropylene glycol salicylate (substance)	4180186
35622912	Assessment using Diabetes Treatment Satisfaction Questionnaire status version (procedure)	4180186
35622912	Assessment using Diabetes Treatment Satisfaction Questionnaire status version	4180186
35622917	Chronic serous otitis media of right ear (disorder)	4180186
35622918	Hypertrophy of right kidney co-occurrent and due to congenital hypoplasia of left kidney (disorder)	4180186
35622921	Small right kidney (finding)	4180186
35622925	Ocular or otic dose form (dose form)	4180186
35622928	Telephone scatologia (disorder)	4180186
35622928	Telephonicophilia	4180186
35622928	Makes obscene phone calls	4180186
35622930	Distal 18q deletion syndrome	4180186
35622930	Distal chromosome 18q deletion syndrome (disorder)	4180186
35622930	Distal monosomy 18q	4180186
35622932	Doppler ultrasonography of blood vessel (procedure)	4180186
35622932	Doppler ultrasound scan of blood vessel	4180186
35622932	Doppler ultrasound of blood vessel	4180186
35622933	Organic acid and/or organic acid derivative	4180186
35622933	Organic acid and/or organic acid derivative (substance)	4180186
35622933	Organic acid and organic acid derivative (substance)	4180186
35622933	Organic acid and derivatives	4180186
35622936	Total deafblindness	4180186
35622936	Total visual and total hearing impairment (disorder)	4180186
35622936	Completely deaf and blind	4180186
35622936	Deaf-blind	4180186
35622938	Thrombosis caused by left ventricular assist device	4180186
35622938	Thrombosis caused by left ventricular assist device (disorder)	4180186
35622938	Thrombosis of left ventricular assist device	4180186
35622942	Stiff skin syndrome (disorder)	4180186
35622949	Familial generalised lentiginosis	4180186
35622949	Familial multiple lentigines syndrome without systemic involvement	4180186
35622949	Familial generalized lentiginosis (disorder)	4180186
35622949	Familial lentigines profusa	4180186
35622952	Genus Medicopsis (organism)	4180186
35622952	Genus Medicopsis	4180186
35622954	Extension Namespace {1000216} (namespace concept)	4180186
35622954	Extension Namespace {1000216}	4180186
35622955	Familial multiple benign meningioma (disorder)	4180186
35622960	Disorder in partial remission (disorder)	4180186
35622962	Disorder in spontaneous remission (disorder)	4180186
35622964	Fomitopsis palustris (organism)	4180186
35622964	Polyporus paluster	4180186
35622964	Tyromyces palustris	4180186
35622964	Postia palustris	4180186
35622964	Pilatoporus palustris	4180186
35622964	Polyporus palustris	4180186
35622964	Trametes palustris	4180186
35622966	Disorder in spontaneous partial remission (disorder)	4180186
35622967	Genus Flavodon (organism)	4180186
35622967	Genus Flavodon	4180186
35622970	Disorder in partial remission in response to treatment (disorder)	4180186
35622971	Disorder in spontaneous complete remission	4180186
35622971	Disorder in spontaneous full remission (disorder)	4180186
35622974	Papular xanthoma (disorder)	4180186
35622976	Diplodia seriata (organism)	4180186
35622977	Leptographium species	4180186
35622977	Genus Leptographium (organism)	4180186
35622977	Genus Leptographium	4180186
35622980	Xylodon lacteus	4180186
35622980	Sistotrema lacteum	4180186
35622980	Trametes lactea	4180186
35622980	Irpex lacteus (organism)	4180186
35622980	Hydnum lacteum	4180186
35622980	Hirschioporus lacteus	4180186
35622980	Coriolus lacteus	4180186
35622980	Irpiciporus lacteus	4180186
35622980	Steccherinum lacteum	4180186
35622981	Eutypella vitis (organism)	4180186
35622982	Family Niessliaceae	4180186
35622982	Family Niessliaceae (organism)	4180186
35622984	Eucasphaeria capensis (organism)	4180186
35622986	Hyphodermella rosae (organism)	4180186
35622986	Odontia rosae	4180186
35622987	Echinodontium taxodii	4180186
35622987	Stereum taxodii	4180186
35622987	Laurilia taxodii (organism)	4180186
35622990	Genus Laurilia	4180186
35622990	Genus Laurilia (organism)	4180186
35622991	Debaryomyces nepalensis (organism)	4180186
35622992	Amoebicide	4180186
35622992	Amebicide (disposition)	4180186
35622993	Bartalinia pondoensis (organism)	4180186
35622996	Genus Bartalinia	4180186
35622996	Genus Bartalinia (organism)	4180186
35622998	Gelatoporia dichroa	4180186
35622998	Caloporus dichrous	4180186
35622998	Polyporus dichrous	4180186
35622998	Polystictus dichrous	4180186
35622998	Boletus pelleporus	4180186
35622998	Gloeoporus dichrous (organism)	4180186
35622998	Boletus pelloporus	4180186
35622998	Polyporus adustus variant pelleporus	4180186
35622998	Leptoporus dichrous	4180186
35622998	Boletus dichrous	4180186
35622998	Bjerkandera dichroa	4180186
35622999	Hamigera insecticola (organism)	4180186
35623001	Genus Hypoxylon	4180186
35623001	Hypoxylon species	4180186
35623001	Genus Hypoxylon (organism)	4180186
35623003	Radionuclide imaging of liver and/or biliary tract using tauroselcholic acid (75-Se) (procedure)	4180186
35623005	Dynamic radionuclide imaging of liver using radioisotope (procedure)	4180186
35623007	Radionuclide imaging of liver using rose bengal (131-I) sodium (procedure)	4180186
35623009	Dynamic radionuclide imaging of liver using technetium (99m-Tc) (procedure)	4180186
35623011	Male infertility with oligospermia due to single gene mutation	4180186
35623011	Male infertility with oligozoospermia due to single gene mutation (disorder)	4180186
35623017	Technetium (99m-Tc) human serum albumin (substance)	4180186
35623018	Radionuclide imaging using technetium (99m-Tc) human serum albumin with cerebral blood flow (procedure)	4180186
35623020	Radionuclide imaging using technetium (99m-Tc) exametazime with cerebral blood flow (procedure)	4180186
35623021	Hyphodontia palmae	4180186
35623021	Kneiffiella palmae (organism)	4180186
35623024	Hymenochaete spreta	4180186
35623024	Hymenochaete cinnamomea subspecies spreta (organism)	4180186
35623024	Hymenochaete cinnamomea subsp. spreta	4180186
35623030	Static radionuclide imaging of spleen using technetium (99m-Tc) (procedure)	4180186
35623031	Dynamic radionuclide imaging of spleen using technetium (99m-Tc) (procedure)	4180186
35623032	Hyalodendron species	4180186
35623032	Genus Hyalodendron (organism)	4180186
35623032	Genus Hyalodendron	4180186
35623033	Static radionuclide imaging of liver and spleen using technetium (99m-Tc) (procedure)	4180186
35623034	Technetium (99m-Tc) sucralfate (substance)	4180186
35623035	Radionuclide imaging of esophagus using technetium (99m-Tc) sucralfate (procedure)	4180186
35623035	Radionuclide imaging of oesophagus using technetium (99m-Tc) sucralfate	4180186
35623036	Technetium (99m-Tc) pentavalent succimer (substance)	4180186
35623037	Radionuclide imaging of kidney using technetium (99m-Tc) pentavalent succimer for renal neoplasm (procedure)	4180186
35623038	Radionuclide imaging of haematopoietic system using iron radioisotope	4180186
35623038	Radionuclide imaging of hematopoietic system using iron radioisotope (procedure)	4180186
35623040	Beta-3 adrenergic receptor agonist (disposition)	4180186
35623045	Manidipine (substance)	4180186
35623048	Congenital sideroblastic anemia, B-cell immunodeficiency, periodic fever, developmental delay syndrome (disorder)	4180186
35623048	Congenital sideroblastic anaemia, B-cell immunodeficiency, periodic fever, developmental delay syndrome	4180186
35623049	Classic mycosis fungoides (disorder)	4180186
35623049	Mycosis fungoides Alibert Bazin type	4180186
35623050	Carbamoyl-phosphate synthetase 1 deficiency (disorder)	4180186
35623050	Carbamoyl-phosphate synthetase I deficiency	4180186
35623050	CPS1 (carbamoyl-phosphate synthetase 1) deficiency	4180186
35623051	ADPKD - autosomal dominant polycystic kidney disease	4180186
35623051	Autosomal dominant polycystic kidney disease (disorder)	4180186
35623052	Tuberous sclerosis, polycystic kidney disease contiguous gene syndrome	4180186
35623052	Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis (disorder)	4180186
35623053	Oxeladin citrate (substance)	4180186
35623054	Dual isotope single photon emission computed tomography of parathyroid using technetium-99m and thallium-201 (procedure)	4180186
35623054	Dual isotope SPECT of parathyroid using technetium (99m-Tc) and thallium-20	4180186
35623055	Technetium (99m-Tc) exametazime labeled leukocytes (substance)	4180186
35623055	Technetium (99m-Tc) exametazime labelled leukocytes	4180186
35623063	Ferrous oxalate dihydrate (substance)	4180186
35623063	Iron oxalate hydrate	4180186
35623064	Pamidronate monosodium (substance)	4180186
35623065	Indium (111-In) labelled octreotide	4180186
35623065	Indium (111-In) labeled octreotide (substance)	4180186
35623067	SPECT using technetium (99m-Tc) sulesomab	4180186
35623067	Single photon emission computed tomography using technetium (99m-Tc) sulesomab (procedure)	4180186
35623070	Sodium perchlorate monohydrate (substance)	4180186
35623073	Ioxitalamate sodium (substance)	4180186
35623073	Sodium ioxithalamate	4180186
35623074	Nimotuzumab (substance)	4180186
35623080	Metesculetol (substance)	4180186
35623081	Conventional release emulsion for infusion (dose form)	4180186
35623081	Conventional release emulsion for infusion	4180186
35623082	Product containing antileishmanial (product)	4180186
35623083	History of primary malignant neoplasm of skin (situation)	4180186
35623084	Class Fibrobacteria (organism)	4180186
35623085	Class Lentisphaeria (organism)	4180186
35623086	Ioxitalamate (substance)	4180186
35623087	Isavuconazole (substance)	4180186
35623093	Codeine hydrochloride anhydrous (substance)	4180186
35623095	Cobaltous gluconate (substance)	4180186
35623096	Sexual relationship problem due to sexual orientation confusion (finding)	4180186
35623097	Mitochondrial deoxyribonucleic acid depletion syndrome encephalomyopathic form	4180186
35623097	Mitochondrial deoxyribonucleic acid depletion syndrome encephalomyopathic form (disorder)	4180186
35623099	Dyella jiangningensis (organism)	4180186
35623100	Dyella ginsengisoli (organism)	4180186
35623101	Dyella humi (organism)	4180186
35623102	Dyella japonica (organism)	4180186
35623103	Dyella jejuensis (organism)	4180186
35623106	Ring chromosome 7 syndrome (disorder)	4180186
35623106	Ring chromosome 7	4180186
35623107	Dyella lipolytica (organism)	4180186
35623112	Dyella yeojuensis	4180186
35623112	Luteibacter yeojuensis (organism)	4180186
35623113	Product containing technetium radioisotope (product)	4180186
35623115	Product containing quaternary ammonium compound (product)	4180186
35623116	Product containing thallium radioisotope (product)	4180186
35623117	Product containing beta-lactam (product)	4180186
35623119	Product containing oil (product)	4180186
35623120	Product containing androstane (product)	4180186
35623121	Product containing samarium radioisotope (product)	4180186
35623126	Product containing gallium radioisotope (product)	4180186
35623127	Product containing fluorine radioisotope (product)	4180186
35623128	Human immunodeficiency virus type I enhancer binding protein 2 related intellectual disability	4180186
35623128	Human immunodeficiency virus type I enhancer binding protein 2 related intellectual disability (disorder)	4180186
35623128	HIVEP2 (human immunodeficiency virus type I enhancer binding protein 2) related intellectual disability	4180186
35623129	OTULIN (OTU deubiquitinase with linear linkage specificity) related autoinflammatory syndrome	4180186
35623129	Otulipenia	4180186
35623129	OTU deubiquitinase with linear linkage specificity related autoinflammatory syndrome (disorder)	4180186
35623129	OTU deubiquitinase with linear linkage specificity related autoinflammatory syndrome	4180186
35623129	Infantile-onset periodic fever, panniculitis, dermatosis syndrome	4180186
35623130	Abusive behavior towards people (finding)	4180186
35623130	Abuses other people	4180186
35623130	Victimises other people	4180186
35623130	Abusive behaviour towards people	4180186
35623130	Victimizes other people	4180186
35623132	Bismuth citrate (substance)	4180186
35623133	Radionuclide imaging of whole body using gallium-67 for localization of inflammation (procedure)	4180186
35623133	Radionuclide imaging of whole body using gallium-67 for localisation of inflammation	4180186
35623135	Substance with oxyquinoline structure (substance)	4180186
35623135	Substance with hydroxyquinoline structure	4180186
35623138	Hysterectomy and right salpingo-oophorectomy sample (specimen)	4180186
35623138	Excised uterus and right fallopian tube and ovary sample	4180186
35623138	Hysterectomy and right salpingo-oophorectomy specimen (specimen)	4180186
35623138	Hysterectomy and right salpingo-oophorectomy specimen	4180186
35623139	X-linked intellectual disability, hypogonadism, ichthyosis, obesity, short stature syndrome (disorder)	4180186
35623139	Young Hughes syndrome	4180186
35623140	Left nephrectomy	4180186
35623140	Excision of left kidney (procedure)	4180186
35623142	Percutaneous cryotherapy of neoplasm of left kidney (procedure)	4180186
35623143	Percutaneous cryotherapy of neoplasm of right kidney (procedure)	4180186
35623144	Computed tomography of left kidney	4180186
35623144	Computed tomography of left kidney (procedure)	4180186
35623145	Computed tomography of right kidney (procedure)	4180186
35623145	Computed tomography of right kidney	4180186
35623147	Allotransplantation of right kidney (procedure)	4180186
35623148	Vomiting co-occurrent and due to infectious disease (disorder)	4180186
35623149	Xanthoma of bone (disorder)	4180186
35623149	Xanthoma of bone	4180186
35623151	Ring chromosome 19 syndrome (disorder)	4180186
35623151	Ring chromosome 19	4180186
35623154	Ring chromosome 5	4180186
35623154	Ring chromosome 5 syndrome (disorder)	4180186
35623157	Non-drug prescription record (record artifact)	4180186
35623158	Product containing precisely diltiazem hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623160	Product containing precisely methylphenidate hydrochloride 18 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623162	Product containing precisely theophylline 400 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623163	Ferrous sulfate+folic acid 160mg/400micrograms prolonged-release oral tablet (product)	4180186
35623165	Product containing precisely dihydrocodeine tartrate 90 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623166	Etodolac 500mg prolonged-release oral tablet (product)	4180186
35623167	Procainamide hydrochloride 750mg prolonged-release oral tablet (product)	4180186
35623168	Product containing precisely felodipine 10 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623170	Product containing precisely metformin hydrochloride 500 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623173	Product containing precisely nifedipine 60 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623177	Product containing precisely omeprazole (as omeprazole magnesium) 10 milligram/1 each gastro-resistant oral tablet (clinical drug)	4180186
35623181	Product containing precisely omeprazole (as omeprazole magnesium) 40 milligram/1 each gastro-resistant oral tablet (clinical drug)	4180186
35623182	Nifedipine 90mg prolonged-release oral tablet (product)	4180186
35623186	Product containing precisely fluvastatin (as fluvastatin sodium) 80 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623189	Product containing precisely fesoterodine fumarate 4 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623191	Product containing precisely metoprolol tartrate 200 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623193	Glipizide 5mg prolonged-release oral tablet (product)	4180186
35623195	Product containing precisely hydrochlorothiazide 25 milligram and metoprolol tartrate 200 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623199	Product containing precisely oxycodone hydrochloride 15 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623200	Tacrolimus 1mg prolonged-release oral tablet (product)	4180186
35623201	Product containing precisely etodolac 600 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623203	Isosorbide mononitrate 120mg prolonged-release oral tablet (product)	4180186
35623205	Trandolapril+verapamil hydrochloride 4mg/240mg prolonged-release oral tablet (product)	4180186
35623206	Lovastatin 10mg prolonged-release oral tablet (product)	4180186
35623209	Product containing precisely dihydrocodeine tartrate 120 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623212	Loratadine+pseudoephedrine sulfate 5mg/120mg prolonged-release oral tablet (product)	4180186
35623213	Product containing precisely metformin hydrochloride 1 gram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623217	Guaifenesin 600mg extended release/pseudoephedrine 60mg tablet	4180186
35623217	Guaifenesin 600mg /pseudoephedrine 60mg prolonged-release oral tablet (product)	4180186
35623218	Product containing precisely fesoterodine fumarate 8 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623219	Product containing precisely lithium carbonate 200 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623224	Product containing precisely oxprenolol hydrochloride 160 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623225	Fenofibrate micronized 67mg gastro-resistant oral tablet (product)	4180186
35623226	Lithium carbonate 300mg prolonged-release oral tablet (product)	4180186
35623227	Oxymorphone 5mg prolonged-release oral tablet (product)	4180186
35623228	Product containing precisely tramadol hydrochloride 300 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623229	Tacrolimus 750microgram prolonged-release orale tablet (product)	4180186
35623231	Product containing precisely oxycodone hydrochloride 80 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623233	Product containing precisely carbamazepine 400 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623236	Brompheniramine maleate + pseudoephedrine hydrochloride 16mg/240mg prolonged-release oral tablet (product)	4180186
35623244	Pioglitazone 30mg + metformin 1g prolonged-release oral tablet (product)	4180186
35623247	Product containing precisely isosorbide dinitrate 40 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623252	Product containing precisely felodipine 5 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623258	Product containing precisely clarithromycin 1 gram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623259	Carbamazepine 100mg prolonged-release oral tablet (product)	4180186
35623263	Reflux nephropathy of left kidney due to vesicoureteral reflux (disorder)	4180186
35623264	Product containing precisely oxycodone hydrochloride 5 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623268	Product containing precisely sodium chloride 600 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623269	Azatadine maleate+pseudoephedrine sulfate 1mg/120mg prolonged-release oral tablet (product)	4180186
35623271	Product containing precisely methylphenidate hydrochloride 36 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623272	Product containing precisely aminophylline 225 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623276	Product containing precisely lithium carbonate 400 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623277	Oxymorphone 20mg prolonged-release oral tablet (product)	4180186
35623278	Enalapril maleate 5mg/felodipine 5mg prolonged-release oral tablet (product)	4180186
35623280	Product containing precisely oxycodone hydrochloride 40 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623282	Product containing precisely isosorbide mononitrate 40 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623287	Theophylline anhydrous 300mg prolonged-release oral tablet (product)	4180186
35623288	Product containing precisely salbutamol (as salbutamol sulfate) 8 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623288	Salbutamol (as salbutamol sulfate) 8 mg prolonged-release oral tablet	4180186
35623289	Stratton Garcia Young syndrome	4180186
35623289	Brachydactyly, mesomelia, intellectual disability, heart defect syndrome (disorder)	4180186
35623292	Lovastatin 20mg prolonged-release oral tablet (product)	4180186
35623296	Pseudoephedrine 240mg prolonged-release oral tablet (product)	4180186
35623298	Zolpidem 12.5mg prolonged-release oral tablet (product)	4180186
35623305	Product containing precisely morphine sulfate 15 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623309	Product containing precisely oxycodone hydrochloride 60 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623312	Mesalazine 500 mg prolonged-release oral tablet	4180186
35623312	Product containing precisely mesalazine 500 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623313	Fexofenadine hydrochloride+pseudoephedrine hydrochloride 60mg/120 mg prolonged-release oral tablet (product)	4180186
35623314	Product containing precisely isosorbide mononitrate 60 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623315	Product containing precisely axitinib 5 milligram/1 each conventional release oral tablet (clinical drug)	4180186
35623316	Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623318	Diltiazem 180mg prolonged-release oral tablet (product)	4180186
35623319	Diltiazem 300mg prolonged-release oral tablet (product)	4180186
35623320	Product containing precisely guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623323	Fenofibrate 200mg gastro-resistant oral tablet (product)	4180186
35623324	Salbutamol (as salbutamol sulfate) 4 mg prolonged-release oral tablet	4180186
35623324	Product containing precisely salbutamol (as salbutamol sulfate) 4 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623327	Product containing precisely bumetanide 500 microgram and potassium chloride 573 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623333	Product containing precisely theophylline 175 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623335	Carbinoxamine maleate+pseudoephedrine hydrochloride 8mg/120mg prolonged-release oral tablet (product)	4180186
35623340	Product containing precisely aspirin 650 milligram/1 each gastro-resistant oral tablet (clinical drug)	4180186
35623342	Zolpidem 6.25mg prolonged-release oral tablet (product)	4180186
35623348	Sodium valproate 100mg conventional release oral tablet (product)	4180186
35623350	Product containing precisely nifedipine 30 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623351	Naproxen sodium 375mg gastro-resistant oral tablet (product)	4180186
35623352	Orphenadrine citrate 100mg prolonged-release oral tablet (product)	4180186
35623355	Fexofenadine hydrochloride 180mg prolonged-release oral tablet (product)	4180186
35623360	Etodolac 400mg prolonged-release oral tablet (product)	4180186
35623361	Product containing precisely omeprazole (as omeprazole magnesium) 20 milligram/1 each gastro-resistant oral tablet (clinical drug)	4180186
35623366	Product containing precisely metformin hydrochloride 750 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623367	Product containing precisely lithium carbonate 450 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623368	Mesalamine 400mg gastro-resistant oral tablet (product)	4180186
35623370	Product containing precisely isosorbide mononitrate 50 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623372	Product containing precisely isosorbide dinitrate 20 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623374	Product containing precisely verapamil hydrochloride 240 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623375	Product containing precisely diltiazem hydrochloride 90 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623377	Product containing precisely theophylline 300 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623378	Theophylline, anhydrous 600mg prolonged-release oral tablet (product)	4180186
35623380	Methamphetamine hydrochloride 10mg prolonged-release oral tablet (product)	4180186
35623382	Frusemide+potassium 20mg/10Mmol prolonged-release oral tablet (product)	4180186
35623383	Divalproex sodium 500mg prolonged-release oral tablet (product)	4180186
35623386	Aminophylline 100mg prolonged-release oral tablet (product)	4180186
35623388	Product containing precisely theophylline 250 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623390	Product containing precisely tramadol hydrochloride 100 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623392	Cefaclor 500mg prolonged-release oral tablet (product)	4180186
35623393	Product containing precisely nifedipine 10 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623394	Product containing precisely cyclopenthiazide 250 microgram and oxprenolol hydrochloride 160 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623396	Product containing precisely mizolastine 10 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623397	Diethylpropion hydrochloride 75mg prolonged-release oral tablet (product)	4180186
35623398	Product containing precisely morphine sulfate 60 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623399	Diltiazem 240mg prolonged-release oral tablet (product)	4180186
35623400	Guaifenesin 600mg /dextromethorphan 30mg prolonged-release oral tablet (product)	4180186
35623400	Guaifenesin 600mg extended release/dextromethorphan 30mg tablet	4180186
35623401	Adenosarcoma of corpus uteri (disorder)	4180186
35623405	Autosomal dominant intermediate Charcot-Marie-Tooth disease type C (disorder)	4180186
35623406	Autosomal dominant intermediate Charcot-Marie-Tooth disease type D (disorder)	4180186
35623409	Anti-IgLON5 disease	4180186
35623409	Autoimmune encephalopathy with parasomnia and obstructive sleep apnea (disorder)	4180186
35623409	Autoimmune encephalopathy with parasomnia and obstructive sleep apnoea	4180186
35623409	Anti-IgLON5 syndrome	4180186
35623411	Russell Weaver Bull syndrome	4180186
35623411	Axial mesodermal dysplasia spectrum (disorder)	4180186
35623411	Blastogenesis defect	4180186
35623417	Fluciclatide (substance)	4180186
35623425	Product containing activated charcoal in oral dose form (medicinal product form)	4180186
35623426	Modified Ashworth Scale (assessment scale)	4180186
35623428	Atrophy of left kidney (disorder)	4180186
35623430	Dysplasia of left kidney (disorder)	4180186
35623432	Congenital left vesicoureterorenal reflux (disorder)	4180186
35623433	Congenital right vesicoureterorenal reflux (disorder)	4180186
35623434	Infection of skin of eyelid caused by Molluscum contagiosum (disorder)	4180186
35623434	Infection of skin of eyelid caused by Molluscum contagiosum	4180186
35623435	Infection of skin caused by Molluscum contagiosum (disorder)	4180186
35623435	Infection of skin caused by Molluscum contagiosum	4180186
35623437	Product containing precisely morphine sulfate 90 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623438	Product containing precisely hydromorphone hydrochloride 24 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623442	Pseudoephedrine hydrochloride 120mg prolonged-release oral capsule (product)	4180186
35623444	Propranolol hydrochloride 120mg prolonged-release oral capsule (product)	4180186
35623445	Product containing precisely trifluoperazine (as trifluoperazine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623446	Congenital absence of brachiocephalic vein	4180186
35623446	Congenital absence of innominate vein (disorder)	4180186
35623451	Product containing precisely droxidopa 200 milligram/1 each conventional release oral capsule (clinical drug)	4180186
35623457	Product containing precisely theophylline 300 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623459	Product containing precisely dipyridamole 200 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623460	Product containing precisely topiramate 25 milligram/1 each conventional release oral capsule (clinical drug)	4180186
35623461	Product containing precisely theophylline 60 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623462	Theophylline 100mg prolonged-release oral capsule (product)	4180186
35623464	Product containing precisely phenytoin sodium 100 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623471	Propafenone hydrochloride 425mg prolonged-release oral capsule (product)	4180186
35623473	Product containing precisely nifedipine 20 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623475	Minocycline 135mg prolonged-release oral capsule (product)	4180186
35623480	Product containing precisely salbutamol (as salbutamol sulfate) 4 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623480	Salbutamol (as salbutamol sulfate) 4 mg prolonged-release oral capsule	4180186
35623482	Product containing precisely methylphenidate hydrochloride 20 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623485	Product containing precisely morphine sulfate 150 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623487	Product containing precisely tramadol hydrochloride 50 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623488	Product containing precisely fenofibric acid 135 milligram/1 each gastro-resistant oral capsule (clinical drug)	4180186
35623489	Carbamazepine 100mg prolonged-release oral capsule (product)	4180186
35623491	Chlorpromazine hydrochloride 150mg prolonged-release oral capsule (product)	4180186
35623493	Product containing precisely morphine sulfate 20 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623494	Fluoromethane (substance)	4180186
35623498	Product containing precisely omeprazole 40 milligram/1 each gastro-resistant oral capsule (clinical drug)	4180186
35623500	Product containing precisely diltiazem hydrochloride 200 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623503	Product containing precisely venlafaxine (as venlafaxine hydrochloride) 150 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623507	Esomeprazole magnesium 40mg gastro-resistant oral capsule (product)	4180186
35623511	Product containing precisely tamsulosin hydrochloride 400 microgram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623513	Phendimetrazine tartrate 105mg prolonged-release oral capsule (product)	4180186
35623514	Product containing precisely clonidine hydrochloride 250 microgram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623517	Product containing precisely hydromorphone hydrochloride 4 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623522	Mesalamine 375mg prolonged-release oral capsule (product)	4180186
35623523	Product containing precisely ketoprofen 200 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623525	Disopyramide phosphate 100mg prolonged-release oral capsule (product)	4180186
35623527	Product containing precisely mebeverine hydrochloride 200 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623530	Product containing precisely venlafaxine (as venlafaxine hydrochloride) 75 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623533	Morphine sulfate 80mg + naltrexone hydrochloride 3.2mg prolonged-release oral capsule (product)	4180186
35623535	Product containing precisely theophylline 250 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623536	Product containing precisely verapamil hydrochloride 240 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623537	Product containing precisely diltiazem hydrochloride 240 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623539	Amphetamine/dextroamphetamine 20mg prolonged-release oral capsule (product)	4180186
35623540	Product containing precisely nifedipine 10 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623542	Product containing precisely ketoprofen 150 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623543	Product containing precisely morphine sulfate 10 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623545	Galantamine 8mg prolonged-release oral capsule (product)	4180186
35623548	Product containing precisely acetazolamide 250 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623549	Product containing precisely verapamil hydrochloride 120 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623550	Disopyramide phosphate 150mg prolonged-release oral capsule (product)	4180186
35623551	Product containing precisely budesonide 3 milligram/1 each gastro-resistant oral capsule (clinical drug)	4180186
35623552	Minocycline 45mg prolonged-release oral capsule (product)	4180186
35623553	Product containing precisely droxidopa 300 milligram/1 each conventional release oral capsule (clinical drug)	4180186
35623559	Product containing precisely diltiazem hydrochloride 300 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623561	Product containing precisely isosorbide mononitrate 40 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623566	Acetazolamide 500mg prolonged-release oral capsule (product)	4180186
35623567	Hydromorphone hydrochloride 12mg prolonged-release oral capsule (product)	4180186
35623569	Galantamine 24mg prolonged-release oral capsule (product)	4180186
35623571	Product containing precisely morphine sulfate 100 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623572	Product containing precisely topiramate 15 milligram/1 each conventional release oral capsule (clinical drug)	4180186
35623574	Product containing precisely salbutamol (as salbutamol sulfate) 8 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623574	Salbutamol (as salbutamol sulfate) 8 mg prolonged-release oral capsule	4180186
35623577	Fluorodeoxyglucose (substance)	4180186
35623578	Product containing precisely trifluoperazine (as trifluoperazine hydrochloride) 2 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623580	Product containing precisely isosorbide mononitrate 25 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623581	Stavudine 75mg prolonged-release oral capsule (product)	4180186
35623582	Verapamil hydrochloride 360mg prolonged-release oral capsule (product)	4180186
35623583	Dextroamphetamine sulfate 5mg prolonged-release oral capsule (product)	4180186
35623584	Oxybutynin hydrochloride 10 mg prolonged-release oral tablet	4180186
35623584	Product containing precisely oxybutynin hydrochloride 10 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35623587	Product containing precisely methylphenidate hydrochloride 30 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623588	Carace (product)	4180186
35623589	Product containing precisely hydromorphone hydrochloride 8 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623594	Product containing precisely nifedipine 60 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623596	Product containing precisely lansoprazole 30 milligram/1 each gastro-resistant oral capsule (clinical drug)	4180186
35623598	Product containing precisely topiramate 50 milligram/1 each conventional release oral capsule (clinical drug)	4180186
35623603	Product containing precisely morphine sulfate 120 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623604	Product containing precisely diltiazem hydrochloride 120 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623605	Propafenone hydrochloride 225mg prolonged-release oral capsule (product)	4180186
35623607	Naproxen sodium 500mg gastro-resistant oral tablet (product)	4180186
35623610	Product containing precisely nitrofurantoin 100 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623613	Product containing precisely dexmethylphenidate hydrochloride 10 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623614	Product containing precisely tramadol hydrochloride 100 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623617	Product containing precisely trifluoperazine (as trifluoperazine hydrochloride) 10 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623618	Product containing precisely amitriptyline hydrochloride 50 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623619	Product containing precisely morphine sulfate 50 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623620	Ferrous sulfate 150mg prolonged-release oral capsule (product)	4180186
35623622	Holoprosencephaly, ectrodactyly, cleft lip, cleft palate syndrome (disorder)	4180186
35623622	Hartsfield Bixler Demyer syndrome	4180186
35623622	Holoprosencephaly, ectrodactyly, cleft lip, cleft palate syndrome	4180186
35623623	Tramadol hydrochloride 300mg prolonged-release oral capsule (product)	4180186
35623627	Fluorethyltyrosine (substance)	4180186
35623628	Fluorothymidine (substance)	4180186
35623629	Acute encephalopathy with biphasic seizures and late reduced diffusion (disorder)	4180186
35623629	Acute infantile encephalopathy predominantly affecting frontal lobe	4180186
35623630	Acute myeloid leukaemia and myelodysplastic syndrome related to alkylating agent	4180186
35623630	Acute myeloid leukemia and myelodysplastic syndrome related to alkylating agent (disorder)	4180186
35623631	Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor (disorder)	4180186
35623631	Acute myeloid leukaemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor	4180186
35623631	Acute myeloid leukaemia and myelodysplastic syndrome related to topoisomerase type II inhibitor	4180186
35623631	Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type II inhibitor	4180186
35623634	Acute sensory ataxic Guillain-Barré syndrome	4180186
35623634	Acute sensory ataxic neuropathy (disorder)	4180186
35623634	ASAN - acute sensory ataxic neuropathy	4180186
35623635	Monosomy 15q26	4180186
35623635	Distal monosomy 15q syndrome	4180186
35623635	15q26 deletion syndrome	4180186
35623635	Telomeric 15q deletion syndrome	4180186
35623635	Distal 15q deletion syndrome	4180186
35623635	Distal monosomy 15q syndrome (disorder)	4180186
35623636	Distal duplication 17q	4180186
35623636	Distal trisomy 17q syndrome (disorder)	4180186
35623636	Distal trisomy 17q syndrome	4180186
35623636	Telomeric duplication 17q	4180186
35623637	Distal duplication 19q	4180186
35623637	Distal trisomy 19q syndrome	4180186
35623637	Telomeric duplication 19q	4180186
35623637	Distal trisomy 19q syndrome (disorder)	4180186
35623638	Distal trisomy 1p36 syndrome	4180186
35623638	Telomeric duplication 1p36	4180186
35623638	Distal duplication 1p36	4180186
35623638	Distal trisomy 1p36 syndrome (disorder)	4180186
35623640	Lamotrigine 2mg tablet for conventional release oral suspension (product)	4180186
35623641	Product containing precisely amitriptyline hydrochloride 25 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623645	Product containing precisely alprostadil 125 microgram/1 each conventional release urethral stick (clinical drug)	4180186
35623647	Product containing precisely alprostadil 500 microgram/1 each conventional release urethral stick (clinical drug)	4180186
35623648	Product containing precisely alprostadil 1 milligram/1 each conventional release urethral stick (clinical drug)	4180186
35623649	Indometacin 75 mg prolonged-release oral capsule	4180186
35623649	Product containing precisely indometacin 75 milligram/1 each prolonged-release oral capsule (clinical drug)	4180186
35623651	Piroxicam 20mg conventional release orodispersible tablet (product)	4180186
35623652	Fluorescein sodium 1mg conventional release ophthalmic strip (product)	4180186
35623653	Sexual relationship problem (finding)	4180186
35623655	Aspirin 227.5mg prolonged-release oral gum (product)	4180186
35623656	Product containing precisely rizatriptan (as rizatriptan benzoate) 5 milligram/1 each conventional release orodispersible tablet (clinical drug)	4180186
35623657	Paroxetine 12.5mg gastro-resistant and prolonged-release oral tablet (product)	4180186
35623663	Fluorodopa (substance)	4180186
35623667	Broad foot	4180186
35623667	Metatarsus latus	4180186
35623667	Spread foot	4180186
35623667	Talipes transversoplanus (disorder)	4180186
35623668	Product containing precisely acetazolamide 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	4180186
35623669	Product containing precisely albiglutide 30 milligram/1 pen powder for conventional release solution for injection (clinical drug)	4180186
35623670	Product containing precisely albiglutide 50 milligram/1 pen powder for conventional release solution for injection (clinical drug)	4180186
35623673	Product containing precisely alprostadil 10 microgram/1 vial powder for conventional release solution for injection (clinical drug)	4180186
35623674	Product containing precisely alprostadil 20 microgram/1 cartridge powder for conventional release solution for injection (clinical drug)	4180186
35623675	Product containing precisely alprostadil 20 microgram/1 vial powder for conventional release solution for injection (clinical drug)	4180186
35623676	Alprostadil 40micrograms powder for conventional release solution for injection cartridge (product)	4180186
35623682	Anti-D (Rh) immunoglobulin 5000iu injection (pdr for recon)+solvent	4180186
35623682	Anti-D (Rh) immunoglobulin 5000iu powder for conventional release solution for injection vial (product)	4180186
35623683	Anti-D (Rh) immunoglobulin 600iu injection (pdr for recon)+solvent	4180186
35623683	Anti-D (Rh) immunoglobulin 600iu powder for conventional release solution for injection vial (product)	4180186
35623684	Product containing precisely basiliximab 10 milligram/1 vial powder for conventional release solution for injection (clinical drug)	4180186
35623685	Product containing precisely basiliximab 20 milligram/1 vial powder for conventional release solution for injection (clinical drug)	4180186
35623691	Choriogonadotrophin alfa 2000iu powder and solvent for injection solution ampoule	4180186
35623691	Choriogonadotrophin alfa 2000iu powder and solvent for injection solution ampule	4180186
35623691	Choriogonadotropin alfa 2000iu powder for conventional release solution for injection ampule (product)	4180186
35623692	Choriogonadotrophin alfa 5000iu powder and solvent for injection solution ampoule	4180186
35623692	Choriogonadotrophin alfa 5000iu powder and solvent for injection solution ampule	4180186
35623692	Choriogonadotropin alfa 5000iu powder for conventional release solution for injection ampule (product)	4180186
35623696	Deferoxamine mesilate 2 g powder for solution for injection vial	4180186
35623696	Product containing precisely deferoxamine mesilate 2 gram/1 vial powder for conventional release solution for injection (clinical drug)	4180186
35623698	Product containing precisely epoprostenol (as epoprostenol sodium) 1.5 milligram/1 vial powder for conventional release solution for injection (clinical drug)	4180186
35623700	Epoetin beta 10,000iu injection cartridge	4180186
35623700	Epoetin beta 10,000iu powder for conventional release solution for injection cartridge (product)	4180186
35623701	Epoetin beta 100,000iu injection (pdr for recon)+solvent	4180186
35623701	Epoetin beta 100,000iu powder for conventional release solution for injection vial (product)	4180186
35623706	Product containing precisely etanercept 25 milligram/1 vial powder for conventional release solution for injection (clinical drug)	4180186
35623707	Product containing precisely etanercept 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)	4180186
35623713	Product containing precisely galactose 3.99 gram and palmitic acid 4 milligram/1 vial powder for conventional release suspension for injection (clinical drug)	4180186
35623714	Product containing precisely gonadorelin (as gonadorelin hydrochloride) 100 microgram/1 vial powder for conventional release solution for injection (clinical drug)	4180186
35623722	Product containing precisely octreotide (as octreotide acetate) 30 milligram/1 vial powder for conventional release suspension for injection (clinical drug)	4180186
35623724	Product containing precisely palivizumab 100 milligram/1 vial powder for conventional release solution for injection (clinical drug)	4180186
35623727	Product containing precisely peginterferon alfa-2b 120 microgram/1 vial powder for conventional release solution for injection (clinical drug)	4180186
35623728	Product containing precisely peginterferon alfa-2b 150 microgram/1 vial powder for conventional release solution for injection (clinical drug)	4180186
35623729	Product containing precisely peginterferon alfa-2b 50 microgram/1 vial powder for conventional release solution for injection (clinical drug)	4180186
35623732	Recombinant coagulation factor IX 1000iu injection (pdr for recon)+solvent	4180186
35623732	Recombinant coagulation factor IX 1000iu powder for conventional release solution for injection vial (product)	4180186
35623733	Recombinant coagulation factor IX 250iu injection (pdr for recon)+solvent	4180186
35623733	Recombinant coagulation factor IX 250iu powder for conventional release solution for injection vial (product)	4180186
35623734	Recombinant coagulation factor IX 500iu injection (pdr for recon)+solvent	4180186
35623734	Recombinant coagulation factor IX 500iu powder for conventional release solution for injection vial (product)	4180186
35623737	Recombinant coagulation factor VIIa 60,000iu powder for conventional release solution for injection vial (product)	4180186
35623741	Product containing precisely sermorelin (as sermorelin acetate) 50 microgram/1 ampule powder for conventional release solution for injection (clinical drug)	4180186
35623741	Sermorelin (as sermorelin acetate) 50 microgram powder for solution for injection ampoule	4180186
35623742	Product containing precisely sodium fusidate 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	4180186
35623744	Product containing precisely somatropin(rbe) 200 microgram/1 syringe powder for conventional release solution for injection (clinical drug)	4180186
35623745	Product containing precisely somatropin(rbe) 400 microgram/1 syringe powder for conventional release solution for injection (clinical drug)	4180186
35623747	Product containing precisely somatropin(rbe) 4 milligram/1 vial powder for conventional release solution for injection (clinical drug)	4180186
35623748	Product containing precisely somatropin(rbe) 6 milligram/1 cartridge powder for conventional release solution for injection (clinical drug)	4180186
35623751	Product containing precisely somatropin(rbe) 12 milligram/1 cartridge powder for conventional release solution for injection (clinical drug)	4180186
35623752	Somatropin(rbe) 3iu(1mg) powder for conventional release solution for injection prefilled syringe (product)	4180186
35623754	Product containing precisely somatropin(rbe) 1.6 milligram/1 syringe powder for conventional release solution for injection (clinical drug)	4180186
35623757	Product containing precisely somatropin(rbe) 2 milligram/1 syringe powder for conventional release solution for injection (clinical drug)	4180186
35623760	Product containing precisely somatropin(rmc) 1.33 milligram/1 vial powder for conventional release solution for injection (clinical drug)	4180186
35623761	Product containing precisely teicoplanin 200 milligram/1 vial powder for conventional release solution for injection (clinical drug)	4180186
35623763	Product containing precisely tenecteplase 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)	4180186
35623765	Product containing precisely tenoxicam 20 milligram/1 vial powder for conventional release solution for injection (clinical drug)	4180186
35623767	Urofollitrophin 150units injection (pdr for recon)+solvent	4180186
35623767	Urofollitrophin 150units powder for conventional release solution for injection ampule (product)	4180186
35623768	Urofollitropin 75iu powder for conventional release solution for injection ampule (product)	4180186
35623770	Bovine thrombin 20000iu powder for conventional release cutaneous solution (product)	4180186
35623771	Bovine thrombin 5000iu powder for conventional release cutaneous solution (product)	4180186
35623772	Recombinant thrombin 20000iu powder for conventional release cutaneous solution (product)	4180186
35623773	Recombinant thrombin 5000iu powder for conventional release cutaneous solution (product)	4180186
35623774	Antihaemophilic factor agent 1000 iu powder for conventional release solution for injection vial	4180186
35623774	Antihemophilic factor agent 1000 iu powder for conventional release solution for injection vial (product)	4180186
35623775	Antihaemophilic factor agent 1500 iu powder for conventional release solution for injection vial	4180186
35623775	Antihemophilic factor agent 1500 iu powder for conventional release solution for injection vial (product)	4180186
35623776	Antihaemophilic factor agent 500 iu powder for conventional release solution for injection vial	4180186
35623776	Antihemophilic factor agent 500 iu powder for conventional release solution for injection vial (product)	4180186
35623778	Haemophilus b polysaccharide 10micrograms/tetanus toxoid 30micrograms powder for conventional release solution for injection vial (product)	4180186
35623780	Product containing precisely clobetasol propionate 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug)	4180186
35623782	Hydroxocobalamin 2.5g powder for conventional release solution for injection vial (product)	4180186
35623783	Product containing precisely ixabepilone 15 milligram/1 vial powder for conventional release solution for injection (clinical drug)	4180186
35623785	Leuprorelin acetate 11.25 mg powder for solution for injection vial	4180186
35623785	Product containing precisely leuprorelin acetate 11.25 milligram/1 vial powder for conventional release solution for injection (clinical drug)	4180186
35623786	Leuprorelin acetate 3.75 mg powder for solution for injection vial	4180186
35623786	Product containing precisely leuprorelin acetate 3.75 milligram/1 vial powder for conventional release solution for injection (clinical drug)	4180186
35623787	Naltrexone microspheres 380mg powder for conventional release solution for injection vial (product)	4180186
35623790	Temsirolimus 25mg/mL powder for conventional release solution for injection vial (product)	4180186
35623791	Thymosin alpha 1 1.6mg powder for conventional release solution for injection vial (product)	4180186
35623792	Product containing precisely treosulfan 5 gram/1 vial powder for conventional release solution for injection (clinical drug)	4180186
35623793	Product containing precisely vecuronium bromide 10 milligram/1 vial powder for conventional release solution for injection (clinical drug)	4180186
35623795	Poisoning by methaqualone	4180186
35623795	Methaqualone poisoning (disorder)	4180186
35623796	Adverse reaction caused by methaqualone (disorder)	4180186
35623796	Adverse reaction caused by methaqualone	4180186
35623797	Accidental poisoning caused by methaqualone (disorder)	4180186
35623797	Accidental poisoning caused by methaqualone	4180186
35623798	Radionuclide imaging of parathyroid using technetium (99m-Tc) and thallium-201 (procedure)	4180186
35623799	Substance with cresol structure (substance)	4180186
35623801	Product containing precisely paracetamol 120 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35623801	Paracetamol 120 mg/mL oral solution	4180186
35623802	Potassium permanganate 400mg tablet for conventional release cutaneous solution (product)	4180186
35623804	Carvedilol 40mg prolonged-release oral capsule (product)	4180186
35623805	Carvedilol 20mg prolonged-release oral capsule (product)	4180186
35623806	Carvedilol 10mg prolonged-release oral capsule (product)	4180186
35623808	Powder for conventional release suspension for inhalation (dose form)	4180186
35623808	Powder for conventional release suspension for inhalation	4180186
35623809	Cavovarus deformity (morphologic abnormality)	4180186
35623810	Cavovalgus deformity (morphologic abnormality)	4180186
35623812	Maternal uniparental disomy of chromosome 4 (disorder)	4180186
35623813	Maternal uniparental disomy of chromosome 6 (disorder)	4180186
35623817	Marburg acute multiple sclerosis (disorder)	4180186
35623817	Acute multiple sclerosis Marburg type	4180186
35623817	Acute multiple sclerosis Marburg variant	4180186
35623818	Primitive neuroectodermal tumor of corpus uteri (disorder)	4180186
35623818	Primitive neuroectodermal tumour of corpus uteri	4180186
35623820	Deafness, nephritis, anorectal malformation syndrome	4180186
35623820	Deafness, nephritis, anorectal malformation syndrome (disorder)	4180186
35623822	Lethal infantile mitochondrial disease	4180186
35623822	Lethal infantile mitochondrial myopathy (disorder)	4180186
35623825	Product containing precisely butenafine hydrochloride 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug)	4180186
35623829	Product containing precisely halobetasol propionate 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug)	4180186
35623830	Product containing precisely haloprogin 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug)	4180186
35623831	Product containing precisely hydroquinone 40 milligram/1 milliliter conventional release cutaneous cream (clinical drug)	4180186
35623832	Hydrous wool fat+zinc oxide 4/8% conventional release cutaneous cream (product)	4180186
35623834	Product containing precisely diiodohydroxyquinoline 10 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug)	4180186
35623834	Diiodohydroxyquinoline 10 mg/mL and hydrocortisone 10 mg/mL cutaneous cream	4180186
35623835	Magnesium salicylate 467mg conventional release oral tablet (product)	4180186
35623836	Mafenide acetate 85mg/g conventional release cutaneous cream (product)	4180186
35623838	Product containing precisely tazarotene 1 milligram/1 milliliter conventional release cutaneous cream (clinical drug)	4180186
35623839	Product containing precisely benzoyl peroxide 25 milligram/1 gram conventional release cutaneous gel (clinical drug)	4180186
35623842	Product containing precisely tazarotene 500 microgram/1 gram conventional release cutaneous gel (clinical drug)	4180186
35623847	Product containing precisely hydrocortisone butyrate 1 milligram/1 milliliter conventional release cutaneous lotion (clinical drug)	4180186
35623850	Magnesium salicylate 500mg conventional release oral tablet (product)	4180186
35623853	Compound salicylic acid powder	4180186
35623853	Salicylic acid+boric acid 3%/5% conventional release cutaneous powder (product)	4180186
35623855	Product containing precisely adapalene 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	4180186
35623858	Product containing precisely magnesium salicylate 580 milligram/1 each conventional release oral tablet (clinical drug)	4180186
35623859	Product containing precisely cetrimide 200 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	4180186
35623860	Product containing precisely cetrimide 400 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	4180186
35623861	Product containing precisely chlorhexidine gluconate 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	4180186
35623862	Product containing precisely budesonide 50 microgram/1 actuation conventional release nasal spray (clinical drug)	4180186
35623863	Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	4180186
35623864	Cocaine hydrochloride 10% topical solution	4180186
35623864	Cocaine viscous 10% conventional release cutaneous solution (product)	4180186
35623870	Product containing precisely sodium hypochlorite 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	4180186
35623871	Coal tar 40% conventional release cutaneous solution (product)	4180186
35623872	Product containing precisely sodium fluoride 6.19 milligram/1 gram conventional release dental paste (clinical drug)	4180186
35623875	Amethocaine hydrochloride 1% conventional release eye drops (product)	4180186
35623875	Amethocaine hydrochloride 1% single-use eye drops	4180186
35623877	Carmellose sodium 1% conventional release eye drops (product)	4180186
35623879	Citrate 6.5% conventional release eye drops (product)	4180186
35623881	Cocaine 4% conventional release eye drops (product)	4180186
35623882	Cyclopentolate hydrochloride 0.5% conventional release eye drops (product)	4180186
35623887	Product containing precisely econazole nitrate 10 milligram/1 milliliter conventional release eye drops (clinical drug)	4180186
35623888	Epinephrine acid tartrate 0.01% conventional release eye drops (product)	4180186
35623890	Fluorescein sodium 1% conventional release eye drops (product)	4180186
35623891	Fluorescein sodium 2% conventional release eye drops (product)	4180186
35623893	Gentamicin 0.3% conventional release eye drops (product)	4180186
35623897	Glycerin 50% conventional release eye drops (product)	4180186
35623902	Metipranolol 0.3% conventional release eye drops (product)	4180186
35623905	Oxybuprocaine hydrochloride 0.4% conventional release eye drops (product)	4180186
35623909	Pilocarpine nitrate 2% conventional release eye drops (product)	4180186
35623911	Pilocarpine nitrate 4% conventional release eye drops (product)	4180186
35623912	Tenben (product)	4180186
35623913	Polyvinyl alcohol 1.4% conventional release eye drops (product)	4180186
35623914	Povidone 5% conventional release eye drops (product)	4180186
35623915	Prednisolone 0.01% conventional release eye drops (product)	4180186
35623916	Prednisolone 0.03% conventional release eye drops (product)	4180186
35623918	Prednisolone 0.3% conventional release eye drops (product)	4180186
35623919	Prednisolone sodium phosphate 0.5% conventional release eye drops (product)	4180186
35623920	Proparacaine hydrochloride 0.5% single-use eye drops	4180186
35623920	Proparacaine hydrochloride 0.5% solution	4180186
35623920	Proxymetacaine hydrochloride 0.5% conventional release eye drops (product)	4180186
35623921	Proxymetacaine hydrochloride+fluorescein sodium 0.5%/0.25% conventional release eye drops (product)	4180186
35623923	Sodium bicarbonate 2% conventional release eye drops (product)	4180186
35623925	Sodium cromoglycate 2% conventional release eye drops (product)	4180186
35623927	Thymoxamine 0.5% conventional release eye drops (product)	4180186
35623928	Tropicamide 0.5% conventional release eye drops (product)	4180186
35623930	Carbomer-980 2mg/g conventional release eye gel (product)	4180186
35623931	Product containing precisely timolol (as timolol maleate) 1 milligram/1 milliliter conventional release eye gel (clinical drug)	4180186
35623933	Product containing precisely timolol (as timolol maleate) 5 milligram/1 milliliter conventional release eye gel (clinical drug)	4180186
35623935	Cocaine hydrochloride 2.5% conventional release eye solution (product)	4180186
35623937	Methotrexate 25mg/mL conventional release solution for injection (product)	4180186
35623938	Lidocaine hydrochloride+epinephrine 4% conventional release nasal drops (product)	4180186
35623939	Cyanocobalamin 5 mg/g nasal gel	4180186
35623939	Product containing precisely cyanocobalamin 5 milligram/1 gram conventional release nasal gel (clinical drug)	4180186
35623939	Product containing precisely cyanocobalamin 5 microgram/1 milligram conventional release nasal gel (clinical drug)	4180186
35623940	Product containing precisely desmopressin acetate 100 microgram/1 milliliter conventional release nasal solution (clinical drug)	4180186
35623943	Product containing precisely budesonide 32 microgram/1 actuation conventional release nasal spray (clinical drug)	4180186
35623945	Product containing precisely fluticasone propionate 50 microgram/1 actuation conventional release nasal spray (clinical drug)	4180186
35623947	Product containing precisely mometasone furoate 50 microgram/1 actuation conventional release nasal spray (clinical drug)	4180186
35623949	Product containing precisely povidone iodine 11.4 milligram/1 gram conventional release powder for cutaneous spray (clinical drug)	4180186
35623951	Diclofenac sodium 0.1% conventional release solution for eye drops (product)	4180186
35623952	Vigam (product)	4180186
35623956	Dothiepin hydrochloride 25mg/5mL conventional release oral elixir (product)	4180186
35623957	Dothiepin hydrochloride 75mg/5mL conventional release oral elixir (product)	4180186
35623960	Ispaghula husk 3.5g/sachet conventional release oral powder (product)	4180186
35623961	Product containing precisely ispaghula husk 6 gram/1 sachet powder for conventional release oral suspension (clinical drug)	4180186
35623962	Product containing precisely alprazolam 1 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35623963	Product containing precisely amiloride hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35623964	Product containing precisely amisulpride 100 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35623965	Product containing precisely amitriptyline hydrochloride 5 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35623966	Product containing precisely amitriptyline hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35623967	Atropine sulfate 500micrograms/5mL conventional release oral solution (product)	4180186
35623968	Product containing precisely baclofen 1 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35623969	Benzhexol 2mg/5mL conventional release oral solution (product)	4180186
35623970	Product containing precisely cetirizine hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35623973	Product containing precisely cimetidine 40 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35623974	Product containing precisely clonazepam 100 microgram/1 milliliter conventional release oral solution (clinical drug)	4180186
35623977	Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35623977	Sodium cromoglicate 20 mg/mL oral solution	4180186
35623978	Ciclosporin 100 mg/mL oral solution	4180186
35623978	Product containing precisely ciclosporin 100 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35623980	Product containing precisely emtricitabine 10 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35623981	Product containing precisely ephedrine hydrochloride 800 microgram/1 milliliter conventional release oral solution (clinical drug)	4180186
35623982	Product containing precisely folic acid 80 microgram/1 milliliter conventional release oral solution (clinical drug)	4180186
35623983	Product containing precisely furosemide 4 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35623984	Product containing precisely furosemide 8 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35623985	Product containing precisely furosemide 10 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35623986	Product containing precisely galantamine (as galantamine hydrobromide) 4 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35623987	Product containing precisely haloperidol 300 microgram/1 milliliter conventional release oral solution (clinical drug)	4180186
35623989	Product containing precisely haloperidol 400 microgram/1 milliliter conventional release oral solution (clinical drug)	4180186
35623991	Product containing precisely lithium citrate 104 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35623992	Histac (product)	4180186
35623994	Product containing precisely methadone hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35623995	Product containing precisely methadone hydrochloride 20 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35624001	Product containing precisely perphenazine 400 microgram/1 milliliter conventional release oral solution (clinical drug)	4180186
35624002	Product containing precisely perphenazine 800 microgram/1 milliliter conventional release oral solution (clinical drug)	4180186
35624003	Product containing precisely pholcodine 1 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35624004	Product containing precisely pholcodine 2 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35624006	Product containing precisely propranolol hydrochloride 2 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35624007	Product containing precisely propranolol hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35624008	Product containing precisely propranolol hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35624010	Sodium valproate 40 mg/mL oral solution	4180186
35624010	Product containing precisely valproate sodium 40 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35624012	Product containing precisely temazepam 2 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35624014	Product containing precisely thioridazine (as thioridazine hydrochloride) 100 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35624015	Thioridazine 50mg/5mL conventional release oral solution (product)	4180186
35624018	Acetaminophen+dextropropoxyphene hydrochloride 325mg/32.5mg/5mL conventional release oral suspension (product)	4180186
35624018	Paracetamol+dextropropoxyphene hydrochloride 325mg/32.5mg/5mL s/f suspension	4180186
35624019	Product containing precisely amoxicillin (as amoxicillin trihydrate) 25 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 6.25 milligram/1 milliliter conventional release oral suspension (clinical drug)	4180186
35624022	Amoxycillin 125mg/sachet powder for conventional release oral suspension (product)	4180186
35624022	Amoxycillin 125mg/sachet s/f powder	4180186
35624024	Product containing precisely amphotericin B 100 milligram/1 milliliter conventional release oral suspension (clinical drug)	4180186
35624027	Product containing precisely chlorpromazine hydrochloride (as chlorpromazine embonate) 20 milligram/1 milliliter conventional release oral suspension (clinical drug)	4180186
35624028	Product containing precisely clarithromycin 50 milligram/1 milliliter conventional release oral suspension (clinical drug)	4180186
35624031	Product containing precisely oxcarbazepine 60 milligram/1 milliliter conventional release oral suspension (clinical drug)	4180186
35624036	Rotavirus live vaccine powder for conventional release oral suspension 1mL (product)	4180186
35624038	Product containing precisely spironolactone 2 milligram/1 milliliter conventional release oral suspension (clinical drug)	4180186
35624039	Product containing precisely spironolactone 5 milligram/1 milliliter conventional release oral suspension (clinical drug)	4180186
35624041	Product containing precisely spironolactone 1 milligram/1 milliliter conventional release oral suspension (clinical drug)	4180186
35624042	Product containing precisely trifluoperazine 1 milligram/1 milliliter conventional release oral suspension (clinical drug)	4180186
35624043	Product containing precisely sulfamethoxazole 40 milligram/1 milliliter and trimethoprim 8 milligram/1 milliliter conventional release oral suspension (clinical drug)	4180186
35624046	Product containing precisely ferrous fumarate 28 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35624046	Ferrous fumarate 140mg/5ml oral solution	4180186
35624047	Product containing precisely folic acid 500 microgram/1 milliliter conventional release oral solution (clinical drug)	4180186
35624049	Folic acid 4mg/5mL conventional release oral syrup (product)	4180186
35624051	Loperamide hydrochloride 1mg/5mL conventional release oral syrup (product)	4180186
35624052	Product containing precisely ondansetron (as ondansetron hydrochloride) 800 microgram/1 milliliter conventional release oral solution (clinical drug)	4180186
35624053	Product containing precisely procyclidine hydrochloride 500 microgram/1 milliliter conventional release oral solution (clinical drug)	4180186
35624057	Product containing precisely salbutamol (as salbutamol sulfate) 400 microgram/1 milliliter conventional release oral solution (clinical drug)	4180186
35624057	Salbutamol (as salbutamol sulfate) 400 microgram/mL oral solution	4180186
35624063	Lyrica (product)	4180186
35624064	Product containing precisely hexetidine 1 milligram/1 milliliter conventional release oromucosal solution (clinical drug)	4180186
35624066	Product containing precisely sodium fluoride 2 milligram/1 gram conventional release oromucosal solution (clinical drug)	4180186
35624070	Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release oromucosal spray (clinical drug)	4180186
35624071	Hydrocortisone 1% + Pramocaine 1% conventional release rectal foam (product)	4180186
35624072	Amikacin 500mg/100mL conventional release solution for infusion (product)	4180186
35624073	Cefoperazone sodium 2gm/50mL conventional release solution for infusion (product)	4180186
35624078	Ciclosporin 50 mg/mL solution for injection	4180186
35624078	Product containing precisely ciclosporin 50 milligram/1 milliliter conventional release solution for injection (clinical drug)	4180186
35624080	Dextrose 60% in water conventional release solution for infusion 1000mL bag (product)	4180186
35624081	Dextrose 60g injection	4180186
35624081	Dextrose 60% in water conventional release solution for infusion 500mL bag (product)	4180186
35624082	Eribulin mesylate 0.5mg/mL conventional release solution for injection (product)	4180186
35624086	Gentamicin 90mg/100mL conventional release solution for infusion (product)	4180186
35624087	Human normal immunoglobulin 6g conventional release solution for injection vial (product)	4180186
35624087	Human normal immunoglobulin 6g intravenous infusion	4180186
35624091	Ramucirumab 10mg/mL conventional release solution for injection (product)	4180186
35624093	Sodium chloride 0.9% conventional release solution for injection 20ml ampule (product)	4180186
35624095	Sodium chloride 0.9% conventional release solution for infusion 50ml ampule (product)	4180186
35624096	Sodium chloride 0.9% conventional release solution for injection 5ml ampule (product)	4180186
35624098	Mabron (product)	4180186
35624099	Streptokinase 250000unt conventional release solution for injection vial (product)	4180186
35624100	Streptokinase 750000unt conventional release solution for injection vial (product)	4180186
35624101	Tocilizumab 20mg/mL conventional release solution for injection (product)	4180186
35624102	Tranexamic acid 100mg/mL conventional release solution for injection 10mL vial (product)	4180186
35624102	Tranexamic acid 100mg/mL injection	4180186
35624103	Vinblastine sulfate 30mg/30mL conventional release solution for injection (product)	4180186
35624105	Vincristine sulfate 10mg/50mL conventional release solution for infusion (product)	4180186
35624106	Vincristine sulfate 5mg/50mL conventional release solution for infusion (product)	4180186
35624107	Lidocaine hydrochloride 1% conventional release solution for injection ampule (product)	4180186
35624107	Lidocaine hydrochloride 1% sterile wrapped injection	4180186
35624107	Lignocaine hydrochloride 1% injection solution sterile ampule	4180186
35624107	Lignocaine hydrochloride 1% sterile wrapped injection	4180186
35624108	Amphotericin 5mg/mL conventional release suspension for injection 20mL vial (product)	4180186
35624113	Triptorelin pamoate 11.25mg/vial lyophilized powder for conventional release suspension for injection (product)	4180186
35624114	Triptorelin pamoate 3.75mg/vial lyophilized powder for conventional release suspension for injection (product)	4180186
35624116	Idiopathic recurrent pericarditis (disorder)	4180186
35624116	Idiopathic relapsing pericarditis	4180186
35624119	Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutation (disorder)	4180186
35624120	Isochromosome Yp	4180186
35624120	Isochromosomy Yp (disorder)	4180186
35624121	Isolated hypoplasia of cerebellar vermis (disorder)	4180186
35624121	Isolated hypoplasia of cerebellar vermis	4180186
35624122	Isolated focal cortical dysplasia (disorder)	4180186
35624123	Isolated SCCH (sternocostoclavicular hyperostosis)	4180186
35624123	Isolated sternocostoclavicular hyperostosis (disorder)	4180186
35624125	Monosomy 13q34 syndrome (disorder)	4180186
35624125	Monosomy 13q34 syndrome	4180186
35624125	Distal deletion 13q34	4180186
35624125	Subtelomeric deletion 13q34	4180186
35624125	Monosomy 13q34 (disorder)	4180186
35624126	Multiple epiphyseal dysplasia due to collagen 9 anomaly (disorder)	4180186
35624127	Biladiene and/or biladiene derivative (substance)	4180186
35624127	Biladiene and/or biladiene derivative	4180186
35624127	Biladienes and derivatives	4180186
35624127	Biladiene and biladiene derivative (substance)	4180186
35624130	Paraparetic variant of Guillain-Barré syndrome (disorder)	4180186
35624133	Paracetamol + orphenadrine citrate 500mg/50mg	4180186
35624133	Paracetamol + orphenadrine citrate 500mg/50mg (product)	4180186
35624137	Product containing precisely quinagolide 50 microgram/1 each conventional release oral tablet (clinical drug)	4180186
35624140	Iopamidol 61.2% suspension (product)	4180186
35624142	Dibasic sodium phosphate dihydrate (substance)	4180186
35624145	Exploration of left adrenal gland (procedure)	4180186
35624147	Exploration of bilateral adrenal glands (procedure)	4180186
35624149	Insertion of silicone breast implant into right breast (procedure)	4180186
35624150	Multiple epiphyseal dysplasia with miniepiphyses (disorder)	4180186
35624151	Neuhauser anomaly (disorder)	4180186
35624152	Neurolymphomatosis (disorder)	4180186
35624155	Tetrasomy 5p syndrome (disorder)	4180186
35624155	Tetrasomy 5p	4180186
35624155	Isochromosome 5p	4180186
35624156	Subaortic course of innominate vein (disorder)	4180186
35624156	Subaortic course of brachiocephalic vein	4180186
35624161	X-linked cleft palate and ankyloglossia (disorder)	4180186
35624162	Morphinan (substance)	4180186
35624163	Morphinane alkaloid (substance)	4180186
35624168	Indium pentetate calcium (substance)	4180186
35624170	Substance with phenol structure (substance)	4180186
35624172	Medicinal product categorized by disposition (product)	4180186
35624172	Medicinal product categorised by disposition	4180186
35624173	Failed supraglottic airway ventilation (situation)	4180186
35624174	Difficult supraglottic airway ventilation (finding)	4180186
35624176	Product containing lymphocyte function-associated antigen 1 antagonist (product)	4180186
35624178	Extracorporeal hemodialysis route (qualifier value)	4180186
35624178	Extracorporeal haemodialysis route	4180186
35624179	Substance with dopamine receptor D2 antagonist mechanism of action (substance)	4180186
35624181	Genus Neoscytalidium (organism)	4180186
35624181	Genus Neoscytalidium	4180186
35624186	Benzoxepin (substance)	4180186
35624190	Parahydroxycinnamic acid	4180186
35624190	4-hydroxycinnamic acid	4180186
35624190	p-coumaric acid (substance)	4180186
35624191	Phytolacca americana root (substance)	4180186
35624194	Ruscus aculeatus root (substance)	4180186
35624194	Ruscus aculeatus root	4180186
35624196	Melilotus officinalis top	4180186
35624196	Melilotus officinalis top (substance)	4180186
35624198	Trichodysplasia xeroderma syndrome (disorder)	4180186
35624199	Trichoodontoonychial dysplasia (disorder)	4180186
35624199	Trichoodontoonychial dysplasia with bone deficiency in frontoparietal region	4180186
35624201	Perioral myoclonia with absences (disorder)	4180186
35624201	POMA - perioral myoclonia with absences	4180186
35624202	2q23.1 microduplication syndrome (disorder)	4180186
35624202	Trisomy 2q23.1	4180186
35624207	Spondyloepimetaphyseal dysplasia, short limb, abnormal calcification syndrome (disorder)	4180186
35624209	Regulated breathing method (regime/therapy)	4180186
35624209	Regulated breathing approach	4180186
35624210	Activity dependent neuroprotector homeobox related multiple congenital anomalies, intellectual disability, autism spectrum disorder (disorder)	4180186
35624210	Helsmoortel-van der Aa syndrome	4180186
35624210	Activity dependent neuroprotector homeobox related multiple congenital anomalies, intellectual disability, autism spectrum disorder	4180186
35624212	Human papillomavirus type 6 L1 capsid protein Ag	4180186
35624212	Antigen of Human papillomavirus type 6 L1 capsid protein	4180186
35624212	HPV (Human papillomavirus) type 6 L1 capsid protein antigen	4180186
35624212	Antigen of Human papillomavirus type 6 L1 capsid protein (substance)	4180186
35624214	Cataract co-occurrent with degenerative disorder of eye (disorder)	4180186
35624216	Antigen of Human papillomavirus type 11 L1 capsid protein	4180186
35624216	HPV (Human papillomavirus) type 11 L1 capsid protein antigen	4180186
35624216	Antigen of Human papillomavirus type 11 L1 capsid protein (substance)	4180186
35624216	Human papillomavirus type 11 L1 capsid protein Ag	4180186
35624217	unit (qualifier value)	4180186
35624217	Unit (qualifier value)	4180186
35624219	Human papillomavirus type 16 L1 capsid protein Ag	4180186
35624219	Antigen of Human papillomavirus type 16 L1 capsid protein	4180186
35624219	Antigen of Human papillomavirus type 16 L1 capsid protein (substance)	4180186
35624219	HPV (Human papillomavirus) type 16 L1 capsid protein antigen	4180186
35624220	Radionuclide imaging using high dose gallium-67 (procedure)	4180186
35624221	HPV (Human papillomavirus) type 18 L1 capsid protein antigen	4180186
35624221	Antigen of Human papillomavirus type 18 L1 capsid protein	4180186
35624221	Antigen of Human papillomavirus type 18 L1 capsid protein (substance)	4180186
35624221	Human papillomavirus type 18 L1 capsid protein Ag	4180186
35624224	Cono-spondylar dysplasia (disorder)	4180186
35624224	Short stature, kyphosis, hypoplasia of basal ilia-cone epiphyses, facial dysmorphism syndrome	4180186
35624225	COXPD4 - combined oxidative phosphorylation defect type 4	4180186
35624225	Combined oxidative phosphorylation defect type 4 (disorder)	4180186
35624229	Codeine hydrochloride (substance)	4180186
35624231	Familial dilated cardiomyopathy with conduction defect due to lamin A/C mutation (disorder)	4180186
35624231	Familial dilated cardiomyopathy with conduction defect due to lamin A/C mutation	4180186
35624233	Technetium (99m-Tc) bicisate (substance)	4180186
35624234	Familial multiple lipomatosis (disorder)	4180186
35624235	Exametazime (substance)	4180186
35624236	Erysimum (substance)	4180186
35624237	Product containing indanedione (product)	4180186
35624239	Product containing plant extract (product)	4180186
35624241	Product containing benzylisoquinolium compound (product)	4180186
35624242	Drug-eluting urethral dilatation catheter (physical object)	4180186
35624245	Lip traction bow (physical object)	4180186
35624245	Self-retaining lip traction device	4180186
35624247	Product containing azo derivative (product)	4180186
35624250	Actinomadura rudentiformis (organism)	4180186
35624252	Chryseobacterium anthropi (organism)	4180186
35624253	Trichinella murrelli (organism)	4180186
35624254	Trichinella pseudospiralis (organism)	4180186
35624255	Trichinella T6 (organism)	4180186
35624258	Plastic and/or related compound	4180186
35624258	Plastic and/or related compound (substance)	4180186
35624258	Plastic and related compound (substance)	4180186
35624261	Product containing volatile oil (product)	4180186
35624262	Product containing Hymenoptera venom (product)	4180186
35624264	Product containing fluorinated corticosteroid (product)	4180186
35624266	Substance with nicotinic receptor antagonist mechanism of action (substance)	4180186
35624271	Hypomyelination neuropathy arthrogryposis syndrome (disorder)	4180186
35624273	Idiopathic panuveitis (disorder)	4180186
35624275	Primary bone lymphoma (disorder)	4180186
35624277	Pseudohyperaldosteronism type 2	4180186
35624277	Early-onset hypertension with exacerbation in pregnancy	4180186
35624277	Hypertension due to gain-of-function mutation in mineralocorticoid receptor (disorder)	4180186
35624278	Extension Namespace {1000217}	4180186
35624278	Extension Namespace {1000217} (namespace concept)	4180186
35624281	Therapeutic role (role)	4180186
35624282	Complete obstruction of colon (disorder)	4180186
35624282	Occlusion of colon	4180186
35624283	Intestinal occlusion	4180186
35624283	Complete obstruction of intestine (disorder)	4180186
35624288	Obstruction of superior vena cava due to neoplasm (disorder)	4180186
35624288	Superior caval vein obstruction due to neoplasm	4180186
35624289	Superior caval vein obstruction	4180186
35624289	Obstruction of superior vena cava (disorder)	4180186
35624291	Acquired obstruction of femoral vein (disorder)	4180186
35624293	Count of active ingredient (attribute)	4180186
35624294	Count of base and modification pair (attribute)	4180186
35624296	Obstruction of ureter (disorder)	4180186
35624296	Ureteral obstruction	4180186
35624297	Obstruction of iliac vein (disorder)	4180186
35624301	Oropharyngeal dose form (dose form)	4180186
35624302	Hypothalamic hormone (disposition)	4180186
35624310	Product containing precisely apalutamide 60 milligram/1 each conventional release oral tablet (clinical drug)	4180186
35624311	Absence of pulmonary valve, Fallot tetralogy, absence of ductus arteriosus syndrome	4180186
35624311	Pulmonary valve agenesis, tetralogy of Fallot, absence of ductus arteriosus syndrome (disorder)	4180186
35624315	Squamous cell carcinoma of stomach (disorder)	4180186
35624315	Gastric squamous cell carcinoma	4180186
35624319	Calcium-sensing receptor activator (disposition)	4180186
35624322	Dihydropyridine derivative (substance)	4180186
35624324	Gamma-aminobutyric acid receptor antagonist (disposition)	4180186
35624328	Substance with beta-lactamase inhibitor mechanism of action (substance)	4180186
35624329	Diphenylmethane (substance)	4180186
35624330	Mast cell stabilizer (disposition)	4180186
35624330	Mast cell stabiliser	4180186
35624331	Adverse reaction caused by hypothalamic hormone (disorder)	4180186
35624331	Adverse reaction caused by hypothalamic hormone	4180186
35624334	Complete occlusion of ureter by external compression (disorder)	4180186
35624334	Occlusion of ureter by external compression	4180186
35624334	Ureteral occlusion due to external compression	4180186
35624336	Larva of order Strongylida	4180186
35624336	Larva of order Strongylida (organism)	4180186
35624337	Filariform larva of order Strongylida (organism)	4180186
35624337	Filariform larva of order Strongylida	4180186
35624338	Rhabditiform larva of order Strongylida	4180186
35624338	Rhabditiform larva of order Strongylida (organism)	4180186
35624339	Antibody to neutrophil (substance)	4180186
35624339	Antibody to neutrophil	4180186
35624339	Neutrophil antibody	4180186
35624340	Period of life beginning after birth and ending before death (qualifier value)	4180186
35624340	Period of life beginning after birth and ending before death	4180186
35624341	Anti-histone antibody	4180186
35624341	Histone antibody	4180186
35624341	Anti-histone antibody (substance)	4180186
35624342	Antibody to Mi-2	4180186
35624342	Antibody to Mi-2 (substance)	4180186
35624342	Anti-Mi-2 antibody	4180186
35624342	Mi-2 antibody	4180186
35624343	Antigen of Hector Battifora mesothelial-1 (substance)	4180186
35624343	HBME-1 (Hector Battifora mesothelial-1) antigen	4180186
35624343	Antigen of Hector Battifora mesothelial-1	4180186
35624349	Congenital macrostomia of right side of mouth	4180186
35624349	Congenital macrostomia of right side of mouth (disorder)	4180186
35624350	Rhabditiform larva of order Rhabditida	4180186
35624350	Rhabditiform larva of order Rhabditida (organism)	4180186
35624351	Jeotgalicoccus schoeneichii (organism)	4180186
35624352	Paracoccus panacisoli (organism)	4180186
35624354	Leucobacter iarius (organism)	4180186
35624356	Clostridium amazonense (organism)	4180186
35624357	Antigen of mitogen-activated protein kinase 14	4180186
35624357	Antigen of mitogen-activated protein kinase 14 (substance)	4180186
35624357	Mitogen-activated protein kinase 14 antigen	4180186
35624358	Mitogen-activated protein kinase 8 antigen	4180186
35624358	Antigen of mitogen-activated protein kinase 8	4180186
35624358	Antigen of mitogen-activated protein kinase 8 (substance)	4180186
35624359	p27 (cyclin dependent kinase inhibitor) antigen	4180186
35624359	Antigen of cyclin dependent kinase inhibitor p27 (substance)	4180186
35624359	Antigen of cyclin dependent kinase inhibitor p27	4180186
35624361	Radioactive seed, device (physical object)	4180186
35624361	Radioactive seed implant	4180186
35624363	Non cavitated coronal lesion (disorder)	4180186
35624366	Propofol 10mg/mL injection emulsion (product)	4180186
35624367	Propofol 20mg/mL injection emulsion (product)	4180186
35624370	Ispaghula husk 3.5g/sachet granules (product)	4180186
35624372	Diatrizoate meglumine 66%/sodium diatrizoate 10% solution (product)	4180186
35624377	First glass contains specks or sediments (finding)	4180186
35624379	Second glass clear (finding)	4180186
35624380	Second glass contains mucous (finding)	4180186
35624382	Second glass contains threads or strands (finding)	4180186
35624383	Disorder of renal parenchyma (disorder)	4180186
35624383	Renal parenchymal disease	4180186
35624383	Kidney parenchyma disease	4180186
35624384	Direct immunofluorescence technique (qualifier value)	4180186
35624384	Primary immunofluorescence technique	4180186
35624385	Indirect immunofluorescence technique (qualifier value)	4180186
35624385	Secondary immunofluorescence technique	4180186
35624386	Actinium and/or actinium compound	4180186
35624386	Actinium and/or actinium compound (substance)	4180186
35624386	Actinium and actinium compound (substance)	4180186
35624387	Metal and/or metal compound (substance)	4180186
35624387	Metal and/or metal compound	4180186
35624387	Metal and metallic compound (substance)	4180186
35624388	Aldehyde allergy	4180186
35624388	Allergy to aldehyde (finding)	4180186
35624390	Medicinal product categorized by chemical element (product)	4180186
35624390	Medicinal product categorised by chemical element	4180186
35624391	Product containing xenon (medicinal product)	4180186
35624392	Progesterone receptor antagonist (disposition)	4180186
35624393	Substance with progesterone receptor antagonist mechanism of action (substance)	4180186
35624394	Glucocorticoid receptor antagonist (disposition)	4180186
35624396	Aluminium and/or aluminium compound (substance)	4180186
35624396	Aluminum and/or aluminum compound	4180186
35624396	Aluminium and/or aluminium compound	4180186
35624396	Aluminium and aluminium compound (substance)	4180186
35624396	Aluminium and aluminium compound	4180186
35624397	Product containing carbon (medicinal product)	4180186
35624399	Product containing oxygen (medicinal product)	4180186
35624400	Product containing cobalt (medicinal product)	4180186
35624401	Product containing calcium (medicinal product)	4180186
35624404	Allergy to substance with ether structure (finding)	4180186
35624405	Product containing sodium (medicinal product)	4180186
35624407	Product containing phosphorus (medicinal product)	4180186
35624408	Product containing lanthanum (medicinal product)	4180186
35624410	Product containing nitrogen (medicinal product)	4180186
35624412	Product containing bisacodyl in oral dose form (medicinal product form)	4180186
35624413	Product containing bisacodyl in rectal dose form (medicinal product form)	4180186
35624416	Arsenic and/or arsenic compound	4180186
35624416	Arsenic and/or arsenic compound (substance)	4180186
35624416	Arsenic and arsenic compound (substance)	4180186
35624419	Lymphangiography of right upper extremity	4180186
35624419	Lymphangiogram of right upper limb	4180186
35624419	Lymphangiogram of right upper extremity	4180186
35624419	Lymphangiography of right upper limb (procedure)	4180186
35624423	Barium and/or barium compound (substance)	4180186
35624423	Barium and/or barium compound	4180186
35624423	Barium and barium compound (substance)	4180186
35624424	Beryllium and/or beryllium compound	4180186
35624424	Beryllium and/or beryllium compound (substance)	4180186
35624424	Beryllium and beryllium compound (substance)	4180186
35624426	Bismuth and/or bismuth compound (substance)	4180186
35624426	Bismuth and/or bismuth compound	4180186
35624426	Bismuth and bismuth compound (substance)	4180186
35624428	Procercoid larva of Diphyllobothrium latum	4180186
35624428	Procercoid larva of Diphyllobothrium latum (organism)	4180186
35624429	Bromine and/or bromine compound	4180186
35624429	Bromine and/or bromine compound (substance)	4180186
35624429	Bromine and bromine compound (substance)	4180186
35624431	Abduction deformity (morphologic abnormality)	4180186
35624433	Insulin antagonist (disposition)	4180186
35624434	Quaternary pyridinium compound (substance)	4180186
35624435	Cadmium and/or cadmium compound	4180186
35624435	Cadmium and/or cadmium compound (substance)	4180186
35624435	Cadmium and cadmium compound (substance)	4180186
35624436	Calcium and/or calcium compound	4180186
35624436	Calcium and/or calcium compound (substance)	4180186
35624436	Calcium and calcium compound (substance)	4180186
35624438	Carbon and/or carbon compound (substance)	4180186
35624438	Carbon and/or carbon compound	4180186
35624438	Carbon and carbon compound (substance)	4180186
35624443	Ganglion of hip (disorder)	4180186
35624446	Synovial cyst of multiple joints (disorder)	4180186
35624451	Streptococcus pneumoniae American serotype 69	4180186
35624451	Streptococcus pneumoniae serotype 39	4180186
35624451	Streptococcus pneumoniae Danish serotype 39 (organism)	4180186
35624456	Talipes cavovalgus (disorder)	4180186
35624457	Bordetella genogroup 3	4180186
35624457	Bordetella bronchialis (organism)	4180186
35624459	Administration of vitamin A (procedure)	4180186
35624465	Product containing belladonna alkaloid in rectal dose form (medicinal product form)	4180186
35624466	Product containing aluminium hydroxide and belladonna alkaloid (medicinal product)	4180186
35624466	Aluminium hydroxide- and belladonna alkaloid-containing product	4180186
35624468	Phenyltriazine derivative (substance)	4180186
35624469	Gadolinium and/or gadolinium compound	4180186
35624469	Gadolinium and/or gadolinium compound (substance)	4180186
35624469	Gadolinium and gadolinium compound (substance)	4180186
35624470	Gadolinium compound (substance)	4180186
35624472	Germanium and/or germanium compound	4180186
35624472	Germanium and/or germanium compound (substance)	4180186
35624472	Germanium and germanium compound (substance)	4180186
35624474	Hafnium and/or hafnium compound	4180186
35624474	Hafnium and/or hafnium compound (substance)	4180186
35624474	Hafnium and hafnium compound (substance)	4180186
35624480	Recurrent benign focal seizures of childhood (disorder)	4180186
35624481	Eosinophilic infiltration	4180186
35624481	Eosinophilic inflammation (morphologic abnormality)	4180186
35624482	Protrusion of upper lip	4180186
35624482	Protrusion of upper lip (finding)	4180186
35624483	Retrusion of upper lip	4180186
35624483	Retrusion of upper lip (finding)	4180186
35624485	Sedlackova syndrome	4180186
35624485	Takao syndrome	4180186
35624485	22q11.2 deletion syndrome (disorder)	4180186
35624485	DiGeorge syndrome	4180186
35624485	Microdeletion 22q11.2	4180186
35624485	DiGeorge sequence	4180186
35624485	Conotruncal anomaly face syndrome	4180186
35624485	Shprintzen syndrome	4180186
35624485	Velocardiofacial syndrome	4180186
35624485	Cayler cardiofacial syndrome	4180186
35624485	CATCH 22	4180186
35624488	Iodine and/or iodine compound (substance)	4180186
35624488	Iodine and/or iodine compound	4180186
35624488	Iodine and iodine compound (substance)	4180186
35624491	Iron and/or iron compound (substance)	4180186
35624491	Iron and/or iron compound	4180186
35624491	Iron and iron compound (substance)	4180186
35624492	Lead and/or lead compound (substance)	4180186
35624492	Lead and/or lead compound	4180186
35624492	Lead and lead compound (substance)	4180186
35624493	Senile involution of ovary (disorder)	4180186
35624494	Mercury and/or mercury compound (substance)	4180186
35624494	Mercury and/or mercury compound	4180186
35624494	Mercury and mercury compound (substance)	4180186
35624496	Streptococcus pneumoniae Danish serotype 48 (organism)	4180186
35624496	Streptococcus pneumoniae American serotype 82	4180186
35624496	Streptococcus pneumoniae serotype 48	4180186
35624499	Streptococcus pneumoniae American serotype 73	4180186
35624499	Streptococcus pneumoniae serotype 46	4180186
35624499	Streptococcus pneumoniae Danish serotype 46 (organism)	4180186
35624502	Streptococcus pneumoniae Danish serotype 43 (organism)	4180186
35624502	Streptococcus pneumoniae serotype 43	4180186
35624502	Streptococcus pneumoniae American serotype 75	4180186
35624503	Streptococcus pneumoniae Danish serotype 42 (organism)	4180186
35624503	Streptococcus pneumoniae serotype 42	4180186
35624503	Streptococcus pneumoniae American serotype 80	4180186
35624506	Toxic effect of mercury and/or mercury compound (disorder)	4180186
35624506	Toxic effect of mercury and/or mercury compound	4180186
35624506	Hydrargyria	4180186
35624506	Mercury compound poisoning	4180186
35624506	Mercurialism	4180186
35624506	Hydrargyrosis	4180186
35624506	Toxic effect of mercury and its compounds (disorder)	4180186
35624506	Mercury poisoning	4180186
35624506	Hydrargyrism	4180186
35624507	Lithium and/or lithium compound	4180186
35624507	Lithium and/or lithium compound (substance)	4180186
35624507	Lithium and lithium compound (substance)	4180186
35624509	Manganese and/or manganese compound	4180186
35624509	Manganese and/or manganese compound (substance)	4180186
35624509	Manganese and manganese compound (substance)	4180186
35624511	Molybdenum and/or molybdenum compound (substance)	4180186
35624511	Molybdenum and/or molybdenum compound	4180186
35624511	Molybdenum and molybdenum compound (substance)	4180186
35624517	Family history of female breast cancer diagnosed before age 50	4180186
35624517	Family history of malignant neoplasm of breast at under age 50 in second degree female relative (situation)	4180186
35624520	Palladium and/or palladium compound	4180186
35624520	Palladium and/or palladium compound (substance)	4180186
35624520	Palladium and palladium compound (substance)	4180186
35624521	Product manufactured as cutaneous dose form (product)	4180186
35624523	Product manufactured as urethral dose form (product)	4180186
35624527	Product manufactured as gingival dose form (product)	4180186
35624528	Product manufactured as oromucosal dose form (product)	4180186
35624534	Right total inguinal orchidectomy	4180186
35624534	Excision of entire right testis by inguinal approach (procedure)	4180186
35624535	Excision of entire left testis and entire left spermatic cord (procedure)	4180186
35624535	Excision of entire left testis and entire left spermatic cord	4180186
35624535	Left radical orchiectomy	4180186
35624540	Right total scrotal orchidectomy	4180186
35624540	Excision of entire right testis by scrotal approach (procedure)	4180186
35624540	Right total scrotal orchiectomy	4180186
35624541	Excision of entire left testis	4180186
35624541	Left total orchiectomy	4180186
35624541	Excision of entire left testis (procedure)	4180186
35624542	Right total orchiectomy	4180186
35624542	Excision of entire right testis (procedure)	4180186
35624542	Excision of entire right testis	4180186
35624544	Right subcapsular orchiectomy	4180186
35624544	Right subcapsular orchidectomy (procedure)	4180186
35624547	Anastomosis of left epididymis to left vas deferens (procedure)	4180186
35624547	Left epididymovasostomy	4180186
35624548	Right epididymovasostomy	4180186
35624548	Anastomosis of right epididymis to right vas deferens (procedure)	4180186
35624549	Nabothian cyst	4180186
35624549	Mucous retention cyst of cervix uteri (disorder)	4180186
35624549	Nabothian follicle	4180186
35624549	Nabothian cyst of cervix	4180186
35624549	Naboth follicles	4180186
35624556	Potassium and/or potassium compound (substance)	4180186
35624556	Potassium and/or potassium compound	4180186
35624556	Potassium and potassium compound (substance)	4180186
35624557	Potassium and/or potassium compound-containing product	4180186
35624557	Product containing potassium and/or potassium compound (product)	4180186
35624557	Product containing potassium and potassium compound (product)	4180186
35624559	Rhodium and/or rhodium compound	4180186
35624559	Rhodium and/or rhodium compound (substance)	4180186
35624559	Rhodium and rhodium compound (substance)	4180186
35624560	Rubidium and/or rubidium compound	4180186
35624560	Rubidium and/or rubidium compound (substance)	4180186
35624560	Rubidium and rubidium compound (substance)	4180186
35624561	Ruthenium and/or ruthenium compound	4180186
35624561	Ruthenium and/or ruthenium compound (substance)	4180186
35624561	Ruthenium and ruthenium compound (substance)	4180186
35624564	Surgical reduction of torsion of left testis with fixation of right testis (procedure)	4180186
35624566	Evacuated blood collection tube with heparin sodium (physical object)	4180186
35624568	Evacuated blood collection tube with clot activator (physical object)	4180186
35624570	Evacuated blood collection tube with sodium citrate 1/9 (physical object)	4180186
35624574	Evacuated blood collection tube with heparin lithium and gel separator (physical object)	4180186
35624575	Product containing metallic compound (product)	4180186
35624576	Product containing mercury compound (product)	4180186
35624577	Samarium and/or samarium compound (substance)	4180186
35624577	Samarium and/or samarium compound	4180186
35624577	Samarium and samarium compound (substance)	4180186
35624578	Selenium and/or selenium compound (substance)	4180186
35624578	Selenium and/or selenium compound	4180186
35624578	Selenium and selenium compound (substance)	4180186
35624579	Silver and/or silver compound	4180186
35624579	Silver and/or silver compound (substance)	4180186
35624579	Silver and silver compound (substance)	4180186
35624582	Sodium and/or sodium compound-containing product	4180186
35624582	Product containing sodium and/or sodium compound (product)	4180186
35624582	Product containing sodium and sodium compound (product)	4180186
35624584	Sulfite and/or sulfite derivative (substance)	4180186
35624584	Sulfite and/or sulfite derivative	4180186
35624584	Sulfite and sulfite derivative (substance)	4180186
35624591	Streptococcus suis antiserum (substance)	4180186
35624593	Pasteurella multocida antiserum (substance)	4180186
35624594	Erysipelothrix rhusiopathiae antiserum (substance)	4180186
35624595	Indium (113-In) chloride (substance)	4180186
35624596	Chlorhexidine digluconate (substance)	4180186
35624598	Tumour imaging agent	4180186
35624598	Tumor imaging agent (product)	4180186
35624599	Lung imaging agent (product)	4180186
35624600	Lung perfusion imaging agent (product)	4180186
35624601	Lung ventilation imaging agent (product)	4180186
35624602	Bone imaging agent (product)	4180186
35624603	Retrusion of lower lip	4180186
35624603	Retrusion of lower lip (finding)	4180186
35624606	Bone marrow imaging agent (product)	4180186
35624607	Colorectal imaging agent (product)	4180186
35624608	Kidney imaging agent (product)	4180186
35624611	Endocrine and exocrine imaging agent (product)	4180186
35624613	Heart and cardiovascular imaging agent (product)	4180186
35624615	Infection and inflammation imaging agent (product)	4180186
35624618	Congenital instability of left hip joint (disorder)	4180186
35624619	Congenital instability of right hip joint (disorder)	4180186
35624620	Thallium and/or thallium compound	4180186
35624620	Thallium and/or thallium compound (substance)	4180186
35624620	Thallium and thallium compound (substance)	4180186
35624622	Tin and/or tin compound	4180186
35624622	Tin and/or tin compound (substance)	4180186
35624622	Tin and tin compound (substance)	4180186
35624623	Titanium and/or titanium compound (substance)	4180186
35624623	Titanium and/or titanium compound	4180186
35624623	Titanium and titanium compound (substance)	4180186
35624625	Respiratory syncytial virus immune globulin (substance)	4180186
35624628	Allergy to fenugreek (finding)	4180186
35624629	Urea allergy	4180186
35624629	Allergy to urea (finding)	4180186
35624630	Allergy to salicylic acid (finding)	4180186
35624630	Salicylic acid allergy	4180186
35624631	Allergy to vitamin B12 and/or vitamin B12 derivative	4180186
35624631	Vitamin B12 and/or vitamin B12 derivative allergy	4180186
35624631	Allergy to vitamin B12 and/or vitamin B12 derivative (finding)	4180186
35624631	Vitamin B12 and vitamin B12 derivative allergy	4180186
35624631	Allergy to vitamin B12 and vitamin B12 derivative (finding)	4180186
35624632	Uranium and/or uranium compound (substance)	4180186
35624632	Uranium and/or uranium compound	4180186
35624632	Uranium and uranium compound (substance)	4180186
35624633	Poliomyelitis human immune globulin (substance)	4180186
35624636	Vanadium and/or vanadium compound	4180186
35624636	Vanadium and/or vanadium compound (substance)	4180186
35624636	Vanadium and vanadium compound (substance)	4180186
35624637	Ytterbium and/or ytterbium compound (substance)	4180186
35624637	Ytterbium and/or ytterbium compound	4180186
35624637	Ytterbium and ytterbium compound (substance)	4180186
35624638	Yttrium and/or yttrium compound (substance)	4180186
35624638	Yttrium and/or yttrium compound	4180186
35624638	Yttrium and yttrium compound (substance)	4180186
35624639	Zirconium and/or zirconium compound (substance)	4180186
35624639	Zirconium and/or zirconium compound	4180186
35624639	Zirconium and zirconium compound (substance)	4180186
35624641	Genus Trichomonascus	4180186
35624641	Genus Trichomonascus (organism)	4180186
35624644	Family Sporidiobolaceae (organism)	4180186
35624644	Family Sporidiobolaceae	4180186
35624645	Order Sporidiobolales (organism)	4180186
35624645	Order Sporidiobolales	4180186
35624646	Class Microbotryomycetes (organism)	4180186
35624646	Class Microbotryomycetes	4180186
35624647	Subdivision Pucciniomycotina (organism)	4180186
35624647	Subdivision Pucciniomycotina	4180186
35624649	Genus Pullulanibacillus (organism)	4180186
35624649	Genus Pullulanibacillus	4180186
35624650	Geotrichum suaveolens	4180186
35624650	Saprochaete suaveolens (organism)	4180186
35624650	Oidium suaveolens	4180186
35624650	Cylindrium suaveolens	4180186
35624651	NADH-methemoglobin reductase deficiency	4180186
35624651	Autosomal recessive congenital methemoglobinemia (disorder)	4180186
35624651	NADH-methaemoglobin reductase deficiency	4180186
35624651	Congenital methaemoglobinaemia due to NADH-cytochrome b5 reductase 3 deficiency	4180186
35624651	Cytochrome b5 reductase deficiency	4180186
35624651	Chronic familial methaemoglobin reductase deficiency	4180186
35624651	Chronic familial methemoglobin reductase deficiency	4180186
35624651	Congenital methemoglobinemia due to NADH-cytochrome b5 reductase 3 deficiency	4180186
35624651	Autosomal recessive congenital methaemoglobinaemia	4180186
35624651	Congenital NADH-methemoglobin reductase deficiency	4180186
35624651	Congenital NADH-methaemoglobin reductase deficiency	4180186
35624653	Autosomal recessive congenital methaemoglobinaemia type I	4180186
35624653	Autosomal recessive congenital methemoglobinemia type I (disorder)	4180186
35624654	Protrusion of lower lip (finding)	4180186
35624654	Protrusion of lower lip	4180186
35624655	Everted lower lip	4180186
35624655	Eversion of lower lip (finding)	4180186
35624657	Genus Millerozyma (organism)	4180186
35624657	Genus Millerozyma	4180186
35624658	Family Mrakiaceae (organism)	4180186
35624658	Family Mrakiaceae	4180186
35624659	Genus Tausonia	4180186
35624659	Genus Tausonia (organism)	4180186
35624660	Aspergillus iizukae (organism)	4180186
35624660	Fennellia flavipes	4180186
35624661	Genus Fennellia (organism)	4180186
35624661	Genus Fennellia	4180186
35624663	Rizatriptan 10mg conventional release oral lyophilisate (product)	4180186
35624664	Open burst fracture (morphologic abnormality)	4180186
35624667	Streptococcus pneumoniae serotype 3 antibody	4180186
35624667	Anti-Streptococcus pneumoniae Danish serotype 3 antibody	4180186
35624667	Streptococcus pneumoniae Danish serotype 3 antibody	4180186
35624667	Antibody to Streptococcus pneumoniae Danish serotype 3 (substance)	4180186
35624667	Antibody to Streptococcus pneumoniae American serotype 3	4180186
35624667	Antibody to Streptococcus pneumoniae Danish serotype 3	4180186
35624668	Antibody to Streptococcus pneumoniae American serotype 4	4180186
35624668	Antibody to Streptococcus pneumoniae Danish serotype 4 (substance)	4180186
35624668	Antibody to Streptococcus pneumoniae Danish serotype 4	4180186
35624668	Streptococcus pneumoniae Danish serotype 4 antibody	4180186
35624668	Anti-Streptococcus pneumoniae Danish serotype 4 antibody	4180186
35624668	Streptococcus pneumoniae serotype 4 antibody	4180186
35624671	Unit of measure (qualifier value)	4180186
35624675	Lipid, lipoprotein, and lipid related analyte (substance)	4180186
35624676	Bile acid and/or bile acid derivative	4180186
35624676	Bile acid and/or bile acid derivative (substance)	4180186
35624676	Bile acid and bile acid derivative (substance)	4180186
35624676	Bile acid and derivatives	4180186
35624677	Sebaceous cyst of skin (disorder)	4180186
35624683	Traumatic volar dislocation (morphologic abnormality)	4180186
35624688	Product containing isosorbide in transdermal dose form (medicinal product form)	4180186
35624689	Streptococcus pneumoniae Danish serotype 7A capsular polysaccharide Ag	4180186
35624689	Antigen of Streptococcus pneumoniae Danish serotype 7A capsular polysaccharide	4180186
35624689	Antigen of Streptococcus pneumoniae Danish serotype 7A capsular polysaccharide (substance)	4180186
35624689	Streptococcus pneumoniae American serotype 7 capsular polysaccharide antigen	4180186
35624692	Noradrenaline reuptake inhibitor and serotonin reuptake inhibitor-containing product	4180186
35624692	Product containing norepinephrine reuptake inhibitor and serotonin reuptake inhibitor (product)	4180186
35624693	Substance with gamma-aminobutyric acid A receptor agonist mechanism of action	4180186
35624693	Substance with gamma-aminobutyric acid A receptor agonist mechanism of action (substance)	4180186
35624698	Product containing gamma-aminobutyric acid receptor agonist (product)	4180186
35624700	Medicinal product acting as antiparasitic agent (product)	4180186
35624701	Streptococcus pneumoniae Danish serotype 1 capsular polysaccharide Ag	4180186
35624701	Antigen of Streptococcus pneumoniae Danish serotype 1 capsular polysaccharide	4180186
35624701	Antigen of Streptococcus pneumoniae Danish serotype 1 capsular polysaccharide (substance)	4180186
35624701	Streptococcus pneumoniae American serotype 1 capsular polysaccharide antigen	4180186
35624702	Streptococcus pneumoniae Danish serotype 4 capsular polysaccharide Ag	4180186
35624702	Streptococcus pneumoniae American serotype 4 capsular polysaccharide antigen	4180186
35624702	Antigen of Streptococcus pneumoniae Danish serotype 4 capsular polysaccharide	4180186
35624702	Antigen of Streptococcus pneumoniae Danish serotype 4 capsular polysaccharide (substance)	4180186
35624703	Product containing human tick borne encephalitis immunoglobulin in parenteral dose form (medicinal product form)	4180186
35624704	Operation on parathyroid gland during thyroidectomy (procedure)	4180186
35624705	Functional communication training (procedure)	4180186
35624705	FCT - functional communication training	4180186
35624706	Speech therapy for compensatory articulation (regime/therapy)	4180186
35624707	Moderate microalbuminuria due to exercise	4180186
35624707	Moderately increased albuminuria due to exercise	4180186
35624707	Moderately increased albuminuria due to exercise (finding)	4180186
35624708	Product containing flecainide in oral dose form (medicinal product form)	4180186
35624709	Difenidol-containing product	4180186
35624709	Product containing difenidol (medicinal product)	4180186
35624720	Product containing vigabatrin in oral dose form (medicinal product form)	4180186
35624722	Product containing vardenafil in oral dose form (medicinal product form)	4180186
35624724	Radionuclide measurement of leakage during isolated limb perfusion using technetium (99m-Tc) labeled erythrocytes (procedure)	4180186
35624724	Radionuclide measurement of leakage during isolated limb perfusion using technetium (99m-Tc) labelled erythrocytes	4180186
35624725	Facilitating symbolic play (procedure)	4180186
35624732	Product containing ethanolamine and/or ethanolamine derivative (product)	4180186
35624732	Ethanolamine and/or ethanolamine derivative-containing product	4180186
35624732	Product containing ethanolamine and ethanolamine derivative (product)	4180186
35624733	Ethylenediamine and/or ethylenediamine derivative (substance)	4180186
35624733	Ethylenediamine and/or ethylenediamine derivative	4180186
35624733	Ethylenediamine and derivatives	4180186
35624733	Ethylenediamine and ethylenediamine derivative (substance)	4180186
35624734	Turpentine and/or turpentine derivative	4180186
35624734	Turpentine and/or turpentine derivative (substance)	4180186
35624734	Turpentine and turpentine derivative (substance)	4180186
35624736	Protamine and/or protamine derivative (substance)	4180186
35624736	Protamine and/or protamine derivative	4180186
35624736	Protamine and protamine derivative (substance)	4180186
35624737	Salmeterol+fluticasone propionate 25micrograms/250micrograms inhaler (product)	4180186
35624738	Salmeterol+fluticasone propionate 25micrograms/125micrograms inhaler (product)	4180186
35624740	Ipratropium bromide 17 mcg/actuation inhaler (product)	4180186
35624746	Varicella-zoster immunization	4180186
35624746	Varicella-zoster vaccination	4180186
35624746	Administration of vaccine product containing only Human alphaherpesvirus 3 antigen (procedure)	4180186
35624746	Administration of vaccine product containing only Human alphaherpesvirus 3 antigen	4180186
35624746	Varicella-zoster immunisation	4180186
35624746	Administration of vaccine product containing only Varicella-zoster virus antigen	4180186
35624747	Bipolar I disorder, most recent episode manic (disorder)	4180186
35624750	Bupivacaine 3.75mg/mL(0.375%) injection solution (product)	4180186
35624753	Allergy to benzodiazepine (finding)	4180186
35624753	Benzodiazepine allergy	4180186
35624754	573 (qualifier value)	4180186
35624754	Five hundred and seventy-three	4180186
35624756	Anaemia due to and following chemotherapy	4180186
35624756	Anemia due to and following chemotherapy (disorder)	4180186
35624757	Neutropenia due to and following chemotherapy (disorder)	4180186
35624757	Neutropaenia due to and following chemotherapy	4180186
35624758	Peripheral neuropathy due to and following chemotherapy	4180186
35624758	Peripheral neuropathy due to and following antineoplastic therapy (disorder)	4180186
35624758	CIPN - Chemotherapy-induced peripheral neuropathy	4180186
35624759	Epithelial inclusion cyst of eyelid (disorder)	4180186
35624760	Epidermal inclusion cyst of eyelid (disorder)	4180186
35624761	Genus Petrimonas	4180186
35624761	Petrimonas species	4180186
35624761	Genus Petrimonas (organism)	4180186
35624767	Recurrent irreducible left inguinal hernia (disorder)	4180186
35624768	Recurrent irreducible right inguinal hernia (disorder)	4180186
35624770	Recurrent right inguinal hernia (disorder)	4180186
35624771	Gangrene co-occurrent and due to recurrent right inguinal hernia (disorder)	4180186
35624773	Gangrene without obstruction co-occurrent and due to recurrent left inguinal hernia (disorder)	4180186
35624774	Gangrene without obstruction co-occurrent and due to recurrent right inguinal hernia (disorder)	4180186
35624775	Gangrene and obstruction co-occurrent and due to recurrent left inguinal hernia (disorder)	4180186
35624776	Gangrene and obstruction co-occurrent and due to recurrent right inguinal hernia (disorder)	4180186
35624778	Irreducible right inguinal hernia (disorder)	4180186
35624779	Bipyridine (substance)	4180186
35624780	Obstruction without gangrene co-occurrent and due to right inguinal hernia (disorder)	4180186
35624781	Obstruction without gangrene co-occurrent and due to left inguinal hernia (disorder)	4180186
35624782	Pelvic binder (physical object)	4180186
35624783	Rigid video hysteroscope (physical object)	4180186
35624785	Remote control insulin infusion patch pump blood glucose analyser	4180186
35624785	Remote control insulin infusion patch pump blood glucose analyzer (physical object)	4180186
35624786	Insulin infusion patch pump administration set (physical object)	4180186
35624788	Mouldable first aid limb splint (physical object)	4180186
35624791	Product containing dexmethylphenidate (medicinal product)	4180186
35624792	Emergency airway clearance suction plunger (physical object)	4180186
35624794	Facial prosthesis implant attachment (physical object)	4180186
35624795	Mechanical positive pressure airway secretion-clearing device sensor (physical object)	4180186
35624796	Anal sphincter surgical ribbon (physical object)	4180186
35624797	Surgical colonic irrigation kit (physical object)	4180186
35624798	Anal fistula seton (physical object)	4180186
35624799	Factor IX deficiency (disorder)	4180186
35624800	Factor XI deficiency (disorder)	4180186
35624804	Mineralocorticoid derivative (substance)	4180186
35624807	Mediator of immune response and inflammation (substance)	4180186
35624809	Ferric ion (substance)	4180186
35624809	Iron III ion	4180186
35624811	Product containing darifenacin in oral dose form (medicinal product form)	4180186
35624812	Product containing didanosine in oral dose form (medicinal product form)	4180186
35624815	Product containing duloxetine in oral dose form (medicinal product form)	4180186
35624816	Product containing doxazosin in oral dose form (medicinal product form)	4180186
35624821	Product containing ergotamine in sublingual dose form (medicinal product form)	4180186
35624825	Obstruction co-occurrent and due to bilateral inguinal hernia (disorder)	4180186
35624826	Laparoscopic adenomyomectomy (procedure)	4180186
35624828	Product containing mizolastine in oral dose form (medicinal product form)	4180186
35624829	Product containing mexiletine in oral dose form (medicinal product form)	4180186
35624830	Product containing mirabegron in oral dose form (medicinal product form)	4180186
35624831	Product containing montelukast in oral dose form (medicinal product form)	4180186
35624832	Product containing mebeverine in oral dose form (medicinal product form)	4180186
35624834	Product containing pentoxifylline in oral dose form (medicinal product form)	4180186
35624837	Product containing phenylbutazone in oral dose form (medicinal product form)	4180186
35624839	Product containing rabeprazole in oral dose form (medicinal product form)	4180186
35624840	Product containing quinidine in oral dose form (medicinal product form)	4180186
35624841	Product containing pseudoephedrine in oral dose form (medicinal product form)	4180186
35624842	Product containing prochlorperazine in oromucosal dose form (medicinal product form)	4180186
35624843	Niobium (substance)	4180186
35624843	Columbium	4180186
35624845	Product containing trospium in oral dose form (medicinal product form)	4180186
35624853	Product containing fesoterodine in oral dose form (medicinal product form)	4180186
35624854	Product containing felodipine in oral dose form (medicinal product form)	4180186
35624855	Product containing guaifenesin in oral dose form (medicinal product form)	4180186
35624856	Product containing hydrocortisone in oromucosal dose form (medicinal product form)	4180186
35624858	Product containing codeine and ibuprofen in oral dose form (medicinal product form)	4180186
35624860	Product containing isosorbide in parenteral dose form (medicinal product form)	4180186
35624863	Product containing isosorbide in oral dose form (medicinal product form)	4180186
35624864	Product containing lanthanum carbonate in oral dose form (medicinal product form)	4180186
35624867	Chronic hepatitis C caused by hepatitis C virus genotype 5 (disorder)	4180186
35624868	Facial lesion	4180186
35624868	Lesion of face (finding)	4180186
35624869	Neoplasm of bone of hand (disorder)	4180186
35624870	Neoplasm of humerus (disorder)	4180186
35624872	Embryonic cyst of omentum (disorder)	4180186
35624872	Congenital cyst of omentum	4180186
35624873	Neoplasm of cervical vertebra (disorder)	4180186
35624874	Neoplasm of bone of sacrum (disorder)	4180186
35624875	Product containing precisely verapamil hydrochloride 120 milligram/1 each prolonged-release oral tablet (clinical drug)	4180186
35624876	Gangrene and obstruction co-occurrent and due to left inguinal hernia (disorder)	4180186
35624877	Gangrene and obstruction co-occurrent and due to right inguinal hernia (disorder)	4180186
35624880	Product containing alprazolam in oral dose form (medicinal product form)	4180186
35624882	Product containing aliskiren and valsartan in oral dose form (medicinal product form)	4180186
35624883	Product containing aliskiren and hydrochlorothiazide in oral dose form (medicinal product form)	4180186
35624887	Product containing alosetron in oral dose form (medicinal product form)	4180186
35624889	Salmonella Typhi capsular polysaccharide Vi Ag	4180186
35624889	Antigen of Salmonella enterica subspecies enterica serovar Typhi capsular polysaccharide Vi (substance)	4180186
35624889	Salmonella enterica subspecies enterica serovar Typhi capsular polysaccharide Vi Ag	4180186
35624889	Antigen of Salmonella enterica subspecies enterica serovar Typhi capsular polysaccharide Vi	4180186
35624889	Salmonella Typhi capsular polysaccharide Vi antigen	4180186
35624891	Organic cyclic compound (substance)	4180186
35624894	Bone cyst of femur (disorder)	4180186
35624898	Product containing abiraterone in oral dose form (medicinal product form)	4180186
35624899	Product containing afatinib in oral dose form (medicinal product form)	4180186
35624901	Product containing aminoglutethimide in oral dose form (medicinal product form)	4180186
35624902	Product containing altretamine in oral dose form (medicinal product form)	4180186
35624903	Product containing amantadine in oral dose form (medicinal product form)	4180186
35624904	Product containing ambenonium in oral dose form (medicinal product form)	4180186
35624905	Product containing acetohexamide in oral dose form (medicinal product form)	4180186
35624907	Product containing amlodipine and atorvastatin in oral dose form (medicinal product form)	4180186
35624908	Product containing amiloride and furosemide in oral dose form (medicinal product form)	4180186
35624909	Product containing amiloride and cyclopenthiazide in oral dose form (medicinal product form)	4180186
35624910	Product containing amiloride and hydrochlorothiazide in oral dose form (medicinal product form)	4180186
35624911	Product containing amitriptyline and chlordiazepoxide (medicinal product)	4180186
35624913	Product containing amitriptyline and perphenazine in oral dose form (medicinal product form)	4180186
35624916	Simeticone-containing product in oral dose form	4180186
35624916	Product containing simeticone in oral dose form (medicinal product form)	4180186
35624917	Product containing amobarbital and secobarbital in oral dose form (medicinal product form)	4180186
35624918	Product containing amlodipine and valsartan in oral dose form (medicinal product form)	4180186
35624919	Product containing amlodipine and benazepril in oral dose form (medicinal product form)	4180186
35624923	Alimemazine-containing product in oral dose form	4180186
35624923	Product containing alimemazine in oral dose form (medicinal product form)	4180186
35624924	Product containing amobarbital in oral dose form (medicinal product form)	4180186
35624927	Product containing ampicillin and flucloxacillin in oral dose form (medicinal product form)	4180186
35624927	Ampicillin- and flucloxacillin-containing product in oral dose form	4180186
35624930	Product containing astemizole in oral dose form (medicinal product form)	4180186
35624933	Product containing ascorbic acid and cyanocobalamin and ferrous fumarate (medicinal product)	4180186
35624936	Product containing aspirin and hydrocodone in oral dose form (medicinal product form)	4180186
35624944	Post bronchodilator spirometry (procedure)	4180186
35624945	Product containing cefaclor in oral dose form (medicinal product form)	4180186
35624946	Product containing carbidopa in oral dose form (medicinal product form)	4180186
35624947	Product containing cefadroxil in oral dose form (medicinal product form)	4180186
35624948	Carbocisteine in oral dosage form	4180186
35624948	Product containing carbocisteine in oral dosage form	4180186
35624948	Product containing carbocisteine in oral dosage form (medicinal product form)	4180186
35624949	Product containing cefradine in oral dose form (medicinal product form)	4180186
35624949	Cefradine-containing product in oral dose form	4180186
35624950	Product containing carbimazole in oral dose form (medicinal product form)	4180186
35624951	Product containing carbinoxamine in oral dose form (medicinal product form)	4180186
35624952	Product containing acebutolol and hydrochlorothiazide in oral dose form (medicinal product form)	4180186
35624955	Product containing aspirin and butalbital and caffeine and codeine (medicinal product)	4180186
35624957	Product containing aspirin and butalbital and caffeine and codeine in oral dose form (medicinal product form)	4180186
35624958	Product containing aspirin and oxycodone (medicinal product)	4180186
35624960	Product containing aspirin and carisoprodol and codeine (medicinal product)	4180186
35624961	Product containing aspirin and carisoprodol and codeine in oral dose form (medicinal product form)	4180186
35624963	Product containing aspirin and caffeine and dihydrocodeine (medicinal product)	4180186
35624964	Product containing buspirone in oral dose form (medicinal product form)	4180186
35624969	Product containing benazepril in oral dose form (medicinal product form)	4180186
35624972	Product containing azatadine in oral dose form (medicinal product form)	4180186
35624974	Product containing atropine and diphenoxylate (medicinal product)	4180186
35624975	Product containing atropine and diphenoxylate in oral dose form (medicinal product form)	4180186
35624976	Product containing bosutinib in oral dose form (medicinal product form)	4180186
35624979	Product containing bromazepam in oral dose form (medicinal product form)	4180186
35624980	Product containing bisoprolol and hydrochlorothiazide in oral dose form (medicinal product form)	4180186
35624982	Product containing domperidone in oral dose form (medicinal product form)	4180186
35624985	Product containing distigmine in oral dose form (medicinal product form)	4180186
35624990	Product containing deflazacort in oral dose form (medicinal product form)	4180186
35624991	Product containing dabrafenib in oral dose form (medicinal product form)	4180186
35624993	Product containing desmopressin in oral dose form (medicinal product form)	4180186
35624994	Product containing desloratadine in oral dose form (medicinal product form)	4180186
35624997	Product containing dihydroergotamine in oral dose form (medicinal product form)	4180186
35624998	Product containing diloxanide and metronidazole in oral dose form (medicinal product form)	4180186
35624999	Product containing dihydrotachysterol in oral dose form (medicinal product form)	4180186
35625000	Product containing dienogest in oral dose form (medicinal product form)	4180186
35625004	Product containing dasatinib in oral dose form (medicinal product form)	4180186
35625007	Product containing delavirdine in oral dose form (medicinal product form)	4180186
35625011	Product containing dantron and poloxamer 188 in oral dose form (medicinal product form)	4180186
35625011	Dantron- and poloxamer 188-containing product in oral dose form	4180186
35625013	Dantron- and docusate-containing product	4180186
35625013	Product containing dantron and docusate (medicinal product)	4180186
35625018	Product containing fenofibrate in oral dose form (medicinal product form)	4180186
35625019	Product containing febuxostat in oral dose form (medicinal product form)	4180186
35625020	Product containing felbamate in oral dose form (medicinal product form)	4180186
35625022	Product containing ezetimibe and simvastatin in oral dose form (medicinal product form)	4180186
35625024	Product containing clemastine in oral dose form (medicinal product form)	4180186
35625027	Product containing citalopram in oral dose form (medicinal product form)	4180186
35625029	Gangrene and obstruction co-occurrent and due to right femoral hernia (disorder)	4180186
35625031	Product containing azatadine and pseudoephedrine (medicinal product)	4180186
35625034	Product containing benazepril and hydrochlorothiazide in oral dose form (medicinal product form)	4180186
35625036	Atropine- and hyoscine- and hyoscyamine-containing product	4180186
35625036	Product containing atropine and hyoscyamine and scopolamine (medicinal product)	4180186
35625040	Chronic hepatitis C caused by Hepatitis C virus genotype 3 (disorder)	4180186
35625041	Peptide hormone (substance)	4180186
35625043	Late effect of homicidal assault	4180186
35625043	Late effect due to homicide attempt (disorder)	4180186
35625044	Deep impinging overbite with soft tissue destruction (disorder)	4180186
35625045	Product containing atropine and difenoxin in oral dose form (medicinal product form)	4180186
35625046	Product containing bendroflumethiazide in oral dose form (medicinal product form)	4180186
35625047	Product containing bezafibrate in oral dose form (medicinal product form)	4180186
35625048	Product containing betahistine in oral dose form (medicinal product form)	4180186
35625050	Product containing benzonatate in oral dose form (medicinal product form)	4180186
35625052	Product containing belladonna alkaloid and ergotamine and phenobarbital (medicinal product)	4180186
35625053	Product containing belladonna alkaloid and ergotamine and phenobarbital in oral dose form (medicinal product form)	4180186
35625054	Product containing bethanechol in oral dose form (medicinal product form)	4180186
35625055	Product containing bosentan in oral dose form (medicinal product form)	4180186
35625057	Betanidine-containing product in oral dose form	4180186
35625057	Product containing betanidine in oral dose form (medicinal product form)	4180186
35625060	Product containing bismuth biskalcitrate and metronidazole and tetracycline in oral dose form (medicinal product form)	4180186
35625065	Product containing busulfan in oral dose form (medicinal product form)	4180186
35625068	Product containing calcium carbonate in oral dose form (medicinal product form)	4180186
35625069	Product containing calcium lactate in oral dose form (medicinal product form)	4180186
35625070	Calcium carbonate- and colecalciferol-containing product in oral dose form	4180186
35625070	Product containing calcium carbonate and colecalciferol in oral dose form (medicinal product form)	4180186
35625071	Product containing cabergoline in oral dose form (medicinal product form)	4180186
35625073	Product containing candesartan in oral dose form (medicinal product form)	4180186
35625075	Product containing captopril in oral dose form (medicinal product form)	4180186
35625076	Product containing captopril and hydrochlorothiazide in oral dose form (medicinal product form)	4180186
35625079	Product containing carbinoxamine and pseudoephedrine (medicinal product)	4180186
35625086	Product containing cerivastatin in oral dose form (medicinal product form)	4180186
35625089	Product containing chlorothiazide and methyldopa in oral dose form (medicinal product form)	4180186
35625090	Product containing ceritinib in oral dose form (medicinal product form)	4180186
35625092	Chlorphenamine- and mepyramine- and phenylephrine- and phenylpropanolamine-containing product	4180186
35625092	Product containing chlorphenamine and mepyramine and phenylephrine and phenylpropanolamine (medicinal product)	4180186
35625093	Chlorphenamine- and mepyramine- and phenylephrine- and phenylpropanolamine-containing product in oral dose form	4180186
35625093	Product containing chlorphenamine and mepyramine and phenylephrine and phenylpropanolamine in oral dose form (medicinal product form)	4180186
35625095	Insecticide (disposition)	4180186
35625097	Product containing choline magnesium trisalicylate in oral dose form (medicinal product form)	4180186
35625098	Pyrethroid (substance)	4180186
35625101	Product containing chlorpropamide in oral dose form (medicinal product form)	4180186
35625102	Product containing cilostazol in oral dose form (medicinal product form)	4180186
35625105	Gangrene co-occurrent and due to left femoral hernia (disorder)	4180186
35625107	Gangrene co-occurrent and due to left recurrent femoral hernia (disorder)	4180186
35625108	Gangrene co-occurrent and due to right recurrent femoral hernia (disorder)	4180186
35625110	Product containing cinnarizine in oral dose form (medicinal product form)	4180186
35625111	Product containing choline and dexpanthenol (medicinal product)	4180186
35625115	Product containing clorazepate in oral dose form (medicinal product form)	4180186
35625121	Recurrent simple left femoral hernia (disorder)	4180186
35625123	Product containing desvenlafaxine in oral dose form (medicinal product form)	4180186
35625124	Diclofenamide-containing product in oral dose form	4180186
35625124	Product containing diclofenamide in oral dose form (medicinal product form)	4180186
35625125	Product containing diazoxide in oral dose form (medicinal product form)	4180186
35625127	Product containing novobiocin in oral dose form (medicinal product form)	4180186
35625131	Product containing diphenhydramine and ibuprofen in oral dose form (medicinal product form)	4180186
35625132	Product containing diiodohydroxyquinoline in oral dose form (medicinal product form)	4180186
35625132	Diiodohydroxyquinoline-containing product in oral dose form	4180186
35625136	Product containing diclofenac and misoprostol (medicinal product)	4180186
35625137	Product containing diclofenac and misoprostol in oral dose form (medicinal product form)	4180186
35625139	Chronic hepatitis C caused by Hepatitis C virus genotype 2 (disorder)	4180186
35625140	Chronic hepatitis C caused by Hepatitis C virus genotype 4 (disorder)	4180186
35625143	Product containing dexchlorpheniramine in oral dose form (medicinal product form)	4180186
35625144	Product containing dextromoramide in oral dose form (medicinal product form)	4180186
35625146	Dexamfetamine-containing product in oral dose form	4180186
35625146	Product containing dexamfetamine in oral dose form (medicinal product form)	4180186
35625148	Product containing ephedrine and guaifenesin in oral dose form (medicinal product form)	4180186
35625149	Product containing encainide in oral dose form (medicinal product form)	4180186
35625154	Product containing enalapril and hydrochlorothiazide in oral dose form (medicinal product form)	4180186
35625155	Product containing enoxacin in oral dose form (medicinal product form)	4180186
35625156	Product containing entacapone in oral dose form (medicinal product form)	4180186
35625158	Product containing dutasteride and tamsulosin in oral dose form (medicinal product form)	4180186
35625160	Product containing drospirenone and ethinylestradiol in oral dose form (medicinal product form)	4180186
35625160	Drospirenone- and ethinylestradiol-containing product in oral dose form	4180186
35625161	Injury due to car accident (disorder)	4180186
35625161	Car accident injury	4180186
35625161	Injury from car accident	4180186
35625162	Device adherence (finding)	4180186
35625163	Product containing ropinirole in oral dose form (medicinal product form)	4180186
35625164	Product containing rivaroxaban in oral dose form (medicinal product form)	4180186
35625166	Product containing rosuvastatin in oral dose form (medicinal product form)	4180186
35625173	Holdemanella biformis (organism)	4180186
35625174	Cellulomonas denverensis (organism)	4180186
35625177	Product containing repaglinide in oral dose form (medicinal product form)	4180186
35625178	Product containing rilpivirine in oral dose form (medicinal product form)	4180186
35625182	Genus Holdemanella (organism)	4180186
35625182	Genus Holdemanella	4180186
35625184	Rouxiella badensis (organism)	4180186
35625186	Genus Sporacetigenium (organism)	4180186
35625186	Genus Sporacetigenium	4180186
35625187	Sporacetigenium mesophilum (organism)	4180186
35625188	Stenotrophomonas chelatiphaga (organism)	4180186
35625189	Stenotrophomonas tumulicola (organism)	4180186
35625190	Product containing regorafenib in oral dose form (medicinal product form)	4180186
35625201	Product containing ephedrine and theophylline in oral dose form (medicinal product form)	4180186
35625204	Product containing thalidomide in oral dose form (medicinal product form)	4180186
35625205	Product containing thyroid hormone in oral dose form (medicinal product form)	4180186
35625211	Product containing telmisartan in oral dose form (medicinal product form)	4180186
35625212	Product containing telithromycin in oral dose form (medicinal product form)	4180186
35625213	Product containing tenoxicam in oral dose form (medicinal product form)	4180186
35625214	Product containing terfenadine in oral dose form (medicinal product form)	4180186
35625218	Product containing amlodipine and telmisartan in oral dose form (medicinal product form)	4180186
35625219	Product containing hydrochlorothiazide and telmisartan in oral dose form (medicinal product form)	4180186
35625222	Product containing tadalafil in oral dose form (medicinal product form)	4180186
35625225	Product containing tasimelteon in oral dose form (medicinal product form)	4180186
35625228	Product containing telbivudine in oral dose form (medicinal product form)	4180186
35625230	Product containing esomeprazole in oral dose form (medicinal product form)	4180186
35625232	Product containing eplerenone in oral dose form (medicinal product form)	4180186
35625233	Product containing eprosartan in oral dose form (medicinal product form)	4180186
35625234	Fatty acid ethyl ester (substance)	4180186
35625235	Product containing pravastatin in oral dose form (medicinal product form)	4180186
35625236	Product containing prasugrel in oral dose form (medicinal product form)	4180186
35625239	Product containing pregabalin in oral dose form (medicinal product form)	4180186
35625240	Product containing quinagolide in oral dose form (medicinal product form)	4180186
35625241	Product containing hydrochlorothiazide and quinapril in oral dose form (medicinal product form)	4180186
35625242	Product containing raloxifene in oral dose form (medicinal product form)	4180186
35625243	Product containing raltegravir in oral dose form (medicinal product form)	4180186
35625244	Product containing ramelteon in oral dose form (medicinal product form)	4180186
35625247	Product containing estriol in oral dose form (medicinal product form)	4180186
35625251	Product containing eszopiclone in oral dose form (medicinal product form)	4180186
35625252	Product containing etamsylate in oral dose form (medicinal product form)	4180186
35625255	Product containing etynodiol in oral dose form (medicinal product form)	4180186
35625255	Etynodiol-containing product in oral dose form	4180186
35625258	Product containing phenylpropanolamine in oral dose form (medicinal product form)	4180186
35625263	Product containing ponatinib in oral dose form (medicinal product form)	4180186
35625266	Product containing conjugated estrogen and norgestrel in oral dose form (medicinal product form)	4180186
35625268	Product containing cobalt chloride in oral dose form (medicinal product form)	4180186
35625269	Product containing cobalt-57 in oral dose form (medicinal product form)	4180186
35625270	Product containing cyclobenzaprine in oral dose form (medicinal product form)	4180186
35625273	Product containing cyproheptadine in oral dose form (medicinal product form)	4180186
35625274	Product containing colchicine in oral dose form (medicinal product form)	4180186
35625276	Product containing colestipol in oral dose form (medicinal product form)	4180186
35625279	Product containing cyproterone in oral dose form (medicinal product form)	4180186
35625282	Product containing cyclopenthiazide in oral dose form (medicinal product form)	4180186
35625283	Ergometrine-containing product in oral dose form	4180186
35625283	Product containing ergometrine in oral dose form (medicinal product form)	4180186
35625284	Product containing ethinylestradiol in oral dose form (medicinal product form)	4180186
35625284	Ethinylestradiol-containing product in oral dose form	4180186
35625286	Ethinylestradiol- and levonorgestrel-containing product in oral dose form	4180186
35625286	Product containing ethinylestradiol and levonorgestrel in oral dose form (medicinal product form)	4180186
35625288	Technetium (99m-Tc) tilmanocept (substance)	4180186
35625289	Product containing vortioxetine (medicinal product)	4180186
35625290	Product containing vortioxetine in oral dose form (medicinal product form)	4180186
35625291	Product containing precisely vortioxetine (as vortioxetine hydrobromide) 5 milligram/1 each conventional release oral tablet (clinical drug)	4180186
35625298	Product containing metformin and pioglitazone in oral dose form (medicinal product form)	4180186
35625305	Product containing potassium iodate in oral dose form (medicinal product form)	4180186
35625307	Product containing potassium perchlorate in oral dose form (medicinal product form)	4180186
35625308	Product containing sevelamer in oral dose form (medicinal product form)	4180186
35625309	Product containing precisely dolutegravir (as dolutegravir sodium) 10 milligram/1 each conventional release oral tablet (clinical drug)	4180186
35625310	Product containing precisely dolutegravir (as dolutegravir sodium) 25 milligram/1 each conventional release oral tablet (clinical drug)	4180186
35625311	Product containing precisely dolutegravir (as dolutegravir sodium) 50 milligram/1 each conventional release oral tablet (clinical drug)	4180186
35625312	Product containing phospholipid (product)	4180186
35625314	Product containing vorinostat in oral dose form (medicinal product form)	4180186
35625315	Product containing vismodegib in oral dose form (medicinal product form)	4180186
35625317	Product containing vemurafenib in oral dose form (medicinal product form)	4180186
35625318	Product containing valsartan in oral dose form (medicinal product form)	4180186
35625319	Product containing troglitazone in oral dose form (medicinal product form)	4180186
35625322	Product containing ulipristal in oral dose form (medicinal product form)	4180186
35625330	Product containing ethinylestradiol and norgestrel in oral dose form (medicinal product form)	4180186
35625330	Ethinylestradiol- and norgestrel-containing product in oral dose form	4180186
35625332	Ethinylestradiol- and norethisterone-containing product in oral dose form	4180186
35625332	Product containing ethinylestradiol and norethisterone in oral dose form (medicinal product form)	4180186
35625336	Product containing ferrous fumarate in oral dose form (medicinal product form)	4180186
35625337	Product containing ferrous fumarate and folic acid in oral dose form (medicinal product form)	4180186
35625339	Product containing ascorbic acid and ferrous gluconate and folic acid in oral dose form (medicinal product form)	4180186
35625341	Product containing fenofibric acid in oral dose form (medicinal product form)	4180186
35625344	Product containing flavoxate in oral dose form (medicinal product form)	4180186
35625345	Eseridine (substance)	4180186
35625345	Geneserine	4180186
35625349	Loperamide- and simeticone-containing product in oral dose form	4180186
35625349	Product containing loperamide and simeticone in oral dose form (medicinal product form)	4180186
35625351	Product containing lomustine in oral dose form (medicinal product form)	4180186
35625352	Product containing lisuride in oral dose form (medicinal product form)	4180186
35625354	Product containing lofepramine in oral dose form (medicinal product form)	4180186
35625355	Fumaria (substance)	4180186
35625356	Fumaria officinalis extract (substance)	4180186
35625356	Fumaria officinalis extract	4180186
35625357	Product containing metirosine in oral dose form (medicinal product form)	4180186
35625357	Metirosine-containing product in oral dose form	4180186
35625358	Product containing mianserin in oral dose form (medicinal product form)	4180186
35625360	Product containing milnacipran in oral dose form (medicinal product form)	4180186
35625362	Product containing miglitol in oral dose form (medicinal product form)	4180186
35625365	Meningococcus group A vaccine (substance)	4180186
35625369	Retinol oleate (substance)	4180186
35625369	Retinyl oleate	4180186
35625370	Polygala (substance)	4180186
35625371	Product containing nateglinide in oral dose form (medicinal product form)	4180186
35625379	Product containing nebivolol in oral dose form (medicinal product form)	4180186
35625380	Product containing naftidrofuryl in oral dose form (medicinal product form)	4180186
35625380	Naftidrofuryl-containing product in oral dose form	4180186
35625383	Product containing nefopam in oral dose form (medicinal product form)	4180186
35625385	Product containing nicorandil in oral dose form (medicinal product form)	4180186
35625387	Product containing ranolazine in oral dose form (medicinal product form)	4180186
35625392	Product containing fluvastatin in oral dose form (medicinal product form)	4180186
35625393	Product containing fosamprenavir in oral dose form (medicinal product form)	4180186
35625395	Product containing fluorouracil in oral dose form (medicinal product form)	4180186
35625397	Product containing fluphenazine and nortriptyline in oral dose form (medicinal product form)	4180186
35625399	Folinic acid-containing product in oral dose form	4180186
35625399	Product containing folinic acid in oral dose form (medicinal product form)	4180186
35625400	Hydrocodone- and paracetamol-containing product	4180186
35625400	Product containing hydrocodone and paracetamol (medicinal product)	4180186
35625401	Product containing hydrocodone and ibuprofen (medicinal product)	4180186
35625405	Product containing hydrocodone in oral dose form (medicinal product form)	4180186
35625409	Product containing gabapentin in oral dose form (medicinal product form)	4180186
35625411	Product containing gestrinone in oral dose form (medicinal product form)	4180186
35625414	Product containing trandolapril in oral dose form (medicinal product form)	4180186
35625415	Product containing furosemide and triamterene in oral dose form (medicinal product form)	4180186
35625422	Product containing lithium succinate in cutaneous dose form (medicinal product form)	4180186
35625424	Product containing selenium and/or selenium compound (product)	4180186
35625424	Selenium and/or selenium compound-containing product	4180186
35625424	Product containing selenium and selenium compound (product)	4180186
35625425	Product containing selenium-75 in oral dose form (medicinal product form)	4180186
35625428	Product containing magnesium chloride in parenteral dose form (medicinal product form)	4180186
35625430	Product containing magnesium malate in oral dose form (medicinal product form)	4180186
35625433	Product containing indium and/or indium compound (product)	4180186
35625433	Indium and/or indium compound-containing product	4180186
35625433	Product containing indium and indium compound (product)	4180186
35625434	Product containing indium (medicinal product)	4180186
35625437	Product containing aluminium hydroxide and magnesium hydroxide in oral dose form (medicinal product form)	4180186
35625437	Aluminium hydroxide- and magnesium hydroxide-containing product in oral dose form	4180186
35625438	Cobalt and/or cobalt compound-containing product	4180186
35625438	Product containing cobalt and/or cobalt compound (product)	4180186
35625438	Product containing cobalt and cobalt compound (product)	4180186
35625441	Chromium and/or chromium compound-containing product	4180186
35625441	Product containing chromium and/or chromium compound (product)	4180186
35625441	Product containing chromium and chromium compound (product)	4180186
35625442	Carbon and/or carbon compound-containing product	4180186
35625442	Product containing carbon and/or carbon compound (product)	4180186
35625442	Product containing carbon and carbon compound (product)	4180186
35625447	Copper and/or copper compound-containing product	4180186
35625447	Product containing copper and/or copper compound (product)	4180186
35625447	Product containing copper and copper compound (product)	4180186
35625448	Product containing copper radioisotope (product)	4180186
35625451	Product containing iron and/or iron compound (product)	4180186
35625451	Iron and/or iron compound-containing product	4180186
35625451	Product containing iron and iron compound (product)	4180186
35625455	Product containing sodium iodide in parenteral dose form (medicinal product form)	4180186
35625456	Product containing phosphorus radioisotope (product)	4180186
35625458	Product containing polypeptide (product)	4180186
35625461	16p12.2 microdeletion	4180186
35625461	16p12.2 microdeletion syndrome (disorder)	4180186
35625463	Purine rich element binding protein A syndrome (disorder)	4180186
35625463	Purine rich element binding protein A syndrome	4180186
35625463	PURA (purine rich element binding protein A) syndrome	4180186
35625463	PURA-related severe neonatal hypotonia, seizure, encephalopathy syndrome	4180186
35625463	PURA-related neurodevelopmental disorder	4180186
35625464	Exercise therapy with supervision by healthcare professional	4180186
35625464	Supervision of exercise therapy by healthcare professional (regime/therapy)	4180186
35625466	Branching hyphae of kingdom Fungi detected (finding)	4180186
35625466	Branching hyphae of fungus detected	4180186
35625466	Finding of presence of branching fungal hyphae	4180186
35625467	Product containing toremifene in oral dose form (medicinal product form)	4180186
35625470	Product containing paracetamol and phenyltoloxamine (medicinal product)	4180186
35625470	Paracetamol- and phenyltoloxamine-containing product	4180186
35625473	Broad irregular hyphae of fungus detected	4180186
35625473	Finding of presence of broad irregular fungal hyphae	4180186
35625473	Broad irregular hyphae of kingdom Fungi detected (finding)	4180186
35625475	Sulfadiazine sodium (substance)	4180186
35625476	Levomenol (substance)	4180186
35625477	Telavancin hydrochloride (substance)	4180186
35625478	Dexamethasone isonicotinate (substance)	4180186
35625480	Revision of one component of total prosthetic replacement of hip joint not using cement (procedure)	4180186
35625481	Glibenclamide-containing product in oral dose form	4180186
35625481	Product containing glibenclamide in oral dose form (medicinal product form)	4180186
35625482	Product containing glibenclamide and metformin (medicinal product)	4180186
35625482	Glibenclamide- and metformin-containing product	4180186
35625485	Product containing glimepiride and pioglitazone in oral dose form (medicinal product form)	4180186
35625486	Product containing glimepiride and rosiglitazone in oral dose form (medicinal product form)	4180186
35625487	Product containing glipizide in oral dose form (medicinal product form)	4180186
35625488	Product containing glipizide and metformin (medicinal product)	4180186
35625489	Product containing glipizide and metformin in oral dose form (medicinal product form)	4180186
35625493	Product containing guanadrel in oral dose form (medicinal product form)	4180186
35625494	Product containing aurothioglucose (medicinal product)	4180186
35625496	Product containing guanethidine and hydrochlorothiazide in oral dose form (medicinal product form)	4180186
35625497	Product containing guaifenesin and theophylline in oral dose form (medicinal product form)	4180186
35625499	Product containing guanfacine in oral dose form (medicinal product form)	4180186
35625500	Product containing guanidine in oral dose form (medicinal product form)	4180186
35625502	Product containing acenocoumarol in oral dose form (medicinal product form)	4180186
35625504	Product containing alendronic acid and colecalciferol in oral dose form (medicinal product form)	4180186
35625504	Alendronic acid- and colecalciferol-containing product in oral dose form	4180186
35625505	Product containing desmopressin in nasal dose form (medicinal product form)	4180186
35625507	Product containing alpha-tocopherol in oral dose form (medicinal product form)	4180186
35625508	Norethisterone-containing product in oral dose form	4180186
35625508	Product containing norethisterone in oral dose form (medicinal product form)	4180186
35625510	Product containing clodronic acid (medicinal product)	4180186
35625512	Product containing ibandronic acid in oral dose form (medicinal product form)	4180186
35625514	Gold and/or gold compound-containing product	4180186
35625514	Product containing gold and/or gold compound (product)	4180186
35625514	Product containing gold and gold compound (product)	4180186
35625515	Product containing levothyroxine in oral dose form (medicinal product form)	4180186
35625516	Product containing ibandronic acid in parenteral dose form (medicinal product form)	4180186
35625521	Risedronic acid (substance)	4180186
35625522	Product containing calcium and risedronic acid (medicinal product)	4180186
35625523	Product containing risedronic acid in oral dose form (medicinal product form)	4180186
35625524	Product containing calcium and risedronic acid in oral dose form (medicinal product form)	4180186
35625527	Anhydrous glucose (substance)	4180186
35625530	Sodium folinate (substance)	4180186
35625530	Sodium folinate	4180186
35625533	Hypermanganesemia with dystonia (disorder)	4180186
35625533	HMNDYT - hypermanganesemia with dystonia	4180186
35625533	Familial manganese-induced neurotoxicity	4180186
35625536	Myelocerebellar disorder	4180186
35625536	Ataxia pancytopenia syndrome (disorder)	4180186
35625537	Aluminium hydroxide gel	4180186
35625537	Aluminium hydroxide gel (substance)	4180186
35625538	Dried aluminium hydroxide gel	4180186
35625538	Dried aluminium hydroxide gel (substance)	4180186
35625543	Product containing loratadine and pseudoephedrine (medicinal product)	4180186
35625544	Product containing hydrochlorothiazide and losartan (medicinal product)	4180186
35625545	Cromoglicic acid- and salbutamol-containing product	4180186
35625545	Product containing cromoglicic acid and salbutamol (medicinal product)	4180186
35625546	Product containing cromoglicic acid and isoprenaline (medicinal product)	4180186
35625546	Cromoglicic acid- and isoprenaline-containing product	4180186
35625550	Cromoglicic acid-containing product in ocular dose form	4180186
35625550	Product containing cromoglicic acid in ocular dose form (medicinal product form)	4180186
35625553	Product containing homatropine and hydrocodone (medicinal product)	4180186
35625554	Product containing hydralazine and isosorbide in oral dose form (medicinal product form)	4180186
35625555	Product containing homatropine and hydrocodone in oral dose form (medicinal product form)	4180186
35625556	Product containing hydrocodone and potassium guaiacolsulfonate (medicinal product)	4180186
35625558	Butalbital- and caffeine- and codeine- and paracetamol-containing product in oral dose form	4180186
35625558	Product containing butalbital and caffeine and codeine and paracetamol in oral dose form (medicinal product form)	4180186
35625559	Product containing hydralazine and hydrochlorothiazide in oral dose form (medicinal product form)	4180186
35625560	Finding of presence of dermatophyte hyphae and spores inside of hair shaft (finding)	4180186
35625560	Finding of presence of endothrix	4180186
35625563	Product containing peptide (product)	4180186
35625564	Product containing coumarin (product)	4180186
35625565	Product containing smoothened receptor antagonist (product)	4180186
35625569	Product containing antibody (product)	4180186
35625570	Product containing benzazepine (product)	4180186
35625572	Product containing pyrimidine (product)	4180186
35625574	Product containing tricyclic compound (product)	4180186
35625576	Nucleoside analogue-containing product	4180186
35625576	Product containing nucleoside analog (product)	4180186
35625580	Product containing naphthalene (product)	4180186
35625581	Product containing titanium and/or titanium compound (product)	4180186
35625581	Titanium and/or titanium compound-containing product	4180186
35625581	Product containing titanium and titanium compound (product)	4180186
35625584	Product containing platinum and/or platinum compound (product)	4180186
35625584	Platinum and/or platinum compound-containing product	4180186
35625584	Product containing platinum and platinum compound (product)	4180186
35625586	Product containing ketone (product)	4180186
35625588	Product containing benzofuran (product)	4180186
35625589	Carboxylic acid and/or carboxylic acid derivative-containing product	4180186
35625589	Product containing carboxylic acid and/or carboxylic acid derivative (product)	4180186
35625589	Product containing carboxylic acid and carboxylic acid derivative (product)	4180186
35625591	Ethylenediamine and/or ethylenediamine derivative-containing product	4180186
35625591	Product containing ethylenediamine and/or ethylenediamine derivative (product)	4180186
35625591	Product containing ethylenediamine and ethylenediamine derivative (product)	4180186
35625593	Substance with Cytomegalovirus terminase complex inhibitor mechanism of action (substance)	4180186
35625593	Substance with Cytomegalovirus terminase complex inhibitor mechanism of action	4180186
35625594	Product containing guanylate cyclase 2C agonist (product)	4180186
35625595	Product containing lipoprotein (product)	4180186
35625597	Product containing halogenated hydrocarbon (product)	4180186
35625599	Initial stage caries of crown of tooth (disorder)	4180186
35625599	Initial stage caries of crown of tooth	4180186
35625601	Initial stage non-active caries of crown of tooth (disorder)	4180186
35625601	Initial stage non-active caries of crown of tooth	4180186
35625602	Moderate stage caries of crown of tooth	4180186
35625602	Moderate stage caries of crown of tooth (disorder)	4180186
35625604	Moderate stage active caries of crown of tooth	4180186
35625604	Moderate stage active caries of crown of tooth (disorder)	4180186
35625605	Moderate stage non-active caries of crown of tooth (disorder)	4180186
35625605	Moderate stage non-active caries of crown of tooth	4180186
35625606	Extensive stage caries of crown of tooth	4180186
35625606	Extensive stage caries of crown of tooth (disorder)	4180186
35625609	Product containing tizanidine in oral dose form (medicinal product form)	4180186
35625610	Equine antithymocyte immunoglobulin (substance)	4180186
35625611	Extensive stage active caries of crown of tooth	4180186
35625611	Extensive stage active caries of crown of tooth (disorder)	4180186
35625613	Live attenuated measles virus (substance)	4180186
35625614	Split virion Influenza virus (substance)	4180186
35625615	Inactivated Hepatitis A virus (substance)	4180186
35625616	Virus derived substance (substance)	4180186
35625618	Human follicle stimulating hormone (substance)	4180186
35625619	CLCN2 (chloride voltage-gated channel 2) related leucoencephalopathy	4180186
35625619	CLCN2-related leucoencephalopathy	4180186
35625619	Leukoencephalopathy with mild cerebellar ataxia and white matter edema (disorder)	4180186
35625619	CLCN2 (chloride voltage-gated channel 2) related leukoencephalopathy	4180186
35625619	Leucoencephalopathy with ataxia	4180186
35625619	Leukoencephalopathy with ataxia	4180186
35625619	Leukoencephalopathy with mild cerebellar ataxia and white matter edema	4180186
35625619	Leucoencephalopathy with mild cerebellar ataxia and white matter oedema	4180186
35625620	Amphotericin B phospholipid complex (substance)	4180186
35625623	Nucleotide binding oligomerization domain containing 2-associated autoinflammatory disease (disorder)	4180186
35625623	NOD2 (nucleotide binding oligomerization domain containing 2) associated autoinflammatory disease	4180186
35625623	NOD2-associated autoinflammatory disease	4180186
35625623	Nucleotide binding oligomerization domain containing 2-associated autoinflammatory disease	4180186
35625624	Product containing dopamine reuptake inhibitor (product)	4180186
35625625	Product containing progesterone receptor antagonist (product)	4180186
35625626	Product containing glucocorticoid receptor antagonist (product)	4180186
35625627	Medicinal product acting as scabicide agent (product)	4180186
35625629	Product containing histamine in parenteral dose form (medicinal product form)	4180186
35625633	PPP2R5D (protein phosphatase 2 regulatory subunit b (b56) delta) related intellectual disability	4180186
35625633	Protein phosphatase 2 regulatory subunit b (b56) delta-related intellectual disability (disorder)	4180186
35625633	Protein phosphatase 2 regulatory subunit b (b56) delta-related intellectual disability	4180186
35625634	Product containing irritant (product)	4180186
35625636	Antimicrobial (disposition)	4180186
35625637	Antibacterial (disposition)	4180186
35625638	Antifungal (disposition)	4180186
35625640	Antimycobacterial (disposition)	4180186
35625641	Antiretroviral (disposition)	4180186
35625642	Zinc and/or zinc compound-containing product	4180186
35625642	Product containing zinc and/or zinc compound (product)	4180186
35625642	Product containing zinc and zinc compound (product)	4180186
35625643	Product containing strontium and/or strontium compound (product)	4180186
35625643	Strontium and/or strontium compound-containing product	4180186
35625643	Product containing strontium and strontium compound (product)	4180186
35625644	Product containing fluorine and/or fluorine compound (product)	4180186
35625644	Fluorine and/or fluorine compound-containing product	4180186
35625644	Product containing fluorine and fluorine compound (product)	4180186
35625645	Aluminium and/or aluminium compound-containing product	4180186
35625645	Aluminum and/or aluminum compound-containing product	4180186
35625645	Product containing aluminium and/or aluminium compound (product)	4180186
35625645	Product containing aluminium and aluminium compound (product)	4180186
35625645	Aluminium and aluminium compound-containing product	4180186
35625646	Product containing antimony and/or antimony compound (product)	4180186
35625646	Antimony and/or antimony compound-containing product	4180186
35625646	Product containing antimony and antimony compound (product)	4180186
35625647	Product containing arsenic and/or arsenic compound (product)	4180186
35625647	Arsenic and/or arsenic compound-containing product	4180186
35625647	Product containing arsenic and arsenic compound (product)	4180186
35625650	Product containing manganese and/or manganese compound (product)	4180186
35625650	Manganese and/or manganese compound-containing product	4180186
35625650	Product containing manganese and manganese compound (product)	4180186
35625651	Product containing nitrogen and/or nitrogen compound (product)	4180186
35625651	Nitrogen and/or nitrogen compound-containing product	4180186
35625651	Product containing nitrogen and nitrogen compound (product)	4180186
35625655	Product containing hydroflumethiazide and spironolactone in oral dose form (medicinal product form)	4180186
35625656	Product containing hydroflumethiazide in oral dose form (medicinal product form)	4180186
35625662	15q13.3 microduplication syndrome (disorder)	4180186
35625664	Urea[13C] 100mg powder for oral solution (product)	4180186
35625665	Somatropin(rbe) 16iu(5.33mg) injection (pdr for recon) (product)	4180186
35625666	Blood pooling imaging agent (product)	4180186
35625667	Caffeine- and dihydrocodeine- and paracetamol-containing product	4180186
35625667	Product containing caffeine and dihydrocodeine and paracetamol (medicinal product)	4180186
35625672	Product containing pemoline in oral dose form (medicinal product form)	4180186
35625673	Lanthanum and/or lanthanum compound	4180186
35625673	Lanthanum and/or lanthanum compound (substance)	4180186
35625673	Lanthanum and lanthanum compound (substance)	4180186
35625674	T and A (tonsillectomy and adenoidectomy) postoperative education	4180186
35625674	Education about postoperative care after adenotonsillectomy (procedure)	4180186
35625675	Advice about drug dosage	4180186
35625675	Advice about medication dosage	4180186
35625675	Drug dosage education (procedure)	4180186
35625677	Home help	4180186
35625677	Home helper (occupation)	4180186
35625678	School health educator (occupation)	4180186
35625682	Product containing pregnane (product)	4180186
35625684	Product containing androgen (product)	4180186
35625685	Product containing isoquinoline (product)	4180186
35625688	Testosterone and/or testosterone derivative-containing product	4180186
35625688	Product containing testosterone and/or testosterone derivative (product)	4180186
35625688	Product containing testosterone and testosterone derivative (product)	4180186
35625689	Product containing steroid (product)	4180186
35625690	Erbium and/or erbium compound-containing product	4180186
35625690	Product containing erbium and/or erbium compound (product)	4180186
35625690	Product containing erbium and erbium compound (product)	4180186
35625693	Gallium and/or gallium compound-containing product	4180186
35625693	Product containing gallium and/or gallium compound (product)	4180186
35625693	Product containing gallium and gallium compound (product)	4180186
35625695	Product containing mercury and/or mercury compound (product)	4180186
35625695	Mercury and/or mercury compound-containing product	4180186
35625695	Product containing mercury and mercury compound (product)	4180186
35625696	Product containing pyrethroid (product)	4180186
35625697	Product containing pteridine (product)	4180186
35625698	Product containing carbohydrate derivative (product)	4180186
35625699	Product containing polymer (product)	4180186
35625700	Product containing tocainide in oral dose form (medicinal product form)	4180186
35625702	Product containing topiramate in oral dose form (medicinal product form)	4180186
35625708	Product containing tolfenamic acid in oral dose form (medicinal product form)	4180186
35625710	Product containing tipranavir in oral dose form (medicinal product form)	4180186
35625714	Product containing colistin and hydrocortisone and neomycin (medicinal product)	4180186
35625715	Product containing delmadinone (medicinal product)	4180186
35625716	Delmadinone (substance)	4180186
35625718	Diabetic cataract of left eye	4180186
35625718	Cataract of left eye due to diabetes mellitus (disorder)	4180186
35625720	Surface epithelial-stromal tumor (morphologic abnormality)	4180186
35625720	Surface epithelial-stromal tumour	4180186
35625720	Surface epithelial-stromal tumor	4180186
35625720	Brenner tumour	4180186
35625724	Iritis of bilateral eyes due to diabetes mellitus (disorder)	4180186
35625724	Iritis of bilateral eyes due to diabetes mellitus	4180186
35625724	Bilateral diabetic iritis	4180186
35625725	Product containing candesartan and hydrochlorothiazide (medicinal product)	4180186
35625730	AAGA - accidental awareness under general anesthesia	4180186
35625730	Accidental awareness under general anaesthesia	4180186
35625730	Accidental awareness under general anesthesia (finding)	4180186
35625730	AAGA - accidental awareness under general anaesthesia	4180186
35625732	Product containing aluminium hydroxide in oral dose form (medicinal product form)	4180186
35625732	Aluminium hydroxide-containing product in oral dose form	4180186
35625733	Product containing idarubicin in oral dose form (medicinal product form)	4180186
35625734	Product containing amiloride and hydrochlorothiazide and timolol in oral dose form (medicinal product form)	4180186
35625736	Investigative specialist (occupation)	4180186
35625741	Care coordinator (occupation)	4180186
35625742	Care team coordinator (occupation)	4180186
35625743	Rehabilitation coordinator (occupation)	4180186
35625744	Doula (occupation)	4180186
35625746	Nutritionist (occupation)	4180186
35625748	Community dietician (occupation)	4180186
35625749	Case manager (occupation)	4180186
35625750	Discharging physician (occupation)	4180186
35625751	Disease manager (occupation)	4180186
35625752	Depression care management (procedure)	4180186
35625753	Patient navigator (occupation)	4180186
35625756	Consultant (occupation)	4180186
35625761	Purine and/or purine derivative	4180186
35625761	Purine and/or purine derivative (substance)	4180186
35625761	Purine and purine derivative (substance)	4180186
35625761	Purine and derivatives	4180186
35625763	Alacrimia, choreoathetosis, liver dysfunction syndrome	4180186
35625763	N-glycanase 1 congenital disorder of deglycosylation (disorder)	4180186
35625763	Deficiency of N-glycanase 1	4180186
35625763	N-glycanase 1 congenital disorder of deglycosylation	4180186
35625764	Revision of one component of total prosthetic replacement of hip joint using cement (procedure)	4180186
35625766	Product containing besifloxacin in ocular dose form (medicinal product form)	4180186
35625767	Product containing sparfloxacin in oral dose form (medicinal product form)	4180186
35625768	Product containing spiramycin in oral dose form (medicinal product form)	4180186
35625773	Product containing imidapril in oral dose form (medicinal product form)	4180186
35625776	Product containing hydrochlorothiazide and lisinopril in oral dose form (medicinal product form)	4180186
35625778	Product containing hydrochlorothiazide and moexipril in oral dose form (medicinal product form)	4180186
35625780	Product containing oxymetholone in oral dose form (medicinal product form)	4180186
35625781	Product containing stanozolol in oral dose form (medicinal product form)	4180186
35625782	Product containing interferon (product)	4180186
35625790	Revision of one component of total prosthetic replacement of shoulder joint not using cement (procedure)	4180186
35625791	Product containing interferon alfa-2b in oral dose form (medicinal product form)	4180186
35625793	Product containing interferon alfacon-1 in parenteral dose form (medicinal product form)	4180186
35625795	Revision of one component of total prosthetic replacement of shoulder joint using cement (procedure)	4180186
35625796	Product containing salbutamol in pulmonary dose form (medicinal product form)	4180186
35625796	Salbutamol-containing product in pulmonary dose form	4180186
35625797	Biphasic isophane insulin human (substance)	4180186
35625798	Biphasic isophane insulin porcine (substance)	4180186
35625799	Technetium (99m-Tc) labeled granulocytes (substance)	4180186
35625799	Technetium (99m-Tc) labelled granulocytes	4180186
35625804	Porcine insulin soluble-containing product in parenteral dose form	4180186
35625804	Product containing porcine regular insulin in parenteral dose form (medicinal product form)	4180186
35625808	Product containing insulin lispro in parenteral dose form (medicinal product form)	4180186
35625811	Psychologically prepared to undergo procedure	4180186
35625811	Psychologically ready to undergo procedure (finding)	4180186
35625812	Physically prepared to undergo procedure	4180186
35625812	Physically ready to undergo procedure (finding)	4180186
35625817	Product containing desloratadine and pseudoephedrine in oral dose form (medicinal product form)	4180186
35625819	Product containing ondansetron in oromucosal dose form (medicinal product form)	4180186
35625821	Product containing clomocycline (medicinal product)	4180186
35625825	Nonoxinol-containing product in vaginal dose form	4180186
35625825	Product containing nonoxinol in vaginal dose form (medicinal product form)	4180186
35625826	Product containing decitabine in parenteral dose form (medicinal product form)	4180186
35625829	Product containing isocarboxazid in oral dose form (medicinal product form)	4180186
35625830	Product containing moclobemide in oral dose form (medicinal product form)	4180186
35625832	Product containing selegiline in oral dose form (medicinal product form)	4180186
35625835	Product containing metformin and sitagliptin in oral dose form (medicinal product form)	4180186
35625839	Serous cystadenoma of ovary in childhood (disorder)	4180186
35625840	Mucinous cystadenoma of ovary in childhood (disorder)	4180186
35625843	Duplication 8p	4180186
35625843	Trisomy 8p syndrome (disorder)	4180186
35625844	Partial duplication short arm chromosome 8	4180186
35625844	Partial trisomy of short arm of chromosome 8 (disorder)	4180186
35625845	Coloboma of choroid and retina (disorder)	4180186
35625846	Semicircular canal dehiscence syndrome (disorder)	4180186
35625848	Multiple epiphyseal dysplasia with Robin phenotype	4180186
35625848	Multiple epiphyseal dysplasia Lowry type (disorder)	4180186
35625850	Primary tethered cord syndrome (disorder)	4180186
35625850	Primary tethered spinal cord syndrome	4180186
35625851	Product containing loracarbef in oral dose form (medicinal product form)	4180186
35625852	Product containing cefamandole in parenteral dose form (medicinal product form)	4180186
35625855	Product containing cefoxitin in parenteral dose form (medicinal product form)	4180186
35625856	Cefapirin-containing product in parenteral dose form	4180186
35625856	Product containing cefapirin in parenteral dose form (medicinal product form)	4180186
35625857	Stevens-Johnson syndrome, toxic epidermal necrolysis spectrum (disorder)	4180186
35625857	Toxic epidermolysis	4180186
35625858	Product containing cefradine in parenteral dose form (medicinal product form)	4180186
35625858	Cefradine-containing product in parenteral dose form	4180186
35625861	Product containing cefoperazone in parenteral dose form (medicinal product form)	4180186
35625862	Product containing ceftibuten in oral dose form (medicinal product form)	4180186
35625865	Product containing periciazine in oral dose form (medicinal product form)	4180186
35625869	Product containing brompheniramine and guaifenesin and hydrocodone (medicinal product)	4180186
35625870	Product containing brompheniramine and guaifenesin and hydrocodone in oral dose form (medicinal product form)	4180186
35625872	Lyell syndrome due to infection	4180186
35625872	Lyell syndrome due to infection (disorder)	4180186
35625873	Toxic epidermal necrolysis	4180186
35625873	Lyell syndrome (disorder)	4180186
35625875	Product containing levorphanol in parenteral dose form (medicinal product form)	4180186
35625878	Tc99m-DTPA (diethylenetriamine pentaacetic acid) renogram	4180186
35625878	Radionuclide imaging of kidney using technetium (99m-Tc) pentetic acid (procedure)	4180186
35625881	Sodium phosphate anhydrous	4180186
35625881	Monobasic sodium phosphate anhydrous (substance)	4180186
35625882	Tc99m-DTPA (diethylenetriamine pentaacetic acid) brain study	4180186
35625882	Radionuclide imaging of brain using technetium (99m-Tc) pentetic acid (procedure)	4180186
35625884	Rifamycin sodium (substance)	4180186
35625885	pH monitoring capsule (physical object)	4180186
35625886	Endoscopic insertion of pH monitoring capsule into oesophagus	4180186
35625886	Endoscopic insertion of pH monitoring capsule into esophagus (procedure)	4180186
35625888	Galactose microparticles+palmitic acid 2497.5mg/2.5mg granules (product)	4180186
35625889	Galactose microparticles+palmitic acid 3996mg/4mg granules (product)	4180186
35625890	Parecoxib 40mg (injection pdr for recon) (product)	4180186
35625892	Recombinant human follicle stimulating hormone alpha 1050iu injection (pdr for recon) (product)	4180186
35625896	Human normal immunoglobulin 2.5g i-v infusion (pdr for recon) (product)	4180186
35625899	Vincristine 2mg powder for injection solution vial (product)	4180186
35625900	Vincristine 1mg powder for injection solution vial (product)	4180186
35625903	Product containing testosterone in parenteral dose form (medicinal product form)	4180186
35625907	Subcutaneous dose form (dose form)	4180186
35625908	Product containing testosterone in subcutaneous dose form (medicinal product form)	4180186
35625909	Product containing dithranol in cutaneous dose form (medicinal product form)	4180186
35625909	Dithranol-containing product in cutaneous dose form	4180186
35625910	Product containing heparin in parenteral dose form (medicinal product form)	4180186
35625911	Product containing bemiparin in parenteral dose form (medicinal product form)	4180186
35625913	Product containing dalteparin in parenteral dose form (medicinal product form)	4180186
35625915	Product containing tinzaparin in parenteral dose form (medicinal product form)	4180186
35625918	Product containing gemeprost in vaginal dose form (medicinal product form)	4180186
35625920	Product containing heparin and lauromacrogol 400 in rectal dose form (medicinal product form)	4180186
35625921	Product containing alprostadil in urethral dose form (medicinal product form)	4180186
35625923	Product containing carteolol in ocular dose form (medicinal product form)	4180186
35625924	Product containing hyaluronic acid in ocular dose form (medicinal product form)	4180186
35625926	Non-cavitated root caries active	4180186
35625926	Active non-cavitated caries of tooth root (disorder)	4180186
35625927	Product containing hyaluronic acid in parenteral dose form (medicinal product form)	4180186
35625929	Product containing atropine and pralidoxime in parenteral dose form (medicinal product form)	4180186
35625933	Product containing blood group antibody D in parenteral dose form (medicinal product form)	4180186
35625934	Product containing potassium phosphate in parenteral dose form (medicinal product form)	4180186
35625936	Product containing terbutaline in pulmonary dose form (medicinal product form)	4180186
35625937	Product containing halibut liver oil in oral dose form (medicinal product form)	4180186
35625940	Researcher (occupation)	4180186
35625948	Product containing metronidazole in dental dose form (medicinal product form)	4180186
35625950	Adrenaline-containing product in dental dose form	4180186
35625950	Product containing epinephrine in dental dose form (medicinal product form)	4180186
35625951	Product containing chlorhexidine in dental dose form (medicinal product form)	4180186
35625955	Tubulin beta 4A class IVa related leukodystrophy (disorder)	4180186
35625955	TUBB4A-related hypomyelinating leukodystrophy	4180186
35625955	TUBB4A (tubulin beta 4A class IVa) related leukodystrophy	4180186
35625955	Tubulin beta 4A class IVa related leukodystrophy	4180186
35625956	Crystal (substance)	4180186
35625957	Finding of presence of yeast	4180186
35625957	Yeast detected (finding)	4180186
35625958	Finding of presence of yeast not Candida albicans	4180186
35625958	Yeast not Candida albicans detected (finding)	4180186
35625961	Yeast not Cryptococcus gattii and not Cryptococcus neoformans detected (finding)	4180186
35625961	Finding of presence of yeast not Cryptococcus gattii and not Cryptococcus neoformans	4180186
35625965	Product containing antimicrobial (product)	4180186
35625968	2.49 (qualifier value)	4180186
35625968	Two point four nine	4180186
35625972	Mebrofenin (substance)	4180186
35625973	Hymecromone (substance)	4180186
35625973	4-methylumbelliferone	4180186
35625974	Ioxaglic acid (substance)	4180186
35625976	Meglumine benzoate (substance)	4180186
35625977	Loflazepic acid (substance)	4180186
35625979	Guaietolin (substance)	4180186
35625979	Guethural	4180186
35625980	Glycopyrronium (substance)	4180186
35625981	Medrogestone (substance)	4180186
35625982	Lopobutan (substance)	4180186
35625982	(+/-)-3-((3-(dodecyloxy)propyl)amino)butyric acid	4180186
35625984	Double wall broad base budding yeast detected	4180186
35625984	Finding of presence of double wall broad base budding yeast (finding)	4180186
35625985	Encapsulated yeast detected (finding)	4180186
35625985	Finding of presence of encapsulated yeast	4180186
35625988	Maxillary midline severe deviation to left	4180186
35625988	Severe midline deviation of maxillary tooth position to left (disorder)	4180186
35625989	Effervescent powder for conventional release oral solution (dose form)	4180186
35625989	Effervescent powder for conventional release oral solution	4180186
35625991	Non-active non-cavitated caries (morphologic abnormality)	4180186
35625992	Active cavitated caries (morphologic abnormality)	4180186
35625993	Active non-cavitated caries (morphologic abnormality)	4180186
35625994	Effervescent powder for conventional release oral suspension	4180186
35625994	Effervescent powder for conventional release oral suspension (dose form)	4180186
35625996	Product containing precisely triptorelin 11.25 milligram/1 vial powder for conventional release suspension for injection (clinical drug)	4180186
35625999	Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection (clinical drug)	4180186
35626001	Product containing precisely hexastarch 60 milligram/1 milliliter conventional release solution for infusion (clinical drug)	4180186
35626002	Product containing precisely imipramine hydrochloride 5 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35626003	Product containing precisely mefenamic acid 10 milligram/1 milliliter conventional release oral suspension (clinical drug)	4180186
35626004	Product containing precisely periciazine 2 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35626006	Product containing precisely spiramycin 25 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35626008	Product containing precisely magnesium alginate 87.5 milligram and sodium alginate 225 milligram/1 sachet powder for conventional release oral suspension (clinical drug)	4180186
35626009	Product containing precisely ispaghula husk 3.5 gram/1 sachet granules for conventional release oral suspension (clinical drug)	4180186
35626010	Midline deviation of maxillary tooth position (disorder)	4180186
35626011	Maxillary midline mild deviation to right	4180186
35626011	Mild midline deviation of maxillary tooth position to right (disorder)	4180186
35626013	Maxillary midline severe deviation to right	4180186
35626013	Severe midline deviation of maxillary tooth position to right (disorder)	4180186
35626015	Fungal unicell detected	4180186
35626015	Finding of presence of unicellular fungus (finding)	4180186
35626016	Product containing estradiol in transdermal dose form (medicinal product form)	4180186
35626018	Cyclic lipopeptide (substance)	4180186
35626019	Anterior lower alveolar excess	4180186
35626019	Excess of anterior part of lower alveolar ridge (disorder)	4180186
35626021	Posterior lower alveolar excess	4180186
35626021	Excess of posterior part of lower alveolar ridge (disorder)	4180186
35626024	Vasoocclusive pain episode in sickle cell disease	4180186
35626024	Vaso-occlusive pain co-occurrent and due to sickle cell disease	4180186
35626024	Vaso-occlusive pain co-occurrent and due to sickle cell disease (disorder)	4180186
35626026	H-CGIN - high grade cervical glandular intraepithelial neoplasia	4180186
35626026	High grade cervical glandular intraepithelial neoplasia (disorder)	4180186
35626029	Bio-impedence navigation spinal needle (physical object)	4180186
35626030	Spinal needle bio-impedence navigation unit (physical object)	4180186
35626034	Silicone gel-filled smooth breast implant (physical object)	4180186
35626036	Preproliferative diabetic retinopathy of right eye	4180186
35626036	Preproliferative retinopathy of right eye due to diabetes mellitus (disorder)	4180186
35626037	Preproliferative diabetic retinopathy of left eye	4180186
35626037	Preproliferative retinopathy of left eye due to diabetes mellitus (disorder)	4180186
35626039	Mild nonproliferative retinopathy of left eye	4180186
35626039	Mild nonproliferative retinopathy of left eye due to diabetes mellitus (disorder)	4180186
35626039	Mild nonproliferative diabetic retinopathy of left eye	4180186
35626039	Mild non-proliferative diabetic retinopathy of left eye	4180186
35626039	Mild non proliferative retinopathy of left eye	4180186
35626040	Million units per minute	4180186
35626040	Million units per minute (qualifier value)	4180186
35626041	Moderate non-proliferative diabetic retinopathy of right eye	4180186
35626041	Moderate nonproliferative retinopathy of right eye due to diabetes mellitus	4180186
35626041	Moderate nonproliferative retinopathy of right eye due to diabetes mellitus (disorder)	4180186
35626042	Moderate nonproliferative retinopathy of left eye due to diabetes mellitus (disorder)	4180186
35626042	Moderate non-proliferative diabetic retinopathy of left eye	4180186
35626042	Moderate nonproliferative retinopathy of left eye due to diabetes mellitus	4180186
35626043	Severe nonproliferative diabetic retinopathy of right eye	4180186
35626043	Severe nonproliferative retinopathy of right eye due to diabetes mellitus (disorder)	4180186
35626043	Severe NPDR (nonproliferative diabetic retinopathy) of right eye	4180186
35626044	Severe NPDR (nonproliferative diabetic retinopathy) of left eye	4180186
35626044	Severe nonproliferative retinopathy of left eye due to diabetes mellitus (disorder)	4180186
35626044	Severe nonproliferative diabetic retinopathy of left eye	4180186
35626045	Sulfur hexafluoride 40microliter powder for injection solution (product)	4180186
35626045	Sulfur hexafluoride 40microlitre powder for injection solution	4180186
35626046	Very severe nonproliferative retinopathy of right eye due to diabetes mellitus (disorder)	4180186
35626046	Very severe NPDR (nonproliferative diabetic retinopathy) of right eye	4180186
35626046	Very severe nonproliferative diabetic retinopathy of right eye	4180186
35626048	Interferon alfa-2b 10million iu powder for injection solution vial (product)	4180186
35626049	Interferon alfa-2b 3million iu powder for injection solution vial (product)	4180186
35626050	Product containing precisely peginterferon alfa-2b 120 microgram/1 pen powder for conventional release solution for injection (clinical drug)	4180186
35626052	Product containing precisely peginterferon alfa-2b 50 microgram/1 pen powder for conventional release solution for injection (clinical drug)	4180186
35626053	Product containing precisely peginterferon alfa-2b 80 microgram/1 pen powder for conventional release solution for injection (clinical drug)	4180186
35626055	Urine novel psychoactive substance positive (finding)	4180186
35626055	Urine new psychoactive substance positive	4180186
35626058	Dehydroascorbic acid (substance)	4180186
35626059	Product containing hydrocortisone in cutaneous dose form (medicinal product form)	4180186
35626068	Macular oedema of left eye due to diabetes mellitus	4180186
35626068	Macular edema of left eye due to diabetes mellitus (disorder)	4180186
35626068	Diabetic macular edema of left eye	4180186
35626068	Diabetic macular oedema of left eye	4180186
35626071	Clinically significant macular edema of right eye due to diabetes mellitus (disorder)	4180186
35626071	Clinically significant macular oedema of right eye due to diabetes mellitus	4180186
35626072	Clinically significant macular oedema of left eye due to diabetes mellitus	4180186
35626072	Clinically significant macular edema of left eye due to diabetes mellitus (disorder)	4180186
35626074	Product containing somatrem in parenteral dose form (medicinal product form)	4180186
35626075	Product containing sermorelin in parenteral dose form (medicinal product form)	4180186
35626076	Product containing somatropin in parenteral dose form (medicinal product form)	4180186
35626078	Disorder due to and following burn of hand (disorder)	4180186
35626078	Sequela of burn of hand	4180186
35626078	Late effect of burn of hand	4180186
35626080	Product containing rivastigmine in transdermal dose form (medicinal product form)	4180186
35626081	Product containing granisetron in transdermal dose form (medicinal product form)	4180186
35626082	Product containing buprenorphine in transdermal dose form (medicinal product form)	4180186
35626084	Product containing fentanyl in transdermal dose form (medicinal product form)	4180186
35626086	Product containing ketorolac in nasal dose form (medicinal product form)	4180186
35626087	Diabetic maculopathy of right eye	4180186
35626087	Maculopathy of right eye due to diabetes mellitus	4180186
35626087	Disorder of right macula due to diabetes mellitus (disorder)	4180186
35626087	Maculopathy of right eye with diabetes mellitus	4180186
35626088	Maculopathy of left eye with diabetes mellitus	4180186
35626088	Disorder of left macula due to diabetes mellitus (disorder)	4180186
35626088	Maculopathy of left eye due to diabetes mellitus	4180186
35626088	Diabetic maculopathy of left eye	4180186
35626089	Abnormal immune process (qualifier value)	4180186
35626090	1.06 (qualifier value)	4180186
35626090	One point zero six	4180186
35626093	31.7 (qualifier value)	4180186
35626093	Thirty-one point seven	4180186
35626094	Product containing precisely tioconazole 283 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	4180186
35626100	Contact hypersensitivity process (qualifier value)	4180186
35626103	Nonimmunoglobulin E-mediated allergic process	4180186
35626103	Non-immunoglobulin E-mediated allergic process (qualifier value)	4180186
35626104	Allergic contact hypersensitivity process (qualifier value)	4180186
35626105	Non-allergic contact hypersensitivity process (qualifier value)	4180186
35626108	Alimemazine tartrate 1.5 mg/mL oral solution	4180186
35626108	Product containing precisely alimemazine tartrate 1.5 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35626109	Product containing precisely alimemazine tartrate 6 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35626109	Alimemazine tartrate 6 mg/mL oral solution	4180186
35626111	Product containing precisely terbutaline sulfate 300 microgram/1 milliliter conventional release oral solution (clinical drug)	4180186
35626113	Product containing precisely sodium feredetate 38 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35626113	Sodium feredetate 38 mg/mL oral solution	4180186
35626114	Product containing precisely sennoside B (as sennoside) 1.5 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35626117	Product containing precisely pseudoephedrine hydrochloride 6 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35626118	Product containing precisely amantadine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35626119	Product containing precisely ampicillin (as ampicillin trihydrate) 25 milligram/1 milliliter and flucloxacillin (as flucloxacillin magnesium) 25 milligram/1 milliliter conventional release oral suspension (clinical drug)	4180186
35626119	Ampicillin (as ampicillin trihydrate) 25 mg/mL and flucloxacillin (as flucloxacillin magnesium) 25 mg/mL oral suspension	4180186
35626120	Product containing precisely atenolol 5 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35626121	Product containing precisely azatadine maleate 100 microgram/1 milliliter conventional release oral solution (clinical drug)	4180186
35626123	Product containing precisely calcium glubionate 218 milligram/1 milliliter and calcium lactobionate 144.6 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35626124	Product containing nitazoxanide in oral dose form (medicinal product form)	4180186
35626125	Carbocisteine 50 mg/mL oral solution	4180186
35626125	Product containing precisely carbocisteine 50 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35626126	Product containing precisely cefalexin 100 milligram/1 milliliter conventional release oral suspension (clinical drug)	4180186
35626126	Cefalexin 100 mg/mL oral suspension	4180186
35626130	Product containing precisely clomethiazole (as clomethiazole edisylate) 50 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35626130	Clomethiazole (as clomethiazole edisilate) 50 mg/mL oral solution	4180186
35626132	Product containing precisely chloroquine sulfate 13.6 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35626133	Product containing precisely codeine phosphate 5 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35626134	Product containing precisely colistin sulfate 50000 unit/1 milliliter conventional release oral solution (clinical drug)	4180186
35626135	Product containing precisely dihydrocodeine tartrate 2 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35626136	Product containing precisely diphenhydramine hydrochloride 2 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35626137	Product containing precisely ephedrine hydrochloride 3 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35626138	Product containing precisely ferric ammonium citrate 16 milligram/1 milliliter and folic acid 500 microgram/1 milliliter conventional release oral solution (clinical drug)	4180186
35626139	Product containing precisely ferric ammonium citrate 16 milligram/1 milliliter and folic acid 100 microgram/1 milliliter conventional release oral solution (clinical drug)	4180186
35626141	Product containing precisely loratadine 1 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35626145	Product containing precisely prochlorperazine mesilate 1 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35626145	Prochlorperazine mesilate 1 mg/mL oral solution	4180186
35626148	Product containing precisely promethazine hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35626151	950 (qualifier value)	4180186
35626151	Nine hundred and fifty	4180186
35626152	Carbocisteine 25 mg/mL oral solution	4180186
35626152	Product containing precisely carbocisteine 25 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35626154	Product containing precisely clarithromycin 25 milligram/1 milliliter conventional release oral suspension (clinical drug)	4180186
35626155	Product containing precisely codeine phosphate 600 microgram/1 milliliter conventional release oral solution (clinical drug)	4180186
35626156	Product containing precisely docusate sodium 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)	4180186
35626157	Product containing precisely pholcodine 400 microgram/1 milliliter conventional release oral solution (clinical drug)	4180186
35626159	Intracellular elementary bodies of virus detected (finding)	4180186
35626159	Finding of presence of intracellular elementary bodies of virus	4180186
35626162	2.083 (qualifier value)	4180186
35626162	Two point zero eight three	4180186
35626164	4.167 (qualifier value)	4180186
35626164	Four point one six seven	4180186
35626165	Seven point zero eight three	4180186
35626165	7.083 (qualifier value)	4180186
35626168	83.333 (qualifier value)	4180186
35626168	Eighty-three point three three three	4180186
35626169	One hundred and four point one six seven	4180186
35626169	104.167 (qualifier value)	4180186
35626173	291.667 (qualifier value)	4180186
35626173	Two hundred and ninety-one point six six seven	4180186
35626182	Medication container empty (qualifier value)	4180186
35626183	Skin is clear	4180186
35626183	Skin is clear (finding)	4180186
35626185	ASRS - Adult ADHD Self-Report Scale	4180186
35626185	Adult ADHD (attention deficit hyperactivity disorder) Self-Report Scale	4180186
35626185	World Health Organization Adult Attention-Deficit Hyperactivity Disorder Self-Report Scale (assessment scale)	4180186
35626186	Non-numeric dose amount	4180186
35626186	Non-numeric dose amount (qualifier value)	4180186
35626190	Thick film dose amount	4180186
35626190	Thick film dose amount (qualifier value)	4180186
35626192	Sufficient dose amount	4180186
35626192	Sufficient dose amount (qualifier value)	4180186
35626194	Thick ribbon dose amount (qualifier value)	4180186
35626194	Thick ribbon dose amount	4180186
35626196	Collection of body fluid from surgical drain (procedure)	4180186
35626196	Collection of drain fluid	4180186
35626197	Million units per kilogram	4180186
35626197	Million units per kilogram (qualifier value)	4180186
35626200	Completely - dosing instruction fragment	4180186
35626200	Completely - dosing instruction fragment (qualifier value)	4180186
35626201	Deeply - dosing instruction fragment (qualifier value)	4180186
35626201	Deeply - dosing instruction fragment	4180186
35626202	Repeatedly - dosing instruction fragment (qualifier value)	4180186
35626202	Repeatedly - dosing instruction fragment	4180186
35626205	Three thousand three hundred and thirty-three	4180186
35626205	3333 (qualifier value)	4180186
35626206	16667 (qualifier value)	4180186
35626206	Sixteen thousand six hundred and sixty-seven	4180186
35626207	Product containing precisely estradiol 1.042 microgram/1 hour prolonged-release transdermal patch (clinical drug)	4180186
35626210	Product containing precisely estradiol 2.083 microgram/1 hour prolonged-release transdermal patch (clinical drug)	4180186
35626211	Product containing precisely estradiol 2.083 microgram/1 hour and norethisterone acetate 7.083 microgram/1 hour prolonged-release transdermal patch (clinical drug)	4180186
35626211	Estradiol 2.083 microgram/hour and norethisterone acetate 7.083 microgram/hour prolonged-release transdermal patch	4180186
35626212	Estradiol 2.083 microgram/hour and norethisterone acetate 10.417 microgram/hour prolonged-release transdermal patch	4180186
35626212	Product containing precisely estradiol 2.083 microgram/1 hour and norethisterone acetate 10.417 microgram/1 hour prolonged-release transdermal patch (clinical drug)	4180186
35626214	Product containing precisely estradiol 3.333 microgram/1 hour prolonged-release transdermal patch (clinical drug)	4180186
35626216	Hyoscine 13.889 microgram/hour prolonged-release transdermal patch	4180186
35626216	Product containing precisely scopolamine 13.889 microgram/1 hour prolonged-release transdermal patch (clinical drug)	4180186
35626217	Product containing precisely fentanyl 25 microgram/1 hour prolonged-release transdermal patch (clinical drug)	4180186
35626219	Product containing precisely fentanyl 50 microgram/1 hour prolonged-release transdermal patch (clinical drug)	4180186
35626220	Product containing precisely buprenorphine 52.5 microgram/1 hour prolonged-release transdermal patch (clinical drug)	4180186
35626221	Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch (clinical drug)	4180186
35626222	Product containing precisely fentanyl 75 microgram/1 hour prolonged-release transdermal patch (clinical drug)	4180186
35626223	Product containing precisely rotigotine 83.333 microgram/1 hour prolonged-release transdermal patch (clinical drug)	4180186
35626225	Product containing precisely testosterone 104.167 microgram/1 hour prolonged-release transdermal patch (clinical drug)	4180186
35626226	Product containing precisely granisetron 129.167 microgram/1 hour prolonged-release transdermal patch (clinical drug)	4180186
35626227	Product containing precisely rotigotine 166.667 microgram/1 hour prolonged-release transdermal patch (clinical drug)	4180186
35626228	Glyceryl trinitrate 208.333 microgram/hour prolonged-release transdermal patch	4180186
35626228	Product containing precisely glyceryl trinitrate 208.333 microgram/1 hour prolonged-release transdermal patch (clinical drug)	4180186
35626229	Product containing precisely testosterone 208.333 microgram/1 hour prolonged-release transdermal patch (clinical drug)	4180186
35626230	Product containing precisely testosterone 250 microgram/1 hour prolonged-release transdermal patch (clinical drug)	4180186
35626231	Product containing precisely rotigotine 250 microgram/1 hour prolonged-release transdermal patch (clinical drug)	4180186
35626235	Product containing precisely nicotine 583.333 microgram/1 hour prolonged-release transdermal patch (clinical drug)	4180186
35626237	Product containing precisely nicotine 625 microgram/1 hour prolonged-release transdermal patch (clinical drug)	4180186
35626238	Product containing precisely nicotine 875 microgram/1 hour prolonged-release transdermal patch (clinical drug)	4180186
35626239	Product containing precisely nicotine 937.5 microgram/1 hour prolonged-release transdermal patch (clinical drug)	4180186
35626241	1667 (qualifier value)	4180186
35626241	One thousand six hundred and sixty-seven	4180186
35626243	Eight hundred and thirty-three point three three three	4180186
35626243	833.333 (qualifier value)	4180186
35626245	Eight hundred and forty	4180186
35626245	840 (qualifier value)	4180186
35626246	7000 (qualifier value)	4180186
35626246	Seven thousand	4180186
35626247	Nine thousand	4180186
35626247	9000 (qualifier value)	4180186
35626248	One hundred and twenty-five thousand	4180186
35626248	125000 (qualifier value)	4180186
35626249	1432 (qualifier value)	4180186
35626249	One thousand four hundred and thirty-two	4180186
35626251	Largest meal	4180186
35626251	With largest meal (qualifier value)	4180186
35626252	Meals	4180186
35626252	With meals (qualifier value)	4180186
35626253	With supper (qualifier value)	4180186
35626253	Supper	4180186
35626255	With lunch (qualifier value)	4180186
35626255	Lunch	4180186
35626256	With breakfast (qualifier value)	4180186
35626256	Breakfast	4180186
35626259	Onset of menstrual cycle (qualifier value)	4180186
35626259	Menstrual cycle	4180186
35626266	Acetylcysteine 2 g/10 mL solution for infusion ampoule	4180186
35626266	Product containing precisely acetylcysteine 2 gram/10 milliliter conventional release solution for infusion ampule (clinical drug)	4180186
35626272	Product containing precisely adenosine 6 milligram/2 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626273	Alfacalcidol 1 microgram/0.5 mL solution for injection ampoule	4180186
35626273	Product containing precisely alfacalcidol 1 microgram/0.5 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626274	Alfacalcidol 2 microgram/mL solution for injection ampoule	4180186
35626274	Product containing precisely alfacalcidol 2 microgram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626276	Alfentanil (as alfentanil hydrochloride) 500 microgram/mL solution for injection ampoule	4180186
35626276	Product containing precisely alfentanil (as alfentanil hydrochloride) 500 microgram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626277	Alfentanil (as alfentanil hydrochloride) 1 mg/2 mL solution for injection ampoule	4180186
35626277	Product containing precisely alfentanil (as alfentanil hydrochloride) 1 milligram/2 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626278	Alfentanil (as alfentanil hydrochloride) 5 mg/mL solution for injection ampoule	4180186
35626278	Product containing precisely alfentanil (as alfentanil hydrochloride) 5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626279	Alprostadil 500 microgram/mL solution for infusion ampoule	4180186
35626279	Product containing precisely alprostadil 500 microgram/1 milliliter conventional release solution for infusion ampule (clinical drug)	4180186
35626282	Aminophylline 250 mg/10 mL solution for injection ampoule	4180186
35626282	Product containing precisely aminophylline 250 milligram/10 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626283	Product containing precisely aminophylline 250 milligram/10 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626285	Amiodarone hydrochloride 150 mg/3 mL solution for injection ampoule	4180186
35626285	Product containing precisely amiodarone hydrochloride 150 milligram/3 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626287	Apomorphine hydrochloride 50 mg/5 mL solution for injection ampoule	4180186
35626287	Product containing precisely apomorphine hydrochloride 50 milligram/5 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626291	Atenolol 5 mg/10 mL solution for injection ampoule	4180186
35626291	Product containing precisely atenolol 5 milligram/10 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626292	Product containing precisely atosiban (as atosiban acetate) 37.5 milligram/5 milliliter conventional release solution for infusion vial (clinical drug)	4180186
35626293	Product containing precisely atosiban (as atosiban acetate) 6.75 milligram/0.9 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626295	Atracurium besilate 250 mg/25 mL solution for injection vial	4180186
35626295	Product containing precisely atracurium besilate 250 milligram/25 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626296	Atracurium besilate 50 mg/5 mL solution for injection ampoule	4180186
35626296	Product containing precisely atracurium besilate 50 milligram/5 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626298	Product containing precisely atropine sulfate 1 milligram/10 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626302	Product containing precisely bemiparin sodium 5000 unit/0.2 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626303	Product containing precisely phospholipid (as beractant) 200 milligram/8 milliliter conventional release suspension for endotracheopulmonary instillation bottle (clinical drug)	4180186
35626304	Betamethasone (as betamethasone sodium phosphate) 4 mg/mL solution for injection ampoule	4180186
35626304	Product containing precisely betamethasone (as betamethasone sodium phosphate) 4 milligram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626305	Product containing precisely bevacizumab 400 milligram/16 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626306	Product containing precisely bevacizumab 100 milligram/4 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626307	Product containing precisely cytarabine 500 milligram/5 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626308	Bretylium tosilate 500 mg/10 mL solution for injection syringe	4180186
35626308	Product containing precisely bretylium tosylate 500 milligram/10 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626310	Bupivacaine hydrochloride 25 mg/10 mL solution for injection ampoule	4180186
35626310	Product containing precisely bupivacaine hydrochloride 25 milligram/10 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626311	Bupivacaine hydrochloride 50 mg/10 mL solution for injection ampoule	4180186
35626311	Product containing precisely bupivacaine hydrochloride 50 milligram/10 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626312	Product containing precisely bupivacaine hydrochloride 312.5 milligram/250 milliliter conventional release solution for infusion bag (clinical drug)	4180186
35626317	Carboprost (as carboprost trometamol) 250 microgram/mL solution for injection ampoule	4180186
35626317	Product containing precisely carboprost (as carboprost trometamol) 250 microgram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626319	Product containing precisely cefuroxime (as cefuroxime sodium) 1.5 gram/50 milliliter conventional release solution for infusion bag (clinical drug)	4180186
35626321	Chlorpromazine hydrochloride 50 mg/2 mL solution for injection ampoule	4180186
35626321	Product containing precisely chlorpromazine hydrochloride 50 milligram/2 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626322	Product containing precisely choriogonadotropin alfa 250 microgram/0.5 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626323	Product containing precisely cidofovir 375 milligram/5 milliliter conventional release solution for infusion vial (clinical drug)	4180186
35626325	Product containing precisely ciprofloxacin (as ciprofloxacin lactate) 200 milligram/100 milliliter conventional release solution for infusion bag (clinical drug)	4180186
35626327	Product containing precisely ciprofloxacin (as ciprofloxacin lactate) 100 milligram/50 milliliter conventional release solution for infusion bottle (clinical drug)	4180186
35626329	Cisatracurium (as cisatracurium besilate) 10 mg/5 mL solution for injection ampoule	4180186
35626329	Product containing precisely cisatracurium (as cisatracurium besilate) 10 milligram/5 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626330	Product containing precisely cladribine 10 milligram/10 milliliter conventional release solution for infusion vial (clinical drug)	4180186
35626331	Clomipramine hydrochloride 25 mg/2 mL solution for injection ampoule	4180186
35626331	Product containing precisely clomipramine hydrochloride 25 milligram/2 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626334	Product containing precisely sulfamethoxazole 800 milligram/10 milliliter and trimethoprim 160 milligram/10 milliliter conventional release solution for infusion ampule (clinical drug)	4180186
35626334	Sulfamethoxazole 800 mg/10 mL and trimethoprim 160 mg/10 mL solution for infusion ampoule	4180186
35626336	Thrombophlebitis of dorsal venous arch of foot (disorder)	4180186
35626341	Product containing precisely cytarabine 2 gram/20 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626342	Product containing precisely cytarabine 500 milligram/25 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626344	Product containing precisely dalteparin sodium 10000 unit/1 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626346	Product containing precisely dalteparin sodium 10000 unit/0.4 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626347	Product containing precisely dalteparin sodium 12500 unit/0.5 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626351	Product containing precisely dalteparin sodium 5000 unit/0.2 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626352	Dalteparin sodium 10000 unit/4 mL solution for injection ampoule	4180186
35626352	Product containing precisely dalteparin sodium 10000 unit/4 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626353	Product containing precisely darbepoetin alfa 500 microgram/1 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626354	Desmopressin acetate 4 microgram/mL solution for injection ampoule	4180186
35626354	Product containing precisely desmopressin acetate 4 microgram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626355	Diazepam 10 mg/2 mL emulsion for injection ampoule	4180186
35626355	Product containing precisely diazepam 10 milligram/2 milliliter conventional release emulsion for injection ampule (clinical drug)	4180186
35626356	Diazepam 10 mg/2 mL solution for injection ampoule	4180186
35626356	Product containing precisely diazepam 10 milligram/2 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626358	Diclofenac sodium 75 mg/3 mL solution for injection ampoule	4180186
35626358	Product containing precisely diclofenac sodium 75 milligram/3 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626360	Digoxin 500 microgram/2 mL solution for injection ampoule	4180186
35626360	Product containing precisely digoxin 500 microgram/2 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626361	Dihydrocodeine tartrate 50 mg/mL solution for injection ampoule	4180186
35626361	Product containing precisely dihydrocodeine tartrate 50 milligram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626363	Dinoprostone 5 mg/0.5 mL solution for infusion ampoule	4180186
35626363	Product containing precisely dinoprostone 5 milligram/0.5 milliliter conventional release solution for infusion ampule (clinical drug)	4180186
35626366	Product containing precisely disodium pamidronate 60 milligram/20 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626367	Disopyramide (as disopyramide phosphate) 50 mg/5 mL solution for injection ampoule	4180186
35626367	Product containing precisely disopyramide (as disopyramide phosphate) 50 milligram/5 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626368	Product containing precisely dobutamine (as dobutamine hydrochloride) 250 milligram/20 milliliter conventional release solution for infusion vial (clinical drug)	4180186
35626369	R & D Labs (USA) (qualifier value)	4180186
35626370	Dobutamine (as dobutamine hydrochloride) 250 mg/5 mL solution for infusion ampoule	4180186
35626370	Product containing precisely dobutamine (as dobutamine hydrochloride) 250 milligram/5 milliliter conventional release solution for infusion ampule (clinical drug)	4180186
35626371	Subsequent patient encounter	4180186
35626371	Subsequent encounter by subject (finding)	4180186
35626373	Dopamine hydrochloride 200 mg/5 mL solution for infusion ampoule	4180186
35626373	Product containing precisely dopamine hydrochloride 200 milligram/5 milliliter conventional release solution for infusion ampule (clinical drug)	4180186
35626376	Dopexamine hydrochloride 50 mg/5 mL solution for infusion ampoule	4180186
35626376	Product containing precisely dopexamine hydrochloride 50 milligram/5 milliliter conventional release solution for infusion ampule (clinical drug)	4180186
35626378	Product containing precisely doxorubicin hydrochloride 200 milligram/100 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626379	Product containing precisely eculizumab 300 milligram/30 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626381	Product containing precisely enoxaparin sodium 20 milligram/0.2 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626382	Product containing precisely enoxaparin sodium 40 milligram/0.4 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626385	Product containing precisely enoxaparin sodium 100 milligram/1 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626386	Product containing precisely enoxaparin sodium 120 milligram/0.8 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626387	Product containing precisely enoxaparin sodium 150 milligram/1 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626389	Ephedrine hydrochloride 30 mg/10 mL solution for injection ampoule	4180186
35626389	Product containing precisely ephedrine hydrochloride 30 milligram/10 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626391	Adrenaline (as adrenaline acid tartrate) 1 mg/10 mL solution for injection syringe	4180186
35626391	Product containing precisely epinephrine (as epinephrine bitartrate) 1 milligram/10 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626393	Adrenaline (as adrenaline acid tartrate) 5 mg/5 mL solution for injection ampoule	4180186
35626393	Product containing precisely epinephrine (as epinephrine bitartrate) 5 milligram/5 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626396	Product containing precisely epirubicin hydrochloride 10 milligram/5 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626399	Product containing precisely epoetin alfa 6000 unit/0.6 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626402	Product containing precisely epoetin alfa 9000 unit/0.9 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626405	Product containing precisely epoetin alfa 40000 unit/1 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626406	Product containing precisely epoetin alfa 2000 unit/0.5 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626407	Product containing precisely epoetin beta 10000 unit/0.6 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626408	Product containing precisely epoetin beta 1000 unit/0.3 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626411	Product containing precisely epoetin beta 3000 unit/0.3 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626415	Product containing precisely epoetin beta 6000 unit/0.3 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626417	Product containing precisely eptifibatide 75 milligram/100 milliliter conventional release solution for infusion vial (clinical drug)	4180186
35626421	Ethanolamine oleate 100 mg/2 mL solution for injection ampoule	4180186
35626421	Product containing precisely ethanolamine oleate 100 milligram/2 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626422	Ethanolamine oleate 250 mg/5 mL solution for injection ampoule	4180186
35626422	Product containing precisely ethanolamine oleate 250 milligram/5 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626424	Fentanyl (as fentanyl citrate) 100 microgram/2 mL solution for injection ampoule	4180186
35626424	Product containing precisely fentanyl (as fentanyl citrate) 100 microgram/2 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626425	Flecainide acetate 150 mg/15 mL solution for injection ampoule	4180186
35626425	Product containing precisely flecainide acetate 150 milligram/15 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626427	Product containing precisely flucytosine 2.5 gram/250 milliliter conventional release solution for infusion bottle (clinical drug)	4180186
35626428	Flumazenil 500 microgram/5 mL solution for injection ampoule	4180186
35626428	Product containing precisely flumazenil 500 microgram/5 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626429	Product containing precisely fluorouracil (as fluorouracil sodium) 2.5 gram/100 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626430	Product containing precisely fluorouracil (as fluorouracil sodium) 250 milligram/10 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626431	Product containing precisely fluorouracil (as fluorouracil sodium) 500 milligram/20 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626433	Flupentixol decanoate 50 mg/0.5 mL solution for injection ampoule	4180186
35626433	Product containing precisely flupentixol decanoate 50 milligram/0.5 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626434	Flupentixol decanoate 200 mg/mL solution for injection ampoule	4180186
35626434	Product containing precisely flupentixol decanoate 200 milligram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626435	Flupentixol decanoate 20 mg/mL solution for injection ampoule	4180186
35626435	Product containing precisely flupentixol decanoate 20 milligram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626436	Flupentixol decanoate 40 mg/2 mL solution for injection ampoule	4180186
35626436	Product containing precisely flupentixol decanoate 40 milligram/2 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626437	Fluphenazine decanoate 50 mg/0.5 mL solution for injection ampoule	4180186
35626437	Product containing precisely fluphenazine decanoate 50 milligram/0.5 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626438	Fluphenazine decanoate 100 mg/mL solution for injection ampoule	4180186
35626438	Product containing precisely fluphenazine decanoate 100 milligram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626441	Fluphenazine decanoate 25 mg/mL solution for injection ampoule	4180186
35626441	Product containing precisely fluphenazine decanoate 25 milligram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626443	Fluphenazine decanoate 50 mg/2 mL solution for injection ampoule	4180186
35626443	Product containing precisely fluphenazine decanoate 50 milligram/2 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626447	Product containing precisely fondaparinux sodium 10 milligram/0.8 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626448	Product containing precisely fondaparinux sodium 2.5 milligram/0.5 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626452	Furosemide 50 mg/5 mL solution for injection ampoule	4180186
35626452	Product containing precisely furosemide 50 milligram/5 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626457	Product containing precisely ganirelix 250 microgram/0.5 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626462	Product containing precisely glatiramer acetate 20 milligram/1 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626464	Glyceryl trinitrate 50 mg/50 mL solution for injection vial	4180186
35626464	Product containing precisely glyceryl trinitrate 50 milligram/50 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626465	Glyceryl trinitrate 5 mg/5 mL solution for injection ampoule	4180186
35626465	Product containing precisely glyceryl trinitrate 5 milligram/5 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626466	Glyceryl trinitrate 50 mg/10 mL solution for injection ampoule	4180186
35626466	Product containing precisely glyceryl trinitrate 50 milligram/10 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626467	Glyceryl trinitrate 25 mg/5 mL solution for injection ampoule	4180186
35626467	Product containing precisely glyceryl trinitrate 25 milligram/5 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626469	Haloperidol (as haloperidol decanoate) 100 mg/mL oil for injection ampoule	4180186
35626469	Product containing precisely haloperidol (as haloperidol decanoate) 100 milligram/1 milliliter prolonged-release oil for injection ampule (clinical drug)	4180186
35626473	Product containing precisely heparin calcium 12500 unit/0.5 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626477	Heparin sodium 1000 unit/mL solution for injection ampoule	4180186
35626477	Product containing precisely heparin sodium 1000 unit/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626478	Product containing precisely heparin sodium 25000 unit/5 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626481	Product containing precisely heparin sodium 125000 unit/5 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626482	Product containing precisely heparin sodium 5000 unit/5 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626483	Heparin sodium 5000 unit/mL solution for injection ampoule	4180186
35626483	Product containing precisely heparin sodium 5000 unit/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626484	Heparin sodium 25000 unit/5 mL solution for injection ampoule	4180186
35626484	Product containing precisely heparin sodium 25000 unit/5 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626486	Product containing precisely hepatitis B surface antigen 10 microgram/0.5 milliliter conventional release suspension for injection vial (clinical drug)	4180186
35626487	Product containing precisely hepatitis B surface antigen 20 microgram/1 milliliter conventional release suspension for injection syringe (clinical drug)	4180186
35626489	Hydrocortisone (as hydrocortisone sodium phosphate) 500 mg/5 mL solution for injection ampoule	4180186
35626489	Product containing precisely hydrocortisone (as hydrocortisone sodium phosphate) 500 milligram/5 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626492	Hydromorphone hydrochloride 2 mg/mL solution for injection ampoule	4180186
35626492	Product containing precisely hydromorphone hydrochloride 2 milligram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626493	Vitamin B>12b< 1 mg/mL solution for injection ampule	4180186
35626493	Product containing precisely hydroxocobalamin 1 milligram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626493	Vitamin B>12b< 1 mg/mL solution for injection ampoule	4180186
35626504	Product containing precisely human insulin (as insulin glargine) 1000 unit/10 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626506	Product containing precisely human insulin (as insulin glargine) 300 unit/3 milliliter conventional release solution for injection cartridge (clinical drug)	4180186
35626508	Product containing precisely human insulin (as human isophane insulin) 300 unit/3 milliliter conventional release suspension for injection cartridge (clinical drug)	4180186
35626510	Product containing precisely granisetron (as granisetron hydrochloride) 200 microgram/1 milliliter conventional release oral solution (clinical drug)	4180186
35626514	Product containing precisely beef insulin (as bovine insulin soluble) 150 unit/1.5 milliliter conventional release solution for injection cartridge (clinical drug)	4180186
35626519	Product containing precisely carbamide peroxide 50 milligram/1 gram conventional release ear drops (clinical drug)	4180186
35626519	Urea hydrogen peroxide 50 mg/g ear drops	4180186
35626520	Product containing precisely human insulin (as human insulin soluble) 1000 unit/10 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626521	Product containing precisely human insulin (as human insulin soluble) 300 unit/3 milliliter conventional release solution for injection cartridge (clinical drug)	4180186
35626527	Product containing precisely irinotecan hydrochloride trihydrate 40 milligram/2 milliliter conventional release solution for infusion vial (clinical drug)	4180186
35626531	Isoniazid 50 mg/2 mL solution for injection ampoule	4180186
35626531	Product containing precisely isoniazid 50 milligram/2 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626535	Product containing precisely ketamine (as ketamine hydrochloride) 1 gram/10 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626536	Product containing precisely ketamine (as ketamine hydrochloride) 200 milligram/20 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626538	Ketoprofen 100 mg/2 mL solution for injection ampoule	4180186
35626538	Product containing precisely ketoprofen 100 milligram/2 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626542	Product containing precisely levobupivacaine (as levobupivacaine hydrochloride) 62.5 milligram/100 milliliter conventional release solution for injection bag (clinical drug)	4180186
35626543	Product containing precisely levobupivacaine (as levobupivacaine hydrochloride) 125 milligram/200 milliliter conventional release solution for injection bag (clinical drug)	4180186
35626545	Product containing precisely levobupivacaine (as levobupivacaine hydrochloride) 250 milligram/200 milliliter conventional release solution for infusion bag (clinical drug)	4180186
35626547	Levobupivacaine (as levobupivacaine hydrochloride) 50 mg/10 mL solution for injection ampoule	4180186
35626547	Product containing precisely levobupivacaine (as levobupivacaine hydrochloride) 50 milligram/10 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626548	Levobupivacaine (as levobupivacaine hydrochloride) 75 mg/10 mL solution for injection ampoule	4180186
35626548	Product containing precisely levobupivacaine (as levobupivacaine hydrochloride) 75 milligram/10 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626549	Product containing precisely levofloxacin (as levofloxacin hemihydrate) 500 milligram/100 milliliter conventional release solution for infusion vial (clinical drug)	4180186
35626553	Lidocaine hydrochloride 50 mg/5 mL solution for injection ampoule	4180186
35626553	Product containing precisely lidocaine hydrochloride 50 milligram/5 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626554	Product containing precisely lidocaine hydrochloride 100 milligram/10 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626555	Product containing precisely lidocaine hydrochloride 100 milligram/5 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626557	Lidocaine hydrochloride 400 mg/20 mL solution for injection ampoule	4180186
35626557	Product containing precisely lidocaine hydrochloride 400 milligram/20 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626559	Product containing precisely linezolid 600 milligram/300 milliliter conventional release solution for infusion bag (clinical drug)	4180186
35626561	Product containing precisely doxorubicin hydrochloride 50 milligram/25 milliliter conventional release solution for infusion vial (clinical drug)	4180186
35626562	Product containing precisely mannitol 50 gram/500 milliliter conventional release solution for infusion bag (clinical drug)	4180186
35626563	Product containing precisely mannitol 50 gram/250 milliliter conventional release solution for infusion bag (clinical drug)	4180186
35626565	Product containing precisely mecasermin 40 milligram/4 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626567	Product containing precisely medroxyprogesterone acetate 150 milligram/1 milliliter conventional release suspension for injection vial (clinical drug)	4180186
35626569	Mesna 1 g/10 mL solution for injection ampoule	4180186
35626569	Product containing precisely mesna 1 gram/10 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626570	Mesna 400 mg/4 mL solution for injection ampoule	4180186
35626570	Product containing precisely mesna 400 milligram/4 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626573	Methadone hydrochloride 35 mg/3.5 mL solution for injection ampoule	4180186
35626573	Product containing precisely methadone hydrochloride 35 milligram/3.5 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626574	Methadone hydrochloride 50 mg/5 mL solution for injection ampoule	4180186
35626574	Product containing precisely methadone hydrochloride 50 milligram/5 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626576	Product containing precisely methotrexate (as methotrexate sodium) 5 gram/50 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626577	Product containing precisely methotrexate (as methotrexate sodium) 5 milligram/2 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626580	Product containing precisely methotrexate (as methotrexate sodium) 50 milligram/2 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626583	Product containing precisely methoxy polyethylene glycol-epoetin beta 150 microgram/0.3 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626587	Product containing precisely methoxy polyethylene glycol-epoetin beta 75 microgram/0.3 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626589	Product containing precisely methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial (clinical drug)	4180186
35626591	Product containing precisely methylprednisolone acetate 120 milligram/3 milliliter conventional release suspension for injection vial (clinical drug)	4180186
35626594	Mexiletine hydrochloride 250 mg/10 mL solution for injection ampoule	4180186
35626594	Product containing precisely mexiletine hydrochloride 250 milligram/10 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626597	Midazolam (as midazolam hydrochloride) 2 mg/2 mL solution for injection ampoule	4180186
35626597	Product containing precisely midazolam (as midazolam hydrochloride) 2 milligram/2 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626598	Midazolam (as midazolam hydrochloride) 5 mg/5 mL solution for injection ampoule	4180186
35626598	Product containing precisely midazolam (as midazolam hydrochloride) 5 milligram/5 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626599	Midazolam (as midazolam hydrochloride) 50 mg/10 mL solution for injection ampoule	4180186
35626599	Product containing precisely midazolam (as midazolam hydrochloride) 50 milligram/10 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626602	Mivacurium (as mivacurium chloride) 10 mg/5 mL solution for injection ampoule	4180186
35626602	Product containing precisely mivacurium (as mivacurium chloride) 10 milligram/5 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626605	Nalbuphine hydrochloride 20 mg/2 mL solution for injection ampoule	4180186
35626605	Product containing precisely nalbuphine hydrochloride 20 milligram/2 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626606	Naloxone hydrochloride 40 microgram/2 mL solution for injection ampoule	4180186
35626606	Product containing precisely naloxone hydrochloride 40 microgram/2 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626609	Nandrolone decanoate 50 mg/mL solution for injection ampoule	4180186
35626609	Product containing precisely nandrolone decanoate 50 milligram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626611	Nefopam hydrochloride 20 mg/mL solution for injection ampoule	4180186
35626611	Product containing precisely nefopam hydrochloride 20 milligram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626612	Glycopyrronium bromide 500 microgram/mL and neostigmine methylsulfate 2.5 mg/mL solution for injection ampoule	4180186
35626612	Product containing precisely glycopyrronium bromide 500 microgram/1 milliliter and neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626616	Netilmicin (as netilmicin sulphate) 15 mg/1.5 mL solution for injection ampoule	4180186
35626616	Product containing precisely netilmicin (as netilmicin sulfate) 15 milligram/1.5 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626617	Netilmicin (as netilmicin sulphate) 50 mg/mL solution for injection ampoule	4180186
35626617	Product containing precisely netilmicin (as netilmicin sulfate) 50 milligram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626619	Nizatidine 100 mg/4 mL solution for injection ampoule	4180186
35626619	Product containing precisely nizatidine 100 milligram/4 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626620	Noradrenaline (as noradrenaline bitartrate) 20 mg/20 mL solution for infusion ampoule	4180186
35626620	Product containing precisely norepinephrine (as norepinephrine bitartrate) 20 milligram/20 milliliter conventional release solution for infusion ampule (clinical drug)	4180186
35626623	Octreotide (as octreotide acetate) 100 microgram/mL solution for injection ampoule	4180186
35626623	Product containing precisely octreotide (as octreotide acetate) 100 microgram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626624	Product containing precisely octreotide (as octreotide acetate) 1 milligram/5 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626625	Octreotide (as octreotide acetate) 500 microgram/mL solution for injection ampoule	4180186
35626625	Product containing precisely octreotide (as octreotide acetate) 500 microgram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626626	Octreotide (as octreotide acetate) 50 microgram/mL solution for injection ampoule	4180186
35626626	Product containing precisely octreotide (as octreotide acetate) 50 microgram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626628	Ondansetron (as ondansetron hydrochloride) 4 mg/2 mL solution for injection ampoule	4180186
35626628	Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/2 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626629	Ondansetron (as ondansetron hydrochloride) 8 mg/4 mL solution for injection ampoule	4180186
35626629	Product containing precisely ondansetron (as ondansetron hydrochloride) 8 milligram/4 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626630	Oxycodone hydrochloride 10 mg/mL solution for injection ampoule	4180186
35626630	Product containing precisely oxycodone hydrochloride 10 milligram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626635	Product containing precisely paclitaxel 150 milligram/25 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626636	Product containing precisely paclitaxel 300 milligram/50 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626637	Product containing precisely palonosetron (as palonosetron hydrochloride) 250 microgram/5 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626638	Product containing precisely disodium pamidronate 15 milligram/5 milliliter conventional release solution for infusion vial (clinical drug)	4180186
35626639	Pancuronium bromide 4 mg/2 mL solution for injection ampoule	4180186
35626639	Product containing precisely pancuronium bromide 4 milligram/2 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626640	Product containing precisely panitumumab 100 milligram/5 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626645	Product containing precisely pegaspargase 3750 unit/5 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626646	Product containing precisely filgrastim (as pegfilgrastim) 6 milligram/0.6 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626647	Product containing precisely peginterferon alfa-2a 135 microgram/0.5 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626648	Product containing precisely peginterferon alfa-2a 180 microgram/0.5 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626650	Pentazocine (as pentazocine lactate) 30 mg/mL solution for injection ampoule	4180186
35626650	Product containing precisely pentazocine (as pentazocine lactate) 30 milligram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626651	Pentazocine (as pentazocine lactate) 60 mg/2 mL solution for injection ampoule	4180186
35626651	Product containing precisely pentazocine (as pentazocine lactate) 60 milligram/2 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626652	Phenobarbital sodium 15 mg/mL solution for injection ampoule	4180186
35626652	Product containing precisely phenobarbital sodium 15 milligram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626655	Phenobarbital sodium 60 mg/mL solution for injection ampoule	4180186
35626655	Product containing precisely phenobarbital sodium 60 milligram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626656	Product containing precisely phenol 1.25 gram/25 milliliter prolonged-release oil for injection vial (clinical drug)	4180186
35626658	Phentolamine mesilate 10 mg/mL solution for injection ampoule	4180186
35626658	Product containing precisely phentolamine mesilate 10 milligram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626660	Phytomenadione 1 mg/0.5 mL solution for injection ampoule	4180186
35626660	Product containing precisely phytomenadione 1 milligram/0.5 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626661	Pipotiazine palmitate 50 mg/mL solution for injection ampoule	4180186
35626661	Product containing precisely pipotiazine palmitate 50 milligram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626662	Pipotiazine palmitate 100 mg/2 mL solution for injection ampoule	4180186
35626662	Product containing precisely pipotiazine palmitate 100 milligram/2 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626663	Piroxicam 20 mg/mL solution for injection ampoule	4180186
35626663	Product containing precisely piroxicam 20 milligram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626666	Monobasic potassium phosphate 1.36 g/10 mL solution for injection ampoule	4180186
35626666	Product containing precisely monobasic potassium phosphate 1.36 gram/10 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626668	Product containing precisely anhydrous glucose 25 gram/500 milliliter and potassium chloride 750 milligram/500 milliliter and sodium chloride 2.25 gram/500 milliliter conventional release solution for infusion bag (clinical drug)	4180186
35626670	Product containing precisely potassium chloride 750 milligram/500 milliliter and sodium chloride 4.5 gram/500 milliliter conventional release solution for infusion bag (clinical drug)	4180186
35626671	Potassium chloride 2 g/10 mL solution for injection ampoule	4180186
35626671	Product containing precisely potassium chloride 2 gram/10 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626679	Product containing precisely felypressin 0.06 unit/2 milliliter and prilocaine hydrochloride 60 milligram/2 milliliter conventional release solution for injection cartridge (clinical drug)	4180186
35626680	Prochlorperazine mesilate 12.5 mg/mL solution for injection ampoule	4180186
35626680	Product containing precisely prochlorperazine mesilate 12.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626682	Product containing precisely progesterone 100 milligram/2 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626682	Progesterone 100 mg/2 mL solution for injection ampoule	4180186
35626685	Product containing precisely propofol 200 milligram/20 milliliter conventional release emulsion for injection vial (clinical drug)	4180186
35626686	Product containing precisely propofol 500 milligram/50 milliliter conventional release emulsion for injection syringe (clinical drug)	4180186
35626688	Product containing precisely propofol 1 gram/50 milliliter conventional release emulsion for injection syringe (clinical drug)	4180186
35626689	Product containing precisely propofol 1 gram/50 milliliter conventional release emulsion for injection vial (clinical drug)	4180186
35626690	Product containing precisely propranolol hydrochloride 1 milligram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626690	Propranolol hydrochloride 1 mg/mL solution for injection ampoule	4180186
35626692	Product containing precisely quinine dihydrochloride 300 milligram/1 milliliter conventional release solution for infusion ampule (clinical drug)	4180186
35626692	Quinine dihydrochloride 300 mg/mL solution for infusion ampoule	4180186
35626696	Product containing precisely rituximab 500 milligram/50 milliliter conventional release solution for infusion vial (clinical drug)	4180186
35626700	Product containing precisely ropivacaine hydrochloride 100 milligram/10 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626700	Ropivacaine hydrochloride 100 mg/10 mL solution for injection ampoule	4180186
35626701	Product containing precisely ropivacaine hydrochloride 20 milligram/10 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626701	Ropivacaine hydrochloride 20 mg/10 mL solution for injection ampoule	4180186
35626702	Product containing precisely ropivacaine hydrochloride 75 milligram/10 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626702	Ropivacaine hydrochloride 75 mg/10 mL solution for injection ampoule	4180186
35626703	Product containing precisely salmon calcitonin 100 unit/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626703	Salmon calcitonin 100 unit/mL solution for injection ampoule	4180186
35626704	Product containing precisely salmon calcitonin 400 unit/2 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626705	Product containing precisely salmon calcitonin 50 unit/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626705	Salmon calcitonin 50 unit/mL solution for injection ampoule	4180186
35626706	Product containing precisely sodium bicarbonate 4.2 gram/50 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626709	Product containing precisely sodium chloride 90 milligram/10 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626710	Product containing precisely sodium chloride 18 milligram/2 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626710	Sodium chloride 18 mg/2 mL solution for injection ampoule	4180186
35626713	Product containing precisely sodium chloride 45 milligram/5 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626714	Clodronate disodium 300 mg/5 mL solution for infusion ampoule	4180186
35626714	Product containing precisely clodronate disodium 300 milligram/5 milliliter conventional release solution for infusion ampule (clinical drug)	4180186
35626715	Product containing precisely sodium glycerophosphate 4.32 gram/20 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626721	Product containing precisely somatropin(epr) 10 milligram/1.5 milliliter conventional release solution for injection cartridge (clinical drug)	4180186
35626722	Product containing precisely sotalol hydrochloride 40 milligram/4 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626722	Sotalol hydrochloride 40 mg/4 mL solution for injection ampoule	4180186
35626724	Testosterone enantate 250 mg/mL solution for injection ampoule	4180186
35626724	Product containing precisely testosterone enantate 250 milligram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626725	Product containing precisely testosterone propionate 100 milligram/2 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626725	Testosterone propionate 100 mg/2 mL solution for injection ampoule	4180186
35626726	Product containing precisely testosterone undecanoate 1 gram/4 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626726	Testosterone undecanoate 1 g/4 mL solution for injection ampoule	4180186
35626727	Product containing precisely tinzaparin sodium 2500 unit/0.25 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626729	Product containing precisely tinzaparin sodium 4500 unit/0.45 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626731	Product containing precisely tinzaparin sodium 10000 unit/0.5 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626735	Product containing precisely tobramycin (as tobramycin sulfate) 40 milligram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626735	Tobramycin (as tobramycin sulphate) 40 mg/mL solution for injection ampoule	4180186
35626736	Product containing precisely tobramycin (as tobramycin sulfate) 80 milligram/2 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626736	Tobramycin (as tobramycin sulphate) 80 mg/2 mL solution for injection ampoule	4180186
35626739	Product containing precisely triamcinolone acetonide 10 milligram/1 milliliter conventional release suspension for injection ampule (clinical drug)	4180186
35626739	Triamcinolone acetonide 10 mg/mL suspension for injection ampoule	4180186
35626741	Product containing precisely triamcinolone acetonide 40 milligram/1 milliliter conventional release suspension for injection syringe (clinical drug)	4180186
35626743	Product containing precisely triamcinolone acetonide 80 milligram/2 milliliter conventional release suspension for injection syringe (clinical drug)	4180186
35626744	Product containing precisely triamcinolone hexacetonide 100 milligram/5 milliliter conventional release suspension for injection vial (clinical drug)	4180186
35626747	Edetate trisodium 1 g/5 mL solution for injection ampoule	4180186
35626747	Product containing precisely edetate trisodium 1 gram/5 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626748	Product containing precisely tropisetron (as tropisetron hydrochloride) 2 milligram/2 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626748	Tropisetron (as tropisetron hydrochloride) 2 mg/2 mL solution for injection ampoule	4180186
35626749	Product containing precisely tropisetron (as tropisetron hydrochloride) 5 milligram/5 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626749	Tropisetron (as tropisetron hydrochloride) 5 mg/5 mL solution for injection ampoule	4180186
35626751	Product containing precisely vincristine sulfate 1 milligram/1 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626752	Product containing precisely vincristine sulfate 2 milligram/2 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626753	Product containing precisely vincristine sulfate 5 milligram/5 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626754	Product containing precisely vinorelbine (as vinorelbine tartrate) 10 milligram/1 milliliter conventional release solution for infusion vial (clinical drug)	4180186
35626755	Product containing precisely vinorelbine (as vinorelbine tartrate) 50 milligram/5 milliliter conventional release solution for infusion vial (clinical drug)	4180186
35626760	Zuclopenthixol decanoate 500 mg/mL solution for injection ampoule	4180186
35626760	Product containing precisely zuclopenthixol decanoate 500 milligram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626762	Cranial nerve palsy due to diabetes mellitus (disorder)	4180186
35626762	Cranial nerve palsy with diabetes mellitus	4180186
35626763	Erectile dysfunction due to diabetes mellitus (disorder)	4180186
35626763	Erectile dysfunction with diabetes mellitus	4180186
35626765	Cranial nerve palsy with type I diabetes mellitus	4180186
35626765	Cranial nerve palsy with type 1 diabetes mellitus	4180186
35626765	Cranial nerve palsy due to type 1 diabetes mellitus (disorder)	4180186
35626771	Powder for conventional release suspension for endotracheal instillation	4180186
35626771	Powder for conventional release suspension for endotracheal instillation (dose form)	4180186
35626772	Delayed union of fracture of foot (disorder)	4180186
35626780	Cisatracurium (as cisatracurium besilate) 20 mg/10 mL solution for injection ampoule	4180186
35626780	Product containing precisely cisatracurium (as cisatracurium besilate) 20 milligram/10 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626781	Clindamycin (as clindamycin phosphate) 300 mg/2 mL solution for injection ampoule	4180186
35626781	Product containing precisely clindamycin (as clindamycin phosphate) 300 milligram/2 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626782	Clindamycin (as clindamycin phosphate) 600 mg/4 mL solution for injection ampoule	4180186
35626782	Product containing precisely clindamycin (as clindamycin phosphate) 600 milligram/4 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626784	Danaparoid sodium 750 unit/0.6 mL solution for injection ampoule	4180186
35626784	Product containing precisely danaparoid sodium 750 unit/0.6 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626787	Adrenaline 300 microgram/0.3 mL solution for injection syringe	4180186
35626787	Product containing precisely epinephrine 300 microgram/0.3 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626789	Ergometrine maleate 500 microgram/mL solution for injection ampoule	4180186
35626789	Product containing precisely ergometrine maleate 500 microgram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626791	Product containing precisely fluorouracil (as fluorouracil sodium) 2.5 gram/50 milliliter conventional release solution for infusion vial (clinical drug)	4180186
35626793	Product containing precisely gadodiamide 7.5 millimole/15 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626794	Product containing precisely gadodiamide 10 millimole/20 milliliter conventional release solution for injection vial (clinical drug)	4180186
35626797	Granisetron (as granisetron hydrochloride) 1 mg/mL solution for injection ampoule	4180186
35626797	Product containing precisely granisetron (as granisetron hydrochloride) 1 milligram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626800	Haloperidol 5 mg/mL solution for injection ampoule	4180186
35626800	Product containing precisely haloperidol 5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626802	Product containing precisely human insulin (as human isophane insulin) 300 unit/3 milliliter conventional release suspension for injection syringe (clinical drug)	4180186
35626804	Product containing precisely human insulin (as human insulin soluble) 300 unit/3 milliliter conventional release solution for injection syringe (clinical drug)	4180186
35626806	Iron (as iron sucrose) 100 mg/5 mL solution for injection ampoule	4180186
35626806	Product containing precisely iron (as iron sucrose) 100 milligram/5 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626809	Metaraminol (as metaraminol bitartrate) 10 mg/mL solution for injection ampoule	4180186
35626809	Product containing precisely metaraminol (as metaraminol bitartrate) 10 milligram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626811	Methoxamine hydrochloride 20 mg/mL solution for injection ampoule	4180186
35626811	Product containing precisely methoxamine hydrochloride 20 milligram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626812	Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial (clinical drug)	4180186
35626813	Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial (clinical drug)	4180186
35626815	Morphine sulfate 15 mg/mL solution for injection ampoule	4180186
35626815	Product containing precisely morphine sulfate 15 milligram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626819	Neostigmine methylsulfate 2.5 mg/mL solution for injection ampoule	4180186
35626819	Product containing precisely neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626820	Pethidine hydrochloride 100 mg/10 mL solution for injection ampoule	4180186
35626820	Product containing precisely pethidine hydrochloride 100 milligram/10 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626825	Phytomenadione 2 mg/0.2 mL solution for injection ampoule	4180186
35626825	Product containing precisely phytomenadione 2 milligram/0.2 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626826	Product containing precisely anhydrous glucose 50 gram/1 liter and potassium chloride 1.5 gram/1 liter conventional release solution for infusion bag (clinical drug)	4180186
35626829	Product containing precisely potassium chloride 1.5 gram/500 milliliter and sodium chloride 4.5 gram/500 milliliter conventional release solution for infusion bag (clinical drug)	4180186
35626830	Product containing precisely anhydrous glucose 40 gram/1 liter and potassium chloride 2 gram/1 liter and sodium chloride 1.8 gram/1 liter conventional release solution for infusion bag (clinical drug)	4180186
35626831	Product containing precisely anhydrous glucose 50 gram/1 liter and potassium chloride 2 gram/1 liter conventional release solution for infusion bag (clinical drug)	4180186
35626832	Product containing precisely potassium chloride 2 gram/1 liter and sodium chloride 9 gram/1 liter conventional release solution for infusion bag (clinical drug)	4180186
35626833	Mycoprotein (substance)	4180186
35626838	Product containing precisely protamine sulfate 100 milligram/10 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626838	Protamine sulfate 100 mg/10 mL solution for injection ampoule	4180186
35626841	Product containing precisely ropivacaine hydrochloride 400 milligram/200 milliliter conventional release solution for infusion bag (clinical drug)	4180186
35626842	Product containing precisely salbutamol (as salbutamol sulfate) 500 microgram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626842	Salbutamol (as salbutamol sulfate) 500 microgram/mL solution for injection ampoule	4180186
35626843	Product containing precisely salbutamol (as salbutamol sulfate) 5 milligram/50 milliliter conventional release solution for infusion vial (clinical drug)	4180186
35626843	Salbutamol (as salbutamol sulfate) 5 mg/50 mL solution for infusion vial	4180186
35626844	Product containing precisely salbutamol (as salbutamol sulfate) 5 milligram/5 milliliter conventional release solution for infusion ampule (clinical drug)	4180186
35626844	Salbutamol (as salbutamol sulfate) 5 mg/5 mL solution for infusion ampoule	4180186
35626845	Product containing precisely sodium aurothiomalate 10 milligram/0.5 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626845	Sodium aurothiomalate 10 mg/0.5 mL solution for injection ampoule	4180186
35626846	Product containing precisely sodium aurothiomalate 20 milligram/0.5 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626846	Sodium aurothiomalate 20 mg/0.5 mL solution for injection ampoule	4180186
35626850	Product containing precisely terbutaline sulfate 500 microgram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626850	Terbutaline sulfate 500 microgram/mL solution for injection ampoule	4180186
35626852	Product containing precisely tetracosactide acetate 250 microgram/1 milliliter conventional release solution for injection ampule (clinical drug)	4180186
35626852	Tetracosactide acetate 250 microgram/mL solution for injection ampoule	4180186
35626854	Product containing precisely aclidinium bromide 375 microgram/1 actuation conventional release powder for inhalation (clinical drug)	4180186
35626857	Beclometasone dipropionate 200 microgram/actuation pressurized solution for inhalation	4180186
35626857	Beclomethasone dipropionate 200 microgram/actuation pressurised solution for inhalation	4180186
35626857	Beclometasone dipropionate 200 microgram/actuation pressurised solution for inhalation	4180186
35626857	Product containing precisely beclometasone dipropionate 200 microgram/1 actuation pressurized conventional release solution for inhalation (clinical drug)	4180186
35626857	Product containing precisely beclometasone dipropionate 200 microgram/1 actuation conventional release pressurized solution for inhalation (clinical drug)	4180186
35626858	Beclometasone dipropionate 250 microgram/actuation powder for inhalation	4180186
35626858	Product containing precisely beclometasone dipropionate 250 microgram/1 actuation conventional release powder for inhalation (clinical drug)	4180186
35626859	Beclometasone dipropionate 250 microgram/actuation pressurized solution for inhalation	4180186
35626859	Beclomethasone dipropionate 250 microgram/actuation pressurised solution for inhalation	4180186
35626859	Product containing precisely beclometasone dipropionate 250 microgram/1 actuation pressurized conventional release solution for inhalation (clinical drug)	4180186
35626859	Beclometasone dipropionate 250 microgram/actuation pressurised solution for inhalation	4180186
35626859	Product containing precisely beclometasone dipropionate 250 microgram/1 actuation conventional release pressurized solution for inhalation (clinical drug)	4180186
35626862	Beclometasone dipropionate 50 microgram/actuation pressurized solution for inhalation	4180186
35626862	Beclomethasone dipropionate 50 microgram/actuation pressurised solution for inhalation	4180186
35626862	Product containing precisely beclometasone dipropionate 50 microgram/1 actuation pressurized conventional release solution for inhalation (clinical drug)	4180186
35626862	Beclometasone dipropionate 50 microgram/actuation pressurised solution for inhalation	4180186
35626862	Product containing precisely beclometasone dipropionate 50 microgram/1 actuation conventional release pressurized solution for inhalation (clinical drug)	4180186
35626863	Product containing precisely budesonide 100 microgram and formoterol fumarate dihydrate 6 microgram/1 actuation conventional release powder for inhalation (clinical drug)	4180186
35626864	Product containing precisely budesonide 100 microgram/1 actuation conventional release powder for inhalation (clinical drug)	4180186
35626867	Product containing precisely budesonide 200 microgram and formoterol fumarate dihydrate 6 microgram/1 actuation conventional release powder for inhalation (clinical drug)	4180186
35626872	Product containing precisely fluticasone propionate 125 microgram/1 actuation pressurized conventional release suspension for inhalation (clinical drug)	4180186
35626872	Fluticasone propionate 125 microgram/actuation pressurised suspension for inhalation	4180186
35626872	Product containing precisely fluticasone propionate 125 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug)	4180186
35626873	Product containing precisely fluticasone propionate 250 microgram/1 actuation conventional release powder for inhalation (clinical drug)	4180186
35626875	Fluticasone propionate 25 microgram/actuation pressurised suspension for inhalation	4180186
35626875	Product containing precisely fluticasone propionate 25 microgram/1 actuation pressurized conventional release suspension for inhalation (clinical drug)	4180186
35626875	Product containing precisely fluticasone propionate 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug)	4180186
35626878	Product containing precisely fluticasone propionate 50 microgram/1 actuation pressurized conventional release suspension for inhalation (clinical drug)	4180186
35626878	Fluticasone propionate 50 microgram/actuation pressurised suspension for inhalation	4180186
35626878	Product containing precisely fluticasone propionate 50 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug)	4180186
35626879	Product containing precisely ipratropium bromide 20 microgram/1 actuation pressurized conventional release solution for inhalation (clinical drug)	4180186
35626879	Ipratropium bromide 20 microgram/actuation pressurised solution for inhalation	4180186
35626879	Product containing precisely ipratropium bromide 20 microgram/1 actuation conventional release pressurized solution for inhalation (clinical drug)	4180186
35626881	Product containing precisely mometasone furoate 200 microgram/1 actuation conventional release powder for inhalation (clinical drug)	4180186
35626882	Product containing precisely mometasone furoate 400 microgram/1 actuation conventional release powder for inhalation (clinical drug)	4180186
35626883	Salbutamol (as salbutamol sulfate) 100 microgram/actuation powder for inhalation	4180186
35626883	Product containing precisely salbutamol (as salbutamol sulfate) 100 microgram/1 actuation conventional release powder for inhalation (clinical drug)	4180186
35626885	Product containing precisely salbutamol 200 microgram/1 actuation conventional release powder for inhalation (clinical drug)	4180186
35626885	Salbutamol 200 microgram/actuation powder for inhalation	4180186
35626887	Product containing precisely salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation pressurized conventional release suspension for inhalation (clinical drug)	4180186
35626887	Salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurised suspension for inhalation	4180186
35626887	Product containing precisely salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug)	4180186
35626888	Product containing precisely salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)	4180186
35626892	Product containing precisely fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)	4180186
35626893	Product containing precisely fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/1 actuation conventional release powder for inhalation (clinical drug)	4180186
35626895	Sodium cromoglicate 5 mg/actuation pressurized suspension for inhalation	4180186
35626895	Cromolyn sodium 5 mg/actuation pressurised suspension for inhalation	4180186
35626895	Product containing precisely cromoglicate sodium 5 milligram/1 actuation pressurized conventional release suspension for inhalation (clinical drug)	4180186
35626895	Sodium cromoglicate 5 mg/actuation pressurised suspension for inhalation	4180186
35626895	Product containing precisely cromoglicate sodium 5 milligram/1 actuation conventional release pressurized suspension for inhalation (clinical drug)	4180186
35626898	Product containing meclofenamic acid in oral dose form (medicinal product form)	4180186
35626899	Product containing dexamethasone and tramazoline in nasal dose form (medicinal product form)	4180186
35626900	19.4 (qualifier value)	4180186
35626900	Nineteen point four	4180186
35626904	Retinal edema due to diabetes mellitus (disorder)	4180186
35626904	Retinal edema with diabetes mellitus	4180186
35626904	Retinal oedema due to diabetes mellitus	4180186
35626904	Retinal oedema with diabetes mellitus	4180186
35626905	Ischaemia of retina due to diabetes mellitus	4180186
35626905	Retinal ischemia with diabetes mellitus	4180186
35626905	Retinal ischaemia with diabetes mellitus	4180186
35626905	Ischemia of retina due to diabetes mellitus (disorder)	4180186
35626905	Retinal ischemia due to diabetes mellitus	4180186
35626905	Retinal ischaemia due to diabetes mellitus	4180186
35626906	Chemist Brokers (qualifier value)	4180186
35626907	First Horizon Pharmaceutical (qualifier value)	4180186
35626908	Life Extension (qualifier value)	4180186
35626910	Axcan Pharma Inc (qualifier value)	4180186
35626912	Tyson Nutraceuticals (qualifier value)	4180186
35626914	C D Medical Ltd (qualifier value)	4180186
35626916	KAL (qualifier value)	4180186
35626920	Schiff (qualifier value)	4180186
35626922	Masons Vitamins Inc. (qualifier value)	4180186
35626925	Medlock Medical (qualifier value)	4180186
35626926	Potter's (Herbal Supplies) Ltd (qualifier value)	4180186
35626927	Denfleet Pharma Ltd (qualifier value)	4180186
35626928	GE Healthcare Biosciences (qualifier value)	4180186
35626933	Huntley Pharmaceuticals Ltd (qualifier value)	4180186
35626934	Nine Lives (qualifier value)	4180186
35626936	Jessup Marketing (qualifier value)	4180186
35626940	Chattem (U.K.) Ltd (qualifier value)	4180186
35626941	Sleep related movement disorder (disorder)	4180186
35626942	S.C.A. Hygiene Products Ltd (qualifier value)	4180186
35626947	NHS dm+d appliance	4180186
35626947	NHS dm+d appliance (physical object)	4180186
35626948	dm+d attribute (attribute)	4180186
35626951	Virtual appliance pack	4180186
35626951	Virtual appliance pack (physical object)	4180186
35626952	Virtual medicinal product pack (product)	4180186
35626953	Bayer Consumer Care (qualifier value)	4180186
35626954	Lifeplan Products Limited (qualifier value)	4180186
35626955	Recordati Pharmaceuticals Ltd (qualifier value)	4180186
35626956	Astellas Pharma Ltd (qualifier value)	4180186
35626957	Benoliel Partners (UK) (qualifier value)	4180186
35626960	Accura Health Ltd (qualifier value)	4180186
35626961	Home CPAP (continuous positive airway pressure) ventilation supply	4180186
35626961	CPAP (continuous positive airway pressure) at home	4180186
35626961	Home CPAP (continuous positive airway pressure) supply	4180186
35626961	Uses home continuous positive airway pressure ventilation supply (finding)	4180186
35626962	NatraHealth Ltd (qualifier value)	4180186
35626965	Caraderm Limited (qualifier value)	4180186
35626967	Laboratorie HRA Pharma (qualifier value)	4180186
35626968	Santen GmbH (qualifier value)	4180186
35626969	Altana Pharma Ltd (qualifier value)	4180186
35626972	Prescribing status	4180186
35626972	Prescribing status (qualifier value)	4180186
35626973	Valid as a prescribable product	4180186
35626973	VMP valid as a prescribable product (qualifier value)	4180186
35626976	Not recommended to prescribe as a VMP (qualifier value)	4180186
35626987	Pharmacy medicine - legal category (qualifier value)	4180186
35626988	General sales list (qualifier value)	4180186
35626991	Re-marketed (qualifier value)	4180186
35626992	Discontinued AMPP(qualifier value)	4180186
35626994	Almond (qualifier value)	4180186
35626995	Aniseed (qualifier value)	4180186
35627000	Blackcurrant (qualifier value)	4180186
35627001	Blackcurrant & apple (qualifier value)	4180186
35627002	Butterscotch (qualifier value)	4180186
35627003	Cappuccino (qualifier value)	4180186
35627004	Caramel (qualifier value)	4180186
35627005	Cherry (qualifier value)	4180186
35627008	Chicken & mushroom (qualifier value)	4180186
35627011	Citrus (qualifier value)	4180186
35627014	Cola (qualifier value)	4180186
35627016	Egg-nog (qualifier value)	4180186
35627021	Leek & potato (qualifier value)	4180186
35627022	Lemon (qualifier value)	4180186
35627027	Mocha (qualifier value)	4180186
35627028	Mushroom (qualifier value)	4180186
35627030	Neutral (qualifier value)	4180186
35627033	Orange & lemon (qualifier value)	4180186
35627035	Peach (qualifier value)	4180186
35627036	Peach & orange (qualifier value)	4180186
35627037	Pear & cherry (qualifier value)	4180186
35627038	Pineapple (qualifier value)	4180186
35627040	Plum (qualifier value)	4180186
35627042	Raspberry & blackcurrant (qualifier value)	4180186
35627043	Savoury tomato (qualifier value)	4180186
35627044	Peppermint (qualifier value)	4180186
35627046	Strawberry & raspberry (qualifier value)	4180186
35627047	Summer fruit(s) (qualifier value)	4180186
35627048	Toffee (qualifier value)	4180186
35627049	Tropical fruits (qualifier value)	4180186
35627051	Unflavoured (qualifier value)	4180186
35627052	Vanilla (qualifier value)	4180186
35627054	Vanilla & lemon (qualifier value)	4180186
35627056	Tomato (qualifier value)	4180186
35627057	Toffee caramel (qualifier value)	4180186
35627058	Cherry vanilla (qualifier value)	4180186
35627063	Spearmint (qualifier value)	4180186
35627064	Tea (qualifier value)	4180186
35627065	Raspberry cola (qualifier value)	4180186
35627066	Aniseed & caramel (qualifier value)	4180186
35627070	Passion fruit (qualifier value)	4180186
35627072	Lemon-Apricot (qualifier value)	4180186
35627075	Cherry menthol (qualifier value)	4180186
35627076	Orange & grapefruit (qualifier value)	4180186
35627077	Banana & orange (qualifier value)	4180186
35627079	Beef & carrot (qualifier value)	4180186
35627081	Chicken & vegetable (qualifier value)	4180186
35627083	Assorted (qualifier value)	4180186
35627084	Loganberry (qualifier value)	4180186
35627087	Lemon & cream (qualifier value)	4180186
35627088	Ginger lemon (qualifier value)	4180186
35627089	Liquorice (qualifier value)	4180186
35627091	Blackberry (qualifier value)	4180186
35627094	Carrot & apple (qualifier value)	4180186
35627095	Tropical surprise (qualifier value)	4180186
35627098	Curry (qualifier value)	4180186
35627099	Tropical (qualifier value)	4180186
35627100	Wild strawberry (qualifier value)	4180186
35627101	Berry (qualifier value)	4180186
35627104	Golden vegetable (qualifier value)	4180186
35627105	Apple & cinnamon (qualifier value)	4180186
35627106	Peach & ginger (qualifier value)	4180186
35627107	Minty Fresh (qualifier value)	4180186
35627108	Honey (qualifier value)	4180186
35627111	Fish (qualifier value)	4180186
35627112	Cool (qualifier value)	4180186
35627113	Vegetable (qualifier value)	4180186
35627116	Curry chicken (qualifier value)	4180186
35627118	Lentil (qualifier value)	4180186
35627119	Chickpea (qualifier value)	4180186
35627120	Ham (qualifier value)	4180186
35627121	Veal (qualifier value)	4180186
35627122	Rice & apple (qualifier value)	4180186
35627123	Freshfruit (qualifier value)	4180186
35627124	Milk (qualifier value)	4180186
35627125	Hypodermic insulin injection pen reusable for 1.5ml cartridge 1 unit dial up / range 1-16 units (physical object)	4180186
35627128	Hypodermic insulin injection pen reusable for 3ml cartridge 1 unit dial up / range 1-21 units (physical object)	4180186
35627130	Hypodermic insulin injection pen reusable for 3ml cartridge 1 unit dial up / range 2-70 units (physical object)	4180186
35627132	Strawberry & vanilla (qualifier value)	4180186
35627137	Unilever UK Home & Personal Care (qualifier value)	4180186
35627139	Chiesi Ltd (qualifier value)	4180186
35627141	Sysmex UK Ltd (qualifier value)	4180186
35627142	iMEDicare Ltd (qualifier value)	4180186
35627146	Apple-strawberry (qualifier value)	4180186
35627148	DHP Healthcare Ltd (qualifier value)	4180186
35627150	Glomerulonephritis co-occurrent and due to vasculitis	4180186
35627150	Glomerulonephritis co-occurrent and due to vasculitis (disorder)	4180186
35627151	ratiopharm GmbH (qualifier value)	4180186
35627153	Abelcet (product)	4180186
35627155	Algesal (product)	4180186
35627156	Respironics (UK) Ltd (qualifier value)	4180186
35627158	Stryker UK (qualifier value)	4180186
35627159	Mathys Orthopaedics Ltd (qualifier value)	4180186
35627160	Alphaderm (product)	4180186
35627165	Teleflex Medical (qualifier value)	4180186
35627167	Percutaneous (qualifier value)	4180186
35627168	Has trade family group (attribute)	4180186
35627169	Trade family (product)	4180186
35627170	Trade family group (qualifier value)	4180186
35627174	ACWY Vax (product)	4180186
35627175	AErrane (product)	4180186
35627176	APO-go (product)	4180186
35627177	Abidec Multivitamin (product)	4180186
35627180	Accolate (product)	4180186
35627182	Accuretic (product)	4180186
35627187	Aci-Jel (product)	4180186
35627189	Acidex (product)	4180186
35627192	Acnamino MR (product)	4180186
35627193	Acnecide (product)	4180186
35627200	Acorvio (product)	4180186
35627201	Acorvio Plus (product)	4180186
35627203	Actal (product)	4180186
35627206	Actidose-Aqua Advance (product)	4180186
35627208	Actinac (product)	4180186
35627210	Actrapid NovoLet (product)	4180186
35627211	Actrapid Penfill (product)	4180186
35627212	Acular (product)	4180186
35627213	Acupan (product)	4180186
35627214	Adalat (product)	4180186
35627215	Adalat LA (product)	4180186
35627216	Adalat retard (product)	4180186
35627218	Adcal (product)	4180186
35627221	Adcortyl in Orabase (product)	4180186
35627223	Adenocor (product)	4180186
35627225	Agenerase (product)	4180186
35627227	Adgyn Medro (product)	4180186
35627228	Adios (product)	4180186
35627229	Adipine MR (product)	4180186
35627231	Adizem-SR (product)	4180186
35627232	Adizem-XL (product)	4180186
35627233	Advagraf (product)	4180186
35627235	AeroBec Autohaler (product)	4180186
35627241	Afrazine (product)	4180186
35627244	Agitane (product)	4180186
35627247	Airomir Autohaler (product)	4180186
35627252	Alba (product)	4180186
35627254	Aldara (product)	4180186
35627259	Alka (product)	4180186
35627262	Alkeran (product)	4180186
35627263	Allegron (product)	4180186
35627268	Almodan (product)	4180186
35627269	Almogran (product)	4180186
35627270	Alomide (product)	4180186
35627271	Aloxi (product)	4180186
35627273	AlphaNine (product)	4180186
35627274	Alphagan (product)	4180186
35627275	Alphanate (product)	4180186
35627276	Alphaparin (product)	4180186
35627279	Alphosyl 2 in 1 (product)	4180186
35627280	Alphosyl HC (product)	4180186
35627283	Aludrox (product)	4180186
35627284	Alupent (product)	4180186
35627287	Alvesco (product)	4180186
35627289	AmBisome (product)	4180186
35627291	Ametop (product)	4180186
35627292	Amias (product)	4180186
35627293	Amiclav (product)	4180186
35627296	Amilamont (product)	4180186
35627297	Amilmaxco (product)	4180186
35627298	Amix (product)	4180186
35627300	Ammonaps (product)	4180186
35627301	Amnivent SR (product)	4180186
35627304	Amoxil (product)	4180186
35627305	Amphocil (product)	4180186
35627306	Amsidine (product)	4180186
35627308	Amytal (product)	4180186
35627309	Anabact (product)	4180186
35627310	Anacal (product)	4180186
35627315	Anapen (product)	4180186
35627316	Ancotil (product)	4180186
35627318	Andrews Plus (product)	4180186
35627319	Androcur (product)	4180186
35627328	Angiopine MR (product)	4180186
35627331	Angiozem CR (product)	4180186
35627335	Anhydrol (product)	4180186
35627337	Anquil (product)	4180186
35627343	Antipressan (product)	4180186
35627347	Apidra (product)	4180186
35627348	Apidra OptiClik (product)	4180186
35627353	Aptivus (product)	4180186
35627354	Aqua Ban (product)	4180186
35627355	AquaBan Herbal (product)	4180186
35627358	Aquasept (product)	4180186
35627362	Arava (product)	4180186
35627363	Arbil MR (product)	4180186
35627365	Aredia (product)	4180186
35627366	Aricept (product)	4180186
35627374	Artelac (product)	4180186
35627377	Arthrotec (product)	4180186
35627379	Asacol (product)	4180186
35627381	Asasantin Retard (product)	4180186
35627382	Ascabiol (product)	4180186
35627383	Asendis (product)	4180186
35627384	Asilone Heartburn (product)	4180186
35627385	Asilone Windcheaters (product)	4180186
35627388	Asmabec Clickhaler (product)	4180186
35627392	Aspro Clear (product)	4180186
35627393	Atarax (product)	4180186
35627396	Atimos Modulite (product)	4180186
35627397	Ativan (product)	4180186
35627398	Atriance (product)	4180186
35627399	Atrovent (product)	4180186
35627401	Audax (product)	4180186
35627402	Audicort (product)	4180186
35627404	Avandamet (product)	4180186
35627406	Avastin (product)	4180186
35627415	Axsain (product)	4180186
35627419	Bactroban (product)	4180186
35627420	Bambec (product)	4180186
35627421	Baraclude (product)	4180186
35627422	Baratol (product)	4180186
35627426	Beclo-Aqua (product)	4180186
35627428	Becloforte (product)	4180186
35627429	Becloforte disks (product)	4180186
35627431	Becotide (product)	4180186
35627432	Becotide Rotacaps (product)	4180186
35627433	Bedol (product)	4180186
35627434	Bedranol SR (product)	4180186
35627435	Begrivac (product)	4180186
35627436	BeneFIX (product)	4180186
35627440	Benquil (product)	4180186
35627441	Benzamycin (product)	4180186
35627445	Beriplex P/N (product)	4180186
35627448	Berotec (product)	4180186
35627449	Besavar XL (product)	4180186
35627450	Beta-Adalat (product)	4180186
35627451	Beta-Prograne (product)	4180186
35627455	Betaferon (product)	4180186
35627456	Betagan (product)	4180186
35627459	Betim (product)	4180186
35627462	Betnesol-N (product)	4180186
35627463	Betnovate (product)	4180186
35627473	BiCNU (product)	4180186
35627477	Bioplex (product)	4180186
35627479	Bipranix (product)	4180186
35627483	Bonefos (product)	4180186
35627486	Bretylate (product)	4180186
35627488	Brevinor (product)	4180186
35627489	Brevoxyl (product)	4180186
35627491	Bricanyl (product)	4180186
35627492	Bricanyl Respules (product)	4180186
35627494	Bricanyl Turbohaler (product)	4180186
35627495	BritLofex (product)	4180186
35627496	Britacef (product)	4180186
35627497	Broflex (product)	4180186
35627499	Brufen Retard (product)	4180186
35627502	BuTrans (product)	4180186
35627505	Burinex A (product)	4180186
35627506	Burinex K (product)	4180186
35627508	Busilvex (product)	4180186
35627510	Butacote (product)	4180186
35627511	Byetta (product)	4180186
35627512	CAM - brand name (product)	4180186
35627513	CX - brand name (product)	4180186
35627516	Cacit (product)	4180186
35627517	Cacit D3 (product)	4180186
35627520	Calchan MR (product)	4180186
35627521	Calcicard CR (product)	4180186
35627522	Calcichew (product)	4180186
35627525	Calcijex (product)	4180186
35627529	Calcort (product)	4180186
35627532	Calgel (product)	4180186
35627534	Calimal (product)	4180186
35627535	Calm Life (product)	4180186
35627539	Calpol Fastmelts (product)	4180186
35627540	Calpol Night (product)	4180186
35627542	Calsalettes (product)	4180186
35627543	Calsynar (product)	4180186
35627544	Camcolit (product)	4180186
35627548	Canusal (product)	4180186
35627549	Capasal (product)	4180186
35627550	Capastat (product)	4180186
35627554	Caprin (product)	4180186
35627555	Capsuvac (product)	4180186
35627556	Captomex (product)	4180186
35627557	Carace Plus (product)	4180186
35627560	Carbagen SR (product)	4180186
35627565	Carbomix (product)	4180186
35627566	Cardene (product)	4180186
35627568	Cardicor (product)	4180186
35627569	Cardilate MR (product)	4180186
35627573	Cardozin XL (product)	4180186
35627574	Cerazette (product)	4180186
35627576	Cardura XL (product)	4180186
35627581	Cascor (product)	4180186
35627583	Catapres (product)	4180186
35627584	Caverject (product)	4180186
35627586	Cedocard (product)	4180186
35627588	Cedocard Retard (product)	4180186
35627589	Cefzil (product)	4180186
35627591	Celebrex (product)	4180186
35627592	Celectol (product)	4180186
35627597	Celsentri (product)	4180186
35627599	Ceporex (product)	4180186
35627600	Ceprotin (product)	4180186
35627602	Cerezyme (product)	4180186
35627603	Cernevit (product)	4180186
35627605	Cervarix (product)	4180186
35627607	Cetavlex (product)	4180186
35627608	Cetec (product)	4180186
35627610	Cetrotide (product)	4180186
35627613	Chimax (product)	4180186
35627614	Chirocaine (product)	4180186
35627615	Chloromycetin (product)	4180186
35627616	Cholestagel (product)	4180186
35627620	Cipramil (product)	4180186
35627621	Ciproxin (product)	4180186
35627622	Ciproxin I.V. Flexibag (product)	4180186
35627623	Citanest (product)	4180186
35627625	Citramag (product)	4180186
35627626	Clairette (product)	4180186
35627627	Clarelux (product)	4180186
35627628	Clarosip (product)	4180186
35627630	Clearsore (product)	4180186
35627632	Clexane (product)	4180186
35627633	Climanor (product)	4180186
35627636	Climesse (product)	4180186
35627637	Clinitar (product)	4180186
35627638	Clinoril (product)	4180186
35627639	Clipper (product)	4180186
35627644	Clotam Rapid (product)	4180186
35627647	Co-Betaloc SA (product)	4180186
35627649	CoAprovel (product)	4180186
35627651	Cobalin (product)	4180186
35627654	Codis (product)	4180186
35627656	Colazide (product)	4180186
35627657	Colestid (product)	4180186
35627658	Colifoam (product)	4180186
35627660	Colofac (product)	4180186
35627661	Colofac MR (product)	4180186
35627662	Colomycin (product)	4180186
35627663	Colpermin (product)	4180186
35627667	Combivir (product)	4180186
35627669	Compound W (product)	4180186
35627671	Condyline (product)	4180186
35627672	Creon (product)	4180186
35627673	Congescor (product)	4180186
35627675	Conray (product)	4180186
35627676	Contac 400 (product)	4180186
35627677	Contiflo XL (product)	4180186
35627679	Copaxone (product)	4180186
35627680	Copegus (product)	4180186
35627681	Coracten SR (product)	4180186
35627684	Cordilox (product)	4180186
35627686	Cystemme (product)	4180186
35627690	Coro-Nitro (product)	4180186
35627692	Cosmegen (product)	4180186
35627693	CosmoFer (product)	4180186
35627694	Cosopt (product)	4180186
35627695	Coversyl (product)	4180186
35627696	Coversyl Plus (product)	4180186
35627699	Cozatabs 750 XL (product)	4180186
35627700	Crampex (product)	4180186
35627702	Crestor (product)	4180186
35627703	Crinone (product)	4180186
35627705	Cromogen (product)	4180186
35627709	Cuplex (product)	4180186
35627710	Cuprofen (product)	4180186
35627711	Curatoderm (product)	4180186
35627712	Curosurf (product)	4180186
35627714	Cyanokit (product)	4180186
35627716	Cyclogest (product)	4180186
35627717	Cyclomydril (product)	4180186
35627723	Cystagon (product)	4180186
35627724	Cysticide (product)	4180186
35627725	Cystocalm (product)	4180186
35627726	Cystopurin (product)	4180186
35627727	Cystrin (product)	4180186
35627730	Cytamen (product)	4180186
35627735	DHC Continus (product)	4180186
35627737	Daktarin (product)	4180186
35627738	Daktarin Gold (product)	4180186
35627741	Dalacin T (product)	4180186
35627742	Dalivit (product)	4180186
35627746	Daonil (product)	4180186
35627747	Daraprim (product)	4180186
35627748	Darmil (product)	4180186
35627749	DaunoXome (product)	4180186
35627754	Decapeptyl SR (product)	4180186
35627758	Defanac Retard (product)	4180186
35627760	Deltacortril Enteric	4180186
35627760	Deltacortril Enteric (product)	4180186
35627764	Dentomycin (product)	4180186
35627765	Denzapine (product)	4180186
35627768	Depo-Medrone with Lidocaine (product)	4180186
35627769	Depo-Provera (product)	4180186
35627771	Dequacaine (product)	4180186
35627775	Dermacort (product)	4180186
35627780	Dermovate-NN (product)	4180186
35627782	Desferal (product)	4180186
35627783	Desmospray (product)	4180186
35627784	Desmotabs (product)	4180186
35627788	Detrunorm XL (product)	4180186
35627790	Detrusitol XL (product)	4180186
35627792	Dexedrine (product)	4180186
35627797	Diaglyk (product)	4180186
35627799	Dialyvit (product)	4180186
35627807	Diareze (product)	4180186
35627810	Dibenyline (product)	4180186
35627811	Dicloflex (product)	4180186
35627813	Diclomax Retard (product)	4180186
35627815	Diclotard (product)	4180186
35627817	Diclovol 75mg SR (product)	4180186
35627817	Diclovol SR	4180186
35627818	Diclovol Retard (product)	4180186
35627819	Diclozip (product)	4180186
35627820	Diconal (product)	4180186
35627821	Dicynene (product)	4180186
35627822	Differin (product)	4180186
35627825	Digamex (product)	4180186
35627826	Dilcardia SR (product)	4180186
35627828	Dilzem XL (product)	4180186
35627829	Dimaval (product)	4180186
35627830	Dimetriose (product)	4180186
35627833	Diocalm Complete (product)	4180186
35627835	Diocaps (product)	4180186
35627836	Dioctyl (product)	4180186
35627845	Dirythmin SA (product)	4180186
35627847	Disogram SR (product)	4180186
35627848	Disprol (product)	4180186
35627853	Dithrocream (product)	4180186
35627856	Diumide-K Continus (product)	4180186
35627857	Diurexan (product)	4180186
35627858	Diva (product)	4180186
35627859	Dixarit (product)	4180186
35627860	Dobutrex (product)	4180186
35627863	Doloxene (product)	4180186
35627864	Dolvan (product)	4180186
35627871	Doublebase (product)	4180186
35627877	Doxorubin (product)	4180186
35627879	Dozol (product)	4180186
35627880	Efalith (product)	4180186
35627881	Drapolene (product)	4180186
35627882	Dreemon (product)	4180186
35627883	Driclor (product)	4180186
35627887	Droxia (product)	4180186
35627890	Dulbalm (product)	4180186
35627891	DulcoEase (product)	4180186
35627892	DuoTrav (product)	4180186
35627895	Duovent (product)	4180186
35627897	Dupromex (product)	4180186
35627900	Durogesic DTrans (product)	4180186
35627902	Duvimex (product)	4180186
35627905	Dynamin (product)	4180186
35627909	Dyspamet (product)	4180186
35627911	Dytac (product)	4180186
35627912	Dytide (product)	4180186
35627913	EarCalm (product)	4180186
35627915	Earex Plus (product)	4180186
35627916	Ebixa (product)	4180186
35627918	Eccoxolac (product)	4180186
35627919	Echovist (product)	4180186
35627920	Econac (product)	4180186
35627922	Econac XL (product)	4180186
35627923	Econacort (product)	4180186
35627927	Efanatal (product)	4180186
35627929	Efcortesol (product)	4180186
35627930	Efexor (product)	4180186
35627932	Effercitrate (product)	4180186
35627933	Effico (product)	4180186
35627935	Elantan (product)	4180186
35627937	Elaprase (product)	4180186
35627938	Eldepryl (product)	4180186
35627940	Eldoquin (product)	4180186
35627942	Elleste Duet (product)	4180186
35627943	Elleste Solo (product)	4180186
35627944	Elleste Solo MX (product)	4180186
35627945	Ellimans (product)	4180186
35627946	Elmiron (product)	4180186
35627948	Eloxatin (product)	4180186
35627949	Eltroxin (product)	4180186
35627950	Elyzol (product)	4180186
35627952	Emblon (product)	4180186
35627953	Emcor (product)	4180186
35627954	Emend (product)	4180186
35627958	Emselex (product)	4180186
35627960	Emulsiderm (product)	4180186
35627961	Endekay (product)	4180186
35627962	Endoxana (product)	4180186
35627965	Enprin (product)	4180186
35627966	Entocort (product)	4180186
35627970	Enzira (product)	4180186
35627972	Epaxal (product)	4180186
35627974	EpiPen (product)	4180186
35627975	Epilim (product)	4180186
35627976	Epilim Chrono (product)	4180186
35627978	Epimaz Retard (product)	4180186
35627980	Epival CR (product)	4180186
35627982	Eposin (product)	4180186
35627983	Eppy (product)	4180186
35627984	Eprex (product)	4180186
35627986	Equasym (product)	4180186
35627987	Equasym XL (product)	4180186
35627988	Equilon (product)	4180186
35627991	Erdotin (product)	4180186
35627993	Ervevax (product)	4180186
35627994	Erwinase (product)	4180186
35627995	Eryacne (product)	4180186
35627996	Erymax (product)	4180186
35627997	Erythrocin (product)	4180186
35628001	Esmeron (product)	4180186
35628002	Estracyt (product)	4180186
35628005	Estradot (product)	4180186
35628006	Estragest (product)	4180186
35628007	Estring (product)	4180186
35628008	Ethimil MR (product)	4180186
35628009	Ethyol (product)	4180186
35628010	Etopan XL (product)	4180186
35628012	NiQuitin (product)	4180186
35628013	NiQuitin Clear (product)	4180186
35628014	Niopam (product)	4180186
35628015	Nipent (product)	4180186
35628019	Nurofen Advance (product)	4180186
35628022	Nurofen Express (product)	4180186
35628024	Nurofen Meltlets (product)	4180186
35628025	Nurofen Migraine Pain (product)	4180186
35628026	Nurofen Plus (product)	4180186
35628028	Nurofen Sinus (product)	4180186
35628029	Nurofen Tension Headache (product)	4180186
35628032	Nutralia (product)	4180186
35628034	Nutrizym GR (product)	4180186
35628035	NutropinAq (product)	4180186
35628037	Nuvelle TS Phase I (product)	4180186
35628038	Nuvelle TS Phase II (product)	4180186
35628039	Nycopren (product)	4180186
35628043	Nystaform HC (product)	4180186
35628044	Nystamont (product)	4180186
35628045	Nystan (product)	4180186
35628047	Obifen (product)	4180186
35628049	Occlusal	4180186
35628049	Occlusal - brand name (product)	4180186
35628050	Octagam (product)	4180186
35628051	Octim (product)	4180186
35628052	Ocufen (product)	4180186
35628053	Oculotect (product)	4180186
35628054	Ocuvite Lutein (product)	4180186
35628055	Ocuvite PreserVision	4180186
35628055	Ocuvite PreserVision (product)	4180186
35628056	Odaban (product)	4180186
35628057	Odrik (product)	4180186
35628059	Oftaquix (product)	4180186
35628063	Oliclinomel N4-720E (product)	4180186
35628064	Oliclinomel N5-800E (product)	4180186
35628069	Oliclinomel N8-800 (product)	4180186
35628070	Olmetec (product)	4180186
35628071	Olmetec Plus (product)	4180186
35628073	Omega Plus (product)	4180186
35628074	Omeran (product)	4180186
35628075	Omneo Comfort 1	4180186
35628075	Omneo Comfort 1 (product)	4180186
35628077	Omnic MR (product)	4180186
35628078	Omnipaque (product)	4180186
35628082	Ondemet (product)	4180186
35628083	One-Alpha (product)	4180186
35628084	Onkotrone (product)	4180186
35628085	Opatanol (product)	4180186
35628086	Opazimes (product)	4180186
35628087	Opilon (product)	4180186
35628089	Opticrom (product)	4180186
35628090	Optil (product)	4180186
35628093	Optimine (product)	4180186
35628098	Optrex Comforting (product)	4180186
35628100	Optrex Infected Eyes (product)	4180186
35628101	Optrex Red Eyes (product)	4180186
35628102	Optrex Sore Eyes (product)	4180186
35628103	Orajel (product)	4180186
35628105	Oral B Sensitive (product)	4180186
35628107	Oramorph (product)	4180186
35628108	Oraqix (product)	4180186
35628111	Orencia (product)	4180186
35628112	Orfadin (product)	4180186
35628113	Orgalutran (product)	4180186
35628116	Orlept (product)	4180186
35628119	Ortho-Gynest (product)	4180186
35628120	Orthoforms (product)	4180186
35628125	Ostex (product)	4180186
35628126	Ostram (product)	4180186
35628128	Otomize (product)	4180186
35628131	Otradrops (product)	4180186
35628134	Otrivine Antistin (product)	4180186
35628139	Ovran (product)	4180186
35628140	Ovranette (product)	4180186
35628145	Oxis Turbohaler (product)	4180186
35628146	Palladone SR (product)	4180186
35628147	Oxivent (product)	4180186
35628150	OxyContin (product)	4180186
35628151	OxyNorm (product)	4180186
35628153	Oxytetramix (product)	4180186
35628154	PEP - brand name (product)	4180186
35628158	Paldesic (product)	4180186
35628159	Palfium (product)	4180186
35628163	Pamsvax XL (product)	4180186
35628164	PanOxyl (product)	4180186
35628166	Panadol ActiFast (product)	4180186
35628167	Panadol Extra (product)	4180186
35628169	Panadol Ultra (product)	4180186
35628171	Pancrex (product)	4180186
35628173	Panto-250 (product)	4180186
35628174	Paracets (product)	4180186
35628175	Paracodol (product)	4180186
35628176	Paradote (product)	4180186
35628178	Paramol (product)	4180186
35628181	Pardelprin MR (product)	4180186
35628183	Parlodel (product)	4180186
35628184	Parmid XL (product)	4180186
35628186	Partobulin (product)	4180186
35628192	PediTech (product)	4180186
35628193	Pediacel (product)	4180186
35628196	Penbritin (product)	4180186
35628197	Pennsaid (product)	4180186
35628198	Pentacarinat (product)	4180186
35628204	Pepcid (product)	4180186
35628207	Peptac (product)	4180186
35628208	Peptimax (product)	4180186
35628210	Percutol (product)	4180186
35628212	Perfalgan (product)	4180186
35628217	Perinal (product)	4180186
35628219	Permitabs (product)	4180186
35628220	Pernaton (product)	4180186
35628221	Peroxyl (product)	4180186
35628223	Persantin Retard (product)	4180186
35628227	Pharmaton Vit-al Plus (product)	4180186
35628228	Pharmorubicin (product)	4180186
35628232	Phosphate Sandoz (product)	4180186
35628233	Phyllocontin Continus (product)	4180186
35628234	Physeptone (product)	4180186
35628235	Physiotens (product)	4180186
35628240	Pickles Colsor (product)	4180186
35628241	Picolax (product)	4180186
35628242	Pilogel (product)	4180186
35628244	Pinetarsol (product)	4180186
35628250	Plaquenil (product)	4180186
35628251	Plavix (product)	4180186
35628255	Pneumovax II (product)	4180186
35628256	Pnu-Imune (product)	4180186
35628257	Pollenase (beclometasone) (product)	4180186
35628258	Pollenase (chlorphenamine) (product)	4180186
35628259	Pollenase (sodium cromoglicate)	4180186
35628259	Pollenase (sodium cromogliate) (product)	4180186
35628259	Pollenase (sodium cromoglicate) (product)	4180186
35628262	Polyfax (product)	4180186
35628265	Polytar Plus (product)	4180186
35628266	Polytrim (product)	4180186
35628267	Ponstan (product)	4180186
35628268	Posalfilin (product)	4180186
35628270	PostMI (product)	4180186
35628271	Potaba (product)	4180186
35628272	Powergel (product)	4180186
35628274	Pralenal (product)	4180186
35628275	Prandin (product)	4180186
35628276	Praxilene (product)	4180186
35628278	Pred Forte (product)	4180186
35628281	Predsol (product)	4180186
35628287	Premique (product)	4180186
35628288	Premjact (product)	4180186
35628292	Prescal (product)	4180186
35628294	Presinex (product)	4180186
35628295	Prestim (product)	4180186
35628296	Prexige (product)	4180186
35628297	Prezista (product)	4180186
35628298	Priadel (lithium carbonate) (product)	4180186
35628302	Salapin (product)	4180186
35628304	Primaxin IM (product)	4180186
35628305	Primene (product)	4180186
35628306	Primolut N (product)	4180186
35628307	Primovist (product)	4180186
35628310	Pripsen (mebendazole) (product)	4180186
35628311	Pripsen (piperazine / senna) (product)	4180186
35628312	Privacom (product)	4180186
35628315	Pro-Epanutin (product)	4180186
35628316	Pro-Viron (product)	4180186
35628318	Procoralan (product)	4180186
35628319	Proctofoam HC (product)	4180186
35628320	Proctosedyl (product)	4180186
35628321	Profasi (product)	4180186
35628324	Progynova (product)	4180186
35628330	Propain (product)	4180186
35628333	Propess (product)	4180186
35628335	Proscar (product)	4180186
35628336	Prostabrit (product)	4180186
35628337	Prostap 3 Depot (product)	4180186
35628339	Prostin E2 (product)	4180186
35628343	Protelos (product)	4180186
35628344	Prothiaden (product)	4180186
35628345	Protium (product)	4180186
35628347	Provera (product)	4180186
35628349	Prowess (product)	4180186
35628350	Prozac (product)	4180186
35628353	Prozit (product)	4180186
35628355	Pulmicort (product)	4180186
35628357	Pulmicort Turbohaler (product)	4180186
35628361	Pulvinal (salbutamol) (product)	4180186
35628362	Puregon (product)	4180186
35628363	Puri-Nethol (product)	4180186
35628365	Pylorid (product)	4180186
35628366	Pyralvex (product)	4180186
35628370	Questran (product)	4180186
35628371	Questran Light (product)	4180186
35628372	Quinil (product)	4180186
35628374	Qvar (product)	4180186
35628375	Qvar Easi-Breathe (product)	4180186
35628376	Qvar Autohaler (product)	4180186
35628377	RBC - brand name (product)	4180186
35628379	Raciran (product)	4180186
35628381	Radian B Pain Relief (product)	4180186
35628383	Rapilysin (product)	4180186
35628384	Ralgex Freeze (product)	4180186
35628385	Ralgex Heat (product)	4180186
35628387	Ranflutin (product)	4180186
35628389	Ranitil (product)	4180186
35628390	Ranovir (product)	4180186
35628392	Ranvera MR (product)	4180186
35628394	Ranzolont (product)	4180186
35628397	Rapitil (product)	4180186
35628399	Rapranol SR (product)	4180186
35628401	Rasilez (product)	4180186
35628404	Readiwash (product)	4180186
35628407	Recombinate (product)	4180186
35628408	Rectogesic (product)	4180186
35628411	Refolinon (product)	4180186
35628413	Regulan (product)	4180186
35628414	Regulose (product)	4180186
35628415	Regurin (product)	4180186
35628421	Relestat (product)	4180186
35628423	Relpax (product)	4180186
35628424	Remedeine (product)	4180186
35628430	Rennie Deflatine (product)	4180186
35628431	Rennie Dual Action (product)	4180186
35628431	Rennie Extra	4180186
35628434	Repevax (product)	4180186
35628436	Replenate (product)	4180186
35628438	RescueFlow (product)	4180186
35628441	Resovist (product)	4180186
35628442	Respillin (product)	4180186
35628443	Respontin (product)	4180186
35628446	Retin-A (product)	4180186
35628450	Revaxis (product)	4180186
35628451	Revlimid (product)	4180186
35628455	Rheumadoron (product)	4180186
35628457	Rheumatac Retard (product)	4180186
35628461	Rhinolast (product)	4180186
35628463	Rhotard SR (product)	4180186
35628464	Rhumalgan CR (product)	4180186
35628466	Rhumalgan SR (product)	4180186
35628467	Rhumalgan XL (product)	4180186
35628469	Ridaura (product)	4180186
35628480	Risperdal Quicklet (product)	4180186
35628482	Rivotril (product)	4180186
35628484	Robaxin (product)	4180186
35628486	Robinul-Neostigmine (product)	4180186
35628487	Robitussin (product)	4180186
35628490	Robitussin Dry Cough (product)	4180186
35628493	Roferon-A (product)	4180186
35628495	Rohypnol (product)	4180186
35628496	Rommix (product)	4180186
35628501	Rynacrom Allergy (product)	4180186
35628503	Rythmodan Retard (product)	4180186
35628504	SMOFlipid (product)	4180186
35628505	Sabril (product)	4180186
35628509	Salamol (product)	4180186
35628510	Salamol Easi-Breathe (product)	4180186
35628511	Salamol Steri-Neb (product)	4180186
35628512	Salatac (product)	4180186
35628516	Salivix (product)	4180186
35628518	Samaritan (product)	4180186
35628522	Sanatogen Vital 50+ (product)	4180186
35628525	Sandocal (product)	4180186
35628529	Sandostatin LAR (product)	4180186
35628532	Savene (product)	4180186
35628534	Savlon Dry (product)	4180186
35628536	Scandonest plain (product)	4180186
35628537	Scandonest special (product)	4180186
35628539	Schering PC4 (product)	4180186
35628542	Scholl Seal and Heal (product)	4180186
35628543	Scleron (product)	4180186
35628545	Sea-Legs (product)	4180186
35628548	Sebren MR (product)	4180186
35628551	Sectral (product)	4180186
35628552	Securon (product)	4180186
35628553	Securon SR (product)	4180186
35628556	Selexid (product)	4180186
35628557	Selsun (product)	4180186
35628560	Senncalax (product)	4180186
35628561	Sporanox (product)	4180186
35628562	Senokot (product)	4180186
35628565	Sensodyne (product)	4180186
35628568	Seractil (product)	4180186
35628569	Serc (product)	4180186
35628570	Serdolect (product)	4180186
35628571	Seredrin (product)	4180186
35628574	Serevent Accuhaler (product)	4180186
35628576	Seroquel (product)	4180186
35628577	Serotone-5HTP (product)	4180186
35628578	Seroxat (product)	4180186
35628579	Setlers Wind-eze	4180186
35628579	Setlers Wind-eze (product)	4180186
35628581	Silkis (product)	4180186
35628583	Simplene (product)	4180186
35628584	Simulect (product)	4180186
35628585	Simvador (product)	4180186
35628586	Sinemet CR (product)	4180186
35628591	Sinthrome (product)	4180186
35628593	Siopel (product)	4180186
35628595	Skinoren (product)	4180186
35628597	Sleepeaze (product)	4180186
35628598	Slo-Indo (product)	4180186
35628599	Slo-Phyllin (product)	4180186
35628600	Slo-Pro (product)	4180186
35628601	Slocinx XL (product)	4180186
35628602	Slofedipine (product)	4180186
35628603	Slofedipine XL (product)	4180186
35628605	Slomon XL (product)	4180186
35628606	Slow Fe Folic (product)	4180186
35628607	Slow Sodium (product)	4180186
35628608	Slow-Fe (product)	4180186
35628610	Slow-Trasicor (product)	4180186
35628611	Slozem (product)	4180186
35628613	Snor-eeze (product)	4180186
35628615	Snufflebabe Cradle Cap (product)	4180186
35628616	Spiriva (product)	4180186
35628617	Soda Mint (product)	4180186
35628623	Solian (product)	4180186
35628625	Solivito N (product)	4180186
35628628	Solpadeine Max (product)	4180186
35628629	Solpadeine Migraine (product)	4180186
35628630	Solpadeine Plus (product)	4180186
35628633	Soltamox (product)	4180186
35628635	Solu-Medrone (product)	4180186
35628636	Solvazinc (product)	4180186
35628637	Somatuline Autogel (product)	4180186
35628638	Somatuline LA (product)	4180186
35628640	Sominex (product)	4180186
35628641	Strepsils Sore Throat and Blocked Nose (product)	4180186
35628642	Sominex Herbal (product)	4180186
35628645	Sonata (product)	4180186
35628649	Sootha (product)	4180186
35628651	Soothake Toothache (product)	4180186
35628652	Soothelip (product)	4180186
35628655	Sorbid-20 SA (product)	4180186
35628656	Sotacor (product)	4180186
35628657	Spasmonal (product)	4180186
35628659	Spatone Iron-Plus (product)	4180186
35628659	Spatone Original	4180186
35628660	SpectraBAN 25 (product)	4180186
35628661	SpectraBAN Ultra (product)	4180186
35628664	Sprilon (product)	4180186
35628665	Sprycel (product)	4180186
35628666	Stalevo (product)	4180186
35628668	Staril (product)	4180186
35628669	Stelazine (product)	4180186
35628672	Ster-Zac (hexachlorophene) (product)	4180186
35628674	Sterets (product)	4180186
35628675	Sterets Chlorasol (product)	4180186
35628676	Sterets H (product)	4180186
35628677	Sterets Tisept (product)	4180186
35628678	Sterets Unisept (product)	4180186
35628679	Sterexidine (product)	4180186
35628680	Tensomex (product)	4180186
35628681	Stesolid (product)	4180186
35628685	Stilnoct (product)	4180186
35628687	Strattera (product)	4180186
35628689	Strepsils (product)	4180186
35628690	Strepsils Cough (product)	4180186
35628694	Streptase (product)	4180186
35628698	StructoKabiven (product)	4180186
35628699	Structolipid (product)	4180186
35628700	Stud 100 (product)	4180186
35628703	Subgam (product)	4180186
35628706	Subutex (product)	4180186
35628710	Sudafed Non-Drowsy Decongestant (pseudoephedrine)	4180186
35628710	Sudafed Non-Drowsy Decongestant (pseudoephedrine) (product)	4180186
35628713	Sudocrem (product)	4180186
35628715	Sulazine EC (product)	4180186
35628716	Suleo-M (product)	4180186
35628718	Sulpor (product)	4180186
35628720	Sunsense daily (product)	4180186
35628721	Sunsense ultra (product)	4180186
35628722	Sunya (product)	4180186
35628723	Super Betavit (product)	4180186
35628729	Surgam (product)	4180186
35628731	Survanta (product)	4180186
35628732	Suscard (product)	4180186
35628733	Sustac (product)	4180186
35628734	Sustanon (product)	4180186
35628735	Sustiva (product)	4180186
35628737	Swarm (product)	4180186
35628742	Synastone (product)	4180186
35628744	Syner-KINASE (product)	4180186
35628745	Synercid (product)	4180186
35628746	Synflex (product)	4180186
35628749	Syntometrine (product)	4180186
35628752	Syscor MR (product)	4180186
35628753	Sytron (product)	4180186
35628754	TISSEEL (product)	4180186
35628758	Tambocor (product)	4180186
35628759	Tambocor XL (product)	4180186
35628760	Tamiflu (product)	4180186
35628761	Tamofen (product)	4180186
35628764	Tarceva (product)	4180186
35628767	Tarivid (product)	4180186
35628769	Tarodent (product)	4180186
35628770	Tasmar (product)	4180186
35628773	Taxol (product)	4180186
35628774	Taxotere (product)	4180186
35628777	Teetha (product)	4180186
35628778	Tegretol (product)	4180186
35628779	Tegretol Chewtabs (product)	4180186
35628781	Telfast (product)	4180186
35628783	Temgesic (product)	4180186
35628785	Tenchlor (product)	4180186
35628786	Tenif (product)	4180186
35628787	Tenkicin (product)	4180186
35628789	Tenoretic (product)	4180186
35628792	Tensium (product)	4180186
35628793	Tensopril (product)	4180186
35628794	Teoptic (product)	4180186
35628797	Terra-Cortril Nystatin (product)	4180186
35628798	Terramycin (product)	4180186
35628799	Terrazine (product)	4180186
35628801	Testim (product)	4180186
35628802	Benefoot UK Ltd (qualifier value)	4180186
35628803	Testoderm (product)	4180186
35628805	Testogel (product)	4180186
35628806	Medical Plastic Devices Inc (qualifier value)	4180186
35628807	Tetabulin (product)	4180186
35628808	Wallace, Cameron & Company Ltd (qualifier value)	4180186
35628809	Tetralysal (product)	4180186
35628813	Thelin (product)	4180186
35628814	Theo-Dur (product)	4180186
35628815	Thovaline (product)	4180186
35628816	Thyrogen (product)	4180186
35628819	Tiger Balm White (product)	4180186
35628822	Tildiem LA (product)	4180186
35628823	Tildiem Retard (product)	4180186
35628827	Tilolec (product)	4180186
35628828	Tiloryth (product)	4180186
35628830	Timodine (product)	4180186
35628833	Tinaderm Plus (product)	4180186
35628834	Tinaderm-M (product)	4180186
35628840	Tixylix Chesty Cough (product)	4180186
35628841	Tractocile (product)	4180186
35628843	Tixylix Dry Cough (product)	4180186
35628845	Tobradex (product)	4180186
35628849	Topal (product)	4180186
35628850	Topamax (product)	4180186
35628853	Torbetol (product)	4180186
35628856	Touch and Go (product)	4180186
35628858	Tracrium (product)	4180186
35628859	Tradorec XL (product)	4180186
35628861	Tramake (product)	4180186
35628862	Tramake Insts (product)	4180186
35628863	Tramquel SR (product)	4180186
35628867	Transiderm-Nitro (product)	4180186
35628868	Univer (product)	4180186
35628871	Tranxene (product)	4180186
35628872	Trasicor (product)	4180186
35628873	Trasidrex (product)	4180186
35628874	Trasylol (product)	4180186
35628875	Travatan (product)	4180186
35628876	Travel Calm (product)	4180186
35628878	Travella (product)	4180186
35628879	Traxam (product)	4180186
35628880	Trental (product)	4180186
35628885	Trifyba (product)	4180186
35628886	Trileptal (product)	4180186
35628888	Trimopan (product)	4180186
35628889	Trimovate (product)	4180186
35628890	Trintek (product)	4180186
35628891	Triptafen (product)	4180186
35628898	Trosyl (product)	4180186
35628899	Trusopt (product)	4180186
35628901	Tuinal (product)	4180186
35628904	Twocal HN (product)	4180186
35628906	Tylex (product)	4180186
35628913	Uftoral (product)	4180186
35628914	Ultec (product)	4180186
35628915	Ultiva (product)	4180186
35628917	Ultra Chloraseptic (phenol) (product)	4180186
35628918	Ultra Heartburn Relief (product)	4180186
35628921	Ultratard (product)	4180186
35628923	Unguentum M (product)	4180186
35628926	Uniroid HC (product)	4180186
35628928	Urantoin (product)	4180186
35628929	Uriben (product)	4180186
35628932	Urizide (product)	4180186
35628933	Uro-Tainer (chlorhexidine) (product)	4180186
35628935	Uromitexan (product)	4180186
35628936	Ursofalk (product)	4180186
35628939	Utovlan (product)	4180186
35628940	Utrogestan (product)	4180186
35628946	Valderma (product)	4180186
35628948	Vallergan (product)	4180186
35628949	Valoid (product)	4180186
35628950	Valpeda (product)	4180186
35628951	Valtrex (product)	4180186
35628953	Vancocin (product)	4180186
35628955	Vancocin Matrigel (product)	4180186
35628956	Vaniqa (product)	4180186
35628957	Varidase Topical (product)	4180186
35628958	Varilrix (product)	4180186
35628959	Varivax (product)	4180186
35628961	Vascalpha (product)	4180186
35628963	Vasogen (product)	4180186
35628964	Vasovist (product)	4180186
35628969	Velcade (product)	4180186
35628970	Velosef (product)	4180186
35628971	Velosulin (product)	4180186
35628972	Venofer (product)	4180186
35628974	Ventavis (product)	4180186
35628975	Ventide (product)	4180186
35628976	Ventide Rotacaps (product)	4180186
35628978	Ventodisks (product)	4180186
35628981	Ventolin Evohaler (product)	4180186
35628982	Ventolin Nebules (product)	4180186
35628983	Ventolin Rotacaps (product)	4180186
35628984	Vepesid (product)	4180186
35628986	Veracur (product)	4180186
35628987	Verapress MR (product)	4180186
35628989	Ego Pharmaceuticals (qualifier value)	4180186
35628990	Verrugon (product)	4180186
35628991	Versatis (product)	4180186
35628994	Vesanoid (product)	4180186
35628995	Vesicare (product)	4180186
35628997	ViATIM (product)	4180186
35629000	Vibramycin (product)	4180186
35629005	Vicks Vaporub (product)	4180186
35629006	Vicks Vaposyrup (product)	4180186
35629008	Videx (product)	4180186
35629011	Vikonon (product)	4180186
35629012	Vioform-Hydrocortisone (product)	4180186
35629014	VioxxAcute (product)	4180186
35629015	Viracept (product)	4180186
35629016	Viraferon (product)	4180186
35629018	Viralief (product)	4180186
35629019	Viramune (product)	4180186
35629021	Viread (product)	4180186
35629022	Virgan (product)	4180186
35629025	Virovir (product)	4180186
35629027	Viscotears (product)	4180186
35629028	Visionace (product)	4180186
35629030	Viskaldix (product)	4180186
35629031	Visken (product)	4180186
35629033	Vistamethasone (product)	4180186
35629034	Vistamethasone N (product)	4180186
35629035	Vistide (product)	4180186
35629037	Vita-E (product)	4180186
35629040	Vitlipid N Infant (product)	4180186
35629041	Vivabec (product)	4180186
35629043	Vivadone (product)	4180186
35629044	Vivaglobin (product)	4180186
35629048	Vividrin (product)	4180186
35629049	Vivioptal (product)	4180186
35629050	Vivotif (product)	4180186
35629053	Volmax (product)	4180186
35629054	Volplex (product)	4180186
35629056	Volsaid Retard (product)	4180186
35629057	Voltarol (product)	4180186
35629058	Voltarol Ophtha (product)	4180186
35629059	Voltarol Ophtha Multidose (product)	4180186
35629060	Voltarol Pain-eze Emulgel (product)	4180186
35629063	Voltarol SR (product)	4180186
35629064	Voluven (product)	4180186
35629065	Wartex (product)	4180186
35629067	Wasp-Eze (product)	4180186
35629072	Wellvone (product)	4180186
35629073	Wilzin (product)	4180186
35629077	Witch Doctor (product)	4180186
35629078	Xagrid (product)	4180186
35629079	Xalacom (product)	4180186
35629080	Xalatan (product)	4180186
35629084	Xatral SR (product)	4180186
35629088	Xenazine (product)	4180186
35629092	Xismox XL (product)	4180186
35629093	Xolair (product)	4180186
35629096	Xyloproct (product)	4180186
35629098	Xyrem (product)	4180186
35629099	Xyzal (product)	4180186
35629103	Yeast-Vite (product)	4180186
35629110	Zaedoc (product)	4180186
35629111	Zamadol (product)	4180186
35629113	Zamadol Melt (product)	4180186
35629115	Zanaflex (product)	4180186
35629117	Zanprol (product)	4180186
35629118	Zispin (product)	4180186
35629119	Zapain (product)	4180186
35629120	Zaponex (product)	4180186
35629122	Zavedos (product)	4180186
35629123	Zavesca (product)	4180186
35629126	Zelapar (product)	4180186
35629128	Zemplar (product)	4180186
35629132	Zenapax (product)	4180186
35629133	Zenoxone (product)	4180186
35629135	Zerobase (product)	4180186
35629137	Ziagen (product)	4180186
35629140	Zildil (product)	4180186
35629142	Zileze (product)	4180186
35629143	Zimbacol XL (product)	4180186
35629149	Zineryt (product)	4180186
35629150	Zinga (product)	4180186
35629151	Zinnat (product)	4180186
35629154	Zispin SolTab (product)	4180186
35629155	Zita (product)	4180186
35629156	Zithromax (product)	4180186
35629157	Ziz (product)	4180186
35629163	Zoladex LA (product)	4180186
35629164	Zoleptil (product)	4180186
35629165	Zolvera (product)	4180186
35629169	Zomig Rapimelt (product)	4180186
35629171	Zonegran (product)	4180186
35629174	Zoton FasTab (product)	4180186
35629177	Zumenon (product)	4180186
35629179	Zydol (product)	4180186
35629180	Zydol SR (product)	4180186
35629181	Zydol XL (product)	4180186
35629189	Lansinoh (UK) Ltd (qualifier value)	4180186
35629191	Recordati Pharmaceuticals (qualifier value)	4180186
35629192	Adalat (qualifier value)	4180186
35629195	APO-go (qualifier value)	4180186
35629196	Acoflam (qualifier value)	4180186
35629199	Adcal (qualifier value)	4180186
35629200	Adcortyl (qualifier value)	4180186
35629201	Adgyn (qualifier value)	4180186
35629202	Adipine (qualifier value)	4180186
35629204	Aerocrom (qualifier value)	4180186
35629205	Airomir (qualifier value)	4180186
35629208	Anacal (qualifier value)	4180186
35629209	Anafranil (qualifier value)	4180186
35629210	Andrews (qualifier value)	4180186
35629211	Angiopine (qualifier value)	4180186
35629215	Aprovel (qualifier value)	4180186
35629216	AquaBan	4180186
35629216	Aqua Ban (qualifier value)	4180186
35629217	Aranesp (qualifier value)	4180186
35629219	Asacol (qualifier value)	4180186
35629221	Atenix (qualifier value)	4180186
35629227	Betnesol (qualifier value)	4180186
35629229	Bricanyl (qualifier value)	4180186
35629232	Cacit (qualifier value)	4180186
35629233	Calcichew (qualifier value)	4180186
35629236	Carace (qualifier value)	4180186
35629240	Cedocard (qualifier value)	4180186
35629246	Cordilox (qualifier value)	4180186
35629247	Coversyl (qualifier value)	4180186
35629248	Cozaar (qualifier value)	4180186
35629250	Cuprofen (qualifier value)	4180186
35629252	Dalacin (qualifier value)	4180186
35629253	Daonil (qualifier value)	4180186
35629255	Dermovate (qualifier value)	4180186
35629256	Detrunorm (qualifier value)	4180186
35629259	Diamox (qualifier value)	4180186
35629262	Dilzem (qualifier value)	4180186
35629264	Diovan (qualifier value)	4180186
35629266	Ditropan (qualifier value)	4180186
35629267	Doxadura (qualifier value)	4180186
35629268	Dromadol (qualifier value)	4180186
35629271	Dynamin (qualifier value)	4180186
35629272	Earex (qualifier value)	4180186
35629273	Econac (qualifier value)	4180186
35629275	Elantan (qualifier value)	4180186
35629278	Entrocalm (qualifier value)	4180186
35629279	Epilim (qualifier value)	4180186
35629281	Equasym (qualifier value)	4180186
35629282	Equilon (qualifier value)	4180186
35629284	Erythroped (qualifier value)	4180186
35629287	NiQuitin (qualifier value)	4180186
35629288	Nurofen (qualifier value)	4180186
35629289	Nuvelle (qualifier value)	4180186
35629291	Ocuvite (qualifier value)	4180186
35629292	Olbas (qualifier value)	4180186
35629295	Optrex (qualifier value)	4180186
35629297	Oxivent (qualifier value)	4180186
35629299	PanOxyl (qualifier value)	4180186
35629302	Persantin (qualifier value)	4180186
35629303	Pickles (qualifier value)	4180186
35629304	Pollenase (qualifier value)	4180186
35629305	Polytar (qualifier value)	4180186
35629307	Priadel (qualifier value)	4180186
35629308	Primaxin (qualifier value)	4180186
35629312	Prostin (qualifier value)	4180186
35629313	Provera (qualifier value)	4180186
35629314	Pulmicort (qualifier value)	4180186
35629315	Pulvinal (qualifier value)	4180186
35629321	Reminyl (qualifier value)	4180186
35629325	Rimactazid (qualifier value)	4180186
35629329	Synalar (qualifier value)	4180186
35629330	Robitussin (qualifier value)	4180186
35629331	Rynacrom (qualifier value)	4180186
35629332	Rythmodan (qualifier value)	4180186
35629333	Salamol (qualifier value)	4180186
35629334	Salazopyrin (qualifier value)	4180186
35629335	Sanatogen (qualifier value)	4180186
35629336	Sandoglobulin (qualifier value)	4180186
35629337	Sandostatin (qualifier value)	4180186
35629340	Scholl (qualifier value)	4180186
35629343	Serevent (qualifier value)	4180186
35629345	Sinemet (qualifier value)	4180186
35629347	Solpadeine (qualifier value)	4180186
35629348	Somatuline (qualifier value)	4180186
35629349	Soothake (qualifier value)	4180186
35629353	Stelazine (qualifier value)	4180186
35629354	Tixylix (qualifier value)	4180186
35629355	Ster-Zac (qualifier value)	4180186
35629357	Stiedex (qualifier value)	4180186
35629359	Sudafed (qualifier value)	4180186
35629360	Surgam (qualifier value)	4180186
35629362	Tambocor (qualifier value)	4180186
35629364	Terra-Cortril (qualifier value)	4180186
35629366	Tilade (qualifier value)	4180186
35629367	Tildiem (qualifier value)	4180186
35629371	Medihoney (Europe) Ltd (qualifier value)	4180186
35629375	Trasicor (qualifier value)	4180186
35629381	Vibramycin (qualifier value)	4180186
35629383	Videx (qualifier value)	4180186
35629384	Vigam (qualifier value)	4180186
35629387	Vistamethasone (qualifier value)	4180186
35629388	Vitlipid N (qualifier value)	4180186
35629389	Voltarol (qualifier value)	4180186
35629391	Xatral (qualifier value)	4180186
35629394	Zamadol (qualifier value)	4180186
35629395	Zildil (qualifier value)	4180186
35629397	Zofran (qualifier value)	4180186
35629399	Zomig (qualifier value)	4180186
35629400	Zoton (qualifier value)	4180186
35629404	Hyalase (product)	4180186
35629406	Hydrex (product)	4180186
35629409	Ibuleve (product)	4180186
35629410	Ibuspray (product)	4180186
35629411	Imodium (product)	4180186
35629412	Imodium Plus (product)	4180186
35629416	Insulatard NovoLet (product)	4180186
35629418	Iomeron (product)	4180186
35629419	Iopidine (product)	4180186
35629420	Ismo (product)	4180186
35629422	Isovorin (product)	4180186
35629423	Januvia (product)	4180186
35629426	Kefzol (product)	4180186
35629427	Kepivance (product)	4180186
35629428	Keppra (product)	4180186
35629430	Lamprene (product)	4180186
35629431	Lanacort (product)	4180186
35629441	Fentazin (product)	4180186
35629445	Flamazine (product)	4180186
35629446	Flammacerium (product)	4180186
35629452	Frumil (product)	4180186
35629453	FSME-Bulin (product)	4180186
35629455	Fungilin (product)	4180186
35629460	Genotropin MiniQuick (product)	4180186
35629461	Glibenese (product)	4180186
35629462	Glurenorm (product)	4180186
35629463	Gonal-f (product)	4180186
35629466	Halciderm Topical (product)	4180186
35629467	Hay-Crom (product)	4180186
35629468	Hedex Ibuprofen (product)	4180186
35629469	Hepatyrix (product)	4180186
35629470	Hiberix (product)	4180186
35629472	Loestrin 20 (product)	4180186
35629473	Lopid (product)	4180186
35629475	Luveris (product)	4180186
35629483	Menthodex (product)	4180186
35629485	Metatone (product)	4180186
35629486	Meted (product)	4180186
35629487	Metoject (product)	4180186
35629488	Minadex (product)	4180186
35629490	Mivacron (product)	4180186
35629491	Mixtard 30 Penfill (product)	4180186
35629493	Mobiflex (product)	4180186
35629495	Monoclate-P (product)	4180186
35629496	Mononine (product)	4180186
35629499	Mydriacyl (product)	4180186
35629500	Myocrisin (product)	4180186
35629504	Neofel XL (product)	4180186
35629505	Neo-Naclex (product)	4180186
35629506	Neurontin (product)	4180186
35629508	Nindaxa (product)	4180186
35629510	Norcuron (product)	4180186
35629515	Humulin Lente (product)	4180186
35629516	Hycamtin (product)	4180186
35629517	Hydrea (product)	4180186
35629518	Hydrocortone (product)	4180186
35629520	Hypolar Retard (product)	4180186
35629521	Hypurin Porcine Neutral (product)	4180186
35629522	Ilube (product)	4180186
35629525	Infanrix-IPV + Hib (product)	4180186
35629526	Infanrix-IPV (product)	4180186
35629531	Jectofer (product)	4180186
35629533	Katya (product)	4180186
35629534	Kefadim (product)	4180186
35629536	Klaricid XL (product)	4180186
35629538	Lanoxin (product)	4180186
35629541	Lemlax (product)	4180186
35629542	Leustat (product)	4180186
35629545	Eumovate (product)	4180186
35629546	Exocin (product)	4180186
35629547	Fanhdi (product)	4180186
35629550	Fenogal (product)	4180186
35629552	Ferrograd (product)	4180186
35629555	Foscavir (product)	4180186
35629559	Galpamol (product)	4180186
35629560	Galprofen (product)	4180186
35629561	Gaviscon Advance (product)	4180186
35629565	Gonapeptyl Depot (product)	4180186
35629566	Gregoderm (product)	4180186
35629567	Haemaccel (product)	4180186
35629568	Haldol (product)	4180186
35629573	Lubri-Tears (product)	4180186
35629575	Maalox TC (product)	4180186
35629576	MabThera (product)	4180186
35629578	Marvelon (product)	4180186
35629581	Megace (product)	4180186
35629582	Menitorix (product)	4180186
35629584	Metosyn FAPG (product)	4180186
35629585	Metrosa (product)	4180186
35629586	Migard (product)	4180186
35629587	Migraleve Pink (product)	4180186
35629589	Mixtard 50 Penfill (product)	4180186
35629591	Multiparin (product)	4180186
35629592	MXL (product)	4180186
35629594	Nasonex (product)	4180186
35629595	Navidrex (product)	4180186
35629596	Negram (product)	4180186
35629598	Neupogen Singleject (product)	4180186
35629599	NeuroBloc (product)	4180186
35629601	Nivemycin (product)	4180186
35629603	Norgeston (product)	4180186
35629604	Noritate (product)	4180186
35629605	Normacol (product)	4180186
35629608	Hypnovel (product)	4180186
35629613	Insulatard Penfill (product)	4180186
35629614	Intal Syncroner (product)	4180186
35629616	Isovist (product)	4180186
35629618	Keloc SR (product)	4180186
35629619	Kentipine MR (product)	4180186
35629620	Ketek (product)	4180186
35629621	Komil (product)	4180186
35629622	Lamictal (product)	4180186
35629623	Lamisil (product)	4180186
35629624	Lantus (product)	4180186
35629625	Lederspan (product)	4180186
35629627	Levovist (product)	4180186
35629629	Lipobase (product)	4180186
35629630	Liposic (product)	4180186
35629631	Eurax Hc (product)	4180186
35629633	Famvir (product)	4180186
35629639	Flaxedil (product)	4180186
35629640	Flixonase (product)	4180186
35629643	Foradil (product)	4180186
35629644	Forsteo (product)	4180186
35629648	Fru-Co (product)	4180186
35629651	Glucophage SR (product)	4180186
35629652	Glutarol (product)	4180186
35629654	Gyno-Daktarin (product)	4180186
35629655	Gyno-Pevaryl (product)	4180186
35629658	Half Securon (product)	4180186
35629659	HCU express (product)	4180186
35629660	Hedex (product)	4180186
35629663	Hexvix (product)	4180186
35629664	Hibiscrub (product)	4180186
35629666	Litarex (product)	4180186
35629669	Locoid Lipocream (product)	4180186
35629670	Maalox (product)	4180186
35629671	Macugen (product)	4180186
35629672	Marcain with Adrenaline (product)	4180186
35629673	Medrone (product)	4180186
35629676	Metalyse (product)	4180186
35629681	Minalka (product)	4180186
35629682	Minulet (product)	4180186
35629683	Miradol (product)	4180186
35629685	Mistamine (product)	4180186
35629687	Molcer (product)	4180186
35629688	Molipaxin CR (product)	4180186
35629690	Monomax XL (product)	4180186
35629692	Hyate:C (product)	4180186
35629694	Motipress (product)	4180186
35629699	Nexium (product)	4180186
35629700	Nicef (product)	4180186
35629702	Norphyllin SR (product)	4180186
35629704	NovoMix 30 Penfill (product)	4180186
35629705	Humulin M5 (product)	4180186
35629706	Hygroton (product)	4180186
35629707	Hypo-Fit	4180186
35629707	Hypo-Fit (product)	4180186
35629709	Hypurin Bovine Protamine Zinc (product)	4180186
35629711	Imdur (product)	4180186
35629712	Imunovir (product)	4180186
35629713	Increlex (product)	4180186
35629715	Innohep (product)	4180186
35629716	Insulatard (product)	4180186
35629718	Insuman Comb 25 (product)	4180186
35629720	IntronA (product)	4180186
35629721	Invanz (product)	4180186
35629722	Invirase (product)	4180186
35629725	Ipramol (product)	4180186
35629726	Kemadrin (product)	4180186
35629727	Kemicetine (product)	4180186
35629729	Lasilactone (product)	4180186
35629736	Faverin (product)	4180186
35629738	Feldene (product)	4180186
35629739	Felogen XL (product)	4180186
35629740	Femara (product)	4180186
35629742	Fenactol Retard (product)	4180186
35629744	Flebogamma (product)	4180186
35629745	Flixotide Diskhaler (product)	4180186
35629746	Fluanxol (product)	4180186
35629753	Ganfort (product)	4180186
35629754	Gardasil (product)	4180186
35629756	Gastromiro (product)	4180186
35629759	Gaviscon Infant (product)	4180186
35629760	Gelofusine (product)	4180186
35629764	Haldol decanoate (product)	4180186
35629769	Liquifilm Tears (product)	4180186
35629771	Lisopress (product)	4180186
35629774	Locoid C (product)	4180186
35629775	Lodine SR (product)	4180186
35629776	Lotriderm (product)	4180186
35629778	Lysovir (product)	4180186
35629780	Magnevist (product)	4180186
35629786	Mercilon (product)	4180186
35629787	Merional (product)	4180186
35629790	Metrozol (product)	4180186
35629792	Micronor (product)	4180186
35629793	Mictral (product)	4180186
35629795	Minitran (product)	4180186
35629796	Mixtard 30 (product)	4180186
35629798	Moditen (product)	4180186
35629799	Moducren (product)	4180186
35629800	Monphytol (product)	4180186
35629801	Morhulin (product)	4180186
35629802	Motilium (product)	4180186
35629803	Mysoline (product)	4180186
35629806	Neo-Cortef (product)	4180186
35629808	Neoral (product)	4180186
35629810	Neupogen (product)	4180186
35629812	Nifedipress MR (product)	4180186
35629814	Nitronal (product)	4180186
35629816	Hypotears (product)	4180186
35629820	Inderetic (product)	4180186
35629823	Intal Fisonair (product)	4180186
35629824	Isoket (product)	4180186
35629826	Isotrexin (product)	4180186
35629828	Istin (product)	4180186
35629831	Kolanticon (product)	4180186
35629833	Larapam SR (product)	4180186
35629835	Lasikal (product)	4180186
35629837	Lentizol (product)	4180186
35629839	FemTab Continuous (product)	4180186
35629840	Lipitor (product)	4180186
35629842	Euglucon (product)	4180186
35629848	Exubera (product)	4180186
35629852	Feldene Melt (product)	4180186
35629853	FemSeven Conti (product)	4180186
35629855	Fibrogammin	4180186
35629855	Fibrogammin P (product)	4180186
35629856	Fibrovein	4180186
35629856	Fibro-Vein (product)	4180186
35629858	Flomaxtra XL (product)	4180186
35629861	Fortipine LA (product)	4180186
35629862	Fortovase (product)	4180186
35629863	Fosavance (product)	4180186
35629864	Freederm (product)	4180186
35629865	Fybogel (product)	4180186
35629866	Gastrobid Continus (product)	4180186
35629868	Gaviscon Extra Strength (product)	4180186
35629869	GelTears (product)	4180186
35629872	GlucoGel (product)	4180186
35629877	HibTITER (product)	4180186
35629878	Honvan (product)	4180186
35629879	HTDEFIX (product)	4180186
35629880	Humalog Pen (product)	4180186
35629882	Loxapac (product)	4180186
35629885	Malarone (product)	4180186
35629887	Marevan (product)	4180186
35629888	Maxalt Melt (product)	4180186
35629891	Menogon (product)	4180186
35629892	Menopur (product)	4180186
35629894	Metosyn (product)	4180186
35629895	Metrolyl (product)	4180186
35629897	Mexitil (product)	4180186
35629899	Mimpara (product)	4180186
35629900	Minocin MR (product)	4180186
35629901	Mintec (product)	4180186
35629902	Miochol-E (product)	4180186
35629903	Mitoxana (product)	4180186
35629906	Moduretic (product)	4180186
35629908	Monit XL (product)	4180186
35629910	Kytril (product)	4180186
35629912	Movelat (product)	4180186
35629913	Naseptin (product)	4180186
35629914	Nebido (product)	4180186
35629919	Nicorette (product)	4180186
35629920	Nocutil (product)	4180186
35629921	Nootropil (product)	4180186
35629922	Normosang (product)	4180186
35629923	Norprolac (product)	4180186
35629926	Human Mixtard 50 Penfill (product)	4180186
35629928	Ibufem (product)	4180186
35629929	Imigran Subject (product)	4180186
35629931	Indocid (product)	4180186
35629935	Inflexal V (product)	4180186
35629940	Keftid (product)	4180186
35629941	Kentera (product)	4180186
35629943	Lactugal (product)	4180186
35629948	Liberim Z (product)	4180186
35629949	Lidoderm (product)	4180186
35629951	Exterol (product)	4180186
35629952	Fareston (product)	4180186
35629954	Felendil XL	4180186
35629954	Felendil XL (product)	4180186
35629955	Felotens XL (product)	4180186
35629960	Ferriprox (product)	4180186
35629961	Ferrograd C (product)	4180186
35629964	Flamrase SR (product)	4180186
35629965	FlavourPac (product)	4180186
35629973	Garamycin (product)	4180186
35629974	Gavilast (product)	4180186
35629975	Glyformin (product)	4180186
35629976	Harmogen (product)	4180186
35629978	Herceptin (product)	4180186
35629979	Hibitane (product)	4180186
35629982	HRF - brand name (product)	4180186
35629984	Human Insulatard (product)	4180186
35629987	Lopace (product)	4180186
35629990	Lymphoglobuline (product)	4180186
35629991	Lyrinel XL (product)	4180186
35629993	Malarivon (product)	4180186
35629997	Matrifen (product)	4180186
35629999	Meptid (product)	4180186
35630000	Metoclomex (product)	4180186
35630002	Metsol (product)	4180186
35630005	Midrid (product)	4180186
35630007	Mircera (product)	4180186
35630008	Mixtard 10 Penfill (product)	4180186
35630009	Mogadon (product)	4180186
35630010	Monit SR (product)	4180186
35630011	Monomil XL (product)	4180186
35630014	Motens (product)	4180186
35630017	Myocet (product)	4180186
35630018	Myozyme (product)	4180186
35630019	Naprosyn (product)	4180186
35630020	Naramig (product)	4180186
35630022	Navoban (product)	4180186
35630024	Neosporin (product)	4180186
35630025	Neotigason (product)	4180186
35630026	Nestargel (product)	4180186
35630027	Neulactil (product)	4180186
35630028	Nicotinell (product)	4180186
35630030	Nivaquine (product)	4180186
35630031	Micanol (product)	4180186
35630032	Nizoral (product)	4180186
35630034	Norgalax (product)	4180186
35630036	Noxyflex-S (product)	4180186
35630038	Hyalgan (product)	4180186
35630042	Imigran (product)	4180186
35630043	Imo LA (product)	4180186
35630046	Isocard (product)	4180186
35630050	Ketozip XL (product)	4180186
35630051	Ketpron XL (product)	4180186
35630052	Kivexa (product)	4180186
35630053	Konakion (product)	4180186
35630056	Lasix (product)	4180186
35630057	Lederfolin (product)	4180186
35630060	Lioresal (product)	4180186
35630065	Flixotide Accuhaler (product)	4180186
35630067	Fluor-a-day (product)	4180186
35630068	FML Liquifilm (product)	4180186
35630070	Franol Plus (product)	4180186
35630071	Frisium (product)	4180186
35630072	Froben SR (product)	4180186
35630074	Gabitril (product)	4180186
35630075	Galenphol (product)	4180186
35630076	Galpseud (product)	4180186
35630077	Gammagard S/D (product)	4180186
35630079	Gastrografin (product)	4180186
35630080	Gaviscon (product)	4180186
35630081	Genotropin (product)	4180186
35630085	Glucophage (product)	4180186
35630086	Glycophos (product)	4180186
35630087	Grisovin (product)	4180186
35630089	Hedex Extra (product)	4180186
35630092	Hiprex (product)	4180186
35630095	Lomont (product)	4180186
35630096	Lomotil (product)	4180186
35630097	Losec (product)	4180186
35630098	MabCampath (product)	4180186
35630099	Macrobid (product)	4180186
35630100	Manusept (product)	4180186
35630101	Maxalt (product)	4180186
35630103	Medicaid (product)	4180186
35630104	Medicoal (product)	4180186
35630106	Mesren MR (product)	4180186
35630107	Metenix (product)	4180186
35630108	Metrotop (product)	4180186
35630111	Mixtard 40 NovoLet (product)	4180186
35630115	Monotrim (product)	4180186
35630116	Monovent (product)	4180186
35630118	Mycobutin (product)	4180186
35630120	Naglazyme (product)	4180186
35630121	Narcan (product)	4180186
35630124	NovoSeven (product)	4180186
35630125	NeoMercazole (product)	4180186
35630127	Neulasta (product)	4180186
35630128	Neulasta SureClick (product)	4180186
35630130	Nicopatch (product)	4180186
35630131	Nifopress Retard (product)	4180186
35630133	Nitrocine (product)	4180186
35630135	Noristerat (product)	4180186
35630136	Norvir (product)	4180186
35630137	NovoMix 30 FlexPen (product)	4180186
35630139	Micralax Micro-enema (product)	4180186
35630148	Hytrin (product)	4180186
35630149	Ikorel (product)	4180186
35630151	Immunoprin (product)	4180186
35630155	Insulatard InnoLet (product)	4180186
35630156	Insuman Comb 15 (product)	4180186
35630157	Intal (product)	4180186
35630159	Integrilin (product)	4180186
35630160	Integrin (product)	4180186
35630162	Ismo Retard (product)	4180186
35630165	Jomethid XL (product)	4180186
35630173	Ladropen (product)	4180186
35630175	Librium (product)	4180186
35630182	Evorel Conti (product)	4180186
35630184	Femodette (product)	4180186
35630185	Femulen (product)	4180186
35630188	Fenopron (product)	4180186
35630189	Feospan Spansules (product)	4180186
35630191	Fluarix (product)	4180186
35630193	Fortral (product)	4180186
35630195	Froop (product)	4180186
35630197	Galcodine (product)	4180186
35630200	Galenamox (product)	4180186
35630202	Galpseud Plus (product)	4180186
35630204	Gemzar (product)	4180186
35630205	Genticin (product)	4180186
35630206	Germoloids (product)	4180186
35630207	Gestone (product)	4180186
35630211	Microval (product)	4180186
35630215	Hemabate (product)	4180186
35630217	Hepsera (product)	4180186
35630219	Histergan (product)	4180186
35630223	Loestrin 30 (product)	4180186
35630227	Medikinet (product)	4180186
35630228	Mestinon (product)	4180186
35630230	Micronor HRT (product)	4180186
35630233	Mizollen (product)	4180186
35630234	Mobic (product)	4180186
35630236	Moduret (product)	4180186
35630237	Monigen XL (product)	4180186
35630238	Motival (product)	4180186
35630242	Mucodyne (product)	4180186
35630243	MultiHance (product)	4180186
35630244	Murine irritation & redness relief	4180186
35630244	Murine (product)	4180186
35630245	Myfortic (product)	4180186
35630247	Natrilix SR (product)	4180186
35630248	Navelbine (product)	4180186
35630249	Neozipine XL (product)	4180186
35630252	Nimodrel XL (product)	4180186
35630254	Norimode (product)	4180186
35630255	Norit (product)	4180186
35630257	NovoRapid Penfill (product)	4180186
35630260	Hypolar (qualifier value)	4180186
35630261	Imodium (qualifier value)	4180186
35630262	Ismo (qualifier value)	4180186
35630263	Kapake (qualifier value)	4180186
35630264	Lescol (qualifier value)	4180186
35630265	Fenbid (qualifier value)	4180186
35630266	Forceval (qualifier value)	4180186
35630268	Galfer (qualifier value)	4180186
35630270	Monit (qualifier value)	4180186
35630271	Lopresor (qualifier value)	4180186
35630273	Migraleve (qualifier value)	4180186
35630277	Ferrograd (qualifier value)	4180186
35630281	Beta-Prograne (qualifier value)	4180186
35630284	Isordil (qualifier value)	4180186
35630287	Froben (qualifier value)	4180186
35630291	Humulin (qualifier value)	4180186
35630295	Evorel (qualifier value)	4180186
35630297	Micronor (qualifier value)	4180186
35630298	Locoid (qualifier value)	4180186
35630302	Fybogel (qualifier value)	4180186
35630305	Metosyn (qualifier value)	4180186
35630306	Mexitil (qualifier value)	4180186
35630307	Nicorette (qualifier value)	4180186
35630310	FemSeven (qualifier value)	4180186
35630311	FemTab (qualifier value)	4180186
35630312	Hibitane (qualifier value)	4180186
35630315	Nicotinell (qualifier value)	4180186
35630316	NovoRapid (qualifier value)	4180186
35630317	Imazin (qualifier value)	4180186
35630318	Imigran (qualifier value)	4180186
35630323	Genotropin (qualifier value)	4180186
35630325	Maxalt (qualifier value)	4180186
35630327	NovoMix (qualifier value)	4180186
35630328	Intal (qualifier value)	4180186
35630329	Klaricid (qualifier value)	4180186
35630333	Germoloids (qualifier value)	4180186
35630335	Marcain (qualifier value)	4180186
35630336	Medikinet (qualifier value)	4180186
35630337	Mestinon (qualifier value)	4180186
35630339	Eumedica Pharma Ltd (qualifier value)	4180186
35630340	Modisal (qualifier value)	4180186
35630342	Uriflex W (product)	4180186
35630343	Xclair (product)	4180186
35630345	Alembicol D (product)	4180186
35630347	Bacticlor MR (product)	4180186
35630353	Cicatrin (product)	4180186
35630354	Cidomycin Intrathecal (product)	4180186
35630359	Dermestril (product)	4180186
35630361	Dermol 600 (product)	4180186
35630363	Prempak-C (product)	4180186
35630366	Synocrom (product)	4180186
35630367	Ultramol (product)	4180186
35630370	Act-HIB DTP (product)	4180186
35630371	Arthrease (product)	4180186
35630373	Calcium-Sandoz (product)	4180186
35630376	Clinorette (product)	4180186
35630379	Coriplast 1 (product)	4180186
35630382	Palacos R-20 with Gentamicin (product)	4180186
35630383	Steripaste (product)	4180186
35630387	Zeridame SR (product)	4180186
35630388	Chemydur 60XL (product)	4180186
35630389	Daktacort (product)	4180186
35630391	Pollinex Grasses + Rye (product)	4180186
35630392	Rotarix (product)	4180186
35630393	Seretide Accuhaler (product)	4180186
35630394	Trisequens (product)	4180186
35630395	Viscopaste (product)	4180186
35630397	Atrogel (product)	4180186
35630398	Canesten Oasis (product)	4180186
35630402	Dermol 500 (product)	4180186
35630403	Diflucan (product)	4180186
35630404	Do-Do ChestEze (product)	4180186
35630405	OptiFlo R (product)	4180186
35630408	Orthovisc (product)	4180186
35630413	Urografin (product)	4180186
35630415	Vectibix (product)	4180186
35630416	Aquagel (product)	4180186
35630418	B-2-50 (product)	4180186
35630419	Balmosa (product)	4180186
35630420	Buscopan (product)	4180186
35630424	Cyclo-Progynova (product)	4180186
35630427	Difflam (product)	4180186
35630428	Dyloject (product)	4180186
35630429	Senset (product)	4180186
35630430	Silgel (product)	4180186
35630431	Sinotar (product)	4180186
35630432	Synphase (product)	4180186
35630435	Actonel Combi (product)	4180186
35630437	Altargo (product)	4180186
35630438	Bazuka Extra Strength (product)	4180186
35630441	Buccastem (product)	4180186
35630442	Tubilux (product)	4180186
35630443	Canesten (clotrimazole) (product)	4180186
35630444	Canesten AF Once Daily (product)	4180186
35630444	Canesten Bifonazole Once Daily	4180186
35630445	Climagest (product)	4180186
35630446	Crystapen (product)	4180186
35630447	Day Nurse (product)	4180186
35630448	Omri-Hep-B (product)	4180186
35630449	OptiFlo S (product)	4180186
35630451	Pollinex Trees (product)	4180186
35630452	Resolve (product)	4180186
35630453	Resolve Extra (product)	4180186
35630456	Sterets Aquasol (product)	4180186
35630457	TicoVac (product)	4180186
35630460	Trinordiol (product)	4180186
35630461	Unique pH (product)	4180186
35630465	Ambirix (product)	4180186
35630466	Bactigras (product)	4180186
35630470	Canesten Hydrocortisone (product)	4180186
35630473	Cilest (product)	4180186
35630477	Cystistat (product)	4180186
35630478	Dermol (product)	4180186
35630479	Duphalac (product)	4180186
35630482	Redoxon Double Action (product)	4180186
35630486	Supartz (product)	4180186
35630487	Trinovum (product)	4180186
35630489	Anugesic-HC (product)	4180186
35630490	Atripla (product)	4180186
35630492	Augmentin (product)	4180186
35630493	Balsamka (product)	4180186
35630495	Canesten Duo (product)	4180186
35630497	Cozachew Meltdown Combi (product)	4180186
35630499	Dermabond (product)	4180186
35630502	Oxyal (product)	4180186
35630505	Redoxon (product)	4180186
35630506	Redoxon All-Day Defence (product)	4180186
35630507	Regaine (product)	4180186
35630509	Scheriproct (product)	4180186
35630510	Ailax (qualifier value)	4180186
35630512	Dermestril (qualifier value)	4180186
35630513	Seretide (qualifier value)	4180186
35630514	Actonel (qualifier value)	4180186
35630515	Contac (qualifier value)	4180186
35630517	Valni (qualifier value)	4180186
35630520	Palacos (qualifier value)	4180186
35630521	Pollinex (qualifier value)	4180186
35630523	OptiFlo (qualifier value)	4180186
35630524	Canesten (qualifier value)	4180186
35630525	Bazuka (qualifier value)	4180186
35630526	Resolve (qualifier value)	4180186
35630528	Dermol (qualifier value)	4180186
35630532	Augmentin (qualifier value)	4180186
35630535	Ex-Lax Senna (product)	4180186
35630536	Feverfen (product)	4180186
35630537	Icaps (product)	4180186
35630539	Karvol (product)	4180186
35630540	Mackenzies (product)	4180186
35630544	Hay-Rite Allergy (product)	4180186
35630546	Kalten (product)	4180186
35630549	Cleen Ready-to-use	4180186
35630549	Fleet Ready-to-use (product)	4180186
35630550	Halycitrol (product)	4180186
35630552	Kenalog (product)	4180186
35630555	Merocaine (product)	4180186
35630556	Night Nurse (product)	4180186
35630557	Nostroline (product)	4180186
35630558	Fam-Lax Phenolphthalein (product)	4180186
35630559	Infadrops (product)	4180186
35630560	Exforge (product)	4180186
35630561	Linola Gamma (product)	4180186
35630563	Nowax (product)	4180186
35630564	Expulin Dry Cough (product)	4180186
35630565	Fenistil (product)	4180186
35630566	Fleet Phospho-soda (product)	4180186
35630566	Phospho-soda	4180186
35630570	Jaaps (product)	4180186
35630571	Klean-Prep (product)	4180186
35630572	Lactocalamine (product)	4180186
35630573	Medinol (product)	4180186
35630574	Mil-Par (product)	4180186
35630576	Lexpec Folic Acid with Iron (product)	4180186
35630582	Kay-Cee-L (product)	4180186
35630583	Medised For Children (product)	4180186
35630584	Mucogel (product)	4180186
35630585	Exorex (product)	4180186
35630586	Fletcher's Enemette (product)	4180186
35630587	Fletcher's Phosphate (product)	4180186
35630589	Happinose (product)	4180186
35630596	Merocets (product)	4180186
35630597	Merocets Plus (product)	4180186
35630598	Exorex Hair and Body (product)	4180186
35630599	Farley's Premcare (product)	4180186
35630601	Galprofen Cold and Flu (product)	4180186
35630604	Lacri-Lube (product)	4180186
35630608	Lisicostad (product)	4180186
35630609	Meggezones (product)	4180186
35630610	Lexpec (qualifier value)	4180186
35630611	Eucerin (qualifier value)	4180186
35630612	Galprofen (qualifier value)	4180186
35630613	Exorex (qualifier value)	4180186
35630614	Fletcher's (qualifier value)	4180186
35630616	Merocets (qualifier value)	4180186
35630617	Feminax (qualifier value)	4180186
35630620	Mixtard 30 InnoLet (product)	4180186
35630623	MigraMax (product)	4180186
35630626	Olbas PowerFlu (product)	4180186
35630629	Mixtard 30 NovoLet (product)	4180186
35630630	NovoRapid FlexPen (product)	4180186
35630632	Hypurin Porcine 30/70 Mix (product)	4180186
35630633	Monoparin calcium (product)	4180186
35630635	TOBI (product)	4180186
35630636	Maxolon (product)	4180186
35630637	Netillin (product)	4180186
35630638	NovoNorm (product)	4180186
35630639	Polycose (product)	4180186
35630640	APO-go Pen (product)	4180186
35630641	ATryn (product)	4180186
35630642	Scholl Corn and Callus removal	4180186
35630642	Scholl Corn and Callus removal (product)	4180186
35630645	Levemir InnoLet (product)	4180186
35630648	Salonpas (product)	4180186
35630650	Cuprofen PLUS (product)	4180186
35630651	Imazin XL forte (product)	4180186
35630652	Kliofem (product)	4180186
35630654	Menthol mint (qualifier value)	4180186
35630655	Blueberry (qualifier value)	4180186
35630656	Paediatric care plan (record artifact)	4180186
35630661	Paediatric cystic fibrosis care plan (record artifact)	4180186
35630662	Paediatric dentistry care plan (record artifact)	4180186
35630663	Paediatric dermatology care plan (record artifact)	4180186
35630667	Paediatric endocrinology care plan (record artifact)	4180186
35630668	Paediatric epilepsy care plan (record artifact)	4180186
35630670	Paediatric gastrointestinal surgery care plan (record artifact)	4180186
35630674	Paediatric nephrology care plan (record artifact)	4180186
35630681	Antenatal care plan (record artifact)	4180186
35630683	Art therapy care plan (record artifact)	4180186
35630685	Asthma action plan (record artifact)	4180186
35630686	Blood transfusion care plan (record artifact)	4180186
35630689	Cardiothoracic surgery care plan (record artifact)	4180186
35630690	Cardiothoracic transplantation care plan (record artifact)	4180186
35630691	Care of the elderly care plan (record artifact)	4180186
35630694	Psychiatric intensive care plan (record artifact)	4180186
35630701	Remote care monitoring care plan (record artifact)	4180186
35630702	Remote health monitoring care plan (record artifact)	4180186
35630703	Remote triage and advice plan (record artifact)	4180186
35630706	Rheumatology care plan (record artifact)	4180186
35630707	School nursing care plan (record artifact)	4180186
35630709	Special care baby care plan (record artifact)	4180186
35630717	Spinal surgery care plan (record artifact)	4180186
35630720	Strabismus surgery care plan (record artifact)	4180186
35630721	Substance misuse care plan (record artifact)	4180186
35630722	Surgical dentistry care plan (record artifact)	4180186
35630728	Tropical medicine care plan (record artifact)	4180186
35630734	Well woman care plan (record artifact)	4180186
35630736	Nozoil (product)	4180186
35630739	Community occupational therapy care plan (record artifact)	4180186
35630740	Hospital occupational therapy care plan (record artifact)	4180186
35630741	Ophthalmic plastic surgery care plan (record artifact)	4180186
35630742	Ophthalmic surgery care plan (record artifact)	4180186
35630743	Ophthalmology care plan (record artifact)	4180186
35630745	Orthodontic care plan (record artifact)	4180186
35630746	Orthopaedic care plan (record artifact)	4180186
35630747	Orthotic care plan (record artifact)	4180186
35630748	Osteopathic manipulative medicine care plan (record artifact)	4180186
35630749	Paediatric genetics care plan (record artifact)	4180186
35630750	Paediatric neurology oncology care plan (record artifact)	4180186
35630751	Paediatric neurosurgery care plan (record artifact)	4180186
35630753	Paediatric ophthalmology care plan (record artifact)	4180186
35630754	Paediatric pain management care plan (record artifact)	4180186
35630755	Paediatric plastic surgery care plan (record artifact)	4180186
35630759	Paediatric thoracic surgery care plan (record artifact)	4180186
35630760	Paediatric transplantation surgery care plan (record artifact)	4180186
35630763	Palliative care plan (record artifact)	4180186
35630767	Perinatal care plan	4180186
35630767	Perinatal care plan (record artifact)	4180186
35630768	Perinatal mental health care plan (record artifact)	4180186
35630769	Physiotherapy care plan (record artifact)	4180186
35630770	Community physiotherapy care plan (record artifact)	4180186
35630772	Iscador Qu c Arg (product)	4180186
35630773	Isomil (product)	4180186
35630777	Jevity 1.5kcal (product)	4180186
35630779	Jevity Plus (product)	4180186
35630780	Hospital podiatry care plan (record artifact)	4180186
35630782	Postnatal care plan (record artifact)	4180186
35630783	Kindergen (product)	4180186
35630790	Nutilis (product)	4180186
35630792	Nutramigen 2 (product)	4180186
35630794	Dementia assessment care plan (record artifact)	4180186
35630797	Nutrison Energy (product)	4180186
35630799	Nutrison Protein Plus (product)	4180186
35630802	Diabetes education care plan (record artifact)	4180186
35630803	Nuvelle TS (product)	4180186
35630804	Osmolite Plus (product)	4180186
35630805	Dietetic care plan (record artifact)	4180186
35630806	Oxysept 1-Step (product)	4180186
35630809	Hospital dietetic care plan (record artifact)	4180186
35630810	Prothromplex Total (product)	4180186
35630811	Drama therapy care plan (record artifact)	4180186
35630812	QuickCal (product)	4180186
35630813	Ear, nose and throat care plan (record artifact)	4180186
35630814	Renilon (product)	4180186
35630815	Early years care plan (record artifact)	4180186
35630816	Resource Dessert Energy (product)	4180186
35630817	Eating disorder care plan (record artifact)	4180186
35630819	Resource Thickened (product)	4180186
35630822	Old age psychiatry care plan (record artifact)	4180186
35630825	Suplena (product)	4180186
35630828	Synthamin 9 without electrolytes (product)	4180186
35630830	Family planning care plan (record artifact)	4180186
35630834	Gastroenterology care plan (record artifact)	4180186
35630836	XLEU Analog (product)	4180186
35630840	General medical care plan (record artifact)	4180186
35630843	Isosource Standard (product)	4180186
35630845	Laxido (product)	4180186
35630846	Glaucoma surgery care plan (record artifact)	4180186
35630847	Lens Plus Purite (product)	4180186
35630848	Lepicol (product)	4180186
35630854	Hand surgery care plan (record artifact)	4180186
35630855	Maxipro (product)	4180186
35630856	Head injury rehabilitation care plan (record artifact)	4180186
35630859	Modulen IBD (product)	4180186
35630860	Nicobrevin (product)	4180186
35630862	Normasol (product)	4180186
35630865	Hospice at home care plan (record artifact)	4180186
35630866	Novofem (product)	4180186
35630867	Homeopathy care plan (record artifact)	4180186
35630870	Nutrini Energy (product)	4180186
35630872	Nutrini Pepti (product)	4180186
35630873	Interventional radiology care plan (record artifact)	4180186
35630875	Community learning disability care plan (record artifact)	4180186
35630876	Nutrison Low Sodium (product)	4180186
35630879	Liaison psychiatry care plan (record artifact)	4180186
35630880	Protenplus (product)	4180186
35630881	Purisole (product)	4180186
35630883	Resource Junior (product)	4180186
35630889	Community mental health care plan (record artifact)	4180186
35630890	Uniflu with Gregovite C (product)	4180186
35630893	Obstetric antenatal care plan (record artifact)	4180186
35630894	XPHEN TYR Tyrosidon Free (product)	4180186
35630895	Obstetric perinatal care plan (record artifact)	4180186
35630896	XPTM Analog (product)	4180186
35630898	Iscador P c Hg (product)	4180186
35630899	Isosource Energy (product)	4180186
35630900	Isosource Energy Fibre (product)	4180186
35630903	Keri Therapeutic (product)	4180186
35630904	Lipofundin N (product)	4180186
35630906	Maxijul Super Soluble (product)	4180186
35630907	Maxisorb (product)	4180186
35630908	Miraflow (product)	4180186
35630910	Multibionta 50+ Multivitamin	4180186
35630910	Multibionta 50+ Probiotic Multivitamin (product)	4180186
35630911	Nasciodine (product)	4180186
35630914	Nutramigen (product)	4180186
35630916	Nutrison (water)	4180186
35630916	Nutrison (water) (product)	4180186
35630917	Nutrison Soya Multi Fibre (product)	4180186
35630918	Nuvelle (product)	4180186
35630919	Osmolite (product)	4180186
35630920	Pepdite (product)	4180186
35630925	Sondalis ISO (product)	4180186
35630926	Vivioptal (qualifier value)	4180186
35630927	Survimed OPD (product)	4180186
35630929	TYR gel (product)	4180186
35630933	Vivioptal Junior	4180186
35630933	Vivioptal Junior (product)	4180186
35630935	XLEU Maxamaid	4180186
35630935	XLEU Maxamaid (product)	4180186
35630936	XLYS LOW TRY Maxamaid	4180186
35630936	XLYS LOW TRY Maxamaid (product)	4180186
35630937	XMTVI Analog (product)	4180186
35630938	XMTVI Maxamaid	4180186
35630938	XMTVI Maxamaid (product)	4180186
35630941	Iscador Qu c Cu (product)	4180186
35630942	Ivelip (product)	4180186
35630943	Jevity Promote (product)	4180186
35630945	Mezavant XL (product)	4180186
35630946	Mezolar Matrix (product)	4180186
35630948	Nobligan (product)	4180186
35630950	Nutramigen AA LIPIL (product)	4180186
35630950	Nutramigen PurAmino	4180186
35630951	Nutrini Multifibre (product)	4180186
35630952	Nutrison 1000 Complete Multi Fibre (product)	4180186
35630953	Nutrison Concentrated (product)	4180186
35630954	Orgran (product)	4180186
35630956	Paediasure (product)	4180186
35630957	Paediasure Plus (product)	4180186
35630959	Plasma-lyte M (product)	4180186
35630960	Polial (product)	4180186
35630961	Pork Insulatard (product)	4180186
35630962	Pork Mixtard 30 (product)	4180186
35630964	Refresh Instant Revival (product)	4180186
35630966	Remegel Wind Relief (product)	4180186
35630968	Resource Fruit Flavour Drink (product)	4180186
35630974	Synthamin 17 without electrolytes (product)	4180186
35630977	Vamin 9 Glucose (product)	4180186
35630978	VitaBite (product)	4180186
35630983	Kabiven Peripheral (product)	4180186
35630984	Litak (product)	4180186
35630986	Logynon (product)	4180186
35630988	Milupa Prejomin (product)	4180186
35630989	Natecal (product)	4180186
35630993	Nutrini Low Energy Multifibre (product)	4180186
35630994	Nutrison 1200 Complete Multi Fibre (product)	4180186
35630995	Nutrison Multi Fibre (product)	4180186
35630997	Pork Actrapid (product)	4180186
35630998	Pregestimil LIPIL	4180186
35630998	Pregestimil (product)	4180186
35630999	Prothromplex TIM 4 (product)	4180186
35631002	ProMod (product)	4180186
35631003	Resource Protein (product)	4180186
35631005	Smartset GHV Gentamicin (product)	4180186
35631008	Synthamin 17 (product)	4180186
35631009	TYR cooler (product)	4180186
35631012	XP Maxamum (product)	4180186
35631016	Iscador Qu (product)	4180186
35631017	Iscador Qu c Hg (product)	4180186
35631018	Kamillosan (product)	4180186
35631019	Kogenate (product)	4180186
35631021	Liga (product)	4180186
35631026	Lythrin (product)	4180186
35631028	Nutrineal PD4 (product)	4180186
35631030	Nutrison Soya (product)	4180186
35631031	Osmach (product)	4180186
35631032	Pabrinex Intramuscular High Potency (product)	4180186
35631034	Plasma-lyte 148 (product)	4180186
35631035	Prosobee (product)	4180186
35631037	SLO Drink 1 (product)	4180186
35631039	Vitaquick (product)	4180186
35631040	Nutrison (qualifier value)	4180186
35631041	Viteyes Original Formula Plus Lutein (product)	4180186
35631044	XP Maxamaid (product)	4180186
35631045	KetoCal (product)	4180186
35631047	K-Y (product)	4180186
35631048	LiquiBand (product)	4180186
35631049	Locasol (product)	4180186
35631051	Lyclear SprayAway (product)	4180186
35631052	Mapleflex	4180186
35631052	Mapleflex (product)	4180186
35631055	Moviprep (product)	4180186
35631057	Multibionta Probiotic Multivitamin (product)	4180186
35631058	NicoBloc (product)	4180186
35631066	SST - brand name (product)	4180186
35631068	Tentrini Energy (product)	4180186
35631069	Thymoglobulin (product)	4180186
35631070	Vamin 18 Electrolyte-Free (product)	4180186
35631072	XLYS Maxamaid	4180186
35631072	XLYS Maxamaid (product)	4180186
35631074	XPHEN TYR Maxamum	4180186
35631074	XPHEN TYR Maxamum (product)	4180186
35631076	Liquigen (product)	4180186
35631077	Loramyc (product)	4180186
35631081	Milupa LP	4180186
35631081	Milupa lpd (product)	4180186
35631083	Modjul (product)	4180186
35631084	Moducare (product)	4180186
35631086	Natravene (product)	4180186
35631087	Neocate Active (product)	4180186
35631088	Nephro-Vite (product)	4180186
35631091	Pabrinex Intravenous High Potency No.2 (product)	4180186
35631092	Pepti-Junior	4180186
35631092	Pepti-Junior (product)	4180186
35631095	Renamil (product)	4180186
35631097	Resource Dessert Fruit (product)	4180186
35631098	Rimso-50 (product)	4180186
35631102	Stressless (product)	4180186
35631104	TachoSil (product)	4180186
35631105	Tasigna (product)	4180186
35631108	Vamin 14 Electrolyte-Free (product)	4180186
35631109	Vivioptal Plus (product)	4180186
35631110	XLYS LOW TRY Analog (product)	4180186
35631111	XMET Homidon (product)	4180186
35631114	Pabrinex (qualifier value)	4180186
35631115	Resource (qualifier value)	4180186
35631116	XMET (qualifier value)	4180186
35631119	Milupa (qualifier value)	4180186
35631122	Multibionta (qualifier value)	4180186
35631124	Nutramigen (qualifier value)	4180186
35631127	Uniflu (qualifier value)	4180186
35631130	Lipofundin (qualifier value)	4180186
35631132	Paediasure (qualifier value)	4180186
35631135	Respiflo (qualifier value)	4180186
35631137	Iscador (qualifier value)	4180186
35631143	Refresh (qualifier value)	4180186
35631144	ReQuip (qualifier value)	4180186
35631145	Sondalis (qualifier value)	4180186
35631146	Synthamin (qualifier value)	4180186
35631147	Vamin (qualifier value)	4180186
35631148	XLYS (qualifier value)	4180186
35631149	XP - brand group (qualifier value)	4180186
35631150	Moviprep (qualifier value)	4180186
35631151	NuTRIflex (qualifier value)	4180186
35631153	Remegel (qualifier value)	4180186
35631154	SLO Drink (qualifier value)	4180186
35631155	Monosol (qualifier value)	4180186
35631158	Viteyes (qualifier value)	4180186
35631159	Prune (qualifier value)	4180186
35631160	E45 emollient shower (product)	4180186
35631161	Actilite (product)	4180186
35631165	Anbesol Adult (product)	4180186
35631166	AOSept (product)	4180186
35631167	Benefiber (product)	4180186
35631168	Bioflex (product)	4180186
35631172	Bonjela (product)	4180186
35631174	Calcichew D3 Forte (product)	4180186
35631175	Centrum Performance (product)	4180186
35631177	CMW 2000 Gentamicin (product)	4180186
35631180	Debrisan (product)	4180186
35631181	Dermablend cover (product)	4180186
35631182	Dermablend Reflections (product)	4180186
35631184	DermaSalve body (product)	4180186
35631185	DermaSalve face (product)	4180186
35631189	Femoston 2/10 (product)	4180186
35631190	Fentalis (product)	4180186
35631199	CUI (INT) Ltd (qualifier value)	4180186
35631204	E45 Itch Relief (product)	4180186
35631206	Endurance (product)	4180186
35631209	Ensure Plus Fibre (product)	4180186
35631212	Atkinsons & Barkers (product)	4180186
35631213	Beconase (product)	4180186
35631216	Benadryl Skin Allergy Relief (product)	4180186
35631220	Clinutren Mix Plus Fibre (product)	4180186
35631221	CMW 2 (product)	4180186
35631222	Dentinox Infant (product)	4180186
35631224	Dioralyte (product)	4180186
35631225	Dispello (product)	4180186
35631228	Femmeherb sweet dreams (product)	4180186
35631229	FemSeven Sequi (product)	4180186
35631230	Forticare (product)	4180186
35631231	Forticreme (product)	4180186
35631233	Frebini Original (product)	4180186
35631236	Galsud Decongestant (product)	4180186
35631239	Couvrance (product)	4180186
35631241	HCU-LV (product)	4180186
35631242	Herbalhypnos (product)	4180186
35631243	Lanacane (product)	4180186
35631244	Vitasavoury (product)	4180186
35631246	Dulcolax	4180186
35631246	Dulco-Lax (bisacodyl) (product)	4180186
35631249	Energivit (product)	4180186
35631251	Anadin Original (product)	4180186
35631253	Chymol (product)	4180186
35631254	Clarityn (Sodium cromoglicate) (product)	4180186
35631255	Clinutren ISO (product)	4180186
35631259	Dermablend compact (product)	4180186
35631260	Dermablend hydrating complex (product)	4180186
35631261	Dermablend Quick Fix (product)	4180186
35631262	Dermacolor cleansing (product)	4180186
35631264	Dietade (product)	4180186
35631265	Entonox (product)	4180186
35631267	Erysidoron (product)	4180186
35631268	Estracombi TTS (product)	4180186
35631270	Femmeherb cystaid (product)	4180186
35631271	Fermathron (product)	4180186
35631278	Inadine (product)	4180186
35631284	Joint-Flex GlucOsamine and Chondroitin (product)	4180186
35631285	Mesitran (product)	4180186
35631287	Duocal Super Soluble (product)	4180186
35631288	easySEPT (product)	4180186
35631289	Anadin Ibuprofen (product)	4180186
35631293	Caprilon (product)	4180186
35631294	Citanest with Octapressin (product)	4180186
35631296	Clivers (product)	4180186
35631298	Colgate Chlorohex (product)	4180186
35631299	Complan Shake (product)	4180186
35631300	Complete (product)	4180186
35631301	Cystadane (product)	4180186
35631302	Dentinox Cradle Cap (product)	4180186
35631303	Dermacolor camouflage (product)	4180186
35631304	Dermacolor fixing (product)	4180186
35631306	Evorel (product)	4180186
35631308	Farley's Soya (product)	4180186
35631310	Fortini Multifibre	4180186
35631310	Fortini Multifibre (product)	4180186
35631311	Fortisip Savoury Multi Fibre (product)	4180186
35631312	Fresubin Energy Fibre (product)	4180186
35631313	Entrolax Constipation Relief (product)	4180186
35631314	Gentafix 1 (product)	4180186
35631315	Gentafix 3 (product)	4180186
35631316	Haliborange Multivitamins Plus Calcium & Iron (product)	4180186
35631321	Icthaband (product)	4180186
35631327	Rennie Liquid Relief	4180186
35631327	Rennie Liquid Relief (product)	4180186
35631329	Ecalta (product)	4180186
35631332	Enrich (product)	4180186
35631333	Ensure Plus Commence (product)	4180186
35631334	Ensure Plus yoghurt style (product)	4180186
35631336	Add Ins (product)	4180186
35631337	Formula VM2000 (product)	4180186
35631339	Adult Meltus Chesty Coughs (product)	4180186
35631341	Adult Meltus for Dry Coughs with Congestion (product)	4180186
35631342	Ambre Solaire Total screen (product)	4180186
35631343	BioBag (product)	4180186
35631347	CMW 2000 (product)	4180186
35631349	Dermablend setting powder (product)	4180186
35631350	Dermacolor Effectiv (product)	4180186
35631351	DermaSalve baby & infant (product)	4180186
35631352	DermaSalve foot & heel (product)	4180186
35631353	Dinneford's (product)	4180186
35631357	Femoston 1/10 (product)	4180186
35631359	Fortisip Multi Fibre (product)	4180186
35631360	Fresubin 2kcal Fibre (product)	4180186
35631363	Haliborange Halibonbons (product)	4180186
35631365	Hypaque (product)	4180186
35631366	Imuderm Therapeutic (product)	4180186
35631370	Disprin Extra (product)	4180186
35631372	Duobar (product)	4180186
35631374	Emsogen (product)	4180186
35631375	Enfamil AR (product)	4180186
35631376	Enfamil Lactofree	4180186
35631376	Enfamil Lactofree (product)	4180186
35631377	Baby Meltus (product)	4180186
35631378	Benadryl Allergy Relief Plus Decongestant	4180186
35631378	Benadryl Plus (product)	4180186
35631379	bicaVera (product)	4180186
35631380	Bonjela Teething (product)	4180186
35631381	Botanics Tea Tree (product)	4180186
35631383	Calogen (product)	4180186
35631384	Cathejell Mono (product)	4180186
35631385	Clinimix N14G30E (product)	4180186
35631387	CMW 1 Original (product)	4180186
35631388	CMW 3 Gentamicin (product)	4180186
35631391	Combudoron (product)	4180186
35631393	Dermablend leg & body (product)	4180186
35631395	DermaSalve hand (product)	4180186
35631398	Dermatodoron (product)	4180186
35631400	Epiglu (product)	4180186
35631404	Fedril Paediatric (product)	4180186
35631405	Femmeherb (product)	4180186
35631406	Femmeherb slim aid (product)	4180186
35631407	Flagyl Compak (product)	4180186
35631408	Focus Aqua (product)	4180186
35631409	Fortijuce (product)	4180186
35631413	Fuzatal XL (product)	4180186
35631416	Hyperamine (product)	4180186
35631417	Iscador M c Cu (product)	4180186
35631419	Isopto Frin (product)	4180186
35631420	Rennie (product)	4180186
35631422	E45 Lipcare (product)	4180186
35631424	E45 Sun moisturising (product)	4180186
35631425	Emollin (product)	4180186
35631427	Ensure Plus (product)	4180186
35631431	Algicon chewable (product)	4180186
35631433	Anadin Joint Pain (product)	4180186
35631439	Caltrate Plus (product)	4180186
35631441	Circadin (product)	4180186
35631444	CMW 2 Gentamicin (product)	4180186
35631450	Dermacolor body (product)	4180186
35631451	Dextro Energy (product)	4180186
35631454	Dimotane Co (product)	4180186
35631455	Eumocream (product)	4180186
35631457	E-Z-Paque (product)	4180186
35631458	Farlutal (product)	4180186
35631459	Fortini (product)	4180186
35631460	Fortisip (product)	4180186
35631464	Frebini Original Fibre (product)	4180186
35631468	Galloway's (product)	4180186
35631470	Herbalache (product)	4180186
35631473	Inovelon (product)	4180186
35631474	Iscador M c Arg (product)	4180186
35631476	Eugynon 50 (product)	4180186
35631478	E45 emollient bath (product)	4180186
35631479	E45 Foot & Heel (product)	4180186
35631484	Adult Meltus Night Time (product)	4180186
35631490	Clarityn (Loratadine) (product)	4180186
35631492	Complete Blink-N-Clean (product)	4180186
35631493	Decan (product)	4180186
35631494	Deep Freeze (product)	4180186
35631496	Dermablend matte and shimmer (product)	4180186
35631497	Dianeal PD1 (product)	4180186
35631499	Dimotane Plus (product)	4180186
35631500	Entrocalm Heartburn and Indigestion Relief (product)	4180186
35631503	Foodlink Complete (product)	4180186
35631504	Formance (product)	4180186
35631505	Forticreme Complete dessert (product)	4180186
35631507	Fostair (product)	4180186
35631508	Fresubin 1200 (product)	4180186
35631509	Fresubin Original Fibre (product)	4180186
35631513	Endurance (qualifier value)	4180186
35631517	Impact with Glutamine (product)	4180186
35631518	Infasoy (product)	4180186
35631520	Intrafusin 22 (product)	4180186
35631523	Ecostatin (qualifier value)	4180186
35631524	Anbesol (qualifier value)	4180186
35631525	Bonjela (qualifier value)	4180186
35631529	Eugynon (qualifier value)	4180186
35631533	Anadin (qualifier value)	4180186
35631535	Covermark (qualifier value)	4180186
35631536	Dioralyte (qualifier value)	4180186
35631538	Fresubin (qualifier value)	4180186
35631540	Lanacane (qualifier value)	4180186
35631541	Enfamil (qualifier value)	4180186
35631542	Benadryl (qualifier value)	4180186
35631543	CalCough (qualifier value)	4180186
35631544	Clinutren (qualifier value)	4180186
35631545	Gentafix (qualifier value)	4180186
35631546	HCU (qualifier value)	4180186
35631547	Jointflex	4180186
35631547	Joint-Flex (qualifier value)	4180186
35631551	Complete - Trade Family Group (qualifier value)	4180186
35631553	Focus (qualifier value)	4180186
35631556	Meltus (qualifier value)	4180186
35631560	Ambre Solaire (qualifier value)	4180186
35631565	Galsud (qualifier value)	4180186
35631568	Centrum (qualifier value)	4180186
35631569	Dentinox (qualifier value)	4180186
35631572	Fortini (qualifier value)	4180186
35631576	Clarityn (qualifier value)	4180186
35631577	Deep Freeze (qualifier value)	4180186
35631578	Dermablend (qualifier value)	4180186
35631579	Haliborange (qualifier value)	4180186
35631580	Impact (qualifier value)	4180186
35631581	Femodene (qualifier value)	4180186
35631582	Femoston (qualifier value)	4180186
35631584	Isopto (qualifier value)	4180186
35631585	Aluminium hydroxide gel	4180186
35631585	Aluminium hydroxide mixture BP	4180186
35631585	Aluminum hydroxide oral suspension BP (product)	4180186
35631586	Magnesium carbonate mixture BPC (product)	4180186
35631587	Aromatic magnesium carbonate mixture BP (product)	4180186
35631590	Peppermint oil BP 0.2mL e/c capsule (product)	4180186
35631591	Peppermint oil BP 0.2mL m/r gel e/c capsule (product)	4180186
35631592	Kaolin pediatric mixture BP (product)	4180186
35631593	Kaolin and morphine mixture BP (product)	4180186
35631594	Liquid paraffin oral emulsion BP (product)	4180186
35631595	Epsom Salts	4180186
35631595	Magnesium sulfate BP crystals (product)	4180186
35631597	Phosphates Formula B long tube enema BP (product)	4180186
35631598	Bismuth subgallate compound suppository BP (product)	4180186
35631599	Lugol's Iodine	4180186
35631599	Aqueous iodine 130mg/mL oral solution BP (product)	4180186
35631600	Sodium citrate mixture BPC (product)	4180186
35631601	Instrumentation Laboratory (UK) Ltd (qualifier value)	4180186
35631602	Ferrous sulfate 60mg/5mL pediatric oral solution BP (product)	4180186
35631603	Phenylalanine,tyrosine-free amino acid mix	4180186
35631603	XPT Tyrosidon mix (product)	4180186
35631604	Purified water BP (product)	4180186
35631605	Methyl salicylate liniment BP (product)	4180186
35631606	Methyl salicylate ointment BP (product)	4180186
35631608	White liniment BP (product)	4180186
35631609	Diethylamine salicylate 10% cream BP (product)	4180186
35631610	Olive oil BP (product)	4180186
35631611	Hydrogen peroxide 6%(20 volume) mouthwash BP (product)	4180186
35631613	Cetomacrogol emulsifying ointment BP (product)	4180186
35631614	Emulsifying ointment BP (product)	4180186
35631614	Emulsifying soap	4180186
35631614	Ung emuls - Ungentum emulsificans	4180186
35631615	Hydrous wool fat ointment BP (product)	4180186
35631616	Paraffin white soft BP (product)	4180186
35631616	White petroleum jelly	4180186
35631616	WSP - White soft paraffin	4180186
35631619	Zinc compound paste BP (product)	4180186
35631621	Dimethicone cream BPC (product)	4180186
35631621	Dimeticone 10% cream	4180186
35631622	Zinc 32% cream BP (product)	4180186
35631623	Zinc 15% ointment BP (product)	4180186
35631624	Zinc+castor oil cream BP	4180186
35631624	Zinc+castor oil ointment BP (product)	4180186
35631625	Talc dusting powder BP (product)	4180186
35631626	Zinc+starch+talc dusting powder BPC (product)	4180186
35631627	Promethazine hydrochloride (product)	4180186
35631630	Calamine 15% ointment BP (product)	4180186
35631633	Coal tar 7.5% paste BP (product)	4180186
35631634	Zinc+coal tar paste BP (product)	4180186
35631636	Coal tar 20% solution BP (product)	4180186
35631636	Liq picis carb	4180186
35631639	Lassar's paste	4180186
35631639	Zinc+salicylic acid paste BP (product)	4180186
35631641	Anthralin 0.1% paste BP (product)	4180186
35631641	Dithranol 0.1% paste BP	4180186
35631642	Sulfur+salicylic acid cream BP (product)	4180186
35631643	Sulfur+salicylic acid ointment BPC (product)	4180186
35631645	Salicylic acid collodion BP 12% (product)	4180186
35631646	Caustic pencil	4180186
35631646	Toughened silver nitrate BP 95% stick (product)	4180186
35631650	Chlorhexidine 5% cream BP (product)	4180186
35631653	Chlorinated soda surgical solution BPC (product)	4180186
35631653	Dakin's solution	4180186
35631655	Hydrogen peroxide 6%(20volume) solution BP (product)	4180186
35631657	Hydrogen peroxide 30%(100volume) solution BP (product)	4180186
35631658	Iodine weak solution BP (product)	4180186
35631659	Iodine strong solution BP (product)	4180186
35631661	Soft soap 65% spirit BP (product)	4180186
35631663	Zinc sulfate 1% lotion BP (product)	4180186
35631664	Solvent ether BP (product)	4180186
35631671	Plaster of Paris bandage BP (physical object)	4180186
35631672	Elastic adhesive tape BP (physical object)	4180186
35631673	Permeable woven synthetic adhesive tape BP (physical object)	4180186
35631674	Permeable non-woven synthetic adhesive tape BP (physical object)	4180186
35631675	Zinc oxide adhesive tape BP (physical object)	4180186
35631677	Animal wool BP (physical object)	4180186
35631677	Lambs' wool for chiropody BP	4180186
35631678	Strong ammonia solution BP (physical object)	4180186
35631681	Industrial methylated spirit BP 99%(74OP) (product)	4180186
35631683	Cetrimide 0.5% cream BP (product)	4180186
35631688	Absorbent lint BP (physical object)	4180186
35631690	Elasticated tubular bandage BP (physical object)	4180186
35631691	Sodium phosphate[32P]74MBq/mL injection BP (product)	4180186
35631693	Sodium chromate[51Cr] 37MBq/mL sterile solution BP (product)	4180186
35631695	Ferric citrate[59Fe] 3.7MBq/mL injection BP (product)	4180186
35631696	Iodinated[125I] human albumin 1.85MBq/mL injection BP (product)	4180186
35631700	Absolute alcohol injection solution ampoule	4180186
35631700	Dehydrated alcohol BP injection solution ampule (product)	4180186
35631702	Knitted viscose primary dressing BP type 1-14.5cm x 12.5cm (physical object)	4180186
35631704	Knitted viscose primary dressing BP type 1-9.5cm x 9.5cm (physical object)	4180186
35631706	Absorbable sutures sterile catgut chromic BP 3.5gauge, 75cm (physical object)	4180186
35631707	Cotton conforming bandage BP 1988 type A 5cm (physical object)	4180186
35631708	Zinc paste 15% and Ichthammol 2% bandage BP 7.5cm (physical object)	4180186
35631711	Cotton conforming bandage BP 1988 type A 15cm (physical object)	4180186
35631712	Cotton conforming bandage BP 1988 type B 10cm (physical object)	4180186
35631713	Cotton conforming bandage BP 1988 type B 15cm (physical object)	4180186
35631716	Cotton crepe bandage BP 1988 10cm (physical object)	4180186
35631718	Cotton stretch bandage BP 1988 10cm (physical object)	4180186
35631721	Cotton stretch bandage BP 1988 7.5cm (physical object)	4180186
35631722	Crepe bandage BP 1988 10cm (physical object)	4180186
35631724	Crepe bandage BP 1988 5cm (physical object)	4180186
35631725	Crepe bandage BP 1988 7.5cm (physical object)	4180186
35631728	Elastic adhesive bandage BP 7.5cm (physical object)	4180186
35631730	Elastic web bandage BP blue line 10cm (physical object)	4180186
35631733	Zinc paste 15% bandage BP 7.5cm (physical object)	4180186
35631737	Open-wove Type 1 bandage BP (physical object)	4180186
35631739	Belladona adhesive plaster BP 1980 19cm x 12.5cm (physical object)	4180186
35631740	Belladona adhesive plaster BP 1980 28cm x 17.5cm (physical object)	4180186
35631741	Technetium[99mTc] etifenin injection BP (product)	4180186
35631745	Technetium[99mTc] pentetate injection BP (product)	4180186
35631749	Technetium[99mTc] medronate injection BP (product)	4180186
35631751	Dehydrated alcohol BP injection solution 2 mL ampule (product)	4180186
35631754	MCT Pepdite 1+ (product)	4180186
35631755	Microgynon 30 ED (product)	4180186
35631756	MSUD express (product)	4180186
35631757	MSUD Maxamaid (product)	4180186
35631758	Multi-Action Actifed Chesty Coughs (product)	4180186
35631759	Nirolex Chesty Coughs with Decongestant (product)	4180186
35631760	Nirolex Dry Cough (product)	4180186
35631761	Nirolex Night Cold and Flu (product)	4180186
35631762	Vicks Vaposyrup for Chesty Coughs (product)	4180186
35631763	Junior Meltus Dry Coughs with Congestion (product)	4180186
35631764	Lockets Medicated (product)	4180186
35631765	MSUD Aid (product)	4180186
35631767	Neutrogena foot (product)	4180186
35631767	Neutrogena foot	4180186
35631768	Neutrogena Norwegian Formula (product)	4180186
35631770	Original Andrews Salts (product)	4180186
35631771	Original Cabdrivers (product)	4180186
35631774	Sudafed Non-Drowsy Congestion Cold and Flu (product)	4180186
35631781	MCT step 1 (product)	4180186
35631783	Neocate LCP (product)	4180186
35631786	Vicks Sinex (product)	4180186
35631789	Multi-Action Actifed Dry Coughs (product)	4180186
35631790	Nirolex Night Time Coughs (product)	4180186
35631791	Ostex Plus (product)	4180186
35631792	Savlon Bites & Stings (product)	4180186
35631793	Savlon disinfectant (product)	4180186
35631794	Sudafed Non-Drowsy inhalant (product)	4180186
35631795	Thick & Easy (product)	4180186
35631797	MSUD express cooler	4180186
35631797	MSUD express cooler (product)	4180186
35631798	Setlers Heartburn (product)	4180186
35631802	SanoSkin Melladerm Plus	4180186
35631802	SanoSkin Melladerm Plus (product)	4180186
35631806	Sofra-tulle (product)	4180186
35631807	Sudafed Non-Drowsy Children's (product)	4180186
35631808	Uvistat lipscreen (product)	4180186
35631809	Neutrogena T/Gel shampoo for dry (product)	4180186
35631812	SanoSkin Melladerm	4180186
35631812	SanoSkin Melladerm (product)	4180186
35631813	VSL#3 (product)	4180186
35631814	PreserVision (qualifier value)	4180186
35631817	Micardis (qualifier value)	4180186
35631819	Actifed (qualifier value)	4180186
35631819	Multi-Action Actifed	4180186
35631821	Microgynon (qualifier value)	4180186
35631824	Premique (qualifier value)	4180186
35631825	Melladerm	4180186
35631825	SanoSkin Melladerm (qualifier value)	4180186
35631828	Mycamine (product)	4180186
35631831	Doxzogen XL (product)	4180186
35631833	Octenisan (product)	4180186
35631835	Eludril (product)	4180186
35631837	Opti-Free Express (product)	4180186
35631839	MSUD Maxamum (product)	4180186
35631840	Hc45 (product)	4180186
35631841	Fybogel Hi-Fibre (product)	4180186
35631844	Mixtard 20 NovoLet (product)	4180186
35631845	Human Mixtard 50 (product)	4180186
35631846	Penlan Medical Ltd (qualifier value)	4180186
35631847	Somex Pharma (qualifier value)	4180186
35631848	Wellfoods Limited (qualifier value)	4180186
35631852	koGEN Limited (qualifier value)	4180186
35631857	Linde Gas UK Ltd (qualifier value)	4180186
35631860	Peptamen Junior (product)	4180186
35631871	Zestoretic (qualifier value)	4180186
35631872	Derma+Flex (product)	4180186
35631879	MucoClear (product)	4180186
35631881	Cymex Ultra (product)	4180186
35631885	Vimpat (product)	4180186
35631887	LMX 4 (product)	4180186
35631888	Ionsys (product)	4180186
35631889	Siklos (product)	4180186
35631897	Sideromal (product)	4180186
35631902	Sudafed Day & Night (product)	4180186
35631904	Tyvera (product)	4180186
35631906	Ice (qualifier value)	4180186
35631908	Varbim XL (product)	4180186
35631909	Zerolatum (product)	4180186
35631911	Clamelle (product)	4180186
35631912	Lozamine (product)	4180186
35631914	Carexil (product)	4180186
35631915	Optive (product)	4180186
35631916	Relactagel (product)	4180186
35631917	Ocusan (product)	4180186
35631919	Full Marks (Phenothrin) (product)	4180186
35631920	Full Marks (qualifier value)	4180186
35631923	Trixat XL (product)	4180186
35631926	Winfex XL (product)	4180186
35631928	Rodomel XL (product)	4180186
35631929	Abstral (product)	4180186
35631930	Fresubin 2250 (product)	4180186
35631933	Blink Intensive (product)	4180186
35631934	Blink (qualifier value)	4180186
35631935	Hyabak (product)	4180186
35631936	Fucidin H (Fusidic acid / Hydrocortisone) (product)	4180186
35631937	Fucidin H (Hydrocortisone / Sodium fusidate) (product)	4180186
35631938	Fucidin (Fusidic acid) (product)	4180186
35631940	Ultralanum Plain (Fluocortolone hexanoate / Fluocortolone pivalate) (product)	4180186
35631941	Ultralanum (qualifier value)	4180186
35631943	Clopixol (Zuclopenthixol decanoate) (product)	4180186
35631946	Joint-Flex (Glucosamine sulphate) (product)	4180186
35631950	Depixol (qualifier value)	4180186
35631952	Epanutin (Phenytoin) (product)	4180186
35631953	Epanutin (Phenytoin sodium) (product)	4180186
35631954	Welldorm (Chloral hydrate) (product)	4180186
35631955	Welldorm (Cloral betaine) (product)	4180186
35631956	Orbifen Cold & Flu (product)	4180186
35631959	Brolene (Dibrompropamidine) (product)	4180186
35631962	Ortisan Fruit (product)	4180186
35631968	ViePax (product)	4180186
35631970	ViePax (qualifier value)	4180186
35631975	Dosage form qualifier (qualifier value)	4180186
35631976	Modified release dosage form	4180186
35631976	Modified release dosage form (qualifier value)	4180186
35631979	Nebuliser administered dose form	4180186
35631979	Nebuliser administered dose form (qualifier value)	4180186
35631980	24-hour modified-release dosage form	4180186
35631980	24-hour modified-release dosage form (qualifier value)	4180186
35631986	Vaxalin XL (product)	4180186
35631987	Firazyr (product)	4180186
35631988	Avamys (product)	4180186
35631991	SNOMED CT UK drug extension reference set module	4180186
35631991	SNOMED CT United Kingdom drug extension reference set module (core metadata concept)	4180186
35631994	ePrescribing route of administration simple reference set (foundation metadata concept)	4180186
35631998	ePrescribing creams, ointments and gels type 6b simple reference set (foundation metadata concept)	4180186
35631999	ePrescribing dressings type 14a simple reference set (foundation metadata concept)	4180186
35632001	ePrescribing dry powder inhaler marked modifier simple reference set (foundation metadata concept)	4180186
35632004	ePrescribing enemas and rectal solutions type 7b simple reference set (foundation metadata concept)	4180186
35632005	ePrescribing enteral feeds type 8 simple reference set (foundation metadata concept)	4180186
35632006	ePrescribing eye, ear and nose liquids and powders type 4 simple reference set (foundation metadata concept)	4180186
35632007	ePrescribing foams type 28 simple reference set (foundation metadata concept)	4180186
35632009	ePrescribing gases type 25b simple reference set (foundation metadata concept)	4180186
35632010	ePrescribing granules and powders type 9a simple reference set (foundation metadata concept)	4180186
35632011	ePrescribing granules and powders type 9b simple reference set (foundation metadata concept)	4180186
35632012	ePrescribing implants and sticks type 15 simple reference set (foundation metadata concept)	4180186
35632014	ePrescribing infusions type 22b simple reference set (foundation metadata concept)	4180186
35632017	ePrescribing instillations type 29a simple reference set (foundation metadata concept)	4180186
35632019	ePrescribing insulin type 21 simple reference set (foundation metadata concept)	4180186
35632022	ePrescribing multi-ingredient rule 1 simple reference set (foundation metadata concept)	4180186
35632024	ePrescribing nebuliser liquids type 13b simple reference set (foundation metadata concept)	4180186
35632024	ePrescribing nebulizer liquids type 13b simple reference set	4180186
35632026	ePrescribing not recommended to prescribe as virtual medicinal product bio-availability rule 5a simple reference set (foundation metadata concept)	4180186
35632026	ePrescribing not recommended to prescribe as VMP (virtual medicinal product) bio-availability rule 5a simple reference set	4180186
35632029	ePrescribing oral liquids type 2a1 simple reference set (foundation metadata concept)	4180186
35632030	ePrescribing oral liquids type 2b simple reference set (foundation metadata concept)	4180186
35632031	ePrescribing oral solids type 1 simple reference set (foundation metadata concept)	4180186
35632032	ePrescribing controlled drugs schedule 1 to 3 rule 6 simple reference set (foundation metadata concept)	4180186
35632033	ePrescribing suppositories and pessaries type 10 simple reference set (foundation metadata concept)	4180186
35632034	ePrescribing topical liquids type 5a simple reference set (foundation metadata concept)	4180186
35632035	ePrescribing topical liquids type 5b simple reference set (foundation metadata concept)	4180186
35632038	ePrescribing total parenteral nutrition type 23 simple reference set (foundation metadata concept)	4180186
35632038	ePrescribing TPN (total parenteral nutrition) type 23 simple reference set	4180186
35632040	ePrescribing modified release 24 hour marked modifier simple reference set (foundation metadata concept)	4180186
35632044	National Health Service dictionary of medicines and devices actual medicinal product pack simple reference set (foundation metadata concept)	4180186
35632044	NHS dm+d (dictionary of medicines and devices) AMPP (actual medicinal product pack) simple reference set	4180186
35632047	National Health Service dictionary of medicines and devices virtual therapeutic moiety simple reference set (foundation metadata concept)	4180186
35632047	NHS dm+d (dictionary of medicines and devices) VTM (virtual therapeutic moiety) simple reference set	4180186
35632048	National Health Service dictionary of medicines and devices parallel import simple reference set (foundation metadata concept)	4180186
35632048	NHS dm+d (dictionary of medicines and devices) parallel import simple reference set	4180186
35632049	National Health Service dictionary of medicines and devices sugar free simple reference set (foundation metadata concept)	4180186
35632049	NHS dm+d (dictionary of medicines and devices) sugar free simple reference set	4180186
35632050	National Health Service dictionary of medicines and devices gluten free simple reference set	4180186
35632050	National Health Service dictionary of medicines and devices gluten free simple reference set (foundation metadata concept)	4180186
35632051	National Health Service dictionary of medicines and devices preservative free simple reference set (foundation metadata concept)	4180186
35632051	NHS dm+d (dictionary of medicines and devices) preservative free simple reference set	4180186
35632053	National Health Service dictionary of medicines and devices trade family group simple reference set (foundation metadata concept)	4180186
35632053	NHS dm+d (dictionary of medicines and devices) TFG (trade family group) simple reference set	4180186
35632054	National Health Service dictionary of medicines and devices chlorofluorocarbon free simple reference set (foundation metadata concept)	4180186
35632054	NHS dm+d (dictionary of medicines and devices) CFC (chlorofluorocarbon) free simple reference set	4180186
35632055	National Health Service dictionary of medicines and devices European Medicines Agency additional monitoring (Black Triangle) medicines list simple reference set (foundation metadata concept)	4180186
35632055	NHS dm+d (dictionary of medicines and devices) EMA (European Medicines Agency) additional monitoring (Black Triangle) medicines list simple reference set	4180186
35632058	National Health Service realm language reference set (pharmacy part) (foundation metadata concept)	4180186
35632058	NHS realm language reference set (pharmacy part)	4180186
35632060	Had virtual medicinal product association reference set (foundation metadata concept)	4180186
35632060	Had VMP (virtual medicinal product) association reference set	4180186
35632064	Allergy Archetypes Drug Groups simple reference set (foundation metadata concept)	4180186
35632066	Enhanced services general practice extraction - Meningococcal B vaccines simple reference set (foundation metadata concept)	4180186
35632067	Enhanced services general practice extraction - Pneumococcal vaccines simple reference set (foundation metadata concept)	4180186
35632069	Enhanced services general practice extraction - Immunosuppressant drugs simple reference set (foundation metadata concept)	4180186
35632072	Enhanced services general practice extraction - Seasonal Flu injectable vaccines simple reference set (foundation metadata concept)	4180186
35632075	National Diabetes Audit general practice extraction - Metformin simple reference set (foundation metadata concept)	4180186
35632076	National Diabetes Audit and National Health Service Health Checks general practice extraction - antihypertensive medication simple reference set (foundation metadata concept)	4180186
35632077	Enhanced services general practice extraction - Antipsychotic drugs simple reference set (foundation metadata concept)	4180186
35632078	QOF (Quality and Outcomes Framework) general practice extraction - Drug Tariff appliance intra-uterine contraceptive devices prescribable within general practice simple reference set	4180186
35632078	Quality and Outcomes Framework general practice extraction - Drug Tariff appliance intra-uterine contraceptive devices prescribable within general practice simple reference set (foundation metadata concept)	4180186
35632085	Sexual health source of attendance simple reference set (foundation metadata concept)	4180186
35632087	Podiatric diagnostic procedures simple reference set (foundation metadata concept)	4180186
35632090	National Cancer Registration and Analysis Service histopathology reporting - CLUSTER 1A Malignant diagnosis simple reference set (foundation metadata concept)	4180186
35632092	National Cancer Registration and Analysis Service histopathology reporting - CLUSTER 1C Uncertain diagnosis simple reference set (foundation metadata concept)	4180186
35632093	National Cancer Registration and Analysis Service histopathology reporting - CLUSTER 1D Central nervous system neoplasms diagnosis simple reference set (foundation metadata concept)	4180186
35632094	National Cancer Registration and Analysis Service histopathology reporting - CLUSTER 2 Benign neoplasms diagnosis simple reference set (foundation metadata concept)	4180186
35632097	Histopathology specimen morphology findings simple reference set (foundation metadata concept)	4180186
35632099	General practice summary data sharing exclusion for termination of pregnancy simple reference set (foundation metadata concept)	4180186
35632100	General practice summary data sharing exclusion for assisted fertilisation simple reference set (foundation metadata concept)	4180186
35632101	General practice summary data sharing exclusion for sexually transmitted disease simple reference set (foundation metadata concept)	4180186
35632102	Bio-Health Ltd (qualifier value)	4180186
35632103	Structure of left suprarenal artery	4180186
35632103	Structure of left adrenal artery (body structure)	4180186
35632106	Structure of right supraclavicular lymph node (body structure)	4180186
35632112	Distal interphalangeal joint of right little finger	4180186
35632112	Structure of distal interphalangeal joint of right little finger (body structure)	4180186
35632115	Distal interphalangeal joint of fourth digit of right hand	4180186
35632115	Distal interphalangeal joint of right ring finger	4180186
35632115	Structure of distal interphalangeal joint of right ring finger (body structure)	4180186
35632117	Structure of interphalangeal joint of left thumb (body structure)	4180186
35632117	Interphalangeal joint of left thumb	4180186
35632119	Structure of metacarpophalangeal joint of left index finger (body structure)	4180186
35632119	Metacarpophalangeal joint of left index finger	4180186
35632120	Structure of metacarpophalangeal joint of right index finger (body structure)	4180186
35632120	Metacarpophalangeal joint of right index finger	4180186
35632121	Structure of metacarpophalangeal joint of left thumb (body structure)	4180186
35632121	Metacarpophalangeal joint of left thumb	4180186
35632122	Structure of metacarpophalangeal joint of left little finger (body structure)	4180186
35632122	Metacarpophalangeal joint of left little finger	4180186
35632123	Structure of metacarpophalangeal joint of right little finger (body structure)	4180186
35632123	Metacarpophalangeal joint of right little finger	4180186
35632127	Structure of metacarpophalangeal joint of left ring finger (body structure)	4180186
35632127	Metacarpophalangeal joint of left ring finger	4180186
35632127	Metacarpophalangeal joint of fourth digit of left hand	4180186
35632130	Structure of metatarsophalangeal joint of right fourth toe (body structure)	4180186
35632130	Metatarsophalangeal joint of right fourth toe	4180186
35632131	Metatarsophalangeal joint of left second toe	4180186
35632131	Structure of metatarsophalangeal joint of left second toe (body structure)	4180186
35632134	Metatarsophalangeal joint of right third toe	4180186
35632134	Structure of metatarsophalangeal joint of right third toe (body structure)	4180186
35632135	Proximal interphalangeal joint of left index finger	4180186
35632135	Structure of proximal interphalangeal joint of left index finger (body structure)	4180186
35632136	Proximal interphalangeal joint of right index finger	4180186
35632136	Structure of proximal interphalangeal joint of right index finger (body structure)	4180186
35632137	Proximal interphalangeal joint of left little finger	4180186
35632137	Structure of proximal interphalangeal joint of left little finger (body structure)	4180186
35632137	Proximal interphalangeal joint of fifth digit of left hand	4180186
35632138	Proximal interphalangeal joint of fifth digit of right hand	4180186
35632138	Structure of proximal interphalangeal joint of right little finger (body structure)	4180186
35632138	Proximal interphalangeal joint of right little finger	4180186
35632139	Proximal interphalangeal joint of third digit of left hand	4180186
35632139	Proximal interphalangeal joint of left middle finger	4180186
35632139	Structure of proximal interphalangeal joint of left middle finger (body structure)	4180186
35632140	Proximal interphalangeal joint of right middle finger	4180186
35632140	Proximal interphalangeal joint of third digit of right hand	4180186
35632140	Structure of proximal interphalangeal joint of right middle finger (body structure)	4180186
35632141	Proximal interphalangeal joint of fourth digit of left hand	4180186
35632141	Proximal interphalangeal joint of left ring finger	4180186
35632141	Structure of proximal interphalangeal joint of left ring finger (body structure)	4180186
35632142	Proximal interphalangeal joint of fourth digit of right hand	4180186
35632142	Structure of proximal interphalangeal joint of right ring finger (body structure)	4180186
35632142	Proximal interphalangeal joint of right ring finger	4180186
35632143	Tarsometatarsal joint of left fifth toe	4180186
35632143	Tarsometatarsal joint of left little toe	4180186
35632143	Structure of tarsometatarsal joint of left fifth toe (body structure)	4180186
35632145	Structure of tarsometatarsal joint of left fourth toe (body structure)	4180186
35632145	Tarsometatarsal joint of left fourth toe	4180186
35632146	Tarsometatarsal joint of right fourth toe	4180186
35632146	Structure of tarsometatarsal joint of right fourth toe (body structure)	4180186
35632149	Structure of tarsometatarsal joint of left second toe (body structure)	4180186
35632149	Tarsometatarsal joint of left second toe	4180186
35632150	Tarsometatarsal joint of right second toe	4180186
35632150	Structure of tarsometatarsal joint of right second toe (body structure)	4180186
35632152	Tarsometatarsal joint of right third toe	4180186
35632152	Structure of tarsometatarsal joint of right third toe (body structure)	4180186
35632153	Bone structure of left lower limb (body structure)	4180186
35632154	Part of left fallopian tube (body structure)	4180186
35632156	Structure of left rhomboid muscle (body structure)	4180186
35632159	Structure of right rhomboid major muscle (body structure)	4180186
35632160	Structure of left rhomboid minor muscle (body structure)	4180186
35632161	Structure of right rhomboid minor muscle (body structure)	4180186
35632162	Structure of left common iliac vein (body structure)	4180186
35632162	Left common iliac vein	4180186
35632164	Structure of soft tissue of hand (body structure)	4180186
35632166	Structure of pars flaccida of left tympanic membrane (body structure)	4180186
35632168	Structure of left pinna (body structure)	4180186
35632168	Left auricle	4180186
35632170	Structure of left postauricular region (body structure)	4180186
35632174	Structure of left acoustic nerve	4180186
35632174	Structure of left vestibulocochlear nerve (body structure)	4180186
35632174	Structure of left eighth cranial nerve	4180186
35632175	Structure of right eighth cranial nerve	4180186
35632175	Structure of right vestibulocochlear nerve (body structure)	4180186
35632175	Structure of right acoustic nerve	4180186
35632176	Structure of articulations of auditory ossicles of left ear (body structure)	4180186
35632179	Structure of right mastoid bone (body structure)	4180186
35632180	Structure of lateral collateral ligament of left knee joint (body structure)	4180186
35632182	Entire left Achilles tendon (body structure)	4180186
35632185	Structure of capsule of right temporomandibular joint (body structure)	4180186
35632189	Structure of right iliac vein (body structure)	4180186
35632191	Structure of deep vein of right upper extremity (body structure)	4180186
35632195	Structure of wall of left subclavian artery (body structure)	4180186
35632197	Structure of left recessus epitympanicus structure (body structure)	4180186
35632197	Attic of left mastoid	4180186
35632198	Attic of right mastoid	4180186
35632198	Structure of right recessus epitympanicus structure (body structure)	4180186
35632202	Structure of bone of left ankle and/or foot (body structure)	4180186
35632203	Structure of soft tissues of right upper extremity (body structure)	4180186
35632207	Bone structure of right lower limb (body structure)	4180186
35632208	Structure of articular cartilage of right upper limb (body structure)	4180186
35632209	Structure of articular cartilage of left upper limb (body structure)	4180186
35632211	Bone structure of cuboid of right foot (body structure)	4180186
35632215	Periungual skin structure of right thumb	4180186
35632215	Periungual skin structure of right thumb (body structure)	4180186
35632215	Periungual skin of right thumb (body structure)	4180186
35632216	Structure of midcervical section of neck of left femur (body structure)	4180186
35632217	Structure of midcervical section of neck of right femur (body structure)	4180186
35632220	Structure of ligament of finger of left hand	4180186
35632220	Structure of ligament of finger of left hand (body structure)	4180186
35632220	Ligament of finger of left hand (body structure)	4180186
35632221	Structure of ligament of finger of right hand (body structure)	4180186
35632221	Structure of ligament of finger of right hand	4180186
35632221	Ligament of finger of right hand (body structure)	4180186
35632226	Structure of tip of finger of left hand	4180186
35632226	Structure of tip of finger of left hand (body structure)	4180186
35632226	Tip of finger of left hand (body structure)	4180186
35632228	Structure of condyle of left humerus (body structure)	4180186
35632229	Structure of condyle of right humerus (body structure)	4180186
35632231	Structure of anatomical neck of right humerus (body structure)	4180186
35632233	Structure of epiphyseal plate of distal right humerus (body structure)	4180186
35632238	Structure of head of left radius (body structure)	4180186
35632240	Structure of ligament of left acromioclavicular joint (body structure)	4180186
35632243	Bone structure of shaft of metacarpal of right hand (body structure)	4180186
35632244	Structure of shaft of first metacarpal bone of right hand (body structure)	4180186
35632245	Structure of shaft of first metacarpal bone of left hand (body structure)	4180186
35632248	Structure of ligament of left distal tibiofibular joint (body structure)	4180186
35632250	Structure of deep vein of left thigh (body structure)	4180186
35632252	Structure of median nerve at right wrist region (body structure)	4180186
35632252	Structure of median nerve at right wrist region	4180186
35632252	Median nerve at right wrist (body structure)	4180186
35632253	Structure of median nerve of left wrist region	4180186
35632253	Structure of median nerve of left wrist region (body structure)	4180186
35632253	Median nerve at left wrist (body structure)	4180186
35632254	Skeletal muscle structure of right lower leg (body structure)	4180186
35632260	Bone structure of distal left femur (body structure)	4180186
35632262	Bone structure of intermediate cuneiform of left foot (body structure)	4180186
35632267	Skin of part of right lower limb (body structure)	4180186
35632268	Structure of apophysis of greater trochanter of femur	4180186
35632268	Structure of greater trochanteric apophysis of femur (body structure)	4180186
35632268	Structure of greater trochanteric apophysis of femur	4180186
35632270	Structure of epiphyseal plate of distal left fibula (body structure)	4180186
35632272	Structure of tendon of muscle of left forearm (body structure)	4180186
35632272	Tendon of muscle of left forearm	4180186
35632275	Structure of fascia of right hand (body structure)	4180186
35632277	Structure of muscle of right forearm (body structure)	4180186
35632281	Structure of tendon of right gluteal region (body structure)	4180186
35632281	Structure of tendon within right gluteal region (body structure)	4180186
35632281	Structure of tendon within right gluteal region	4180186
35632283	Structure of sesamoid bone of right foot (body structure)	4180186
35632286	Structure of epiphyseal plate of phalanx of left thumb (body structure)	4180186
35632288	Structure of ligament of left foot (body structure)	4180186
35632289	Structure of ligament of right foot (body structure)	4180186
35632290	Structure of apophysis of medial epicondyle of humerus (body structure)	4180186
35632291	Structure of apophysis of medial epicondyle of left humerus (body structure)	4180186
35632292	Structure of apophysis of medial epicondyle of right humerus (body structure)	4180186
35632293	Structure of apophysis of lesser trochanter of femur	4180186
35632293	Structure of lesser trochanteric apophysis of femur (body structure)	4180186
35632293	Structure of lesser trochanteric apophysis of femur	4180186
35632295	Structure of apophysis of distal femur	4180186
35632295	Structure of apophysis of distal femur (body structure)	4180186
35632296	Entire apophysis of distal femur	4180186
35632296	Entire apophysis of distal femur (body structure)	4180186
35632297	Entire proximal femoral apophysis	4180186
35632297	Entire apophysis of proximal femur (body structure)	4180186
35632298	Entire lesser trochanteric apophysis of femur (body structure)	4180186
35632298	Entire lesser trochanteric apophysis of femur	4180186
35632298	Entire apophysis of lesser trochanter of femur	4180186
35632300	Structure of perilunate joint of right wrist (body structure)	4180186
35632302	Bone structure of right tarsus (body structure)	4180186
35632304	Structure of lateral condyle of right humerus (body structure)	4180186
35632305	Structure of skeletal muscle of left thigh (body structure)	4180186
35632306	Structure of skeletal muscle of right thigh (body structure)	4180186
35632307	Structure of extensor tendon of left hand (body structure)	4180186
35632307	Structure of extensor tendon within left hand (body structure)	4180186
35632307	Structure of extensor tendon within left hand	4180186
35632309	Structure of capitate bone of left wrist (body structure)	4180186
35632310	Structure of capitate bone of right wrist (body structure)	4180186
35632311	Bone structure of trapezium of left wrist (body structure)	4180186
35632319	Skin of part of right forearm (body structure)	4180186
35632320	Entire apophysis of medial epicondyle of humerus (body structure)	4180186
35632323	Structure of capsule of left ankle joint (body structure)	4180186
35632326	Structure of capsule of metatarsophalangeal joint of right foot (body structure)	4180186
35632327	Structure of cruciate ligament of left knee joint (body structure)	4180186
35632330	Structure of greater trochanter of right femur (body structure)	4180186
35632333	Entire epiphyseal plate of proximal femur (body structure)	4180186
35632334	Structure of epiphyseal plate of proximal left femur (body structure)	4180186
35632336	Structure of epiphyseal plate of distal left femur (body structure)	4180186
35632338	Bone structure of hamate of left wrist (body structure)	4180186
35632339	Bone structure of hamate of right wrist (body structure)	4180186
35632342	Structure of medial condyle of left humerus (body structure)	4180186
35632343	Structure of medial condyle of right humerus (body structure)	4180186
35632344	Bone structure of medial cuneiform of left foot (body structure)	4180186
35632345	Bone structure of medial cuneiform of right foot (body structure)	4180186
35632346	Structure of right accessory nerve (body structure)	4180186
35632347	Structure of left accessory nerve (body structure)	4180186
35632348	Structure of right obturator nerve (body structure)	4180186
35632349	Structure of left patellar ligament	4180186
35632349	Structure of left patellar tendon (body structure)	4180186
35632350	Structure of right patellar tendon (body structure)	4180186
35632350	Structure of right patellar ligament	4180186
35632351	Structure of tendon and tendon sheath of right hip (body structure)	4180186
35632351	Structure of tendon and/or tendon sheath within right hip region (body structure)	4180186
35632351	Structure of tendon and/or tendon sheath within right hip region	4180186
35632352	Structure of nail bed of left thumb (body structure)	4180186
35632352	Nail bed of left thumb	4180186
35632353	Structure of nail bed of right thumb	4180186
35632353	Structure of nail bed of right thumb (body structure)	4180186
35632354	Structure of epiphyseal plate of proximal left radius (body structure)	4180186
35632356	Right triquetum	4180186
35632356	Structure of triangular bone of right wrist (body structure)	4180186
35632357	Left triquetum	4180186
35632357	Structure of triangular bone of left wrist (body structure)	4180186
35632358	Structure of region of proximal left femur (body structure)	4180186
35632358	Structure of region of proximal left femur	4180186
35632358	Region of proximal left femur (body structure)	4180186
35632359	Structure of region of proximal right femur (body structure)	4180186
35632359	Structure of region of proximal right femur	4180186
35632359	Region of proximal right femur (body structure)	4180186
35632360	Structure of flexor aspect of left wrist region	4180186
35632360	Structure of flexor aspect of left wrist region (body structure)	4180186
35632360	Flexor aspect of left wrist (body structure)	4180186
35632361	Structure of flexor aspect of right wrist region	4180186
35632361	Structure of flexor aspect of right wrist region (body structure)	4180186
35632361	Flexor aspect of right wrist (body structure)	4180186
35632363	Structure of right tarsal canal (body structure)	4180186
35632367	Entire tendon sheath of forearm (body structure)	4180186
35632367	Entire tendon sheath within forearm	4180186
35632367	Entire tendon sheath within forearm (body structure)	4180186
35632370	Structure of ligament of left thumb (body structure)	4180186
35632373	Structure of synovium of right foot joint (body structure)	4180186
35632375	Skin structure of ischial tuberosity subregion of right buttock region (body structure)	4180186
35632379	Structure of lateral surface of left thigh (body structure)	4180186
35632383	Structure of blood vessel of hand (body structure)	4180186
35632383	Structure of blood vessel of hand	4180186
35632384	Entire blood vessel of hand	4180186
35632384	Entire blood vessel of hand (body structure)	4180186
35632385	Lower inner quadrant of left female breast	4180186
35632385	Structure of lower inner quadrant of left female breast (body structure)	4180186
35632386	Lower inner quadrant of right female breast	4180186
35632386	Structure of lower inner quadrant of right female breast (body structure)	4180186
35632390	Structure of lymphatic system of right upper limb (body structure)	4180186
35632394	Structure of right femoral vein (body structure)	4180186
35632396	Entire smooth muscle of bronchiole (body structure)	4180186
35632397	Structure of lumen of tracheobronchial tree (body structure)	4180186
35632398	Entire lumen of biliary tract (body structure)	4180186
35632399	Entire lumen of tracheobronchial tree (body structure)	4180186
35632402	Structure of lymphatic system of left half of abdomen (body structure)	4180186
35632404	Structure of wall of small intestine (body structure)	4180186
35632407	Entire wall of small intestine (body structure)	4180186
35632408	Bone structure of clavicle and/or sternum (body structure)	4180186
35632409	Entire undescended left testis (body structure)	4180186
35632411	Bone structure of anterior nasal spine of maxilla (body structure)	4180186
35632412	Entire anterior nasal spine of maxilla (body structure)	4180186
35632413	Structure of meibomian gland of upper eyelid (body structure)	4180186
35632413	Tarsal gland of upper eyelid	4180186
35632414	Structure of meibomian gland of lower eyelid (body structure)	4180186
35632414	Tarsal gland of lower eyelid	4180186
35632416	Entire meibomian gland of lower eyelid (body structure)	4180186
35632416	Entire tarsal gland of lower eyelid	4180186
35632420	Structure of superior posterior pancreaticoduodenal artery (body structure)	4180186
35632421	Structure of superior anterior pancreaticoduodenal artery (body structure)	4180186
35632423	Entire superior anterior pancreaticoduodenal artery (body structure)	4180186
35632425	Entire distal part of pancreas (body structure)	4180186
35632426	Structure of costal margin of rib cage (body structure)	4180186
35632429	Entire extrapancreatic portion of common bile duct (body structure)	4180186
35632430	Structure of confluence of superior mesenteric vein and hepatic portal vein (body structure)	4180186
35632430	Superior mesenteric-portal venous confluence	4180186
35632431	Entire confluence of superior mesenteric vein and hepatic portal vein (body structure)	4180186
35632435	Sarcoplasmic reticulum (cell structure)	4180186
35632437	Dermablend camouflaging preparation (navigational concept)	4180186
35632439	Dermacolor camouflaging preparation (navigational concept)	4180186
35632442	Prescribed item not within scope of dm+d (navigational concept)	4180186
35632442	Prescribed item not within scope of NHS dictionary of medicines and devices	4180186
35632443	Prescribed item not yet in dm+d (navigational concept)	4180186
35632443	Prescribed item not yet in NHS dictionary of medicines and devices	4180186
35632444	Bath additive (qualifier value)	4180186
35632445	Dispersible tablet (qualifier value)	4180186
35632447	Medicated nail lacquer (qualifier value)	4180186
35632449	Soluble tablet (qualifier value)	4180186
35632450	Homeopathic liquid potency (qualifier value)	4180186
35632452	Gastroenteral liquid (qualifier value)	4180186
36031154	Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA-DRB3 + 4 + 5; HLA-DRB5; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
36031154	HLA-DRB3 + 4 + 5 Donr Low res	4180186
36031154	HLA-DRB3 & HLA-DRB4 & HLA DRB5:类型:时间点:全血/组织^供体:名义型:低分辨率法	4182948
36031155	在出现症状之前的14天之内旅行过:发现:时间点:^患者:序数型	4182948
36031155	Finding; Findings; H+P; H+P.HX; Ordinal; P prime; PH; Point in time; Public Health; PublicHealth; Ql; Qual; Qualitative; Random; Screen; Sx; Travel 14D prior to symp	4180186
36031155	Travel 14D prior to symp	4180186
36031158	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbovirus; Autoantibodies; Autoantibody; BFV; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; PH; Point in time; PR; Public Health; PublicHealth; Ql; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
36031158	BFV Ab Ser Ql IA	4180186
36031158	巴马森林病毒 抗体:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
36031160	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Chicken pox; Chicken pox virus; Chickenpox; EIA; ELFA; ELISA; Enzyme immunoassay; Herpes zoster; HHV-3; Human herpesvirus 3; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; Shingles; Spec; SUDS; To be specified in another part of the message; Unspecified; VZ; VZV; Zoster	4180186
36031160	VZV IgG Spec IA-aCnc	4180186
36031160	水痘带状疱疹病毒 抗体.IgG:任意型浓度:时间点:XXX:定量型:免疫测定法	4182948
36031161	3 months; Finding; Findings; Last; Mental health; MentalHealth; Ordinal; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey; SURVEY.NIDA	4180186
36031163	3 months; Finding; Findings; Last; Mental health; MentalHealth; Ordinal; Othr; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey; SURVEY.NIDA	4180186
36031166	Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
36031166	HLA-DQA1 Donr Low res	4180186
36031166	HLA-DQA1:类型:时间点:全血/组织^供体:名义型:低分辨率法	4182948
36031168	达雷妥尤单抗:存在情况或阈值:时间点:血清:序数型:免疫固定电泳分析法	4182948
36031168	Daratumumab Ser Ql IFE	4180186
36031168	Chemistry; DARZALEX; IFE; Ifix; Immunofixation electrophoresis; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
36031171	蜱传脑炎病毒 抗体.IgG:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031171	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enc; Enceph; Encephalomyelitis; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; TBEV; To be specified in another part of the message; Unspecified	4180186
36031171	TBEV IgG Spec Ql IA	4180186
36031173	美沙酮与2-亚乙基-1,5-二乙基-3,3-二苯基吡咯烷组套:-:时间点:血清/血浆:-	4182948
36031173	Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; EDDP; i; II; III; METD; Methadone + EDDP Pnl; Methadone metabolite; Methadose; MTD; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36031173	Methadone + EDDP Pnl SerPl	4180186
36031174	生长激素^在给予剂量马西瑞林之后90分钟:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36031174	90M p Macimorelin; After; Chemistry; EIA; ELFA; ELISA; Endocrine; Endocrinology; Enzyme immunoassay; GH; Growth hormone; HGH; Human growth hormone; IAA; Level; Mass concentration; MEIA; p dose; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Serum; Somatotropic hormone; SR; STH; SUDS	4180186
36031174	GH 90M p Macimorelin Ser IA-mCnc	4180186
36031176	细胞.CD3+CD8+CD27+CD45RO+CD62L+:计数型浓度:时间点:全血:定量型	4182948
36031176	CD3+CD8+CD27+CD45RO+CD62L+ cells # Bld	4180186
36031176	#; ABS; absolute; absolutes; Blood; CD3 Cells; CD3+CD8+ Cells; CD3+CD8+CD27- cells; CD3+CD8+CD27+CD45RO+CD62L+ cells; CD3+CD8+CD27-CD45RO+CD62L- cells; CD8 T cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; LAM-1; LECAM-1; Leu2; Leu-2; Leu4; Leu-4; Leu8; Leu-8; L-selectin; MEL-14; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; S152; Suppressor T cells; Suppressor/cytotoxic T cells; T14; T3; T8; T-8; T8 suppressor cells; TQ-1; Tsuppressor; UCHL-1; WB; Whole blood	4180186
36031179	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Random; Resp therapy; Visit note	4180186
36031179	Resp therapy Eval note	4180186
36031179	评价记录:发现:时间点:{环境}:文档型:呼吸疗法	4182948
36031180	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; DXO; GCMS; Illicit; Level; Mass concentration; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
36031180	DXO Sal Cfm-mCnc	4180186
36031180	去甲右美沙芬:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
36031181	DNA 错配修复蛋白 Msh3:存在情况或阈值:时间点:癌标本:序数型:免疫染色法	4182948
36031181	CA; Ca spec; Deoxyribonucleic acid; Divergent upstream protein; DNA MMR; DUP; hMSH3; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Mismatch repair protein 1; MRP1; Oncology; Ordinal; Pathology; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Spec; St; Stains; Stn	4180186
36031181	hMSH3 Ca spec Ql ImStn	4180186
36031185	3 months; Last; Mental health; MentalHealth; Nominal; Psych; Psychiatry; Survey; SURVEY.NIDA; Typ	4180186
36031186	眼内压^经补偿:压力或压强:时间点:眼睛.左侧:定量型:计算法	4182948
36031186	Calc; Calculation; Eye; EYE.TONOMETRY; Eyeball; Glaucoma testing; IOP; IOPcc; L; L eye; LT; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
36031186	L eye IOP--comp Calc	4180186
36031188	屋尘螨 重组 (rDer p) 23 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
36031188	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; D pteronyss; D pteronyss (rDer p) 23; D pteronyss (rDer p) 23 IgE; D pteronyssinus; d001; d1; D209; European house dust mite; HDM; House dust mite; Immune globulin E; Immunoglobulin E; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
36031188	D pteronyss (rDer p) 23 IgE Qn	4180186
36031189	Delamanid Islt Genotyp	4180186
36031189	ANTIBIOTIC SUSCEPTIBILITIES; AST; Deltyba; Genotype; Genotypic; Islt; Isol; OPC-67683; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
36031189	迪拉马尼:抗生素敏感性:时间点:分离株:序数型:基因分型	4182948
36031190	Neo peri med Eval note	4180186
36031190	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; Neo peri med; notes; Point in time; Random; Visit note	4180186
36031190	评价记录:发现:时间点:{环境}:文档型:新生儿围产医学	4182948
36031191	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36031192	ABL1 基因.c.944C>T:存在情况或阈值:时间点:全血/骨髓:序数型:分子遗传学类实验室方法	4182948
36031192	ABL; ABL proto-oncogene 1, non-receptor tyrosine kinase; ABL1 c.944C&gt;T; bcr/abl; Bld/Mar; Blood; BM; BON; Bone marrow; c-ABL; c-ABL1; CHDSKM; Chronic myeloid leukemia; Genetics; Heredity; Heritable; Inherited; JTK7; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; NM_005157.6(ABL1):c.944C&gt;T (p.Thr315Ile); Ordinal; p150; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Screen; T prime; T315I; v-abl; v-abl Abelson murine leukemia viral oncogene homolog 1; WB; Whole blood; Whole blood or Bone marrow	4180186
36031192	ABL1 c.944C>T Bld/Mar Ql	4180186
36031193	5-孕烯二醇:Z评分:24小时:尿液:定量型	4182948
36031193	1 day; 24 hours; 24HR; Chemistry; Endocrine; Endocrinology; QNT; Quan; Quant; Quantitative; Standard score; UA; UR; Urn; Z score; Z value; Z-score	4180186
36031193	5-Pregnenediol 24h Z-score Ur	4180186
36031196	生长激素^在给予剂量马西瑞林之后45分钟:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36031196	45M p Macimorelin; After; Chemistry; EIA; ELFA; ELISA; Endocrine; Endocrinology; Enzyme immunoassay; GH; Growth hormone; HGH; Human growth hormone; IAA; Level; Mass concentration; MEIA; p dose; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Serum; Somatotropic hormone; SR; STH; SUDS	4180186
36031196	GH 45M p Macimorelin Ser IA-mCnc	4180186
36031199	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey; Sx	4180186
36031200	肝细胞癌风险组套:-:时间点:血清/血浆:-	4182948
36031200	Chemistry; Hep Ca Risk; Hep Ca Risk Pnl; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36031200	Hep Ca Risk Pnl SerPl	4180186
36031201	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; Heart function; History and physical; notes; Point in time; Random; Visit note	4180186
36031201	Heart failure Eval note	4180186
36031201	评价记录:发现:时间点:{环境}:文档型:心力衰竭	4182948
36031205	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Coccidiodes; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; San Joaquin Valley fever; Screen; SDA; species; spp; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification; Valley fever	4180186
36031205	Coccidioides DNA Tiss Ql NAA+probe	4180186
36031205	球孢子菌属单个未知种 DNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36031206	Gastroenterology Eval note	4180186
36031206	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Random; Visit note	4180186
36031206	评价记录:发现:时间点:{环境}:文档型:胃肠病学	4182948
36031209	功能:发现:时间点:视神经盘+视网膜神经纤维层.左侧:序数型:视网膜电图	4182948
36031209	ERG; EYE; EYE.ERG; FCN; Fibers; Finding; Findings; Func; Funct; L; L optic disc+RNFL; LT; Ophthalmology; Ophtho; Ophthy; Ordinal; Point in time; QL; Qual; Qualitative; Random; RNFL; Screen	4180186
36031209	L optic disc+RNFL Function ERG	4180186
36031210	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36031211	Mental health; MentalHealth; Point in time; Psych; Psychiatry; QNT; Quan; Quant; Quantitative; Random; Scale; Subs; Survey; SURVEY.NIDA	4180186
36031212	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cervix; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Genital warts; HPV; HPV31; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Papilloma virus high risk; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36031212	HPV31 DNA Cvx Ql NAA+probe	4180186
36031212	人乳头瘤病毒 31 型 DNA:存在情况或阈值:时间点:子宫颈:序数型:探针法.基因扩增.靶向	4182948
36031215	Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
36031215	HLA-A Donr Low res	4180186
36031215	HLA-A:类型:时间点:全血/组织^供体:名义型:低分辨率法	4182948
36031216	马亚罗病毒 抗体.IgG:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031216	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MAYV; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36031216	MAYV IgG Spec Ql IA	4180186
36031219	ABS; Aby; Alphaviruses; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SFV; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36031219	SFV IgG Spec Ql IA	4180186
36031219	塞姆利基森林病毒 抗体.IgG:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031220	T 细胞制品特性描述组套:-:时间点:^血液制品单位:-:流式细胞测量术	4182948
36031220	T cell product panel BPU FC	4180186
36031220	BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Dynamic; FC; Pan; PANEL.BLOODBANK; Panl; Pnl; Point in time; Random; T cell product panel; T prime; UCHL-1	4180186
36031223	3 months; Finding; Findings; Last; Mental health; MentalHealth; Ordinal; Psych; Psychiatry; Ql; Qual; Qualitative; Rx; Screen; Survey; SURVEY.NIDA	4180186
36031224	布尼亚维拉病毒 抗体.IgM:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031224	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Orthobunyaviruses; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36031224	Bunyamwera virus IgM Spec Ql IA	4180186
36031225	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36031226	马亚罗病毒 抗体.中和:滴定度:时间点:XXX:定量型:中和试验	4182948
36031226	MAYV NAb Titr Spec Nt	4180186
36031226	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; MAYV; Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; Other; Point in time; Random; Serum virus neutralization; SmQn; Spec; SVN; Titer; Titered; Titre; To be specified in another part of the message; Ttr; Unspecified; Virus neutralization test; VNT	4180186
36031227	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CVV; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Orthobunyaviruses; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36031227	CVV IgM Spec Ql IA	4180186
36031227	卡赤谷病病毒 抗体.IgM:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031228	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Azalea spp IgE; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; w46	4180186
36031228	Azalea spp IgE Qn	4180186
36031228	杜鹃花属多个未知种 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
36031231	胰多肽^假饲后20分钟:质量浓度:时间点:血清/血浆:定量型	4182948
36031231	20M p Sham Feed; After; Chemistry; Endocrine; Endocrinology; Level; Mass concentration; Panc Polypept; Pancr; Pancreatc; Pl; Plasma; Plsm; Point in time; Polypeptides; PP; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36031231	Panc Polypept 20M p Sham Feed SerPl-mCnc	4180186
36031232	HLA-B Donr	4180186
36031232	Blood; Donr; HLA ANTIGEN; Human Leukocyte Antigen; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
36031232	HLA-B:类型:时间点:全血/组织^供体:名义型	4182948
36031233	Activated clotting time; Blood; CFT; CFT form kaolin ind; Clot Form Kaolin Ind Pnl; Clot time; COAGULATION; Kinetics; k-time; MicrVisc; Pan; PANEL.COAGULATION; Panl; Pnl; Point in time; Random; WB; Whole blood	4180186
36031233	凝块形成.白陶土诱导型组套:-:时间点:全血:-:微黏度测定法	4182948
36031233	Clot Form Kaolin Ind Pnl Bld MicrVisc	4180186
36031234	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36031235	视黄醇结合蛋白组套:-:时间点:尿液:定量型	4182948
36031235	RBP panel Ur	4180186
36031235	alpha 2 microglobulin; alpha-2-microglobulin; Axerol; Axerophthol; Bind; Biosterol; Chemistry; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; RBP; RBP panel; Retinol Bind Prot; UA; UR; Urn; Vit A; Vit A alcohol; Vit A1; Vit A1 alcohol; Vitamin A; Vitamin A alcohol; Vitamin A binding protein; Vitamin A1	4180186
36031236	HEDIS 评测年度 2020 取值集合 - 乳房X线照相术:-:时间点:^患者:-	4182948
36031236	HEDIS MY 2020 Mammography; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
36031236	HEDIS MY 2020 Mammography	4180186
36031240	3 months; Finding; Findings; Last; Mental health; MentalHealth; Ordinal; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey; SURVEY.NIDA	4180186
36031241	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36031243	四氢-11-皮质酮:Z评分:24小时:尿液:定量型	4182948
36031243	1 day; 24 hours; 24HR; B; Chemistry; Compound B; Cort; Corticoster; Endocrine; Endocrinology; QNT; Quan; Quant; Quantitative; Standard score; TH-11-corticosterone; UA; UR; Urn; Z score; Z value; Z-score	4180186
36031243	TH-11-corticosterone 24h Z-score Ur	4180186
36031246	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbovirus; Autoantibodies; Autoantibody; BFV; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36031246	BFV IgA Spec Ql IA	4180186
36031246	巴马森林病毒 抗体.IgA:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031247	与上一报告周期的病例数量增加或减少百分比:百分数差:报告期:^事件:定量型	4182948
36031247	% diff in case # from prev rpt period; Case # compared to prev rpt period; PH; Prev; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Report period	4180186
36031247	% diff in cases since prev RptPeriod	4180186
36031248	1 week; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Survey; SURVEY.GNHLTH	4180186
36031249	静脉吸毒:发现:一生:^患者:序数型	4182948
36031249	Drugs; Finding; Findings; H+P; H+P.HX; Inj; Ordinal; P prime; QL; Qual; Qualitative; Screen	4180186
36031251	Wound care management Photo image	4180186
36031251	Continuity assessment record and evaluation; DOC.ONT; Document; Finding; Findings; Photo image; Point in time; Random	4180186
36031251	数字摄影图像:发现:时间点:{环境}:文档型:伤口护理管理	4182948
36031252	镇静程度.四肢张力:发现:时间点:^患者:序数型	4182948
36031252	Finding; Findings; Levels; Levl; LV; LVL; NEONAT; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sed level.extrem tone; Sed lvl	4180186
36031252	Sed level.extrem tone	4180186
36031253	BLOOD BANK; Dynamic; FC; Ordinal; Point in time; PR; Pt + bld; Pt ser+Don bld; Ql; Qual; Qualitative; Random; Screen; Serum; SR; T Cell XM; T prime; UCHL-1	4180186
36031253	T Cell XM Pt ser+Don bld Ql FC	4180186
36031253	T 细胞交叉配型:存在情况或阈值:时间点:血清^患者+全血:序数型:流式细胞测量术	4182948
36031254	屈光指数:长度倒数:时间点:角膜曲率计:定量型	4182948
36031254	EYE; EYE.REFRACTION; Inverse Length; KM; Ophthalmology; Ophthalmometer; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random; Refract Indx	4180186
36031254	Keratometer Refract Indx	4180186
36031255	HLA-A 未决等位基因:类型:时间点:全血/组织:名义型:高分辨率方法	4182948
36031255	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA-A Unreslvd Alleles; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
36031255	HLA-A Unreslvd Alleles High Res	4180186
36031256	by LM; Corr lens; Distance; EYE; EYE.LENSOMETRY; Focimeter; Inverse Length; Lensometer; LM; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36031256	Corr lens Sphere far by LM	4180186
36031256	球面距离:长度倒数:时间点:矫正镜片:定量型:透镜屈光度计法	4182948
36031257	HLA-DRB1 未决等位基因:类型:时间点:全血/组织:名义型:高分辨率方法	4182948
36031257	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA-DRB1 Unreslvd Alleles; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
36031257	HLA-DRB1 Unreslvd Alleles High Res	4180186
36031258	HLA-A 与 B 与 C (I 类) 分型组套:-:时间点:全血/组织^供体:-:高分辨率方法	4182948
36031258	A,B; Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA class I; HLA Cls I Typ Pnl; HLA-A+B; HLA-A+B+C; HLA-A+B+C (class I); Human Leukocyte Antigen; Inherited; Pan; PANEL.HLA; Panl; Pnl; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36031258	HLA Cls I Typ Pnl Bld/T Donr High Res	4180186
36031265	4 weeks; Derm; Dermatology; Finding; Findings; Integument; Last; Ordinal; Ql; Qual; Qualitative; Screen; Skin; Survey; SURVEY.GNHLTH	4180186
36031267	胆固醇.LDL 之中的:物质的量浓度:时间点:血清/血浆:定量型:计算法.Martin-Hopkins	4182948
36031267	Calc; Calculation; Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; LDLc; LDL-C; Level; Lipid; Low density lipoprotein cholesterol; Low density lipoprotein cholesterols; Mart-Hopk; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
36031267	LDLc SerPl Mart-Hopk-sCnc	4180186
36031268	Immunology Initial eval note	4180186
36031268	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; Initial eval note; notes; Point in time; Random; Visit note	4180186
36031268	初步评价记录:发现:时间点:{环境}:文档型:免疫学	4182948
36031269	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SSHV; SUDS; To be specified in another part of the message; Unspecified	4180186
36031269	SSHV IgM Spec Ql IA	4180186
36031269	雪鞋野兔病毒 抗体.IgM:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031270	1 week; Derm; Dermatology; Finding; Findings; Integument; Job; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Skin; Survey; SURVEY.GNHLTH	4180186
36031272	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Integrated medicine; notes; Point in time; Random; Visit note	4180186
36031272	记录:发现:时间点:{环境}:文档型:整合医学	4182948
36031277	Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
36031277	HLA-A Donr High Res	4180186
36031277	HLA-A:类型:时间点:全血/组织^供体:名义型:高分辨率方法	4182948
36031279	S aureus DNA L resp NAA+non-prb-NCncRng	4180186
36031279	金黄色葡萄球菌 DNA:计数型浓度范围:时间点:呼吸道.下:序数型:非探针法.基因扩增.靶向	4182948
36031279	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; NCncRng; Nucleic acid sequence based analysis; o71; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; S aureus; SDA; SmQn; Staph; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36031281	功能与上一次的评估相比:发现:时间点:视杆细胞.左侧:序数型:视网膜电图	4182948
36031281	Comp func; ERG; EYE; EYE.ERG; FCN; Finding; Findings; Func; Funct; L; L rods; LT; Ophthalmology; Ophtho; Ophthy; Ordinal; Point in time; Prev; QL; Qual; Qualitative; Random; Screen	4180186
36031281	L rods Comp func ERG	4180186
36031283	Mental health; MentalHealth; Point in time; Psych; Psychiatry; QNT; Quan; Quant; Quantitative; Random; Rx; Scale; Stimul; Stimulant; Subs; Survey; SURVEY.NIDA	4180186
36031285	7-hydroxymitragynine; Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Kratom; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn	4180186
36031285	Mitragynine Ur Scn-mCnc	4180186
36031285	帽柱碱:质量浓度:时间点:尿液:定量型:毒理学筛查试验	4182948
36031286	N1 波振幅^明适应型:电势:时间点:黄斑.右侧:定量型:视网膜电图.多焦	4182948
36031286	Electrical potential; ERG; EYE; EYE.ERG; mfERG; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R macula; Random; RT; Voltage	4180186
36031286	R macula N1 amp--light-adapt mfERG	4180186
36031287	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36031287	操作记录:发现:时间点:{环境}:文档型:免疫学	4182948
36031288	HLA-B 未决等位基因:类型:时间点:全血/组织:名义型:高分辨率方法	4182948
36031288	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA-B Unreslvd Alleles; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
36031288	HLA-B Unreslvd Alleles High Res	4180186
36031289	B; Cardio; Cardiology; Chemistry; Heart Disease; LDL; LDL med; LDL particle concentration; LDL particle number; Level; Lip; Lipoprot; Lipoproteins; Low density lipoproteins; LP; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Substance concentration	4180186
36031289	LDL med Ser-sCnc	4180186
36031289	脂蛋白.Beta.亚微颗粒.中型:物质的量浓度:时间点:血清:定量型	4182948
36031291	Mental health; MentalHealth; Point in time; Psych; Psychiatry; QNT; Quan; Quant; Quantitative; Random; Rx; Scale; Subs; Survey; SURVEY.NIDA	4180186
36031294	A glaucus; ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Asperg; Aspergil; Aspergilis; Aspergilla; Aspergillin; Aspergillosis; Aspergillus glaucus IgE; Aspergils; Aspergilus; Autoantibodies; Autoantibody; Farmers lung; Immune globulin E; Immunoglobulin E; m300; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
36031294	A glaucus IgE Qn	4180186
36031294	灰绿曲霉 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
36031295	Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
36031295	HLA-B Donr Low res	4180186
36031295	HLA-B:类型:时间点:全血/组织^供体:名义型:低分辨率法	4182948
36031298	功能:发现:时间点:视神经.左侧:序数型:视觉诱发电位	4182948
36031298	EYE; EYE.PX; FCN; Finding; Findings; Func; Funct; L; L optic n; LT; Ophthalmology; Ophtho; Ophthy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36031298	L optic n Function VEP	4180186
36031299	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CVV; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Orthobunyaviruses; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36031299	CVV IgG Spec Ql IA	4180186
36031299	卡赤谷病病毒 抗体.IgG:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031300	功能:发现:时间点:黄斑.右侧:序数型:视网膜电图	4182948
36031300	ERG; EYE; EYE.ERG; FCN; Finding; Findings; Func; Funct; Ophthalmology; Ophtho; Ophthy; Ordinal; Point in time; QL; Qual; Qualitative; R; R macula; Random; RT; Screen	4180186
36031300	R macula Function ERG	4180186
36031304	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36031305	罗西奥病毒 抗体.IgM:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031305	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Flavivirus; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36031305	Rocio virus IgM Spec Ql IA	4180186
36031306	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36031309	Conventional virus neutralization test; cVNT; Flavi virus; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Misc; Miscellaneous; NEUTRALIZATION; Neutralization test; Nominal; NT; Other; PH; Point in time; Public Health; PublicHealth; Random; Serum virus neutralization; Spec; SVN; To be specified in another part of the message; Unspecified; Virus neutralization test; VNT	4180186
36031309	Flavivirus Spec Nt	4180186
36031309	黄病毒 已鉴定的:存在与否或特征标识:时间点:XXX:名义型:中和试验	4182948
36031310	教育完成状态:发现:时间点:^患者:名义型	4182948
36031310	Educ completion status	4180186
36031310	Educ completion status; Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random	4180186
36031312	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cervix; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Genital warts; HPV; HPV45; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Papilloma virus intermediate risk; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36031312	HPV45 DNA Cvx Ql NAA+probe	4180186
36031312	人乳头瘤病毒 45 型 DNA:存在情况或阈值:时间点:子宫颈:序数型:探针法.基因扩增.靶向	4182948
36031313	疼痛和/或躁动严重程度:发现:时间点:^患者:序数型	4182948
36031313	Finding; Findings; Levels; Levl; LV; LVL; NEONAT; Ordinal; Pain/agi sev level; Pain/agitat; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36031313	Pain/agi sev level	4180186
36031315	Amplification; Blood; Del; Del+Dup; Del+Dup + Full Mut Anl; Deletions; Document; Dp; Finding; Findings; full gene sequencing; Full Mut Anl; G/T mismatch-binding protein gene; Genetics; GTBP; GTMBP; Heredity; Heritable; HNPCC; HNPCC5; HSAP; Inherited; Lynch syndrome; Molecular genetics; Molecular pathology; MOLPATH; Mut; Mutations; mutS homolog 6; p160; PCR; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36031315	MSH6 gene Del+Dup + Full Mut Anl Bld/T	4180186
36031315	MSH6 基因 缺失+重复与全面的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36031317	Powassan 病毒 抗体.中和:滴定度:时间点:XXX:定量型:中和试验	4182948
36031317	POWV NAb Titr Spec Nt	4180186
36031317	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; Other; Point in time; POWV; Random; Serum virus neutralization; SmQn; Spec; SVN; Titer; Titered; Titre; To be specified in another part of the message; Ttr; Unspecified; Virus neutralization test; VNT	4180186
36031318	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lyme; Lyme disease; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Relapsing fever; Screen; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36031318	Borrelia DNA Bld Ql NAA+probe	4180186
36031318	疏螺旋体属单个未知种 DNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
36031319	Mental health; MentalHealth; Nominal; Point in time; Psych; Psychiatry; Random; Survey; SURVEY.NIDA; Typ	4180186
36031320	Blood; BSA pred.black; Chemistry; DBS; Dried blood spot; EGFR; Estimated GFR; Filter paper; FP; GFR; GFR/1.73 sq M; Glom; Kidney; Nephrology; Point in time; Pred GFR; Pred GFR.black; QNT; Quan; Quant; Quantitative; Random; Renal; Square Meter; Volume rate/area; Volume Rate/Ratio; WB; Whole blood	4180186
36031320	GFR/BSA pred.black DBS-ArVRat	4180186
36031320	肾小球滤过率/1.73 平方米.预测型.黑人:单位面积体积速率:时间点:全血.斑点:定量型	4182948
36031321	伤口对生活质量的影响:发现:时间点:^患者:名义型	4182948
36031321	Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random; Wound impact on QOL	4180186
36031321	Wound impact on QOL	4180186
36031322	1 month; 1 month (30 days); 30 days; Finding; Findings; month; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; SDOH; T prime	4180186
36031323	生长激素^在给予剂量马西瑞林之后30分钟:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36031323	30M p Macimorelin; After; Chemistry; EIA; ELFA; ELISA; Endocrine; Endocrinology; Enzyme immunoassay; GH; Growth hormone; HGH; Human growth hormone; IAA; Level; Mass concentration; MEIA; p dose; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Serum; Somatotropic hormone; SR; STH; SUDS	4180186
36031323	GH 30M p Macimorelin Ser IA-mCnc	4180186
36031324	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CVV; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Orthobunyaviruses; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36031324	CVV IgA Spec Ql IA	4180186
36031324	卡赤谷病病毒 抗体.IgA:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031325	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C trac; C trach; C trach+GC; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; CT + NG + TV; CT + NG + TV DNA; CT + NG + TV DNA Pnl; CT/GC; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; GC; Gono; Gonorrhea; ID; Infectious Disease; InfectiousDisease; LAT; LCR; LGV; Ligase chain reaction; Ligation-activated transcription; Lymphogranuloma venereum; Microbiology; Misc; Miscellaneous; N gonorrhoea; N gonorrhoeae; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spec; Strand Displacement Amplification; T vaginalis; TMA; To be specified in another part of the message; Trachoma; Transcription mediated amplification; Tric; Trich; Trichimoniasis; Trichomonad; Trichomonads; Trichomoniasis; Unspecified	4180186
36031325	CT + NG + TV DNA Pnl Spec NAA+probe	4180186
36031325	沙眼衣原体 & 淋病奈瑟菌 & 阴道毛滴虫 DNA 组套:-:时间点:XXX:-:探针法.基因扩增.靶向	4182948
36031326	过去一年出于非医疗原因的处方药物使用情况:发现:1年:^患者:序数型	4182948
36031326	Drugs; Finding; Findings; H+P; H+P.HX; Last; Ordinal; P prime; QL; Qual; Qualitative; Rx; Screen	4180186
36031326	Prescription drug use 1Y	4180186
36031327	Gp B Strep DNA L resp NAA+non-prb-NCncRng	4180186
36031327	无乳链球菌 DNA:计数型浓度范围:时间点:呼吸道.下:序数型:非探针法.基因扩增.靶向	4182948
36031327	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; GBS; Gp B Strep; Group B; Group B Strep; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; NCncRng; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; S agalactiae; SDA; SmQn; Steptococcus Group B; Strand Displacement Amplification; Strep; Strep B; Strep group B; Strept; Streptococci group B; TMA; Transcription mediated amplification	4180186
36031328	白蛉热那不勒斯病毒 抗体.IgM:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031328	SFNV IgM Spec Ql IA	4180186
36031328	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin M; Immunoglobulin M; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Phleboviruses; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SFNV; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36031329	Proteus DNA L resp NAA+non-prb-NCncRng	4180186
36031329	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; NCncRng; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; SmQn; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36031329	变形杆菌属单个未知种 DNA:计数型浓度范围:时间点:呼吸道.下:序数型:非探针法.基因扩增.靶向	4182948
36031330	医疗服务计划记录:发现:时间点:{环境}:文档型:变态反应法	4182948
36031330	Allergy; Care plan; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Treatment plan; Visit note	4180186
36031332	N2 波潜伏时间^明适应型:时间:时间点:黄斑.右侧:定量型:视网膜电图.多焦	4182948
36031332	ERG; EYE; EYE.ERG; mfERG; N2 impl time; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R macula; Random; RT	4180186
36031332	R macula N2 impl time--light-adapt mfERG	4180186
36031333	功能与上一次的评估相比:发现:时间点:黄斑.左侧:序数型:视网膜电图	4182948
36031333	Comp func; ERG; EYE; EYE.ERG; FCN; Finding; Findings; Func; Funct; L; L macula; LT; Ophthalmology; Ophtho; Ophthy; Ordinal; Point in time; Prev; QL; Qual; Qualitative; Random; Screen	4180186
36031333	L macula Comp func ERG	4180186
36031337	人乳头瘤病毒高风险基因型组套:-:时间点:子宫颈:-:探针法.基因扩增.靶向	4182948
36031337	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cervix; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Genital warts; HPV; HPV HR genotypes Pnl; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36031337	HPV HR genotypes Pnl Cvx NAA+probe	4180186
36031339	Col+rec surg Eval note	4180186
36031339	Assessment; Col+rec surg; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Random; Surg; Visit note	4180186
36031339	评价记录:发现:时间点:{环境}:文档型:结肠与直肠外科学	4182948
36031340	多重视图 完整:发现:时间点:头部>牙齿:文档型:X射线摄影术	4182948
36031340	Brain; Cranial; Cranium; Dental; Dentistry; Document; Films; Finding; Findings; Imaging; Intracranial; Plain Films; Point in time; Rad; Radiology; Random; Skull; View; VWS; Xray; X-ray	4180186
36031340	XR Teeth Views complete	4180186
36031341	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36031345	5-孕烯二醇:质量速率:24小时:尿液:定量型	4182948
36031345	1 day; 24 hours; 24HR; Chemistry; Endocrine; Endocrinology; Mass Rate; mRate; QNT; Quan; Quant; Quantitative; UA; UR; Urn	4180186
36031345	5-Pregnenediol 24h Ur-mRate	4180186
36031349	1 day; 17-Hydroxycorticosterone; 24 hours; 24HR; Chemistry; Compound F; Coritsol; Cort; Endocrine; Endocrinology; F; hydrocortisone; QNT; Quan; Quant; Quantitative; Standard score; UA; UR; Urn; Z score; Z value; Z-score	4180186
36031349	Cortis 24h Z-score Ur	4180186
36031349	皮质醇:Z评分:24小时:尿液:定量型	4182948
36031351	胰多肽^假饲后30分钟:质量浓度:时间点:血清/血浆:定量型	4182948
36031351	30M p Sham Feed; After; Chemistry; Endocrine; Endocrinology; Level; Mass concentration; Panc Polypept; Pancr; Pancreatc; Pl; Plasma; Plsm; Point in time; Polypeptides; PP; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36031351	Panc Polypept 30M p Sham Feed SerPl-mCnc	4180186
36031356	4 weeks; Derm; Dermatology; Finding; Findings; Integument; Last; Ordinal; Ql; Qual; Qualitative; Screen; Skin; Survey; SURVEY.GNHLTH	4180186
36031357	干草粉尘 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
36031357	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Hay dust IgE; Immune globulin E; Immunoglobulin E; K7; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
36031357	Hay dust IgE Qn	4180186
36031359	造血祖细胞输注品之中的单核细胞剂量:计数型含量:时间点:^患者:定量型	4182948
36031359	Mono Cell dose in HPC transplant Patient	4180186
36031359	BLOOD BANK; Count/mass; Mono Cell dose in HPC transplant; Number content; Point in time; QNT; Quan; Quant; Quantitative; Random; Tx	4180186
36031360	细菌甲氧西林耐药 mecA+mecC 基因+SCCmec-OrfX 结合部:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36031360	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Celbenin; Dimethoxypenicillin; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; mecA+mecC+MREJ; Metacillin; Metin; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec; Staficyn; Staphicillin	4180186
36031360	mecA+mecC+MREJ Islt/Spm Ql	4180186
36031362	1 week; Derm; Dermatology; Finding; Findings; Integument; Last; Ordinal; Ql; Qual; Qualitative; Screen; Skin; Survey; SURVEY.GNHLTH	4180186
36031364	Hyperoxaluria Pnl SerPl	4180186
36031364	Chemistry; Hyperoxaluria Pnl; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36031364	高草酸尿症组套:-:时间点:血清/血浆:-	4182948
36031365	Mental health; MentalHealth; Othr; Point in time; Psych; Psychiatry; QNT; Quan; Quant; Quantitative; Random; Scale; Subs; Survey; SURVEY.NIDA	4180186
36031367	Squamous # Spt Manual	4180186
36031367	#; ABS; absolute; absolutes; Cell; Cellularity; Cnt; Count; Count/volume; CT; Epi; Epi Cells; Epith; Epithelia; HEMATOLOGY/CELL COUNTS; Lower respiratory; Manl; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; SEC; Spt; Sputum; Sq; Squamous cell; Squamous epithelial cell; Squamous epithelial cells	4180186
36031367	上皮细胞.鳞状上皮细胞型:计数型浓度:时间点:痰液:定量型:手工计数方法	4182948
36031370	皮肤病自身免疫抗体组套:-:时间点:血清/血浆:-	4182948
36031370	Derm autoimmune Ab pnl; Pan; PANEL.SEROLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36031370	Derm autoimmune Ab pnl SerPl	4180186
36031371	SARS 冠状病毒 2 刺激型 gamma 干扰素组套:-:时间点:全血:-	4182948
36031371	SARS-CoV-2 IFN-g Pnl Bld	4180186
36031371	2019 Novel Coronavirus; 2019-nCoV; Blood; Corona virus; COVID19; COVID-19; IFN; IGRA; II; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 IFN-g; SARS-CoV-2 IFN-g Pnl; Severe Acute Respiratory Syndrome; Viral Pneumonias; WB; Whole blood; Wuhan coronavirus	4180186
36031373	1,4,5-三磷酸肌醇受体 1型 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:免疫荧光法	4182948
36031373	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Cyclohexane-1,2,3,4,5,6-hexol; FA; Fluorescent antibody; Fluoresent; i; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; InsP3R1; IP3 receptor isoform 1; IP3R 1; IP3R 1 Ab; IP3R 1 IgG; ITPR; ITPR1; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF; Type 1 inositol 1,4,5-trisphosphate receptor; Type 1 InsP3 receptor	4180186
36031373	IP3R 1 IgG CSF Ql IF	4180186
36031375	ADMIN; Mat; Maternal; Matnl; Nominal; Person name; Point in time; Random	4180186
36031375	娘家姓:人员姓名:时间点:^母亲:名义型	4182948
36031377	#/area; EPS; expressed prostatic secretion; Genitourinary; GU; HEMATOLOGY/CELL COUNTS; LM; Macrop; Macrophage; Macros; Macrphg; Micro; Micros; Microscopic; Number areic; Point in time; Prost; Prost fld; Prostate; Prostate secretion; Prostati; Prostatic secretion; QNT; Quan; Quant; Quantitative; Random; URO; Urology	4180186
36031377	Macrophages #/area Prost fld Micro	4180186
36031377	巨噬细胞:单位面积数量或计数:时间点:前列腺液:定量型:显微镜检查.光学	4182948
36031378	已诱发肺血管扩张:发现:时间点:肺部脉管系统:序数型	4182948
36031378	Finding; Findings; Lung; Ordinal; Point in time; Pulm; Pulm vasodilation induced; Pulmonary; Pulmonary vascular; Pulmonology; PV; Ql; Qual; Qualitative; Random; Respiratory; Screen	4180186
36031378	Pulm vasodilation induced	4180186
36031379	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; Neuro; Neurology; notes; Point in time; Random; Visit note	4180186
36031379	Neurology Eval note	4180186
36031379	评价记录:发现:时间点:{环境}:文档型:神经病学	4182948
36031380	Wound care management H&P note	4180186
36031380	Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Hx; notes; Point in time; Random; Visit note	4180186
36031380	病史与体格检查记录:发现:时间点:{环境}:文档型:伤口护理管理	4182948
36031381	相位偏移^明适应型:时间:时间点:视网膜.右侧:定量型:视网膜电图.图形	4182948
36031381	ERG; EYE; EYE.ERG; Ophthalmology; Ophtho; Ophthy; PERG; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; RT	4180186
36031381	R ret Ph shift--light-adapt [Time] PERG	4180186
36031382	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; H&P; History and physical; notes; Point in time; Random; Visit note	4180186
36031382	Gynecology Eval note	4180186
36031382	评价记录:发现:时间点:{环境}:文档型:妇科学	4182948
36031383	Assessment; CCM; Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Random; Visit note	4180186
36031383	CCM Eval note	4180186
36031383	评价记录:发现:时间点:{环境}:文档型:危重病监护医学	4182948
36031384	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
36031384	HLA-C Low res	4180186
36031384	HLA-C:类型:时间点:全血/组织:名义型:低分辨率法	4182948
36031385	BP mean by Noninv--during anesthesia	4180186
36031385	Art sys; Average; Avg; Blood pressure mean; BLOOD PRESSURE MEASUREMENTS.MOLEC; BP; BP mean; Intravenous; IV; MBP; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
36031385	血管内平均值^在麻醉过程中:压力或压强:时间点:动脉系统:定量型:无创法	4182948
36031387	铜.游离型:质量浓度:时间点:血清/血浆:定量型	4182948
36031387	Chemistry; Copper free; Cu; FR; Level; Mass concentration; Non-protein bound; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36031387	Copper free SerPl-mCnc	4180186
36031388	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey; Sx	4180186
36031389	HTN; Lung; Nominal; Point in time; Pulm; Pulmonary; Pulmonology; Random; Respiratory	4180186
36031389	Pulmonary hypertension class	4180186
36031389	肺动脉高压:分类:时间点:^患者:名义型	4182948
36031391	Finding; Findings; Mental health; MentalHealth; Ordinal; Point in time; Psych; Psychiatry; Ql; Qual; Qualitative; Random; Rel; Screen; Survey; SURVEY.NIDA	4180186
36031393	Finding; Findings; Levels; Levl; LV; LVL; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
36031395	S pyo DNA L resp NAA+non-prb-NCncRng	4180186
36031395	化脓性链球菌 DNA:计数型浓度范围:时间点:呼吸道.下:序数型:非探针法.基因扩增.靶向	4182948
36031395	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; GAS; Group A Strep; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; NCncRng; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; S pyogenes; SDA; SmQn; Steptococcus Group A; Strand Displacement Amplification; Strep; Strept; Streptococci group A; Streptococcus group A; TMA; Transcription mediated amplification	4180186
36031397	胶状小体:存在情况或阈值:时间点:精液:序数型:显微镜检查类实验室方法	4182948
36031397	bod; Body; Ejaculate; FERTILITY TESTING; Gel bodies; Genitourinary; GU; Jelly-like grains; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Sem; Seminal fluid; Smn; SMPLS; URO; Urology	4180186
36031397	Gel bodies Smn Ql Micro	4180186
36031398	美国水青冈木材粉尘 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
36031398	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Amer Beech; Amer Beech wood dust; American beech; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; K32; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; t005; t5	4180186
36031398	Amer Beech wood dust IgE Qn	4180186
36031402	表面诱导型凝血过程.因子替换^在添加1:1正常血浆后孵育之后1小时:时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
36031402	1 hour; 1.0Hr; 1h p 1:1 NP; 1h p Inc; 60 min; 60 minutes; 60M; 60min; Activated partial thromboplastin time; After; aPTT; aPTT correction study; Clot; Clottable; Coag; Coagulation assay; Control; Fac; Fact; Hematology; Heme; i; Little(A)PTT; Mixing studies; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; PST; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube	4180186
36031402	aPTT 1h p 1:1 NP PPP	4180186
36031404	胆固醇.LDL 之中的:质量浓度:时间点:血清/血浆:定量型:计算法.Martin-Hopkins	4182948
36031404	Calc; Calculation; Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; LDLc; LDL-C; Level; Lipid; Low density lipoprotein cholesterol; Low density lipoprotein cholesterols; Mart-Hopk; Mass Concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36031404	LDLc SerPl Mart-Hopk-mCnc	4180186
36031406	100WBC; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lower respiratory; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spt; Sputum; WBC; WBCs; White blood cell; White blood cells	4180186
36031406	Lymphocytes/leuk NFr Spt Manual	4180186
36031406	淋巴细胞/100 个白细胞:计数型分数:时间点:痰液:定量型:手工计数方法	4182948
36031407	功能:发现:时间点:视神经.右侧:序数型:视网膜电图	4182948
36031407	ERG; EYE; EYE.ERG; FCN; Finding; Findings; Func; Funct; Ophthalmology; Ophtho; Ophthy; Ordinal; Point in time; QL; Qual; Qualitative; R; R optic n; Random; RT; Screen	4180186
36031407	R optic n Function ERG	4180186
36031408	停止物质滥用时的年龄:时间:时间点:^患者:定量型	4182948
36031408	H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Subs	4180186
36031409	伊利乌斯病毒 抗体.IgG:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031409	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Flaviviruses; IAA; ID; ILHV; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36031409	ILHV IgG Spec Ql IA	4180186
36031410	轮椅推动次数:计数型速率:XXX:^患者:定量型	4182948
36031410	# wheelchair push; ?Tm; Activity; Count/time; Exercise; H+P; H+P.HX; No; nRate; Num; Number rate; Number Rate = Count/Time; P prime; QNT; Quan; Quant; Quantitative	4180186
36031410	# wheelchair push nRate	4180186
36031413	Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36031413	操作记录:发现:时间点:{环境}:文档型:伤口护理管理	4182948
36031414	活化凝血时间.硅藻土诱导型:时间:时间点:全血:定量型:微黏度测定法	4182948
36031414	ACT; ACT Diatom earth Ind; Activ; Activated coagulation time; Blood; Celite; Clot; Clottable; COAGULATION; Coagulation activated; Coagulation time; Hematology; Heme; MicrVisc; Point in time; QNT; Quan; Quant; Quantitative; Random; Rate; R-time; WB; Whole blood	4180186
36031414	ACT Diatom earth Ind Bld MicrVisc	4180186
36031422	HLA-DP 与 DQ 与 DR (II 类) 分型组套:-:时间点:全血/组织^供体:-:高分辨率方法	4182948
36031422	2; Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA class II; HLA Cls II Typ Pnl; HLA-DP+DQ+DR; HLA-DP+DQ+DR (class II); Human Leukocyte Antigen; Inherited; Pan; PANEL.HLA; Panl; Pnl; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36031422	HLA Cls II Typ Pnl Bld/T Donr High Res	4180186
36031423	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; E faecium; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36031423	E faecium DNA Bld Pos Ql NAA+non-probe	4180186
36031423	屎肠球菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36031424	血液肿瘤:类型:时间点:^患者:名义型	4182948
36031424	H+P; H+P.HX; Hemato; Hematology; Heme; Nominal; P prime; Point in time; Random; Typ	4180186
36031426	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
36031426	Immunology Prog note	4180186
36031426	病程记录:发现:时间点:{环境}:文档型:免疫学	4182948
36031427	N2 波振幅^明适应型:电势:时间点:黄斑.右侧:定量型:视网膜电图.多焦	4182948
36031427	Electrical potential; ERG; EYE; EYE.ERG; mfERG; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R macula; Random; RT; Voltage	4180186
36031427	R macula N2 amp--light-adapt mfERG	4180186
36031428	感染等级:发现:时间点:下肢:序数型:WIfI	4182948
36031428	CLIN; EXT; Finding; Findings; LE; Leg; Low; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36031428	Infection grade LE WIfI	4180186
36031429	3 months; Benzoylmethylecgonine; Coke; Crack; Ecgonine methyl ester benzoate; Finding; Findings; Last; Mental health; MentalHealth; Ordinal; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Snow; Survey; SURVEY.NIDA	4180186
36031430	死亡人数/100,000 人口:计数型分数:时间点:^事件:定量型	4182948
36031430	Fatalities; Number fraction; Percent; PH; Point in time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random	4180186
36031430	Death rate per 100,000 pop	4180186
36031431	HEDIS 评测年度 2020 取值集合 - 葡萄糖检验项目:-:时间点:^患者:-	4182948
36031431	HEDIS MY 2020 Glucose Tests	4180186
36031431	Glu; Gluc; Glucoseur; HEDIS MY 2020 Glucose Tests; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
36031432	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SINV; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36031432	SINV IgM Spec Ql IA	4180186
36031432	辛德毕斯病毒 抗体.IgM:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031433	1 day; 24 hours; 24HR; Chemistry; Endocrine; Endocrinology; QNT; Quan; Quant; Quantitative; Standard score; tetrahydro-11-deoxycortisol; TH-DC; UA; UR; Urn; Z score; Z value; Z-score	4180186
36031433	TH-DC 24h Z-score Ur	4180186
36031433	四氢脱氧皮质醇:Z评分:24小时:尿液:定量型	4182948
36031435	棱镜基准方向:角度:时间点:矫正镜片:定量型:透镜屈光度计法	4182948
36031435	by LM; Corr lens; EYE; EYE.LENSOMETRY; Focimeter; Lensometer; LM; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36031435	Corr lens Prism base dir by LM	4180186
36031436	视黄醇结合蛋白/肌酐:质量比率:时间点:尿液:定量型	4182948
36031436	Retinol Bind Prot/Creat Ur	4180186
36031436	alpha 2 microglobulin; alpha-2-microglobulin; Axerol; Axerophthol; Bind; Biosterol; Chemistry; CR; Crea; Creat; Mass concentration ratio; Mass ratio; MCRto; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; RBP; Retinol Bind Prot; UA; UCr; UR; Urn; Vit A; Vit A alcohol; Vit A1; Vit A1 alcohol; Vitamin A; Vitamin A alcohol; Vitamin A binding protein; Vitamin A1	4180186
36031438	已占据的重症监护病房床位/重症监护病房床位:计数型分数:时间点:{环境}:定量型	4182948
36031438	ICU beds; ICU beds occupied; Number Fraction; Percent; PH; Point in time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random	4180186
36031438	ICU beds occupied/ICU beds NFr	4180186
36031439	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36031440	羟苯丁酯 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
36031440	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Butylparaben IgE; Immune globulin E; Immunoglobulin E; Ko2; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
36031440	Butylparaben IgE Qn	4180186
36031441	肾上腺皮质功能不全紧急行动计划:发现:时间点:{环境}:文档型:{角色}	4182948
36031441	Adrenal Crisis Action Plan; Adrenal Insufficiency Action Plan; Adrnl; DOC.ONT; Document; Finding; Findings; Point in time; Random	4180186
36031441	Adrenal insufficiency action plan	4180186
36031442	Arbitrary; BLOOD BANK; Dynamic; FC; Point in time; Pt + bld; Pt ser+Don bld; QNT; Quan; Quant; Quantitative; Random; Serum; SR; T cell MCS; T prime; UCHL-1	4180186
36031442	T cell MCS Pt ser+Don bld FC	4180186
36031442	T 细胞中位通道偏移:任意型:时间点:血清^患者+全血:定量型:流式细胞测量术	4182948
36031443	#/area; Artificial Intelligence; Automated detection; Comp Assist; Number areic; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urn	4180186
36031443	人工假象:单位面积数量或计数:时间点:尿液:定量型:计算机辅助法	4182948
36031443	Artifact #/area Ur Comp Assist	4180186
36031449	Date latest lab test for cond of int; Disease; Disorder; PH; Point in time; Public Health; PublicHealth; QNT; Quan; Quant; Quantitative; Random; Virus	4180186
36031449	针对所关注的情况的最新实验室检验项目的日期:日期:时间点:^患者:定量型	4182948
36031449	Date latest lab test for cond of int	4180186
36031451	1 month; 1 month (30 days); 30 days; Finding; Findings; month; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; SDOH; T prime	4180186
36031453	2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 RdRp; Screen; SDA; Severe Acute Respiratory Syndrome; Strand Displacement Amplification; TMA; Transcription mediated amplification; Up; Upper resp; Viral Pneumonias; Wuhan coronavirus	4180186
36031453	SARS-CoV-2 RdRp Upper resp Ql NAA+probe	4180186
36031453	SARS 冠状病毒 2 RdRp 基因:存在情况或阈值:时间点:呼吸道.上:序数型:探针法.基因扩增.靶向	4182948
36031456	功能发现:印象:时间点:视觉通路.左侧:叙述型	4182948
36031456	EYE; EYE.PX; Func find; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; L; LT; Narrative; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Report; Visual pathway-L	4180186
36031456	Visual pathway-L Func find [Imp]	4180186
36031459	拉克罗斯病毒 抗体.中和:滴定度:时间点:XXX:定量型:中和试验	4182948
36031459	LACV NAb Titr Spec Nt	4180186
36031459	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; California Encephalitis Virus; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Lacrosse virus; LACV; Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; Other; Point in time; Random; Serum virus neutralization; SmQn; Spec; SVN; Titer; Titered; Titre; To be specified in another part of the message; Ttr; Unspecified; Virus neutralization test; VNT	4180186
36031460	Blood; Chemistry; DBS; Dried blood spot; Endocrine; Endocrinology; Filter paper; FP; Level; Mass concentration; P4; Point in time; Prog; Proges; Progest; Progestin; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
36031460	Progest DBS-mCnc	4180186
36031460	孕酮:质量浓度:时间点:全血.斑点:定量型	4182948
36031469	B Cell XM Pt ser+Don bld Ql FC	4180186
36031469	B Cell XM; B-ALL; B-cell acute lymphoblastic leukemia; BCELLS; BLOOD BANK; Dynamic; FC; Ordinal; Point in time; PR; Pt + bld; Pt ser+Don bld; Ql; Qual; Qualitative; Random; Screen; Serum; SR	4180186
36031469	B 细胞交叉配型:存在情况或阈值:时间点:血清^患者+全血:序数型:流式细胞测量术	4182948
36031470	西方马脑炎病毒 抗体.中和:滴定度:时间点:XXX:定量型:中和试验	4182948
36031470	WEEV NAb Titr Spec Nt	4180186
36031470	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); Enc; Enceph; Encephalomyelitis; Equin; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; Other; Point in time; Random; Serum virus neutralization; SmQn; Spec; SVN; Titer; Titered; Titre; To be specified in another part of the message; Togavirus; Ttr; Unspecified; Virus neutralization test; VNT; WEE virus; WEEV; West	4180186
36031474	伤口对情绪健康的影响:发现:时间点:^患者:名义型	4182948
36031474	Wound impact on emot health	4180186
36031474	Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random; Wound impact on emot health	4180186
36031476	PH; Point in time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random; Started	4180186
36031476	开始日期:日期:时间点:^事件:定量型	4182948
36031481	塔希纳病毒 抗体.IgM:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031481	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; TAHV; To be specified in another part of the message; Unspecified	4180186
36031481	TAHV IgM Spec Ql IA	4180186
36031482	4 weeks; Derm; Dermatology; Finding; Findings; Integument; Last; Ordinal; Ql; Qual; Qualitative; Screen; Skin; Survey; SURVEY.GNHLTH	4180186
36031483	甘氨酸受体 alpha-1 亚基 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:CBA IFA	4182948
36031483	A1; ABS; Aby; Alfa; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Gly; GlyR; GlyRa-1; GlyRa-1 Ab; i; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36031483	GlyRa-1 IgG CSF Ql CBA IFA	4180186
36031487	1 day; 24 hours; 24HR; Chemistry; Endocrine; Endocrinology; Pregnanetr; Pregntrl; QNT; Quan; Quant; Quantitative; Standard score; UA; UR; Urn; Z score; Z value; Z-score	4180186
36031487	Pregntrl 24h Z-score Ur	4180186
36031487	孕三醇:Z评分:24小时:尿液:定量型	4182948
36031488	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; C auris; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36031488	C auris DNA Bld Ql NAA+non-probe	4180186
36031488	耳道假丝酵母菌 DNA:存在情况或阈值:时间点:全血:序数型:非探针法.基因扩增.靶向	4182948
36031489	HLA-A Donr	4180186
36031489	Blood; Donr; HLA ANTIGEN; Human Leukocyte Antigen; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
36031489	HLA-A:类型:时间点:全血/组织^供体:名义型	4182948
36031490	健康相关行为和治疗依从性:发现:时间点:^患者:文档型	4182948
36031490	Health behav + tx compliance Doc	4180186
36031490	CLIN; Document; Finding; Findings; Health behav; Health behav + tx compliance; Point in time; Random; Tx	4180186
36031491	3 months; Finding; Findings; Last; Mental health; MentalHealth; Ordinal; Othr; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey; SURVEY.NIDA	4180186
36031493	Chemistry; Kidney; Nephrology; Osmo; Osmol; osmolarity; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Ratios; Renal; Rto; UA; UR; Urn	4180186
36031493	Prot/Osmolality Ur-Rto	4180186
36031493	蛋白质/渗透压:比率:时间点:尿液:定量型	4182948
36031495	1 year; 12Mos; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Scream/curse; Screen; SDOH; Survey	4180186
36031496	HEDIS 评测年度 2020 取值集合 - 尿液白蛋白肌酐比值检验项目:-:时间点:^患者:-	4182948
36031496	HEDIS MY 2020 Ur Alb Creat Rto Lab Test	4180186
36031496	Alb; CR; Crea; Creat; HEDIS MY 2020 Ur Alb Creat Rto Lab Test; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Protein.albumin; Random; UCr	4180186
36031497	NPASS pnl; Pan; PANEL.NEONAT; Panl; Pnl; Point in time; Random	4180186
36031497	NPASS pnl	4180186
36031499	3 months; Finding; Findings; Last; Mental health; MentalHealth; Ordinal; Psych; Psychiatry; Ql; Qual; Qualitative; Rx; Screen; Stimul; Stimulant; Survey; SURVEY.NIDA	4180186
36031501	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Random; Visit note	4180186
36031501	Psych Eval note	4180186
36031501	评价记录:发现:时间点:{环境}:文档型:心理学	4182948
36031503	铬:质量浓度:时间点:滑液:定量型	4182948
36031503	c609; Chrome; CR; DRUG/TOXICOLOGY; Drugs; Joint aspirate; Joint fld; Joint flu; Joint fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; SF; SNV; Syn; Syn fl; Synov; Synovial fluid	4180186
36031503	Cr Snv-mCnc	4180186
36031504	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S epidermidis; Screen; SDA; Staph; Staph epi; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36031504	S epidermidis DNA Bld Pos Ql NAA+non-prb	4180186
36031504	表皮葡萄球菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36031505	免疫球蛋白轻链.游离型与免疫固定电泳分析法组套:-:-:尿液:-	4182948
36031505	Bence Jones protein; BJ Protein; BJ Protein Free; BJP; Chain; Chemistry; FLC; FR; Immune globulin; Immuno; Immunoglob; Immunoglobin; Immunoglobulin LC free + IFE Pnl; Imunoglbon; Imunoglobn; Non-protein bound; Pan; PANEL.CHEMISTRY; Panl; Pnl; UA; UR; Urn	4180186
36031505	Immunoglobulin LC free + IFE Pnl Ur	4180186
36031508	Rho GTP 酶活化蛋白 26 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:CBA IFA	4182948
36031508	ABS; Aby; Antby; Anti; Antibodies; Antibody; ARHGAP26; Autoantibodies; Autoantibody; Autoimmune cerebellar ataxia; Cerebral spinal fluid; Cerebrospinal Fl; GRAF; GRAF Ab; GRAF IgG; GTPase Regulator Associated with Focal Adhesion Kinase pp125; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; Neuro; Neurology; Oligophrenin-1-like protein; OPHN1L; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36031508	GRAF IgG CSF Ql CBA IFA	4180186
36031510	1 day; 24 hours; 24HR; Chemistry; Endocrine; Endocrinology; QNT; Quan; Quant; Quantitative; Standard score; THcortisone; UA; UR; Urn; Z score; Z value; Z-score	4180186
36031510	THcortisone 24h Z-score Ur	4180186
36031510	四氢可的松:Z评分:24小时:尿液:定量型	4182948
36031513	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enc; Enceph; Encephalomyelitis; Enzyme immunoassay; Flavivirus; IAA; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; Japanese B encephalitis; Japanese encephalitis; JBE; JE virus; JEV; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36031513	JEV IgA Spec Ql IA	4180186
36031513	日本脑炎病毒 抗体.IgA:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031514	疼痛和/或躁动严重程度.行为状态:发现:时间点:^患者:序数型	4182948
36031514	Pain/agit severity behav	4180186
36031514	Finding; Findings; NEONAT; Ordinal; Pain/agit severity behav; Pain/agitat; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36031515	MyMemCheck pnl; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36031519	照护服务缺陷报告:发现:时间点:{环境}:文档型:{角色}	4182948
36031519	DOC.ONT; Document; Finding; Findings; Point in time; Random	4180186
36031520	近用瞳距测量过程中的焦距:长度:时间点:眼睛:定量型	4182948
36031520	Eye; EYE.REFRACTION; Eyeball; Focus dist n PD; Length; Occular; Oculis; Ophthalmologic; Ophthalmology; Ophtho; Ophthy; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Vision; Visual	4180186
36031520	Eye Focus dist n PD	4180186
36031522	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Revia; Sal; Screen; Vivitrol	4180186
36031522	Naltrexone Sal Ql Cfm	4180186
36031522	纳曲酮:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
36031523	室内呼吸系统变应原抗体.IgE 组套:-:时间点:血清:-	4182948
36031523	Indoor resp allergen IgE Pnl Ser	4180186
36031523	Allergen; Allergens; ALLERGY TESTING; Alrgen; Immune globulin E; Immunoglobulin E; Indoor resp allergen IgE Pnl; Pan; PANEL.ALLERGY; Panl; Pnl; Point in time; Random; Serum; SR	4180186
36031526	住院治疗:数量(计数):时间点:^事件:定量型	4182948
36031526	Cnt; Count; Number; PH; Point in time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random	4180186
36031526	Total Event hospitalizations	4180186
36031528	甘氨酸受体 抗体:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法	4182948
36031528	GlyR Ab SerPl Ql IA	4180186
36031528	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Gly; GlyR; GlyR Ab; IAA; MEIA; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
36031530	功能:发现:时间点:视神经.左侧:序数型:视网膜电图	4182948
36031530	ERG; EYE; EYE.ERG; FCN; Finding; Findings; Func; Funct; L; L optic n; LT; Ophthalmology; Ophtho; Ophthy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36031530	L optic n Function ERG	4180186
36031533	接纳治疗:发现:时间点:^患者:序数型	4182948
36031533	CLIN; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Treatment accept; Tx	4180186
36031533	Treatment accept	4180186
36031535	3 months; Last; Othr; Pan; Panel; Panl; Pnl; Survey; SURVEY.NIDA	4180186
36031536	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbovirus; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; RRV; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36031536	RRV IgG Spec Ql IA	4180186
36031536	罗斯河病毒 抗体.IgG:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031540	组织因子诱导型凝血过程.因子替换^在添加1:1正常血浆后孵育之后2小时:时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
36031540	120 min; 120 minutes; 120min; 2 hours; 2h p 1:1 NP; 2h p Inc; After; Clot; Clottable; Coag; Coagulation assay; Control; Fac; Fact; Hematology; Heme; i; Mixing studies; Plas; Platelet poor plasma; Point in time; Pro time; Prothrombin time; Protime; PST; PT; PT correction study; PT immediate mix; PT incubated mix; QNT; Quan; Quant; Quantitative; Random; Tilt tube	4180186
36031540	PT 2h p 1:1 NP PPP	4180186
36031541	辛德毕斯病毒 抗体.中和:滴定度:时间点:XXX:定量型:中和试验	4182948
36031541	SINV NAb Titr Spec Nt	4180186
36031541	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; Other; Point in time; Random; Serum virus neutralization; SINV; SmQn; Spec; SVN; Titer; Titered; Titre; To be specified in another part of the message; Ttr; Unspecified; Virus neutralization test; VNT	4180186
36031542	评价记录:发现:时间点:{环境}:文档型:母乳喂养	4182948
36031542	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Random; Visit note	4180186
36031542	Breastfeeding Eval note	4180186
36031543	Dialy+Ther Apher Admit eval note	4180186
36031543	Admit eval note; Assessment; Dialy; Dialy+Ther Apher; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Random; Ther; Visit note	4180186
36031543	入院评价记录:发现:时间点:{环境}:文档型:透析+治疗性血浆置换	4182948
36031544	除肾上腺皮质癌之外（外、以外）的肾上腺恶性肿瘤的概率:似然性:时间点:^患者:定量型:基于临床数据	4182948
36031544	ACC Prob; Adrnl; CLIN.RISK; from clin data; Malig; Oncology; Other adrenal malig Prob; Othr; Point in time; QNT; Quan; Quant; Quantitative; Random; Risk	4180186
36031544	Other adrenal malig Prob from clin data	4180186
36031546	After; Calorie Fast; Chemistry; Endocrine; Endocrinology; Fast; Fasting; Level; Mass concentration; p fast; Panc Polypept; Pancr; Pancreatc; PC; Pl; Plasma; Plsm; Point in time; Polypeptides; PP; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36031546	Panc Polypept p fast SerPl-mCnc	4180186
36031546	胰多肽^在热量型禁食之后:质量浓度:时间点:血清/血浆:定量型	4182948
36031547	活化凝血时间.玻璃珠诱导型^在肝素中和之后:时间:时间点:全血:定量型:微黏度测定法	4182948
36031547	ACT; ACT Glass Bead Ind; ACT Glss Bead Ind P Hep Ntr; Activ; Activated coagulation time; After; Blood; Clot; Clottable; COAGULATION; Coagulation activated; Coagulation time; Hematology; Heme; Hep; Hepar; Heparin Nt; Heparn; MicrVisc; Neut; Neutr; p hep neut; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rate; R-time; WB; Whole blood	4180186
36031547	ACT Glass Bead Ind HepNtr Bld MicrVisc	4180186
36031550	Blood; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; DBS; Dried blood spot; Filter paper; FP; HDLc; HDL-C; High density lipoprotein cholesterols; Lipid; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; TC; TCHHDL; Tot; Totl; WB; Whole blood	4180186
36031550	Cholest/HDLc DBS	4180186
36031550	胆固醇.总计/胆固醇.HDL 之中的:质量比率:时间点:全血.斑点:定量型	4182948
36031554	Finding; Findings; Mental health; MentalHealth; Ordinal; Othr; Point in time; Psych; Psychiatry; Ql; Qual; Qualitative; Random; Rel; Screen; Survey; SURVEY.NIDA	4180186
36031555	Immunoglobulin LC free Pnl Ur	4180186
36031555	Bence Jones protein; BJ Protein; BJ Protein Free; BJP; Chain; Chemistry; FLC; FR; Immune globulin; Immuno; Immunoglob; Immunoglobin; Immunoglobulin LC free Pnl; Imunoglbon; Imunoglobn; Non-protein bound; Pan; PANEL.CHEMISTRY; Panl; Pnl; UA; UR; Urn	4180186
36031555	免疫球蛋白轻链.游离型 组套:-:-:尿液:-	4182948
36031556	人乳头瘤病毒 35+39+68 DNA:存在情况或阈值:时间点:子宫颈:序数型:探针法.基因扩增.靶向	4182948
36031556	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cervix; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Genital warts; HPV; HPV35; HPV35+39+68; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36031556	HPV35+39+68 DNA Cvx Ql NAA+probe	4180186
36031559	1 week; Derm; Dermatology; Finding; Findings; Integument; Last; Ordinal; Ql; Qual; Qualitative; Screen; Skin; Survey; SURVEY.GNHLTH	4180186
36031560	与上一报告周期的健康医疗服务人员之中的病例数量增加或减少:数量差:报告期:^事件:定量型	4182948
36031560	# diff; Cases # diff HCP from prev RptPeriod; Cases among HCP; PH; Prev; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Report period	4180186
36031560	Event HCP cases # since prev RptPeriod	4180186
36031562	学校代码:标识符:时间点:学校:名义型	4182948
36031562	School code ID	4180186
36031562	ADMIN; Ident; Identifier; Intradermal; Nominal; Point in time; Random	4180186
36031564	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified; ZIKV	4180186
36031564	ZIKV IgG Spec Ql IA	4180186
36031564	寨卡病毒 抗体.IgG:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031568	Pain medicine Eval note	4180186
36031568	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Random; Visit note	4180186
36031568	评价记录:发现:时间点:{环境}:文档型:疼痛医学	4182948
36031569	Addiction; Desmeth; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; N-desmethyltramadol; NDT; Notramadol; O-desmethyltramadol; ODT; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Tramadol metabolite; UA; UR; Urn	4180186
36031569	O-nortramadol Ur Ql Scn	4180186
36031569	O-去甲基曲马多:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
36031570	1 month; 1 month (30 days); 30 days; Pan; Panel; Panl; Pnl; S prime; SDOH	4180186
36031571	所关注疾病患者已占据的住院床位/已占据的住院床位:计数型分数:时间点:{环境}:定量型	4182948
36031571	Beds occup w illness; Dis; Diseases; Dz; Inpt beds; Inpt beds occup; Number Fraction; Percent; PH; Point in time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random	4180186
36031571	Beds occup w illness/Inpt beds occup NFr	4180186
36031572	去甲右美沙芬+羟甲左吗南:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
36031572	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dromoran; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; DXO; DXO+Levorphanol; GCMS; Illicit; Levo-dromoran; Levorphan; Methorphinan; Oral fluid; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen	4180186
36031572	DXO+Levorphanol Sal Ql Cfm	4180186
36031574	甘氨酸受体 alpha-1 亚基 抗体.IgG:存在情况或阈值:时间点:血清:序数型:CBA IFA	4182948
36031574	GlyRa-1 IgG Ser Ql CBA IFA	4180186
36031574	A1; ABS; Aby; Alfa; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Gly; GlyR; GlyRa-1; GlyRa-1 Ab; i; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Serum; SR	4180186
36031576	镇静程度.面部表情:发现:时间点:^患者:序数型	4182948
36031576	Finding; Findings; Levels; Levl; LV; LVL; NEONAT; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sed level.facial exp; Sed lvl	4180186
36031576	Sed level.facial exp	4180186
36031577	#; ABS; absolute; absolutes; Auto; Automated detection; Blood; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Hematology; HEMATOLOGY/CELL COUNTS; Heme; Lg Platelets; Number concentration; Number Concentration (count/vol); Platelet; Platelet count; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrb; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
36031577	Lg Platelets # Bld Auto	4180186
36031577	血小板.大型:计数型浓度:时间点:全血:定量型:自动化计数方法	4182948
36031579	3 months; Finding; Findings; Last; Mental health; MentalHealth; Ordinal; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey; SURVEY.NIDA	4180186
36031580	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Random; Surg; Visit note	4180186
36031580	Cardiac surgery OP Note	4180186
36031580	记录:发现:时间点:门诊病人:文档型:心脏外科学	4182948
36031584	Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
36031584	HLA-C Donr Low res	4180186
36031584	HLA-C:类型:时间点:全血/组织^供体:名义型:低分辨率法	4182948
36031586	HEDIS 评测年度 2020 取值集合 - 铅检验项目:-:时间点:^患者:-	4182948
36031586	HEDIS MY 2020 Lead Tests; Painter's colic; Pan; Panel; PANEL.HEDIS; Panl; PB; Plumbism; Pnl; Point in time; Random	4180186
36031586	HEDIS MY 2020 Lead Tests	4180186
36031588	Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
36031588	HLA-DPB1 Donr High Res	4180186
36031588	HLA-DPB1:类型:时间点:全血/组织^供体:名义型:高分辨率方法	4182948
36031590	四氢-11-皮质酮:质量速率:24小时:尿液:定量型	4182948
36031590	1 day; 24 hours; 24HR; B; Chemistry; Compound B; Cort; Corticoster; Endocrine; Endocrinology; Mass Rate; mRate; QNT; Quan; Quant; Quantitative; TH-11-corticosterone; UA; UR; Urn	4180186
36031590	TH-11-corticosterone 24h Ur-mRate	4180186
36031595	Derm; DOC.ONT; Document; Finding; Findings; Photo image; Point in time; Random	4180186
36031595	Dermatology Photo image	4180186
36031595	数字摄影图像:发现:时间点:{环境}:文档型:皮肤病学	4182948
36031598	镇静程度.行为状态:发现:时间点:^患者:序数型	4182948
36031598	Finding; Findings; Levels; Levl; LV; LVL; NEONAT; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sed level.behav state; Sed lvl	4180186
36031598	Sed level.behav state	4180186
36031600	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; Metabolic and bariatric surgery; notes; Point in time; Random; Surg; Visit note	4180186
36031600	Bariatric surg Eval note	4180186
36031600	评价记录:发现:时间点:{环境}:文档型:减肥外科手术	4182948
36031602	Care plan; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Treatment plan; Visit note	4180186
36031602	医疗服务计划记录:发现:时间点:{环境}:文档型:免疫学	4182948
36031603	100WBC; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Lower respiratory; Macrop; Macrophage; Macros; Macrphg; Manl; Mono; Monocyte; Monos; Monos+Macros; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spt; Sputum; WBC; WBCs; White blood cell; White blood cells	4180186
36031603	Monos+Macros/leuk NFr Spt Manual	4180186
36031603	单核细胞+巨噬细胞/100 个白细胞:计数型分数:时间点:痰液:定量型:手工计数方法	4182948
36031605	镇静程度:发现:时间点:^患者:序数型	4182948
36031605	Sed lvl	4180186
36031605	Finding; Findings; Levels; Levl; LV; LVL; NEONAT; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sed lvl	4180186
36031606	ABS; Aby; American plague; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified; yellow jack; YFV	4180186
36031606	YFV IgM Spec Ql IA	4180186
36031606	黄热病病毒 抗体.IgM:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031607	School ID assign auth	4180186
36031607	ADMIN; ID assign auth; Ident; Identifier; Intradermal; Nominal; Point in time; Random	4180186
36031607	标识符指定机构:标识符:时间点:学校:名义型	4182948
36031611	3 months; Finding; Findings; Last; Mental health; MentalHealth; Ordinal; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey; SURVEY.NIDA	4180186
36031612	Centers for Medicare and Medicaid Assessment; Finding; Findings; Memory/recall ability; Nominal; Report period; Survey	4180186
36031613	单核细胞.程序性细胞死亡配体 1/100 个单核细胞:计数型分数:时间点:全血:定量型:流式细胞测量术	4182948
36031613	B7 homolog 1; B7-H1; Blood; CD274; CELL MARKERS; Cluster of differentiation 274; Dynamic; FC; i; Mono; Mono.PD-L1; Monocyte; Monos; Number fraction; PDL1; PD-L1; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
36031613	Mono.PD-L1/100 Mono NFr Bld FC	4180186
36031616	过去一年的烟草使用情况:发现:1年:^患者:序数型	4182948
36031616	Finding; Findings; H+P; H+P.HX; Last; Ordinal; P prime; QL; Qual; Qualitative; Screen	4180186
36031616	Tobacco use 1Y	4180186
36031617	表面诱导型凝血过程.狼疮敏感性.因子替换^在添加1:1正常血浆后孵育之后1小时:时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
36031617	1 hour; 1.0Hr; 1h p 1:1 NP; 1h p Inc; 60 min; 60 minutes; 60M; 60min; Activated partial thromboplastin time; After; aPTT; aPTT with Platelin LS; aPTT-LA; Clot; Clottable; Coag; Coagulation assay; Control; Fac; Fact; Hematology; Heme; i; Little(A)PTT; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; PST; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube	4180186
36031617	aPTT-LA 1h p 1:1 NP PPP	4180186
36031621	相位偏移^明适应型:时间:时间点:视网膜.左侧:定量型:视网膜电图.图形	4182948
36031621	ERG; EYE; EYE.ERG; L; L ret; LT; Ophthalmology; Ophtho; Ophthy; PERG; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36031621	L ret Ph shift--light-adapt [Time] PERG	4180186
36031622	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Human T-cell Leukemia Virus; Human T-cell Lymphotrophic Virus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Viral load	4180186
36031622	HTLV I DNA # Spec NAA+probe	4180186
36031622	HTLV I DNA:计数型浓度:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36031623	血液黏弹性描记:发现:检查过程持续时间:全血:文档型	4182948
36031623	Blood; Coag; Coag Viscoelast Tracing; Document; Finding; Findings; Hematology; Heme; Studies; Study; Sutdies; WB; Whole blood	4180186
36031623	Coag Viscoelast Tracing Bld Doc	4180186
36031624	亚甲蓝 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
36031624	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; C710; Immune globulin E; Immunoglobulin E; Methylene blue IgE; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
36031624	Methylene blue IgE Qn	4180186
36031626	与上一报告周期的死亡人数增加或减少百分比:百分数差:报告期:^事件:定量型	4182948
36031626	% diff in deaths from prev rpt period; Death # diff from prev RptPeriod; Fatalities; PH; Prev; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Report period	4180186
36031626	% diff in deaths since prev RptPeriod	4180186
36031628	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; H capsul; H capsulatum; H farciminosum; Histo; Histopl; Histoplasma farciminosum; Histoplasmos; Histoplasmosis; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36031628	H capsul DNA Lower resp Ql NAA+probe	4180186
36031628	荚膜组织胞浆菌 DNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36031629	加利福尼亚脑炎病毒 抗体.中和:滴定度:时间点:XXX:定量型:中和试验	4182948
36031629	CEV NAb Titr Spec Nt	4180186
36031629	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CA; Calif; CEV; CEV Ab; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); Enc; Enceph; Encephalomyelitis; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; Other; Point in time; Random; Serum virus neutralization; SmQn; Spec; SVN; Titer; Titered; Titre; To be specified in another part of the message; Ttr; Unspecified; Virus neutralization test; VNT	4180186
36031630	良性肿块概率:似然性:时间点:^患者:定量型:基于临床数据	4182948
36031630	CLIN.RISK; from clin data; Oncology; Point in time; QNT; Quan; Quant; Quantitative; Random; Risk	4180186
36031630	Benign mass Prob from clin data	4180186
36031633	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enc; Enceph; Encephalomyelitis; Enzyme immunoassay; Flavivirus; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Japanese B encephalitis; Japanese encephalitis; JBE; JE virus; JEV; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36031633	JEV IgM Spec Ql IA	4180186
36031633	日本脑炎病毒 抗体.IgM:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031634	伤口持续时间:时间:时间点:^患者:定量型	4182948
36031634	Durat; H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36031642	功能发现:印象:时间点:视觉通路.右侧:叙述型:视觉诱发电位	4182948
36031642	EYE; EYE.PX; Func find; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Ophthalmology; Ophtho; Ophthy; Point in time; R; Random; Report; RT; Visual pathway-R	4180186
36031642	Visual pathway-R Func find [Imp] VEP	4180186
36031644	Bind; Ca; Cal; Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; S100 Ca binding protein B; S-100B; S-100-beta; Serum; SR; SUDS	4180186
36031644	S100 Ca binding protein B Ser IA-mCnc	4180186
36031644	S100 钙结合蛋白 B:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36031645	(庆大霉素+林可霉素+新链丝菌素+链霉素+妥布霉素) 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
36031645	ABS; Aby; Albiotic; Allergen; Allergens; Allergy; ALLERGY TESTING; Aminoglycoside Mix; Aminoglycoside Mix IgE; Aminoglycosides; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; c115; c232; c288; C295; Cidam est; Cillimicina; Cillimycin; Immune globulin E; Immunoglobulin E; Lincocin; Lincocine; NEBCIN; NEBDIN; Neosporin; Novostrep; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Solustrep; SR; Streptocol; Strepto-fatol; Streptomyc; TOBJ; TOBRA	4180186
36031645	Aminoglycoside Mix IgE Qn	4180186
36031648	Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
36031648	HLA-DRB1 Donr High Res	4180186
36031648	HLA-DRB1:类型:时间点:全血/组织^供体:名义型:高分辨率方法	4182948
36031649	Alpha-1-胎儿球蛋白与 Alpha-1-胎儿球蛋白.L3 组套:-:时间点:血清/血浆:-	4182948
36031649	A1; AFP; AFP L3; AFP+AFP.L3 Pnl; Alfa; Alpha fetoprotein; Alphafetoprotein; Chemistry; Feto; i; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker	4180186
36031649	AFP+AFP.L3 Pnl SerPl	4180186
36031650	甲状腺球蛋白^甲状腺球蛋白抗体中和之后:质量浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
36031650	Ab; After; Chemistry; EIA; ELFA; ELISA; Endocrine; Endocrinology; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Neut; Neutr; p TG Ab neut; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Tg; Thyglobulin; Thyroglbn; Thyroglob; Thyroglob^p thyroglob Ab neut; Tumor marker	4180186
36031650	Thyrogl p thyrogl Ab neut SerPl IA-mCnc	4180186
36031652	2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 RdRp; Screen; SDA; Severe Acute Respiratory Syndrome; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral Pneumonias; Wuhan coronavirus	4180186
36031652	SARS-CoV-2 RdRp Lower resp Ql NAA+probe	4180186
36031652	SARS 冠状病毒 2 RdRp 基因:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36031654	詹姆斯敦峡谷病毒 抗体.中和:滴定度:时间点:XXX:定量型:中和试验	4182948
36031654	JCV NAb Titr Spec Nt	4180186
36031654	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; JCV; Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; Other; Point in time; Random; Serum virus neutralization; SmQn; Spec; SVN; Titer; Titered; Titre; To be specified in another part of the message; Ttr; Unspecified; Virus neutralization test; VNT	4180186
36031655	11-beta HSD; 11-beta-HSD1; 11-beta-HSD2; 11-beta-hydroxy steroid dehydrogenase; 11-ß-HSD1; 11-ß-HSD2; 17-Hydroxycorticosterone; Blood; c155; Chemistry; Compound E; Compound F; Coritsol; Cort; DBS; Dried blood spot; Endocrine; Endocrinology; F; Filter paper; FP; hydrocortisone; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
36031655	Cortis/Cortisone DBS	4180186
36031655	皮质醇/可的松:质量比率:时间点:全血.斑点:定量型	4182948
36031656	1 year; 12Mos; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; SDOH; Survey	4180186
36031659	功能:发现:时间点:视神经.右侧:序数型:视觉诱发电位	4182948
36031659	EYE; EYE.PX; FCN; Finding; Findings; Func; Funct; Ophthalmology; Ophtho; Ophthy; Ordinal; Point in time; QL; Qual; Qualitative; R; R optic n; Random; RT; Screen	4180186
36031659	R optic n Function VEP	4180186
36031664	健在配偶姓名:人员姓名:时间点:^患者:名义型	4182948
36031664	ADMIN; Nominal; Person name; Point in time; Random	4180186
36031665	雪鞋野兔病毒 抗体.中和:滴定度:时间点:XXX:定量型:中和试验	4182948
36031665	SSHV NAb Titr Spec Nt	4180186
36031665	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; Other; Point in time; Random; Serum virus neutralization; SmQn; Spec; SSHV; SVN; Titer; Titered; Titre; To be specified in another part of the message; Ttr; Unspecified; Virus neutralization test; VNT	4180186
36031669	B burgdor IgA Spec Ql	4180186
36031669	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; Bb; Burgdorf; Immune globulin A; Immunoglobulin A; Lyme; Lyme disease; Lymes; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
36031669	伯氏疏螺旋体 抗体.IgA:存在情况或阈值:时间点:XXX:序数型	4182948
36031670	神经中间丝 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:免疫荧光法	4182948
36031670	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuro; Neurology; NIF; NIF Ab; NIF IgG; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF	4180186
36031670	NIF IgG CSF Ql IF	4180186
36031671	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enc; Enceph; Encephalomyelitis; Enzyme immunoassay; Equin; IAA; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Togavirus; Unspecified; VEE virus; VEEV	4180186
36031671	VEEV IgA Spec Ql IA	4180186
36031671	委内端拉马脑脊髓炎病毒 抗体.IgA:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031673	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SPEC	4180186
36031673	Clot Fld Ql	4180186
36031673	凝块:存在情况或阈值:时间点:体液:序数型	4182948
36031674	HMGCR Ab SerPl IA-aCnc	4180186
36031674	3-羟基-3-甲基戊二酰-辅酶 A 还原酶 抗体:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
36031674	3-OH-3-Methylglutaryl-coA reductase Ab; ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HMGCR; Hydrox; IAA; III; MEIA; NAM; Necrotizing autoimmune myopathy; OH; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
36031676	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Dextro-methorphan; D-methorphan; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Oral fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
36031676	D-methorphan Sal Cfm-mCnc	4180186
36031676	右美沙芬:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
36031677	1 day; 24 hours; 24HR; Chemistry; DHEA; Endocrine; Endocrinology; Prasterone; QNT; Quan; Quant; Quantitative; Standard score; UA; UR; Urn; Z score; Z value; Z-score	4180186
36031677	DHEA 24h Z-score Ur	4180186
36031677	脱氢表雄酮:Z评分:24小时:尿液:定量型	4182948
36031679	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
36031679	HLA-DPA1 Low res	4180186
36031679	HLA-DPA1:类型:时间点:全血/组织:名义型:低分辨率法	4182948
36031682	HEDIS 评测年度 2020 取值集合 - PSA 检验项目:-:时间点:^患者:-	4182948
36031682	HEDIS MY 2020 PSA Tests; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
36031682	HEDIS MY 2020 PSA Tests	4180186
36031685	疼痛和/或躁动严重程度.生命体征变异程度:发现:时间点:^患者:序数型	4182948
36031685	Finding; Findings; NEONAT; Ordinal; Pain/agi severity vital sign var; Pain/agitat; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36031685	Pain/agi severity vital sign var	4180186
36031687	Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
36031687	HLA-DQA1 Donr High Res	4180186
36031687	HLA-DQA1:类型:时间点:全血/组织^供体:名义型:高分辨率方法	4182948
36031691	Assessment; DOC.ONT; Document; Emotional stability; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Random; Visit note	4180186
36031691	Mental health Eval note	4180186
36031691	评价记录:发现:时间点:{环境}:文档型:心理健康	4182948
36031692	ED Summary note	4180186
36031692	DOC.ONT; Document; ED; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36031692	摘要:发现:时间点:急诊科:文档型:{角色}	4182948
36031694	活化凝血时间.白陶土诱导型:时间:时间点:全血:定量型:微黏度测定法	4182948
36031694	ACT; ACT Kaolin Ind; Activ; Activated coagulation time; Blood; Clot; Clottable; COAGULATION; Coagulation activated; Coagulation time; Hematology; Heme; MicrVisc; Point in time; QNT; Quan; Quant; Quantitative; Random; Rate; R-time; WB; Whole blood	4180186
36031694	ACT Kaolin Ind Bld MicrVisc	4180186
36031697	标准厚度参数:长度:时间点:角膜.左侧:定量型:眼压测量法	4182948
36031697	Corneal; EYE; EYE.TONOMETRY; Glaucoma testing; L; L cornea; Length; LT; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random; Thick	4180186
36031697	L cornea Standard thickness Tono	4180186
36031698	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified; WNV	4180186
36031698	WNV IgA Spec Ql IA	4180186
36031698	西尼罗河病毒 抗体.IgA:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031700	Document; Films; Finding; Findings; Imaging; Misc; Miscellaneous; Other; Plain Films; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified; View; VWS; XR port; Xray; X-ray	4180186
36031700	XR port Views	4180186
36031700	多重视图:发现:时间点:XXX:文档型:X射线摄影术.便携式	4182948
36031703	珊瑚状纤维:计数型浓度:时间点:呼吸道.下:定量型:手工计数方法	4182948
36031703	#; ABS; absolute; absolutes; Cnt; Coppen-Jones fibers; Count; Count/volume; CT; Fiber; Low; Lower resp; Manl; Number concentration; Number Concentration (count/vol); PATHOLOGY; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36031703	Coral fibers # Lower resp Manual	4180186
36031704	3 months; Finding; Findings; Last; Mental health; MentalHealth; Ordinal; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey; SURVEY.NIDA	4180186
36031706	2-(meta-benzylphenyl) propionate; ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; C16H14O3; c388; Immune globulin E; Immunoglobulin E; Ketoprofen IgE; Orudis; Oruvail; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
36031706	Ketoprofen IgE Qn	4180186
36031706	酮洛芬 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
36031708	HLA-DRB3 与 HLA-DRB4 与 HLA DRB5 未决等位基因:类型:时间点:全血/组织^供体:名义型:高分辨率方法	4182948
36031708	Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA-DRB3 + 4 + 5; HLA-DRB345 Unreslvd; HLA-DRB5; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
36031708	HLA-DRB345 Unreslvd Donr High Res	4180186
36031709	Clot; Clottable; Coag; Coagulation assay; Fac; Fact; Fact XII; Fact XII Inhib; Factor 12; FXII; Hageman factor; Hematology; Heme; Inhib; Inhibit; Ordinal; Plas; Platelet poor plasma; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tilt tube	4180186
36031709	Fact XII Inhib PPP Ql	4180186
36031709	凝血因子 XII 抑制剂:存在情况或阈值:时间点:贫血小板血浆:序数型:凝血功能分析	4182948
36031710	圣路易型脑炎病毒抗体.IgG 与 IgM 组套:-:时间点:血清:-	4182948
36031710	Enc; Enceph; Encephalomyelitis; ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Serum; SLE virus; SLEV; SLEV IgG+IgM Pnl; SR; St Louis	4180186
36031710	SLEV IgG+IgM Pnl Ser	4180186
36031715	Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.NIDA	4180186
36031721	良性肿块概率:似然性:时间点:^患者:定量型:基于临床数据和实验室数据	4182948
36031721	CLIN.RISK; from clin+lab data; Oncology; Point in time; QNT; Quan; Quant; Quantitative; Random; Risk	4180186
36031721	Benign mass Prob from clin+lab data	4180186
36031722	肺炎克雷伯菌+变栖克雷伯菌+类肺炎克雷伯菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36031722	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; K pneumon; K. pneumon group; Klebsiella pneumoniae group; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36031722	Klebsiella sp DNA Bld Pos Ql NAA+non-prb	4180186
36031724	HLA-A 与 B 与 C (I 类) 分型组套:-:时间点:全血/组织^供体:-:低分辨率法	4182948
36031724	A,B; Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA class I; HLA Cls I Typ Pnl; HLA-A+B; HLA-A+B+C; HLA-A+B+C (class I); Human Leukocyte Antigen; Inherited; Pan; PANEL.HLA; Panl; Pnl; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36031724	HLA Cls I Typ Pnl Bld/T Donr Low res	4180186
36031725	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdorferi; Bb; Burgdorf; Immune globulin M; Immunoglobulin M; Lyme; Lyme disease; Lymes; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
36031725	B burgdor IgM Spec Ql	4180186
36031725	伯氏疏螺旋体 抗体.IgM:存在情况或阈值:时间点:XXX:序数型	4182948
36031728	HEDIS 评测年度 2020 取值集合 - A 组链球菌试验:-:时间点:^患者:-	4182948
36031728	HEDIS MY 2020 Grp A Strep	4180186
36031728	HEDIS MY 2020 Grp A Strep; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
36031729	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blasto; Blastomycosis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
36031729	Blastomyces DNA Tiss Ql NAA+probe	4180186
36031729	芽生菌属单个未知种 DNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36031730	Appearance; Colour; EPS; expressed prostatic secretion; Genitourinary; GU; Nominal; Point in time; Prost; Prost fld; Prostate; Prostate secretion; Prostati; Prostatic secretion; Random; SPEC; Typ; URO; Urology	4180186
36031730	Color Prost fld	4180186
36031730	颜色:类型:时间点:前列腺液:名义型	4182948
36031732	Blood; Chromosom; Chromosomes; Del; Deletions; Document; Finding; Findings; Fluorescent in situ hybridization; Molecular pathology; MOLPATH; MOLPATH.DELDUP; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36031732	4p16.3 Del Bld/T FISH	4180186
36031732	4p16.3 染色体 缺失:发现:时间点:全血/组织:文档型:FISH	4182948
36031736	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Highland J virus; HJV; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36031736	HJV IgM Spec Ql IA	4180186
36031736	高地 J 病毒 抗体.IgM:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031737	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA-DRB3 + 4 + 5; HLA-DRB5; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
36031737	HLA-DRB3 + 4 + 5 Low res	4180186
36031737	HLA-DRB3 & HLA-DRB4 & HLA DRB5:类型:时间点:全血/组织:名义型:低分辨率法	4182948
36031738	伊利乌斯病毒 抗体.IgM:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031738	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Flaviviruses; IAA; ID; ILHV; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36031738	ILHV IgM Spec Ql IA	4180186
36031742	功能:发现:时间点:视椎细胞.右侧:序数型:视网膜电图	4182948
36031742	ERG; EYE; EYE.ERG; FCN; Finding; Findings; Func; Funct; Ophthalmology; Ophtho; Ophthy; Ordinal; Point in time; QL; Qual; Qualitative; R; R cones; Random; RT; Screen	4180186
36031742	R cones Function ERG	4180186
36031750	Blood; Donr; HLA ANTIGEN; Human Leukocyte Antigen; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
36031750	HLA-DQB1 Donr	4180186
36031750	HLA-DQB1:类型:时间点:全血/组织^供体:名义型	4182948
36031752	1,4,5-三磷酸肌醇受体 1型 抗体.IgG:存在情况或阈值:时间点:血清:序数型:CBA IFA	4182948
36031752	IP3R 1 IgG Ser Ql CBA IFA	4180186
36031752	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cyclohexane-1,2,3,4,5,6-hexol; i; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; InsP3R1; IP3 receptor isoform 1; IP3R 1; IP3R 1 Ab; IP3R 1 IgG; ITPR; ITPR1; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Serum; SR; Type 1 inositol 1,4,5-trisphosphate receptor; Type 1 InsP3 receptor	4180186
36031753	Phone Eval note	4180186
36031753	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Random; Visit note	4180186
36031753	评价记录:发现:时间点:电话就医:文档型:{角色}	4182948
36031755	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Highland J virus; HJV; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36031755	HJV IgG Spec Ql IA	4180186
36031755	高地 J 病毒 抗体.IgG:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031757	Rheumatology Eval note	4180186
36031757	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Random; Visit note	4180186
36031757	评价记录:发现:时间点:{环境}:文档型:风湿病学	4182948
36031761	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; C112; c711; E250; Erinitrit; Immune globulin E; Immunoglobulin E; Na; Na+; Na-nitrite; Nitrous acid sodium salt; NO2; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Sodium nitrite IgE; SR	4180186
36031761	Sodium nitrite IgE Qn	4180186
36031761	亚硝酸钠 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
36031764	Fld Micro	4180186
36031764	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; Identity or presence; LM; Micro; Micros; Microscopic; Nominal; Pathology; Point in time; Random	4180186
36031764	显微镜观察:存在与否或特征标识:时间点:体液:名义型:显微镜检查.光学	4182948
36031765	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Lyrica; Mass concentration; Oral fluid; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sal	4180186
36031765	Pregabalin Sal Cfm-mCnc	4180186
36031765	普瑞巴林:质量浓度:时间点:唾液:定量型:毒理学确认试验	4182948
36031767	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Gerbera spp IgE; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; w59	4180186
36031767	Gerbera spp IgE Qn	4180186
36031767	大丁草属多个未知种 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
36031768	1 week; Derm; Dermatology; Finding; Findings; Integument; Last; Ordinal; Ql; Qual; Qualitative; Screen; Skin; Survey; SURVEY.GNHLTH; Sx	4180186
36031770	Desoxyn; Finding; Findings; Mental health; MentalHealth; Methamphet; Ordinal; Point in time; Psych; Psychiatry; Ql; Qual; Qualitative; Random; Screen; Survey; SURVEY.NIDA	4180186
36031775	HEDIS 评测年度 2020 取值集合 - 尿液肌酐检验项目:-:时间点:^患者:-	4182948
36031775	CR; Crea; Creat; HEDIS MY 2020 Ur Creat Lab Test; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; UCr	4180186
36031775	HEDIS MY 2020 Ur Creat Lab Test	4180186
36031776	25 Hydroxyvitamin D 2; 25 Hydroxyvitamin D2; 25(OH)D2; 25-Hydroxy calciferol; 25-Hydroxycalciferol; 25-Hydroxyergocalciferol; 25-Hydroxyvitamin D 2; 25-Hydroxyvitamin D2; 9,10-Secoergosta-5,7,10(19),22-tetraene-3 beta,25-diol; Blood - capillary; Cap bld; Cap blood; Capillary bld; Capillary blood; Chemistry; Endocrine; Endocrinology; Ercalcidiol; Finger stick; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36031776	25(OH)D2 BldC-mCnc	4180186
36031776	羟基钙二醇:质量浓度:时间点:毛细血管全血:定量型	4182948
36031777	3 months; Last; Mental health; MentalHealth; Nominal; Psych; Psychiatry; Survey; SURVEY.NIDA; Typ	4180186
36031780	Assessment; Cancer; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Random; Visit note	4180186
36031780	Oncology Eval note	4180186
36031780	评价记录:发现:时间点:{环境}:文档型:肿瘤学	4182948
36031781	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Rad; Radiology; Random; Visit note	4180186
36031781	Radiology OP Note	4180186
36031781	记录:发现:时间点:门诊病人:文档型:放射医学	4182948
36031785	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CTFV; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36031785	CTFV IgA Spec Ql IA	4180186
36031785	科洛拉多蜱传热病毒 抗体.IgA:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031788	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enc; Enceph; Encephalomyelitis; Enzyme immunoassay; Equin; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Togavirus; Unspecified; WEE virus; WEEV; West	4180186
36031788	WEEV IgG Spec Ql IA	4180186
36031788	西方马脑炎病毒 抗体.IgG:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031792	Amph; Amphet; Amphetam; Amphetamines; Ampht; Finding; Findings; Mental health; MentalHealth; Ordinal; Point in time; Psych; Psychiatry; Ql; Qual; Qualitative; Random; Screen; Speed; Stimul; Stimulant; Survey; SURVEY.NIDA	4180186
36031794	A terreus; ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Asperg; Aspergil; Aspergilis; Aspergilla; Aspergillin; Aspergillosis; Aspergils; Aspergilus; Autoantibodies; Autoantibody; Farmers lung; Immune globulin G; Immunoglobulin G; m309; m36; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
36031794	A terreus IgG Ql	4180186
36031794	土曲霉 抗体.IgG:存在情况或阈值:时间点:血清:序数型	4182948
36031797	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CA; Calif; CEV; CEV Ab; CEV IgM; EIA; ELFA; ELISA; Enc; Enceph; Encephalomyelitis; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36031797	CEV IgM Spec Ql IA	4180186
36031797	加利福尼亚脑炎病毒 抗体.IgM:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031800	1 month; 1 month (30 days); 30 days; Finding; Findings; month; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; SDOH	4180186
36031802	1 week; Derm; Dermatology; QNT; Quan; Quant; Quantitative; Scale; Skin; Survey; SURVEY.GNHLTH	4180186
36031803	Blood; Donr; HLA ANTIGEN; Human Leukocyte Antigen; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
36031803	HLA-C Donr	4180186
36031803	HLA-C:类型:时间点:全血/组织^供体:名义型	4182948
36031804	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enc; Enceph; Encephalomyelitis; Enzyme immunoassay; Equin; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Togavirus; Unspecified; VEE virus; VEEV	4180186
36031804	VEEV IgM Spec Ql IA	4180186
36031804	委内端拉马脑脊髓炎病毒 抗体.IgM:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031805	1 day; 24 hours; 24HR; 6B-OH-Cortisol; B; Chemistry; Endocrine; Endocrinology; QNT; Quan; Quant; Quantitative; Standard score; UA; UR; Urn; Z score; Z value; Z-score	4180186
36031805	6B-OH-Cortisol 24h Z-score Ur	4180186
36031805	6-beta-羟基四氢-11-脱氢皮质甾醇:Z评分:24小时:尿液:定量型	4182948
36031807	Breath; ExG; Exhaled gas; Exhaled gas (=breath); Gases; Lung; NO; Percent; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Volfr; Volume fraction	4180186
36031807	FeNO VFr	4180186
36031807	一氧化氮/已呼出的气体:体积分数:时间点:呼出的气体:定量型	4182948
36031808	活 CD3 细胞/100 个细胞.CD3:计数型分数:时间点:^血液制品单位:定量型	4182948
36031808	100 CD3; BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Cell; Cellularity; Leu4; Leu-4; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T3	4180186
36031808	Viable CD3 cells/100 CD3 NFr BPU	4180186
36031809	Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
36031809	HLA-DQB1 Donr High Res	4180186
36031809	HLA-DQB1:类型:时间点:全血/组织^供体:名义型:高分辨率方法	4182948
36031810	Cardiac surgery Eval note	4180186
36031810	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Random; Surg; Visit note	4180186
36031810	评价记录:发现:时间点:{环境}:文档型:心脏外科学	4182948
36031811	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Random; Visit note	4180186
36031811	Kinesiotherapy Eval note	4180186
36031811	评价记录:发现:时间点:{环境}:文档型:运动疗法	4182948
36031812	脂肪酸盐类:存在情况或阈值:时间点:大便:序数型:显微镜检查.光学	4182948
36031812	FA salts Stl Ql Micro	4180186
36031812	Acd; Acids; Bowel movement; Chemistry; FA salts; Faecal; Faeces; Fecal; Feces; LM; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Soap; Soaps; Stl; Stool = Fecal	4180186
36031815	塔希纳病毒 抗体.中和:滴定度:时间点:XXX:定量型:中和试验	4182948
36031815	TAHV NAb Titr Spec Nt	4180186
36031815	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; Other; Point in time; Random; Serum virus neutralization; SmQn; Spec; SVN; TAHV; Titer; Titered; Titre; To be specified in another part of the message; Ttr; Unspecified; Virus neutralization test; VNT	4180186
36031816	布汪巴病毒 抗体.IgG:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031816	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Orthobunyaviruses; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36031816	Bwamba virus IgG Spec Ql IA	4180186
36031817	梅毒螺旋体与杜克雷嗜血杆菌与单纯疱疹病毒 DNA 组套:-:时间点:XXX:-:探针法.基因扩增.靶向	4182948
36031817	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Chancroid; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; H ducreyi; Haemoph; Herp splx; HSV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spec; Strand Displacement Amplification; Syphilis; T pall+H ducr+HSV DNA Pnl; T pallidum; TMA; To be specified in another part of the message; Transcription mediated amplification; Treponemal; Unspecified	4180186
36031817	T pall+H ducr+HSV DNA Pnl Spec NAA+probe	4180186
36031821	初步评价记录:发现:时间点:{环境}:文档型:变态反应法	4182948
36031821	Allergy; Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; Initial eval note; notes; Point in time; Random; Visit note	4180186
36031821	Allergy Initial eval note	4180186
36031822	HLA-C 未决等位基因:类型:时间点:全血/组织:名义型:高分辨率方法	4182948
36031822	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA-C Unreslvd Alleles; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
36031822	HLA-C Unreslvd Alleles High Res	4180186
36031824	1,4,5-三磷酸肌醇受体 1型 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
36031824	IP3R 1 IgG Titr Ser IF	4180186
36031824	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cyclohexane-1,2,3,4,5,6-hexol; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; i; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; InsP3R1; IP3 receptor isoform 1; IP3R 1; IP3R 1 Ab; IP3R 1 IgG; ITPR; ITPR1; Point in time; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Type 1 inositol 1,4,5-trisphosphate receptor; Type 1 InsP3 receptor	4180186
36031826	与上一报告周期的病例数量增加或减少:数量差:报告期:^事件:定量型	4182948
36031826	# diff; Case # compared to prev rpt period; PH; Prev; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Report period	4180186
36031826	Event cases # since prev RptPeriod	4180186
36031828	过硫酸铵 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
36031828	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Amm; Ammon; Ammonium persulfate IgE; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; C604; Immune globulin E; Immunoglobulin E; NH4; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
36031828	Ammonium persulfate IgE Qn	4180186
36031829	3 Self-Sustaining Sequence Replication; 3SR SR; Adeno virus; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HAdV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36031829	HAdV RNA Spec Ql NAA+probe	4180186
36031829	腺病毒 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36031830	GATA2 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36031830	Blood; DCML; Document; Finding; Findings; full gene sequencing; Full Mut Anl; GATA binding protein 2; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; IMD21; Inherited; Molecular pathology; MOLPATH; MONOMAC; Mut; Mutations; Next generation sequencing; NFE1B; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36031830	GATA2 gene Full Mut Anl Bld/T Seq	4180186
36031831	已报告的阳性实验室检验结果:数量(计数):报告期:^事件:定量型	4182948
36031831	Cnt; Count; Lab test results reported; Number; PH; Pos; Pos lab tests; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Report period	4180186
36031831	Pos lab test results in RptPeriod	4180186
36031832	凝血因子 V 活性与抑制剂组套:-:时间点:贫血小板血浆:-:凝血功能分析	4182948
36031832	Activ; Actvty; Clot; Clottable; Coag; Coagulation assay; Fac; Fact; Fact V; Fact V Act + Inhib Pnl; Factor 5; FV; Inhib; Inhibit; Movements; Pan; PANEL.COAGULATION; Panl; Plas; Platelet poor plasma; Pnl; Point in time; Proaccelerin; Proaccelerin accelerator globulin; Random; The labile factor; Tilt tube	4180186
36031832	Fact V Act + Inhib Pnl PPP	4180186
36031834	凝块形成.白陶土诱导型^在肝素中和之后:时间:时间点:全血:定量型:超声	4182948
36031834	Clot init kaolin ind p hep neut Bld US	4180186
36031834	After; Blood; Clot init kao ind p hep neut; Clot init kaolin ind; COAGULATION; CT; CTH; Echography; Hematology; Heme; Hep; Hepar; Heparin Nt; Heparn; Neut; Neutr; p hep neut; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; WB; Whole blood	4180186
36031836	托珠单抗:质量浓度:时间点:血清:定量型	4182948
36031836	Tocilizumab Ser-mCnc	4180186
36031836	Actemra; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
36031837	生长激素^在给予剂量马西瑞林之后60分钟:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36031837	60M p Macimorelin; After; Chemistry; EIA; ELFA; ELISA; Endocrine; Endocrinology; Enzyme immunoassay; GH; Growth hormone; HGH; Human growth hormone; IAA; Level; Mass concentration; MEIA; p dose; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Serum; Somatotropic hormone; SR; STH; SUDS	4180186
36031837	GH 60M p Macimorelin Ser IA-mCnc	4180186
36031841	容积调整参数:长度倒数:时间点:角膜.左侧:定量型:眼压测量法	4182948
36031841	Corneal; EYE; EYE.TONOMETRY; Glaucoma testing; Inverse Length; L; L cornea; LT; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random; Vol; Vol Adj	4180186
36031841	L cornea Vol Adj Tono	4180186
36031843	Blood; Document; Fam Mut Anl; Finding; Findings; Genetics; Heredity; Heritable; Inherited; LMTED; LTD; Molecular genetics; Molecular pathology; MOLPATH; Mut; Mutation; Mutations; Muts; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36031843	Gene XXX Fam Mut Anl Bld/T	4180186
36031843	基因 XXX 局限于已知家族性突变的突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36031845	4 weeks; Derm; Dermatology; Finding; Findings; Integument; Last; Ordinal; Ql; Qual; Qualitative; Screen; Skin; Survey; SURVEY.GNHLTH	4180186
36031846	Blood; BSA pred.non black; Chemistry; DBS; Dried blood spot; EGFR; Estimated GFR; Filter paper; FP; GFR; GFR/1.73 sq M; Glom; Kidney; Nephrology; Point in time; Pred GFR; Pred GFR.non Black; QNT; Quan; Quant; Quantitative; Random; Renal; Square Meter; Volume rate/area; Volume Rate/Ratio; WB; Whole blood	4180186
36031846	GFR/BSA pred.non black DBS-ArVRat	4180186
36031846	肾小球滤过率/1.73 平方米.预测型.非黑人:单位面积体积速率:时间点:全血.斑点:定量型	4182948
36031848	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdor 49736; B burgdorferi; Bb; Blt; Burgdorf; Cnt; Count; Immune blot; Immune globulin G; Immunobl; Immunoblot; Immunoglobulin G; Lyme; Lyme disease; Lymes; Microbiology; Misc; Miscellaneous; Number; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; RIBA; Spec; To be specified in another part of the message; Unspecified; WB; WBLOT; West blot; West blt; Western blot	4180186
36031848	B burgdor 49736 IgG bands Spec IB	4180186
36031848	伯氏疏螺旋体 49736 抗体.IgG 区带:数量(计数):时间点:XXX:定量型:免疫印迹法	4182948
36031850	按照感染预防和控制指南给予了隔离:发现:时间点:^患者:序数型	4182948
36031850	Finding; Findings; ID; Infectious Disease; InfectiousDisease; Isolated per IPC guidelines; Ordinal; PH; Point in time; Public Health; PUBLICHEALTH; Ql; Qual; Qualitative; Random; Screen	4180186
36031850	Isolated per IPC guidelines	4180186
36031851	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Enterobacter aerogenes; ID; Infectious Disease; InfectiousDisease; K. aerogenes; K. aerogenes DNA; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36031851	Klebsiella sp DNA Bld Pos Ql NAA+non-prb	4180186
36031851	产气克雷伯菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36031853	Finding; Findings; Mental health; MentalHealth; Ordinal; Point in time; Psych; Psychiatry; Ql; Qual; Qualitative; Random; Screen; Survey; SURVEY.NIDA	4180186
36031855	1 day; 24 hours; 24HR; CLIN; Gases; IhG; Inhaled Gas; Inspired; Lung; Maximum; O2; Percent; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; tO2; Tot; Totl; Volfr; Volume fraction	4180186
36031855	FIO2 24h Max	4180186
36031855	氧/气体.总计:体积分数:24小时^最大值:吸入的气体:定量型	4182948
36031856	ABS; Aby; Antby; Anti; Antibodies; Antibody; Australian encephalitis; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enc; Enceph; Encephalomyelitis; Enzyme immunoassay; IAA; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; MVEV; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36031856	MVEV IgA Spec Ql IA	4180186
36031856	墨累山谷脑炎病毒 抗体.IgA:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031858	GNS 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36031858	Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; G6S; Genetics; glucosamine (N-acetyl)-6-sulfatase; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mucopolysaccharidosis 3; Mucopolysaccharidosis type IIID; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; Sanfilippo disease IIID; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36031858	GNS Full Mut Anl Bld/T Seq	4180186
36031859	1 year; 12Mos; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; SDOH; Survey; Threaten w/ physical harm	4180186
36031860	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36031861	流感病毒 A & 流感病毒 B & SARS 冠状病毒 2 & 呼吸道合胞病毒 RNA 组套:-:时间点:呼吸道:-:探针法.基因扩增.靶向	4182948
36031861	FLUABV+SARS-CoV-2+RSV Pnl Resp NAA+probe	4180186
36031861	2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; Breathing; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUABV + SARS-CoV-2; FLUABV+SARS-CoV-2+RSV RNA Pnl; FLUAV; FLUB; FLUBV; FLUV; Fowl plague; HRSV; ID; II; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Influenza B; Influenza B virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Ribonucleic acid; RS; RSV; SARS (COVID-2) + RSV; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SDA; Severe Acute Respiratory Syndrome; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral Pneum...	4180186
36031862	肢体障碍信息:发现:时间点:^患者:文档型	4182948
36031862	Phys impair info Doc	4180186
36031862	CLIN; Document; Finding; Findings; Phys impair info; Point in time; Random	4180186
36031863	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; species; spp; SR; SUDS	4180186
36031863	Toxocara IgG Ser Ql IA	4180186
36031863	弓首线虫属单个未知种 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
36031868	黑婆罗门参 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
36031868	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Black salsify; Black salsify IgE; f142; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; Spanish salsify; SR	4180186
36031868	Black salsify IgE Qn	4180186
36031870	甘氨酸受体 抗体:存在情况或阈值:时间点:血清/血浆:序数型:免疫荧光法	4182948
36031870	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; Gly; GlyR; GlyR Ab; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Time Resolved Fluorescence; TRF	4180186
36031870	GlyR Ab SerPl Ql IF	4180186
36031871	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; C auris; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36031871	C auris DNA Bld Pos Ql NAA+non-probe	4180186
36031871	耳道假丝酵母菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36031872	Cancer; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Oncology; OP; Point in time; Random; Visit note	4180186
36031872	Oncology OP Note	4180186
36031872	记录:发现:时间点:门诊病人:文档型:肿瘤学	4182948
36031873	照护服务体验偏好:发现:时间点:^患者:名义型	4182948
36031873	Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random	4180186
36031874	铜.游离型:物质的量浓度:时间点:血清/血浆:定量型	4182948
36031874	Copper free SerPl-sCnc	4180186
36031874	Chemistry; Copper free; Cu; FR; Level; Non-protein bound; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
36031875	蜱传脑炎病毒 抗体.IgM:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031875	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enc; Enceph; Encephalomyelitis; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; TBEV; To be specified in another part of the message; Unspecified	4180186
36031875	TBEV IgM Spec Ql IA	4180186
36031878	在过去3个月当中所使用过的物质:类型:时间点:^患者:名义型	4182948
36031878	Substances used past 3Mo	4180186
36031878	H+P; H+P.HX; Last; Nominal; P prime; Point in time; Random; Substances used past 3Mo; Typ	4180186
36031880	PCA-Tr Ab CSF Line blot-aCnc	4180186
36031880	浦肯雅细胞胞浆 Tr 型 抗体:任意型浓度:时间点:脑脊液:定量型:线点印迹法	4182948
36031880	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Cytopl; Cytoplas; Hodgkin's lymphoma; Limbic encephalopathy; Neuro; Neurology; Paraneoplastic cerebellar degeneration; Paraneoplastic neurological syndrome; Paraneoplastic syndrome; PCD; PNS; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36031882	3 months; Desoxyn; Finding; Findings; Last; Mental health; MentalHealth; Methamphet; Ordinal; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey; SURVEY.NIDA	4180186
36031884	纤维蛋白形成速率.玻璃珠诱导型:任意型速率:时间点:全血:定量型:微黏度测定法	4182948
36031884	Arbitrary rate; Blood; Clot Rate Glass Bead Ind; COAGULATION; Hematology; Heme; MicrVisc; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
36031884	Clot Rate Glass Bead Ind Bld MicrVisc	4180186
36031886	Chemistry; EIA; ELFA; ELISA; Endocrine; Endocrinology; Enzyme immunoassay; i; IAA; Level; MEIA; Parathormone; Parathyroid hormone; Pl; Plasma; Plsm; Point in time; PTH; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; SUDS; Tumor marker	4180186
36031886	Parathyrin.1-84 SerPl IA-sCnc	4180186
36031886	甲状旁腺素.1-84:物质的量浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
36031888	3 months; Finding; Findings; Last; Mental health; MentalHealth; Ordinal; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey; SURVEY.NIDA	4180186
36031889	Sports medicine Eval note	4180186
36031889	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Random; Visit note	4180186
36031889	评价记录:发现:时间点:{环境}:文档型:运动医学	4182948
36031891	Address; ADMIN; Nominal; Point in time; Random	4180186
36031891	地址:地址:时间点:学校:名义型	4182948
36031897	3 months; Desoxyn; Finding; Findings; Last; Mental health; MentalHealth; Methamphet; Ordinal; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey; SURVEY.NIDA	4180186
36031900	细菌碳青霉烯类耐药 blaIMP+blaVIM 基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36031900	blaIMP+blaVIM Islt/Spm Ql	4180186
36031900	ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
36031902	纤维蛋白形成速率.硅藻土+黏土诱导型:任意型速率:时间点:全血:定量型:微黏度测定法	4182948
36031902	Arbitrary rate; Blood; Celite; Clot Rt Diat Erth+Kaoln; COAGULATION; Hematology; Heme; MicrVisc; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
36031902	Clot Rt Diat Erth+Kaoln Bld MicrVisc	4180186
36031903	Rho GTP 酶活化蛋白 26 抗体.IgG:存在情况或阈值:时间点:血清:序数型:CBA IFA	4182948
36031903	ABS; Aby; Antby; Anti; Antibodies; Antibody; ARHGAP26; Autoantibodies; Autoantibody; Autoimmune cerebellar ataxia; GRAF; GRAF Ab; GRAF IgG; GTPase Regulator Associated with Focal Adhesion Kinase pp125; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; Oligophrenin-1-like protein; OPHN1L; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
36031903	GRAF IgG Ser Ql CBA IFA	4180186
36031904	25 Hydroxyvitamin D 2; 25 Hydroxyvitamin D2; 25(OH)D2; 25(OH)D3; 25(OH)D3+25(OH)D2; 25-Hydroxy calciferol; 25-Hydroxy Vit D total; 25-Hydroxycalciferol; 25-hydroxycholecalciferol; 25-Hydroxyergocalciferol; 25-hydroxyvitamin D; 25-Hydroxyvitamin D 2; 25-hydroxyvitamin D 3; 25-Hydroxyvitamin D2; 25-hydroxyvitamin D3; 9,10-Secoergosta-5,7,10(19),22-tetraene-3 beta,25-diol; Blood - capillary; Calciderol; Calcidiol+Calciferol; Calcidiol+Ercalcidiol; Calcifediol; Cap bld; Cap blood; Capillary bld; Capillary blood; Chemistry; Endocrine; Endocrinology; Ercalcidiol; Finger stick; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Vitamin D 25 hydroxy	4180186
36031904	25(OH)D3+25(OH)D2 BldC-mCnc	4180186
36031904	钙二醇+羟基钙二醇:质量浓度:时间点:毛细血管全血:定量型	4182948
36031906	Imi+Rel Susc Islt	4180186
36031906	ANTIBIOTIC SUSCEPTIBILITIES; AST; Imi+Rel; Imipeneum; Imp; Islt; Isol; Point in time; Primaxin; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
36031906	亚胺培南+瑞雷巴坦:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
36031907	Hosp Summary note	4180186
36031907	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hosp; Inpatient; notes; Point in time; Random; Visit note	4180186
36031907	摘要:发现:时间点:医院:文档型:{角色}	4182948
36031909	Disease; Disorder; Finding; Findings; Nominal; PH; Point in time; Public Health; PublicHealth; Random; Result latest lab test for cond of int; Virus	4180186
36031909	针对所关注的情况的最新实验室检验项目的结果:发现:时间点:^患者:名义型	4182948
36031909	Result latest lab test for cond of int	4180186
36031912	11-beta HSD; 11-beta-HSD1; 11-beta-HSD2; 11-beta-hydroxy steroid dehydrogenase; 11-ß-HSD1; 11-ß-HSD2; Blood; c155; Chemistry; Compound E; DBS; Dried blood spot; Endocrine; Endocrinology; Filter paper; FP; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
36031912	Cortisone DBS-mCnc	4180186
36031912	可的松:质量浓度:时间点:全血.斑点:定量型	4182948
36031913	1 day; 24 hours; 24HR; Androster; Chemistry; Endocrine; Endocrinology; QNT; Quan; Quant; Quantitative; Standard score; UA; UR; Urn; Z score; Z value; Z-score	4180186
36031913	Androsterone 24h Z-score Ur	4180186
36031913	雄酮:Z评分:24小时:尿液:定量型	4182948
36031914	abn; abnorm; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
36031915	BP mean--during anesthesia	4180186
36031915	Art sys; Average; Avg; Blood pressure mean; BLOOD PRESSURE MEASUREMENTS.MOLEC; BP; BP mean; Intravenous; IV; MBP; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
36031915	血管内平均值^在麻醉过程中:压力或压强:时间点:动脉系统:定量型	4182948
36031917	Blood; Document; Finding; Findings; galactose-1-phosphate uridylyltransferase; Galactose-1-phosphate uridylyltransferase gene; Genetics; Heredity; Heritable; Inherited; Molecular genetics; Molecular pathology; MOLPATH; Mut; Mut Anl; Mutations; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36031917	GALT gene Mut Anl Bld/T	4180186
36031917	GALT 基因 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36031919	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bhanja virus serocomplex; EIA; ELFA; ELISA; Enzyme immunoassay; Heartland virus; HRTV; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; lone star tick; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Phleboviruses; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36031919	HRTV IgG Spec Ql IA	4180186
36031919	心地班阳病毒 抗体.IgG:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031922	B + T crossmatch Pnl; BLOOD BANK; Dynamic; FC; Pan; PANEL.BLOODBANK; Panl; Pnl; Point in time; Pt + bld; Pt ser+Don bld; Random; Serum; SR; T Cell XM; T prime; UCHL-1	4180186
36031922	B + T crossmatch Pnl Pt ser+Don bld FC	4180186
36031922	B 细胞+T 细胞交叉配型组套:-:时间点:血清^患者+全血:-:流式细胞测量术	4182948
36031924	HLA-DPB1 未决等位基因:类型:时间点:全血/组织:名义型:高分辨率方法	4182948
36031924	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA-DPB1 Unreslvd Alleles; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
36031924	HLA-DPB1 Unreslvd Alleles High Res	4180186
36031925	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Flav Ab; Flavi virus; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36031925	Flavivirus Ab SerPl Ql	4180186
36031925	黄病毒 抗体:存在情况或阈值:时间点:血清/血浆:序数型	4182948
36031930	评价记录:发现:时间点:{环境}:文档型:变态反应法	4182948
36031930	Allergy; Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Random; Visit note	4180186
36031930	Allergy Eval note	4180186
36031933	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Eye fluid; IAA; Immune globulin G; Immunoglobulin G; MEIA; Microbiology; Occular Fluid; OcFlu; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; species; spp; SUDS	4180186
36031933	Toxocara IgG Ocflu Ql IA	4180186
36031933	弓首线虫属单个未知种 抗体.IgG:存在情况或阈值:时间点:眼液:序数型:免疫测定法	4182948
36031938	多焦视网膜电图组套:-:时间点:黄斑:-:视网膜电图.多焦	4182948
36031938	mfERG Pnl	4180186
36031938	ERG; ERG Pnl; EYE; mfERG; mfERG Pnl; Pan; PANEL.EYE; Panl; Pnl; Point in time; Random	4180186
36031942	Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Random; Visit note	4180186
36031942	Wound care management OP Note	4180186
36031942	记录:发现:时间点:门诊病人:文档型:伤口护理管理	4182948
36031943	HEDIS 评测年度 2020 取值集合 - LDL-C 检验项目:-:时间点:^患者:-	4182948
36031943	HEDIS MY 2020 LDL-C Tests	4180186
36031943	HEDIS MY 2020 LDL-C Tests; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
36031950	重症监护病房床位:数量(计数):时间点:{环境}:定量型	4182948
36031950	Cnt; Count; ICU beds; Number; PH; Point in time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random	4180186
36031950	ICU beds	4180186
36031951	胰多肽^假饲后5分钟:质量浓度:时间点:血清/血浆:定量型	4182948
36031951	5M p Sham Feed; After; Chemistry; Endocrine; Endocrinology; Level; Mass concentration; Panc Polypept; Pancr; Pancreatc; Pl; Plasma; Plsm; Point in time; Polypeptides; PP; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36031951	Panc Polypept 5M p Sham Feed SerPl-mCnc	4180186
36031952	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SSHV; SUDS; To be specified in another part of the message; Unspecified	4180186
36031952	SSHV IgG Spec Ql IA	4180186
36031952	雪鞋野兔病毒 抗体.IgG:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031953	功能发现:印象:时间点:视网膜.左侧:叙述型	4182948
36031953	EYE; EYE.PX; Func find; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; L; L ret; LT; Narrative; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Report	4180186
36031953	L ret Func find [Imp]	4180186
36031958	ADMIN; Nominal; Person name; Point in time; Random	4180186
36031958	名称:人员姓名:时间点:^联系人:名义型	4182948
36031959	BSA; Chemistry; Cl; Clear; Clearanc; Clearances; Clr; Kidney; p Aminohippurate; PAH; PAH Cl/1.73 sq M; Para amino hippurate; Pl; Plasma; Plsm; QNT; Quan; Quant; Quantitative; SerP; SerPl; SerPlas; Serum; Serum or plasma; Square Meter; SR; Studies; Study; Sutdies; UA; UR; Ur+SerPl; Urn; Volume rate/area; Volume Rate/Ratio	4180186
36031959	PAH Cl/1.73 sq M Ur+SerPl-ArVRat	4180186
36031959	对氨基马尿酸 肾脏清除率/1.73 平方米:单位面积体积速率:检查过程持续时间:尿液+血清/血浆:定量型	4182948
36031961	转诊介绍信:发现:时间点:{环境}:文档型:{角色}	4182948
36031961	DOC.ONT; Document; Finding; Findings; Point in time; Random	4180186
36031963	鼻骨:存在情况或阈值:时间点:^胎儿:序数型	4182948
36031963	Fetal; Gyn; Gynecology; Nasal bn; OB; ObGyn; OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
36031963	Fet Nasal bn	4180186
36031968	4 weeks; Derm; Dermatology; QNT; Quan; Quant; Quantitative; Scale; Skin; Survey; SURVEY.GNHLTH; Sx	4180186
36031973	患者正在接受高血压治疗:发现:时间点:^患者:序数型	4182948
36031973	AOEObservation; BP; Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Patient treated for high BP; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36031973	Patient treated for high BP	4180186
36031975	阿尼昂尼昂病毒 抗体.IgM:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36031975	ABS; Aby; Alphaviruses; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; ONN virus; O'nyong-nyong virus; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36031975	ONN virus IgM Spec Ql IA	4180186
36031978	Clot; Clottable; Coag; Coagulation assay; Control; Fac; Fact; Hematology; Heme; i; imm 1:1 NP; Mixing studies; Plas; Platelet poor plasma; Point in time; Pro time; Prothrombin time; Protime; PT; PT correction study; PT immediate mix; PT incubated mix; QNT; Quan; Quant; Quantitative; Random; Tilt tube	4180186
36031978	PT imm 1:1 NP PPP	4180186
36031978	组织因子诱导型凝血过程.因子替换^紧接着在添加1:1正常血浆之后:时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
36031979	柱镜远距:长度倒数:时间点:矫正镜片:定量型:透镜屈光度计法	4182948
36031979	by LM; Corr lens; CYL; Distance; EYE; EYE.LENSOMETRY; Focimeter; Inverse Length; Lensometer; LM; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36031979	Corr lens Cylinder far by LM	4180186
36031980	HEDIS 评测年度 2020 取值集合:-:时间点:^患者:-	4182948
36031980	HEDIS MY 2020 Value Sets; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
36031983	HEDIS 评测年度 2020 取值集合 - 定量型尿液白蛋白检验项目:-:时间点:^患者:-	4182948
36031983	HEDIS MY 2020 Qn Ur Alb Lab Test	4180186
36031983	Alb; HEDIS MY 2020 Qn Ur Alb Lab Test; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Protein.albumin; Random	4180186
36031984	Child Adolsnt Psych Eval note	4180186
36031984	Assessment; Child Adolsnt Psych; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Random; Visit note	4180186
36031984	评价记录:发现:时间点:{环境}:文档型:儿童与青少年心理学	4182948
36031985	EPS; expressed prostatic secretion; Genitourinary; GU; Nominal; Point in time; Prost; Prost fld; Prostate; Prostate secretion; Prostati; Prostatic secretion; Random; SPEC; Typ; URO; Urology	4180186
36031985	Odor Prost fld	4180186
36031985	气味:类型:时间点:前列腺液:名义型	4182948
36031987	神经中间丝 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
36031987	NIF IgG Titr Ser IF	4180186
36031987	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; NIF; NIF Ab; NIF IgG; Point in time; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
36031988	巴马森林病毒 抗体.中和:滴定度:时间点:XXX:定量型:中和试验	4182948
36031988	BFV NAb Titr Spec Nt	4180186
36031988	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbovirus; Autoantibodies; Autoantibody; BFV; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; Other; Point in time; Random; Serum virus neutralization; SmQn; Spec; SVN; Titer; Titered; Titre; To be specified in another part of the message; Ttr; Unspecified; Virus neutralization test; VNT	4180186
36031990	功能发现:印象:时间点:视网膜.右侧:叙述型:视网膜电图	4182948
36031990	ERG; EYE; EYE.ERG; Func find; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Ophthalmology; Ophtho; Ophthy; Point in time; R; R ret; Random; Report; RT	4180186
36031990	R ret Func find [Imp] ERG	4180186
36031992	C&S; Cult; Cultures; EHV; EHV1; EHV-1; Equid; Equid alphaherpesvirus 1; Equin; Equine abortion herpesvirus; Equine rhinopneumonitis; Herpes virus; i; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36031992	EHV1 Spec Ql Cult	4180186
36031992	马疱疹病毒 1 型:存在情况或阈值:时间点:XXX:序数型:微生物特异性培养	4182948
36031994	HLA-DPB1 未决等位基因:类型:时间点:全血/组织^供体:名义型:高分辨率方法	4182948
36031994	Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA-DPB1 Unreslvd Alleles; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
36031994	HLA-DPB1 Unreslvd Alleles Donr High Res	4180186
36031995	圣路易型脑炎病毒抗体.IgG 与 IgM 组套:-:时间点:脑脊液:-	4182948
36031995	Cerebral spinal fluid; Cerebrospinal Fl; Enc; Enceph; Encephalomyelitis; ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; SLE virus; SLEV; SLEV IgG+IgM Pnl; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; St Louis	4180186
36031995	SLEV IgG+IgM Pnl CSF	4180186
36031996	ANTIBIOTIC SUSCEPTIBILITIES; AST; Extensively drug resistant tuberculosis; Genotype; Genotypic; Islt; Isol; MDR TB; MDR Tuberculosis; Multi drug resistant tuberculosis; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sirturo; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis; XDR TB	4180186
36031996	Bedaquiline Islt Genotyp	4180186
36031996	贝达喹啉:抗生素敏感性:时间点:分离株:序数型:基因分型	4182948
36031997	HLA-DRB3 与 HLA-DRB4 与 HLA DRB5 未决等位基因:类型:时间点:全血/组织:名义型:高分辨率方法	4182948
36031997	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA-DRB3 + 4 + 5; HLA-DRB345 Unreslvd; HLA-DRB5; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
36031997	HLA-DRB345 Unreslvd High Res	4180186
36031998	因病错过工作或上学的天数:数量(计数):时间点:^患者:定量型	4182948
36031998	Cnt; Count; Dextro; H+P; H+P.HX; Job; Number; Occupation; P prime; PH; Point in time; Public Health; PublicHealth; QNT; Quan; Quant; Quantitative; Random; Work/school D missed due to illness	4180186
36031998	Work/school D missed due to illness	4180186
36032001	操作记录:发现:时间点:{环境}:文档型:变态反应法	4182948
36032001	Allergy; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36032004	3 months; Finding; Findings; Last; Mental health; MentalHealth; Ordinal; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey; SURVEY.NIDA	4180186
36032005	黏液丝:存在情况或阈值:时间点:精液:序数型:显微镜检查类实验室方法	4182948
36032005	Ejaculate; FERTILITY TESTING; Genitourinary; GU; Micro; Micros; Microscopic; Mucous; Mucous Threads; Mucus threads; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Sem; Seminal fluid; Smn; SMPLS; URO; Urology	4180186
36032005	Mucus strands Smn Ql Micro	4180186
36032007	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36032009	pH Prost fld	4180186
36032009	pH:对数型物质的量浓度:时间点:前列腺液:定量型	4182948
36032009	Chemistry; EPS; expressed prostatic secretion; Genitourinary; GU; Log molar concentration; Point in time; Prost; Prost fld; Prostate; Prostate secretion; Prostati; Prostatic secretion; Random; SmQn; URO; Urology	4180186
36032014	功能与上一次的评估相比:发现:时间点:神经节细胞.右侧:序数型:视网膜电图	4182948
36032014	Comp func; ERG; EYE; EYE.ERG; FCN; Finding; Findings; Func; Funct; Ophthalmology; Ophtho; Ophthy; Ordinal; Point in time; Prev; QL; Qual; Qualitative; R; R ganglion cells; Random; RT; Screen	4180186
36032014	R ganglion cells Comp func ERG	4180186
36032015	住院治疗:数量(计数):报告期:^事件:定量型	4182948
36032015	Cnt; Count; Number; PH; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Report period	4180186
36032015	Hospitalizations # in RptPeriod	4180186
36032017	镇静程度.啼哭或烦躁:发现:时间点:^患者:序数型	4182948
36032017	Sed level.cry irritab	4180186
36032017	Finding; Findings; Levels; Levl; LV; LVL; NEONAT; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sed level.cry irritab; Sed lvl	4180186
36032020	Finding; Findings; Mental health; MentalHealth; Ordinal; Point in time; Psych; Psychiatry; Ql; Qual; Qualitative; Random; Rel; Screen; Survey; SURVEY.NIDA	4180186
36032021	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36032023	Surg Onc Eval note	4180186
36032023	Assessment; Cancer; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; General surgical oncology; H&P; History and physical; notes; Point in time; Random; Surg; Surg Onc; Visit note	4180186
36032023	评价记录:发现:时间点:{环境}:文档型:外科肿瘤学	4182948
36032025	视黄醇结合蛋白组套:-:24小时:尿液:定量型	4182948
36032025	1 day; 24 hours; 24HR; alpha 2 microglobulin; alpha-2-microglobulin; Axerol; Axerophthol; Bind; Biosterol; Chemistry; Pan; PANEL.CHEMISTRY; Panl; Pnl; PR; Prot; QNT; Quan; Quant; Quantitative; RBP; RBP panel; Retinol Bind Prot; UA; UR; Urn; Vit A; Vit A alcohol; Vit A1; Vit A1 alcohol; Vitamin A; Vitamin A alcohol; Vitamin A binding protein; Vitamin A1	4180186
36032025	RBP panel 24h Ur	4180186
36032026	N1 波潜伏时间^明适应型:时间:时间点:黄斑.左侧:定量型:视网膜电图.多焦	4182948
36032026	ERG; EYE; EYE.ERG; L; L macula; LT; mfERG; N1 impl time; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36032026	L macula N1 impl time--light-adapt mfERG	4180186
36032027	人乳头瘤病毒 56+59+66 DNA:存在情况或阈值:时间点:子宫颈:序数型:探针法.基因扩增.靶向	4182948
36032027	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cervix; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Genital warts; HPV; HPV56; HPV56+59+66; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36032027	HPV56+59+66 DNA Cvx Ql NAA+probe	4180186
36032028	与上一报告周期的健康医疗服务人员之中的病例死亡人数增加或减少百分比:百分数差:报告期:^事件:定量型	4182948
36032028	% diff in HCP deaths from prev rpt period; Deaths among HCP; Fatalities; HCP deaths since prev rpt period; PH; Prev; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Report period	4180186
36032028	% diff in HCP deaths since prev RptPeriod	4180186
36032032	Amph; Amphet; Amphetam; Amphetamines; Ampht; Finding; Findings; Mental health; MentalHealth; Ordinal; Point in time; Psych; Psychiatry; Ql; Qual; Qualitative; Random; Rel; Screen; Speed; Stimul; Stimulant; Survey; SURVEY.NIDA	4180186
36032034	已占据的重症监护病房床位:数量(计数):时间点:{环境}:定量型	4182948
36032034	Cnt; Count; ICU beds; ICU beds occupied; Number; PH; Point in time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random	4180186
36032034	ICU beds occupied	4180186
36032035	针对骨密度的多层:发现:时间点:下肢>跟骨:文档型:CT	4182948
36032035	BMD; Calcaneous; CAT scan; Computed tomography; Computerized tomography; CT scan; Den; Document; Endocrine; Endocrinology; EXT; Finding; Findings; for BMD; Heel; Imaging; LE; Leg; Low; Os calcis; Oscalcis; Point in time; Rad; RADIOLOGY; Random	4180186
36032035	CT Heel for BMD	4180186
36032038	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Random; Visit note	4180186
36032038	Trauma Eval note	4180186
36032038	评价记录:发现:时间点:{环境}:文档型:创伤专业	4182948
36032039	伤口、缺血和足部感染分类系统组套:-:时间点:下肢:-:WIfI	4182948
36032039	WIfI pnl LE WIfI	4180186
36032039	CLIN; CLIN.RISK; EXT; LE; Leg; Low; Lower extremity; Pan; PANEL.CLINICAL; Panl; Pnl; Point in time; Random; WIfI pnl	4180186
36032040	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CHIKV; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36032040	CHIKV IgA Spec Ql IA	4180186
36032040	基孔肯亚病毒 抗体.IgA:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36032041	氯普唑仑:质量浓度:时间点:血清:定量型:毒理学确认试验	4182948
36032041	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Triazulenone	4180186
36032041	Loprazolam Ser Cfm-mCnc	4180186
36032042	纤维蛋白形成速率.白陶土诱导型:任意型速率:时间点:全血:定量型:微黏度测定法	4182948
36032042	Arbitrary rate; Blood; Clot Rate Kaolin Ind; COAGULATION; Hematology; Heme; MicrVisc; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
36032042	Clot Rate Kaolin Ind Bld MicrVisc	4180186
36032045	3 months; Finding; Findings; Last; Mental health; MentalHealth; Ordinal; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey; SURVEY.NIDA	4180186
36032046	3 months; Finding; Findings; Last; Mental health; MentalHealth; Ordinal; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey; SURVEY.NIDA	4180186
36032047	紅菊苣 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
36032047	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Chicory; f284; f371; Immune globulin E; Immunoglobulin E; Italian chicory Rad; Italian chicory Rad IgE; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
36032047	Italian chicory Rad IgE Qn	4180186
36032049	1 day; 24 hours; 24HR; Aetiocholanolone; Chemistry; Endocrine; Endocrinology; Etiochol; QNT; Quan; Quant; Quantitative; Standard score; UA; UR; Urn; Z score; Z value; Z-score	4180186
36032049	Etiocholanolone 24h Z-score Ur	4180186
36032049	本胆烷醇酮:Z评分:24小时:尿液:定量型	4182948
36032052	Point in time; QNT; Quan; Quant; Quantitative; Random; S prime; Scale; SDOH	4180186
36032054	多重视图 咬合:发现:时间点:头部>牙齿:文档型:X射线摄影术	4182948
36032054	Brain; Cranial; Cranium; Dental; Dentistry; Document; Films; Finding; Findings; Imaging; Intracranial; Plain Films; Point in time; Rad; Radiology; Random; Skull; View; VWS; Xray; X-ray	4180186
36032054	XR Teeth Occlusal	4180186
36032055	科洛拉多蜱传热病毒 抗体.中和:滴定度:时间点:XXX:定量型:中和试验	4182948
36032055	CTFV NAb Titr Spec Nt	4180186
36032055	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; CTFV; cVNT; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; Other; Point in time; Random; Serum virus neutralization; SmQn; Spec; SVN; Titer; Titered; Titre; To be specified in another part of the message; Ttr; Unspecified; Virus neutralization test; VNT	4180186
36032056	ABS; Aby; AIDS; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; HIV 1 and 2 Ab; HIV type 1; HIV type I; HIV1; HIV1+2; Human immunodeficiency virus; i; IAA; ID; Identity or presence; II; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
36032056	HIV 1 & 2 Ab SerPl IA	4180186
36032056	HIV 1 型 与 2 型 抗体:存在与否或特征标识:时间点:血清/血浆:名义型:免疫测定法	4182948
36032058	丙烯酸纤维 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
36032058	ABS; Aby; Acrylic fiber IgE; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Fibers; Immune globulin E; Immunoglobulin E; K1; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
36032058	Acrylic fiber IgE Qn	4180186
36032059	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OMS; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Surg; Visit note	4180186
36032059	OMS Prog note	4180186
36032059	病程记录:发现:时间点:{环境}:文档型:口腔颌面外科学	4182948
36032060	组织因子诱导型凝血过程.因子替换^在添加1:1正常血浆后孵育之后1小时:时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
36032060	1 hour; 1.0Hr; 1h p 1:1 NP; 1h p Inc; 60 min; 60 minutes; 60M; 60min; After; Clot; Clottable; Coag; Coagulation assay; Control; Fac; Fact; Hematology; Heme; i; Mixing studies; Plas; Platelet poor plasma; Point in time; Pro time; Prothrombin time; Protime; PST; PT; PT correction study; PT immediate mix; PT incubated mix; QNT; Quan; Quant; Quantitative; Random; Tilt tube	4180186
36032060	PT 1h p 1:1 NP PPP	4180186
36032065	4 weeks; Derm; Dermatology; Finding; Findings; Integument; Job; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Skin; Survey; SURVEY.GNHLTH	4180186
36032068	流程记录单:发现:时间点:{环境}:文档型:变态反应法	4182948
36032068	Allergy; DOC.ONT; Document; Finding; Findings; Point in time; Random	4180186
36032069	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Random; Visit note	4180186
36032069	Nephrology Eval note	4180186
36032069	评价记录:发现:时间点:{环境}:文档型:肾病学	4182948
36032070	醋酸钙不动杆菌-鲍曼不动杆菌复合群 DNA:计数型浓度范围:时间点:呼吸道.下:序数型:非探针法.基因扩增.靶向	4182948
36032070	ACB cmplx DNA L resp NAA+non-prb-NCncRng	4180186
36032070	3 Self-Sustaining Sequence Replication; 3SR SR; ACB complex; Amplif; Amplification; Amplified; Compx; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; NCncRng; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; SmQn; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36032071	BLOOD BANK; Blood product unit; Blood Product Unit (Pack); CD34 Cells; Cell; Cellularity; Cnt; Count; gp105-120; Hematopoietic stem cell; HSC; My10; My-10; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Stem cells	4180186
36032071	CD34 Cells BPU	4180186
36032071	细胞.CD34:数量(计数):时间点:^血液制品单位:定量型	4182948
36032074	Pharmacology Eval note	4180186
36032074	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Pharmacy; Point in time; Random; Visit note	4180186
36032074	评价记录:发现:时间点:{环境}:文档型:药理学	4182948
36032075	凝块形成与血小板功能.玻璃珠诱导型组套:-:时间点:全血:-:微黏度测定法	4182948
36032075	Activated clotting time; Blood; CFT; Closure time; Closure Tme; Clot time; Clt Frm+Plt Fnc Gls Ind Pnl; COAGULATION; FCN; Func; Funct; Kinetics; k-time; MicrVisc; Pan; PANEL.COAGULATION; Panl; Pl; Platelets; Platelt; Plt; Pnl; Point in time; Random; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
36032075	Clt Frm+Plt Fnc Gls Ind Pnl Bld MicrVisc	4180186
36032082	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fentanyl metabolite; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
36032082	Norfentanyl Ur Ql Scn	4180186
36032082	去甲基芬太尼:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
36032083	Sirolimus Bld IA-sCnc	4180186
36032083	Blood; DRUG/TOXICOLOGY; Drugs; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Rapamune; Rapamycin; SRL; Substance concentration; SUDS; WB; Whole blood	4180186
36032083	西罗莫司:物质的量浓度:时间点:全血:定量型:免疫测定法	4182948
36032087	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36032087	Orthotics prosthetics Admin note	4180186
36032087	行政管理记录:发现:时间点:{环境}:文档型:矫形学和修复术	4182948
36032088	伤口护理方法说明:发现:时间点:^患者:名义型	4182948
36032088	CLIN; Finding; Findings; Nominal; Point in time; Random	4180186
36032088	Wound care instruct	4180186
36032091	甘氨酸受体 抗体:存在情况或阈值:时间点:脑脊液:序数型:免疫荧光法	4182948
36032091	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; FA; Fluorescent antibody; Fluoresent; Gly; GlyR; GlyR Ab; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF	4180186
36032091	GlyR Ab CSF Ql IF	4180186
36032092	Alpha-中间丝蛋白 抗体.IgG:存在情况或阈值:时间点:血清:序数型:CBA IFA	4182948
36032092	Alpha-internexin IgG Ser Ql CBA IFA	4180186
36032092	66 kDa neurofilament protein; ABS; Aby; Alfa; Alpha-internexin IgG; Alpha-Inx; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; Neurofilament 5; Neurofilament-66; NF-66; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR	4180186
36032094	Blood; Chemistry; DBS; Dried blood spot; Endocrine; Endocrinology; Filter paper; FP; GHb; Glycated hemoglobin; Glycohaemogolobin; Glycohemogolobin; Glycosylated hemoglobin; HA1c; Haemoglobin; Hb; HbA1c; Hgb; Hgb A1c; Mass fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
36032094	HbA1c MFr DBS	4180186
36032094	血红蛋白 A1c/血红蛋白.总计:质量分数:时间点:全血.斑点:定量型	4182948
36032095	羟苯乙酯 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
36032095	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Ethylparaben IgE; Immune globulin E; Immunoglobulin E; Ko1; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
36032095	Ethylparaben IgE Qn	4180186
36032096	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blasto; Blastomycosis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36032096	Blastomyces DNA Lower resp Ql NAA+probe	4180186
36032096	芽生菌属单个未知种 DNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36032098	1 week; Derm; Dermatology; Finding; Findings; Integument; Last; Ordinal; Ql; Qual; Qualitative; Screen; Skin; Survey; SURVEY.GNHLTH	4180186
36032101	#/area; Discocytes; EPS; Erthrocyte; Erythrocyte; expressed prostatic secretion; Genitourinary; GU; HEMATOLOGY/CELL COUNTS; LM; Micro; Micros; Microscopic; Number areic; Point in time; Prost; Prost fld; Prostate; Prostate secretion; Prostati; Prostatic secretion; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells; URO; Urology	4180186
36032101	RBC #/area Prost fld Micro	4180186
36032101	红细胞:单位面积数量或计数:时间点:前列腺液:定量型:显微镜检查.光学	4182948
36032102	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbovirus; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; RRV; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36032102	RRV IgM Spec Ql IA	4180186
36032102	罗斯河病毒 抗体.IgM:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36032103	造血祖细胞制品特性描述组套:-:时间点:^血液制品单位:-:流式细胞测量术	4182948
36032103	HPC product panel BPU FC	4180186
36032103	BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Dynamic; FC; HPC product panel; Pan; PANEL.BLOODBANK; Panl; Pnl; Point in time; Random	4180186
36032104	凝块形成.玻璃珠诱导型组套:-:时间点:全血:-:微黏度测定法	4182948
36032104	Clt Frm Glss Bd Ind Pnl Bld MicrVisc	4180186
36032104	Activated clotting time; Blood; CFT; Clot time; Clt Frm Glss Bd Ind Pnl; COAGULATION; Kinetics; k-time; MicrVisc; Pan; PANEL.COAGULATION; Panl; Pnl; Point in time; Random; WB; Whole blood	4180186
36032105	塔希纳病毒 抗体.IgA:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36032105	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; TAHV; To be specified in another part of the message; Unspecified	4180186
36032105	TAHV IgA Spec Ql IA	4180186
36032106	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Nucynta; Oral fluid; Ordinal; Palexia; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sal; Screen; Tapal	4180186
36032106	Tapentadol Sal Ql Cfm	4180186
36032106	他喷他多:存在情况或阈值:时间点:唾液:序数型:毒理学确认试验	4182948
36032108	HLA-DP 与 DQ 与 DR (II 类) 分型组套:-:时间点:全血/组织:-:低分辨率法	4182948
36032108	2; Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA class II; HLA Cls II Typ Pnl; HLA-DP+DQ+DR; HLA-DP+DQ+DR (class II); Human Leukocyte Antigen; Inherited; Pan; PANEL.HLA; Panl; Pnl; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36032108	HLA Cls II Typ Pnl Bld/T Low res	4180186
36032111	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CHIKV; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36032111	CHIKV IgG Spec Ql IA	4180186
36032111	基孔肯亚病毒 抗体.IgG:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36032112	Mental health; MentalHealth; Point in time; Psych; Psychiatry; QNT; Quan; Quant; Quantitative; Random; Scale; Subs; Survey; SURVEY.NIDA	4180186
36032113	凝块形成.白陶土诱导型/凝块形成.白陶土诱导型^在肝素中和之后:时间比率:时间点:全血:定量型:计算法	4182948
36032113	Clot init kaol ind to post hep neut TRto	4180186
36032113	After; Blood; Calc; Calculation; Clot init kao ind p hep neut; Clot init kaolin ind; COAGULATION; CT; CTH; CTR; Hematology; Heme; Hep; Hepar; Heparin Nt; Heparn; Neut; Neutr; p hep neut; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Time ratio; WB; Whole blood	4180186
36032115	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbovirus; Autoantibodies; Autoantibody; BFV; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36032115	BFV IgM Spec Ql IA	4180186
36032115	巴马森林病毒 抗体.IgM:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36032119	4 weeks; Derm; Dermatology; Finding; Findings; Integument; Last; Ordinal; Ql; Qual; Qualitative; Screen; Skin; Survey; SURVEY.GNHLTH	4180186
36032122	东方马脑炎病毒 抗体.中和:滴定度:时间点:XXX:定量型:中和试验	4182948
36032122	EEEV NAb Titr Spec Nt	4180186
36032122	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); EEE virus; EEEV; Enc; Enceph; Encephalomyelitis; Equin; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; Other; PH; Point in time; Public Health; PublicHealth; Random; Serum virus neutralization; SmQn; Spec; SVN; Titer; Titered; Titre; To be specified in another part of the message; Togavirus; Ttr; Unspecified; Virus neutralization test; VNT	4180186
36032123	4 weeks; Derm; Dermatology; Finding; Findings; Integument; Last; Ordinal; Ql; Qual; Qualitative; Screen; Skin; Survey; SURVEY.GNHLTH	4180186
36032126	黄瘤细胞:计数型浓度:时间点:呼吸道.下:定量型:手工计数方法	4182948
36032126	Xanthoma cells # Lower resp Manual	4180186
36032126	#; ABS; absolute; absolutes; Cell; Cellularity; Cnt; Count; Count/volume; CT; Foamy histiocyte; HEMATOLOGY/CELL COUNTS; Histiocyte; Low; Lower resp; Manl; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36032127	P1 波潜伏时间^明适应型:时间:时间点:黄斑.右侧:定量型:视网膜电图.多焦	4182948
36032127	ERG; EYE; EYE.ERG; mfERG; Ophthalmology; Ophtho; Ophthy; P1 impl time; Point in time; QNT; Quan; Quant; Quantitative; R; R macula; Random; RT	4180186
36032127	R macula P1 impl time--light-adapt mfERG	4180186
36032129	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Integrated medicine; notes; Point in time; Random; Telemedicine; Visit note	4180186
36032129	记录:发现:时间点:远程医疗:文档型:整合医学	4182948
36032133	砷.无机+甲基化:质量浓度:时间点:尿液:定量型	4182948
36032133	Arsenic.inorganic+methylated Ur-mCnc	4180186
36032133	AS; DRUG/TOXICOLOGY; Drugs; Inorg Arsenic; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Toxic arsenic; UA; UR; Urn	4180186
36032134	Cust care fac Procedure note	4180186
36032134	Cust care fac; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36032134	操作记录:发现:时间点:监护设施:文档型:{角色}	4182948
36032135	Chr 17p11.2 Del Bld/T FISH	4180186
36032135	Blood; Chr 17p11.2; Chr 17p11.2 deletion; Chromosom; Chromosomes; Cyto loc; Del; Deletions; Document; Finding; Findings; Fluorescent in situ hybridization; Molecular pathology; MOLPATH; MOLPATH.DELDUP; Point in time; Potocki-Lupski syndrome; PTLS; RAI1; Random; Smith-Magenis syndrome; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36032135	染色体区域 17p11.2 缺失:发现:时间点:全血/组织:文档型:FISH	4182948
36032136	诊断时所在的国家/地区:位置:时间点:^患者:名义型	4182948
36032136	Country where dx; Location; Nominal; PH; Point in time; Public Health; PUBLICHEALTH; Random	4180186
36032136	Country where dx	4180186
36032137	墨累山谷脑炎病毒 抗体.中和:滴定度:时间点:XXX:定量型:中和试验	4182948
36032137	MVEV NAb Titr Spec Nt	4180186
36032137	ABS; Aby; Antby; Anti; Antibodies; Antibody; Australian encephalitis; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); Enc; Enceph; Encephalomyelitis; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; MVEV; NAb; NEUTRALIZATION; Neutralization test; NT; Other; Point in time; Random; Serum virus neutralization; SmQn; Spec; SVN; Titer; Titered; Titre; To be specified in another part of the message; Ttr; Unspecified; Virus neutralization test; VNT	4180186
36032141	功能:发现:时间点:视杆细胞.左侧:序数型:视网膜电图	4182948
36032141	ERG; EYE; EYE.ERG; FCN; Finding; Findings; Func; Funct; L; L rods; LT; Ophthalmology; Ophtho; Ophthy; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36032141	L rods Function ERG	4180186
36032142	伤口分类和诊断:发现:时间点:^患者:文档型	4182948
36032142	Document; Finding; Findings; H+P; H+P.PX; P prime; Point in time; Random; Wound class + dx	4180186
36032142	Wound class + dx	4180186
36032144	7-hydroxymitragynine; Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Kratom; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
36032144	Mitragynine Ur Ql Scn	4180186
36032144	帽柱碱:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
36032145	功能与上一次的评估相比:发现:时间点:视神经.左侧:序数型:视觉诱发电位	4182948
36032145	Comp func; EYE; EYE.ERG; FCN; Finding; Findings; Func; Funct; L; L optic n; LT; Ophthalmology; Ophtho; Ophthy; Ordinal; Point in time; Prev; QL; Qual; Qualitative; Random; Screen	4180186
36032145	L optic n Comp func VEP	4180186
36032147	芦荟 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
36032147	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Aloe vera IgE; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; w65	4180186
36032147	Aloe vera IgE Qn	4180186
36032148	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CTFV; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36032148	CTFV IgG Spec Ql IA	4180186
36032148	科洛拉多蜱传热病毒 抗体.IgG:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36032150	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbovirus; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; RRV; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36032150	RRV IgA Spec Ql IA	4180186
36032150	罗斯河病毒 抗体.IgA:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36032151	N95 波振幅^明适应型:电势:时间点:视网膜.右侧:定量型:视网膜电图.图形	4182948
36032151	Electrical potential; ERG; EYE; EYE.ERG; Ophthalmology; Ophtho; Ophthy; PERG; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; RT; Voltage	4180186
36032151	R ret N95 amp--light-adapt PERG	4180186
36032154	25(OH)D3; 25-hydroxycholecalciferol; 25-hydroxyvitamin D 3; 25-hydroxyvitamin D3; Blood - capillary; Calciderol; Calcifediol; Cap bld; Cap blood; Capillary bld; Capillary blood; Chemistry; Endocrine; Endocrinology; Finger stick; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Vitamin D 25 hydroxy	4180186
36032154	25(OH)D3 BldC-mCnc	4180186
36032154	钙二醇:质量浓度:时间点:毛细血管全血:定量型	4182948
36032160	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbovirus; Autoantibodies; Autoantibody; BFV; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36032160	BFV IgG Spec Ql IA	4180186
36032160	巴马森林病毒 抗体.IgG:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36032168	HLA-A 与 B 与 C (I 类) 分型组套:-:时间点:全血/组织:-:高分辨率方法	4182948
36032168	A,B; Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA class I; HLA Cls I Typ Pnl; HLA-A+B; HLA-A+B+C; HLA-A+B+C (class I); Human Leukocyte Antigen; Inherited; Pan; PANEL.HLA; Panl; Pnl; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36032168	HLA Cls I Typ Pnl Bld/T High Res	4180186
36032169	经过处理的绵羊毛 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
36032169	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; K20; k21; Ovine; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Treated sheep wool IgE	4180186
36032169	Treated sheep wool IgE Qn	4180186
36032170	1 week; Derm; Dermatology; Finding; Findings; Integument; Last; Ordinal; Ql; Qual; Qualitative; Screen; Skin; Survey; SURVEY.GNHLTH	4180186
36032175	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cervix; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; GC; Genital tract; Gono; Gonorrhea; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; N gonorrhoea; N gonorrhoeae; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36032175	N gonorrhoea DNA Cvx Ql NAA+probe	4180186
36032175	淋病奈瑟菌 DNA:存在情况或阈值:时间点:子宫颈:序数型:探针法.基因扩增.靶向	4182948
36032177	马亚罗病毒 抗体.IgA:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36032177	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; MAYV; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36032177	MAYV IgA Spec Ql IA	4180186
36032179	功能:发现:时间点:视神经盘+视网膜神经纤维层.右侧:序数型:视网膜电图	4182948
36032179	ERG; EYE; EYE.ERG; FCN; Fibers; Finding; Findings; Func; Funct; Ophthalmology; Ophtho; Ophthy; Ordinal; Point in time; QL; Qual; Qualitative; R; R optic disc+RNFL; Random; RNFL; RT; Screen	4180186
36032179	R optic disc+RNFL Function ERG	4180186
36032180	布汪巴病毒 抗体.IgM:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36032180	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Orthobunyaviruses; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36032180	Bwamba virus IgM Spec Ql IA	4180186
36032182	HEDIS 评测年度 2020 取值集合 - PSA 检验项目排除组合:-:时间点:^患者:-	4182948
36032182	HEDIS MY 2020 PSA Test Excl; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
36032182	HEDIS MY 2020 PSA Test Excl	4180186
36032183	活化凝血时间.硅藻土+黏土诱导型:时间:时间点:全血:定量型:微黏度测定法	4182948
36032183	ACT; ACT Diatom Earth+Clay Ind; Activ; Activated coagulation time; Blood; Celite; Clot; Clottable; COAGULATION; Coagulation activated; Coagulation time; Hematology; Heme; MicrVisc; Point in time; QNT; Quan; Quant; Quantitative; Random; Rate; R-time; WB; Whole blood	4180186
36032183	ACT Diatom Earth+Clay Ind Bld MicrVisc	4180186
36032184	健康医疗服务人员之中的病例数量:数量(计数):时间点:^事件:定量型	4182948
36032184	Cases among HCP; Cnt; Count; Number; PH; Point in time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random	4180186
36032184	Total Event cases among HCP	4180186
36032186	Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; Tot; Totl	4180186
36032190	C&S; Cult; Cultures; EHV; EHV4; Equin; Equine rhinopneumonitis; Herpes virus; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36032190	EHV4 Spec Ql Cult	4180186
36032190	马疱疹病毒 4 型:存在情况或阈值:时间点:XXX:序数型:微生物特异性培养	4182948
36032192	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; PEDS; Peds surgery; Point in time; Random; Surg; Visit note	4180186
36032192	Peds surgery Eval note	4180186
36032192	评价记录:发现:时间点:{环境}:文档型:小儿外科学	4182948
36032195	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B burg; B burgdor; B burgdor G39/40; B burgdorferi; Bb; Blt; Burgdorf; Cnt; Count; Immune blot; Immune globulin G; Immunobl; Immunoblot; Immunoglobulin G; Lyme; Lyme disease; Lymes; Microbiology; Misc; Miscellaneous; Number; Other; Point in time; QNT; Quan; Quant; Quantitative; Random; RIBA; Spec; To be specified in another part of the message; Unspecified; WB; WBLOT; West blot; West blt; Western blot	4180186
36032195	伯氏疏螺旋体 G39_40 抗体.IgG 区带:数量(计数):时间点:XXX:定量型:免疫印迹法	4182948
36032195	B burgdor G39/40 IgG bands Spec IB	4180186
36032196	Assessment; Dis; Diseases; DOC.ONT; Document; Dz; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; ID; Infectious Disease; InfectiousDisease; notes; Point in time; Random; Visit note	4180186
36032196	Infectious disease Eval note	4180186
36032196	评价记录:发现:时间点:{环境}:文档型:感染性疾病	4182948
36032199	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; California Encephalitis Virus; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; Lacrosse virus; LACV; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36032199	LACV IgA Spec Ql IA	4180186
36032199	拉克罗斯病毒 抗体.IgA:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36032200	肝细胞癌:评分:时间点:^患者:定量型:GALAD	4182948
36032200	Chemistry; Hep Ca Risk; Hepatology; Liver; Oncology; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale	4180186
36032200	GALAD Score	4180186
36032204	凝块硬度因为纤维蛋白溶解而降低:压力或压强的比率:时间点:全血:定量型:计算法	4182948
36032204	Clot stiff red % due to fibrinolysis	4180186
36032204	Blood; Calc; Calculation; Clot stability to lysis; Clot stiff reduct due to fibrinolysis; COAGULATION; CSL; Hematology; Heme; Point in time; PressureRatio; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
36032205	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; C gattii+neofor; C. gattii; Crypt; Crypto; Cryptococcal; Cryptococcosis; Cryptococcosus; Cryptococcus neoformans var gattii; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36032205	C gattii+neofor DNA Bld Pos Ql NAA+n-prb	4180186
36032205	格特隐球菌+新型隐球菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36032208	17-Hydroxycorticosterone; Blood; Chemistry; Compound F; Coritsol; Cort; DBS; Dried blood spot; Endocrine; Endocrinology; F; Filter paper; FP; hydrocortisone; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; Testo; Testos; Testost; WB; Whole blood	4180186
36032208	Testost/Cortis DBS	4180186
36032208	睾酮/皮质醇:质量比率:时间点:全血.斑点:定量型	4182948
36032211	WIfI 分类:发现:时间点:下肢:序数型:WIfI	4182948
36032211	WIfI class LE WIfI	4180186
36032211	CLIN; CLIN.RISK; EXT; Finding; Findings; LE; Leg; Low; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36032213	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cervix; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Genital warts; HPV; HPV51; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Papilloma virus high risk; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36032213	HPV51 DNA Cvx Ql NAA+probe	4180186
36032213	人乳头瘤病毒 51 型 DNA:存在情况或阈值:时间点:子宫颈:序数型:探针法.基因扩增.靶向	4182948
36032215	2; Clot; Clottable; Coag; Coagulation assay; Fac; Fact; Fact II Inhib; Factor 2; FII; Hematology; Heme; Inhib; Inhibit; Ordinal; Plas; Platelet poor plasma; Point in time; PR; Prothrombin inhibitor; QL; Qual; Qualitative; Random; Screen; Tilt tube	4180186
36032215	Fact II Inhib PPP Ql	4180186
36032215	凝血因子 II 抑制剂:存在情况或阈值:时间点:贫血小板血浆:序数型:凝血功能分析	4182948
36032216	4 weeks; Derm; Dermatology; Finding; Findings; Integument; Last; Ordinal; Ql; Qual; Qualitative; Screen; Skin; Survey; SURVEY.GNHLTH	4180186
36032217	1,4,5-三磷酸肌醇受体 1型 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:CBA IFA	4182948
36032217	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Cyclohexane-1,2,3,4,5,6-hexol; i; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; InsP3R1; IP3 receptor isoform 1; IP3R 1; IP3R 1 Ab; IP3R 1 IgG; ITPR; ITPR1; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Type 1 inositol 1,4,5-trisphosphate receptor; Type 1 InsP3 receptor	4180186
36032217	IP3R 1 IgG CSF Ql CBA IFA	4180186
36032218	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SINV; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36032218	SINV IgA Spec Ql IA	4180186
36032218	辛德毕斯病毒 抗体.IgA:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36032220	1 year; 12Mos; Pan; Panel; Panl; Pnl; SDOH; Survey	4180186
36032223	经肺压力梯度:压差:时间点:肺动脉:定量型:计算法	4182948
36032223	Art; Calc; Calculation; Grad; Lung; PA; Point in time; Press grad; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Transpulm press grad	4180186
36032223	Transpulm press grad	4180186
36032226	凝血因子 XI 活性与抑制剂组套:-:时间点:贫血小板血浆:-:凝血功能分析	4182948
36032226	Activ; Actvty; Antihemophilic factor C; Clot; Clottable; Coag; Coagulation assay; Fac; Fact; Fact XI; Fact XI Act + Inhib Pnl; Factor 11; FXI; Inhib; Inhibit; Movements; Pan; PANEL.COAGULATION; Panl; Plas; Plasma thromboplastin antecedent; Platelet poor plasma; Pnl; Point in time; PTA; Random; Tilt tube	4180186
36032226	Fact XI Act + Inhib Pnl PPP	4180186
36032229	Blood; Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; DBS; Dried blood spot; Filter paper; FP; HDLc; HDL-C; Heart Disease; High density lipoprotein cholesterols; Level; Lipid; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; TCHHDL; WB; Whole blood	4180186
36032229	HDLc DBS-mCnc	4180186
36032229	胆固醇.HDL 之中的:质量浓度:时间点:全血.斑点:定量型	4182948
36032231	CARD.US; Cardiac; Cardio; Cardiology; Echography; Est; estimation; Finding; Findings; Heart Disease; Hrt; Hrt ventr; Ordinal; Point in time; predicted; QL; Qual; Qualitative; R; Random; RT; RV; Screen; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ventricular; Vol	4180186
36032231	RV Volume US+est	4180186
36032231	体积:发现:时间点:心脏.心室.右侧:序数型:超声+估计法	4182948
36032232	凝血因子 X 活性与抑制剂组套:-:时间点:贫血小板血浆:-:凝血功能分析	4182948
36032232	Activ; Actvty; Autoprothrombin III; Clot; Clottable; Coag; Coagulation assay; Fac; Fact; Fact X; Fact X Act + Inhib Pnl; Factor 10; FX; Inhib; Inhibit; Movements; Pan; PANEL.COAGULATION; Panl; Plas; Platelet poor plasma; Pnl; Point in time; Prothrombokinase; Random; Stuart-prower factor; Tilt tube	4180186
36032232	Fact X Act + Inhib Pnl PPP	4180186
36032234	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Breakbone fever; Dengue type I; Dengue type I+II+III+IV; Denv; DENV 1+2+3+4; DENV1; DENV1+2+3+4; EIA; ELFA; ELISA; Enzyme immunoassay; Flavivirus; i; IAA; ID; II; III; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36032234	DENV1+2+3+4 IgG Spec Ql IA	4180186
36032234	登革热病毒 1+2+3+4 型 抗体.IgG:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36032237	Wound care management Eval note	4180186
36032237	Assessment; Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Random; Visit note	4180186
36032237	评价记录:发现:时间点:{环境}:文档型:伤口护理管理	4182948
36032239	1 week; Derm; Dermatology; Finding; Findings; Integument; Last; Ordinal; Ql; Qual; Qualitative; Screen; Skin; Survey; SURVEY.GNHLTH	4180186
36032240	ABS; Aby; Alfa; Allergen; Allergens; Allergy; ALLERGY TESTING; Amyloglucosidase; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Disaccharidase; Glucan 1,4 alpha glucosidase IgE; Glucan 1,4-A glucosidase; Glucoamylase; Glucoinvertase; Glucosidosucrase; Glycogen storage disease type II; i; Immune globulin E; Immunoglobulin E; k88; Maltase; Maltase-glucoamylase; Point in time; Pompe disease; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
36032240	Glucan 1,4-A glucosidase IgE Qn	4180186
36032240	葡聚糖 1,4 alpha 葡糖苷酶 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
36032241	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; Geri med; Gerontology; H&P; History and physical; notes; Point in time; Random; Visit note	4180186
36032241	Geri med Eval note	4180186
36032241	评价记录:发现:时间点:{环境}:文档型:老年医学	4182948
36032243	Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random; Sx	4180186
36032243	感官症状:发现:时间点:^患者:名义型	4182948
36032245	3 months; Finding; Findings; Last; Mental health; MentalHealth; Ordinal; Psych; Psychiatry; Ql; Qual; Qualitative; Rx; Screen; Survey; SURVEY.NIDA	4180186
36032248	单核细胞.收获的/单核细胞.总计:计数型分数:时间点:^患者:定量型	4182948
36032248	BLOOD BANK; Cell; Cellularity; Mononuc; Mononuc Cells; Monos Recovered; Monos Total; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl	4180186
36032248	Monos Recovered/Monos Total NFr Patient	4180186
36032249	肾上腺皮质癌的概率:似然性:时间点:^患者:定量型:基于临床数据	4182948
36032249	ACC Prob; Adrnl; CLIN.RISK; from clin data; Oncology; Point in time; QNT; Quan; Quant; Quantitative; Random; Risk	4180186
36032249	ACC Prob from clin data	4180186
36032251	Ala; Alanine transaminase; ALAT; Alpha alanine; ALT; Blood; Catalytic Concentration; Chemistry; DBS; Dried blood spot; Filter paper; FP; Glutamic-pyruvic transferase; L-alanine; Point in time; QNT; Quan; Quant; Quantitative; Random; SGPT; WB; Whole blood	4180186
36032251	ALT DBS-cCnc	4180186
36032251	丙氨酸氨基转移酶:催化浓度:时间点:全血.斑点:定量型	4182948
36032252	1-azanaphthalene; 1-benzazine; 1-benzine; ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Benzopyridine; c704; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Quinoline IgE; Random; Serum; SR	4180186
36032252	喹啉 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
36032252	Quinoline IgE Qn	4180186
36032257	Rho GTP 酶活化蛋白 26 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:免疫荧光法	4182948
36032257	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; ARHGAP26; Autoantibodies; Autoantibody; Autoimmune cerebellar ataxia; Cerebral spinal fluid; Cerebrospinal Fl; FA; Fluorescent antibody; Fluoresent; GRAF; GRAF Ab; GRAF IgG; GTPase Regulator Associated with Focal Adhesion Kinase pp125; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuro; Neurology; Oligophrenin-1-like protein; OPHN1L; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF	4180186
36032257	GRAF IgG CSF Ql IF	4180186
36032259	HLA-DPA1 未决等位基因:类型:时间点:全血/组织:名义型:高分辨率方法	4182948
36032259	Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA-DPA1 Unreslvd Alleles; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
36032259	HLA-DPA1 Unreslvd Alleles High Res	4180186
36032261	NEONAT; Pain agi tot score; Pain/agitat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Tot; Totl	4180186
36032261	Pain agi tot score NPASS	4180186
36032262	内耳 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36032262	Inner ear Ab Ser IA-aCnc	4180186
36032262	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
36032263	1 day; 24 hours; 24HR; B; Chemistry; Endocrine; Endocrinology; QNT; Quan; Quant; Quantitative; Standard score; UA; UR; Urn; Z score; Z value; Z-score	4180186
36032263	Beta cortol 24h Z-score Ur	4180186
36032263	Beta 皮五醇:Z评分:24小时:尿液:定量型	4182948
36032265	3 months; Amph; Amphet; Amphetam; Amphetamines; Ampht; Finding; Findings; Last; Mental health; MentalHealth; Ordinal; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Speed; Stimul; Stimulant; Survey; SURVEY.NIDA	4180186
36032267	3 months; Finding; Findings; Last; Mental health; MentalHealth; Ordinal; Othr; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey; SURVEY.NIDA	4180186
36032269	Calc; Calculation; Chemistry; Endocrine; Endocrinology; FR; Level; Ly-Handelsman; Nanjee-Wheeler; Non-protein bound; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sodergard; SR; Substance concentration; Testo; Testos; Testost; Testost Free; Testosterone.unconjugated; Vermeulen	4180186
36032269	Testost Free SerPl Calc-sCnc	4180186
36032269	睾酮.游离型:物质的量浓度:时间点:血清/血浆:定量型:计算法	4182948
36032272	Benzoylmethylecgonine; Coke; Crack; Ecgonine methyl ester benzoate; Mental health; MentalHealth; Point in time; Psych; Psychiatry; QNT; Quan; Quant; Quantitative; Random; Scale; Snow; Subs; Survey; SURVEY.NIDA	4180186
36032275	对医学状况的理解存在问题:发现:时间点:^患者:序数型	4182948
36032275	Prob understand med cond	4180186
36032275	CLIN; Finding; Findings; Ordinal; Point in time; Prob understand med cond; Ql; Qual; Qualitative; Random; Screen	4180186
36032276	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enc; Enceph; Encephalomyelitis; Enzyme immunoassay; Equin; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Togavirus; Unspecified; WEE virus; WEEV; West	4180186
36032276	WEEV IgM Spec Ql IA	4180186
36032276	西方马脑炎病毒 抗体.IgM:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36032277	1 week; Derm; Dermatology; QNT; Quan; Quant; Quantitative; Scale; Skin; Survey; SURVEY.GNHLTH; Tot; Totl	4180186
36032279	细胞.CD3-CD14-CD19+CD45+DOCK8+/100 个细胞.CD3-CD14-CD19+CD45+:计数型分数:时间点:全血:定量型:流式细胞测量术	4182948
36032279	B Cells DOCK8+/B Cells NFr Bld FC	4180186
36032279	B Cells; B Cells DOCK8+; B220; B4; B-4; Blood; CD3 Cells; CD45R; CD45RA; CD45RB; CD45RC; CD45RO; Cell; CELL MARKERS; Cellularity; Dynamic; FC; HD-37; LCA; Leu12; Leu-12; Leu4; Leu-4; Leukocyte common antigen; LeuM3; Leu-M3; LPS receptor; LPS-R; Ly5; Mo2; Mo-2; My4; My-4; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T200; T3; WB; Whole blood	4180186
36032281	清创方法:类型:时间点:伤口:名义型	4182948
36032281	CLIN; Debride method; Meth; Method of; Nominal; Point in time; Random; Typ; Wnd	4180186
36032281	Debride method Wnd	4180186
36032283	肺炎克雷伯菌+变栖克雷伯菌+类肺炎克雷伯菌 DNA:计数型浓度范围:时间点:呼吸道.下:序数型:非探针法.基因扩增.靶向	4182948
36032283	K pneumo grp L resp NAA+non-prb-NCncRng	4180186
36032283	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; K pneumon; K. pneumon group; Klebsiella pneumoniae group; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; NCncRng; Nucleic acid sequence based analysis; PCR; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; SmQn; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36032284	标准厚度参数:长度:时间点:角膜.右侧:定量型:眼压测量法	4182948
36032284	Corneal; EYE; EYE.TONOMETRY; Glaucoma testing; Length; Ophthalmology; Ophtho; Ophthy; Point in time; QNT; Quan; Quant; Quantitative; R; R cornea; Random; RT; Thick	4180186
36032284	R cornea Standard thickness Tono	4180186
36032288	Clofazamine Islt Genotyp	4180186
36032288	ANTIBIOTIC SUSCEPTIBILITIES; AST; Clofazamine; Genotype; Genotypic; Islt; Isol; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
36032288	氯法齐明:抗生素敏感性:时间点:分离株:序数型:基因分型	4182948
36032289	Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Study report; Visit note	4180186
36032289	Diabetology Diag study note	4180186
36032289	诊断性检查记录:发现:时间点:{环境}:文档型:糖尿病学	4182948
36032291	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enc; Enceph; Encephalomyelitis; Enzyme immunoassay; Equin; IAA; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Togavirus; Unspecified; WEE virus; WEEV; West	4180186
36032291	WEEV IgA Spec Ql IA	4180186
36032291	西方马脑炎病毒 抗体.IgA:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36032295	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; SARSr-CoV; SARS-rel CoV E gene; Screen; SDA; Severe Acute Respiratory Syndrome; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36032295	SARS-rel CoV E gene Low resp Ql NAA+prb	4180186
36032295	SARS 冠状病毒 2 E 基因:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
36032296	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cervix; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Genital warts; HPV; HPV52; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36032296	HPV52 DNA Cvx Ql NAA+probe	4180186
36032296	人乳头瘤病毒 52 型 DNA:存在情况或阈值:时间点:子宫颈:序数型:探针法.基因扩增.靶向	4182948
36032297	1 week; Derm; Dermatology; Finding; Findings; Integument; Last; Ordinal; Ql; Qual; Qualitative; Screen; Skin; Survey; SURVEY.GNHLTH	4180186
36032298	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
36032299	HEDIS 评测年度 2020 取值集合 - 非 LDL 的胆固醇检验项目:-:时间点:^患者:-	4182948
36032299	HEDIS MY 2020 Chol Tests not LDL	4180186
36032299	Chol; Choles; Cholest; Cholesterol total; Cholesterols; HEDIS MY 2020 Chol Tests not LDL; Lipid; Othr; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
36032303	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bunyavirus; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Rift valley fever; RVFV; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36032303	RVFV IgM Spec Ql IA	4180186
36032303	裂谷热病毒 抗体.IgM:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36032305	Drug given for pulm vaso test; Drugs; Ident; Identifier; Lung; Nominal; Point in time; Pulm; Pulmonary; Pulmonology; Random; Respiratory	4180186
36032305	Drug given for pulm vaso test	4180186
36032305	因肺血管扩张剂试验而给予的药物:标识符:时间点:^患者:名义型	4182948
36032309	T-细胞的 SARS 冠状病毒 2 刺激型 gamma 干扰素释放:任意型浓度:时间点:全血:定量型	4182948
36032309	2019 Novel Coronavirus; 2019-nCoV; Arbitrary concentration; Blood; Cell; Cellularity; Corona virus; COVID19; COVID-19; IFN; IGRA; II; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 IFN-g; SARS-CoV-2 IFN-g T cells; Severe Acute Respiratory Syndrome; T prime; Viral Pneumonias; WB; Whole blood; Wuhan coronavirus	4180186
36032309	SARS-CoV-2 IFN-g T cells Bld-aCnc	4180186
36032311	血小板诱导型凝块收缩.玻璃珠诱导型^在肝素中和之后:任意型:时间点:全血:定量型:微黏度测定法	4182948
36032311	After; Arbitrary; Blood; COAGULATION; Hematology; Heme; Hep; Hepar; Heparin Nt; Heparn; MicrVisc; Neut; Neutr; p hep neut; Pl; Platelets; Platelt; Plt; Plt Ind Clt Retr Gls; Plt Ind Clt Retr Gls HepNtr; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Retract; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
36032311	Plt-Ind CltRetr Gls HepNtr Bld MicrVisc	4180186
36032313	4 weeks; Derm; Dermatology; Finding; Findings; Integument; Last; Ordinal; Ql; Qual; Qualitative; Screen; Skin; Survey; SURVEY.GNHLTH	4180186
36032315	IgLON 家族成员 5 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:免疫荧光法	4182948
36032315	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; FA; Fluorescent antibody; Fluoresent; IFA; IgLON5; IgLON5 Ab; IgLON5 IgG; IMMUNE FLUORESCENCE; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF	4180186
36032315	IgLON5 IgG CSF Ql IF	4180186
36032320	Centers for Medicare and Medicaid Assessment; Levels; Levl; LV; LVL; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36032321	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C auris; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn	4180186
36032321	C auris DNA Ur Ql NAA+non-probe	4180186
36032321	耳道假丝酵母菌 DNA:存在情况或阈值:时间点:尿液:序数型:非探针法.基因扩增.靶向	4182948
36032324	Rho GTP 酶活化蛋白 26 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
36032324	GRAF IgG Titr Ser IF	4180186
36032324	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; ARHGAP26; Autoantibodies; Autoantibody; Autoimmune cerebellar ataxia; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; GRAF; GRAF Ab; GRAF IgG; GTPase Regulator Associated with Focal Adhesion Kinase pp125; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Oligophrenin-1-like protein; OPHN1L; Point in time; PR; Prot; Random; Serology; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
36032325	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Staph; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36032325	S lugdunensis DNA Bld Pos Ql NAA+non-prb	4180186
36032325	里昂葡萄球菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36032327	孕龄 <30 周:发现:时间点:^患者:序数型	4182948
36032327	Finding; Findings; GA; GA&lt;30w; Gest; Gestation; NEONAT; Ordinal; Point in time; Prenatal; QL; Qual; Qualitative; Random; Screen	4180186
36032327	GA<30w	4180186
36032331	3 months; Benzoylmethylecgonine; Coke; Crack; Ecgonine methyl ester benzoate; Finding; Findings; Last; Mental health; MentalHealth; Ordinal; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Snow; Survey; SURVEY.NIDA	4180186
36032332	3 months; Finding; Findings; Last; Mental health; MentalHealth; Ordinal; Psych; Psychiatry; Ql; Qual; Qualitative; Screen; Survey; SURVEY.NIDA	4180186
36032333	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enc; Enceph; Encephalomyelitis; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SLE virus; SLEV; Spec; St Louis; SUDS; To be specified in another part of the message; Unspecified	4180186
36032333	SLEV IgM Spec Ql IA	4180186
36032333	圣路易型脑炎病毒 抗体.IgM:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36032336	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
36032337	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36032337	转诊记录:发现:时间点:{环境}:文档型:免疫学	4182948
36032339	Haem influ DNA L resp NAA+non-prb-NCncRng	4180186
36032339	流感嗜血杆菌 DNA:计数型浓度范围:时间点:呼吸道.下:序数型:非探针法.基因扩增.靶向	4182948
36032339	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; H flu; H influenza; H influenzae; Haem influ; Haemoph; ID; Infectious Disease; InfectiousDisease; Influ; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; NCncRng; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; SmQn; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36032341	Nutr+diet Eval note	4180186
36032341	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Nutr+diet; Nutrition+Dietetics; Point in time; Random; Visit note	4180186
36032341	评价记录:发现:时间点:{环境}:文档型:营养学与膳食学	4182948
36032345	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CA; Calif; CEV; CEV Ab; CEV IgG; EIA; ELFA; ELISA; Enc; Enceph; Encephalomyelitis; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36032345	CEV IgG Spec Ql IA	4180186
36032345	加利福尼亚脑炎病毒 抗体.IgG:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36032347	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Phleboviruses; Point in time; PR; QL; Qual; Qualitative; Random; Sand fly fever; Screen; Spec; SUDS; To be specified in another part of the message; TOSV; TOSV Ab; Unspecified	4180186
36032347	TOSV IgG Spec Ql IA	4180186
36032347	托斯卡纳病毒 抗体.IgG:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36032351	5-孕烯三醇:Z评分:24小时:尿液:定量型	4182948
36032351	1 day; 24 hours; 24HR; Chemistry; Endocrine; Endocrinology; QNT; Quan; Quant; Quantitative; Standard score; UA; UR; Urn; Z score; Z value; Z-score	4180186
36032351	5-Pregnenetriol 24h Z-score Ur	4180186
36032352	SARS 冠状病毒 2 & SARS-相关冠状病毒 RNA 组套:-:时间点:呼吸道:-:探针法.基因扩增.靶向	4182948
36032352	SARS-CoV-2+SARSr-CoV pnl Resp NAA+probe	4180186
36032352	2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breathing; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Ribonucleic acid; RS; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2+SARSr-CoV; SARS-CoV-2+SARSr-CoV RNA; SARS-CoV-2+SARSr-CoV RNA pnl; SARSr-CoV; SDA; Severe Acute Respiratory Syndrome; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral Pneumonias; Wuhan coronavirus	4180186
36032353	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
36032353	Sleep med Prog note	4180186
36032353	病程记录:发现:时间点:{环境}:文档型:睡眠医学	4182948
36032354	HLA-C 未决等位基因:类型:时间点:全血/组织^供体:名义型:高分辨率方法	4182948
36032354	Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA-C Unreslvd Alleles; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
36032354	HLA-C Unreslvd Alleles Donr High Res	4180186
36032355	功能与上一次的评估相比:发现:时间点:视椎细胞+视杆细胞.左侧:序数型:视网膜电图	4182948
36032355	Comp func; ERG; EYE; EYE.ERG; FCN; Finding; Findings; Func; Funct; L; L cones+rods; L rods; LT; Ophthalmology; Ophtho; Ophthy; Ordinal; Point in time; Prev; QL; Qual; Qualitative; Random; Screen	4180186
36032355	L cones+rods Comp func ERG	4180186
36032356	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enc; Enceph; Encephalomyelitis; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SLE virus; SLEV; Spec; St Louis; SUDS; To be specified in another part of the message; Unspecified	4180186
36032356	SLEV IgG Spec Ql IA	4180186
36032356	圣路易型脑炎病毒 抗体.IgG:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36032359	非恶性息肉切除的适宜性:发现:时间点:标本:序数型	4182948
36032359	Resection adeq non-malig polyp Spec Ql	4180186
36032359	Finding; Findings; Malig; Ordinal; PATHOLOGY; Point in time; QL; Qual; Qualitative; Random; Resection adeq non-malig polyp; Screen; Spec	4180186
36032361	健康医疗服务人员之中的病例数量:数量(计数):报告期:^事件:定量型	4182948
36032361	Cases among HCP; Cnt; Count; Number; PH; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Report period	4180186
36032361	Event HCP cases dur RptPeriod	4180186
36032362	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enc; Enceph; Encephalomyelitis; Enzyme immunoassay; Flavivirus; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Japanese B encephalitis; Japanese encephalitis; JBE; JE virus; JEV; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36032362	JEV IgG Spec Ql IA	4180186
36032362	日本脑炎病毒 抗体.IgG:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36032366	视黄醇结合蛋白/肌酐:质量比率:24小时:尿液:定量型	4182948
36032366	Retinol Bind Prot/Creat 24h Ur	4180186
36032366	1 day; 24 hours; 24HR; alpha 2 microglobulin; alpha-2-microglobulin; Axerol; Axerophthol; Bind; Biosterol; Chemistry; CR; Crea; Creat; Mass concentration ratio; Mass ratio; MCRto; PR; Prot; QNT; Quan; Quant; Quantitative; RBP; Retinol Bind Prot; UA; UCr; UR; Urn; Vit A; Vit A alcohol; Vit A1; Vit A1 alcohol; Vitamin A; Vitamin A alcohol; Vitamin A binding protein; Vitamin A1	4180186
36032369	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Sal; Salmonel; Screen; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36032369	Salmonella DNA Bld Pos Ql NAA+non-probe	4180186
36032369	沙门菌属单个未知种 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36032372	Anion Gap3 Bld-sCnc	4180186
36032372	Ag; AnGAP; Anion Gap3; Blood; Chemistry; III; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood	4180186
36032372	阴离子间隙 3:物质的量浓度:时间点:全血:定量型	4182948
36032373	所关注疾病患者已占据的住院床位:数量(计数):时间点:{环境}:定量型	4182948
36032373	Beds occup w illness; Cnt; Count; Dis; Diseases; Dz; Inpt beds; Inpt beds occup; Number; PH; Point in time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random	4180186
36032373	Beds occup w illness	4180186
36032381	发生肝细胞癌的概率:似然性:时间点:^患者:定量型	4182948
36032381	CLIN; CLIN.RISK; Hepatology; Liver; Oncology; Point in time; Probability HCC; QNT; Quan; Quant; Quantitative; Random; Risk	4180186
36032381	Probability HCC	4180186
36032382	#; ABS; absolute; absolutes; Cell; Cellularity; Cnt; Count; Count/volume; CT; HEMATOLOGY/CELL COUNTS; Lower respiratory; Manl; Nuc; Nuc cell; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Spt; Sputum	4180186
36032382	Nuc cell # Spt Manual	4180186
36032382	有核细胞类:计数型浓度:时间点:痰液:定量型:手工计数方法	4182948
36032384	诊断时所在的省份、州或者区域:位置:时间点:^患者:名义型	4182948
36032384	Location; Nominal; PH; Point in time; Province, state or region where dx; Public Health; PUBLICHEALTH; Random	4180186
36032384	Province, state or region where dx	4180186
36032388	马亚罗病毒 抗体.IgM:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36032388	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; MAYV; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified	4180186
36032388	MAYV IgM Spec Ql IA	4180186
36032389	已愈合伤口信息:发现:时间点:^患者:文档型	4182948
36032389	Healed wnd info Doc	4180186
36032389	Document; Finding; Findings; H+P; H+P.HX; Healed wnd info; P prime; Point in time; Random	4180186
36032393	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; P carinii; P jiroveci; PCP; PCR; Pneumocystis carinii; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
36032393	P jiroveci DNA Tiss Ql NAA+probe	4180186
36032393	耶氏肺孢子菌 DNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36032397	睡眠质量 - 1-5 数字型评级:评分:24小时:^患者:定量型	4182948
36032397	Sleep quality 1-5 rating 24h	4180186
36032397	1 day; 24 hours; 24HR; H+P; H+P.HX; i; P prime; QNT; Quan; Quant; Quantitative; Scale; Sleep quality (1-5)	4180186
36032398	C&S; Cult; Cultures; EHV; EHV3; Equin; Herpes virus; III; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36032398	EHV3 Spec Ql Cult	4180186
36032398	马疱疹病毒 3 型:存在情况或阈值:时间点:XXX:序数型:微生物特异性培养	4182948
36032402	观察场所:类型:时间点:^患者:名义型	4182948
36032402	H+P; H+P.HX; Nominal; Obs set; P prime; Point in time; Random; Typ	4180186
36032402	Obs set	4180186
36032403	Assessment; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Random; Visit note	4180186
36032403	Emergency med Eval note	4180186
36032403	评价记录:发现:时间点:{环境}:文档型:急诊医学	4182948
36032405	Blood; Donr; HLA ANTIGEN; HLA-DRB3 + 4 + 5; HLA-DRB5; Human Leukocyte Antigen; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
36032405	HLA-DRB3 + 4 + 5 Donr	4180186
36032405	HLA-DRB3 & HLA-DRB4 & HLA DRB5:类型:时间点:全血/组织^供体:名义型	4182948
36032406	HLA-B 未决等位基因:类型:时间点:全血/组织^供体:名义型:高分辨率方法	4182948
36032406	Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; HLA-B Unreslvd Alleles; Human Leukocyte Antigen; Inherited; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Typ; WB; Whole blood; Whole blood or Tissue	4180186
36032406	HLA-B Unreslvd Alleles Donr High Res	4180186
36032407	胰多肽^假饲后25分钟:质量浓度:时间点:血清/血浆:定量型	4182948
36032407	25M p Sham Feed; After; Chemistry; Endocrine; Endocrinology; Level; Mass concentration; Panc Polypept; Pancr; Pancreatc; Pl; Plasma; Plsm; Point in time; Polypeptides; PP; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36032407	Panc Polypept 25M p Sham Feed SerPl-mCnc	4180186
36032408	cN-1A Ab Ser IA-aCnc	4180186
36032408	5NT; ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; cN1A; cN-1A; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Inclusion body myositis; Inclusion Body Myositis, Sporadic; MEIA; Mup44; NT; NT5C1A; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
36032408	胞质-5'-核苷酸酶 1A 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36032409	免疫状态:发现:时间点:^患者:序数型	4182948
36032409	Finding; Findings; H+P; H+P.HX; Host, Immunosuppressed; Imm; Immunocompromised Patient; Imun; Imune; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36032410	表面诱导型凝血过程.狼疮敏感性.因子替换^在添加1:1正常血浆后孵育之后2小时:时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
36032410	120 min; 120 minutes; 120min; 2 hours; 2h p 1:1 NP; 2h p Inc; Activated partial thromboplastin time; After; aPTT; aPTT with Platelin LS; aPTT-LA; Clot; Clottable; Coag; Coagulation assay; Control; Fac; Fact; Hematology; Heme; i; Little(A)PTT; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; PST; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube	4180186
36032410	aPTT-LA 2h p 1:1 NP PPP	4180186
36032411	4 weeks; Derm; Dermatology; QNT; Quan; Quant; Quantitative; Scale; Skin; Survey; SURVEY.GNHLTH; Tot; Totl	4180186
36032412	CD3 Cells BPU	4180186
36032412	BLOOD BANK; Blood product unit; Blood Product Unit (Pack); CD3 Cells; Cell; Cellularity; Cnt; Count; Leu4; Leu-4; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; T3	4180186
36032412	细胞.CD3:数量(计数):时间点:^血液制品单位:定量型	4182948
36032414	胰多肽^假饲后10分钟:质量浓度:时间点:血清/血浆:定量型	4182948
36032414	10M p Sham Feed; After; Chemistry; Endocrine; Endocrinology; Level; Mass concentration; Panc Polypept; Pancr; Pancreatc; Pl; Plasma; Plsm; Point in time; Polypeptides; PP; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
36032414	Panc Polypept 10M p Sham Feed SerPl-mCnc	4180186
36032416	Blood; Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; DBS; Dir; Dried blood spot; Filter paper; FP; Heart Disease; LDLc; LDL-C; Level; Lipid; Low density lipoprotein cholesterol; Low density lipoprotein cholesterols; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
36032416	LDLc DBS Direct Assay-mCnc	4180186
36032416	胆固醇.LDL 之中的:质量浓度:时间点:全血.斑点:定量型:直接分析法	4182948
36032417	ACAD3; acyl-CoA dehydrogenase, C-2 to C-3 short chain; Acyl-CoA dehydrogenase, short-chain specific gene; Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; SCAD; SCAD gene; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36032417	ACADS gene Full Mut Anl Bld/T Seq	4180186
36032417	ACADS 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
36032419	2019 Novel Coronavirus; 2019-nCoV; Antigen; Antigens; Corona virus; COVID19; COVID-19; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; II; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; Screen; Severe Acute Respiratory Syndrome; SUDS; Up; Upper resp; Viral Pneumonias; Wuhan coronavirus	4180186
36032419	SARS-CoV-2 Ag Upper resp Ql IA	4180186
36032419	SARS 冠状病毒 2 抗原:存在情况或阈值:时间点:呼吸道.上:序数型:免疫测定法	4182948
36032420	黑穗醋栗 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
36032420	ABS; Aby; Allergen; Allergens; Allergy; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Black currant; Blackcurrant; Blackcurrant IgE; Cassis; F356; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
36032420	Blackcurrant IgE Qn	4180186
36032425	#; ABS; absolute; absolutes; Cell; Cellularity; Cnt; Count; Count/volume; CT; Epi; Epi Cells; Epith; Epithelia; HEMATOLOGY/CELL COUNTS; Low; Lower resp; Manl; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36032425	Ciliated # Lower resp Manual	4180186
36032425	上皮细胞.纤毛化:计数型浓度:时间点:呼吸道.下:定量型:手工计数方法	4182948
36032478	IO_IN.TIMED.MOLEC	4180186
36033050	IO_OUT.ATOM	4180186
36033267	IO_IN.MOLEC	4180186
36033359	Straw dust Ab.IgE	4180186
36033636	COVID-19 临床状态:发现:时间点:^患者:序数型:WHO 分类	4182948
36033636	2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Screen; WHO Ordinal Scale for Clinical Improvement; World Heatlth Organization	4180186
36033636	COVID-19 clinical status WHO	4180186
36033637	COVID-19 恢复证书:发现:时间点:{环境}:文档型:{角色}	4182948
36033637	Proof of COVID-19 recovery Cert	4180186
36033637	2019 Novel Coronavirus; 2019-nCoV; ADMIN; Coronavirus disease 2019; COVID19; DOC.ADMIN; Document; Finding; Findings; ID; Infectious Disease; InfectiousDisease; Point in time; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus	4180186
36033638	COVID-19 免疫接种证明或阴性状态证书:发现:时间点:{环境}:文档型:{角色}	4182948
36033638	2019 Novel Coronavirus; 2019-nCoV; ADMIN; Coronavirus disease 2019; COVID19; COVID-19 Immunization or Neg Cert; DCC; DGC; Digital COVID Certificate; Digital Green Certificate; DOC.ADMIN; Document; EU COVID 19 certificate; EU DCC; EU Digital COVID Certificate; Finding; Findings; ID; Immunization status; Infectious Disease; InfectiousDisease; NEG; Point in time; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Vaccination; Vaccinations; Vaccine	4180186
36033638	COVID-19 Immunization or Neg Cert	4180186
36033641	SARS 冠状病毒 2 抗原:存在情况或阈值:时间点:呼吸道.上:序数型:免疫测定法.快速	4182948
36033641	2019 Novel Coronavirus; 2019-nCoV; Antigen; Antigens; Corona virus; COVID19; COVID-19; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; II; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; Screen; Severe Acute Respiratory Syndrome; SUDS; Up; Upper resp; Viral Pneumonias; Wuhan coronavirus	4180186
36033641	SARS-CoV-2 Ag Upper resp Ql IA.rapid	4180186
36033643	流感病毒 A & 流感病毒 B & SARS 冠状病毒 2 抗原组套:-:时间点:呼吸道.上:-:免疫测定法.快速	4182948
36033643	2019 Novel Coronavirus; 2019-nCoV; Avian influenza; Bird flu; Corona virus; COVID19; COVID-19; EIA; ELFA; ELISA; Enzyme immunoassay; FLUA; FLUABV + SARS-CoV-2; FLUABV+SARS-CoV2 Ag Pnl; FLUAV; FLUB; FLUBV; FLUV; Fowl plague; IAA; ID; II; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Influenza B; Influenza B virus; MEIA; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; Severe Acute Respiratory Syndrome; SUDS; Up; Upper resp; Viral Pneumonias; Wuhan coronavirus	4180186
36033643	FLUABV+SARS-CoV2 Ag Pnl Up resp IA.rapid	4180186
36033644	SARS 冠状病毒 2 N 基因:存在情况或阈值:时间点:鼻:序数型:非探针法.基因扩增.靶向	4182948
36033644	2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; Nasal; NASBA; Nos; Nose (nasal passage); Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 N gene; Screen; SDA; Severe Acute Respiratory Syndrome; Smell; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral Pneumonias; Wuhan coronavirus	4180186
36033644	SARS-CoV-2 N gene Nose Ql NAA+non-probe	4180186
36033647	SARS 冠状病毒 2 RNA 组套:-:时间点:口咽洗液:-:探针法.基因扩增.靶向	4182948
36033647	SARS-CoV-2 RNA Pnl OPA wash NAA+probe	4180186
36033647	2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Mouthwash; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OPA wash; Oph; Oral cavity wash; Oropharyngeal; Oropharynx; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pharynx gargle; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Ribonucleic acid; Saline gargle; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 RNA Pnl; SDA; Severe Acute Respiratory Syndrome; Strand Displacement Amplification; Throat rinse; TMA; Transcription mediated amplification; Viral Pneumonias; Wuhan coronavirus	4180186
36033648	SARS 冠状病毒 2 N 基因:阈值循环圈数:时间点:口咽洗液:定量型:探针法.基因扩增.靶向	4182948
36033648	SARS-CoV-2 N gene Ct OPA wash Qn NAA+prb	4180186
36033648	2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Mouthwash; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OPA wash; Oph; Oral cavity wash; Oropharyngeal; Oropharynx; PCR; Pharynx gargle; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Saline gargle; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 N gene; SDA; Severe Acute Respiratory Syndrome; Strand Displacement Amplification; Throat rinse; TMA; Transcription mediated amplification; Viral Pneumonias; Wuhan coronavirus	4180186
36033651	SARS 冠状病毒 2 序列测定与鉴定组套:-:时间点:XXX:-:分子遗传学类实验室方法	4182948
36033651	2019 Novel Coronavirus; 2019-nCoV; Corona virus; COVID19; COVID-19; ID; II; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Molecular genetics; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 Seq and ID Pnl; Severe Acute Respiratory Syndrome; Spec; To be specified in another part of the message; Unspecified; Viral Pneumonias; Wuhan coronavirus	4180186
36033651	SARS-CoV-2 Seq and ID Pnl Spec	4180186
36033653	SARS 冠状病毒 2 分支:类型:时间点:XXX:名义型:分子遗传学类实验室方法	4182948
36033653	SARS-CoV-2 clade Spec	4180186
36033653	2019 Novel Coronavirus; 2019-nCoV; Corona virus; COVID19; COVID-19; ID; II; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Molecular genetics; Nominal; Other; PCR; Point in time; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 clade; Severe Acute Respiratory Syndrome; Spec; To be specified in another part of the message; Typ; Unspecified; Viral Pneumonias; Wuhan coronavirus	4180186
36033654	COVID-19+疫苗接种记录:发现:时间点:{环境}:文档型:{角色}	4182948
36033654	2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; COVID-19 Immunization note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Immunization status; notes; Point in time; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Vaccination; Vaccinations; Vaccine; Visit note	4180186
36033655	SARS 冠状病毒 2 RNA:存在情况或阈值:时间点:XXX^供体:序数型:探针法.基因扩增.靶向	4182948
36033655	2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; Donr; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; Screen; SDA; Severe Acute Respiratory Syndrome; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Viral Pneumonias; Wuhan coronavirus	4180186
36033655	SARS-CoV-2 RNA Spec Donr Ql NAA+probe	4180186
36033656	SARS 冠状病毒 2 RNA:存在情况或阈值:时间点:口咽洗液:序数型:探针法.基因扩增.靶向	4182948
36033656	SARS-CoV-2 RNA OPA wash Ql NAA+probe	4180186
36033656	2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Mouthwash; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OPA wash; Oph; Oral cavity wash; Ordinal; Oropharyngeal; Oropharynx; PCR; Pharynx gargle; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Saline gargle; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; Screen; SDA; Severe Acute Respiratory Syndrome; Strand Displacement Amplification; Throat rinse; TMA; Transcription mediated amplification; Viral Pneumonias; Wuhan coronavirus	4180186
36033657	GISAID 登录号:标识符:时间点:分离株:名义型	4182948
36033657	GISAID seq accession ID; ID; Ident; Identifier; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; No; Nominal; Num; Point in time; Random; Virus sequence number	4180186
36033657	GISAID seq accession ID	4180186
36033658	SARS 冠状病毒 2 E 基因:存在情况或阈值:时间点:呼吸道:序数型:探针法.基因扩增.靶向	4182948
36033658	SARS-CoV-2 E gene Resp Ql NAA+probe	4180186
36033658	2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breathing; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; RS; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 E gene; Screen; SDA; Severe Acute Respiratory Syndrome; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral Pneumonias; Wuhan coronavirus	4180186
36033660	SARS 冠状病毒 2 S 基因:存在情况或阈值:时间点:唾液:序数型:探针法.基因扩增.靶向	4182948
36033660	SARS-CoV-2 S gene Sal Ql NAA+probe	4180186
36033660	2019 Novel Coronavirus; 2019-nCoV; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; COVID19; COVID-19; DNA NUCLEIC ACID PROBE; DNA probe; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Oral fluid; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S prime; Sal; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 S gene; SARS-Related Coronavirus; Screen; SDA; Severe Acute Respiratory Syndrome; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral Pneumonias; Wuhan coronavirus	4180186
36033665	SARS 冠状病毒 2 S 基因突变:存在情况或阈值:时间点:XXX:序数型:分子遗传学类实验室方法	4182948
36033665	SARS-CoV-2 S gene mut Spec Ql	4180186
36033665	2019 Novel Coronavirus; 2019-nCoV; Corona virus; COVID19; COVID-19; ID; II; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Molecular genetics; Mut; Mutations; Ordinal; Other; PCR; Point in time; PR; QL; Qual; Qualitative; Random; S prime; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SARS-CoV-2 S gene; SARS-CoV-2 S gene mut; SARS-Related Coronavirus; Screen; Severe Acute Respiratory Syndrome; Spec; To be specified in another part of the message; Unspecified; Viral Pneumonias; Wuhan coronavirus	4180186
36033668	COVID-19+操作记录:发现:时间点:{环境}:文档型:{角色}	4182948
36033668	COVID-19 Proced note	4180186
36033668	2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; COVID-19 Proced note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Visit note	4180186
36033670	COVID-19 记录:发现:时间点:{环境}:文档型:{角色}	4182948
36033670	2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Visit note	4180186
36033671	COVID-19 记录:发现:时间点:远程医疗:文档型:{角色}	4182948
36033671	2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus; Telemedicine; Visit note	4180186
36033672	COVID-19 信函:发现:时间点:{环境}:文档型:{角色}	4182948
36033672	2019 Novel Coronavirus; 2019-nCoV; Coronavirus disease 2019; COVID19; DOC.ONT; Document; Finding; Findings; Point in time; Random; SARS Coronavirus; SARS-CoV-2; SARS-Related Coronavirus	4180186
36033674	免疫接种优先等级:类型:时间点:^患者:名义型	4182948
36033674	Immunization status; Nominal; PH; Point in time; Public Health; PUBLICHEALTH; Random; Typ; Vaccination; Vaccinations; Vaccine	4180186
36033682	During the past 1W, how often have you been bothered by the appearance of your skin condition	4180186
36033684	During the past 3Mo, how often has your use of prescription stimulants led to health, social, legal or financial problems	4180186
36033687	During the past 1W, how often have you been bothered by the effects of your skin condition on your daily activities	4180186
36033697	Freesia spp Ab.IgE	4180186
36033709	Ganglion cells.right	4180186
36033721	During the past 3Mo, how often have you failed to do what was normally expected of you because of your use of cocaine	4180186
36033729	House dust Japan Ab.IgE	4180186
36033731	Ribes nigrum Ab.IgE	4180186
36033737	During the past 1W, how often have you been bothered by embarrassment about your skin condition	4180186
36033743	NIDA	4180186
36033744	HEDIS Measurement Year 2020 Value Set - Diastolic Blood Pressure	4180186
36033748	During the past 4W, my skin condition is a problem for the people I love	4180186
36033760	HEDIS Measurement Year 2020 Value Set - FOBT	4180186
36033770	Neuronal intermediate filament light chain Ab.IgG	4180186
36033771	Aloe vera Ab.IgE	4180186
36033776	During the past 1W, how often have you been bothered by effects of your skin problem on your activities	4180186
36033786	Cones+Rods.left	4180186
36033788	Neuronal intermediate filament heavy chain Ab.IgG	4180186
36033793	Saccharum officinarum pollen	4180186
36033795	During the past 4W, my skin condition makes me feel depressed	4180186
36033806	Neuronal intermediate filament Ab.IgG	4180186
36033811	Influenza virus A & Influenza virus B & SARS coronavirus 2 & Respiratory syncytial virus RNA panel	4180186
36033814	Cones+Rods.right	4180186
36033823	IgLON family member 5 Ab	4180186
36033825	During the past 1W, how often have you been bothered by feeling depressed about your skin condition	4180186
36033838	HEDIS Measurement Year 2020 Value Set - Mammography	4180186
36033840	Renal clearance & Renal plasma flow panel	4180186
36033848	Ribes uva-crispa Ab.IgE	4180186
36033852	During the past 4W, my skin condition affects how close I can be with those I love	4180186
36033860	Argas reflexus Ab.IgE	4180186
36033868	Inositol 1,4,5-trisphosphate receptor type 1 Ab.IgG	4180186
36033870	Tobacco amount per D	4180186
36033882	(Amphotericin B+Erythromycin+Nystatin+Spiramycin)	4180186
36033884	Illegal drug use in the past 1Y	4180186
36033895	Has symptoms related to condition of interest	4180186
36033898	Streptomycin Ab.IgE	4180186
36033901	Cichorium intybus var foliosum Ab.IgE	4180186
36033920	During the past 3Mo, how often have you had a strong desire or urge to use cannabis	4180186
36033927	Ribes nigrum	4180186
36033931	Coagulation factor XI activity & inhibitor panel	4180186
36033936	Resides in a congregate care setting	4180186
36033940	During the last Mo did you have to skip a meal because your family didn't have enough money for food	4180186
36033944	Clot formation & Platelet function.glass bead induced panel	4180186
36033951	Methylene blue Ab.IgE	4180186
36033952	Optic disc+retinal nerve fiber layer.left	4180186
36033956	During the past 3Mo, how often has your use of cannabis led to health, social, legal or financial problems	4180186
36033964	Influenza virus A & Influenza virus B & SARS coronavirus+SARS coronavirus 2 Ag panel	4180186
36033967	Scorzonera hispanica	4180186
36033973	During the last Mo did you not eat for a whole day because your family didn't have enough money for food	4180186
36033977	During the past 4W, I am angry about my skin condition	4180186
36033982	Isolated per Infection Prevention and Control guidelines	4180186
36033989	Morphine Ab.IgE	4180186
36033998	During the past 4W, I worry that my skin condition may get worse	4180186
36034003	Rods.left	4180186
36034006	HIV 1 & 2 RNA panel	4180186
36034007	During the past 3Mo, how often have you had a strong desire or urge to use cocaine	4180186
36034009	Fagus grandifolia wood dust	4180186
36034013	SARS coronavirus 2 specific TCRB gene rearrangements	4180186
36034014	(Amphotericin B+Erythromycin+Nystatin+Spiramycin) Ab.IgE	4180186
36034015	Pain &or agitation severity.behavior state	4180186
36034017	(Gentamycin+Lincomycin+Neomycin+Streptomycin+Tobramycin)	4180186
36034025	During the past 1W, how often have you been bothered by your skin condition itching	4180186
36034029	HEDIS Measurement Year 2020 Value Set - Lead Tests	4180186
36034032	Work or school D missed due to illness	4180186
36034033	During the past 4W, my skin itches	4180186
36034039	Prescription drug use for non-medical reasons in the past 1Y	4180186
36034049	La Crosse virus Ab.IgG & IgM panel	4180186
36034061	During the past 3Mo, how often have you had a strong desire or urge to use sedatives or sleeping pills	4180186
36034067	During the past 3Mo, how often has your use of sedatives or sleeping pills led to health, social, legal or financial problems	4180186
36034068	Dermatophagoides pteronyssinus recombinant (rDer p) 23 Ab.IgE	4180186
36034074	Fraxinus excelsior wood dust Ab.IgE	4180186
36034084	HEDIS Measurement Year 2020 Value Set - Cervical Cytology	4180186
36034088	During the past 3Mo, how often has your use of inhalants led to health, social, legal or financial problems	4180186
36034093	Acrylic fiber Ab.IgE	4180186
36034094	Pain &or agitation severity.facial expression	4180186
36034095	Pain &or agitation severity.vital signs variability	4180186
36034101	Electroretinogram.multifocal	4180186
36034102	T-cell naive & memory & activated subsets panel	4180186
36034104	Coagulation factor X activity & inhibitor panel	4180186
36034111	During the past 3Mo, how often have you had a strong desire or urge to use methamphetamine	4180186
36034119	HEDIS Measurement Year 2020 Value Set - HPV Tests	4180186
36034120	During the past 3Mo, how often have you used hallucinogens	4180186
36034128	During the last Mo did the food that your family bought run out, and you didn't have money to get more	4180186
36034138	During the past 3Mo, how often have you had a strong desire or urge to use prescription stimulants	4180186
36034153	During the past 3Mo, how often have you used methamphetamine	4180186
36034170	During the past 4W, my skin condition makes me tired	4180186
36034174	Alcuronium Ab.IgE	4180186
36034176	Monocytes.programmed cell death ligand 1	4180186
36034193	SARS coronavirus 2 stimulated gamma interferon	4180186
36034204	Quinoline Ab.IgE	4180186
36034210	Saint Louis encephalitis virus Ab.IgG & IgM panel	4180186
36034217	Other substances that you have had a strong desire or urge to use in the past 3Mo	4180186
36034221	SARS coronavirus 2+SARS-related coronavirus	4180186
36034227	During the past 3Mo, how often have you failed to do what was normally expected of you because of your use of other substances	4180186
36034231	During the past 3Mo, how often have you failed to do what was normally expected of you because of your use of prescription opioids	4180186
36034233	HEDIS Measurement Year 2020 Value Set - Urine Creatinine Lab Test	4180186
36034244	Pain &or agitation severity.extremities tone	4180186
36034248	HEDIS Measurement Year 2020 Value Set - Urine Albumin Creatinine Ratio Lab Test	4180186
36034258	Pain &or agitation severity level	4180186
36034271	Cymbopogon citratus Ab.IgE	4180186
36034272	During the last Mo has the size of your meals been cut because your family didn't have enough money for food	4180186
36034292	During the past 3Mo, how often has your use of hallucinogens led to health, social, legal or financial problems	4180186
36034310	Glucan 1,4 alpha glucosidase Ab.IgE	4180186
36034314	During the past 3Mo, how often have you failed to do what was normally expected of you because of your use of street opioids	4180186
36034329	Aspergillus glaucus Ab.IgE	4180186
36034331	Pain &or agitation severity.crying or irritability	4180186
36034333	HEDIS Measurement Year 2020 Value Set - Estimated Glomerular Filtration Rate Lab Test	4180186
36034334	During the past 3Mo, how often have you failed to do what was normally expected of you because of your use of methamphetamine	4180186
36034335	During the past 3Mo, how often have you used cocaine	4180186
36034340	Ribes uva-crispa	4180186
36034346	During the past 3Mo, how often have you failed to do what was normally expected of you because of your use of prescribed Amphetamine type stimulants	4180186
36034349	IDH1 gene & IDH2 gene targeted mutation analysis	4180186
36034355	Delta coagulation surface induced.hexagonal phase phospholipid	4180186
36034367	Ser^Patient+Bld^Donor	4180186
36034374	HLA-DRB3 & HLA-DRB4 & HLA DRB5 unresolved alleles	4180186
36034379	During the past 4W, I am humiliated by my skin condition	4180186
36034384	During the past 4W, my skin condition affects my desire to be with people	4180186
36034386	HEDIS Measurement Year 2020 Value Set - LDL-C Tests	4180186
36034387	During the last Mo were you hungry but didn't eat because your family didn't have enough food	4180186
36034402	During the past 1W, how often have you been bothered by worry about your skin condition	4180186
36034407	During the past 4W, my skin condition makes it hard to work or do hobbies	4180186
36034408	SARS coronavirus 2 & SARS-related coronavirus RNA panel	4180186
36034414	During the past 4W, my skin condition affects my interactions with others	4180186
36034415	During the past 1W, how often have you been bothered by the effects of your skin condition on your desire to be with people	4180186
36034417	HEDIS Measurement Year 2020 Value Set - Urine Protein Tests	4180186
36034420	predniSONE Ab.IgE	4180186
36034424	Cells.CD3+CD8+CD27+CD45RO+CD62L+	4180186
36034429	Indoor respiratory allergen Ab.IgE panel	4180186
36034434	Substances that have caused you to fail to do what was normally expected of you during the past 3Mo	4180186
36034440	HEDIS Measurement Year 2020 Value Set - Glucose Tests	4180186
36034441	During the past 3Mo, how often have you used prescription stimulants	4180186
36034445	Cholesterol & triglyceride & chylomicrons panel	4180186
36034450	Retinol & Alpha tocopherol panel	4180186
36034453	F7 gene.p.Arg353Gln	4180186
36034454	Angiotensin II & angiotensin (1-7) panel	4180186
36034463	Other substances used during the past 3Mo	4180186
36034477	Macrophages.alveolar	4180186
36034493	During the past 3Mo, how often has your use of prescription opioids led to health, social, legal or financial problems	4180186
36034498	IgLON family member 5	4180186
36034530	During the past 3Mo, how often have you used prescription opioids	4180186
36034539	HLA-A & B & C (class I) typing panel	4180186
36034540	HEDIS Measurement Year 2020 Value Set - FIT-DNA	4180186
36034559	Pain &or agitation panel	4180186
36034563	Gliadin Ab.IgE	4180186
36034564	Cones.right	4180186
36034565	Azalea spp Ab.IgE	4180186
36203098	Activ; Activity; Actvty; Exercise; IPAQ SA Short Form; Movements; Pan; Panel; Panl; Pnl; Point in time; Random; Survey	4180186
36203100	1 day; 24 hours; 24H; 24HR; Count/time; Dextro; nRate; Number rate; Number Rate = Count/Time; QNT; Quan; Quant; Quantitative; Survey	4180186
36203103	Activity; Count/time; Dextro; Exercise; nRate; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36203105	Count/time; nRate; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36203106	Activ; Activity; Actvty; Arbitrary rate; Exercise; Movements; QNT; Quan; Quant; Quantitative; Survey; Walking phys activity	4180186
36203107	Activ; Activity; Actvty; Arbitrary rate; Exercise; Moderate phys activity; Movements; QNT; Quan; Quant; Quantitative; Survey	4180186
36203108	Activ; Activity; Actvty; Arbitrary rate; Exercise; Movements; QNT; Quan; Quant; Quantitative; Survey; Vigorous phys activity	4180186
36203109	Activ; Activity; Actvty; Arbitrary rate; Exercise; Movements; QNT; Quan; Quant; Quantitative; Survey; Tot; Totl	4180186
36203113	ERBB2 基因 复制:存在情况或阈值:时间点:乳腺癌标本:序数型:FISH	4182948
36203113	Amplification; Br ca spec; Brst; CA; Ca spec; CD340; c-erb B2; Dp; ERBB2 duplication; erb-b2 receptor tyrosine kinase 2; Fluorescent in situ hybridization; Genetics; HER2; HER-2; HER-2/neu; Heredity; Heritable; Inherited; MLN 19; Molecular pathology; MOLPATH; NEU; NGL; Oncology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; TKR1; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog)	4180186
36203113	ERBB2 gene Dp Br ca spec Ql FISH	4180186
36203116	DOCUMENT.REF; FDA insert; SPL; Structured Product Labelling	4180186
36203116	FDA insert REMS release	4180186
36203116	REMS 发布:-:-:^FDA 包装说明书:-	4182948
36203118	Clos uninvolv margin CRC spec Micro	4180186
36203118	CA; Ca spec; Clos uninvolv margin; CRC spec; LM; Micro; Micros; Microscopic; Nominal; Pathology; Point in time; Random; Spec; Surg; Typ	4180186
36203118	并未累及所有边缘时的最近手术边缘:类型:时间点:结直肠癌标本:名义型:显微镜检查.光学	4182948
36203120	Ca dist closest uninv marg Ca spec Micro	4180186
36203120	CA; Ca dist closest uninv marg; Ca spec; Clos uninvolv margin; Length; LM; Micro; Micros; Microscopic; Pathology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; Surg	4180186
36203120	当并未累及所有边缘时癌相距最近手术边缘的距离:长度:时间点:癌标本:定量型:显微镜检查.光学	4182948
36203121	Len; Length; LGI; Pathology; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36203121	Excised len Colon Macro	4180186
36203121	切除长度:长度:时间点:结肠:定量型:大体检查	4182948
36203122	CA; Ca spec; Finding; Findings; Intratum lymph resp; LM; Micro; Micros; Microscopic; Ordinal; PATHOLOGY; Point in time; QL; Qual; Qualitative; Random; Screen; Spec	4180186
36203122	Intratum lymph resp Ca spec Ql Micro	4180186
36203122	肿瘤内部淋巴细胞反应:发现:时间点:癌标本:序数型:显微镜检查.光学	4182948
36203123	CA; Ca spec; CRC spec; Frac; Fract; Fractionation; Fractions; LM; Micro; Micros; Microscopic; Pathology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec	4180186
36203123	Mucinous fraction AreaFr CRC spec Micro	4180186
36203123	黏液性组分:面积分数:时间点:结直肠癌标本:定量型:显微镜检查.光学	4182948
36203124	Anatomy; CA; Ca spec; CRC spec; LM; Micro; Micros; Microscopic; Nominal; Organ tum adherent to; PATHOLOGY; Point in time; Random; Spec	4180186
36203124	Organ tum adherent to CRC spec Micro	4180186
36203124	器官肿瘤粘附于:解剖学:时间点:结直肠癌标本:名义型:显微镜检查.光学	4182948
36203128	CA; Ca spec; CRC spec; LM; Micro; Micros; Microscopic; PATH.HISTO; PATHOLOGY; Point in time; QNT; Quan; Quant; Quantitative; Radial pos inv muc margin; Random; Spec	4180186
36203128	Radial pos inv muc margin CRC spec	4180186
36203128	当浸润性癌累及黏膜边缘时最近黏膜边缘的径向位置:角度:时间点:结直肠癌标本:定量型:显微镜检查.光学	4182948
36203129	Radial pos uninv muc margin CRC spec	4180186
36203129	CA; Ca spec; CRC spec; LM; Micro; Micros; Microscopic; PATH.HISTO; PATHOLOGY; Point in time; QNT; Quan; Quant; Quantitative; Radial pos uninv muc margin; Random; Spec	4180186
36203129	当浸润性癌并未累及黏膜边缘时最近黏膜边缘的径向位置:角度:时间点:结直肠癌标本:定量型:显微镜检查.光学	4182948
36203131	Marg tumor involve CRC spec Ql Micro	4180186
36203131	CA; Ca spec; CRC spec; LM; Marg tumor involve; Micro; Micros; Microscopic; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Surg	4180186
36203131	手术边缘肿瘤累及:存在情况或阈值:时间点:结直肠癌标本:序数型:显微镜检查.光学	4182948
36203134	Marg tumor invol.mes CRC spec Ql Micro	4180186
36203134	CA; Ca spec; CRC spec; LM; Marg tumor invol.mes; Marg tumor involve; Micro; Micros; Microscopic; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Surg	4180186
36203134	手术边缘肿瘤累及.肠系膜:存在情况或阈值:时间点:结直肠癌标本:序数型:显微镜检查.光学	4182948
36203136	Marg tumor invol.prox CRC spec Ql Micro	4180186
36203136	CA; Ca spec; CRC spec; LM; Marg tumor invol.prox; Marg tumor involve; Micro; Micros; Microscopic; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Surg	4180186
36203136	外科手术边界肿瘤累及.近端:存在情况或阈值:时间点:结直肠癌标本:序数型:显微镜检查.光学	4182948
36203137	Adj struct invaded Br ca spec Macro	4180186
36203137	Adj struct invaded; Anatomy; Br ca spec; Brst; CA; Ca spec; Nominal; PATH.HISTO; PATHOLOGY; Point in time; Random; Spec	4180186
36203137	肿瘤所侵犯的邻近结构:解剖学:时间点:乳腺癌标本:名义型:大体检查	4182948
36203138	DCIS growth patt Br ca spec Micro	4180186
36203138	Br ca spec; Brst; CA; Ca spec; DCIS growth patt; Ductal carcinoma in situ; LM; Micro; Micros; Microscopic; Nominal; Pathology; Point in time; Random; Spec; Typ	4180186
36203138	DCIS 生长模式:类型:时间点:乳腺癌标本:名义型:显微镜检查.光学	4182948
36203139	Struct of origin Br ca spec	4180186
36203139	Anatomy; bod; Bodies; Br ca spec; Brst; CA; Ca spec; Nominal; Pathology; Point in time; Random; Spec; Struct of origin	4180186
36203139	来源身体结构:解剖学:时间点:乳腺癌标本:名义型	4182948
36203142	Br ca spec; Brst; CA; Ca spec; Dist Ca lat marg; Lat; Length; LM; Micro; Micros; Microscopic; Pathology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec	4180186
36203142	Dist Ca lat marg Br ca spec Micro	4180186
36203142	癌相距未累及侧缘的距离:长度:时间点:乳腺癌标本:定量型:显微镜检查.光学	4182948
36203143	Dist Ca med marg Br ca spec Micro	4180186
36203143	Br ca spec; Brst; CA; Ca spec; Dist Ca med marg; Length; LM; Micro; Micros; Microscopic; Pathology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec	4180186
36203143	癌相距未累及内侧缘的距离:长度:时间点:乳腺癌标本:定量型:显微镜检查.光学	4182948
36203145	Dist Ca sup marg Br ca spec Micro	4180186
36203145	Br ca spec; Brst; CA; Ca spec; Dist Ca sup marg; Length; LM; Micro; Micros; Microscopic; Pathology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec	4180186
36203145	癌相距未累及上缘的距离:长度:时间点:乳腺癌标本:定量型:显微镜检查.光学	4182948
36203146	Br ca spec; Brst; CA; Ca spec; ER; ER fluor intensity; ERA; Est; Estr; Estroge; Estrogens; Estrone+estradiol; Estrone+estradiol+estriol; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Oncology; Ordinal; Pathology; Point in time; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Spec; St; Stains; Stn; Typ	4180186
36203146	ER fluor intensity Br ca spec Ql ImStn	4180186
36203146	雌激素受体荧光强度:类型:时间点:乳腺癌标本:序数型:免疫染色法	4182948
36203148	Inf marg Ca extent Br ca spec Ql Micro	4180186
36203148	Br ca spec; Brst; CA; Ca spec; Finding; Findings; Inf; Inf marg Ca extent; LM; Micro; Micros; Microscopic; Ordinal; PATHOLOGY; Point in time; QL; Qual; Qualitative; Random; Screen; Spec	4180186
36203148	下缘癌累及范围:发现:时间点:乳腺癌标本:序数型:显微镜检查.光学	4182948
36203149	Lat marg Ca extent Br ca spec Ql Micro	4180186
36203149	Br ca spec; Brst; CA; Ca spec; Finding; Findings; Lat; Lat marg Ca extent; LM; Micro; Micros; Microscopic; Ordinal; PATHOLOGY; Point in time; QL; Qual; Qualitative; Random; Screen; Spec	4180186
36203149	侧缘癌累及范围:发现:时间点:乳腺癌标本:序数型:显微镜检查.光学	4182948
36203150	Br ca spec; Brst; CA; Ca spec; Finding; Findings; LM; Med marg Ca extent; Micro; Micros; Microscopic; Ordinal; PATHOLOGY; Point in time; QL; Qual; Qualitative; Random; Screen; Spec	4180186
36203150	Med marg Ca extent Br ca spec Ql Micro	4180186
36203150	内侧缘癌累及范围:发现:时间点:乳腺癌标本:序数型:显微镜检查.光学	4182948
36203152	Foci Br ca spec Ql Micro	4180186
36203152	Br ca spec; Brst; CA; Ca spec; LM; Micro; Micros; Microscopic; Ordinal; PATHOLOGY; Point in time; QL; Qual; Qualitative; Random; Screen; Spec; Typ	4180186
36203152	病灶:类型:时间点:乳腺癌标本:序数型:显微镜检查.光学	4182948
36203154	Adj struct invaded; Anatomy; Br ca spec; Brst; CA; Ca spec; LM; Micro; Micros; Microscopic; Nominal; PATH.HISTO; PATHOLOGY; Point in time; Random; Spec	4180186
36203154	Adj struct invaded Br ca spec Micro	4180186
36203154	肿瘤所侵犯的邻近结构:解剖学:时间点:乳腺癌标本:名义型:显微镜检查.光学	4182948
36203155	Resp to neoadjvt therapy Br ca spec Ql	4180186
36203155	Br ca spec; Brst; CA; Ca spec; Finding; Findings; Ordinal; PATHOLOGY; Point in time; QL; Qual; Qualitative; Random; Resp to neoadjvt therapy; Screen; Spec	4180186
36203155	对新辅助疗法的反应:发现:时间点:乳腺癌标本:序数型	4182948
36203157	Blocks pos for DCIS; Br ca spec; Brst; CA; Ca spec; Cnt; Count; Ductal carcinoma in situ; LM; Micro; Micros; Microscopic; Number; Pathology; Point in time; Pos; QNT; Quan; Quant; Quantitative; Random; Spec	4180186
36203157	Blocks pos for DCIS Br ca spec Micro	4180186
36203157	DCIS 阳性的组织块:数量(计数):时间点:乳腺癌标本:定量型:显微镜检查.光学	4182948
36203159	Br ca spec; Brst; CA; Ca spec; Cell; Cellularity; C-ERBB-2; erb; ERB2; ERB-2; erbB2; Gated cells; HER-2; HER2 unif int; HER-2/neu; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Number fraction; Oncology; PATHOLOGY; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec; St; Stains; Stn	4180186
36203159	HER2 unif int NFr Br ca spec ImStn	4180186
36203159	细胞.HER2 强度一致型细胞膜染色/100 个细胞:计数型分数:时间点:乳腺癌标本:定量型:免疫染色法	4182948
36203160	Br ca spec; Brst; CA; Ca spec; Cell; Cellularity; ER; ER+ cells; ERA; Est; Estr; Estroge; Estrogens; Estrone+estradiol; Estrone+estradiol+estriol; Gated cells; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Number fraction; Oncology; PATHOLOGY; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Rec; Recept; Receptors; Recp; Recptr; Spec; St; Stains; Stn	4180186
36203160	ER+ cells NFr Br ca spec ImStn	4180186
36203160	细胞.雌激素受体/100 个细胞:计数型分数:时间点:乳腺癌标本:定量型:免疫染色法	4182948
36203161	Ki-67 nuclear Ag NFr Br ca spec ImStn	4180186
36203161	Antigen; Antigens; Br ca spec; Brst; CA; Ca spec; Cell; Cellularity; Gated cells; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Ki/SL; KI-67; Mindbomb homolog 1; Nuc; Nuclear Ki-67 cells; Number Fraction; Pathology; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; SL; SL-Ki; Spec; St; Stains; Stn	4180186
36203161	细胞.Ki-67 细胞核 抗原/100 个细胞:计数型分数:时间点:乳腺癌标本:定量型:免疫染色法	4182948
36203163	Br ca spec; Brst; CA; Ca spec; PATHOLOGY; Point in time; QNT; Quan; Quant; Quantitative; Radial pos in breast; Random; Spec	4180186
36203163	Radial pos in breast Angle Br ca spec	4180186
36203163	乳腺内的径向位置:角度:时间点:乳腺癌标本:定量型	4182948
36203166	Add; Br ca spec; Brst; CA; Ca spec; DCIS.addl dim 2; Ductal carcinoma in situ; II; Length; LM; Micro; Micros; Microscopic; Pathology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec	4180186
36203166	DCIS.addl dim 2 Br ca spec Micro	4180186
36203166	DCIS.附加尺寸 2:长度:时间点:乳腺癌标本:定量型:显微镜检查.光学	4182948
36203167	Br ca spec; Brst; CA; Ca spec; DCIS intraduct ext; Ductal carcinoma in situ; EIC; EXT; Extensive intraductal component; Finding; Findings; Intraductal spread of carcinoma; ISC; LM; Micro; Micros; Microscopic; Ordinal; PATHOLOGY; Point in time; QL; Qual; Qualitative; Random; Screen; Spec	4180186
36203167	DCIS intraduct ext Br ca spec Ql Micro	4180186
36203167	DCIS 导管内范围:发现:时间点:乳腺癌标本:序数型:显微镜检查.光学	4182948
36203168	Antigen; Antigens; Br ca spec; Brst; CA; Ca spec; ER; ERA; Est; Estr; Estroge; Estrogens; Estrone+estradiol; Estrone+estradiol+estriol; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Oncology; Ordinal; Pathology; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Spec; St; Stains; Stn	4180186
36203168	ER Ag Br ca spec Ql ImStn	4180186
36203168	雌激素受体 抗原:存在情况或阈值:时间点:乳腺癌标本:序数型:免疫染色法	4182948
36203169	LCIS Br ca spec Ql Micro	4180186
36203169	Br ca spec; Brst; CA; Ca spec; LCIS; LM; Lobular carcinoma in situ; Micro; Micros; Microscopic; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec	4180186
36203169	小叶原位癌:存在情况或阈值:时间点:乳腺癌标本:序数型:显微镜检查.光学	4182948
36203170	Antigen; Antigens; Br ca spec; Brst; CA; Ca spec; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Oncology; Ordinal; P4; Pathology; PGRA; Point in time; PR; PRA; Prog; Proges; Progest; Progestin; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Spec; St; Stains; Stn	4180186
36203170	PR Ag Br ca spec Ql ImStn	4180186
36203170	孕酮受体 抗原:存在情况或阈值:时间点:乳腺癌标本:序数型:免疫染色法	4182948
36203172	Ident; Identifier; Nominal; Path; Path report reviewed; Pathology; Point in time; Random; Spec	4180186
36203172	Path report reviewed Spec	4180186
36203172	已审核的病理学报告:标识符:时间点:标本:名义型	4182948
36203174	CA; Ca spec; Cnt; Count; LM; LN macromets; Micro; Micros; Microscopic; Number; Pathology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec	4180186
36203174	LN macromets Ca spec Micro	4180186
36203174	存在大体转移的淋巴结:数量(计数):时间点:癌标本:定量型:显微镜检查.光学	4182948
36203180	LN resp neoadj therapy Ca spec CAP prot	4180186
36203180	CA; Ca spec; CAP prot; Finding; Findings; LN; LN resp to neoadj therapy; Nominal; Pathology; Point in time; Random; Resp to neoadjvt therapy; Spec	4180186
36203180	淋巴结对于新辅助疗法的反应:发现:时间点:癌标本:名义型:美国病理学家协会癌症方案	4182948
36203181	Extranodal ext of ca Ca spec Ql Micro	4180186
36203181	CA; Ca spec; EXT; Extranodal ext of ca; LM; Micro; Micros; Microscopic; Ordinal; PATHOLOGY; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec	4180186
36203181	癌的淋巴结外范围:存在情况或阈值:时间点:癌标本:序数型:显微镜检查.光学	4182948
36203183	CA; Ca spec; Cell; Cellularity; Cnt; Count; LM; LN with isol tum cells; Micro; Micros; Microscopic; Number; Pathology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec	4180186
36203183	LN with isol tum cells Ca spec Micro	4180186
36203183	存在孤立肿瘤细胞的淋巴结:数量(计数):时间点:癌标本:定量型:显微镜检查.光学	4182948
36203186	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; PEDv; PEDV S INDEL S gene; Point in time; Polymerase chain reaction; Pork; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; S prime; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36203186	PEDV S INDEL S gene Ct Spec Qn NAA+probe	4180186
36203186	猪流行性腹泻病毒 S INDEL 毒株 S 基因:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203189	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; COAGULATION; Coagulation factor II; Compx; EIA; ELFA; ELISA; Enzyme immunoassay; Factor 2; Factor II; Hematology; Heme; IAA; Immune globulin M; Immunoglobulin M; MEIA; Phosphatidyl serine; Pl; Plasma; Plsm; Point in time; Prothombin; Prothrm; Prothromb; PS; PS-prothrom cmplx; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
36203189	PS-prothrom cmplx IgM SerPl IA-aCnc	4180186
36203189	磷脂酰丝氨酸-凝血酶原复合物 抗体.IgM:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
36203190	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; COAGULATION; Coagulation factor II; Compx; EIA; ELFA; ELISA; Enzyme immunoassay; Factor 2; Factor II; Hematology; Heme; IAA; Immune globulin G; Immunoglobulin G; MEIA; Phosphatidyl serine; Pl; Plasma; Plsm; Point in time; Prothombin; Prothrm; Prothromb; PS; PS-prothrom cmplx; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
36203190	PS-prothrom cmplx IgG SerPl IA-aCnc	4180186
36203190	磷脂酰丝氨酸-凝血酶原复合物 抗体.IgG:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
36203192	3 Self-Sustaining Sequence Replication; 3SR SR; AIDS; Amplif; Amplification; Amplified; Blood; DNA NUCLEIC ACID PROBE; DNA probe; HIV 1 & 2; HIV 1 + 2 RNA; HIV type 1; HIV type I; HIV1; HIV1+2; Human immunodeficiency virus; i; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36203192	HIV1+2 RNA Bld Ql NAA+probe	4180186
36203192	HIV 1 型+2 型 RNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
36203194	21Hydroxylase Ab Ser Ql	4180186
36203194	21Hydroxylase; 21-Hydroxylase p450c21; 21-OH; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Hydroxyl; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Steroid 21-hydroxylase; Steroid 21-monooxygenase	4180186
36203194	21-羟化酶 抗体:存在情况或阈值:时间点:血清:序数型	4182948
36203195	ABS; Aby; Acetylch; ACH; AChR; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Muscarinic AChR M3; Muscarinic AChR M3 Ab; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Serum; SR	4180186
36203195	Muscarinic AChR M3 Ab Ser Ql	4180186
36203195	毒蕈碱型乙酰胆碱受体 M3 抗体:存在情况或阈值:时间点:血清:序数型	4182948
36203197	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Neut; Neutr; Neutrophils; Ordinal; PMN; PNM; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Time Resolved Fluorescence; TRF	4180186
36203197	Neutrophil membrane IgM Ser Ql IF	4180186
36203197	嗜中性粒细胞膜 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
36203199	3 Self-Sustaining Sequence Replication; 3SR SR; AIDS; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HIV 1 & 2; HIV 1 + 2 RNA; HIV type 1; HIV type I; HIV1; HIV1+2; Human immunodeficiency virus; i; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36203199	HIV1+2 RNA SerPl Ql NAA+probe	4180186
36203199	HIV 1 型+2 型 RNA:存在情况或阈值:时间点:血清/血浆:序数型:探针法.基因扩增.靶向	4182948
36203201	Neut.fMLP stim.DHR MFI Bld FC	4180186
36203201	Arbitrary; Average; Avg; Blood; Dynamic; FC; HEMATOLOGY/CELL COUNTS; MFI; Neut; Neut.fMLP DHR; Neut.fMLP stim.DHR MFI; Neutr; Neutrophil oxidative bursts; Neutrophils; n-formyl methionyl leucyl phenylalanine; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
36203201	嗜中性粒细胞.经 fMLP 刺激.DHR 平均荧光强度:任意型:时间点:全血:定量型:流式细胞测量术	4182948
36203202	Neut.fMLP stim.DHR MFI Cont Bld FC	4180186
36203202	Arbitrary; Average; Avg; Blood; Contrl; Dynamic; FC; HEMATOLOGY/CELL COUNTS; MFI; Neut; Neut.fMLP DHR; Neut.fMLP stim.DHR MFI; Neutr; Neutrophil oxidative bursts; Neutrophils; n-formyl methionyl leucyl phenylalanine; Normal; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
36203202	嗜中性粒细胞.经 fMLP 刺激.DHR 平均荧光强度:任意型:时间点:全血^对照:定量型:流式细胞测量术	4182948
36203203	Neut.fMLP DHR/Neut fMLP NFr Cont Bld FC	4180186
36203203	Blood; Contrl; Dynamic; FC; HEMATOLOGY/CELL COUNTS; Neut; Neut fMLP; Neut.fMLP DHR; Neutr; Neutrophil oxidative bursts; Neutrophils; n-formyl methionyl leucyl phenylalanine; Normal; Number fraction; Percent; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
36203203	嗜中性粒细胞.经 fMLP 刺激.DHR/嗜中性粒细胞.经 fMLP 刺激.总计:计数型分数:时间点:全血^对照:定量型:流式细胞测量术	4182948
36203204	Neut.fMLP DHR/Neut fMLP NFr Bld FC	4180186
36203204	Blood; Dynamic; FC; HEMATOLOGY/CELL COUNTS; Neut; Neut fMLP; Neut.fMLP DHR; Neutr; Neutrophil oxidative bursts; Neutrophils; n-formyl methionyl leucyl phenylalanine; Number fraction; Percent; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
36203204	嗜中性粒细胞.经 fMLP 刺激.DHR/嗜中性粒细胞.经 fMLP 刺激.总计:计数型分数:时间点:全血:定量型:流式细胞测量术	4182948
36203208	Neut PMA DHR/Neut PMA NFr Cont Bld FC	4180186
36203208	Blood; Contrl; Dynamic; FC; HEMATOLOGY/CELL COUNTS; Neut; Neut PMA; Neut PMA DHR; Neutr; Neutrophil oxidative bursts; Neutrophils; Normal; Number fraction; Percent; Phorbol myristate acetate stimulated; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood	4180186
36203208	嗜中性粒细胞.经 PMA 刺激.DHR/嗜中性粒细胞.经 PMA 刺激.总计:计数型分数:时间点:全血^对照:定量型:流式细胞测量术	4182948
36203210	Chemistry; Erythrocytes; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Red blood cells; Red blood corpusles; Rto	4180186
36203210	Purine/Pyrimidine RBC Spect-Rto	4180186
36203210	嘌呤/嘧啶:比率:时间点:红细胞:定量型:分光光度测定法	4182948
36203211	1 month; 1 month (30 days); 30 days; Arterial Stenosis; Finding; Findings; Last; Minnesota Living with Heart Failure Questionnaire; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36203214	1 month; 1 month (30 days); 30 days; Arterial Stenosis; Finding; Findings; Last; Minnesota Living with Heart Failure Questionnaire; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36203216	1 month; 1 month (30 days); 30 days; Arterial Stenosis; Finding; Findings; Last; Minnesota Living with Heart Failure Questionnaire; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36203218	3 days; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36203222	Assessment; Centers for Medicare and Medicaid Assessment; Eval; H&P; History and physical; Hosp; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36203226	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; N men; N menigitidis; N meningitidis; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36203226	N men DNA Bld Pos Ql NAA+non-probe	4180186
36203226	脑膜炎奈瑟菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36203227	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; P aeruginosa; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36203227	P aeruginosa DNA Bld Pos NAA+non-probe	4180186
36203227	铜绿假单胞菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36203229	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 12F; S pneum Da 12F Ab; S pneum Da 12F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 12	4180186
36203229	S pneum Da 12F IgG Ser-aCnc	4180186
36203229	肺炎链球菌丹麦血清型 12F 抗体.IgG:任意型浓度:时间点:血清:定量型	4182948
36203233	2:1; ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; S pn Da sero 19F; S pneum Da 19F Ab; S pneum Da 19F IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp1; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 19	4180186
36203233	S pn Da sero 19F IgG 2:1 Ser-Rto	4180186
36203233	肺炎链球菌丹麦血清型 19F 抗体.IgG^第2个标本/第1个标本:比率:时间点:血清:定量型	4182948
36203234	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; First; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pn Da sero 19F; S pneum Da 19F Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 19	4180186
36203234	S pn Da sero 19F Ab sp1 Ser IA-aCnc	4180186
36203234	肺炎链球菌丹麦血清型 19F 抗体^第1个标本:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36203237	AIDS; Blood; HIV IA algorithm interp; HIV imm testing algorithm; Human immunodeficiency virus; ID; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpret; Interpretation; Interpt; Intrp; Microbiology; Nominal; Pl; PlasBld; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood	4180186
36203237	HIV IA algorithm interp SerPlBld-Imp	4180186
36203237	HIV 免疫测定法检测算法解释:印象:时间点:血清/血浆/全血:名义型	4182948
36203238	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Triazole	4180186
36203238	Isavuconazole Islt MIC	4180186
36203238	艾沙康唑:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
36203239	Osmolarity Tear	4180186
36203239	Chemistry; Point in time; QNT; Quan; Quant; Quantitative; Random; Tears	4180186
36203239	渗量:渗量:时间点:泪液:定量型	4182948
36203242	Arm; BMD; Bone Densiometry; Bone Density Scan; Den; Densiometry; DEX; DEXA; Dual Energy X Ray Absorptiometry; EXT; Films; Imaging; MAric; Point in time; QNT; Quan; Quant; Quantitative; Rad; RADIOLOGY; Random; UE; Up; Upper arm; Upper extremity; View; Views for BMD; VWS	4180186
36203242	DXA Humerus ArMass BMD	4180186
36203242	针对骨密度的多重视图:质量/面积:时间点:上肢>肱骨:定量型:双能X线吸收法	4182948
36203244	Arm; BMD; Bone Densiometry; Bone Density Scan; Den; Densiometry; DEX; DEXA; Dual Energy X Ray Absorptiometry; EXT; Extr-R; Films; Humerus-R; Imaging; MAric; Point in time; QNT; Quan; Quant; Quantitative; R; Rad; RADIOLOGY; Random; RT; RUE; UE; UE-R; Up; Upper extremity; View; Views for BMD; VWS	4180186
36203244	DXA Humerus-R ArMass BMD	4180186
36203244	针对骨密度的多重视图:质量/面积:时间点:上肢.右侧>肱骨:定量型:双能X线吸收法	4182948
36203245	Arm; BMD; Bone Densiometry; Bone Density Scan; Den; Densiometry; DEX; DEXA; Dual Energy X Ray Absorptiometry; EXT; Extr-R; Films; Humerus-R; Imaging; Point in time; QNT; Quan; Quant; Quantitative; R; Rad; RADIOLOGY; Random; RT; RUE; T-score; UE; UE-R; Up; Upper extremity; View; Views for BMD; VWS	4180186
36203245	DXA Humerus-R T-score BMD	4180186
36203245	针对骨密度的多重视图:T评分:时间点:上肢.右侧>肱骨:定量型:双能X线吸收法	4182948
36203246	Arm; BMD; Bone Densiometry; Bone Density Scan; Den; Densiometry; DEX; DEXA; Dual Energy X Ray Absorptiometry; EXT; Extr-L; Films; Humerus-L; Imaging; L; LT; LUE; Point in time; QNT; Quan; Quant; Quantitative; Rad; RADIOLOGY; Random; T-score; UE; UE-L; Up; Upper extremity; View; Views for BMD; VWS	4180186
36203246	DXA Humerus-L T-score BMD	4180186
36203246	针对骨密度的多重视图:T评分:时间点:上肢.左侧>肱骨:定量型:双能X线吸收法	4182948
36203247	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36203248	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36203249	Centers for Medicare and Medicaid Assessment; Nominal; Point in time; Random; Survey; Typ	4180186
36203252	Centers for Medicare and Medicaid Assessment; Finding; Findings; Housing; Living Arrangements; Nominal; Point in time; Random; Residence; Survey	4180186
36203253	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36203254	Centers for Medicare and Medicaid Assessment; Nominal; Pay source.primary; Point in time; Random; Srce; Survey; Typ	4180186
36203255	Centers for Medicare and Medicaid Assessment; Nominal; Point in time; Random; Srce; Survey; Typ	4180186
36203258	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36203262	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36203264	Centers for Medicare and Medicaid Assessment; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; S prime; Screen; Survey	4180186
36203265	Centers for Medicare and Medicaid Assessment; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
36203266	Centers for Medicare and Medicaid Assessment; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
36203268	Disch; Nominal; Point in time; Random; Survey; Typ	4180186
36203273	Bact; Bact ID + susc Pnl; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Sus; Susc; Suscept; Susceptibilities; Susceptibilty	4180186
36203273	Bact ID + susc Pnl Islt	4180186
36203273	细菌鉴定与抗生素敏感性组套:-:时间点:分离株:-	4182948
36203274	Ancef; ANTIBIOTIC SUSCEPTIBILITIES; AST; C32; Cefamezin; ID; Infectious Disease; InfectiousDisease; Islt; Islt.UTI; Isol; Kefj; Kefzol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Totacef; Zolicef	4180186
36203274	ceFAZolin Islt.UTI MIC	4180186
36203274	头孢唑林:抗生素敏感性:时间点:分离株.尿路感染:定量型或序数型:最小抑菌浓度法	4182948
36203277	来法莫林:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
36203277	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
36203277	Lefamulin Islt MIC	4180186
36203281	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Islt.pneum; Isol; Minimum inhibitory concentration; PCN; Pen; Penicilloyl; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Wycillin	4180186
36203281	Penicillin Islt.pneum MIC	4180186
36203281	青霉素:抗生素敏感性:时间点:分离株.肺炎:定量型或序数型:最小抑菌浓度法	4182948
36203283	Marital status Contact	4180186
36203283	ADMIN; Nominal; Point in time; Random; Typ	4180186
36203283	婚姻状况:类型:时间点:^联系人:名义型	4182948
36203286	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36203286	Rheumatology D/C sum	4180186
36203286	出院摘要记录:发现:时间点:{环境}:文档型:风湿病学	4182948
36203290	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Neo peri med; notes; Point in time; Random; Visit note	4180186
36203290	Neo peri med Note	4180186
36203290	记录:发现:时间点:{环境}:文档型:新生儿围产医学	4182948
36203291	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Mat fetal med; notes; Point in time; Random; Visit note	4180186
36203291	Mat fetal med Note	4180186
36203291	记录:发现:时间点:{环境}:文档型:母胎医学	4182948
36203293	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Surg; Visit note	4180186
36203293	Vascular surgery Prog note	4180186
36203293	病程记录:发现:时间点:{环境}:文档型:血管外科学	4182948
36203294	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hematology; Heme; notes; Point in time; Random; Visit note	4180186
36203294	Hematology D/C sum	4180186
36203294	出院摘要记录:发现:时间点:{环境}:文档型:血液学	4182948
36203296	Cancer; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn Onc; notes; Oncology; Point in time; Random; Visit note	4180186
36203296	Gyn Onc Note	4180186
36203296	记录:发现:时间点:{环境}:文档型:妇科肿瘤学	4182948
36203299	electronic Patient Centered Assessment Method; Levels; Levl; LV; LVL; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.GNHLTH	4180186
36203300	electronic Patient Centered Assessment Method; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Totl	4180186
36203302	electronic Patient Centered Assessment Method; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SDOH; Survey; SURVEY.GNHLTH; Tot; Totl	4180186
36203304	electronic Patient Centered Assessment Method; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Totl	4180186
36203306	electronic Patient Centered Assessment Method; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.GNHLTH	4180186
36203307	electronic Patient Centered Assessment Method; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36203309	electronic Patient Centered Assessment Method; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
36203310	electronic Patient Centered Assessment Method; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
36203311	electronic Patient Centered Assessment Method; Othr; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
36203312	electronic Patient Centered Assessment Method; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; SDOH; Survey; SURVEY.GNHLTH	4180186
36203316	electronic Patient Centered Assessment Method; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
36203319	CARD.US; Cardiac; Cardiac Echo; Cardio; Cardiology; Document; Echography; Finding; Findings; Heart Disease; Hrt; Point in time; Random; Sonogram; Sonograph; Sonography; Thorax; ULS; Ultrasound	4180186
36203319	经食管多层:发现:时间点:胸部>心脏:文档型:超声	4182948
36203323	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HRSV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; RSV; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Up; Upper resp	4180186
36203323	RSV RNA Upper resp Ql NAA+probe	4180186
36203323	呼吸道合胞病毒 RNA:存在情况或阈值:时间点:呼吸道.上:序数型:探针法.基因扩增.靶向	4182948
36203324	DOCUMENT.REGULATORY; Est exmpt notif; FDA label; Narrative; Report	4180186
36203324	FDA label Est exmpt notif	4180186
36203324	企业注册豁免通知:-:-:^FDA 产品标签:叙述型	4182948
36203326	Cell Tiss Est Reg; DOCUMENT.REGULATORY; FDA label; Narrative; Report	4180186
36203326	FDA label Cell Tiss Est Reg	4180186
36203326	人类细胞与组织制品企业注册与产品列名:-:-:^FDA 产品标签:叙述型	4182948
36203327	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36203328	FDA label Est temp inact notif	4180186
36203328	DOCUMENT.REGULATORY; Est temp inact notif; FDA label; Narrative; Report	4180186
36203328	企业临时冻结通知:-:-:^FDA 产品标签:叙述型	4182948
36203330	Antigen; Antigens; Bennett-Goodspeed Antigen; Bg sup(c); BLOOD BANK; c; Erythrocytes; Hematology; Heme; HLA-A28; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Rh; Rh Blood Group System; Screen	4180186
36203330	Bg sup(c) Ag RBC Ql	4180186
36203330	Bg^c 抗原:存在情况或阈值:时间点:红细胞:序数型	4182948
36203331	Sc1 抗原:存在情况或阈值:时间点:红细胞:序数型	4182948
36203331	Sc1 Ag RBC Ql	4180186
36203331	Antigen; Antigens; BLOOD BANK; c; Erythrocytes; i; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; S prime; Sc1; Screen	4180186
36203332	Sc2 抗原:存在情况或阈值:时间点:红细胞:序数型	4182948
36203332	Sc2 Ag RBC Ql	4180186
36203332	Antigen; Antigens; BLOOD BANK; c; Erythrocytes; II; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; S prime; Sc2; Screen	4180186
36203334	Centers for Medicare and Medicaid Assessment; i; Path; QNT; Quan; Quant; Quantitative; Report period; Survey	4180186
36203337	Centers for Medicare and Medicaid Assessment; i; Pan; Panel; PANEL.SURVEY.CMS; Panl; Path; Pnl; Report period; Survey	4180186
36203343	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Anorectl; AnorectlIslt; ANTIBIOTIC SUSCEPTIBILITIES; Bact; Carbapenem resistance gene; CPR; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Rectum; Resist; Resistanc; Resistant; Resistent; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36203343	blaKPC AnorectlIslt Ql NAA+probe	4180186
36203343	细菌碳青霉烯类耐药 blaKPC 基因:存在情况或阈值:时间点:肛门直肠/分离株:序数型:探针法.基因扩增.靶向	4182948
36203347	ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
36203347	blaOXA-48 Islt/Spm Ql	4180186
36203347	细菌碳青霉烯类耐药 blaOXA-48 基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36203348	ABO.presumptive; BLOOD BANK; Hematology; Heme; Molecular genetics; Nominal; Oral fluid; PCR; Point in time; Random; Sal; Typ	4180186
36203348	ABO.presumptive Sal by Molgen	4180186
36203348	ABO 血型.推断的:类型:时间点:唾液:名义型:分子遗传学类实验室方法	4182948
36203354	ALPS4; CA; Ca spec; CMNS; CRC spec; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; NCMS; neuroblastoma RAS viral (v-ras) oncogene homolog; Nominal; N-ras; NRAS1; NS6; Oncogene NRAS; PCR; Point in time; Random; Spec; v-ras neuroblastoma RAS viral oncogene homolog	4180186
36203354	NRAS gene Mut Anl CRC spec	4180186
36203354	NRAS 基因 突变分析:存在与否或特征标识:时间点:结直肠癌标本:名义型:分子遗传学类实验室方法	4182948
36203355	B-Raf proto-oncogene, serine/threonine kinase; BRAF1; B-RAF1; CA; Ca spec; CRC spec; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; NS7; PCR; Point in time; RAFB1; Random; Spec; v-raf	4180186
36203355	BRAF gene Mut Anl CRC spec	4180186
36203355	BRAF 基因 突变分析:存在与否或特征标识:时间点:结直肠癌标本:名义型:分子遗传学类实验室方法	4182948
36203358	Bariatric surg D/C sum	4180186
36203358	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Metabolic and bariatric surgery; notes; Point in time; Random; Surg; Visit note	4180186
36203358	出院摘要记录:发现:时间点:{环境}:文档型:减肥外科手术	4182948
36203359	Bariatric surg Prog note	4180186
36203359	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Metabolic and bariatric surgery; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Surg; Visit note	4180186
36203359	病程记录:发现:时间点:{环境}:文档型:减肥外科手术	4182948
36203361	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Metabolic and bariatric surgery; notes; Point in time; Random; Surg; Visit note	4180186
36203361	Bariatric surg Consult note	4180186
36203361	会诊记录:发现:时间点:{环境}:文档型:减肥外科手术	4182948
36203364	Child Adolsnt Psych D/C sum	4180186
36203364	Child Adolsnt Psych; D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36203364	出院摘要记录:发现:时间点:{环境}:文档型:儿童与青少年心理学	4182948
36203368	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
36203371	Document; Finding; Findings; ID; Infectious Disease; InfectiousDisease; M hyopneumo; M hyopneumo P146; M hyopneumo seq + phylo; M hyopneumoniae; Microbiology; Misc; Miscellaneous; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; Other; Point in time; Porcine respiratory mycoplasmosis; Random; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36203371	M hyopneumo seq + phylo Spec Doc	4180186
36203371	猪肺炎支原体 P146 基因序列与系统发育分析:发现:时间点:XXX:文档型	4182948
36203372	PRRSV European IgG Titr Ser IF	4180186
36203372	猪生殖与呼吸综合征病毒欧洲株 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
36203372	Abortus blauw; ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Blue-eared pig disease; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Lelystad virus; Microbiology; Mystery swine disease; Point in time; Porcine epidemic abortion & respiratory syndrome; Porcine reproductive and respiratory syndrome; Pork; PRRS; PRRSV; PRRSV European; PRRSV European strain IgG; Random; Serum; Seuchenhafter spatabort der schweine; SIRSV; SmQn; SR; Swine; Swine infertility and respiratory syndrome; Syndrome dysgenesique et respiratoire porcin; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr; Vet; Veterinary	4180186
36203374	Abortus blauw; ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Blue-eared pig disease; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Lelystad virus; Microbiology; Mystery swine disease; Ordinal; Point in time; Porcine epidemic abortion & respiratory syndrome; Porcine reproductive and respiratory syndrome; Pork; PR; PRRS; PRRSV; PRRSV European; PRRSV European strain IgG; Ql; Qual; Qualitative; Random; Screen; Serum; Seuchenhafter spatabort der schweine; SIRSV; SR; Swine; Swine infertility and respiratory syndrome; Syndrome dysgenesique et respiratoire porcin; Time Resolved Fluorescence; TRF; Vet; Veterinary	4180186
36203374	PRRSV European IgG Ser Ql IF	4180186
36203374	猪生殖与呼吸综合征病毒欧洲株 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
36203380	3 Self-Sustaining Sequence Replication; 3SR SR; Abortus blauw; Amplif; Amplification; Amplified; Blue-eared pig disease; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Lelystad virus; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; Mystery swine disease; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Porcine epidemic abortion & respiratory syndrome; Porcine reproductive and respiratory syndrome; Pork; Probe amp; Probe with ampification; Probe with target amplification; PRRS; PRRSV; PRRSV Ingel MLV ORF5; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Seuchenhafter spatabort der schweine; SIRSV; Spec; Strand Displacement Amplification; Swine; Swine infertility and respiratory syndrome; Syndrome dysgenesique et respiratoire porcin; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36203380	PRRSV Ingel MLV ORF5 Ct Spec Qn NAA+prb	4180186
36203380	猪生殖与呼吸综合征病毒 Ingelvac MLV 株 ORF5 基因:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203384	3 Self-Sustaining Sequence Replication; 3SR SR; Abortus blauw; Amplif; Amplification; Amplified; Blue-eared pig disease; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Lelystad virus; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; Mystery swine disease; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; Porcine epidemic abortion & respiratory syndrome; Porcine reproductive and respiratory syndrome; Pork; PR; Probe amp; Probe with ampification; Probe with target amplification; PRRS; PRRSV; PRRSV NA strain; PRRSV NA strain RNA; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Seuchenhafter spatabort der schweine; SIRSV; Spec; Strand Displacement Amplification; Swine; Swine infertility and respiratory syndrome; Syndrome dysgenesique et respiratoire porcin; TMA; To be specified in another part of the message; Tr...	4180186
36203384	PRRSV NA strain RNA Spec Ql NAA+probe	4180186
36203384	猪生殖与呼吸综合征病毒北美株 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36203385	3 Self-Sustaining Sequence Replication; 3SR SR; Abortus blauw; Amplif; Amplification; Amplified; Blue-eared pig disease; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Lelystad virus; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; Mystery swine disease; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; Porcine epidemic abortion & respiratory syndrome; Porcine reproductive and respiratory syndrome; Pork; PR; Probe amp; Probe with ampification; Probe with target amplification; PRRS; PRRSV; PRRSV European; PRRSV European strain RNA; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Seuchenhafter spatabort der schweine; SIRSV; Spec; Strand Displacement Amplification; Swine; Swine infertility and respiratory syndrome; Syndrome dysgenesique et respiratoire porcin; TMA; To be specified in another part of the messag...	4180186
36203385	PRRSV European RNA Spec Ql NAA+probe	4180186
36203385	猪生殖与呼吸综合征病毒欧洲株 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36203386	PRRSV NA strain NAb Titr Ser Nt	4180186
36203386	猪生殖与呼吸综合征病毒北美株 抗体.中和:滴定度:时间点:血清:定量型:中和试验	4182948
36203386	Abortus blauw; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blue-eared pig disease; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); Lelystad virus; Microbiology; Mystery swine disease; NAb; NEUTRALIZATION; Neutralization test; NT; Point in time; Porcine epidemic abortion & respiratory syndrome; Porcine reproductive and respiratory syndrome; Pork; PRRS; PRRSV; PRRSV NA strain; Random; Serum; Serum virus neutralization; Seuchenhafter spatabort der schweine; SIRSV; SmQn; SR; SVN; Swine; Swine infertility and respiratory syndrome; Syndrome dysgenesique et respiratoire porcin; Titer; Titered; Titre; Ttr; Vet; Veterinary; Virus neutralization test; VNT	4180186
36203388	Abortus blauw; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blue-eared pig disease; Conventional virus neutralization test; cVNT; ID; Infectious Disease; InfectiousDisease; Lelystad virus; Microbiology; Mystery swine disease; NAb; NEUTRALIZATION; Neutralization test; NT; Ordinal; Point in time; Porcine epidemic abortion & respiratory syndrome; Porcine reproductive and respiratory syndrome; Pork; PR; PRRS; PRRSV; PRRSV European; Ql; Qual; Qualitative; Random; Screen; Serum; Serum virus neutralization; Seuchenhafter spatabort der schweine; SIRSV; SR; SVN; Swine; Swine infertility and respiratory syndrome; Syndrome dysgenesique et respiratoire porcin; Vet; Veterinary; Virus neutralization test; VNT	4180186
36203388	PRRSV European NAb Ser Ql Nt	4180186
36203388	猪生殖与呼吸综合征病毒欧洲株 抗体.中和:存在情况或阈值:时间点:血清:序数型:中和试验	4182948
36203390	Abortus blauw; Blue-eared pig disease; Conventional virus neutralization test; cVNT; Lelystad virus; Microbiology; Mystery swine disease; NEUTRALIZATION; Neutralization test; NT; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Porcine epidemic abortion & respiratory syndrome; Porcine reproductive and respiratory syndrome; Pork; PRRS; PRRSV; PRRSV Euro + NA NAb Pnl; Random; Serum; Serum virus neutralization; Seuchenhafter spatabort der schweine; SIRSV; SR; SVN; Swine; Swine infertility and respiratory syndrome; Syndrome dysgenesique et respiratoire porcin; Vet; Veterinary; Virus neutralization test; VNT	4180186
36203390	PRRSV Euro + NA NAb Pnl Ser Nt	4180186
36203390	猪生殖与呼吸综合征病毒欧洲株 & 北美株抗体.中和试验组套:-:时间点:血清:-:中和试验	4182948
36203394	electronic Patient Centered Assessment Method; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36203395	RI Score Calc	4180186
36203395	Calc; Calculation; CLIN; Point in time; QNT; Quan; Quant; Quantitative; Random; RI; Scale	4180186
36203397	Centers for Medicare and Medicaid Assessment; i; PT; QNT; Quan; Quant; Quantitative; Report period; Survey	4180186
36203398	Centers for Medicare and Medicaid Assessment; i; PT; QNT; Quan; Quant; Quantitative; Report period; Survey	4180186
36203399	Centers for Medicare and Medicaid Assessment; i; PT; QNT; Quan; Quant; Quantitative; Report period; Survey; Tx	4180186
36203400	Centers for Medicare and Medicaid Assessment; i; OT; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36203401	Centers for Medicare and Medicaid Assessment; i; OT; QNT; Quan; Quant; Quantitative; Report period; Survey	4180186
36203403	Centers for Medicare and Medicaid Assessment; i; OT; QNT; Quan; Quant; Quantitative; Report period; Survey	4180186
36203406	Centers for Medicare and Medicaid Assessment; II; PT; QNT; Quan; Quant; Quantitative; Report period; Survey	4180186
36203407	Centers for Medicare and Medicaid Assessment; II; PT; QNT; Quan; Quant; Quantitative; Report period; Survey	4180186
36203408	Centers for Medicare and Medicaid Assessment; II; PT; QNT; Quan; Quant; Quantitative; Report period; Survey	4180186
36203411	Centers for Medicare and Medicaid Assessment; II; OT; QNT; Quan; Quant; Quantitative; Report period; Survey	4180186
36203412	Centers for Medicare and Medicaid Assessment; II; OT; QNT; Quan; Quant; Quantitative; Report period; Survey	4180186
36203415	Centers for Medicare and Medicaid Assessment; II; Path; QNT; Quan; Quant; Quantitative; Report period; Survey	4180186
36203416	Centers for Medicare and Medicaid Assessment; II; Path; QNT; Quan; Quant; Quantitative; Report period; Survey	4180186
36203418	3 Self-Sustaining Sequence Replication; 3SR SR; Abortus blauw; Amplif; Amplification; Amplified; Blue-eared pig disease; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Lelystad virus; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; Mystery swine disease; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; Porcine epidemic abortion & respiratory syndrome; Porcine reproductive and respiratory syndrome; Pork; PR; Probe amp; Probe with ampification; Probe with target amplification; PRRS; PRRSV; PRRSV European; PRRSV European ORF5; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Seuchenhafter spatabort der schweine; SIRSV; Spec; Strand Displacement Amplification; Swine; Swine infertility and respiratory syndrome; Syndrome dysgenesique et respiratoire porcin; TMA; To be specified in another part of the message; Transcription mediate...	4180186
36203418	PRRSV European ORF5 Spec Ql NAA+probe	4180186
36203418	猪生殖与呼吸综合征病毒欧洲株 ORF5 基因:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36203421	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breakbone fever; CHIKV; CHIKV RNA+DENV; CHIKV+DENV RNA; DENV; DENV RNA; DNA NUCLEIC ACID PROBE; DNA probe; Donr; Flavivirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36203421	CHIKV RNA+DENV RNA Plas Donr Ql NAA+pr	4180186
36203421	基孔肯亚病毒 RNA+登革热病毒 RNA:存在情况或阈值:时间点:血浆^供体:序数型:探针法.基因扩增.靶向	4182948
36203422	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; CHIKV; DNA NUCLEIC ACID PROBE; DNA probe; Donr; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36203422	CHIKV RNA Plas Donr Ql NAA+probe	4180186
36203422	基孔肯亚病毒 RNA:存在情况或阈值:时间点:血浆^供体:序数型:探针法.基因扩增.靶向	4182948
36203423	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Breakbone fever; Denv; DENV RNA; DNA NUCLEIC ACID PROBE; DNA probe; Donr; Flavivirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36203423	DENV RNA Plas Donr Ql NAA+probe	4180186
36203423	登革热病毒 RNA:存在情况或阈值:时间点:血浆^供体:序数型:探针法.基因扩增.靶向	4182948
36203424	Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.GNHLTH	4180186
36203425	Abortus blauw; ACIF; Anticomplement Immunofluorescence; Blue-eared pig disease; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Lelystad virus; Microbiology; Mystery swine disease; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Porcine epidemic abortion & respiratory syndrome; Porcine reproductive and respiratory syndrome; Pork; PRRS; PRRSV; PRRSV Euro + NA IgG Pnl; Random; Serum; Seuchenhafter spatabort der schweine; SIRSV; SR; Swine; Swine infertility and respiratory syndrome; Syndrome dysgenesique et respiratoire porcin; Time Resolved Fluorescence; TRF; Vet; Veterinary	4180186
36203425	PRRSV Euro + NA IgG Pnl Ser IF	4180186
36203425	猪生殖与呼吸综合征病毒欧洲株 & 北美株抗体.IgG 组套:-:时间点:血清:-:免疫荧光法	4182948
36203426	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36203426	Aerospace med Note	4180186
36203426	记录:发现:时间点:{环境}:文档型:航空航天医学	4182948
36203427	Cancer; Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Hematology; Hematology and Oncology; Hematology+Oncology; Heme; HemOnc; notes; Oncology; Point in time; Random; Study report; Visit note	4180186
36203427	HemOnc Diag study note	4180186
36203427	诊断性检查记录:发现:时间点:{环境}:文档型:血液学+内科肿瘤学	4182948
36203428	Centers for Medicare and Medicaid Assessment; II; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; PT; Report period; Survey	4180186
36203429	Centers for Medicare and Medicaid Assessment; II; OT; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
36203435	CLIN; Dis; Diseases; Dz; Nominal; Point in time; Pref kidney failure tx if needed; Random; Tx; Typ	4180186
36203435	Pref kidney failure tx if needed	4180186
36203435	肾脏疾病进展至肾功能衰竭时的首选肾功能衰竭治疗手段:类型:时间点:^患者:名义型	4182948
36203436	CLIN; Kidney; National Kidney Disease Education Program; Pan; PANEL.CLINICAL; Panl; Pnl; Point in time; Random; RRT goals Pnl	4180186
36203436	RRT goals Pnl NKDEP	4180186
36203436	肾脏替代疗法目标组套:-:时间点:^患者:-:美国国家肾病教育计划	4182948
36203446	1 month; 1 month (30 days); 30 days; Arterial Stenosis; Finding; Findings; Last; Minnesota Living with Heart Failure Questionnaire; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36203448	1 month; 1 month (30 days); 30 days; Arterial Stenosis; Finding; Findings; Last; Minnesota Living with Heart Failure Questionnaire; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36203449	1 month; 1 month (30 days); 30 days; Arterial Stenosis; Finding; Findings; Last; Minnesota Living with Heart Failure Questionnaire; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36203453	Chemistry; Kidney fail 2Y risk; Kidney Failure Risk Equation - dynamic; Point in time; QNT; Quan; Quant; Quantitative; Random; Risk	4180186
36203453	Kidney fail 2Y risk KFRE.dynamic	4180186
36203453	肾功能衰竭 2 年风险:似然性:时间点:^患者:定量型:肾功能衰竭风险公式	4182948
36203456	3 Self-Sustaining Sequence Replication; 3SR SR; 4HPPD; 4-HPPD; 4-hydroxyphenylpyruvate dioxygenase; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; GLOD3; H flu; H influenz hpd; H influenza; H influenzae; Haem influ; Haemoph; HAWK; Hawkinsinuria; HPPDASE; ID; Infectious Disease; InfectiousDisease; Influ; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; PPD; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; TYRO3; Tyrosinemia type 3; Unspecified	4180186
36203456	H influenz hpd Ct Spec Qn NAA+probe	4180186
36203456	流感嗜血杆菌 hpd 基因:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203457	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; Misc; Miscellaneous; N men; N menigitidis; N mening sodC; N meningitidis; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203457	N mening sodC Spec Ql NAA+probe	4180186
36203457	脑膜炎奈瑟菌 sodC 基因:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36203458	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36203459	3 days; abn; abnorm; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36203460	3 days; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36203465	Admin info; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36203468	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36203469	3 days; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36203471	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36203472	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Special Txs, procedures and programs; Survey; Tx; Txs	4180186
36203475	3 days; Control; Finding; Findings; Levels; Levl; LV; LVL; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36203476	Coll; Collect; Collected; Narrative; Person name; Persons; Point in time; Random; Report; Survey	4180186
36203478	3 days; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey; Sx	4180186
36203479	Coll; Collect; Collected; Nominal; Persons; Point in time; Random; Survey; Typ	4180186
36203481	3 days; bod; Bodies; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; Up	4180186
36203485	Activ; Actvty; H+P; H+P.HX; Last; Movements; Ordinal; P prime; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Sex new partner past 60D	4180186
36203485	Sex new partner past 60D	4180186
36203485	在过去的60天当中与某个新的伴侣之间的性活动:存在情况或阈值:时间点:^患者:序数型	4182948
36203486	ADMIN; ADMIN.PATIENT; ADMIN.PT.DEMOG; Job; Nominal; Point in time; Random; Typ; Work	4180186
36203486	Industry CDC Census code	4180186
36203486	职业行业 CDC 普查代码:类型:时间点:^患者:名义型	4182948
36203487	ADMIN; ADMIN.PATIENT; ADMIN.PT.DEMOG; Job; Nominal; Point in time; Random; Typ; Work	4180186
36203487	Occupation Type	4180186
36203487	职业:类型:时间点:^患者:名义型	4182948
36203488	ADMIN; ADMIN.PATIENT; ADMIN.PT.DEMOG; Job; Nominal; Occup CDC Census code; Point in time; Random; Typ; Work	4180186
36203488	Occup CDC Census code	4180186
36203488	职业 CDC 普查代码:类型:时间点:^患者:名义型	4182948
36203490	3 days; Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36203492	Admin info; Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36203495	Serologic tx result pre pregnancy Mother	4180186
36203495	Before; Finding; Findings; Gestation; Gestations; Gravida; H+P; H+P.HX; Mat; Maternal; Matnl; Nominal; P prime; Point in time; Pregnancies; Random; Serologic tx result	4180186
36203495	血清学检验结果^在妊娠之前:发现:时间点:^母亲:名义型	4182948
36203497	CRS case classification; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random; Survey; SURVEY.CDC	4180186
36203501	H influen dcs Ct Spec Qn NAA+probe	4180186
36203501	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; H flu; H influen dcs; H influenza; H influenzae; Haem influ; Haemoph; Influ; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203501	流感嗜血杆菌 dcs 基因:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203503	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; H flu; H influen bcs; H influenza; H influenzae; Haem influ; Haemoph; ID; Infectious Disease; InfectiousDisease; Influ; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203503	H influen bcs Ct Spec Qn NAA+probe	4180186
36203503	流感嗜血杆菌 bcs 基因:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203504	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B pert; B pert.PT; B pert.PT Ab; B pert.PT IgG; B pertussis; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pertussis; Point in time; PR; PT; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; Whooping cough	4180186
36203504	B pert.PT IgG Ser Ql IA	4180186
36203504	百日咳博德特菌.百日咳毒素 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
36203508	Activ; Actvty; C trac; C trach; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; H+P; H+P.HX; LGV; Lymphogranuloma venereum; Movements; Ordinal; P prime; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Sex cont w CT &or NG case; Trachoma	4180186
36203508	Sex cont w CT &or NG case	4180186
36203508	与已知的沙眼衣原体 &or 淋病奈瑟菌病例之间的性活动:存在情况或阈值:时间点:^患者:序数型	4182948
36203509	Congenital rubella syndrome; Gentyp; German measles; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; RUBV; RubV genotype; Spec; To be specified in another part of the message; Typ; Unspecified	4180186
36203509	RUBV Gentyp Spec	4180186
36203509	风疹病毒 基因型:类型:时间点:XXX:名义型	4182948
36203511	Congenital rubella syndrome; German measles; Point in time; QNT; Quan; Quant; Quantitative; Random; RUBV; VACCINE; Y prev tested for rubella immun	4180186
36203511	Y prev tested for rubella immun	4180186
36203511	既往检测风疹病毒免疫力时的年份:日期:时间点:^患者:定量型	4182948
36203513	Documenation prev rubella tx	4180186
36203513	Documenation prev rubella tx; Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; Prev; QL; Qual; Qualitative; Random; Screen	4180186
36203513	关于既往风疹免疫力检测的文档记录:发现:时间点:^患者:序数型	4182948
36203515	Dis; Diseases; Dz; Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; Prev; Prev rubella serologically confirm; Ql; Qual; Qualitative; Random; Screen	4180186
36203515	Prev rubella serologically confirm	4180186
36203515	既往风疹疾病当时得到了血清学确认:发现:时间点:^患者:序数型	4182948
36203516	Before; Dx; Finding; Findings; Gestation; Gestations; Gravida; H+P; H+P.HX; Ordinal; P prime; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Rubella dx; Screen	4180186
36203516	Rubella dx pre pregnancy	4180186
36203516	风疹诊断^在妊娠之前:发现:时间点:^患者:序数型	4182948
36203518	Autopsy performed; Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36203518	Autopsy performed	4180186
36203518	尸体解剖已执行:发现:时间点:^患者:序数型	4182948
36203519	Prev deliveries in U.S. Mother	4180186
36203519	Finding; Findings; H+P; H+P.HX; Mat; Maternal; Matnl; Ordinal; P prime; Point in time; Prev; Prev deliveries in U.S.; Ql; Qual; Qualitative; Random; S prime; Screen	4180186
36203519	既往在美国国内有过若干次分娩:发现:时间点:^母亲:序数型	4182948
36203522	Exposed to confirmed case Mother	4180186
36203522	Exposed to confirmed case; Finding; Findings; H+P; H+P.HX; Mat; Maternal; Matnl; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36203522	直接暴露于某个已确认的病例:发现:时间点:^母亲:序数型	4182948
36203523	Travel outside US dur 1st tri Mother	4180186
36203523	Finding; Findings; Gestation; Gestations; Gravida; H+P; H+P.HX; Mat; Maternal; Matnl; Ordinal; P prime; Point in time; Pregnancies; QL; Qual; Qualitative; Random; S prime; Screen; Travel outside US dur 1st tri	4180186
36203523	曾经在早期妊娠期间在美国之外旅行:发现:时间点:^母亲:序数型	4182948
36203524	Mother Knows loc expose illness	4180186
36203524	Exp; Finding; Findings; H+P; H+P.HX; Knows loc exposure illness; Mat; Maternal; Matnl; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36203524	知道疾病的暴露地点:发现:时间点:^母亲:序数型	4182948
36203526	at cess of preg; Fetal; GA; GA (weeks); Gest; Gestation; Gestations; Gravida; Gyn; Gynecology; H+P; H+P.HX; OB; ObGyn; Obstetrics; P prime; Point in time; Pregnancies; Prenatal; QNT; Quan; Quant; Quantitative; Random	4180186
36203526	GA (weeks)--at cess of preg	4180186
36203526	以星期为单位的孕龄^终止妊娠时:时间:时间点:^胎儿:定量型	4182948
36203531	Age at delivery Mother	4180186
36203531	Age at delivery; H+P; H+P.HX; Mat; Maternal; Matnl; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36203531	年龄^分娩时:时间:时间点:^母亲:定量型	4182948
36203532	Duration in the U.S. Mother	4180186
36203532	Durat; H+P; H+P.HX; Mat; Maternal; Matnl; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; S prime	4180186
36203532	在美国国内居留的持续时间:时间:时间点:^母亲:定量型	4182948
36203535	Durat; H+P; H+P.HX; Mat; Maternal; Matnl; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36203535	Fever duration Mother	4180186
36203535	发热持续时间:时间:时间点:^母亲:定量型	4182948
36203537	Fever Mother	4180186
36203537	Finding; Findings; H+P; H+P.HX; Mat; Maternal; Matnl; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
36203537	发热:发现:时间点:^母亲:序数型	4182948
36203538	Rash duration Mother	4180186
36203538	Durat; H+P; H+P.HX; Mat; Maternal; Matnl; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36203538	皮疹持续时间:时间:时间点:^母亲:定量型	4182948
36203539	H+P; H+P.HX; Mat; Maternal; Matnl; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36203539	Date of rash onset Mother	4180186
36203539	皮疹起始日期:日期:时间点:^母亲:定量型	4182948
36203541	Assessment; Eval; H&P; H+P; H+P.HX; History and physical; P prime; Past; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36203541	Date of last eval	4180186
36203541	最后评价日期:日期:时间点:^患者:定量型	4182948
36203542	Congenital rubella case report Pnl	4180186
36203542	Case rprt; Congenital rubella case report Pnl; H+P; P prime; Pan; PANEL.H&P; Panl; Pnl; Point in time; Random	4180186
36203542	先天性风疹案例报告组套:-:时间点:^患者:-	4182948
36203543	1 year; 12Mos; Count/time; H+P; H+P.HX; No; nRate; Num; Num of sex partners; Number rate; Number Rate = Count/Time; P prime; Past; QNT; Quan; Quant; Quantitative	4180186
36203543	Num of sex partners nRate	4180186
36203543	过去12个月当中的性伴侣人数:计数型速率:12个月:^患者:定量型	4182948
36203545	BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Erythrocytes; Hematology; Heme; O sub h phenotype; O(null) phenotype; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
36203545	Bombay phenotype RBC BPU Ql	4180186
36203545	孟买表型:存在情况或阈值:时间点:红细胞^血液制品单位:序数型	4182948
36203547	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PPSV23; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; S pneum Da 5; S pneum Da 5 DNA; S pneum Da type; S pneumo; S pneumoniae; SDA; Spec; Spn; Strand Displacement Amplification; Strep; Strept; TMA; To be specified in another part of the message; Transcription mediated amplification; U.S. serotype 5; Unspecified	4180186
36203547	S pneum Da 5 DNA Ct Spec Qn NAA+probe	4180186
36203547	肺炎链球菌丹麦血清型 5 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203553	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PPSV23; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; S pneum Da 14; S pneum Da 14 DNA; S pneum Da type; S pneumo; S pneumoniae; SDA; Spec; Spn; Strand Displacement Amplification; Strep; Strept; TMA; To be specified in another part of the message; Transcription mediated amplification; U.S. serotype 14; Unspecified	4180186
36203553	S pneum Da 14 DNA Ct Spec Qn NAA+probe	4180186
36203553	肺炎链球菌丹麦血清型 14 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203555	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; S pneum Da 7A+7F; S pneum Da 7A+7F DNA; S pneumo; S pneumoniae; SDA; Spec; Spn; Strand Displacement Amplification; Strep; Strept; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203555	S pneum Da 7A+7F DNA Ct Spec Qn NAA+prb	4180186
36203555	肺炎链球菌丹麦血清型 7A+7F DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203557	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; S pneum Da 23A; S pneum Da 23A DNA; S pneum Da type; S pneumo; S pneumoniae; SDA; Spec; Spn; Strand Displacement Amplification; Strep; Strept; TMA; To be specified in another part of the message; Transcription mediated amplification; U.S. serotype 46; Unspecified	4180186
36203557	S pneum Da 23A DNA Ct Spec Qn NAA+probe	4180186
36203557	肺炎链球菌丹麦血清型 23A DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203558	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; S pneum Da 16F; S pneum Da 16F DNA; S pneum Da type; S pneumo; S pneumoniae; SDA; Spec; Spn; Strand Displacement Amplification; Strep; Strept; TMA; To be specified in another part of the message; Transcription mediated amplification; U.S. serotype 16; Unspecified	4180186
36203558	S pneum Da 16F DNA Ct Spec Qn NAA+probe	4180186
36203558	肺炎链球菌丹麦血清型 16F DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203559	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; S pneum Da 9A+9V; S pneum Da 9A+9V DNA; S pneumo; S pneumoniae; SDA; Spec; Spn; Strand Displacement Amplification; Strep; Strept; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203559	S pneum Da 9A+9V DNA Ct Spec Qn NAA+prb	4180186
36203559	肺炎链球菌丹麦血清型 9A+9V DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203561	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; S pn Da 6(A+B+C+D); S pneumo; S pneumoniae; SDA; Spec; Spn; Spneu Da 6A+6B+6C+6D DNA; Strand Displacement Amplification; Strep; Strept; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203561	S pn Da 6(A+B+C+D) DNA Ct Spec Qn NAA+pr	4180186
36203561	肺炎链球菌丹麦血清型 6A+6B+6C+6D DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203566	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; S pn Da 11A+11D; S pneum Da 11A+11D DNA; S pneumo; S pneumoniae; SDA; Spec; Spn; Strand Displacement Amplification; Strep; Strept; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203566	S pn Da 11A+11D DNA Ct Spec Qn NAA+probe	4180186
36203566	肺炎链球菌丹麦血清型 11A+11D DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203567	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PPSV23; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; S pneum Da 19A; S pneum Da 19A DNA; S pneum Da type; S pneumo; S pneumoniae; SDA; Spec; Spn; Strand Displacement Amplification; Strep; Strept; TMA; To be specified in another part of the message; Transcription mediated amplification; U.S. serotype 57; Unspecified	4180186
36203567	S pneum Da 19A DNA Ct Spec Qn NAA+probe	4180186
36203567	肺炎链球菌丹麦血清型 19A DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203568	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; o71; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S aureus; Screen; SDA; Staph; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36203568	S aureus DNA Bld Pos Ql NAA+non-probe	4180186
36203568	金黄色葡萄球菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36203570	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; GBS; Gp B Strep; Group B; Group B Strep; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S agalactiae; Screen; SDA; Steptococcus Group B; Strand Displacement Amplification; Strep; Strep B; Strep group B; Strept; Streptococci group B; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36203570	Gp B Strep DNA Bld Pos Ql NAA+non-probe	4180186
36203570	无乳链球菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36203571	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S pneumo; S pneumoniae; S pneumoniase DNA; Screen; SDA; Spn; Strand Displacement Amplification; Strep; Strept; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36203571	S pneum DNA Bld Pos Ql NAA+non-probe	4180186
36203571	肺炎链球菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36203578	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36203578	Enterococ DNA Bld Pos Ql NAA+non-probe	4180186
36203578	肠球菌属单个未知种 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36203580	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S marcescens; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36203580	S marcescens DNA Bld Pos NAA+non-probe	4180186
36203580	粘质沙雷氏菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36203582	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; C glabrata; C glabrata DNA; Cand; Candidiasis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Torulopsis glabrata; Transcription mediated amplification; WB; Whole blood	4180186
36203582	C glabrata DNA Bld Pos Ql NAA+non-probe	4180186
36203582	光滑假丝酵母 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36203588	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bld Pos; Blood; Carbapenem resistance gene; CPR; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36203588	blaKPC Bld Pos Ql NAA+non-probe	4180186
36203588	细菌碳青霉烯类耐药 blaKPC 基因:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36203589	CD3+CD8+CD45RO+/100 CD3 NFr Bld	4180186
36203589	100 CD3; Blood; CD3 Cells; CD3+CD8+ Cells; CD8 T cells; Cell; CELL MARKERS; Cellularity; Leu2; Leu-2; Leu4; Leu-4; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Suppressor T cells; Suppressor/cytotoxic T cells; T3; T8; T-8; T8 suppressor cells; Tsuppressor; UCHL-1; WB; Whole blood	4180186
36203589	细胞.CD3+CD8+CD45RO+/100 个细胞.CD3:计数型分数:时间点:全血:定量型	4182948
36203590	#; ABS; absolute; absolutes; Blood; CD3 Cells; CD3+CD8+ Cells; CD8 T cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Leu2; Leu-2; Leu4; Leu-4; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; Suppressor T cells; Suppressor/cytotoxic T cells; T3; T8; T-8; T8 suppressor cells; Tsuppressor; UCHL-1; WB; Whole blood	4180186
36203590	CD3+CD8+CD45RO+ # Bld	4180186
36203590	细胞.CD3+CD8+CD45RO+:计数型浓度:时间点:全血:定量型	4182948
36203593	Nominal; Point in time; Random; Spec; Spec source subj; Srce; Typ	4180186
36203593	Spec source subj	4180186
36203593	标本来源对象:类型:时间点:*:名义型	4182948
36203596	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Congenital rubella syndrome; DNA NUCLEIC ACID PROBE; DNA probe; German measles; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; RUBV; RUBV E1; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203596	RUBV E1 Ct Spec Qn NAA+probe	4180186
36203596	风疹病毒 E1 基因:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203598	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; MeV; MeV N gene; Microbiology; Misc; Miscellaneous; Msls; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Rubeola; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203598	MeV N gene Ct Spec Qn NAA+probe	4180186
36203598	麻疹病毒 N 基因:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203599	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B pert; B pert+bron+holm IS481; B pertussis; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Pertussis; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QNT; Quan; Quant; Quantitative; Random; Respiratory; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Whooping cough	4180186
36203599	B per+bron+holm IS481 DNA Ct Spec NAA+pr	4180186
36203599	百日咳博德特菌+支气管败血性百日咳博德特菌+霍氏博德特菌 IS481 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203601	FLUBV Yam Ag Titr Islt HAI	4180186
36203601	流感病毒 B 型 Yamagata 谱系 抗原:滴定度:时间点:分离株:定量型:红细胞凝集抑制试验法	4182948
36203601	Antigen; Antigens; Dilution factor; Dilution Factor (Titer); FLUB; FLUBV; FLUBV Yam; FLUV; HEMAGGLUTINATION INHIBITION; HI; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; Islt; Isol; Microbiology; Point in time; Random; SmQn; Titer; Titered; Titre; Ttr	4180186
36203604	FLUAV H5 Ag Titr Islt HAI	4180186
36203604	流感病毒 A 型血凝素 H5 型 抗原:滴定度:时间点:分离株:定量型:红细胞凝集抑制试验法	4182948
36203604	Antigen; Antigens; Avian influenza; Bird flu; Dilution factor; Dilution Factor (Titer); FLUA; FLUAV; FLUAV H5; FLUV; Fowl plague; Hemagglutination inhibition; HI; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Islt; Isol; Microbiology; Point in time; Random; SmQn; Titer; Titered; Titre; Ttr	4180186
36203605	FLUAV H7 Ag Titr Islt HAI	4180186
36203605	流感病毒 A 型血凝素 H7 型 抗原:滴定度:时间点:分离株:定量型:红细胞凝集抑制试验法	4182948
36203605	Antigen; Antigens; Avian influenza; Bird flu; Dilution factor; Dilution Factor (Titer); FLUA; FLUAV; FLUAV H7; FLUV; Fowl plague; Hemagglutination inhibition; HI; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Islt; Isol; Microbiology; Point in time; Random; SmQn; Titer; Titered; Titre; Ttr	4180186
36203607	Gentyp; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; MuV; MuV genotype; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Typ; Unspecified	4180186
36203607	MuV Gentyp Spec	4180186
36203607	流行性腮腺炎病毒 基因型:类型:时间点:XXX:名义型	4182948
36203610	3 Self-Sustaining Sequence Replication; 3SR SR; Adeno virus; AdV serotype DNA Pnl; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HAdV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203610	AdV serotype DNA Pnl Spec NAA+probe	4180186
36203610	腺病毒血清型 DNA 组套:-:时间点:XXX:-:探针法.基因扩增.靶向	4182948
36203611	3 days; Centers for Medicare and Medicaid Assessment; Levels; Levl; LV; LVL; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36203612	3 days; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36203614	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36203616	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36203617	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36203618	Activated clotting time; Blood; CFT; Clot; Clot form+Clot time; Clot time; Clottable; COAGULATION; Coagulation time; Hematology; Heme; Kinetics; k-time; Point in time; QNT; Quan; Quant; Quantitative; Random; Rate; R-time; TEG; Thrombelastography; Thrombelastometry; WB; Whole blood	4180186
36203618	Clot form+Clot time Bld TEG	4180186
36203618	凝块形成+凝血时间:时间:时间点:全血:定量型:血栓弹力描记术	4182948
36203620	凝块稳固性降低^在添加肝素酶后达到最大凝固幅度之后30分钟:长度分数:时间点:全血:定量型:血栓弹力描记术	4182948
36203620	CF reduc 30M p MA p hep LenFr Bld TEG	4180186
36203620	30M p MA p hep; add heparinase; Blood; CF; CF reduc; COAGULATION; Hematology; Heme; Length Fraction; P Hpase; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; TEG; Thrombelastography; Thrombelastometry; WB; Whole blood	4180186
36203621	Antigen; Antigens; FLUB; FLUBV; FLUBV Vic; FLUBV Victoria; FLUBV Victoria Ag; FLUV; HEMAGGLUTINATION INHIBITION; HI; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; Islt; Isol; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
36203621	FLUBV Vic Ag Islt Ql HAI	4180186
36203621	流感病毒 B 型 Victoria 谱系 抗原:存在情况或阈值:时间点:分离株:序数型:红细胞凝集抑制试验法	4182948
36203624	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36203624	blaIMP Islt Ql NAA+probe	4180186
36203624	细菌碳青霉烯类耐药 blaIMP 基因:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
36203625	ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
36203625	blaOXA-23-like Islt/Spm Ql	4180186
36203625	细菌碳青霉烯类耐药 blaOXA-23-样基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36203626	ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
36203626	blaOXA-24-like Islt/Spm Ql	4180186
36203626	细菌碳青霉烯类耐药 blaOXA-24-样基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36203628	ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
36203628	blaOXA-58-like Islt/Spm Ql	4180186
36203628	细菌碳青霉烯类耐药 blaOXA-58-样基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36203630	high-throughput sequencing; HTS; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random; Ribonucleic acid; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; RVB	4180186
36203630	RVB RNA Islt-Seq	4180186
36203630	轮状病毒 B RNA:序列:时间点:分离株:名义型:序列测定	4182948
36203633	high-throughput sequencing; HTS; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random; Ribonucleic acid; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; RVC	4180186
36203633	RVC RNA Islt-Seq	4180186
36203633	轮状病毒 C RNA:序列:时间点:分离株:名义型:序列测定	4182948
36203637	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Pork; PRCoV; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36203637	PRCoV RNA Ct Spec Qn NAA+probe	4180186
36203637	猪呼吸道冠状病毒 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203639	L intracell Ab Titr Ser IA	4180186
36203639	胞内劳森菌 抗体:滴定度:时间点:血清:定量型:免疫测定法	4182948
36203639	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; L intracell; MEIA; Microbiology; Point in time; Random; Serum; SmQn; SR; SUDS; Titer; Titered; Titre; Ttr; Vet; Veterinary	4180186
36203640	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Cnt; Count; Count/volume; CT; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; L intracell; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary; Viral load	4180186
36203640	L intracell RNA # Spec NAA+probe	4180186
36203640	胞内劳森菌 RNA:计数型浓度:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203644	A pleuropn 7 Ab Titr Ser CF	4180186
36203644	胸膜肺炎放线杆菌血清型 7 抗体:滴定度:时间点:血清:定量型:补体结合试验	4182948
36203644	A pleuropn; A pleuropn 7; A pleuropn Sertyp; A pleuropneumoniae; ABS; Aby; Actino; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CF; Comp fixation; Compfix; Complement fixation; Contagious swine pleuropneumonia; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr; Vet; Veterinary	4180186
36203648	C&S; Cult; Cultures; E rhusiopathiae; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36203648	E rhusiopathiae Spec Ql Cult	4180186
36203648	猪红斑丹毒丝菌:存在情况或阈值:时间点:XXX:序数型:微生物特异性培养	4182948
36203650	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; E rhusiopathiae; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36203650	E rhusiopathiae DNA Ct Spec Qn NAA+probe	4180186
36203650	猪红斑丹毒丝菌 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203651	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Erysip sp str 2; Erysip sp strain 2 DNA; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; species; spp; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36203651	Erysip sp str 2 DNA Ct Spec Qn NAA+probe	4180186
36203651	丹毒丝菌属 2 号株 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203655	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Leptospirosis; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; species; spp; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203655	Leptospira DNA Ct Spec Qn NAA+probe	4180186
36203655	钩端螺旋体属单个未知种 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203656	high-throughput sequencing; HTS; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Isolated; Leptospirosis; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random; species; spp; Typ	4180186
36203656	Leptospira Islt Seq	4180186
36203656	钩端螺旋体属单个未知种 已鉴定的:类型:时间点:分离株:名义型:序列测定	4182948
36203658	PPV Ab Titr Ser HAI	4180186
36203658	猪细小病毒 抗体:滴定度:时间点:血清:定量型:红细胞凝集抑制试验法	4182948
36203658	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); HEMAGGLUTINATION INHIBITION; HI; ID; Infectious Disease; InfectiousDisease; Microbiology; Parvo; Parvo virus; Parvov; Point in time; Porcine reproductive parvovirus; Pork; PPV; Random; Serum; SmQn; SR; Swine; Titer; Titered; Titre; Ttr; Vet; Veterinary	4180186
36203659	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Parvo; Parvo virus; Parvov; PCR; Point in time; Polymerase chain reaction; Porcine reproductive parvovirus; Pork; PPV; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36203659	PPV DNA Ct Spec Qn NAA+probe	4180186
36203659	猪细小病毒 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203660	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Parvo; Parvo virus; Parvov; PCR; Point in time; Polymerase chain reaction; Porcine reproductive parvovirus; Pork; PPV; PPV 1; PPV 1 DNA; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
36203660	PPV 1 DNA Ct Spec Qn NAA+probe	4180186
36203660	猪细小病毒 1 型 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203661	Antigen; Antigens; ID; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; T gondii; Tissue; Tissue, unspecified; Toxo; Toxoplasmosis	4180186
36203661	T gondii Ag Tiss Ql ImStn	4180186
36203661	刚地弓形虫 抗原:存在情况或阈值:时间点:组织与涂片:序数型:免疫染色法	4182948
36203665	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Islt; Isol; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36203665	blaVIM Islt Ql NAA+probe	4180186
36203665	细菌碳青霉烯类耐药 blaVIM 基因:存在情况或阈值:时间点:分离株:序数型:探针法.基因扩增.靶向	4182948
36203667	ANTIBIOTIC SUSCEPTIBILITIES; B; Bact; ESBL blaCTX-M-1 Grp gene; i; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
36203667	ESBL blaCTX-M-1 Grp gene Islt/Spm Ql	4180186
36203667	细菌 beta-内酰胺耐药 ESBL blaCTX-M-1 组基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36203669	ANTIBIOTIC SUSCEPTIBILITIES; B; Bact; ESBL blaCTX-M9 Grp gene; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
36203669	ESBL blaCTX-M9 Grp gene Islt/Spm Ql	4180186
36203669	细菌 beta-内酰胺耐药 ESBL blaCTX-M-9 组基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36203672	ANTIBIOTIC SUSCEPTIBILITIES; B; Bact; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
36203672	ESBL blaPER gene Islt/Spm Ql	4180186
36203672	细菌 beta-内酰胺耐药 ESBL blaPER 基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36203673	ANTIBIOTIC SUSCEPTIBILITIES; B; Bact; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
36203673	ESBL blaSHV gene Islt/Spm Ql	4180186
36203673	细菌 beta-内酰胺耐药 ESBL blaSHV 基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36203674	ANTIBIOTIC SUSCEPTIBILITIES; B; Bact; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
36203674	ESBL blaTEM gene Islt/Spm Ql	4180186
36203674	细菌 beta-内酰胺耐药 ESBL blaTEM 基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36203677	Anesthesia; D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Recovery rm; Visit note	4180186
36203677	Anesthesiology Recovery rm D/C sum	4180186
36203677	出院摘要记录:发现:时间点:恢复室:文档型:麻醉学	4182948
36203678	Cardio; Cardiology; Cardiothor surg; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; H&P note; Heart Disease; Hx; notes; Point in time; Random; Surg; Visit note	4180186
36203678	Cardiothor surg H&P note	4180186
36203678	病史与体格检查记录:发现:时间点:{环境}:文档型:胸心外科学	4182948
36203679	Cardiothorac surg Interdis Note	4180186
36203679	Cardiothor surg; Cardiothorac surg Interdis; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; multidisciplinary; notes; Point in time; Random; Surg; Surg Interdiscip; Visit note	4180186
36203679	记录:发现:时间点:{环境}:文档型:胸心外科学.跨学科	4182948
36203680	Cardiothor surg; Cardiothorac surg Nurse; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Nurse.surgery; nursing; Point in time; Random; Surg; Surgery Nurse; Visit note	4180186
36203680	Cardiothorac surg Nurse Note	4180186
36203680	记录:发现:时间点:{环境}:文档型:胸心外科学.护士	4182948
36203683	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; nursing; OP; Point in time; Random; Visit note; Wmns hlth; Wmns hlth Nurse	4180186
36203683	Wmns hlth Nurse OP Note	4180186
36203683	记录:发现:时间点:门诊病人:文档型:女性健康.护士	4182948
36203684	Wmns hlth Nurse Note	4180186
36203684	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; nursing; Point in time; Random; Visit note; Wmns hlth; Wmns hlth Nurse	4180186
36203684	记录:发现:时间点:{环境}:文档型:女性健康.护士	4182948
36203685	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36203685	记录:发现:时间点:远程影像学:文档型:{角色}	4182948
36203686	Sleep med Note	4180186
36203686	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36203686	记录:发现:时间点:{环境}:文档型:睡眠医学	4182948
36203687	Sleep med Diag study note	4180186
36203687	Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Study report; Visit note	4180186
36203687	诊断性检查记录:发现:时间点:{环境}:文档型:睡眠医学	4182948
36203690	Wmns hlth Group counseling note	4180186
36203690	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note; Wmns hlth	4180186
36203690	团体咨询记录:发现:时间点:{环境}:文档型:女性健康	4182948
36203691	Wmns hlth Educ note	4180186
36203691	DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note; Wmns hlth	4180186
36203691	教育记录:发现:时间点:{环境}:文档型:女性健康	4182948
36203692	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note; Wmns hlth	4180186
36203692	Wmns hlth Note	4180186
36203692	记录:发现:时间点:{环境}:文档型:女性健康	4182948
36203694	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Mental health; MentalHealth; notes; Point in time; Psych; Psychiatric; Psychiatry; Random; Visit note	4180186
36203694	Psychiatric Restraint note	4180186
36203694	约束记录:发现:时间点:{环境}:文档型:精神病学	4182948
36203696	Nurse Recovery rm Note	4180186
36203696	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; nursing; Point in time; Random; Recovery rm; Visit note	4180186
36203696	记录:发现:时间点:恢复室:文档型:护士	4182948
36203697	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; nursing; Point in time; Random; Recovery rm; Visit note	4180186
36203697	Nurse Recovery rm D/C sum	4180186
36203697	出院摘要记录:发现:时间点:恢复室:文档型:护士	4182948
36203698	Neuropsych Note	4180186
36203698	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36203698	记录:发现:时间点:{环境}:文档型:神经心理学	4182948
36203701	MH Nurse Restraint note	4180186
36203701	DOC.ONT; Document; Emotional stability; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; MH Nurse; notes; nursing; Point in time; Random; Visit note	4180186
36203701	约束记录:发现:时间点:{环境}:文档型:心理健康.护士	4182948
36203702	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; LTC fac; LTCF; notes; Point in time; Random; Visit note	4180186
36203702	LTC fac Restraint note	4180186
36203702	约束记录:发现:时间点:长期医疗服务设施:文档型:{角色}	4182948
36203704	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Eye; Eye care; Finding; Findings; notes; Ophthalmology; Ophtho; Ophthy; Point in time; Random; Visit note	4180186
36203704	Ophthalmol Teleimaging Consult note	4180186
36203704	会诊记录:发现:时间点:远程影像学:文档型:眼科学	4182948
36203705	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36203705	记录:发现:时间点:{环境}:文档型:癫痫	4182948
36203706	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36203706	会诊记录:发现:时间点:{环境}:文档型:癫痫	4182948
36203708	Multi-spec prog Telehealth Note	4180186
36203708	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Multi-spec prog; notes; Point in time; Random; Telemedicine; Visit note	4180186
36203708	记录:发现:时间点:远程医疗:文档型:多专业计划	4182948
36203709	Cardio; Cardiology; Cardiothor surg; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart Disease; notes; Point in time; Random; Surg; Visit note	4180186
36203709	Cardiothor surg Phone Note	4180186
36203709	记录:发现:时间点:电话就医:文档型:胸心外科学	4182948
36203710	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36203710	Neuropsych Consult note	4180186
36203710	会诊记录:发现:时间点:{环境}:文档型:神经心理学	4182948
36203711	Cardiothor surg; Cardiothorac surg Fellow; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Surg; Visit note	4180186
36203711	Cardiothorac surg Fellow Note	4180186
36203711	记录:发现:时间点:{环境}:文档型:胸心外科学.培训期医师	4182948
36203712	Wmns hlth NP Note	4180186
36203712	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; nursing; Point in time; Random; Visit note; Wmns hlth; Wmns hlth NP; Wmns hlth Nurse	4180186
36203712	记录:发现:时间点:{环境}:文档型:女性健康.执业护士	4182948
36203713	AE; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36203713	不良事件记录:发现:时间点:{环境}:文档型:{角色}	4182948
36203714	Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; nursing; Point in time; Random; Study report; Visit note	4180186
36203714	Nurse Diag study note	4180186
36203714	诊断性检查记录:发现:时间点:{环境}:文档型:护士	4182948
36203715	Comm hlth care; Consult note; Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36203715	Comm hlth care Consult note	4180186
36203715	会诊记录:发现:时间点:{环境}:文档型:社区医疗保健服务	4182948
36203716	Cardiothorac surg Res Note	4180186
36203716	Cardiothor surg; Cardiothorac surg Res; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Surg; Surg Res; Visit note	4180186
36203716	记录:发现:时间点:{环境}:文档型:胸心外科学.住院	4182948
36203717	Comm hlth care; Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36203717	Comm hlth care Note	4180186
36203717	记录:发现:时间点:{环境}:文档型:社区医疗保健服务	4182948
36203718	CHC Nurse; Comm hlth care; Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; nursing; Point in time; Random; Visit note	4180186
36203718	CHC Nurse Note	4180186
36203718	记录:发现:时间点:{环境}:文档型:社区医疗保健服务.护士	4182948
36203720	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
36203720	Pentylone Ur Cfm-mCnc	4180186
36203720	3,4-亚甲基双氧苯基甲胺戊酮:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
36203723	C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; PEDv; Point in time; Pork; PR; QL; Qual; Qualitative; Random; Screen; Spec; Swine; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36203723	PEDv Spec Ql Cult	4180186
36203723	猪流行性腹泻病毒:存在情况或阈值:时间点:XXX:序数型:微生物特异性培养	4182948
36203725	ID; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; PEDv; Point in time; Pork; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Swine; Tissue; Tissue, unspecified; Vet; Veterinary	4180186
36203725	PEDv Tiss Ql ImStn	4180186
36203725	猪流行性腹泻病毒:存在情况或阈值:时间点:组织与涂片:序数型:免疫染色法	4182948
36203728	Whole exome seq analysis Bld/T	4180186
36203728	Blood; Document; Finding; Findings; Molecular genetics; Molecular pathology; MOLPATH; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue; Whole exome seq analysis	4180186
36203728	全外显子组序列分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36203729	Blood; Document; Finding; Findings; Molecular genetics; Molecular pathology; MOLPATH; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue; Whole genome seq analysis	4180186
36203729	Whole genome seq analysis Bld/T	4180186
36203729	全基因组序列分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
36203730	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; PEDv; PEDV Ab; PEDv IgG; Point in time; Pork; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Swine; Time Resolved Fluorescence; TRF; Vet; Veterinary	4180186
36203730	PEDv IgG Ser Ql IF	4180186
36203730	猪流行性腹泻病毒 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
36203731	cardiology; cards; CVD; Dis; Diseases; DOC.ONT; Document; Dz; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Telemedicine; Visit note	4180186
36203731	记录:发现:时间点:远程医疗:文档型:心血管疾病	4182948
36203733	Cl; Clear; Clearanc; Clearances; Clr; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; M.D.; MD; Med clearance note; notes; Point in time; Random; Visit note	4180186
36203733	MD Med clearance note	4180186
36203733	体检合格记录:发现:时间点:{环境}:文档型:医师	4182948
36203735	EYE; EYE.OCT; Fibers; L; L ret; Length; LT; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL nasal sup thickness; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203735	L ret RNFL nasal sup thickness OCT	4180186
36203735	视网膜神经纤维层.鼻上厚度:长度:时间点:视网膜.左侧:定量型:光学相干断层扫描术	4182948
36203736	EYE; EYE.OCT; Fibers; Inf; Length; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL nasal inf thickness; RT; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203736	R ret RNFL nasal inf thickness OCT	4180186
36203736	视网膜神经纤维层.鼻下厚度:长度:时间点:视网膜.右侧:定量型:光学相干断层扫描术	4182948
36203737	EYE; EYE.OCT; Fibers; Inf; Length; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL inf thickness; RT; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203737	R ret RNFL inf thickness OCT	4180186
36203737	视网膜神经纤维层.下方厚度:长度:时间点:视网膜.右侧:定量型:光学相干断层扫描术	4182948
36203740	Brst; Brst-L; CorePlaybook; Diagnostic MG + US pnl; Document; Finding; Findings; Imaging; L; LT; Pan; PANEL.RADIOLOGY; Panl; Playbook; Pnl; Point in time; Radiology; Random	4180186
36203740	Diagnostic MG + US pnl Brst-L Doc	4180186
36203740	诊断性乳房X线摄影术与超声组套:发现:时间点:乳腺.左侧:文档型	4182948
36203744	Brst; Brst-L; Clip place; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; L; LT; Marker placement; Playbook; Point in time; Rad; Radiology; Random	4180186
36203744	MG Guided Brst-L Clip place	4180186
36203744	旨在置入夹的引导:发现:时间点:乳腺.左侧:文档型:乳房X线摄影术	4182948
36203745	Brst; Brst-R; Clip place; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Marker placement; Playbook; Point in time; R; Rad; Radiology; Random; RT	4180186
36203745	MG Guided Brst-R Clip place	4180186
36203745	旨在置入夹的引导:发现:时间点:乳腺.右侧:文档型:乳房X线摄影术	4182948
36203746	Add; Brst; Brst-L; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; L; Local; LT; NDL; Needle loc addl; Playbook; Point in time; Rad; RADIOLOGY; Random	4180186
36203746	MG Guided Brst-L Needle loc addl	4180186
36203746	旨在额外针定位的引导:发现:时间点:乳腺.左侧:文档型:乳房X线摄影术	4182948
36203749	Brst; Brst-R; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Local; NDL; Playbook; Point in time; R; Rad; Radiology; Random; RT	4180186
36203749	MG Guided Brst-R Needle loc	4180186
36203749	旨在针定位的引导:发现:时间点:乳腺.右侧:文档型:乳房X线摄影术	4182948
36203750	Brst; Brst-R; CorePlaybook; Diagnostic MG + US pnl; Document; Finding; Findings; Imaging; Pan; PANEL.RADIOLOGY; Panl; Playbook; Pnl; Point in time; R; Radiology; Random; RT	4180186
36203750	Diagnostic MG + US pnl Brst-R Doc	4180186
36203750	诊断性乳房X线摄影术与超声组套:发现:时间点:乳腺.右侧:文档型	4182948
36203751	Brst; Brst + Brst specimen-R; Brst spec; Brst spec-R; Brst-R; CorePlaybook; Document; Films; Finding; Findings; Guid; Guide; Guided; Imaging; Local; NDL; Needle loc + Views; Playbook; Point in time; R; Rad; RADIOLOGY; Random; RT; Spec; View; VWS	4180186
36203751	MG Brst-R Needle loc + Brst spec View	4180186
36203751	旨在针定位的引导 && 多重视图:发现:时间点:乳腺.右侧 &&^乳腺标本.右侧:文档型:乳房X线摄影术	4182948
36203752	Add; Brst; Brst-L; Bx; Bx addl; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; L; LT; Playbook; Point in time; Rad; Radiology; Random; Stereo	4180186
36203752	MG.stereo Guided Brst-L Bx addl	4180186
36203752	旨在额外活组织检查的引导:发现:时间点:乳腺.左侧:文档型:乳房X线摄影术.立体定位	4182948
36203753	Chicken pox; Chicken pox virus; Chickenpox; Herpes zoster; HHV-3; Human herpesvirus 3; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Molecular genetics; Nominal; Other; PCR; Point in time; Random; Shingles; Spec; To be specified in another part of the message; Typ; Unspecified; VZ; VZV; VZV clade; Zoster	4180186
36203753	VZV clade Spec	4180186
36203753	水痘带状疱疹病毒进化枝:类型:时间点:XXX:名义型:分子遗传学类实验室方法	4182948
36203754	3 Self-Sustaining Sequence Replication; 3SR SR; Adeno virus; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HAdV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
36203754	HAdV DNA Tiss Ql NAA+probe	4180186
36203754	腺病毒 DNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36203756	3 Self-Sustaining Sequence Replication; 3SR SR; Adeno virus; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HAdV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn	4180186
36203756	HAdV DNA Ur Ql NAA+probe	4180186
36203756	腺病毒 DNA:存在情况或阈值:时间点:尿液:序数型:探针法.基因扩增.靶向	4182948
36203758	3 Self-Sustaining Sequence Replication; 3SR SR; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Amplif; Amplification; Amplified; CHIKV; DNA NUCLEIC ACID PROBE; DNA probe; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36203758	CHIKV RNA Amn Ql NAA+probe	4180186
36203758	基孔肯亚病毒 RNA:存在情况或阈值:时间点:羊水:序数型:探针法.基因扩增.靶向	4182948
36203759	Sex in last Y Ql Reported	4180186
36203759	Activ; Actvty; Finding; Findings; H+P; H+P.HX; Movements; Ordinal; P prime; Past; QL; Qual; Qualitative; Screen; Sex in last Y	4180186
36203759	在过去那一年当中的性活动:发现:1年:^患者:序数型:报告法	4182948
36203762	Contraception; Contraceptive Method; H+P; H+P.HX; Meth; Method of; Nominal; P prime; Point in time; Random; Typ	4180186
36203762	Birth control method at exit Reported	4180186
36203762	节育方法^离开时:类型:时间点:^患者:名义型:报告法	4182948
36203763	Addiction med MD Note	4180186
36203763	Addiction med MD; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; M.D.; MD; notes; Point in time; Random; Substance abuse; Visit note	4180186
36203763	记录:发现:时间点:{环境}:文档型:成瘾医学.医师	4182948
36203769	CAP; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; RVA; RVA VP6 capsid protein; Screen; Spec; SUDS; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36203769	RVA VP6 capsid protein Spec Ql IA	4180186
36203769	轮状病毒 A 组 VP6 衣壳蛋白:存在情况或阈值:时间点:XXX:序数型:免疫测定法	4182948
36203772	Dermatologic; Epidermis; Integument; LM; Micro; Micros; Microscopic; Nominal; PATH.HISTO; PATHOLOGY; Point in time; Random; Skn; Typ	4180186
36203772	Growth phase Mel Micro	4180186
36203772	生长阶段:类型:时间点:皮肤黑色素瘤:名义型:显微镜检查.光学	4182948
36203776	Coded race+ethnicity CDA R2.1 Sec; Congenital dyserythropoietic anaemia; Ethnicity; Pan; Panel; PANEL.DOC; Panl; Pnl; Point in time; Random	4180186
36203776	Coded race+ethnicity CDA R2.1 Sec	4180186
36203776	编码型种族与族群 - 推荐 CDA R1 小节:-:时间点:{环境}:-	4182948
36203778	Cause of death+related info Doc	4180186
36203778	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
36203778	死亡原因+相关信息:发现:时间点:^患者:文档型	4182948
36203780	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
36203780	Death classification+related info Doc	4180186
36203780	死亡原因分类+相关信息:发现:时间点:^患者:文档型	4182948
36203789	DENV4 NAb Titr Spec Nt	4180186
36203789	登革热病毒 4 型 抗体.中和:滴定度:时间点:XXX:定量型:中和试验	4182948
36203789	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Breakbone fever; Conventional virus neutralization test; cVNT; Dengue type IV; Denv; DENV4; Dilution factor; Dilution Factor (Titer); Flavivirus; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; Other; Point in time; Random; Serum virus neutralization; SmQn; Spec; SVN; Titer; Titered; Titre; To be specified in another part of the message; Ttr; Unspecified; Virus neutralization test; VNT	4180186
36203791	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Breakbone fever; Conventional virus neutralization test; cVNT; Dengue type III; Denv; DENV3; Flavivirus; ID; III; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum virus neutralization; Spec; SVN; To be specified in another part of the message; Unspecified; Virus neutralization test; VNT	4180186
36203791	DENV3 NAb Spec Ql Nt	4180186
36203791	登革热病毒 3 型 抗体.中和:存在情况或阈值:时间点:XXX:序数型:中和试验	4182948
36203792	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Breakbone fever; Conventional virus neutralization test; cVNT; Dengue type II; Denv; DENV2; Flavivirus; ID; II; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; NAb; NEUTRALIZATION; Neutralization test; NT; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum virus neutralization; Spec; SVN; To be specified in another part of the message; Unspecified; Virus neutralization test; VNT	4180186
36203792	DENV2 NAb Spec Ql Nt	4180186
36203792	登革热病毒 2 型 抗体.中和:存在情况或阈值:时间点:XXX:序数型:中和试验	4182948
36203794	Comm hlth care Phone Note	4180186
36203794	Comm hlth care; Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36203794	记录:发现:时间点:电话就医:文档型:社区医疗保健服务	4182948
36203798	Salivary gland swelling dur	4180186
36203798	Durat; H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36203798	唾液腺肿胀持续时间:时间:时间点:^患者:定量型	4182948
36203802	Durat; H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36203802	咳嗽持续时间:时间:时间点:^患者:定量型	4182948
36203803	H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
36203803	咳嗽初次发作年龄:时间:时间点:^患者:定量型	4182948
36203804	Vocational rehab Educ note	4180186
36203804	DOC.ONT; Document; Educ note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36203804	教育记录:发现:时间点:{环境}:文档型:职业康复	4182948
36203805	Vocational rehab Risk assess+scrn note	4180186
36203805	Asympt; Asymptomatic; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Risk assess and screen; Risk assess+scrn note; Scn; Visit note	4180186
36203805	风险评估与筛查记录:发现:时间点:{环境}:文档型:职业康复	4182948
36203807	Cardiology Post-op E/M note	4180186
36203807	Assessment; cardiology; cards; Clinical encounter note; CVD; Dis; Diseases; DOC.ONT; Document; Dz; E/M note; Encounter; Eval; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Post-op E/M note; Post-operative; Random; Visit note	4180186
36203807	术后评价与管理记录:发现:时间点:{环境}:文档型:心血管疾病	4182948
36203814	Surgery OP Post-op E/M note	4180186
36203814	Assessment; Clinical encounter note; DOC.ONT; Document; E/M note; Encounter; Eval; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; OP; Point in time; Post-op E/M note; Post-operative; Random; Surg; Visit note	4180186
36203814	术后评价与管理记录:发现:时间点:门诊病人:文档型:外科学	4182948
36203815	Surgery OP Pre-op note	4180186
36203815	Assessment; Clinical encounter note; DOC.ONT; Document; E/M note; Encounter; Eval; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; OP; Point in time; Pre-Op; Pre-op note; Pre-Operative; Random; Surg; Visit note	4180186
36203815	术前评价与管理记录:发现:时间点:门诊病人:文档型:外科学	4182948
36203817	Assessment; Clinical encounter note; DOC.ONT; Document; E/M note; Encounter; Eval; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Pre-Op; Pre-op note; Pre-Operative; Random; Surg; Surg attend; Visit note	4180186
36203817	Surg attend Pre-op note	4180186
36203817	术前评价与管理记录:发现:时间点:{环境}:文档型:外科学.主治	4182948
36203821	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; i; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 1; S pneum Da 1 Ab; S pneum Da 1 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 1	4180186
36203821	S pneum Da 1 IgG Ser-mCnc	4180186
36203821	肺炎链球菌丹麦血清型 1 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
36203823	EYE; EYE.OCT; Fibers; Length; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL 4 o'clock thickness; RT; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203823	R ret RNFL 4 o'clock thickness OCT	4180186
36203823	视网膜神经纤维层.4点钟位厚度:长度:时间点:视网膜.右侧:定量型:光学相干断层扫描术	4182948
36203824	EYE; EYE.OCT; Fibers; Length; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL 5 o'clock thickness; RT; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203824	R ret RNFL 5 o'clock thickness OCT	4180186
36203824	视网膜神经纤维层.5点钟位厚度:长度:时间点:视网膜.右侧:定量型:光学相干断层扫描术	4182948
36203825	EYE; EYE.OCT; Fibers; Length; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL 6 o'clock thickness; RT; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203825	R ret RNFL 6 o'clock thickness OCT	4180186
36203825	视网膜神经纤维层.6点钟位厚度:长度:时间点:视网膜.右侧:定量型:光学相干断层扫描术	4182948
36203826	EYE; EYE.OCT; Fibers; Length; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL 7 o'clock thickness; RT; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203826	R ret RNFL 7 o'clock thickness OCT	4180186
36203826	视网膜神经纤维层.7点钟位厚度:长度:时间点:视网膜.右侧:定量型:光学相干断层扫描术	4182948
36203827	EYE; EYE.OCT; Fibers; Length; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL 8 o'clock thickness; RT; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203827	R ret RNFL 8 o'clock thickness OCT	4180186
36203827	视网膜神经纤维层.8点钟位厚度:长度:时间点:视网膜.右侧:定量型:光学相干断层扫描术	4182948
36203828	EYE; EYE.OCT; Fibers; Length; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL 9 o'clock thickness; RT; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203828	R ret RNFL 9 o'clock thickness OCT	4180186
36203828	视网膜神经纤维层.9点钟位厚度:长度:时间点:视网膜.右侧:定量型:光学相干断层扫描术	4182948
36203835	14 days; 2 weeks; Finding; Findings; Kansas City Cardiomyopathy Questionnaire; Last; LMTED; LTD; Ordinal; Ql; Qual; Qualitative; Screen; SOB limited ability past 2W; Survey; SURVEY.GNHLTH	4180186
36203840	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Celbenin; Dimethoxypenicillin; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Metacillin; Metin; Molecular genetics; MRB mecC; MRSA; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec; Staficyn; Staphicillin	4180186
36203840	MRB mecC Islt/Spm Ql	4180186
36203840	细菌甲氧西林耐药 mecC 基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36203844	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Coronavirus; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TGEV; TMA; To be specified in another part of the message; Transcription mediated amplification; Transmissible gastroenteritis; Unspecified; Vet; Veterinary	4180186
36203844	TGEV RNA Ct Spec Qn NAA+probe	4180186
36203844	传染性胃肠炎病毒 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203846	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203846	blaOXA-48 Spec Ql NAA+probe	4180186
36203846	细菌碳青霉烯类耐药 blaOXA-48 基因:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36203850	Midazolam/Creat Ur Cfm	4180186
36203850	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn; Versed	4180186
36203850	咪达唑仑/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36203851	Norsufentanil SerPlBld Cfm-mCnc	4180186
36203851	Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Pl; PlasBld; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood	4180186
36203851	去甲基舒芬太尼:质量浓度:时间点:血清/血浆/全血:定量型:毒理学确认试验	4182948
36203854	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Group B; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; Misc; Miscellaneous; N men; N men serogroup; N men sg B; N men sg B synD; N menigitidis; N meningitidis; NAA+probe; NAAT; NASBA; Neisseria meningitidis group B; Neisseria meningitidis type B; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203854	N men sg B synD Ct Spec Qn NAA+probe	4180186
36203854	脑膜炎奈瑟菌血清群 B synD 基因:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203856	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; Misc; Miscellaneous; N men; N men serogroup; N men sg W135; N men sg w135 synG; N menigitidis; N meningitidis; NAA+probe; NAAT; NASBA; Neisseria meningitidis group w135; Neisseria meningitidis type w135; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203856	N men sg w135 synG Ct Spec Qn NAA+probe	4180186
36203856	脑膜炎奈瑟菌血清群 w135 synG 基因:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203857	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; Misc; Miscellaneous; N men; N men serogroup; N men sg X; N men sg X xcbB; N menigitidis; N meningitidis; NAA+probe; NAAT; NASBA; Neisseria meningitidis group X; Neisseria meningitidis type X; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203857	N men sg X xcbB Ct Spec Qn NAA+probe	4180186
36203857	脑膜炎奈瑟菌血清群 X xcbB 基因:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203861	Appearance; Colour; Nominal; Point in time; Random; SPEC; Typ	4180186
36203861	Color Nasal fluid	4180186
36203861	颜色:类型:时间点:鼻腔液体:名义型	4182948
36203862	Color Spt	4180186
36203862	Appearance; Colour; Lower respiratory; Nominal; Point in time; Random; SPEC; Spt; Sputum; Typ	4180186
36203862	颜色:类型:时间点:痰液:名义型	4182948
36203863	Bowel movement; Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; Faecal; Faeces; Fecal; Feces; GI; IAA; Level; Mass concentration; MEIA; Occult blood; Point in time; QNT; Quan; Quant; Quantitative; Random; Siderophilin; Stl; Stool = Fecal; SUDS; Tf; Trf; TRFRN	4180186
36203863	Transferrin.gastrointestinal Stl IA-mCnc	4180186
36203863	转铁蛋白.胃肠道:质量浓度:时间点:大便:定量型:免疫测定法	4182948
36203864	EYE; EYE.OCT; Fibers; Inf; L; L ret; Length; LT; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL nasal inf thickness; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203864	L ret RNFL nasal inf thickness OCT	4180186
36203864	视网膜神经纤维层.鼻下厚度:长度:时间点:视网膜.左侧:定量型:光学相干断层扫描术	4182948
36203874	EYE; EYE.OCT; Fibers; Inf; Length; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL inf temp thickness; RT; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203874	R ret RNFL inf temp thickness OCT	4180186
36203874	视网膜神经纤维层.颞下厚度:长度:时间点:视网膜.右侧:定量型:光学相干断层扫描术	4182948
36203880	EYE; EYE.OCT; Fibers; i; L; L ret; Length; LT; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL 1 o'clock thickness; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203880	L ret RNFL 1 o'clock thickness OCT	4180186
36203880	视网膜神经纤维层.1点钟位厚度:长度:时间点:视网膜.左侧:定量型:光学相干断层扫描术	4182948
36203881	EYE; EYE.OCT; Fibers; II; L; L ret; Length; LT; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL 2 o'clock thickness; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203881	L ret RNFL 2 o'clock thickness OCT	4180186
36203881	视网膜神经纤维层.2点钟位厚度:长度:时间点:视网膜.左侧:定量型:光学相干断层扫描术	4182948
36203883	EYE; EYE.OCT; Fibers; L; L ret; Length; LT; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL 4 o'clock thickness; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203883	L ret RNFL 4 o'clock thickness OCT	4180186
36203883	视网膜神经纤维层.4点钟位厚度:长度:时间点:视网膜.左侧:定量型:光学相干断层扫描术	4182948
36203884	EYE; EYE.OCT; Fibers; L; L ret; Length; LT; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL 5 o'clock thickness; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203884	L ret RNFL 5 o'clock thickness OCT	4180186
36203884	视网膜神经纤维层.5点钟位厚度:长度:时间点:视网膜.左侧:定量型:光学相干断层扫描术	4182948
36203885	EYE; EYE.OCT; Fibers; L; L ret; Length; LT; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL 6 o'clock thickness; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203885	L ret RNFL 6 o'clock thickness OCT	4180186
36203885	视网膜神经纤维层.6点钟位厚度:长度:时间点:视网膜.左侧:定量型:光学相干断层扫描术	4182948
36203887	EYE; EYE.OCT; Fibers; L; L ret; Length; LT; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL 8 o'clock thickness; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203887	L ret RNFL 8 o'clock thickness OCT	4180186
36203887	视网膜神经纤维层.8点钟位厚度:长度:时间点:视网膜.左侧:定量型:光学相干断层扫描术	4182948
36203896	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; i; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 1; S pneum Da 1 Ab; S pneum Da 1 IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 1	4180186
36203896	S pneum Da 1 IgG sp2 Ser IA-mCnc	4180186
36203896	肺炎链球菌丹麦血清型 1 抗体.IgG^第2个标本:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36203897	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; i; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 1; S pneum Da 1 Ab; S pneum Da 1 IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 1	4180186
36203897	S pneum Da 1 IgG sp2 Ser-mCnc	4180186
36203897	肺炎链球菌丹麦血清型 1 抗体.IgG^第2个标本:质量浓度:时间点:血清:定量型	4182948
36203898	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Convalescent; i; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 1; S pneum Da 1 Ab; S pneum Da 1 IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 1	4180186
36203898	S pneum Da 1 IgG sp2 Ser-aCnc	4180186
36203898	肺炎链球菌丹麦血清型 1 抗体.IgG^第2个标本:任意型浓度:时间点:血清:定量型	4182948
36203900	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; First; i; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 1; S pneum Da 1 Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 1	4180186
36203900	S pneum Da 1 Ab sp1 Ser-mCnc	4180186
36203900	肺炎链球菌丹麦血清型 1 抗体^第1个标本:质量浓度:时间点:血清:定量型	4182948
36203902	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; First; i; ID; Infectious Disease; InfectiousDisease; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 1; S pneum Da 1 Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 1	4180186
36203902	S pneum Da 1 Ab sp1 Ser-aCnc	4180186
36203902	肺炎链球菌丹麦血清型 1 抗体^第1个标本:任意型浓度:时间点:血清:定量型	4182948
36203904	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; i; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 1; S pneum Da 1 Ab; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 1	4180186
36203904	S pneum Da 1 Ab sp2 Ser IA-aCnc	4180186
36203904	肺炎链球菌丹麦血清型 1 抗体^第2个标本:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36203905	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Convalescent; i; ID; Infectious Disease; InfectiousDisease; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 1; S pneum Da 1 Ab; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 1	4180186
36203905	S pneum Da 1 Ab sp2 Ser-aCnc	4180186
36203905	肺炎链球菌丹麦血清型 1 抗体^第2个标本:任意型浓度:时间点:血清:定量型	4182948
36203906	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 12F; S pneum Da 12F Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 12	4180186
36203906	S pneum Da 12F Ab Ser-mCnc	4180186
36203906	肺炎链球菌丹麦血清型 12F 抗体:质量浓度:时间点:血清:定量型	4182948
36203908	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; PR; QL; Qual; Qualitative; Random; S pneum Da 12F; S pneum Da 12F Ab; S pneum Da type; S pneumo; S pneumoniae; Screen; Serum; Spn; SR; Strep; Strept; U.S. serotype 12	4180186
36203908	S pneum Da 12F Ab Ser Ql	4180186
36203908	肺炎链球菌丹麦血清型 12F 抗体:存在情况或阈值:时间点:血清:序数型	4182948
36203909	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 12F; S pneum Da 12F Ab; S pneum Da 12F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; SUDS; U.S. serotype 12	4180186
36203909	S pneum Da 12F IgG Ser IA-mCnc	4180186
36203909	肺炎链球菌丹麦血清型 12F 抗体.IgG:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36203910	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 12F; S pneum Da 12F Ab; S pneum Da 12F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 12	4180186
36203910	S pneum Da 12F IgG sp1 Ser-aCnc	4180186
36203910	肺炎链球菌丹麦血清型 12F 抗体.IgG^第1个标本:任意型浓度:时间点:血清:定量型	4182948
36203912	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 12F; S pneum Da 12F Ab; S pneum Da 12F IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 12	4180186
36203912	S pneum Da 12F IgG sp2 Ser-mCnc	4180186
36203912	肺炎链球菌丹麦血清型 12F 抗体.IgG^第2个标本:质量浓度:时间点:血清:定量型	4182948
36203914	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 12F; S pneum Da 12F Ab; S pneum Da 12F IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 12	4180186
36203914	S pneum Da 12F IgG sp2 Ser IA-mCnc	4180186
36203914	肺炎链球菌丹麦血清型 12F 抗体.IgG^第2个标本:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36203917	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Convalescent; ID; Infectious Disease; InfectiousDisease; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 12F; S pneum Da 12F Ab; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 12	4180186
36203917	S pneum Da 12F Ab sp2 Ser-aCnc	4180186
36203917	肺炎链球菌丹麦血清型 12F 抗体^第2个标本:任意型浓度:时间点:血清:定量型	4182948
36203919	2:1; ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; First; ID; Infectious Disease; InfectiousDisease; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; S pneum Da 12F; S pneum Da 12F Ab; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp1; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 12	4180186
36203919	S pneum Da 12F Ab 2:1 Ser-Rto	4180186
36203919	肺炎链球菌丹麦血清型 12F 抗体^第2个标本/第1个标本:比率:时间点:血清:定量型	4182948
36203920	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 14; S pneum Da 14 Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 14	4180186
36203920	S pneum Da 14 Ab Ser-mCnc	4180186
36203920	肺炎链球菌丹麦血清型 14 抗体:质量浓度:时间点:血清:定量型	4182948
36203924	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 14; S pneum Da 14 Ab; S pneum Da 14 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 14	4180186
36203924	S pneum Da 14 IgG Ser-aCnc	4180186
36203924	肺炎链球菌丹麦血清型 14 抗体.IgG:任意型浓度:时间点:血清:定量型	4182948
36203926	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; First; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 14; S pneum Da 14 Ab; S pneum Da 14 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 14	4180186
36203926	S pneum Da 14 IgG sp1 Ser IA-mCnc	4180186
36203926	肺炎链球菌丹麦血清型 14 抗体.IgG^第1个标本:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36203927	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 14; S pneum Da 14 Ab; S pneum Da 14 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 14	4180186
36203927	S pneum Da 14 IgG sp1 Ser-mCnc	4180186
36203927	肺炎链球菌丹麦血清型 14 抗体.IgG^第1个标本:质量浓度:时间点:血清:定量型	4182948
36203929	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 14; S pneum Da 14 Ab; S pneum Da 14 IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 14	4180186
36203929	S pneum Da 14 IgG sp2 Ser IA-mCnc	4180186
36203929	肺炎链球菌丹麦血清型 14 抗体.IgG^第2个标本:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36203930	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 14; S pneum Da 14 Ab; S pneum Da 14 IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 14	4180186
36203930	S pneum Da 14 IgG sp2 Ser-mCnc	4180186
36203930	肺炎链球菌丹麦血清型 14 抗体.IgG^第2个标本:质量浓度:时间点:血清:定量型	4182948
36203931	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Convalescent; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 14; S pneum Da 14 Ab; S pneum Da 14 IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 14	4180186
36203931	S pneum Da 14 IgG sp2 Ser-aCnc	4180186
36203931	肺炎链球菌丹麦血清型 14 抗体.IgG^第2个标本:任意型浓度:时间点:血清:定量型	4182948
36203933	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; First; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 14; S pneum Da 14 Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 14	4180186
36203933	S pneum Da 14 Ab sp1 Ser IA-aCnc	4180186
36203933	肺炎链球菌丹麦血清型 14 抗体^第1个标本:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36203934	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; First; ID; Infectious Disease; InfectiousDisease; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 14; S pneum Da 14 Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 14	4180186
36203934	S pneum Da 14 Ab sp1 Ser-aCnc	4180186
36203934	肺炎链球菌丹麦血清型 14 抗体^第1个标本:任意型浓度:时间点:血清:定量型	4182948
36203935	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 14; S pneum Da 14 Ab; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 14	4180186
36203935	S pneum Da 14 Ab sp2 Ser-mCnc	4180186
36203935	肺炎链球菌丹麦血清型 14 抗体^第2个标本:质量浓度:时间点:血清:定量型	4182948
36203936	EYE; EYE.OCT; Fibers; L; L ret; Length; LT; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL 11 o'clock thickness; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203936	L ret RNFL 11 o'clock thickness OCT	4180186
36203936	视网膜神经纤维层.11点钟位厚度:长度:时间点:视网膜.左侧:定量型:光学相干断层扫描术	4182948
36203940	EYE; EYE.OCT; Fibers; III; Length; Ophthalmology; Ophtho; Ophthy; Optical Coherence Tomography; Point in time; QNT; Quan; Quant; Quantitative; R; R ret; Random; Retinaldehyde; Retinene; Retinene 1; RNFL; RNFL 3 o'clock thickness; RT; Thick; Vit A aldehyde; Vit A1 aldehyde; Vitamin A aldehyde; Vitamin A1 aldehyde	4180186
36203940	R ret RNFL 3 o'clock thickness OCT	4180186
36203940	视网膜神经纤维层.3点钟位厚度:长度:时间点:视网膜.右侧:定量型:光学相干断层扫描术	4182948
36203941	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; P prime; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonuclease; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203941	Human RNase P RNA Ct Spec Qn NAA+probe	4180186
36203941	人核糖核酸酶 P RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203944	C&S; Cult; Cultures; Food sample; Foods; ID; Infectious Disease; InfectiousDisease; Microbiology; o71; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; S aureus; Screen; Staph	4180186
36203944	S aureus Food Ql Cult	4180186
36203944	金黄色葡萄球菌:存在情况或阈值:时间点:食物:序数型:培养	4182948
36203947	C&S; Cult; Cultures; Entero virus; EV; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
36203947	EV Spec Ql Cult	4180186
36203947	肠道病毒:存在情况或阈值:时间点:XXX:序数型:微生物特异性培养	4182948
36203948	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; DFA; Entero virus; EV; EV Ag; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Time Resolved Fluorescence; To be specified in another part of the message; TRF; Unspecified	4180186
36203948	EV Ag Spec Ql IF	4180186
36203948	肠道病毒 抗原:存在情况或阈值:时间点:XXX:序数型:免疫荧光法	4182948
36203950	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B pert; B pert+parap ptxS1; B pertussis; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Pertussis; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Whooping cough	4180186
36203950	B pert+parap ptxS1 Ct Spec Qn NAA+probe	4180186
36203950	百日咳博德特菌+副百日咳博德特菌 ptxS1 基因:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36203954	3 Self-Sustaining Sequence Replication; 3SR SR; Adeno virus; AdV 16 DNA; AdV B(16); Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HAdV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203954	AdV B(16) DNA Spec Ql NAA+probe	4180186
36203954	腺病毒 16 型 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36203955	3 Self-Sustaining Sequence Replication; 3SR SR; Adeno virus; AdV 11 DNA; AdV B(11); Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HAdV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203955	AdV B(11) DNA Spec Ql NAA+probe	4180186
36203955	腺病毒 11 型 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36203957	3 Self-Sustaining Sequence Replication; 3SR SR; Adeno virus; AdV 7 DNA; AdV B(7); Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HAdV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203957	AdV B(7) DNA Spec Ql NAA+probe	4180186
36203957	腺病毒 7 型 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36203958	3 Self-Sustaining Sequence Replication; 3SR SR; Adeno virus; AdV 4 DNA; AdV E(4); Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HAdV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203958	AdV E(4) DNA Spec Ql NAA+probe	4180186
36203958	腺病毒 4 型 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36203959	3 Self-Sustaining Sequence Replication; 3SR SR; Adeno virus; AdV B(3); Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HAdV; ID; III; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36203959	AdV B(3) DNA Spec Ql NAA+probe	4180186
36203959	腺病毒 3 型 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36203960	Exchange; HOOS JR; Point in time; QNT; Quan; Quant; Quantitative; Random; Replace; Score difference; Survey; SURVEY.GNHLTH; Tot; Totl	4180186
36203961	Exchange; Knee injury and Osteoarthritis Outcome Score for Joint Replacement; KOOS JR; KOOS, JR; Point in time; QNT; Quan; Quant; Quantitative; Random; Replace; Score difference; Survey; SURVEY.GNHLTH; Tot; Totl	4180186
36203962	C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Islt; Isol; Isolated; Microbiology; Nominal; Point in time; Random; SVC	4180186
36203962	Virus Islt Shell Vial Cult	4180186
36203962	病毒 已鉴定的:存在与否或特征标识:时间点:分离株:名义型:细胞培养瓶培养法	4182948
36203965	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; QNT; Quan; Quant; Quantitative; Random; S pneum Da 6A; S pneum Da 6A+6B; S pneum Da 6A+6B IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; SUDS; U.S. serotype 6	4180186
36203965	S pneum Da 6A+6B IgG Ab Ser IA-aCnc	4180186
36203965	肺炎链球菌丹麦血清型 6A+6B IgG 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36203967	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; QNT; Quan; Quant; Quantitative; Random; S pneum Da 6A; S pneum Da 6A+6B; S pneum Da 6A+6B Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 6	4180186
36203967	S pneum Da 6A+6B Ab Ser-mCnc	4180186
36203967	肺炎链球菌丹麦血清型 6A+6B 抗体:质量浓度:时间点:血清:定量型	4182948
36203968	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; First; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 6A; S pneum Da 6A+6B; S pneum Da 6A+6B Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 6	4180186
36203968	S pneum Da 6A+6B Ab sp1 Ser-mCnc	4180186
36203968	肺炎链球菌丹麦血清型 6A+6B 抗体^第1个标本:质量浓度:时间点:血清:定量型	4182948
36203969	U.S. Death cert 2003 set	4180186
36203969	Pan; Panel; PANEL.DOC; Panl; Pnl; Point in time; Random; S prime; U.S. Death cert 2003 set	4180186
36203969	美国标准死亡证明 - 推荐 2003 年修订版集合:-:时间点:{环境}:-	4182948
36203970	Pan; Panel; PANEL.DOC; Panl; Pnl; Point in time; Random; S prime; U.S. FDR 2003 set	4180186
36203970	U.S. FDR 2003 set	4180186
36203970	美国标准胎儿死亡报告 - 推荐 2003 年修订版集合:-:时间点:{环境}:-	4182948
36203976	Brst; Brst-R; Bx; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Playbook; Point in time; R; Rad; Radiology; Random; RT; Vac Bx	4180186
36203976	MG Guided Brst-R Vac Bx	4180186
36203976	旨在真空活组织检查的引导:发现:时间点:乳腺.右侧:文档型:乳房X线摄影术	4182948
36203978	Brst; Brst-L; CorePlaybook; Document; Dx; Dx for clin call back; Films; Finding; Findings; Imaging; L; LT; Playbook; Point in time; Rad; RADIOLOGY; Random; Symptomatic; View; VWS	4180186
36203978	MG Brst-L Dx for clin call back	4180186
36203978	针对临床性唤回的诊断性多重视图:发现:时间点:乳腺.左侧:文档型:乳房X线摄影术	4182948
36203984	Abd; Abd+Pelvis; Abdo; Abdominal; CorePlaybook; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Kid+Uret+Blad; Kidney; Nephric; Nephrology; Pelvic; Playbook; Point in time; Pyelogram; Pyelography; Rad; Radiology; Random; Renal; Ureter+Blad; View; VWS	4180186
36203984	RF Kid+Uret+Blad Views for fistula	4180186
36203984	针对瘘管的多重视图:发现:时间点:腹部>肾脏 & 腹部+盆腔>输尿管 & 盆腔>膀胱:文档型:放射荧光透视法	4182948
36203985	Abd; Abd+Pelvis; Abdo; Abdominal; ACBE; Air contrast barium enema; Asympt; Asymptomatic; Ba; Barium Enema; BE; c; Contr; Contra; Contrst; CorePlaybook; Document; Double Contrast Barium Enema; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; LGI; Pelvic; Playbook; Point in time; Rad; Radiology; Random; Scn; View; VWS; W Air contr PR; W Air+Ba PR; W Ba PR	4180186
36203985	RF Colon screening W Air+Ba PR	4180186
36203985	多重视图 筛查^采用经直肠给予空气+采用经直肠给予钡对比剂:发现:时间点:腹部+盆腔>结肠:文档型:放射荧光透视法	4182948
36203986	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 14; S pneum Da 14 Ab; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 14	4180186
36203986	S pneum Da 14 Ab sp2 Ser IA-aCnc	4180186
36203986	肺炎链球菌丹麦血清型 14 抗体^第2个标本:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36203987	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Convalescent; ID; Infectious Disease; InfectiousDisease; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 14; S pneum Da 14 Ab; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 14	4180186
36203987	S pneum Da 14 Ab sp2 Ser-aCnc	4180186
36203987	肺炎链球菌丹麦血清型 14 抗体^第2个标本:任意型浓度:时间点:血清:定量型	4182948
36203994	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 17F; S pneum Da 17F Ab; S pneum Da 17F IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 17	4180186
36203994	S pneum Da 17F IgG sp2 Ser-mCnc	4180186
36203994	肺炎链球菌丹麦血清型 17F 抗体.IgG^第2个标本:质量浓度:时间点:血清:定量型	4182948
36203995	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 17F; S pneum Da 17F Ab; S pneum Da 17F IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 17	4180186
36203995	S pneum Da 17F IgG sp2 Ser IA-mCnc	4180186
36203995	肺炎链球菌丹麦血清型 17F 抗体.IgG^第2个标本:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36203999	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; First; ID; Infectious Disease; InfectiousDisease; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 18F; S pneum Da 18F Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 18	4180186
36203999	S pneum Da 18F Ab sp1 Ser-aCnc	4180186
36203999	肺炎链球菌丹麦血清型 18F 抗体^第1个标本:任意型浓度:时间点:血清:定量型	4182948
36204000	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pn Da sero 19F; S pneum Da 19F Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 19	4180186
36204000	S pn Da sero 19F Ab Ser-aCnc	4180186
36204000	肺炎链球菌丹麦血清型 19F 抗体:任意型浓度:时间点:血清:定量型	4182948
36204001	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pn Da sero 19F; S pneum Da 19F Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 19	4180186
36204001	S pn Da sero 19F Ab Ser-mCnc	4180186
36204001	肺炎链球菌丹麦血清型 19F 抗体:质量浓度:时间点:血清:定量型	4182948
36204002	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pn Da sero 19F; S pneum Da 19F Ab; S pneum Da 19F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; SUDS; U.S. serotype 19	4180186
36204002	S pn Da sero 19F IgG Ser IA-mCnc	4180186
36204002	肺炎链球菌丹麦血清型 19F 抗体.IgG:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204003	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pn Da sero 19F; S pneum Da 19F Ab; S pneum Da 19F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 19	4180186
36204003	S pn Da sero 19F IgG Ser-aCnc	4180186
36204003	肺炎链球菌丹麦血清型 19F 抗体.IgG:任意型浓度:时间点:血清:定量型	4182948
36204004	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pn Da sero 19F; S pneum Da 19F Ab; S pneum Da 19F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; SUDS; U.S. serotype 19	4180186
36204004	S pn Da sero 19F IgG Ser IA-aCnc	4180186
36204004	肺炎链球菌丹麦血清型 19F 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36204005	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pn Da sero 19F; S pneum Da 19F Ab; S pneum Da 19F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 19	4180186
36204005	S pn Da sero 19F IgG Ser-mCnc	4180186
36204005	肺炎链球菌丹麦血清型 19F 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
36204007	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pn Da sero 19F; S pneum Da 19F Ab; S pneum Da 19F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 19	4180186
36204007	S pn Da sero 19F IgG sp1 Ser-aCnc	4180186
36204007	肺炎链球菌丹麦血清型 19F 抗体.IgG^第1个标本:任意型浓度:时间点:血清:定量型	4182948
36204008	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; First; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pn Da sero 19F; S pneum Da 19F Ab; S pneum Da 19F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 19	4180186
36204008	S pn Da sero 19F IgG sp1 Ser IA-mCnc	4180186
36204008	肺炎链球菌丹麦血清型 19F 抗体.IgG^第1个标本:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204010	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Convalescent; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pn Da sero 19F; S pneum Da 19F Ab; S pneum Da 19F IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 19	4180186
36204010	S pn Da sero 19F IgG sp2 Ser-aCnc	4180186
36204010	肺炎链球菌丹麦血清型 19F 抗体.IgG^第2个标本:任意型浓度:时间点:血清:定量型	4182948
36204013	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Convalescent; ID; Infectious Disease; InfectiousDisease; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pn Da sero 19F; S pneum Da 19F Ab; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 19	4180186
36204013	S pn Da sero 19F Ab sp2 Ser-aCnc	4180186
36204013	肺炎链球菌丹麦血清型 19F 抗体^第2个标本:任意型浓度:时间点:血清:定量型	4182948
36204014	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pn Da sero 19F; S pneum Da 19F Ab; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 19	4180186
36204014	S pn Da sero 19F Ab sp2 Ser-mCnc	4180186
36204014	肺炎链球菌丹麦血清型 19F 抗体^第2个标本:质量浓度:时间点:血清:定量型	4182948
36204015	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; II; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 19F Ab; S pneum Da 19F IgG; S pneum Da 2; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; SUDS; U.S. serotype 2	4180186
36204015	S pneum Da 2 IgG Ser IA-mCnc	4180186
36204015	肺炎链球菌丹麦血清型 2 抗体.IgG:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204025	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; First; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 20A; S pneum Da 20A Ab; S pneum Da 20A IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 20	4180186
36204025	S pneum Da 20A IgG sp1 Ser IA-mCnc	4180186
36204025	肺炎链球菌丹麦血清型 20A 抗体.IgG^第1个标本:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204026	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 20A; S pneum Da 20A Ab; S pneum Da 20A IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 20	4180186
36204026	S pneum Da 20A IgG sp2 Ser-mCnc	4180186
36204026	肺炎链球菌丹麦血清型 20A 抗体.IgG^第2个标本:质量浓度:时间点:血清:定量型	4182948
36204027	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 20A; S pneum Da 20A Ab; S pneum Da 20A IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 20	4180186
36204027	S pneum Da 20A IgG sp2 Ser IA-mCnc	4180186
36204027	肺炎链球菌丹麦血清型 20A 抗体.IgG^第2个标本:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204028	2:1; ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; S pneum Da 20A; S pneum Da 20A Ab; S pneum Da 20A IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp1; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 20	4180186
36204028	S pneum Da 20A IgG 2:1 Ser-Rto	4180186
36204028	肺炎链球菌丹麦血清型 20A 抗体.IgG^第2个标本/第1个标本:比率:时间点:血清:定量型	4182948
36204030	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 22F; S pneum Da 22F Ab; S pneum Da 22F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; SUDS; U.S. serotype 22	4180186
36204030	S pneum Da 22F IgG Ser IA-mCnc	4180186
36204030	肺炎链球菌丹麦血清型 22F 抗体.IgG:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204031	Abd; Abdo; Abdomen+; Abdominal; BDs; Bile tract; Biliary tract; CorePlaybook; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; in Surg; Intra operative; Intraop; Intraoperative; LMTED; LTD; Playbook; Point in time; Rad; Radiology; Random; Surg; View; Views Ltd; VWS	4180186
36204031	RF BDs Views Ltd in Surg	4180186
36204031	多重视图 局部^术中:发现:时间点:腹部>胆管类:文档型:放射荧光透视法	4182948
36204032	Abd; Abdo; Abdomen+; Abdominal; BDs; Bile tract; Biliary tract; c; CAG; CHGM; Cholangiogram; Cholangiography; Contr; Contra; Contrst; CorePlaybook; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; View; VWS; W contr IV; WC	4180186
36204032	RF BDs Views W contr IV	4180186
36204032	多重视图^采用静脉注射对比剂:发现:时间点:腹部>胆管类:文档型:放射荧光透视法	4182948
36204035	Abd; Abdo; Abdomen+; Abdominal; Ba; c; Contr; Contra; Contrst; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; GI; Imaging; Point in time; Rad; RADIOLOGY; Random; UGI; Up; View; VWS; W Ba PO	4180186
36204035	RF UGI Views W Ba PO	4180186
36204035	多重视图^采用口服钡对比剂:发现:时间点:腹部>胃肠道.上段:文档型:放射荧光透视法	4182948
36204038	Abd; Abd+Pelvis; Abdo; Abdominal; c; Contr; Contra; Contrst; CorePlaybook; Cystogram; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; in Surg; in Surg W contr retro; Intra operative; Intraop; Intraoperative; Kid+Uret+Blad; Kidney; Nephric; Nephrology; Pelvic; Playbook; Point in time; Pyelogram; Pyelography; Rad; Radiology; Random; Renal; Retro; Surg; Ureter+Blad; View; VWS; W contr Retro; WC	4180186
36204038	RF Kid+Uret+Blad Vs in Surg W contr Retr	4180186
36204038	多重视图^术中采用逆行性对比剂:发现:时间点:腹部>肾脏 & 腹部+盆腔>输尿管 & 盆腔>膀胱:文档型:放射荧光透视法	4182948
36204040	Arteriovenous Fistula; AVF; c; Cath; Contr; Contra; Contrst; CorePlaybook; Document; Films; Finding; Findings; Fistulogram; Fluor; Fluoro; Fluoroscopy; Hemodialysis access; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified; View; VWS; W contr via exist cath; WC	4180186
36204040	RF AVF Views W contr via exist cath	4180186
36204040	多重视图^采用经已有导管的对比剂:发现:时间点:XXX>动静脉瘘:文档型:放射荧光透视法	4182948
36204041	Abd; Abd+Pelvis; Abdo; Abdominal; c; Contr; Contra; Contrst; CorePlaybook; Cystogram; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Kid+Uret+Blad; Kidney; LMTED; LTD; Nephric; Nephrogram; Nephrography; Nephrology; Pelvic; Playbook; Point in time; Pyelogram; Pyelography; Rad; RADIOLOGY; Random; Renal; Ureter+Blad; View; Views Ltd; VWS; W contr IV; WC	4180186
36204041	RF Kid+Uret+Blad Views Ltd W contr IV	4180186
36204041	多重视图 局部^采用静脉注射对比剂:发现:时间点:腹部>肾脏 & 腹部+盆腔>输尿管 & 盆腔>膀胱:文档型:放射荧光透视法	4182948
36204042	Cath; CorePlaybook; Document; Drain; Drain+Suprapub cath place; Exudate; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Imaging; Pelvic; Playbook; Point in time; Rad; RADIOLOGY; Random; Removal of fluid	4180186
36204042	RF Guided Bladder Drain+SP cath place	4180186
36204042	旨在引流+置入耻骨上导管的引导:发现:时间点:盆腔>膀胱:文档型:放射荧光透视法	4182948
36204043	Brain; c; Cereb; Contr; Contra; Contrst; CorePlaybook; Cranial; Cranium; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Intracranial; Intrathecal; Playbook; Point in time; Rad; RADIOLOGY; Random; Skull; View; VWS; W contr IT; WC	4180186
36204043	RF Cerebral cist Views W contr IT	4180186
36204043	多重视图^采用鞘内对比剂:发现:时间点:头部+颈部>脑池类:文档型:放射荧光透视法	4182948
36204046	c; Contr; Contra; Contrst; CorePlaybook; Cystogram; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Pelvic; Playbook; Point in time; Rad; RADIOLOGY; Random; View; VWS; W contr IUB; WC	4180186
36204046	RF Bladder Views W contr IUB	4180186
36204046	多重视图^采用膀胱内对比剂:发现:时间点:盆腔>膀胱:文档型:放射荧光透视法	4182948
36204047	Arm; Arthrogram; Arthrography; c; Contr; Contra; Contrst; CorePlaybook; Document; EXT; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; intraarticular; intrasynovial; LMTED; LTD; MSK; Musculoskeletal; Ortho; Orthopedics; Playbook; Point in time; Rad; Radiology; Random; UE; Up; Upper extremity joint; View; Views Ltd; VWS; W contr IS; WC	4180186
36204047	RF Should Views Ltd W contr IS	4180186
36204047	多重视图 局部^采用关节内对比剂:发现:时间点:上肢>肩部:文档型:放射荧光透视法	4182948
36204050	Change; CorePlaybook; Document; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guidance for exchange; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Replace; Spec; To be specified in another part of the message; Tube exch; Unspecified	4180186
36204050	RF Guided Tube exch	4180186
36204050	旨在更换管道的引导:发现:时间点:XXX:文档型:放射荧光透视法	4182948
36204051	&lt;1h; CorePlaybook; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; in Surg; Intra operative; Intraop; Intraoperative; Misc; Miscellaneous; Other; Playbook; Rad; Radiology; Spec; Surg; To be specified in another part of the message; Unspecified; View; VWS	4180186
36204051	RF <1h Views in Surg	4180186
36204051	多重视图^术中:发现:小于1小时:XXX:文档型:放射荧光透视法	4182948
36204053	CorePlaybook; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Pelvic; Playbook; Point in time; Rad; Radiology; Random; View; VWS	4180186
36204053	针对集尿袋的多重视图:发现:时间点:盆腔:文档型:放射荧光透视法	4182948
36204055	Ba; Barium Swallow; c; Cerv; Contr; Contra; Contrst; CorePlaybook; Document; Esophageal; Esophagram; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Pharynx+Cerv esophagus; Playbook; Point in time; Rad; RADIOLOGY; Random; View; VWS; W Ba PO	4180186
36204055	RF Pharynx+Cerv esophagus Views W Ba PO	4180186
36204055	多重视图^采用口服钡对比剂:发现:时间点:颈部>咽部+食管.颈段:文档型:放射荧光透视法	4182948
36204056	Bil; Bilat; Both; Brain; c; Contr; Contra; Contrst; CorePlaybook; Cranial; Cranium; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Intracranial; Intrathecal; Playbook; Point in time; Post fossa; Post fossa-Bl; Rad; Radiology; Random; Skull; View; VWS; W contr IT; WC	4180186
36204056	RF Post fossa-Bl Views W contr IT	4180186
36204056	多重视图^采用鞘内对比剂:发现:时间点:头部>后颅窝.双侧:文档型:放射荧光透视法	4182948
36204058	Abd; Abd+Pelvis; Abdo; Abdominal; CorePlaybook; Document; Finding; Findings; Fluor; Fluoro; Fluoroscopy; GI; GI tract; Guid; Guide; Guided; Imaging; Long feed tube place; Pelvic; Playbook; Point in time; Rad; Radiology; Random	4180186
36204058	RF Guided GI tract Long feed tube place	4180186
36204058	旨在置入饲管的引导:发现:时间点:腹部+盆腔>胃肠道:文档型:放射荧光透视法	4182948
36204059	Abd; Abdo; Abdomen+; Abdominal; Arteriogram; c; Contr; Contra; Contrst; CorePlaybook; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Kidney; Playbook; Point in time; Rad; Radiology; Random; Renal aa; Renal aa-Ul; RFA; View; VWS; W contr IA; WC	4180186
36204059	RFA Renal aa-Ul Views W contr IA	4180186
36204059	多重视图^采用动脉注射对比剂:发现:时间点:腹部>肾动脉类.单侧:文档型:放射荧光透视法.血管造影术	4182948
36204060	Abd; Abdo; Abdomen+; Abdominal; c; Cardio; Cardiology; Contr; Contra; Contrst; CorePlaybook; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Heart Disease; Imaging; Kidney; Playbook; Point in time; Rad; RADIOLOGY; Random; Renal v-Ul; RFA; Ven; Venogram; Venography; Venous; View; VWS; W contr IV; WC	4180186
36204060	RFA Renal v-Ul Views W contr IV	4180186
36204060	多重视图^采用静脉注射对比剂:发现:时间点:腹部>肾静脉.单侧:文档型:放射荧光透视法.血管造影术	4182948
36204063	Arteriogram; c; Contr; Contra; Contrst; CorePlaybook; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; PA; PAA; Playbook; Point in time; Pulm aa-Ul; Rad; RADIOLOGY; Random; RFA; Thorax; View; VWS; W contr IA; WC	4180186
36204063	RFA Pulm aa-Ul Views W contr IA	4180186
36204063	多重视图^采用动脉注射对比剂:发现:时间点:胸部>肺动脉类.单侧:文档型:放射荧光透视法.血管造影术	4182948
36204069	1V; Abd; Abdo; Abdomen+; Abdominal; Ba; c; Contr; Contra; Contrst; CorePlaybook; Document; Film; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; GI; Imaging; Plain Films; Playbook; Point in time; Rad; RADIOLOGY; Random; Single View; UGI; Up; View; View + Views; VW; VWS; W Ba PO; XR and Flr; Xray; X-ray	4180186
36204069	AXR and Flr UGI W Ba PO	4180186
36204069	视图 && 多重视图^采用口服钡对比剂:发现:时间点:腹部>胃肠道.上段:文档型:X射线摄影术 && 放射荧光透视法	4182948
36204070	Abd; Abdo; Abdomen+; Abdominal; CorePlaybook; Document; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Guid; Guide; Guided; Imaging; Kidney; Nephric; Nephrology; Playbook; Point in time; Rad; Radiology; Random; Renal	4180186
36204070	RF Guided Kidney Manometry	4180186
36204070	旨在压力测量的引导:发现:时间点:腹部>肾脏:文档型:放射荧光透视法	4182948
36204072	Abd; Abdo; Abdomen+; Abdominal; Ba; c; Contr; Contra; Contrst; CorePlaybook; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; GI; Imaging; Playbook; Point in time; Rad; Radiology; Random; SB; Small Intestine; UGI; UGI+SB; Up; View; VWS; W Air contr PO; W air PO+W Ba PO; W Ba PO	4180186
36204072	RF UGI+SB Views W air PO+W Ba PO	4180186
36204072	多重视图^采用口服空气对比剂+采用口服钡对比剂:发现:时间点:腹部>胃肠道.上段+小肠:文档型:放射荧光透视法	4182948
36204073	Arteriogram; c; Contr; Contra; Contrst; CorePlaybook; Document; EXT; Extr aa-Ul; Extr-Ul; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Playbook; Point in time; Rad; Radiology; Random; RFA; View; VWS; W contr IA; WC	4180186
36204073	RFA Extr aa-Ul Views W contr IA	4180186
36204073	多重视图^采用动脉注射对比剂:发现:时间点:肢体.单侧>肢体动脉类:文档型:放射荧光透视法.血管造影术	4182948
36204074	Arteriogram; Brain; c; Cereb; Cerebral aa; Cerebral aa-Ul; Contr; Contra; Contrst; CorePlaybook; Cranial; Cranium; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Intracranial; Playbook; Point in time; Rad; Radiology; Random; RFA; Skull; View; VWS; W contr IA; WC	4180186
36204074	RFA Cerebral aa-Ul Views W contr IA	4180186
36204074	多重视图^采用动脉注射对比剂:发现:时间点:头部>脑动脉类.单侧:文档型:放射荧光透视法.血管造影术	4182948
36204075	Brain; c; Contr; Contra; Contrst; CorePlaybook; Cranial; Cranium; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Intracranial; Intrathecal; Playbook; Point in time; Post fossa; Post fossa-Ul; Rad; Radiology; Random; Skull; View; VWS; W contr IT; WC	4180186
36204075	RF Post fossa-Ul Views W contr IT	4180186
36204075	多重视图^采用鞘内对比剂:发现:时间点:头部>后颅窝.单侧:文档型:放射荧光透视法	4182948
36204076	Arteriogram; Bil; Bilat; Both; Brain; c; Cereb; Cereb aa-Bl+Cerv aa-Bl; Cerebral aa; Cerebral aa-Bl; Cerv; Contr; Contra; Contrst; CorePlaybook; Cranial; Cranium; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Intracranial; Playbook; Point in time; Rad; Radiology; Random; RFA; Skull; View; VWS; W contr IA; WC	4180186
36204076	RFA Cereb aa-Bl+Cerv aa-Bl Vs W contr IA	4180186
36204076	多重视图^采用动脉注射对比剂:发现:时间点:头部>脑动脉类.双侧 & 颈部>颈部动脉类.双侧:文档型:放射荧光透视法.血管造影术	4182948
36204077	Arteriogram; Brain; c; Cereb; Cereb aa-Ul+Cerv aa-Ul; Cerebral aa; Cerebral aa-Ul; Cerv; Contr; Contra; Contrst; CorePlaybook; Cranial; Cranium; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Intracranial; Playbook; Point in time; Rad; RADIOLOGY; Random; RFA; Skull; View; VWS; W contr IA; WC	4180186
36204077	RFA Cereb aa-Ul+Cerv aa-Ul Vs W contr IA	4180186
36204077	多重视图^采用动脉注射对比剂:发现:时间点:头部>脑动脉类.单侧 & 颈部>颈部动脉类.单侧:文档型:放射荧光透视法.血管造影术	4182948
36204078	Abd; Abdo; Abdomen+; Abdominal; Arteriogram; c; Contr; Contra; Contrst; CorePlaybook; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; L/sp; L-spine; L-spine intercost aa; Lumbar; Lumbo; Playbook; Point in time; Rad; RADIOLOGY; Random; RFA; Spinal; Spinal Cord; View; VWS; W contr IA; WC	4180186
36204078	RFA L-spine intercost aa Vs W contr IA	4180186
36204078	多重视图^采用动脉注射对比剂:发现:时间点:腹部>脊椎.腰部肋间动脉类:文档型:放射荧光透视法.血管造影术	4182948
36204079	Arteriogram; Brain; c; Carotid aa; Carotid aa-Ul; Contr; Contra; Contrst; CorePlaybook; Cranial; Cranium; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Intracranial; Playbook; Point in time; Rad; Radiology; Random; RFA; Skull; View; VWS; W contr IA; WC	4180186
36204079	RFA Carotid aa-Ul Views W contr IA	4180186
36204079	多重视图^采用动脉注射对比剂:发现:时间点:头部+颈部>颈动脉类.单侧:文档型:放射荧光透视法.血管造影术	4182948
36204082	c; Contr; Contra; Contrst; CorePlaybook; Document; Dx; Films; Finding; Findings; Fistulogram; Fluor; Fluoro; Fluoroscopy; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Spec; Symptomatic; To be specified in another part of the message; Unspecified; View; VWS; W contr intra fist; WC	4180186
36204082	RF Fistula Dx W contr intra fist	4180186
36204082	诊断性多重视图^采用瘘管内对比剂:发现:时间点:XXX>瘘管:文档型:放射荧光透视法	4182948
36204083	Abd; Abdo; Abdomen+; Abdominal; CorePlaybook; Document; Feed tube check; Finding; Findings; Fluor; Fluoro; Fluoroscopy; GI; Guid; Guide; Guided; Imaging; Inspection; Playbook; Point in time; Rad; Radiology; Random; UGI; Up	4180186
36204083	RF Guided UGI Feed tube check	4180186
36204083	旨在检查饲管的引导:发现:时间点:腹部>胃肠道.上段:文档型:放射荧光透视法	4182948
36204087	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 22F; S pneum Da 22F Ab; S pneum Da 22F IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 22	4180186
36204087	S pneum Da 22F IgG sp2 Ser IA-mCnc	4180186
36204087	肺炎链球菌丹麦血清型 22F 抗体.IgG^第2个标本:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204088	2:1; ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; S pneum Da 22F; S pneum Da 22F Ab; S pneum Da 22F IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp1; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 22	4180186
36204088	S pneum Da 22F IgG 2:1 Ser-Rto	4180186
36204088	肺炎链球菌丹麦血清型 22F 抗体.IgG^第2个标本/第1个标本:比率:时间点:血清:定量型	4182948
36204089	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 23F; S pneum Da 23F Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 23	4180186
36204089	S pneum Da 23F Ab Ser-aCnc	4180186
36204089	肺炎链球菌丹麦血清型 23F 抗体:任意型浓度:时间点:血清:定量型	4182948
36204090	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 23F; S pneum Da 23F Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 23	4180186
36204090	S pneum Da 23F Ab Ser-mCnc	4180186
36204090	肺炎链球菌丹麦血清型 23F 抗体:质量浓度:时间点:血清:定量型	4182948
36204092	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 23F; S pneum Da 23F Ab; S pneum Da 23F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 23	4180186
36204092	S pneum Da 23F IgG Ser-aCnc	4180186
36204092	肺炎链球菌丹麦血清型 23F 抗体.IgG:任意型浓度:时间点:血清:定量型	4182948
36204094	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 23F; S pneum Da 23F Ab; S pneum Da 23F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 23	4180186
36204094	S pneum Da 23F IgG Ser-mCnc	4180186
36204094	肺炎链球菌丹麦血清型 23F 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
36204095	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 23F; S pneum Da 23F Ab; S pneum Da 23F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 23	4180186
36204095	S pneum Da 23F IgG sp1 Ser-mCnc	4180186
36204095	肺炎链球菌丹麦血清型 23F 抗体.IgG^第1个标本:质量浓度:时间点:血清:定量型	4182948
36204096	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 23F; S pneum Da 23F Ab; S pneum Da 23F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 23	4180186
36204096	S pneum Da 23F IgG sp1 Ser-aCnc	4180186
36204096	肺炎链球菌丹麦血清型 23F 抗体.IgG^第1个标本:任意型浓度:时间点:血清:定量型	4182948
36204097	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; First; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 23F; S pneum Da 23F Ab; S pneum Da 23F IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 23	4180186
36204097	S pneum Da 23F IgG sp1 Ser IA-mCnc	4180186
36204097	肺炎链球菌丹麦血清型 23F 抗体.IgG^第1个标本:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204098	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 23F; S pneum Da 23F Ab; S pneum Da 23F IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 23	4180186
36204098	S pneum Da 23F IgG sp2 Ser-mCnc	4180186
36204098	肺炎链球菌丹麦血清型 23F 抗体.IgG^第2个标本:质量浓度:时间点:血清:定量型	4182948
36204101	2:1; ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; S pneum Da 23F; S pneum Da 23F Ab; S pneum Da 23F IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp1; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 23	4180186
36204101	S pneum Da 23F IgG 2:1 Ser-Rto	4180186
36204101	肺炎链球菌丹麦血清型 23F 抗体.IgG^第2个标本/第1个标本:比率:时间点:血清:定量型	4182948
36204105	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 23F; S pneum Da 23F Ab; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 23	4180186
36204105	S pneum Da 23F Ab sp2 Ser IA-aCnc	4180186
36204105	肺炎链球菌丹麦血清型 23F 抗体^第2个标本:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36204110	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; III; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 3; S pneum Da 3 Ab; S pneum Da 3 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 3	4180186
36204110	S pneum Da 3 IgG Ser-mCnc	4180186
36204110	肺炎链球菌丹麦血清型 3 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
36204113	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; III; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 3; S pneum Da 3 Ab; S pneum Da 3 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; SUDS; U.S. serotype 3	4180186
36204113	S pneum Da 3 IgG Ser IA-aCnc	4180186
36204113	肺炎链球菌丹麦血清型 3 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36204115	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; First; ID; III; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 3; S pneum Da 3 Ab; S pneum Da 3 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 3	4180186
36204115	S pneum Da 3 IgG sp1 Ser-mCnc	4180186
36204115	肺炎链球菌丹麦血清型 3 抗体.IgG^第1个标本:质量浓度:时间点:血清:定量型	4182948
36204116	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; First; ID; III; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 3; S pneum Da 3 Ab; S pneum Da 3 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 3	4180186
36204116	S pneum Da 3 IgG sp1 Ser-aCnc	4180186
36204116	肺炎链球菌丹麦血清型 3 抗体.IgG^第1个标本:任意型浓度:时间点:血清:定量型	4182948
36204117	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; III; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 3; S pneum Da 3 Ab; S pneum Da 3 IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 3	4180186
36204117	S pneum Da 3 IgG sp2 Ser IA-mCnc	4180186
36204117	肺炎链球菌丹麦血清型 3 抗体.IgG^第2个标本:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204118	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; ID; III; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 3; S pneum Da 3 Ab; S pneum Da 3 IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 3	4180186
36204118	S pneum Da 3 IgG sp2 Ser-mCnc	4180186
36204118	肺炎链球菌丹麦血清型 3 抗体.IgG^第2个标本:质量浓度:时间点:血清:定量型	4182948
36204120	2:1; ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; First; ID; III; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; S pneum Da 3; S pneum Da 3 Ab; S pneum Da 3 IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp1; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 3	4180186
36204120	S pneum Da 3 IgG 2:1 Ser-Rto	4180186
36204120	肺炎链球菌丹麦血清型 3 抗体.IgG^第2个标本/第1个标本:比率:时间点:血清:定量型	4182948
36204123	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; First; ID; III; Infectious Disease; InfectiousDisease; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 3; S pneum Da 3 Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 3	4180186
36204123	S pneum Da 3 Ab sp1 Ser-aCnc	4180186
36204123	肺炎链球菌丹麦血清型 3 抗体^第1个标本:任意型浓度:时间点:血清:定量型	4182948
36204124	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; ID; III; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 3; S pneum Da 3 Ab; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 3	4180186
36204124	S pneum Da 3 Ab sp2 Ser-mCnc	4180186
36204124	肺炎链球菌丹麦血清型 3 抗体^第2个标本:质量浓度:时间点:血清:定量型	4182948
36204125	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; III; Infectious Disease; InfectiousDisease; MEIA; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 3; S pneum Da 3 Ab; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 3	4180186
36204125	S pneum Da 3 Ab sp2 Ser IA-aCnc	4180186
36204125	肺炎链球菌丹麦血清型 3 抗体^第2个标本:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36204126	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Convalescent; ID; III; Infectious Disease; InfectiousDisease; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 3; S pneum Da 3 Ab; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 3	4180186
36204126	S pneum Da 3 Ab sp2 Ser-aCnc	4180186
36204126	肺炎链球菌丹麦血清型 3 抗体^第2个标本:任意型浓度:时间点:血清:定量型	4182948
36204128	Brain; c; Cereb; Contr; Contra; Contrst; CorePlaybook; Cranial; Cranium; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Intracranial; Paranasal sinuses; Playbook; Point in time; Rad; RADIOLOGY; Random; Sinus; Skull; View; VWS; W contr IV; WC	4180186
36204128	RF Cerebral sinuses Views W contr IV	4180186
36204128	多重视图^采用静脉注射对比剂:发现:时间点:头部>脑静脉窦类:文档型:放射荧光透视法	4182948
36204134	FDA insert Blnkt no chngs cert prod list	4180186
36204134	Blnkt no chngs cert prod list; DOCUMENT.REGULATORY; FDA insert; Narrative; Report; SPL; Structured Product Labelling	4180186
36204134	关于产品列名的综合式无变更证书:-:-:^FDA 包装说明书:叙述型	4182948
36204135	Bld est reg + prd lst chg info; Bld estabt reg + prod listing; DOCUMENT.REGULATORY; Exchange; FDA label; Narrative; Replace; Report	4180186
36204135	FDA label Bld est reg + prd lst chg info	4180186
36204135	血液制品企业注册与产品列名信息变更:-:-:^FDA 产品标签:叙述型	4182948
36204137	FDA label Human salvaged drug	4180186
36204137	DOCUMENT.REGULATORY; Drugs; FDA label; Narrative; Report	4180186
36204137	人用被救药物:-:-:^FDA 产品标签:叙述型	4182948
36204138	Against med advice note	4180186
36204138	Against med advice note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36204138	违反医疗忠告记录:发现:时间点:{环境}:文档型:{角色}	4182948
36204139	Assessment; Clinical encounter note; DOC.ONT; Document; E/M note; Encounter; Eval; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Pre-Op; Pre-op note; Pre-Operative; Rad; Radiology; Random; Visit note	4180186
36204139	Radiology Pre-op note	4180186
36204139	术前评价与管理记录:发现:时间点:{环境}:文档型:放射医学	4182948
36204140	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36204140	会诊记录:发现:时间点:{环境}:文档型:伦理学	4182948
36204142	Addiction; Desmeth; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; N-desmethyltramadol; NDT; Notramadol; O-desmethyltramadol; ODT; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Tramadol metabolite; UA; UR; Urn	4180186
36204142	O-nortramadol Ur Ql	4180186
36204142	O-去甲基曲马多:存在情况或阈值:时间点:尿液:序数型	4182948
36204143	Desmeth; DRUG/TOXICOLOGY; Drugs; N-desmethyltramadol; NDT; Notramadol; O-desmethyltramadol; ODT; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tramadol metabolite; UA; UR; Urn	4180186
36204143	N-nortramadol Ur Ql	4180186
36204143	N-去甲基曲吗多:存在情况或阈值:时间点:尿液:序数型	4182948
36204144	ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BAPA; Bruc; Brucellosis; Buff plate aggl; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Plate aggl; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; species; spp; SR; Vet; Veterinary	4180186
36204144	Brucella Ab Ser Ql Buff plate aggl	4180186
36204144	布鲁氏菌属单个未知种 抗体:存在情况或阈值:时间点:血清:序数型:凝集试验法.平板.酸化缓冲	4182948
36204145	ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bruc; Brucellosis; Card aggl; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; species; spp; SR; Vet; Veterinary	4180186
36204145	Brucella Ab Ser Ql Card aggl	4180186
36204145	布鲁氏菌属单个未知种 抗体:存在情况或阈值:时间点:血清:序数型:凝集试验法.卡片	4182948
36204146	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bruc; Brucellosis; FPA; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; species; spp; SR; Vet; Veterinary	4180186
36204146	Brucella Ab Ser Ql FPA	4180186
36204146	布鲁氏菌属单个未知种 抗体:存在情况或阈值:时间点:血清:序数型:荧光偏振测定法	4182948
36204148	Brucella Ab Titr Ser Plate aggl	4180186
36204148	ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Bruc; Brucellosis; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Plate aggl; Point in time; Random; Serum; SmQn; species; spp; SR; Titer; Titered; Titre; Ttr; Vet; Veterinary	4180186
36204148	布鲁氏菌属单个未知种 抗体:滴定度:时间点:血清:定量型:凝集法.平板	4182948
36204149	Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Misc; Miscellaneous; Other; Point in time; Rad; Radiology; Random; RFA; Spec; Spinal; Spinal Cord; To be specified in another part of the message; Unspecified; Vesl; View; VWS	4180186
36204149	RFA Spine ves Views	4180186
36204149	多重视图:发现:时间点:XXX>脊椎血管:文档型:放射荧光透视法.血管造影术	4182948
36204150	Abd; Abdo; Abdomen+; Abdominal; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Point in time; Rad; Radiology; Random; RFA; Vesl; View; VWS	4180186
36204150	RFA Adrenal ves Views	4180186
36204150	多重视图:发现:时间点:腹部>肾上腺血管:文档型:放射荧光透视法.血管造影术	4182948
36204151	Brst; Brst-Ul; DBT; Document; Finding; Findings; Imaging; Mammography tomo; Mammography tomosynthesis; Point in time; Rad; Radiology; Random	4180186
36204151	DBT Brst-Ul	4180186
36204151	多层:发现:时间点:乳腺.单侧:文档型:乳房X线摄影术.断层合成	4182948
36204152	Bil; Bilat; Both; Breast-Bl; Breasts; Brst; Brst-Bl; DBT; Document; Finding; Findings; Imaging; Mammography tomo; Mammography tomosynthesis; Point in time; Rad; Radiology; Random	4180186
36204152	DBT Brst-Bl	4180186
36204152	多层:发现:时间点:乳腺.双侧:文档型:乳房X线摄影术.断层合成	4182948
36204155	Betsy Humphreys; H+P; H+P.HX; History; Honorary; Maestro scalable info infrastructure; Narrative; P prime; Point in time; Random; Report	4180186
36204155	Maestro scalable info infrastructure	4180186
36204155	可伸缩性信息基础设施大师:历史记录:时间点:^患者:叙述型:汉弗莱斯·贝茜	4182948
36204156	报告注释:发现:时间点:^患者:叙述型	4182948
36204156	Rpt comment	4180186
36204156	CLIN; cmmt; cmnt; Com; Comm; Comments; Commt; Finding; Findings; Narrative; Point in time; Random; Remarks; Report; Rpt comment	4180186
36204157	Rpt comment section	4180186
36204157	CLIN; cmmt; cmnt; Com; Comm; Comments; Commt; Document; Finding; Findings; Point in time; Random; Remarks; Rpt comment; Rpt comment section	4180186
36204157	报告备注小节:发现:时间点:^患者:文档型	4182948
36204159	14 days; 2 weeks; Arterial Stenosis; Finding; Findings; hurry jog HF limited past 2W; Kansas City Cardiomyopathy Questionnaire; Last; LMTED; LTD; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36204160	Exchange; Finding; Findings; HF symptoms change comp w 2W ago; Kansas City Cardiomyopathy Questionnaire; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH; Sx	4180186
36204161	14 days; 2 weeks; Finding; Findings; Kansas City Cardiomyopathy Questionnaire; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; times swelling in the am over past 2W	4180186
36204162	14 days; 2 weeks; Finding; Findings; Kansas City Cardiomyopathy Questionnaire; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; swelling feet ankles legs past 2W	4180186
36204164	14 days; 2 weeks; Fatigue past 2W; Finding; Findings; Kansas City Cardiomyopathy Questionnaire; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36204165	14 days; 2 weeks; Finding; Findings; Kansas City Cardiomyopathy Questionnaire; Last; LMTED; LTD; Ordinal; Ql; Qual; Qualitative; Screen; Shower or bath HF limited past 2W; Survey; SURVEY.GNHLTH	4180186
36204167	14 days; 2 weeks; Finding; Findings; III; Kansas City Cardiomyopathy Questionnaire; Last; Ordinal; Ql; Qual; Qualitative; Screen; Sleep sitting in chair bc of SOB past 2W; Survey; SURVEY.GNHLTH	4180186
36204170	14 days; 2 weeks; Finding; Findings; HF limited enjoyment past 2W; Kansas City Cardiomyopathy Questionnaire; Last; LMTED; LTD; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36204171	Feel if rest of life with HF; Finding; Findings; Kansas City Cardiomyopathy Questionnaire; Ordinal; Point in time; QL; Qual; Qualitative; R; Random; RT; Screen; Survey; SURVEY.GNHLTH	4180186
36204172	14 days; 2 weeks; discouraged or down bc HF past 2W; Finding; Findings; Kansas City Cardiomyopathy Questionnaire; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36204176	14 days; 2 weeks; Finding; Findings; HF limited relationships past 2W; Kansas City Cardiomyopathy Questionnaire; Last; LMTED; LTD; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36204177	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; DNA NUCLEIC ACID PROBE; DNA probe; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Orthohantavirus; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; SNV; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36204177	Hantavirus RNA Bld Ql NAA+probe	4180186
36204177	汉坦病毒 RNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
36204178	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 10A; S pneum Da 10A Ab; S pneum Da 10A IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 34	4180186
36204178	S pneum Da 10A IgG Ser-mCnc	4180186
36204178	肺炎链球菌丹麦血清型 10A 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
36204185	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 4; S pneum Da 4 Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 4	4180186
36204185	S pneum Da 4 Ab Ser-mCnc	4180186
36204185	肺炎链球菌丹麦血清型 4 抗体:质量浓度:时间点:血清:定量型	4182948
36204186	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 4; S pneum Da 4 Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 4	4180186
36204186	S pneum Da 4 Ab Ser-aCnc	4180186
36204186	肺炎链球菌丹麦血清型 4 抗体:任意型浓度:时间点:血清:定量型	4182948
36204189	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 4; S pneum Da 4 Ab; S pneum Da 4 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 4	4180186
36204189	S pneum Da 4 IgG Ser-aCnc	4180186
36204189	肺炎链球菌丹麦血清型 4 抗体.IgG:任意型浓度:时间点:血清:定量型	4182948
36204193	Alfa; Cardio; Cardiology; Chemistry; HDL; HDL alpha 3; HDL particle concentration; HDL particle number; Heart Disease; High density lipoproteins; III; Level; Lip; Lipoprot; Lipoproteins; LP; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Substance concentration	4180186
36204193	HDL alpha 3 Ser-sCnc	4180186
36204193	脂蛋白.alpha 3:物质的量浓度:时间点:血清:定量型	4182948
36204196	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GCMS; Klonopin; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
36204196	clonazePAM/Creat Ur Cfm	4180186
36204196	氯硝安定/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36204202	CorePlaybook; Finding; Findings; Imaging; Interp; Interp of outside study; Interpret; Interpt; Intrp; Ordinal; Playbook; Point in time; QL; Qual; Qualitative; Radiology; Random; Screen; Study report	4180186
36204202	Study Interp of outside study	4180186
36204202	外部机构检查的解释:发现:时间点:检查:序数型	4182948
36204203	Abd; Abd+Pelvis; Abdo; Abdominal; c; Contr; Contra; Contrst; CorePlaybook; Cystogram; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Kid+Uret+Blad; Kidney; Nephric; Nephrogram; Nephrography; Nephrology; Pelvic; Playbook; Point in time; Pyelogram; Pyelography; Rad; RADIOLOGY; Random; Renal; Ureter+Blad; View; VWS; W contr IV; WC	4180186
36204203	RF Kid+Uret+Blad Views W contr IV	4180186
36204203	多重视图^采用静脉注射对比剂:发现:时间点:腹部>肾脏 & 腹部+盆腔>输尿管 & 盆腔>膀胱:文档型:放射荧光透视法	4182948
36204204	Add; Arteriovenous Fistula; AVF; c; Contr; Contra; Contrst; CorePlaybook; Document; Films; Finding; Findings; Fistulogram; Fluor; Fluoro; Fluoroscopy; Hemodialysis access; Imaging; Misc; Miscellaneous; Other; Playbook; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified; View; VWS; W contr via addl punc; WC	4180186
36204204	RF AVF Views W contr via addl punc	4180186
36204204	多重视图^采用经额外穿刺的对比剂:发现:时间点:XXX>动静脉瘘:文档型:放射荧光透视法	4182948
36204208	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; CHIKV; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn	4180186
36204208	CHIKV RNA Ur Ql NAA+probe	4180186
36204208	基孔肯亚病毒 RNA:存在情况或阈值:时间点:尿液:序数型:探针法.基因扩增.靶向	4182948
36204209	CV A Ab Titr Ser CF	4180186
36204209	柯萨奇病毒 A 型 抗体:滴定度:时间点:血清:定量型:补体结合试验	4182948
36204209	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; CF; Comp fixation; Compfix; Complement fixation; Coxsackie; Coxsackie virus; CV; CV A; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
36204213	ANTIBIOTIC SUSCEPTIBILITIES; Bact; CPR; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
36204213	blaOXA-134-like Islt/Spm Ql	4180186
36204213	细菌碳青霉烯类耐药 blaOXA-134-样基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36204219	A pleuropn 5 Ab Titr Ser CF	4180186
36204219	胸膜肺炎放线杆菌血清型 5 抗体:滴定度:时间点:血清:定量型:补体结合试验	4182948
36204219	A pleuropn; A pleuropn 5; A pleuropn Sertyp; A pleuropneumoniae; ABS; Aby; Actino; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CF; Comp fixation; Compfix; Complement fixation; Contagious swine pleuropneumonia; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr; Vet; Veterinary	4180186
36204220	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note; Visit notifctn note	4180186
36204220	就诊通知记录:发现:时间点:{环境}:文档型:{角色}	4182948
36204221	Disch; Discharge notifctn note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36204221	出院通知记录:发现:时间点:{环境}:文档型:{角色}	4182948
36204231	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 2; Herpes simplex virus type II; HSV; HSV2; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
36204231	HSV2 DNA Tiss Ql NAA+probe	4180186
36204231	单纯疱疹病毒 2 型 DNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36204234	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpesvirus; HHV; HHV7; Human herpes virus; Human herpes virus type 7; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36204234	HHV7 DNA Bld Ql NAA+probe	4180186
36204234	疱疹病毒 7 型 DNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
36204235	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpesvirus; HHV; HHV8; HHV-8; Human herpes virus; ID; Infectious Disease; InfectiousDisease; Kaposi's Sarcoma-Associated Herpesvirus; KSHV; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36204235	HHV8 DNA Bld Ql NAA+probe	4180186
36204235	疱疹病毒 8 型 DNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
36204236	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpesvirus; HHV; HHV8; HHV-8; Human herpes virus; ID; Infectious Disease; InfectiousDisease; Kaposi's Sarcoma-Associated Herpesvirus; KSHV; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
36204236	HHV8 DNA Tiss Ql NAA+probe	4180186
36204236	疱疹病毒 8 型 DNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36204238	#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; AIDS; Amplif; Amplification; Amplified; Cnt; Count; Count/volume; CT; DNA NUCLEIC ACID PROBE; DNA probe; HIV type 2; HIV type II; Human immunodeficiency virus; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load	4180186
36204238	HIV 2 RNA # Plas NAA+probe	4180186
36204238	HIV 2 RNA:计数型浓度:时间点:血浆:定量型:探针法.基因扩增.靶向	4182948
36204240	2; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; DNA NUCLEIC ACID PROBE; DNA probe; HTLV type 1+2; HTLV type I+II; Human T-cell Leukemia Virus; Human T-cell Lymphotrophic Virus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36204240	HTLV I+II RNA Bld Ql NAA+probe	4180186
36204240	HTLV I+II RNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
36204242	Cnt; Count; i; Number; QNT; Quan; Quant; Quantitative; Report period; Staff worked 1D+ Oct 1 - Mar 31; Survey; SURVEY.CDC; World Heatlth Organization	4180186
36204243	Cnt; Count; Immunizations; Number; QNT; Quan; Quant; Quantitative; Report period; Staff who received flu vacc at fac; Survey; SURVEY.CDC; Vaccine; World Heatlth Organization	4180186
36204244	Cnt; Count; Number; QNT; Quan; Quant; Quantitative; Report period; Staff provide doc FLU vac; Survey; SURVEY.CDC; World Heatlth Organization	4180186
36204246	Cnt; Count; Number; QNT; Quan; Quant; Quantitative; Report period; Staff who declined flu vaccine; Survey; SURVEY.CDC; World Heatlth Organization	4180186
36204247	Cnt; Count; Immunizations; Number; QNT; Quan; Quant; Quantitative; Report period; Staff unk FLUV vac status; Survey; SURVEY.CDC; Tx; Vaccine	4180186
36204250	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; HPV16; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Papilloma virus high risk; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
36204250	HPV16 DNA Tiss Ql NAA+probe	4180186
36204250	人乳头瘤病毒 16 型 DNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36204251	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; HPV I/H Risk 1; HPV IHR; HPV16; HPV16 and 18; HPV16+18; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Papilloma virus high risk; Papilloma virus intermediate/high risk; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
36204251	HPV I/H Risk 1 DNA Tiss Ql NAA+probe	4180186
36204251	人乳头瘤病毒 16+18+31+33+35+39+45+51+52+56+58+59+68 型 DNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36204254	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; Human papillomavirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
36204254	HPV DNA Tiss Ql NAA+probe	4180186
36204254	人乳头瘤病毒 DNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36204255	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Avian influenza; Bird flu; DFA; FA; FLUA; FLUAV; Fluorescent antibody; Fluoresent; FLUV; Fowl plague; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Time Resolved Fluorescence; Tissue; Tissue, unspecified; TRF	4180186
36204255	FLUAV Ag Tiss Ql IF	4180186
36204255	流感病毒 A 型 抗原:存在情况或阈值:时间点:组织与涂片:序数型:免疫荧光法	4182948
36204257	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avian influenza; Bird flu; EIA; ELFA; ELISA; Enzyme immunoassay; FLUA; FLUAV; FLUV; Fowl plague; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
36204257	FLUAV IgM Ser Ql IA	4180186
36204257	流感病毒 A 型 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
36204259	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
36204259	FLUAV RNA Tiss Ql NAA+probe	4180186
36204259	流感病毒 A 型 RNA:存在情况或阈值:时间点:组织与涂片:序数型:探针法.基因扩增.靶向	4182948
36204260	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; FLUB; FLUBV; FLUV; IAA; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
36204260	FLUBV IgM Ser Ql IA	4180186
36204260	流感病毒 B 型 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
36204261	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; DNA NUCLEIC ACID PROBE; DNA probe; FLUB; FLUBV; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36204261	FLUBV RNA CSF Ql NAA+probe	4180186
36204261	流感病毒 B 型 RNA:存在情况或阈值:时间点:脑脊液:序数型:探针法.基因扩增.靶向	4182948
36204263	JCPyV DNA Bld Ql NAA+probe	4180186
36204263	JC 病毒 DNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
36204263	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Human polyomavirus 2; ID; Infectious Disease; InfectiousDisease; JC Polyomavirus; JCPyV; JCV; John Cunningham Virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36204264	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; MARV; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36204264	MARV RNA Bld Ql NAA+probe	4180186
36204264	马尔堡病毒 RNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
36204266	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; MeV; Microbiology; Msls; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Rubeola; Screen; SDA; Serum; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36204266	MeV RNA Ser Ql NAA+probe	4180186
36204266	麻疹病毒 RNA:存在情况或阈值:时间点:血清:序数型:探针法.基因扩增.靶向	4182948
36204269	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 4; S pneum Da 4 Ab; S pneum Da 4 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 4	4180186
36204269	S pneum Da 4 IgG sp1 Ser-aCnc	4180186
36204269	肺炎链球菌丹麦血清型 4 抗体.IgG^第1个标本:任意型浓度:时间点:血清:定量型	4182948
36204271	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 4; S pneum Da 4 Ab; S pneum Da 4 IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 4	4180186
36204271	S pneum Da 4 IgG sp2 Ser-mCnc	4180186
36204271	肺炎链球菌丹麦血清型 4 抗体.IgG^第2个标本:质量浓度:时间点:血清:定量型	4182948
36204273	2:1; ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; S pneum Da 4; S pneum Da 4 Ab; S pneum Da 4 IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp1; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 4	4180186
36204273	S pneum Da 4 IgG 2:1 Ser-Rto	4180186
36204273	肺炎链球菌丹麦血清型 4 抗体.IgG^第2个标本/第1个标本:比率:时间点:血清:定量型	4182948
36204274	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; First; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 4; S pneum Da 4 Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 4	4180186
36204274	S pneum Da 4 Ab sp1 Ser-mCnc	4180186
36204274	肺炎链球菌丹麦血清型 4 抗体^第1个标本:质量浓度:时间点:血清:定量型	4182948
36204275	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; First; ID; Infectious Disease; InfectiousDisease; Microbiology; PCV13; PCV7; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 4; S pneum Da 4 Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 4	4180186
36204275	S pneum Da 4 Ab sp1 Ser-aCnc	4180186
36204275	肺炎链球菌丹麦血清型 4 抗体^第1个标本:任意型浓度:时间点:血清:定量型	4182948
36204278	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 11A; S pneum Da 11A Ab; S pneum Da 11A IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 43	4180186
36204278	S pneum Da 11A IgG Ser-mCnc	4180186
36204278	肺炎链球菌丹麦血清型 11A 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
36204279	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 11A; S pneum Da 11A Ab; S pneum Da 11A IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; SUDS; U.S. serotype 43	4180186
36204279	S pneum Da 11A IgG Ser IA-mCnc	4180186
36204279	肺炎链球菌丹麦血清型 11A 抗体.IgG:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204280	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 11A; S pneum Da 11A Ab; S pneum Da 11A IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 43	4180186
36204280	S pneum Da 11A IgG sp1 Ser-mCnc	4180186
36204280	肺炎链球菌丹麦血清型 11A 抗体.IgG^第1个标本:质量浓度:时间点:血清:定量型	4182948
36204281	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; First; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 11A; S pneum Da 11A Ab; S pneum Da 11A IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 43	4180186
36204281	S pneum Da 11A IgG sp1 Ser IA-mCnc	4180186
36204281	肺炎链球菌丹麦血清型 11A 抗体.IgG^第1个标本:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204286	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 5; S pneum Da 5 Ab; S pneum Da 5 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 5	4180186
36204286	S pneum Da 5 IgG Ser-mCnc	4180186
36204286	肺炎链球菌丹麦血清型 5 抗体.IgG:质量浓度:时间点:血清:定量型	4182948
36204288	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; First; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 5; S pneum Da 5 Ab; S pneum Da 5 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; U.S. serotype 5	4180186
36204288	S pneum Da 5 IgG sp1 Ser-mCnc	4180186
36204288	肺炎链球菌丹麦血清型 5 抗体.IgG^第1个标本:质量浓度:时间点:血清:定量型	4182948
36204290	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 5; S pneum Da 5 Ab; S pneum Da 5 IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 5	4180186
36204290	S pneum Da 5 IgG sp2 Ser-mCnc	4180186
36204290	肺炎链球菌丹麦血清型 5 抗体.IgG^第2个标本:质量浓度:时间点:血清:定量型	4182948
36204294	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; PCV13; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; QNT; Quan; Quant; Quantitative; Random; S pneum Da 6A; S pneum Da 6A Ab; S pneum Da 6A IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; SUDS; U.S. serotype 6	4180186
36204294	S pneum Da 6A IgG Ser IA-mCnc	4180186
36204294	肺炎链球菌丹麦血清型 6A 抗体.IgG:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204298	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; QNT; Quan; Quant; Quantitative; Random; S pneum Da 7A; S pneum Da 7A Ab; S pneum Da 7A IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; SUDS; U.S. serotype 7	4180186
36204298	S pneum Da 7A IgG Ser IA-aCnc	4180186
36204298	肺炎链球菌丹麦血清型 7A 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36204301	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Camel flu; Corona virus; DNA NUCLEIC ACID PROBE; DNA probe; HCoV-EMC/2012; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; MERS-CoV; MERS-CoV RNA; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn	4180186
36204301	MERS-CoV RNA Ur Ql NAA+probe	4180186
36204301	中东呼吸综合征冠状病毒 RNA:存在情况或阈值:时间点:尿液:序数型:探针法.基因扩增.靶向	4182948
36204302	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; MuV; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; UA; UR; Urn	4180186
36204302	MuV RNA Ur Ql NAA+probe	4180186
36204302	流行性腮腺炎病毒 RNA:存在情况或阈值:时间点:尿液:序数型:探针法.基因扩增.靶向	4182948
36204303	C&S; Cerebral spinal fluid; Cerebrospinal Fl; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; N men; N menigitidis; N meningitidis; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
36204303	N men CSF Ql Cult	4180186
36204303	脑膜炎奈瑟菌:存在情况或阈值:时间点:脑脊液:序数型:微生物特异性培养	4182948
36204304	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; DNA NUCLEIC ACID PROBE; DNA probe; HPeV A RNA; Human Parecho virus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Ljungan virus; LV; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; PeV; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36204304	Parechovirus A RNA Bld Ql NAA+probe	4180186
36204304	副肠孤病毒 A RNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
36204307	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lyssavirus; Microbiology; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Rabies; RABV; Random; Ribonucleic acid; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36204307	RABV RNA CSF Ql NAA+probe	4180186
36204307	狂犬病病毒 RNA:存在情况或阈值:时间点:脑脊液:序数型:探针法.基因扩增.靶向	4182948
36204310	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Phleboviruses; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Sand fly fever; Screen; SDA; Serum; SR; Strand Displacement Amplification; TMA; TOSV; Transcription mediated amplification	4180186
36204310	TOSV RNA Ser Ql NAA+probe	4180186
36204310	托斯卡纳病毒 RNA:存在情况或阈值:时间点:血清:序数型:探针法.基因扩增.靶向	4182948
36204311	ACIF; Anticomplement Immunofluorescence; Antigen; Antigens; Chicken pox; Chicken pox virus; Chickenpox; DFA; FA; Fluorescent antibody; Fluoresent; Herpes zoster; HHV-3; Human herpesvirus 3; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Shingles; Time Resolved Fluorescence; Tissue; Tissue, unspecified; TRF; VZ; VZV; Zoster	4180186
36204311	VZV Ag Tiss Ql IF	4180186
36204311	水痘带状疱疹病毒 抗原:存在情况或阈值:时间点:组织与涂片:序数型:免疫荧光法	4182948
36204312	3 Self-Sustaining Sequence Replication; 3SR SR; AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; Amplif; Amplification; Amplified; Chicken pox; Chicken pox virus; Chickenpox; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Gyn; Gynecology; Herpes zoster; HHV-3; Human herpesvirus 3; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Shingles; Strand Displacement Amplification; TMA; Transcription mediated amplification; VZ; VZV; Zoster	4180186
36204312	VZV DNA Amn Ql NAA+probe	4180186
36204312	水痘带状疱疹病毒 DNA:存在情况或阈值:时间点:羊水:序数型:探针法.基因扩增.靶向	4182948
36204314	Influenza season DateRange	4180186
36204314	QNT; Quan; Quant; Quantitative; Report period; VACCINE	4180186
36204314	流行性感冒季节:日期范围:报告期:{事件}:定量型	4182948
36204316	Alfentanil/Creat Ur Cfm	4180186
36204316	Alfenta; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Fanaxal; GCMS; Limefen; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; Rapifen; UA; UCr; UR; Urn	4180186
36204316	阿芬太尼/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36204322	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Mass concentration ratio; Mass ratio; MCRto; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sufenta; UA; UCr; UR; Urn	4180186
36204322	SUFentanil/Creat Ur Cfm	4180186
36204322	舒芬太尼/肌酐:质量比率:时间点:尿液:定量型:毒理学确认试验	4182948
36204323	AF; Amn; Amn fl; Amn/CVS; Amnio; Amniotic flu; Amniotic fluid; arrCGH; Chorionic villi; Chorionic villus sample; Chrom analy; Chromosom; Chromosomes; Cytogenetics; Document; Finding; Findings; Genetics; Gyn; Gynecology; Heredity; Heritable; Inherited; Karyotype; Molecular pathology; MOLPATH; OB; ObGyn; Obstetrics; Point in time; Random	4180186
36204323	Chrom analy Amn/CVS Microarray	4180186
36204323	染色体分析:发现:时间点:羊水/绒毛膜绒毛样本:文档型:微阵列	4182948
36204324	ATTACH; ATTACH.MODIFIER; Cancer; Point in time; Random; Scope.mod.doc temp; Send Doc Conforms Onc Plan R1.2; Tx	4180186
36204324	发送符合肿瘤学治疗计划摘要 R1.2 模板的文档:范围.修饰成分.文档模板:时间点:X12^277:-	4182948
36204325	ATTACH; ATTACH.MODIFIER; Emergency Medical Service(s); III; Levels; Levl; LV; LVL; Point in time; Random; Scope.mod.doc temp; Send Doc Conforms L3 EMS R1	4180186
36204325	发送符合第 3 级 EMS R1 模板的文档:范围.修饰成分.文档模板:时间点:X12^277:-	4182948
36204326	1 week; Knee injury and Osteoarthritis Outcome Score for Joint Replacement; KOOS JR; KOOS, JR; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Survey; SURVEY.GNHLTH	4180186
36204329	1 week; FCN; Func; Funct; HOOS JR; Pan; PANEL.SURVEY.GNHLTH; Panl; Pnl; Survey; SURVEY.GNHLTH	4180186
36204333	Admin info; Family Planning Annual Report; Pan; PANEL.SURVEY.HHS; Panl; Pnl; Point in time; Random; Survey; SURVEY.HHS	4180186
36204337	Family Planning Annual Report; Gestation; Gestations; Gravida; Pan; PANEL.SURVEY.HHS; Panl; Pnl; Point in time; Preg and contraception Pnl; Pregnancies; Random; Survey; SURVEY.HHS	4180186
36204338	Gestation; Gestations; Gravida; H+P; H+P.HX; Nominal; P prime; Point in time; Pregnancies; Random; Source of info; Srce; Typ	4180186
36204338	Source for pregnancy status	4180186
36204338	关于妊娠状态的信息来源:类型:时间点:^患者:名义型	4182948
36204339	Gestation; Gestations; Gravida; Pan; Panel; PANEL.SURVEY.HHS; Panl; Pnl; Point in time; Preg lab tests FPAR 2.0; Pregnancies; Random; Survey; SURVEY.HHS	4180186
36204340	Pregnancy intention next year Pt Rpted	4180186
36204340	Finding; Findings; Gestation; Gestations; Gravida; H+P; H+P.HX; Nominal; P prime; Point in time; Pregnancies; Pregnancy intention next year; Random	4180186
36204340	明年的妊娠意向:发现:时间点:^患者:名义型:报告法	4182948
36204342	Sex last 3Mo Ql Reported	4180186
36204342	3 months; Activ; Actvty; Finding; Findings; H+P; H+P.HX; Movements; Ordinal; P prime; Past; QL; Qual; Qualitative; Screen; Sex last 3Mo	4180186
36204342	在过去3个月当中的性活动:发现:3个月:^患者:序数型:报告法	4182948
36204343	Birth control method provided	4180186
36204343	Birth control method provided; Contraception; Contraceptive Method; Finding; Findings; H+P; H+P.HX; Meth; Method of; Nominal; P prime; Point in time; Random	4180186
36204343	当时是如何提供节育方法的:发现:时间点:^患者:名义型	4182948
36204344	Reason no birth control at exit Reported	4180186
36204344	Contraception; Contraceptive Method; Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random; Reason no birth control	4180186
36204344	关于未使用任何节育措施的原因^离开时:发现:时间点:^患者:名义型:报告法	4182948
36204347	Lab FPAR 2.0 sets; Pan; Panel; PANEL.SURVEY.HHS; Panl; Pnl; Point in time; Random; Survey; SURVEY.HHS	4180186
36204350	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 8; S pneum Da 8 Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 8	4180186
36204350	S pneum Da 8 Ab Ser-mCnc	4180186
36204350	肺炎链球菌丹麦血清型 8 抗体:质量浓度:时间点:血清:定量型	4182948
36204352	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 8; S pneum Da 8 Ab; S pneum Da 8 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; SUDS; U.S. serotype 8	4180186
36204352	S pneum Da 8 IgG Ser IA-mCnc	4180186
36204352	肺炎链球菌丹麦血清型 8 抗体.IgG:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204354	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 8; S pneum Da 8 Ab; S pneum Da 8 IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; SUDS; U.S. serotype 8	4180186
36204354	S pneum Da 8 IgG Ser IA-aCnc	4180186
36204354	肺炎链球菌丹麦血清型 8 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36204358	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 8; S pneum Da 8 Ab; S pneum Da 8 IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 8	4180186
36204358	S pneum Da 8 IgG sp2 Ser IA-mCnc	4180186
36204358	肺炎链球菌丹麦血清型 8 抗体.IgG^第2个标本:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204359	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 8; S pneum Da 8 Ab; S pneum Da 8 IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 8	4180186
36204359	S pneum Da 8 IgG sp2 Ser-mCnc	4180186
36204359	肺炎链球菌丹麦血清型 8 抗体.IgG^第2个标本:质量浓度:时间点:血清:定量型	4182948
36204360	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Convalescent; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 8; S pneum Da 8 Ab; S pneum Da 8 IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 8	4180186
36204360	S pneum Da 8 IgG sp2 Ser-aCnc	4180186
36204360	肺炎链球菌丹麦血清型 8 抗体.IgG^第2个标本:任意型浓度:时间点:血清:定量型	4182948
36204364	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 8; S pneum Da 8 Ab; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 8	4180186
36204364	S pneum Da 8 Ab sp2 Ser-mCnc	4180186
36204364	肺炎链球菌丹麦血清型 8 抗体^第2个标本:质量浓度:时间点:血清:定量型	4182948
36204367	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 9N; S pneum Da 9N Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 9	4180186
36204367	S pneum Da 9N Ab Ser-aCnc	4180186
36204367	肺炎链球菌丹麦血清型 9N 抗体:任意型浓度:时间点:血清:定量型	4182948
36204368	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 9N; S pneum Da 9N Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; U.S. serotype 9	4180186
36204368	S pneum Da 9N Ab Ser-mCnc	4180186
36204368	肺炎链球菌丹麦血清型 9N 抗体:质量浓度:时间点:血清:定量型	4182948
36204369	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; PR; QL; Qual; Qualitative; Random; S pneum Da 9N; S pneum Da 9N Ab; S pneum Da type; S pneumo; S pneumoniae; Screen; Serum; Spn; SR; Strep; Strept; U.S. serotype 9	4180186
36204369	S pneum Da 9N Ab Ser Ql	4180186
36204369	肺炎链球菌丹麦血清型 9N 抗体:存在情况或阈值:时间点:血清:序数型	4182948
36204372	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 9N; S pneum Da 9N Ab; S pneum Da 9N IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; SUDS; U.S. serotype 9	4180186
36204372	S pneum Da 9N IgG Ser IA-aCnc	4180186
36204372	肺炎链球菌丹麦血清型 9N 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36204376	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; First; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 9N; S pneum Da 9N Ab; S pneum Da 9N IgG; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 9	4180186
36204376	S pneum Da 9N IgG sp1 Ser IA-mCnc	4180186
36204376	肺炎链球菌丹麦血清型 9N 抗体.IgG^第1个标本:质量浓度:时间点:血清:定量型:免疫测定法	4182948
36204377	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 9N; S pneum Da 9N Ab; S pneum Da 9N IgG; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 9	4180186
36204377	S pneum Da 9N IgG sp2 Ser-mCnc	4180186
36204377	肺炎链球菌丹麦血清型 9N 抗体.IgG^第2个标本:质量浓度:时间点:血清:定量型	4182948
36204381	ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; First; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; S pneum Da 9N; S pneum Da 9N Ab; S pneum Da type; S pneumo; S pneumoniae; Serum; sp1; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 9	4180186
36204381	S pneum Da 9N Ab sp1 Ser IA-aCnc	4180186
36204381	肺炎链球菌丹麦血清型 9N 抗体^第1个标本:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
36204384	1:2; ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; First; ID; Infectious Disease; InfectiousDisease; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; S pneum Da 9N; S pneum Da 9N Ab; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp1; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 9	4180186
36204384	S pneum Da 9N Ab 1:2 Ser-Rto	4180186
36204384	肺炎链球菌丹麦血清型 9N 抗体^第1个标本/第2个标本:比率:时间点:血清:定量型	4182948
36204385	1:2; ABS; Aby; Acute specimen; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; EIA; ELFA; ELISA; Enzyme immunoassay; First; IAA; ID; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; Pre immunization; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; S pneum Da 9N; S pneum Da 9N Ab; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp1; sp2; Spec; Spn; SR; Strep; Strept; SUDS; U.S. serotype 9	4180186
36204385	S pneum Da 9N Ab 1:2 Ser IA-Rto	4180186
36204385	肺炎链球菌丹麦血清型 9N 抗体^第1个标本/第2个标本:比率:时间点:血清:定量型:免疫测定法	4182948
36204388	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Convalescent; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Post immunization; PPSV23; QNT; Quan; Quant; Quantitative; Random; S pneum Da 9N; S pneum Da 9N Ab; S pneum Da type; S pneumo; S pneumoniae; Second; Serum; sp2; Spec; Spn; SR; Strep; Strept; U.S. serotype 9	4180186
36204388	S pneum Da 9N Ab sp2 Ser-mCnc	4180186
36204388	肺炎链球菌丹麦血清型 9N 抗体^第2个标本:质量浓度:时间点:血清:定量型	4182948
36204390	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Donr; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; ZIKV; ZIKV RNA	4180186
36204390	ZIKV RNA Plas Donr Ql NAA+probe	4180186
36204390	寨卡病毒 RNA:存在情况或阈值:时间点:血浆^供体:序数型:探针法.基因扩增.靶向	4182948
36204391	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
36204391	Eutylone Ur Cfm-mCnc	4180186
36204391	β-酮-1,3-双氧苯基-N-乙基正丁胺:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
36204393	Addiction; Cathinone; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
36204393	Pentedrone Ur Cfm-mCnc	4180186
36204393	伪麻黄碱:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
36204395	4-EMC; Addiction; Cathinone; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
36204395	4-EMC Ur Cfm-mCnc	4180186
36204395	4-乙基甲卡西酮:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
36204396	HPV FPAR 2.0 set; Pan; Panel; PANEL.SURVEY.HHS; Panl; Pnl; Point in time; Random; Survey; SURVEY.HHS	4180186
36204398	GC; Gono; Gonorrhea; Gonorrhea FPAR 2.0 set; N gonorrhoea; N gonorrhoeae; Pan; Panel; PANEL.SURVEY.HHS; Panl; Pnl; Point in time; Random; Survey; SURVEY.HHS	4180186
36204403	Loc within LN Mel Micro	4180186
36204403	Anatomy; Dermatologic; Epidermis; Integument; LM; LN; Loc within LN; Micro; Micros; Microscopic; Nominal; PATH.HISTO; PATHOLOGY; Point in time; Random; Skn	4180186
36204403	淋巴结内的位置:解剖学:时间点:皮肤黑色素瘤:名义型:显微镜检查.光学	4182948
36204409	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; RVC; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36204409	RVC RNA Spec Ql NAA+probe	4180186
36204409	轮状病毒 C RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36204410	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; RVB; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36204410	RVB RNA Spec Ql NAA+probe	4180186
36204410	轮状病毒 B RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36204411	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Rota virus; ROTAV; Rotaviral; Rotaviurs; RV; RVA; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
36204411	RVA RNA Spec Ql NAA+probe	4180186
36204411	轮状病毒 A 组 RNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
36204412	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Other; PEDv; PEDV Ab; PEDv IgA; Point in time; Pork; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Spec; SUDS; Swine; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36204412	PEDv IgA/Pos cntrl Spec IA	4180186
36204412	猪流行性腹泻病毒 抗体.IgA/阳性对照:相对比率:时间点:XXX:定量型:免疫测定法	4182948
36204413	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Misc; Miscellaneous; Other; PEDv; PEDV Ab; PEDv IgG; Point in time; Pork; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Spec; SUDS; Swine; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
36204413	PEDv IgG/Pos cntrl Spec IA	4180186
36204413	猪流行性腹泻病毒 抗体.IgG/阳性对照:相对比率:时间点:XXX:定量型:免疫测定法	4182948
36204416	Arm; BMD; Bone Densiometry; Bone Density Scan; Den; Densiometry; DEX; DEXA; Dual Energy X Ray Absorptiometry; EXT; Extr-L; Films; Humerus-L; Imaging; L; LT; LUE; Point in time; QNT; Quan; Quant; Quantitative; Rad; RADIOLOGY; Random; Standard score; UE; UE-L; Up; Upper extremity; View; Views for BMD; VWS; Z score; Z value; Z-score	4180186
36204416	DXA Humerus-L Z-score BMD	4180186
36204416	针对骨密度的多重视图:Z评分:时间点:上肢.左侧>肱骨:定量型:双能X线吸收法	4182948
36204419	Rubella surveillance Pnl	4180186
36204419	H+P; P prime; Pan; PANEL.H&P; Panl; Pnl; Point in time; Random; Rubella surveillance Pnl	4180186
36204419	风疹监测组套:-:时间点:^患者:-	4182948
36204420	Finding; Findings; Immunizations; Mat; Maternal; Matnl; Ordinal; Point in time; QL; Qual; Qualitative; Random; Recvd vaccine for illness; Screen; Vaccine	4180186
36204420	Mother Recvd vaccine for illness	4180186
36204420	已接受针对所关注疾病的疫苗接种:发现:时间点:^母亲:序数型	4182948
36204423	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; K pneumon; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36204423	K pneumon DNA Bld Pos Ql NAA+non-probe	4180186
36204423	肺炎克雷伯菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:非探针法.基因扩增.靶向	4182948
36204427	Assessment; Cardio; Cardiology; Cardiothor surg; Clinical encounter note; DOC.ONT; Document; E/M note; Encounter; Eval; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; Heart Disease; History and physical; notes; Point in time; Post-op E/M note; Post-operative; Random; Surg; Visit note	4180186
36204427	Cardiothor surg Post-op E/M note	4180186
36204427	术后评价与管理记录:发现:时间点:{环境}:文档型:胸心外科学	4182948
36204428	Cardio; Cardiology; Cardiothor surg; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart Disease; notes; Point in time; Random; Surg; Visit note	4180186
36204428	Cardiothor surg Procedure note	4180186
36204428	操作记录:发现:时间点:{环境}:文档型:胸心外科学	4182948
36204430	Wmns hlth Risk assess+scrn note	4180186
36204430	Asympt; Asymptomatic; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Risk assess and screen; Risk assess+scrn note; Scn; Visit note; Wmns hlth	4180186
36204430	风险评估与筛查记录:发现:时间点:{环境}:文档型:女性健康	4182948
36204434	#/area; CA; Ca spec; LM; Micro; Micros; Microscopic; Number areic; Pathology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spec	4180186
36204434	Tumor buds #/area Ca spec Micro	4180186
36204434	肿瘤芽:单位面积数量或计数:时间点:癌标本:定量型:显微镜检查.光学	4182948
36204437	Centers for Medicare and Medicaid Assessment; Integument; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36204438	3 days; Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36204441	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36204442	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36204443	BRAF V600E Ca spec Ql ImStn	4180186
36204443	BRAF protein; BRAF V600E; CA; Ca spec; IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Ordinal; p94; Pathology; Point in time; PR; Prot; Prot Kinase; Proto-oncogene B-Raf; QL; Qual; Qualitative; Random; Screen; Ser; Spec; St; Stains; Stn; Thr; v-Raf murine sarcoma viral oncogene homolog B1	4180186
36204443	丝氨酸-苏氨酸蛋白激酶 B-raf V600E:存在情况或阈值:时间点:癌标本:序数型:免疫染色法	4182948
36204444	有丝分裂率:评分:时间点:乳腺癌标本:序数型:诺丁汉法	4182948
36204444	Mitotic rate Score Br ca spec Nottingham	4180186
36204444	Br ca spec; Brst; CA; Ca spec; PATHOLOGY; Point in time; Random; Scale; SmQn; Spec	4180186
36204445	Arm; BMD; Bone Densiometry; Bone Density Scan; Den; Densiometry; DEX; DEXA; Dual Energy X Ray Absorptiometry; EXT; Films; Imaging; Point in time; QNT; Quan; Quant; Quantitative; Rad; RADIOLOGY; Random; T-score; UE; Up; Upper arm; Upper extremity; View; Views for BMD; VWS	4180186
36204445	DXA Humerus T-score BMD	4180186
36204445	针对骨密度的多重视图:T评分:时间点:上肢>肱骨:定量型:双能X线吸收法	4182948
36204448	electronic Patient Centered Assessment Method; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SDOH; Survey; SURVEY.GNHLTH	4180186
36204449	electronic Patient Centered Assessment Method; Othr; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
36204450	electronic Patient Centered Assessment Method; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH	4180186
36204454	#; 3 Self-Sustaining Sequence Replication; 3SR SR; Abortus blauw; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Blue-eared pig disease; Cnt; Count; Count/volume; CT; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Lelystad virus; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; Mystery swine disease; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Other; PCR; Point in time; Polymerase chain reaction; Porcine epidemic abortion & respiratory syndrome; Porcine reproductive and respiratory syndrome; Pork; Probe amp; Probe with ampification; Probe with target amplification; PRRS; PRRSV; PRRSV NA strain; PRRSV NA strain RNA; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Seuchenhafter spatabort der schweine; SIRSV; Spec; Strand Displacement Amplification; Swine; Swine infertility and respiratory syndrome; Syndrome dysgenesique et respiratoire por...	4180186
36204454	PRRSV NA strain RNA # Spec NAA+probe	4180186
36204454	猪生殖与呼吸综合征病毒北美株 RNA:计数型浓度:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36204455	PRRSV European RNA # Spec NAA+probe	4180186
36204455	#; 3 Self-Sustaining Sequence Replication; 3SR SR; Abortus blauw; ABS; absolute; absolutes; Amplif; Amplification; Amplified; Blue-eared pig disease; Cnt; Count; Count/volume; CT; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Lelystad virus; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; Mystery swine disease; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Other; PCR; Point in time; Polymerase chain reaction; Porcine epidemic abortion & respiratory syndrome; Porcine reproductive and respiratory syndrome; Pork; Probe amp; Probe with ampification; Probe with target amplification; PRRS; PRRSV; PRRSV European; PRRSV European strain RNA; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Seuchenhafter spatabort der schweine; SIRSV; Spec; Strand Displacement Amplification; Swine; Swine infertility and respiratory syndrome; Syndrome dysgenesique et respiratoir...	4180186
36204455	猪生殖与呼吸综合征病毒欧洲株 RNA:计数型浓度:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
36204457	1 month; 1 month (30 days); 30 days; Arterial Stenosis; Finding; Findings; Last; Minnesota Living with Heart Failure Questionnaire; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey; Tx; Txs	4180186
36204458	1 month; 1 month (30 days); 30 days; Arterial Stenosis; Finding; Findings; Last; Minnesota Living with Heart Failure Questionnaire; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36204459	1 month; 1 month (30 days); 30 days; Arterial Stenosis; Finding; Findings; Last; Minnesota Living with Heart Failure Questionnaire; month; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36204460	Finding; Findings; H+P; H+P.HX; Mat; Maternal; Matnl; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Rubella sero confirm dur illness; Screen	4180186
36204460	Mother Rubella sero confirm dur illness	4180186
36204460	当时在患病时风疹得到了血清学确认:发现:时间点:^母亲:序数型	4182948
36204461	H+P; H+P.HX; Nominal; P prime; Point in time; Random; Typ	4180186
36204461	Expected delivery loc	4180186
36204461	预期分娩地点:类型:时间点:^患者:名义型	4182948
36204462	Vaccinated based on guidelines	4180186
36204462	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Vaccinated based on guidelines; VACCINE	4180186
36204462	是否依据所推荐的指导原则进行了疫苗接种:发现:时间点:^患者:序数型	4182948
36204464	Gestation; Gestations; Gravida; H+P; H+P.HX; Mat; Maternal; Matnl; Mo preg rubella symp; month; P prime; Point in time; Pregnancies; QNT; Quan; Quant; Quantitative; Random; Sx	4180186
36204464	Mo preg rubella symp Mother	4180186
36204464	出现风疹样症状时的妊娠月份:日期:时间点:^母亲:定量型	4182948
36204466	Before; Finding; Findings; Gestation; Gestations; Gravida; H+P; H+P.HX; Mat; Maternal; Matnl; Ordinal; P prime; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen; Serologic tx	4180186
36204466	Serologic tx pre pregnancy Mother	4180186
36204466	当时已进行血清学检测^在妊娠之前:发现:时间点:^母亲:序数型	4182948
36204467	ANTIBIOTIC SUSCEPTIBILITIES; B; Bact; ID; Infectious Disease; InfectiousDisease; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
36204467	AmpC blaACT+blaMIR genes Islt/Spm Ql	4180186
36204467	细菌 beta-内酰胺耐药 AmpC blaACT+blaMIR 基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
36204473	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; nursing; Point in time; Random; Visit note	4180186
36204473	约束记录:发现:时间点:{环境}:文档型:护士	4182948
36204474	HOOS; HOOS JR; HOOS score; HOOS, JR; Lower extremity joint; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
36204476	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Surf; Survey; SURVEY.GNHLTH	4180186
36204479	1 week; Finding; Findings; Hip dysfunction and Osteoarthritis Outcome Score; HOOS JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36204481	HOOS JR; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Totl	4180186
36204482	KOOS; KOOS JR; KOOS score; KOOS, JR; Lower extremity joint; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH; Ulcer	4180186
36204484	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36204486	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36204487	1 week; Erect; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH; Upr; Uprt	4180186
36204489	1 week; Finding; Findings; Knee Injury and Osteoarthritis Outcome Score; KOOS JR; KOOS, JR; Lower extremity joint; Ordinal; Past; QL; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
36204490	Knee injury and Osteoarthritis Outcome Score for Joint Replacement; KOOS JR; KOOS, JR; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Totl	4180186
36204494	2; 3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; Wheel 50ft 2 turns ability	4180186
36204495	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Pick up obj goal; Ql; Qual; Qualitative; Screen; Survey	4180186
36204496	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Pick up obj ability; Ql; Qual; Qualitative; Screen; Survey	4180186
36204497	12 steps goal; 3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36204503	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; Walk 10 ft uneven goal	4180186
36204505	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; Walk 150 ft goal	4180186
36204506	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; Walk 150 ft ability	4180186
36204507	2; 3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; Walk 50 ft 2 turn goal	4180186
36204508	2; 3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; Walk 50 ft 2 turn ability	4180186
36204510	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; Walk 10 ft ability	4180186
36204512	3 days; Car transfer ability; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36204514	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; Toilet transfer ability	4180186
36204520	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Lie to sit ability; Ordinal; QL; Qual; Qualitative; Screen; Survey	4180186
36204522	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Sit to lie ability; Survey	4180186
36204524	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; L; LT; Ordinal; Ql; Qual; Qualitative; R; Roll ability; RT; Screen; Survey	4180186
36204525	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Footwear goal; Ordinal; QL; Qual; Qualitative; Screen; Survey	4180186
36204528	3 days; bod; Bodies; Centers for Medicare and Medicaid Assessment; Finding; Findings; Low; Lower dressing ability; Ordinal; QL; Qual; Qualitative; Screen; Survey	4180186
36204532	3 days; Bathe ability; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36204533	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; Toilieting goal	4180186
36204534	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; Toileting ability	4180186
36204535	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Oral hygiene goal; Ordinal; QL; Qual; Qualitative; Screen; Survey	4180186
36204541	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; Wheel 150ft ability	4180186
36204542	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; Wheel 150ft goal	4180186
36204547	Assess mental status; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36204548	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36204553	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Special Txs, procedures and programs; Survey; Tx; Tx, px, programs discharge; Txs	4180186
36204557	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36204559	3 days; Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36204565	Centers for Medicare and Medicaid Assessment; IRF-PAI v1.4; LTPAC; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36204566	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36204568	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36204575	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36204576	3 days; Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36204577	3 days; Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey	4180186
36204578	3 days; Centers for Medicare and Medicaid Assessment; Disch; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
36204580	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
36204581	Centers for Medicare and Medicaid Assessment; Disch; Integument; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36204583	Centers for Medicare and Medicaid Assessment; Cnt; Count; II; Number; Point in time; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
36204585	Centers for Medicare and Medicaid Assessment; Cnt; Count; Number; Point in time; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey	4180186
36204587	Centers for Medicare and Medicaid Assessment; Cnt; Count; Number; Point in time; pressure injury; Pressure ulcer; Pressure Ulcers; QNT; Quan; Quant; Quantitative; Random; Survey; Ulcer	4180186
36204692	Neutrophil.PMA stimulated.DHR mean fluorescence intensity	4180186
36204839	XXX>Spinal artery	4180186
36205138	California serogroup virus	4180186
36205199	Head+Neck>Carotid arteries.unilateral	4180186
36205279	Abdomen>Abdominal lymphatic vessels.bilateral	4180186
36205447	Bacterial vancomycin resistance vanA+vanB genes	4180186
36206018	Abdomen>Abdominal lymphatic vessels	4180186
36206065	Abdomen>Small bowel	4180186
36206073	HNA 1b-1b	4180186
36206123	Human papilloma virus 16 & 18 & 31+33+35+39+45+51+52+56+58+59+66+68	4180186
36206220	Porcine reproductive and respiratory syndrome virus European & North American strains Ab.neut panel	4180186
36206554	Porcine reproductive and respiratory syndrome virus North American strain	4180186
36206645	Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 1	4180186
36206646	Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2	4180186
36206688	Advance directive &or living will completed	4180186
36206840	Pelvis>Pelvic lymphatic vessels	4180186
36207052	Purkinje cell cytoplasmic type Tr	4180186
36207274	HNA 4b-4b	4180186
36207304	Neck>Carotid artery.cervical	4180186
36207375	Abdomen>Hepatic artery	4180186
36207376	Abdomen>Mesenteric artery	4180186
36207381	Pelvis>Rectum	4180186
36207444	HNA 1a-1b	4180186
36208263	Head+Neck>Carotid artery & Head>Cerebral artery.left	4180186
36208307	A little n W little j	4180186
36208314	W little r super little a	4180186
36208463	Borrelia burgdorferi 83_93kD	4180186
36208786	Protein S+Acarboxy.free	4180186
36208911	S little c 1	4180186
36208954	CD3 & CD20	4180186
36209059	Head+Neck>Carotid artery	4180186
36209213	Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 1+2	4180186
36209541	XXX>Peripheral vessels	4180186
36209578	Borrelia burgdorferi 18_20kD	4180186
36210072	Plant.toxic	4180186
36210315	Actin.smooth muscle	4180186
36210343	Purkinje cell cytoplasmic type 2	4180186
36210572	Head>Submandibular gland	4180186
36210607	Abdomen>Kidney & Abdomen+Pelvis>Ureter & Pelvis>Urinary bladder	4180186
36210626	Upper extremity>Brachial artery	4180186
36303232	CD19+CD38+IgM- cells # Bld	4180186
36303232	#; ABS; absolute; absolutes; ADP-ribosyl cyclase; B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; Blood; CD19 Cells; CD19+CD38+ Cells; CD19+CD38+IgM- cells; CD19+CD38+IgM+ cells; Cell; CELL MARKERS; Cellularity; Cnt; Count; Count/volume; CT; Cyclic ADP-ribose hydrolase; HD-37; Immune globulin M; Immunoglobulin M; Leu12; Leu-12; Leu17; Leu-17; Number concentration; Number Concentration (count/vol); Plasmablasts; Point in time; QNT; Quan; Quant; Quantitative; Random; T10; Transitional B cells; WB; Whole blood	4180186
36303232	细胞.CD19+CD38+IgM-:计数型浓度:时间点:全血:定量型	4182948
36303233	Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; i Phos; Inorganic phosphate; Level; Mass concentration; Phos; Phosphate total; Phosphorous; Phosphorus; Phosphrous; Pi; PO4; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal	4180186
36303233	Phosphate Stl-mCnc	4180186
36303233	磷酸盐:质量浓度:时间点:大便:定量型	4182948
36303234	# days of training & skill practice in walking; Centers for Medicare and Medicaid Assessment; Count/time; Dextro; No; nRate; Num; Number rate; Number Rate = Count/Time; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
36303237	ACIF; Adeno virus; Anticomplement Immunofluorescence; Antigen; Antigens; DFA; FA; Fluorescent antibody; Fluoresent; HAdV; ID; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Infectious Disease; InfectiousDisease; Low; Lower resp; Lung; Microbiology; Ordinal; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen; Time Resolved Fluorescence; TRF	4180186
36303237	HAdV Ag Lower resp Ql IF	4180186
36303237	腺病毒 抗原:存在情况或阈值:时间点:呼吸道.下:序数型:免疫荧光法	4182948
36303240	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Aspirate; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
36303240	Francisella sp DNA Aspirate Ql NAA+probe	4180186
36303240	弗朗西斯菌属单个未知种 DNA:存在情况或阈值:时间点:吸出物:序数型:探针法.基因扩增.靶向	4182948
36303242	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Babesiosis; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Piroplasmosis; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
36303242	Babesia DNA Bld Ql NAA+probe	4180186
36303242	巴贝斯虫属单个未知种 DNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
36303244	C6G Ur Ql Scn	4180186
36303244	c260; C300; C6G; Codeine-6-beta-glucuronide; DRUG/TOXICOLOGY; Drugs; Gluc; Glucouronide; Methylmorphine; Morphine methyl ether; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
36303244	可待因-6-葡糖苷酸:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
36303245	Disch; Discharge teach note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; OB; ObGyn; Obstetrics; Point in time; Random; Visit note	4180186
36303245	Gynecology Discharge teach note	4180186
36303245	出院宣教记录:发现:时间点:{环境}:文档型:妇科学	4182948
36303246	Centers for Medicare and Medicaid Assessment; No; Num; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Pressure ulcer; Pressure Ulcers; Random; Survey	4180186
36303251	Centers for Medicare and Medicaid Assessment; Dextro; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303254	Centers for Medicare and Medicaid Assessment; Deglutition; Finding; Findings; Nominal; Report period; Survey; Sx	4180186
36303258	Activ; Actvty; Arbitrary rate; Movements; QNT; Quan; Quant; Quantitative; Survey; Walking PA.active transport; Walking phys activity	4180186
36303259	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Boutonneuse fever; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Mediterranean spotted fever; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; R conorii; Random; Ricket; Rickettsial; Screen; Serum; Spotted fever; SR; SUDS	4180186
36303259	R conorii IgG Ser Ql IA	4180186
36303259	康氏立克次体 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
36303262	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; species; spp; Survey	4180186
36303264	apolipoprotein B; Apolipoprotein B gene; Blood; FLDB; Genetics; Heredity; Heritable; Identity or presence; Inherited; LDLCQ4; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
36303264	APOB gene Mut Anl Bld/T	4180186
36303264	APOB 基因 突变分析:存在与否或特征标识:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
36303267	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; R; Random; RT; Screen; Survey; SURVEY.GNHLTH	4180186
36303268	20M p Lac PO; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; Gastro; Gastroenterology; GI; H2; Hyd; LTT; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
36303268	Breath H2 20M p Lac PO	4180186
36303268	氢/已呼出的气体^在口服剂量乳糖之后20分钟:体积分数:时间点:呼出的气体:定量型	4182948
36303269	CLIN; CLIN.RISK; HSCT risk score; Ordinal; Point in time; QL; Qual; Qualitative; Random; Scale; Screen	4180186
36303269	HSCT risk score EBMT	4180186
36303269	造血干细胞移植风险评分:评分:时间点:^患者:序数型:EBMT	4182948
36303270	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303271	Eastern Cooperative Oncology Group; Everyday Cognition; Exchange; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36303274	ANTIBIOTIC SUSCEPTIBILITIES; AST; BS Poeder; Coccidiox; Coliprim; Cordixina; Cosumix; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Prinzone; Pyradan; Random; Sulfachlorpyridazine; Sulfaclozine sodium; Sulphachlorpyridazine; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vet; Veterinary; Vetisulid	4180186
36303274	Sulfachloropyridazine Islt MIC	4180186
36303274	磺胺氯哒嗪:抗生素敏感性:时间点:分离株:定量型或序数型:最小抑菌浓度法	4182948
36303275	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303276	CLIN; CLIN.RISK; Pan; PANEL.CLINICAL; Panl; Pnl; Point in time; Random	4180186
36303276	Revised Geneva pnl	4180186
36303278	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn; Gynecology; notes; nursing; OB; Ob Nurse; ObGyn; Obstetric; Obstetrics; OP; Point in time; Prenatal; Random; Visit note	4180186
36303278	Ob Nurse OP Note	4180186
36303278	记录:发现:时间点:门诊病人:文档型:产科学.护士	4182948
36303281	ADL; Centers for Medicare and Medicaid Assessment; Finding; Findings; FunctionalStatus; IADL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
36303282	Ang; Angio; Angiography; Angm; Bil; Bilat; Both; Cardio; Cardiology; CAT scan; Computed tomography; Computerized tomography; CT Angiogram; CT angiography; CT scan; CT venography; CTA; CTV; Document; DVT; EXT; Extr-Bl; Finding; Findings; for PE; for PE+DVT; Heart Disease; Imaging; LE; LE vv; LE vv-Bl; LE-Bl; Leg; Low; PA; PAA; PA-Bl; PA-Bl + LE vv-Bl; PE; Point in time; Pulm; Rad; Radiology; Random; Thorax; Ven; Venous	4180186
36303282	CTA PA-Bl + LE vv-Bl for PE+DVT	4180186
36303282	针对肺栓塞+深静脉血栓形成的多层:发现:时间点:胸部>肺动脉类.双侧 & 下肢.双侧>下肢静脉类:文档型:CT.血管造影术	4182948
36303283	bod; Bodies; Breathing; Lung; Lungs; Point in time; Pred capacity; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Relative volume; Respiratory; RS; TC; TLC; Tot; Totl	4180186
36303283	TLC meas/pred Plethysmograph	4180186
36303283	容量.总计/容量.预测型:相对体积:时间点:呼吸系统:定量型:体积描记器.体箱计	4182948
36303284	Addiction; AM-694; AM694 N-5OH-pentyl; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; Synthetic cannabinoid; UA; UR; Urn	4180186
36303284	AM694 N-5OH-pentyl Ur Ql Cfm	4180186
36303284	AM694 N-5-羟戊基:存在情况或阈值:时间点:尿液:序数型:毒理学确认试验	4182948
36303285	100 CD19 cells; ADP-ribosyl cyclase; B Cells; B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; Blood; CD19 Cells; CD38 Cells; CD38+IgM- cells; CD38+IgM+ cells; Cell; CELL MARKERS; Cellularity; Cyclic ADP-ribose hydrolase; HD-37; Immune globulin M; Immunoglobulin M; Leu12; Leu-12; Leu17; Leu-17; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T10; WB; Whole blood	4180186
36303285	CD38+IgM+ cells/100 CD19 cells NFr Bld	4180186
36303285	细胞.CD38+IgM+/100 个细胞.CD19:计数型分数:时间点:全血:定量型	4182948
36303287	CLIN; Karnofsky Index; Karnofsky Performance Scale; Perform status; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale	4180186
36303287	KPS score	4180186
36303287	日常体能状态:评分:时间点:^患者:定量型:卡诺夫斯基法	4182948
36303291	Clip place; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Marker placement; Misc; Miscellaneous; Other; Playbook; Point in time; Pre-Op; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified	4180186
36303291	Guided Unsp region Clip place--Preop	4180186
36303291	旨在置入夹的引导^术前:发现:时间点:XXX:文档型:{成像方式}	4182948
36303293	Acd; Acid fast Stn; Acids; AFB stain; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; St; Stains; Stn; Wnd	4180186
36303293	Acid fast Stn Wnd	4180186
36303293	显微镜观察:存在与否或特征标识:时间点:伤口:名义型:抗酸染色法	4182948
36303294	Centers for Medicare and Medicaid Assessment; Correctn; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303295	Centers for Medicare and Medicaid Assessment; Dextro; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
36303296	Cath; Cath part of CVC exch; Change; CorePlaybook; Document; Finding; Findings; Guid; Guidance for exchange; Guide; Guided; Imaging; Playbook; Point in time; Rad; RADIOLOGY; Random; Replace; Thorax	4180186
36303296	Guided Chest Cath part of CVC exch	4180186
36303296	旨在仅仅更换带有输液港的中心静脉导管之中导管部分的引导:发现:时间点:胸部:文档型:{成像方式}	4182948
36303297	CESD-R; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; Tot; Totl	4180186
36303303	ADMIN; No; Nominal; Num; Phone #; Point in time; Random; Telecommunication number; Telephone number	4180186
36303303	Contact Phone #	4180186
36303303	电话号码:电话号码:时间点:^联系人:名义型	4182948
36303304	CLIN; Pan; PANEL.CLINICAL; Panl; Pnl; Point in time; Random; Ther; Therapeutic goals pnl	4180186
36303304	Therapeutic goals pnl	4180186
36303304	治疗目标组套:-:时间点:^患者:-	4182948
36303308	Feline; Felis domesticus; III; Pan; Panel; Panl; Pnl; Point in time; Pos; Random	4180186
36303309	ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sulphathiazole; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Vet; Veterinary	4180186
36303309	Sulfathiazole Susc Islt	4180186
36303309	磺胺噻唑:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
36303310	Abd; Abdo; Abdomen+; Abdominal; Bx; CorePlaybook; Document; Finding; Findings; Guid; Guide; Guided; Hepar; Hepatic; Imaging; Playbook; Point in time; Rad; Radiology; Random; Transjugular Bx	4180186
36303310	Guided Liver Transjugular Bx	4180186
36303310	旨在经颈静脉活组织检查的引导:发现:时间点:腹部>肝脏:文档型:{成像方式}	4182948
36303312	Eastern Cooperative Oncology Group; Everyday Cognition; Everyday Cognition Partner version; Exchange; Finding; Findings; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Replace; Screen; Survey; SURVEY.GNHLTH	4180186
36303313	Acd; Acid fast Stn; Acids; AFB stain; Cardio; Cardiology; Heart Disease; Identity or presence; Microbiology; Nominal; PCAR; Pericardial Fluid; Point in time; Random; St; Stains; Stn	4180186
36303313	Acid fast Stn Pcar	4180186
36303313	显微镜观察:存在与否或特征标识:时间点:心包液:名义型:抗酸染色法	4182948
36303315	Mental health Pre-op note	4180186
36303315	Assessment; Clinical encounter note; DOC.ONT; Document; E/M note; Emotional stability; Encounter; Eval; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Point in time; Pre-Op; Pre-op note; Pre-Operative; Random; Visit note	4180186
36303315	术前评价与管理记录:发现:时间点:{环境}:文档型:心理健康	4182948
36303316	Comm hlth care ADCC D/C sum	4180186
36303316	ADCC; Comm hlth care; Continuity assessment record and evaluation; D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
36303316	出院摘要记录:发现:时间点:成人日间照护中心:文档型:社区医疗保健服务	4182948
36303317	Billing info pnl	4180186
36303317	ADMIN; Billing info pnl; Pan; PANEL.ADMIN; Panl; Pnl; Point in time; Random	4180186
36303317	记账信息组套:-:时间点:^患者:-	4182948
36303322	MDW Bld Auto	4180186
36303322	Auto; Automated detection; Blood; Elec; Elect; Electr; Entitic volume; HEMATOLOGY/CELL COUNTS; MDW; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
36303322	单核细胞分布宽度:实体体积:时间点:全血:定量型:自动化法	4182948
36303324	Eastern Cooperative Oncology Group; Everyday Cognition; Finding; Findings; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
36303325	Assessment; Cardio; Cardiology; DOC.ONT; Document; Encounter; Eval; Eval note; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; Heart Disease; History and physical; Initial eval note; Neuro; Neurology; notes; Point in time; Random; Vasc Neuro; Visit note	4180186
36303325	Vasc Neuro Initial eval note	4180186
36303325	初步评价记录:发现:时间点:{环境}:文档型:血管神经病学	4182948
36303327	Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; Enterobact gyrB+metB; ID; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; species; spp; WB; Whole blood	4180186
36303327	Enterobact gyrB+metB Bld Pos Ql Probe	4180186
